Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Ahmedabad,1.1,Total number of pregnant women Registered for ANC,TOTAL,13495.0,14288.0,15075.0,14065.0,12703.0,11389.0,11729.0,12859.0,13489.0,13632.0,11546.0,10423.0,154693.0
Ahmedabad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,8364.0,9099.0,9714.0,9325.0,8385.0,7312.0,7955.0,8995.0,8802.0,8565.0,7668.0,7077.0,101261.0
Ahmedabad,1.2,Number of Pregnant women registered under JSY,TOTAL,1862.0,1574.0,1895.0,1838.0,1562.0,1582.0,1535.0,1599.0,1553.0,1920.0,1592.0,1675.0,20187.0
Ahmedabad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,9980.0,11102.0,11158.0,12091.0,10351.0,9249.0,9563.0,11311.0,11357.0,11797.0,8497.0,8777.0,125233.0
Ahmedabad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,7472.0,8589.0,9070.0,8250.0,7677.0,6816.0,6763.0,7323.0,7333.0,7854.0,7428.0,7258.0,91833.0
Ahmedabad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,12949.0,15082.0,14839.0,13652.0,12531.0,13665.0,13478.0,13100.0,8211.0,9475.0,7502.0,9070.0,143554.0
Ahmedabad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,11344.0,14366.0,15321.0,12519.0,12322.0,10237.0,11767.0,13433.0,13272.0,12240.0,10447.0,11320.0,148588.0
Ahmedabad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,579.0,589.0,299.0,419.0,279.0,274.0,214.0,392.0,484.0,240.0,178.0,203.0,4150.0
Ahmedabad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,13.0,30.0,29.0,49.0,42.0,28.0,19.0,31.0,36.0,31.0,7.0,22.0,337.0
Ahmedabad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,6456.0,6758.0,5574.0,4917.0,4931.0,4813.0,4794.0,5508.0,5315.0,4976.0,4492.0,4389.0,62923.0
Ahmedabad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,246.0,236.0,86.0,72.0,53.0,43.0,34.0,55.0,66.0,41.0,52.0,59.0,1043.0
Ahmedabad,1.8,Number of pregnancy test kits used at SC level,TOTAL,490.0,428.0,358.0,216.0,351.0,480.0,475.0,559.0,537.0,566.0,471.0,293.0,5224.0
Ahmedabad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,255.0,333.0,235.0,325.0,310.0,316.0,225.0,234.0,223.0,202.0,286.0,264.0,3208.0
Ahmedabad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,17.0,113.0,25.0,24.0,22.0,16.0,9.0,8.0,4.0,2.0,148.0,4.0,392.0
Ahmedabad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,272.0,446.0,260.0,349.0,332.0,332.0,234.0,242.0,227.0,204.0,434.0,268.0,3600.0
Ahmedabad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,242.0,414.0,244.0,250.0,237.0,238.0,204.0,222.0,196.0,111.0,217.0,223.0,2798.0
Ahmedabad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,10.0,12.0,11.0,17.0,7.0,10.0,4.0,3.0,5.0,0.0,0.0,1.0,80.0
Ahmedabad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2777.0,3737.0,3984.0,4292.0,4718.0,3794.0,4186.0,5095.0,4365.0,4208.0,3587.0,3003.0,47746.0
Ahmedabad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,784.0,823.0,1001.0,1274.0,1892.0,1532.0,1390.0,1917.0,1245.0,1595.0,1453.0,1073.0,15979.0
Ahmedabad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,190.0,226.0,291.0,241.0,165.0,253.0,208.0,161.0,163.0,163.0,205.0,230.0,2496.0
Ahmedabad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,66.0,86.0,129.0,81.0,64.0,77.0,80.0,64.0,109.0,101.0,109.0,81.0,1047.0
Ahmedabad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,186.0,0.0,0.0,294.0,0.0,0.0,1.0,0.0,481.0
Ahmedabad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,5655.0,6525.0,6160.0,5221.0,7595.0,10345.0,9426.0,10526.0,9553.0,8794.0,6025.0,6298.0,92123.0
Ahmedabad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,320.0,183.0,235.0,125.0,75.0,125.0,154.0,214.0,203.0,0.0,0.0,0.0,1634.0
Ahmedabad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Ahmedabad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,4.0,6.0,11.0,8.0,23.0,90.0,15.0,41.0,20.0,18.0,26.0,9.0,271.0
Ahmedabad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,41.0,27.0,13.0,8.0,39.0,18.0,31.0,31.0,30.0,26.0,14.0,24.0,302.0
Ahmedabad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,439.0,610.0,693.0,570.0,658.0,606.0,695.0,860.0,925.0,937.0,749.0,586.0,8328.0
Ahmedabad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ahmedabad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,484.0,643.0,717.0,586.0,720.0,714.0,741.0,932.0,975.0,981.0,789.0,619.0,8901.0
Ahmedabad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,367.0,46.0,57.0,42.0,47.0,57.0,54.0,54.0,5762.0,5749.0,4153.0,2170.0,18558.0
Ahmedabad,4.1.1.a,Number of male live births,TOTAL,4621.0,5467.0,5554.0,5642.0,6609.0,7512.0,7214.0,8674.0,7662.0,7170.0,5218.0,5156.0,76499.0
Ahmedabad,4.1.1.b,Number of female live births,TOTAL,3949.0,5068.0,4872.0,4851.0,5930.0,6232.0,6486.0,7317.0,6583.0,6083.0,4588.0,4788.0,66747.0
Ahmedabad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,8570.0,10535.0,10426.0,10493.0,12539.0,13744.0,13700.0,15991.0,14245.0,13253.0,9806.0,9944.0,143246.0
Ahmedabad,4.1.2,Number of still births,TOTAL,111.0,121.0,125.0,145.0,108.0,122.0,110.0,122.0,127.0,93.0,75.0,102.0,1361.0
Ahmedabad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,186.0,192.0,224.0,128.0,161.0,160.0,218.0,181.0,225.0,225.0,251.0,260.0,2411.0
Ahmedabad,4.2.1,Number of Newborns weighed at birth,TOTAL,8561.0,10339.0,10312.0,10514.0,12476.0,13543.0,13473.0,15742.0,14260.0,12530.0,9476.0,9939.0,141165.0
Ahmedabad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,687.0,1214.0,1021.0,1155.0,1227.0,1384.0,1465.0,1591.0,1450.0,1005.0,1382.0,980.0,14561.0
Ahmedabad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,8333.0,10081.0,9758.0,9866.0,11848.0,13076.0,13261.0,15223.0,13736.0,12071.0,8853.0,9279.0,135385.0
Ahmedabad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,20.0,26.0,30.0,63.0,71.0,61.0,59.0,45.0,51.0,33.0,35.0,12.0,506.0
Ahmedabad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,106.0,115.0,97.0,128.0,104.0,184.0,170.0,75.0,156.0,118.0,122.0,131.0,1506.0
Ahmedabad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,460.0,241.0,433.0,371.0,474.0,248.0,326.0,327.0,249.0,266.0,253.0,205.0,3853.0
Ahmedabad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ahmedabad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,586.0,382.0,560.0,562.0,649.0,493.0,555.0,447.0,456.0,417.0,410.0,348.0,5865.0
Ahmedabad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,18.0,6.0,32.0,24.0,22.0,14.0,23.0,16.0,18.0,8.0,12.0,13.0,206.0
Ahmedabad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,798.0,1426.0,1816.0,728.0,846.0,675.0,1315.0,1290.0,975.0,805.0,847.0,1229.0,12750.0
Ahmedabad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,66.0,156.0,133.0,39.0,27.0,76.0,48.0,71.0,73.0,79.0,55.0,66.0,889.0
Ahmedabad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,730.0,1314.0,1706.0,594.0,1122.0,1045.0,1363.0,1128.0,1127.0,901.0,1280.0,1196.0,13506.0
Ahmedabad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,123.0,175.0,241.0,45.0,37.0,64.0,61.0,66.0,15.0,40.0,64.0,102.0,1033.0
Ahmedabad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,8995.0,9654.0,8646.0,10093.0,11595.0,11041.0,6644.0,7168.0,12867.0,11153.0,9535.0,8725.0,116116.0
Ahmedabad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,3448.0,4251.0,6620.0,6052.0,4752.0,5482.0,5883.0,6028.0,6057.0,6164.0,5009.0,4924.0,64670.0
Ahmedabad,6.3,PNC maternal complications attended,TOTAL,175.0,215.0,225.0,187.0,357.0,410.0,220.0,128.0,212.0,179.0,209.0,257.0,2774.0
Ahmedabad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,53.0,78.0,107.0,84.0,71.0,74.0,83.0,82.0,83.0,145.0,132.0,141.0,1133.0
Ahmedabad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,3.0,2.0,4.0,2.0,1.0,0.0,5.0,0.0,2.0,9.0,28.0
Ahmedabad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,53.0,78.0,110.0,86.0,75.0,76.0,84.0,82.0,88.0,145.0,134.0,150.0,1161.0
Ahmedabad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,2.0,3.0,9.0
Ahmedabad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,557.0,619.0,633.0,591.0,782.0,733.0,745.0,414.0,354.0,293.0,264.0,308.0,6293.0
Ahmedabad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1060.0,1303.0,1311.0,1234.0,1444.0,1429.0,1558.0,1290.0,1295.0,1006.0,1087.0,1120.0,15137.0
Ahmedabad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1617.0,1922.0,1944.0,1825.0,2226.0,2162.0,2303.0,1704.0,1649.0,1299.0,1351.0,1428.0,21430.0
Ahmedabad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,110.0,51.0,18.0,26.0,32.0,0.0,46.0,33.0,35.0,112.0,83.0,130.0,676.0
Ahmedabad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,8.0,15.0,4.0,38.0,22.0,10.0,10.0,18.0,19.0,22.0,54.0,33.0,253.0
Ahmedabad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,4.0,7.0
Ahmedabad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,2.0,0.0,3.0,0.0,1.0,11.0,3.0,0.0,1.0,0.0,1.0,22.0
Ahmedabad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ahmedabad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,8.0,17.0,4.0,43.0,22.0,12.0,21.0,21.0,19.0,23.0,54.0,38.0,282.0
Ahmedabad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Ahmedabad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,205.0,192.0,169.0,179.0,245.0,260.0,177.0,285.0,349.0,633.0,644.0,647.0,3985.0
Ahmedabad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,19.0,0.0,0.0,0.0,0.0,22.0
Ahmedabad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,59.0,101.0,54.0,68.0,61.0,58.0,926.0,93.0,102.0,126.0,156.0,111.0,1915.0
Ahmedabad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ahmedabad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,264.0,296.0,223.0,247.0,306.0,318.0,1103.0,397.0,451.0,759.0,800.0,758.0,5922.0
Ahmedabad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,588.0,649.0,781.0,775.0,713.0,862.0,1020.0,1119.0,951.0,806.0,1020.0,535.0,9819.0
Ahmedabad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,44.0,81.0,132.0,103.0,175.0,113.0,132.0,357.0,582.0,546.0,248.0,226.0,2739.0
Ahmedabad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,110.0,100.0,224.0,202.0,169.0,144.0,282.0,379.0,536.0,433.0,358.0,290.0,3227.0
Ahmedabad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,43.0,10.0,11.0,6.0,4.0,6.0,1242.0,36.0,45.0,47.0,36.0,18.0,1504.0
Ahmedabad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ahmedabad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,197.0,191.0,367.0,311.0,348.0,263.0,1656.0,772.0,1163.0,1026.0,642.0,534.0,7470.0
Ahmedabad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,1008.0,1131.0,1167.0,1597.0,1267.0,1234.0,1548.0,1606.0,1362.0,1246.0,1312.0,1143.0,15621.0
Ahmedabad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,8.0,13.0,32.0,31.0,29.0,18.0,12.0,33.0,27.0,53.0,13.0,9.0,278.0
Ahmedabad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,2.0,8.0,9.0,5.0,0.0,1.0,3.0,17.0,12.0,12.0,51.0,17.0,137.0
Ahmedabad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,6.0,59.0,53.0,59.0,89.0,61.0,70.0,122.0,116.0,72.0,58.0,71.0,836.0
Ahmedabad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ahmedabad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,16.0,80.0,94.0,95.0,118.0,80.0,85.0,172.0,155.0,137.0,122.0,97.0,1251.0
Ahmedabad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,5.0,12.0,9.0,20.0,10.0,13.0,42.0,3.0,19.0,73.0,46.0,28.0,280.0
Ahmedabad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1834.0,1977.0,2307.0,2247.0,2117.0,2040.0,1961.0,2099.0,2118.0,2045.0,2016.0,2591.0,25352.0
Ahmedabad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,2604.0,2899.0,3213.0,3271.0,3233.0,2846.0,2670.0,3466.0,2388.0,2255.0,2599.0,2379.0,33823.0
Ahmedabad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,35.0,48.0,79.0,64.0,64.0,69.0,41.0,76.0,54.0,55.0,32.0,220.0,837.0
Ahmedabad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,269.0,62.0,240.0,255.0,286.0,139.0,2295.0,1219.0,228.0,1501.0,267.0,607.0,7368.0
Ahmedabad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ahmedabad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,4742.0,4986.0,5839.0,5837.0,5700.0,5094.0,6967.0,6860.0,4788.0,5856.0,4914.0,5797.0,67380.0
Ahmedabad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,160.0,149.0,152.0,167.0,135.0,146.0,170.0,114.0,156.0,176.0,130.0,129.0,1784.0
Ahmedabad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,268.0,272.0,328.0,738.0,319.0,437.0,300.0,352.0,562.0,459.0,581.0,807.0,5423.0
Ahmedabad,9.06,Number of IUCD removals,TOTAL,791.0,876.0,875.0,1519.0,949.0,1092.0,799.0,859.0,909.0,874.0,850.0,880.0,11273.0
Ahmedabad,9.07,Number of Oral Pills cycles distributed,TOTAL,30038.0,32494.0,35517.0,47811.0,50433.0,53066.0,41445.0,59290.0,42370.0,30457.0,49887.0,47177.0,519985.0
Ahmedabad,9.08,Number of Condom pieces distributed,TOTAL,410072.0,461204.0,452631.0,551961.0,549290.0,503730.0,538518.0,646398.0,559258.0,465998.0,567696.0,537643.0,6244399.0
Ahmedabad,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,600.0,6.0,6.0,11.0,1221.0,3.0,3.0,4.0,1854.0
Ahmedabad,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,11.0,5.0,14.0,22.0,18.0,29.0,15.0,49.0,27.0,34.0,22.0,24.0,270.0
Ahmedabad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Ahmedabad,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,3.0
Ahmedabad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ahmedabad,9.12,Number of Institutions having NSV trained doctors,TOTAL,24.0,27.0,27.0,23.0,24.0,26.0,27.0,28.0,29.0,42.0,51.0,55.0,-1.0
Ahmedabad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,9934.0,11594.0,10094.0,9755.0,12536.0,9071.0,13626.0,15975.0,14342.0,9872.0,9343.0,13368.0,139510.0
Ahmedabad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,6.0,219.0,19.0,78.0,45.0,50.0,17.0,11.0,19.0,7.0,246.0,1423.0,2140.0
Ahmedabad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,11.0,178.0,11.0,80.0,39.0,50.0,16.0,12.0,13.0,13.0,182.0,1008.0,1613.0
Ahmedabad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,18.0,159.0,10.0,61.0,41.0,44.0,11.0,61.0,11.0,5.0,191.0,840.0,1452.0
Ahmedabad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,10244.0,10607.0,8940.0,9274.0,8763.0,8115.0,12471.0,14130.0,13413.0,9173.0,9013.0,10021.0,124164.0
Ahmedabad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,9891.0,10051.0,8474.0,8829.0,8474.0,7301.0,11432.0,13375.0,12557.0,8702.0,8945.0,10141.0,118172.0
Ahmedabad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,9880.0,10003.0,8339.0,8382.0,9712.0,7277.0,11003.0,12372.0,11614.0,8792.0,9504.0,10302.0,117180.0
Ahmedabad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,7685.0,9956.0,8279.0,7696.0,8713.0,7868.0,11998.0,14564.0,12954.0,8789.0,7995.0,14091.0,120588.0
Ahmedabad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,10244.0,10706.0,8968.0,9589.0,8742.0,8171.0,12826.0,14155.0,13468.0,9180.0,9006.0,9565.0,124620.0
Ahmedabad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,9891.0,9392.0,8496.0,8925.0,8427.0,7351.0,11522.0,14030.0,12587.0,8678.0,8937.0,8731.0,116967.0
Ahmedabad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,9875.0,10084.0,8468.0,8484.0,10226.0,7280.0,11045.0,12379.0,11645.0,8689.0,9514.0,10250.0,117939.0
Ahmedabad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1839.0,3081.0,2776.0,2478.0,4005.0,3156.0,6381.0,7474.0,7376.0,3595.0,3004.0,3075.0,48240.0
Ahmedabad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,103.0,846.0,168.0,190.0,323.0,10.0,379.0,57.0,13.0,6.0,5.0,62.0,2162.0
Ahmedabad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,117.0,280.0,168.0,174.0,233.0,11.0,267.0,26.0,7.0,8.0,5.0,69.0,1365.0
Ahmedabad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,133.0,252.0,199.0,159.0,212.0,6.0,237.0,28.0,5.0,5.0,7.0,61.0,1304.0
Ahmedabad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,10262.0,11009.0,9859.0,9319.0,8964.0,7825.0,9238.0,8829.0,11649.0,7831.0,7640.0,10066.0,112491.0
Ahmedabad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,8200.0,9767.0,8675.0,8290.0,7246.0,6950.0,7568.0,7643.0,7184.0,7270.0,7598.0,8616.0,95007.0
Ahmedabad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,5013.0,5779.0,5269.0,5391.0,4531.0,4351.0,5295.0,4657.0,4159.0,4630.0,4243.0,10059.0,63377.0
Ahmedabad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4436.0,5112.0,4719.0,4671.0,3963.0,3810.0,4687.0,4115.0,3899.0,4180.0,3607.0,8894.0,56093.0
Ahmedabad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,9449.0,10891.0,9988.0,10062.0,8494.0,8161.0,9982.0,8772.0,8058.0,8810.0,7850.0,18953.0,119470.0
Ahmedabad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,8430.0,9684.0,8959.0,8455.0,7154.0,6885.0,7046.0,7501.0,6870.0,7087.0,7521.0,8686.0,94278.0
Ahmedabad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,8189.0,9735.0,8989.0,8466.0,7188.0,6896.0,7066.0,7497.0,6928.0,7081.0,7543.0,8682.0,94260.0
Ahmedabad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2037.0,2537.0,2398.0,2344.0,2125.0,1954.0,2112.0,1931.0,1881.0,1914.0,1845.0,2089.0,25167.0
Ahmedabad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1745.0,2216.0,2142.0,2136.0,1940.0,1761.0,1784.0,1721.0,1598.0,1696.0,1598.0,1877.0,22214.0
Ahmedabad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3782.0,4753.0,4540.0,4480.0,4065.0,3715.0,3896.0,3652.0,3479.0,3610.0,3443.0,3966.0,47381.0
Ahmedabad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,3722.0,4529.0,4268.0,4333.0,4228.0,3717.0,3838.0,4946.0,5144.0,4848.0,4828.0,5481.0,53882.0
Ahmedabad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,3081.0,3481.0,3476.0,3911.0,3724.0,3194.0,3282.0,3930.0,3865.0,3985.0,3784.0,3828.0,43541.0
Ahmedabad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2714.0,3355.0,3579.0,3842.0,3787.0,3337.0,3342.0,3693.0,3693.0,3393.0,3144.0,2918.0,40797.0
Ahmedabad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,8.0,13.0,17.0,18.0,29.0,20.0,30.0,33.0,20.0,30.0,21.0,32.0,271.0
Ahmedabad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,41.0,50.0,65.0,55.0,75.0,61.0,46.0,48.0,47.0,44.0,39.0,70.0,641.0
Ahmedabad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2570.0,3616.0,3282.0,3402.0,3198.0,2882.0,3187.0,3397.0,3190.0,3064.0,3124.0,3321.0,38233.0
Ahmedabad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2383.0,3482.0,3183.0,3300.0,3035.0,2689.0,3047.0,3180.0,2872.0,2753.0,3015.0,3228.0,36167.0
Ahmedabad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2154.0,3021.0,2767.0,2866.0,2649.0,2426.0,2671.0,2875.0,2551.0,2487.0,2690.0,2778.0,31935.0
Ahmedabad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,7376.0,9487.0,9690.0,9597.0,10754.0,8275.0,8935.0,7960.0,7581.0,7323.0,12704.0,9762.0,109444.0
Ahmedabad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,4988.0,910.0,1041.0,1399.0,16270.0,8550.0,8753.0,7120.0,912.0,969.0,17545.0,20970.0,89427.0
Ahmedabad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,4064.0,924.0,457.0,1136.0,12247.0,7785.0,7791.0,6269.0,833.0,614.0,16093.0,19903.0,78116.0
Ahmedabad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,19.0,7.0,3.0,5.0,9.0,2.0,4.0,1.0,1.0,1.0,4.0,32.0,88.0
Ahmedabad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,1.0,3.0,2.0,1.0,2.0,2.0,1.0,2.0,4.0,3.0,0.0,21.0
Ahmedabad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Ahmedabad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,8.0
Ahmedabad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,8.0,10.0,3.0,0.0,2.0,0.0,8.0,1.0,1.0,2.0,13.0,50.0
Ahmedabad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1040.0,951.0,749.0,725.0,855.0,785.0,636.0,658.0,584.0,634.0,632.0,763.0,9012.0
Ahmedabad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,55.0,76.0,30.0,29.0,107.0,93.0,36.0,14.0,25.0,5.0,6.0,12.0,488.0
Ahmedabad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,313.0,191.0,178.0,134.0,173.0,204.0,181.0,278.0,271.0,188.0,840.0,373.0,3324.0
Ahmedabad,13.1,Number of Patients operated for cataract,TOTAL,267.0,220.0,41.0,226.0,267.0,268.0,18.0,341.0,410.0,354.0,376.0,301.0,3089.0
Ahmedabad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,264.0,209.0,37.0,223.0,260.0,266.0,6.0,208.0,260.0,232.0,288.0,284.0,2537.0
Ahmedabad,13.3,Number of School children detected with Refractive errors,TOTAL,710.0,240.0,979.0,3405.0,2342.0,2374.0,1072.0,1556.0,3084.0,818.0,817.0,1438.0,18835.0
Ahmedabad,13.4,Number of children provided free glasses,TOTAL,16.0,209.0,16.0,88.0,166.0,478.0,593.0,277.0,665.0,619.0,817.0,1454.0,5398.0
Ahmedabad,13.5,Number of eyes collected through eye donation,TOTAL,0.0,4.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Ahmedabad,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ahmedabad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,10.0,11.0,12.0,12.0,10.0,9.0,10.0,11.0,9.0,9.0,9.0,-1.0
Ahmedabad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,32.0,32.0,30.0,29.0,33.0,27.0,33.0,32.0,34.0,45.0,51.0,64.0,-1.0
Ahmedabad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,188.0,200.0,220.0,229.0,261.0,284.0,373.0,306.0,296.0,246.0,256.0,213.0,-1.0
Ahmedabad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,12.0,13.0,15.0,14.0,13.0,12.0,11.0,11.0,12.0,10.0,9.0,9.0,-1.0
Ahmedabad,14.05,Number of RKS meetings held during the month,TOTAL,11.0,9.0,13.0,17.0,11.0,21.0,10.0,10.0,12.0,16.0,13.0,17.0,160.0
Ahmedabad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,45.0,46.0,42.0,44.0,45.0,46.0,49.0,45.0,49.0,58.0,64.0,78.0,-1.0
Ahmedabad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,213.0,241.0,400.0,343.0,220.0,172.0,240.0,240.0,305.0,327.0,225.0,113.0,3039.0
Ahmedabad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,10.0,11.0,10.0,10.0,10.0,10.0,9.0,10.0,12.0,12.0,10.0,9.0,-1.0
Ahmedabad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,5.0,4.0,4.0,5.0,3.0,5.0,6.0,5.0,7.0,4.0,6.0,-1.0
Ahmedabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,708.0,513.0,806.0,797.0,611.0,997.0,757.0,614.0,688.0,815.0,929.0,1008.0,9243.0
Ahmedabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1731.0,1694.0,2386.0,2423.0,2373.0,3436.0,2794.0,2809.0,2294.0,2605.0,3135.0,3118.0,30798.0
Ahmedabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,526.0,409.0,516.0,598.0,520.0,715.0,649.0,623.0,577.0,663.0,699.0,731.0,7226.0
Ahmedabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3837.0,3543.0,5543.0,5363.0,4978.0,6037.0,4614.0,4491.0,4854.0,5084.0,5569.0,5070.0,58983.0
Ahmedabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1234.0,922.0,1322.0,1395.0,1131.0,1712.0,1406.0,1237.0,1265.0,1478.0,1628.0,1739.0,16469.0
Ahmedabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5568.0,5237.0,7929.0,7786.0,7351.0,9473.0,7408.0,7300.0,7148.0,7689.0,8704.0,8188.0,89781.0
Ahmedabad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,66.0,10.0,69.0,46.0,46.0,47.0,56.0,62.0,47.0,103.0,89.0,69.0,710.0
Ahmedabad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,42.0,7.0,58.0,32.0,43.0,40.0,46.0,52.0,39.0,91.0,60.0,53.0,563.0
Ahmedabad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,108.0,17.0,127.0,78.0,89.0,87.0,102.0,114.0,86.0,194.0,149.0,122.0,1273.0
Ahmedabad,14.11,In-Patient Head Count at midnight,TOTAL,18776.0,7732.0,18749.0,17078.0,19199.0,19061.0,17158.0,19528.0,17738.0,15128.0,15166.0,15421.0,200734.0
Ahmedabad,14.12.1,OPD attendance (All),TOTAL,176727.0,153347.0,183541.0,193968.0,236905.0,232167.0,211324.0,243516.0,226488.0,191947.0,310976.0,312588.0,2673494.0
Ahmedabad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,953.0,716.0,1157.0,1184.0,1032.0,1292.0,977.0,1333.0,1459.0,1507.0,1041.0,1183.0,13834.0
Ahmedabad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,476.0,112.0,457.0,41.0,0.0,122.0,77.0,90.0,203.0,433.0,424.0,91.0,2526.0
Ahmedabad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,264.0,334.0,315.0,776.0,737.0,676.0,619.0,730.0,906.0,506.0,398.0,757.0,7018.0
Ahmedabad,14.14.a,Number of patients given AYUSH treatment,TOTAL,1231.0,1378.0,1331.0,1358.0,1383.0,1588.0,1563.0,2315.0,2453.0,2698.0,2881.0,2927.0,23106.0
Ahmedabad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,468.0,439.0,368.0,416.0,397.0,123.0,197.0,351.0,718.0,211.0,360.0,323.0,4371.0
Ahmedabad,14.14.c,Number of Adolescents counselled,TOTAL,823.0,742.0,606.0,645.0,722.0,482.0,442.0,644.0,902.0,391.0,310.0,355.0,7064.0
Ahmedabad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,16159.0,21953.0,16341.0,19174.0,19314.0,20794.0,17603.0,19622.0,21123.0,17561.0,24628.0,24898.0,239170.0
Ahmedabad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,290.0,390.0,266.0,817.0,193.0,398.0,376.0,495.0,383.0,327.0,301.0,370.0,4606.0
Ahmedabad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,3431.0,4989.0,4464.0,4800.0,3108.0,4514.0,4576.0,4533.0,3946.0,3705.0,3384.0,4201.0,49651.0
Ahmedabad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,64.0,74.0,96.0,91.0,75.0,224.0,75.0,90.0,79.0,469.0,552.0,692.0,2581.0
Ahmedabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2241.0,2799.0,1993.0,2519.0,2000.0,3311.0,3151.0,3746.0,3810.0,3745.0,2706.0,2866.0,34887.0
Ahmedabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,12.0,23.0,13.0,19.0,17.0,38.0,19.0,16.0,31.0,204.0,266.0,356.0,1014.0
Ahmedabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,5485.0,6652.0,6636.0,5208.0,4373.0,4812.0,3915.0,5617.0,5746.0,5496.0,5258.0,5919.0,65117.0
Ahmedabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,62.0,57.0,57.0,85.0,812.0,94.0,364.0,67.0,4.0,283.0,591.0,616.0,3092.0
Ahmedabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,11157.0,14440.0,13093.0,12527.0,9481.0,12637.0,11642.0,13896.0,13502.0,12946.0,11348.0,12986.0,149655.0
Ahmedabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,138.0,154.0,166.0,195.0,904.0,356.0,458.0,173.0,114.0,956.0,1409.0,1664.0,6687.0
Ahmedabad,15.2,Number of Widal tests conducted,Number tested,1277.0,2269.0,692.0,818.0,1084.0,1622.0,1501.0,1733.0,1442.0,1231.0,1313.0,1591.0,16573.0
Ahmedabad,15.3.a,Number of VDRL tests conducted on males,Number tested,651.0,485.0,147.0,176.0,174.0,190.0,358.0,415.0,348.0,984.0,1524.0,1112.0,6564.0
Ahmedabad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,251.0,637.0,183.0,281.0,277.0,216.0,242.0,275.0,238.0,186.0,295.0,963.0,4044.0
Ahmedabad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1416.0,2271.0,1526.0,608.0,1016.0,872.0,1038.0,1724.0,2107.0,2167.0,2077.0,3121.0,19943.0
Ahmedabad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2318.0,3393.0,1856.0,1065.0,1467.0,1278.0,1638.0,2414.0,2693.0,3337.0,3896.0,5196.0,30551.0
Ahmedabad,15.4.1,Number of blood smears examined for Malaria,TOTAL,45661.0,47803.0,50509.0,48669.0,63885.0,56997.0,43095.0,46609.0,44627.0,32819.0,48513.0,46743.0,575930.0
Ahmedabad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1175.0,953.0,1018.0,241.0,471.0,1969.0,956.0,1001.0,223.0,41.0,351.0,44.0,8443.0
Ahmedabad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,27.0,37.0,7.0,6.0,60.0,147.0,94.0,113.0,119.0,22.0,7.0,4.0,643.0
Ahmedabad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3500.0,5000.0,2500.0,3500.0,7000.0,11000.0,4500.0,1500.0,5500.0,9500.0,4000.0,4500.0,62000.0
Ahmedabad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,5000.0,5000.0,7500.0,10500.0,12500.0,7500.0,0.0,12000.0,8000.0,0.0,10000.0,24000.0,102000.0
Ahmedabad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3500.0,7500.0,6500.0,7000.0,8500.0,14000.0,3000.0,8000.0,4000.0,5500.0,9500.0,9500.0,86500.0
Ahmedabad,16.1.1,Stock position of DPT vaccines,5. Total Stock,5000.0,2500.0,3500.0,7000.0,11000.0,4500.0,1500.0,5500.0,9500.0,4000.0,4500.0,19000.0,77500.0
Ahmedabad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,22500.0,27000.0,25000.0,11000.0,19000.0,27000.0,15000.0,8500.0,20500.0,16500.0,14000.0,17500.0,223500.0
Ahmedabad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,12000.0,12000.0,0.0,18000.0,15000.0,0.0,0.0,24000.0,0.0,0.0,15000.0,12000.0,108000.0
Ahmedabad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,7500.0,14000.0,14000.0,10000.0,7000.0,12000.0,6500.0,12000.0,4000.0,2500.0,11500.0,11500.0,112500.0
Ahmedabad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,27000.0,25000.0,11000.0,19000.0,27000.0,15000.0,8500.0,20500.0,16500.0,14000.0,17500.0,18000.0,219000.0
Ahmedabad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,6500.0,29000.0,15000.0,6500.0,500.0,15500.0,2200.0,2000.0,400.0,15500.0,1500.0,14500.0,109100.0
Ahmedabad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,30000.0,0.0,10000.0,7000.0,45000.0,7000.0,10000.0,10000.0,35000.0,363000.0,405000.0,20000.0,942000.0
Ahmedabad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7500.0,14000.0,18500.0,13000.0,30000.0,20300.0,10200.0,11600.0,19900.0,377000.0,392000.0,15500.0,929500.0
Ahmedabad,16.1.2,Stock position of OPV vaccines,5. Total Stock,29000.0,15000.0,6500.0,500.0,15500.0,2200.0,2000.0,400.0,15500.0,1500.0,14500.0,19000.0,121600.0
Ahmedabad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,18000.0,15500.0,23500.0,18500.0,13500.0,24000.0,16500.0,22000.0,11500.0,22500.0,15500.0,15500.0,216500.0
Ahmedabad,16.1.3,Stock position of TT vaccines,2. Stocks Received,5000.0,20000.0,10000.0,8000.0,12000.0,8000.0,10000.0,0.0,20000.0,0.0,15000.0,10000.0,118000.0
Ahmedabad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,7500.0,12000.0,15000.0,13000.0,1500.0,15500.0,4500.0,10500.0,9000.0,7000.0,15000.0,15000.0,125500.0
Ahmedabad,16.1.3,Stock position of TT vaccines,5. Total Stock,15500.0,23500.0,18500.0,13500.0,24000.0,16500.0,22000.0,11500.0,22500.0,15500.0,15500.0,10500.0,209000.0
Ahmedabad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1200.0,6700.0,6300.0,3100.0,1100.0,2000.0,9500.0,7500.0,9300.0,21300.0,15800.0,19800.0,103600.0
Ahmedabad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,7000.0,5000.0,5500.0,6000.0,20000.0,5000.0,10000.0,20000.0,0.0,15000.0,0.0,103500.0
Ahmedabad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4500.0,7400.0,8200.0,7500.0,5100.0,12500.0,7000.0,8200.0,8000.0,5500.0,11000.0,10800.0,95700.0
Ahmedabad,16.1.5,Stock position of BCG vaccines,5. Total Stock,6700.0,6300.0,3100.0,1100.0,2000.0,9500.0,7500.0,9300.0,21300.0,15800.0,19800.0,9000.0,111400.0
Ahmedabad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,150.0,1500.0,3900.0,1250.0,3500.0,250.0,3500.0,750.0,4000.0,10000.0,6250.0,12750.0,47800.0
Ahmedabad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,5250.0,5000.0,11000.0,1000.0,15000.0,0.0,10000.0,10000.0,0.0,15000.0,10000.0,87250.0
Ahmedabad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3650.0,2850.0,7650.0,8750.0,4250.0,11750.0,2750.0,6750.0,4000.0,3750.0,8500.0,8000.0,72650.0
Ahmedabad,16.1.6,Stock position of Measles vaccines,5. Total Stock,1500.0,3900.0,1250.0,3500.0,250.0,3500.0,750.0,4000.0,10000.0,6250.0,12750.0,14750.0,62400.0
Ahmedabad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3000.0,27000.0,1500.0,900.0,1500.0,2700.0,1500.0,2400.0,2400.0,2100.0,1200.0,2700.0,48900.0
Ahmedabad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,12000.0,0.0,1500.0,3000.0,0.0,1500.0,2100.0,0.0,0.0,3000.0,0.0,23100.0
Ahmedabad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,300.0,14000.0,600.0,900.0,1800.0,1200.0,600.0,2100.0,300.0,900.0,1500.0,2100.0,26300.0
Ahmedabad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2700.0,25000.0,900.0,1500.0,2700.0,1500.0,2400.0,2400.0,2100.0,1200.0,2700.0,600.0,45700.0
Ahmedabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,9000.0,0.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10200.0
Ahmedabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,9000.0,0.0,16800.0,0.0,0.0,0.0,0.0,600.0,0.0,0.0,438480.0,464880.0
Ahmedabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,9000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0
Ahmedabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,15600.0,1200.0,0.0,0.0,0.0,600.0,0.0,0.0,438480.0,455880.0
Ahmedabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,9000.0,0.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10200.0
Ahmedabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,502140.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,502140.0
Ahmedabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1046460.0,0.0,0.0,0.0,6000.0,6000.0,0.0,0.0,0.0,1058460.0
Ahmedabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,544320.0,502140.0,0.0,0.0,6000.0,6000.0,0.0,0.0,0.0,1058460.0
Ahmedabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,502140.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,502140.0
Ahmedabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,51600.0,0.0,0.0,0.0,1000.0,1000.0,0.0,0.0,0.0,53600.0
Ahmedabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,51600.0,0.0,0.0,0.0,1000.0,1000.0,0.0,0.0,0.0,53600.0
Ahmedabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0
Ahmedabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0
Ahmedabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,2700.0,1300.0,500.0,500.0,300.0,300.0,200.0,200.0,200.0,6200.0
Ahmedabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,3300.0,0.0,0.0,0.0,0.0,500.0,0.0,0.0,0.0,0.0,3800.0
Ahmedabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,100.0
Ahmedabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,600.0,1400.0,800.0,0.0,200.0,500.0,,0.0,0.0,0.0,3500.0
Ahmedabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,2700.0,1300.0,500.0,500.0,300.0,300.0,200.0,200.0,200.0,200.0,6400.0
Ahmedabad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,6600.0,16400.0,5900.0,2600.0,2600.0,2600.0,7600.0,5800.0,800.0,800.0,51700.0
Ahmedabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,6600.0,26400.0,0.0,0.0,0.0,0.0,6600.0,0.0,0.0,0.0,13200.0,52800.0
Ahmedabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,16600.0,10500.0,3300.0,0.0,0.0,1600.0,1800.0,5000.0,0.0,10900.0,49700.0
Ahmedabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,6600.0,16400.0,5900.0,2600.0,2600.0,2600.0,7600.0,5800.0,800.0,800.0,3100.0,54800.0
Ahmedabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,6000.0,6000.0,93000.0,0.0,0.0,0.0,0.0,0.0,180000.0,0.0,0.0,0.0,285000.0
Ahmedabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,93000.0,0.0,0.0,0.0,0.0,0.0,180000.0,0.0,0.0,0.0,240000.0,513000.0
Ahmedabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,6000.0,6000.0,93000.0,0.0,0.0,0.0,0.0,0.0,180000.0,0.0,0.0,240000.0,525000.0
Ahmedabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,93000.0,0.0,0.0,0.0,0.0,0.0,180000.0,0.0,0.0,0.0,0.0,273000.0
Ahmedabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,24000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24000.0
Ahmedabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,24000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24000.0
Ahmedabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,24000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24000.0
Ahmedabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ahmedabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,24000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24000.0
Ahmedabad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,1.0,,1.0,1.0,1.0,2.0,,4.0,,,2.0,13.0
Ahmedabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,2.0,,,,,,1.0,,3.0
Ahmedabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ahmedabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,2.0,,,,,,1.0,,3.0
Ahmedabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,6.0,2.0,,3.0,1.0,,2.0,1.0,,,16.0
Ahmedabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,,1.0
Ahmedabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,6.0,2.0,,3.0,1.0,,2.0,2.0,,,17.0
Ahmedabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,9.0,9.0,5.0,2.0,4.0,5.0,3.0,3.0,7.0,2.0,3.0,3.0,55.0
Ahmedabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,,,,,1.0,1.0,,,,3.0
Ahmedabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,9.0,9.0,6.0,2.0,4.0,5.0,3.0,4.0,8.0,2.0,3.0,3.0,58.0
Ahmedabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,3.0,8.0,6.0,4.0,6.0,13.0,4.0,3.0,4.0,7.0,6.0,65.0
Ahmedabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,,,1.0,3.0,,,,,,5.0
Ahmedabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,3.0,9.0,6.0,4.0,7.0,16.0,4.0,3.0,4.0,7.0,6.0,70.0
Ahmedabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,1.0,,1.0,,,,,,3.0
Ahmedabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,,,,2.0,,1.0,4.0
Ahmedabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,1.0,1.0,,1.0,,,2.0,,1.0,7.0
Ahmedabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,1.0,,1.0
Ahmedabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ahmedabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,1.0,,1.0
Ahmedabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,2.0,,1.0,,1.0,4.0
Ahmedabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,1.0,,1.0,2.0
Ahmedabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,2.0,,2.0,,2.0,6.0
Ahmedabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Ahmedabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ahmedabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,1.0,,,,,,,,,,,,1.0
Ahmedabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,6.0,6.0,4.0,5.0,7.0,3.0,10.0,3.0,4.0,5.0,5.0,5.0,63.0
Ahmedabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,1.0,1.0,1.0,2.0,4.0,,,2.0,2.0,,15.0
Ahmedabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,8.0,5.0,6.0,8.0,5.0,14.0,3.0,4.0,7.0,7.0,5.0,78.0
Ahmedabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,1.0,,,,,,,1.0,1.0,1.0,4.0
Ahmedabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,1.0,,,,,,1.0,7.0,1.0,1.0,11.0
Ahmedabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,2.0,,,,,,1.0,8.0,2.0,2.0,15.0
Ahmedabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,2.0,1.0,,2.0,,2.0,,,13.0,13.0,16.0,49.0
Ahmedabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,2.0,2.0,1.0,2.0,,,2.0,,5.0,6.0,10.0,31.0
Ahmedabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,4.0,3.0,1.0,4.0,,2.0,2.0,,18.0,19.0,26.0,80.0
Ahmedabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Ahmedabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,1.0,4.0,1.0,3.0,1.0,2.0,3.0,1.0,15.0,11.0,11.0,55.0
Ahmedabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,2.0,3.0,2.0,5.0,7.0,5.0,3.0,6.0,33.0,21.0,20.0,109.0
Ahmedabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,4.0,3.0,7.0,3.0,8.0,8.0,7.0,6.0,7.0,48.0,32.0,32.0,165.0
Ahmedabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,4.0,3.0,,1.0,,,8.0
Ahmedabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,4.0,,1.0,5.0
Ahmedabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,4.0,3.0,,5.0,,1.0,13.0
Ahmedabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,5.0,1.0,1.0,7.0
Ahmedabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,,,,,,,11.0,1.0,2.0,15.0
Ahmedabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,,,,,,,16.0,2.0,3.0,22.0
Ahmedabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,1.0,,,,,,,,,2.0,1.0,,4.0
Ahmedabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Ahmedabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,,,,,,,,,2.0,1.0,,4.0
Ahmedabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,2.0,,2.0
Ahmedabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,5.0,14.0,8.0,5.0,7.0,10.0,2.0,5.0,51.0,50.0,65.0,227.0
Ahmedabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,7.0,11.0,5.0,7.0,1.0,8.0,4.0,6.0,121.0,91.0,111.0,375.0
Ahmedabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,8.0,12.0,25.0,13.0,12.0,8.0,18.0,6.0,11.0,172.0,143.0,176.0,604.0
Ahmedabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,2.0,2.0
Ahmedabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,2.0,2.0,,1.0,,,,,4.0,2.0,5.0,16.0
Ahmedabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,4.0,3.0,6.0,13.0
Ahmedabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,2.0,,1.0,,,,,8.0,5.0,13.0,31.0
Ahmedabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Ahmedabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Ahmedabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Ahmedabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Ahmedabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,2.0,1.0,3.0
Ahmedabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Ahmedabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,2.0,1.0,3.0
Ahmedabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,1.0,,,1.0,2.0
Ahmedabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Ahmedabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,1.0,,,1.0,2.0
Ahmedabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,1.0,,1.0,2.0
Ahmedabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Ahmedabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,1.0,,1.0,2.0
Ahmedabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,,,,,,28.0,12.0,10.0,51.0
Ahmedabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Ahmedabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,,,,,,28.0,12.0,10.0,51.0
Ahmedabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,1.0,,1.0,,1.0,1.0,,,3.0,8.0
Ahmedabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,11.0,12.0,,5.0,4.0,4.0,3.0,2.0,3.0,7.0,10.0,66.0
Ahmedabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,2.0,,1.0,1.0,3.0,2.0,2.0,,2.0,3.0,17.0
Ahmedabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,12.0,15.0,1.0,6.0,6.0,7.0,6.0,5.0,3.0,9.0,16.0,91.0
Ahmedabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,,,,,,1.0,2.0
Ahmedabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,2.0,3.0,,2.0,3.0,2.0,1.0,2.0,15.0,6.0,6.0,44.0
Ahmedabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,1.0,1.0,,,,1.0,,1.0,4.0
Ahmedabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,2.0,3.0,,3.0,5.0,2.0,1.0,2.0,16.0,6.0,8.0,50.0
Ahmedabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Ahmedabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,,,,,1.0,,,1.0,,4.0
Ahmedabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,2.0,,,,,,1.0,,3.0
Ahmedabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,2.0,1.0,,2.0,,,1.0,,,2.0,,8.0
Ahmedabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Ahmedabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,1.0,,,,,,1.0,,5.0,2.0,5.0,15.0
Ahmedabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,1.0,1.0,,,,,,2.0,5.0,3.0,13.0
Ahmedabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,2.0,1.0,1.0,,,,1.0,,7.0,7.0,8.0,28.0
Ahmedabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Ahmedabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,2.0,1.0,2.0,2.0,3.0,4.0,,,9.0,11.0,13.0,47.0
Ahmedabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,1.0,3.0,,,15.0,27.0,24.0,70.0
Ahmedabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,2.0,1.0,2.0,2.0,4.0,7.0,,,24.0,39.0,37.0,118.0
Ahmedabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,2.0,4.0,2.0,,1.0,1.0,,,1.0,4.0,4.0,21.0
Ahmedabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,11.0,11.0,15.0,7.0,13.0,5.0,9.0,5.0,8.0,101.0,94.0,120.0,399.0
Ahmedabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,19.0,27.0,17.0,15.0,15.0,12.0,25.0,26.0,12.0,390.0,393.0,405.0,1356.0
Ahmedabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,32.0,40.0,36.0,24.0,28.0,18.0,35.0,31.0,20.0,492.0,491.0,529.0,1776.0
Amreli,1.1,Total number of pregnant women Registered for ANC,TOTAL,2876.0,2800.0,3075.0,3078.0,2884.0,3477.0,3049.0,3117.0,2937.0,3001.0,2988.0,2984.0,36266.0
Amreli,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2226.0,2148.0,2364.0,2339.0,2211.0,2544.0,2235.0,2340.0,2155.0,2233.0,2178.0,2095.0,27068.0
Amreli,1.2,Number of Pregnant women registered under JSY,TOTAL,882.0,832.0,912.0,1093.0,905.0,978.0,1156.0,1267.0,1136.0,819.0,1153.0,1151.0,12284.0
Amreli,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2205.0,2247.0,2652.0,2528.0,2544.0,2824.0,2483.0,2507.0,2447.0,2654.0,2394.0,2325.0,29810.0
Amreli,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2194.0,2393.0,2701.0,2699.0,2686.0,2866.0,2556.0,2715.0,2584.0,2546.0,2499.0,2535.0,30974.0
Amreli,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2546.0,2732.0,2977.0,3011.0,2961.0,2930.0,2902.0,2825.0,2715.0,2661.0,2762.0,2642.0,33664.0
Amreli,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2687.0,2766.0,3236.0,3024.0,3370.0,3172.0,2973.0,3166.0,2737.0,3104.0,3161.0,3254.0,36650.0
Amreli,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,15.0,8.0,36.0,32.0,29.0,22.0,17.0,26.0,64.0,13.0,21.0,16.0,299.0
Amreli,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,1.0,0.0,4.0,6.0,5.0,6.0,4.0,2.0,4.0,7.0,11.0,50.0
Amreli,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1409.0,1416.0,1718.0,1547.0,1631.0,1612.0,1494.0,1508.0,1446.0,1349.0,1156.0,1417.0,17703.0
Amreli,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,13.0,31.0,84.0,21.0,13.0,23.0,95.0,89.0,17.0,47.0,6.0,16.0,455.0
Amreli,1.8,Number of pregnancy test kits used at SC level,TOTAL,55.0,75.0,66.0,95.0,131.0,114.0,77.0,113.0,140.0,124.0,114.0,44.0,1148.0
Amreli,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,47.0,52.0,51.0,85.0,64.0,86.0,61.0,68.0,46.0,70.0,41.0,34.0,705.0
Amreli,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,42.0,35.0,32.0,30.0,37.0,46.0,45.0,55.0,58.0,33.0,22.0,29.0,464.0
Amreli,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,89.0,87.0,83.0,115.0,101.0,132.0,106.0,123.0,104.0,103.0,63.0,63.0,1169.0
Amreli,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,75.0,72.0,69.0,103.0,85.0,117.0,93.0,94.0,91.0,90.0,61.0,55.0,1005.0
Amreli,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,7.0,7.0,9.0,5.0,25.0,16.0,20.0,15.0,20.0,11.0,6.0,11.0,152.0
Amreli,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,804.0,830.0,930.0,1081.0,1070.0,992.0,1162.0,1223.0,1201.0,1017.0,884.0,797.0,11991.0
Amreli,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,670.0,699.0,773.0,826.0,854.0,826.0,939.0,879.0,925.0,792.0,681.0,681.0,9545.0
Amreli,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,22.0,19.0,33.0,46.0,12.0,168.0,67.0,91.0,77.0,63.0,59.0,80.0,737.0
Amreli,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,1.0,2.0,0.0,0.0,2.0,20.0,0.0,41.0,0.0,37.0,1.0,104.0
Amreli,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1418.0,1149.0,1504.0,1131.0,1244.0,1500.0,1399.0,1438.0,1436.0,1478.0,1377.0,1381.0,16455.0
Amreli,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,4.0,2.0,7.0,0.0,33.0,13.0,0.0,1.0,10.0,15.0,85.0
Amreli,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,15.0,16.0,10.0,6.0,16.0,16.0,19.0,17.0,18.0,24.0,12.0,18.0,187.0
Amreli,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amreli,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,15.0,16.0,14.0,8.0,23.0,16.0,52.0,30.0,18.0,25.0,22.0,33.0,272.0
Amreli,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,12.0,0.0,0.0,23.0,39.0,26.0,33.0,16.0,11.0,160.0
Amreli,4.1.1.a,Number of male live births,TOTAL,1148.0,1068.0,1287.0,1225.0,1219.0,1294.0,1389.0,1461.0,1394.0,1366.0,1242.0,1157.0,15250.0
Amreli,4.1.1.b,Number of female live births,TOTAL,1127.0,997.0,1203.0,1064.0,1138.0,1195.0,1216.0,1309.0,1296.0,1201.0,1084.0,1098.0,13928.0
Amreli,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2275.0,2065.0,2490.0,2289.0,2357.0,2489.0,2605.0,2770.0,2690.0,2567.0,2326.0,2255.0,29178.0
Amreli,4.1.2,Number of still births,TOTAL,15.0,15.0,19.0,11.0,32.0,27.0,24.0,27.0,27.0,23.0,24.0,12.0,256.0
Amreli,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,41.0,36.0,51.0,51.0,75.0,62.0,45.0,56.0,47.0,59.0,57.0,45.0,625.0
Amreli,4.2.1,Number of Newborns weighed at birth,TOTAL,2018.0,2041.0,2251.0,1970.0,2099.0,2171.0,2328.0,2144.0,2388.0,2241.0,2051.0,2060.0,25762.0
Amreli,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,64.0,70.0,77.0,54.0,77.0,107.0,154.0,112.0,122.0,109.0,82.0,77.0,1105.0
Amreli,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2168.0,2078.0,2278.0,1987.0,2069.0,2180.0,2377.0,2182.0,2402.0,2276.0,2045.0,2095.0,26137.0
Amreli,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Amreli,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,11.0,22.0,26.0,35.0,41.0,47.0,38.0,54.0,30.0,24.0,11.0,5.0,344.0
Amreli,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,133.0,87.0,84.0,83.0,126.0,160.0,139.0,115.0,119.0,123.0,148.0,140.0,1457.0
Amreli,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amreli,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,151.0,109.0,110.0,118.0,167.0,207.0,177.0,169.0,149.0,147.0,159.0,145.0,1808.0
Amreli,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,12.0,11.0,10.0,14.0,14.0,12.0,18.0,14.0,20.0,0.0,0.0,0.0,125.0
Amreli,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,171.0,88.0,103.0,147.0,190.0,246.0,322.0,314.0,164.0,124.0,168.0,204.0,2241.0
Amreli,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,37.0,44.0,43.0,59.0,112.0,89.0,61.0,76.0,60.0,62.0,15.0,15.0,673.0
Amreli,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,136.0,113.0,107.0,118.0,185.0,290.0,470.0,359.0,292.0,152.0,166.0,192.0,2580.0
Amreli,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,36.0,41.0,65.0,53.0,54.0,77.0,77.0,69.0,95.0,60.0,45.0,40.0,712.0
Amreli,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2014.0,1863.0,1975.0,2108.0,2041.0,1960.0,2146.0,2256.0,2222.0,1882.0,1646.0,1963.0,24076.0
Amreli,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2120.0,2044.0,2344.0,2117.0,2194.0,2256.0,2354.0,2578.0,2314.0,2284.0,1954.0,2009.0,26568.0
Amreli,6.3,PNC maternal complications attended,TOTAL,14.0,10.0,4.0,13.0,15.0,22.0,23.0,26.0,3.0,2.0,3.0,2.0,137.0
Amreli,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,8.0,8.0,6.0,2.0,4.0,6.0,2.0,9.0,0.0,0.0,7.0,53.0
Amreli,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Amreli,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2.0,8.0,8.0,6.0,2.0,4.0,6.0,3.0,9.0,0.0,0.0,7.0,55.0
Amreli,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,48.0,47.0,47.0,54.0,39.0,26.0,26.0,27.0,47.0,27.0,45.0,51.0,484.0
Amreli,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,139.0,132.0,154.0,139.0,131.0,94.0,91.0,60.0,101.0,101.0,106.0,141.0,1389.0
Amreli,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,187.0,179.0,201.0,193.0,170.0,120.0,117.0,87.0,148.0,128.0,151.0,192.0,1873.0
Amreli,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,0.0,0.0,0.0,11.0
Amreli,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amreli,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,13.0,9.0,14.0,9.0,10.0,1.0,7.0,13.0,5.0,3.0,2.0,7.0,93.0
Amreli,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,6.0,4.0,8.0,9.0,17.0,0.0,0.0,0.0,0.0,0.0,0.0,44.0
Amreli,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amreli,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,13.0,15.0,18.0,17.0,19.0,18.0,7.0,13.0,5.0,3.0,2.0,7.0,137.0
Amreli,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,11.0,21.0,12.0,12.0,11.0,18.0,20.0,39.0,21.0,43.0,31.0,16.0,255.0
Amreli,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,261.0,227.0,242.0,179.0,113.0,203.0,160.0,278.0,244.0,289.0,276.0,272.0,2744.0
Amreli,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,130.0,106.0,171.0,111.0,67.0,118.0,110.0,116.0,218.0,188.0,155.0,79.0,1569.0
Amreli,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,97.0,88.0,38.0,92.0,71.0,152.0,52.0,175.0,157.0,134.0,88.0,81.0,1225.0
Amreli,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amreli,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,488.0,421.0,451.0,382.0,251.0,473.0,322.0,569.0,619.0,611.0,519.0,432.0,5538.0
Amreli,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,71.0,94.0,80.0,109.0,93.0,125.0,107.0,110.0,170.0,193.0,147.0,166.0,1465.0
Amreli,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,10.0,0.0,0.0,31.0,32.0,24.0,29.0,0.0,0.0,0.0,126.0
Amreli,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,26.0,39.0,20.0,18.0,14.0,13.0,55.0,57.0,22.0,24.0,26.0,22.0,336.0
Amreli,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,5.0,5.0,2.0,2.0,3.0,6.0,2.0,3.0,5.0,5.0,3.0,5.0,46.0
Amreli,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amreli,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,31.0,44.0,32.0,20.0,17.0,50.0,89.0,84.0,56.0,29.0,29.0,27.0,508.0
Amreli,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,3.0,0.0,2.0,7.0,0.0,14.0,7.0,0.0,5.0,6.0,2.0,2.0,48.0
Amreli,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1196.0,1235.0,1400.0,1547.0,1459.0,1493.0,1346.0,1345.0,1404.0,1255.0,1116.0,1064.0,15860.0
Amreli,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,216.0,326.0,298.0,70.0,61.0,66.0,46.0,84.0,93.0,26.0,127.0,110.0,1523.0
Amreli,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,111.0,120.0,100.0,95.0,97.0,84.0,99.0,56.0,90.0,119.0,104.0,107.0,1182.0
Amreli,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,197.0,242.0,47.0,304.0,253.0,271.0,76.0,135.0,109.0,76.0,231.0,227.0,2168.0
Amreli,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amreli,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1720.0,1923.0,1845.0,2016.0,1870.0,1914.0,1567.0,1620.0,1696.0,1476.0,1578.0,1508.0,20733.0
Amreli,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,9.0,6.0,10.0,20.0,16.0,21.0,15.0,26.0,47.0,61.0,109.0,126.0,466.0
Amreli,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,50.0,50.0,76.0,53.0,279.0
Amreli,9.06,Number of IUCD removals,TOTAL,462.0,385.0,445.0,380.0,443.0,478.0,413.0,433.0,458.0,426.0,415.0,409.0,5147.0
Amreli,9.07,Number of Oral Pills cycles distributed,TOTAL,3268.0,2890.0,3675.0,3070.0,3605.0,3697.0,3866.0,4038.0,4181.0,4259.0,4161.0,4441.0,45151.0
Amreli,9.08,Number of Condom pieces distributed,TOTAL,36484.0,33644.0,39982.0,42692.0,55733.0,45988.0,44194.0,47285.0,49854.0,45261.0,41614.0,46405.0,529136.0
Amreli,9.09,Number of Centchroman (weekly) pills given,TOTAL,56.0,2.0,27.0,3.0,11.0,37.0,48.0,316.0,784.0,12.0,157.0,61.0,1514.0
Amreli,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,19.0,25.0,44.0,39.0,46.0,33.0,32.0,18.0,23.0,39.0,25.0,16.0,359.0
Amreli,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Amreli,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,9.12,Number of Institutions having NSV trained doctors,TOTAL,9.0,10.0,9.0,7.0,9.0,8.0,9.0,6.0,6.0,5.0,6.0,7.0,-1.0
Amreli,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2361.0,2481.0,2798.0,2700.0,2789.0,2749.0,2850.0,3022.0,2962.0,2976.0,2709.0,2582.0,32979.0
Amreli,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,3.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
Amreli,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Amreli,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Amreli,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2269.0,2429.0,2673.0,2533.0,2529.0,2746.0,2607.0,2841.0,2725.0,2650.0,2736.0,2496.0,31234.0
Amreli,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2497.0,2359.0,2617.0,2556.0,2555.0,2757.0,2669.0,2683.0,2758.0,2647.0,2666.0,2494.0,31258.0
Amreli,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2560.0,2473.0,2737.0,2576.0,2506.0,2689.0,2619.0,2618.0,2651.0,2670.0,2677.0,2449.0,31225.0
Amreli,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2077.0,2114.0,2473.0,2256.0,2534.0,2198.0,2502.0,2323.0,2522.0,2371.0,2019.0,1775.0,27164.0
Amreli,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2463.0,2641.0,2822.0,2616.0,2575.0,2727.0,2590.0,2841.0,2730.0,2650.0,2703.0,2499.0,31857.0
Amreli,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2492.0,2584.0,2815.0,2623.0,2659.0,2737.0,2641.0,2685.0,2751.0,2635.0,2662.0,2485.0,31769.0
Amreli,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2558.0,2687.0,2958.0,2648.0,2589.0,2683.0,2617.0,2617.0,2641.0,2676.0,2678.0,2455.0,31807.0
Amreli,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,527.0,473.0,499.0,433.0,562.0,479.0,567.0,672.0,860.0,721.0,661.0,546.0,7000.0
Amreli,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,169.0,95.0,50.0,62.0,61.0,77.0,17.0,0.0,2.0,29.0,15.0,11.0,588.0
Amreli,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,6.0,47.0,0.0,0.0,0.0,0.0,0.0,0.0,41.0,0.0,6.0,11.0,111.0
Amreli,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,69.0,143.0,51.0,51.0,49.0,50.0,58.0,59.0,0.0,0.0,7.0,92.0,629.0
Amreli,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2448.0,2666.0,3008.0,2809.0,2976.0,3082.0,2773.0,2949.0,2742.0,2805.0,2919.0,2718.0,33895.0
Amreli,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1993.0,2256.0,2560.0,2220.0,2480.0,2497.0,2449.0,2275.0,2151.0,2282.0,2329.0,2056.0,27548.0
Amreli,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1291.0,1425.0,1578.0,1495.0,1505.0,1618.0,1470.0,1532.0,1419.0,1442.0,1495.0,1218.0,17488.0
Amreli,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1100.0,1205.0,1341.0,1291.0,1425.0,1456.0,1291.0,1315.0,1302.0,1312.0,1357.0,1128.0,15523.0
Amreli,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2391.0,2630.0,2919.0,2786.0,2930.0,3074.0,2761.0,2847.0,2721.0,2754.0,2852.0,2346.0,33011.0
Amreli,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2295.0,2505.0,2807.0,2706.0,2780.0,2803.0,2803.0,2653.0,2542.0,2772.0,2838.0,2726.0,32230.0
Amreli,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2297.0,2300.0,2805.0,2706.0,2774.0,2821.0,2818.0,2643.0,2541.0,2771.0,2829.0,2725.0,32030.0
Amreli,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,795.0,931.0,1089.0,955.0,1014.0,1125.0,1109.0,1045.0,896.0,1045.0,1031.0,1723.0,12758.0
Amreli,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,717.0,840.0,949.0,845.0,938.0,1102.0,1070.0,907.0,852.0,927.0,938.0,1568.0,11653.0
Amreli,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1512.0,1771.0,2038.0,1800.0,1952.0,2227.0,2179.0,1952.0,1748.0,1972.0,1969.0,3291.0,24411.0
Amreli,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1695.0,2135.0,2377.0,2700.0,3264.0,3785.0,2628.0,2400.0,2328.0,2369.0,3674.0,3194.0,32549.0
Amreli,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1654.0,2234.0,2349.0,2852.0,3213.0,4343.0,2941.0,2178.0,2244.0,2289.0,2082.0,2017.0,30396.0
Amreli,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2044.0,2313.0,2554.0,2775.0,2899.0,4152.0,2661.0,2394.0,2140.0,1985.0,1875.0,1909.0,29701.0
Amreli,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Amreli,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,4.0,0.0,0.0,3.0,7.0,1.0,2.0,2.0,1.0,0.0,0.0,24.0
Amreli,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1229.0,1254.0,1267.0,1244.0,1284.0,1291.0,1286.0,1288.0,1328.0,1292.0,1351.0,1260.0,15374.0
Amreli,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1214.0,1232.0,1245.0,1231.0,1258.0,1281.0,1271.0,1281.0,1265.0,1269.0,1264.0,1258.0,15069.0
Amreli,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1106.0,1103.0,1126.0,1082.0,1090.0,1100.0,1139.0,1128.0,1103.0,1141.0,1167.0,1123.0,13408.0
Amreli,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2285.0,2622.0,2884.0,2818.0,2960.0,2983.0,2743.0,2914.0,2677.0,2742.0,3054.0,2806.0,33488.0
Amreli,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,3872.0,149.0,157.0,395.0,12675.0,2471.0,882.0,291.0,372.0,259.0,7492.0,9774.0,38789.0
Amreli,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,3319.0,52.0,128.0,193.0,12077.0,2331.0,384.0,271.0,249.0,210.0,6860.0,12735.0,38809.0
Amreli,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0,0.0,0.0,0.0,0.0,19.0
Amreli,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,4.0,6.0,0.0,0.0,0.0,51.0,0.0,24.0,1.0,1.0,10.0,6.0,103.0
Amreli,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,4186.0,4142.0,4603.0,3445.0,3739.0,3766.0,3519.0,3711.0,3962.0,3742.0,4425.0,4290.0,47530.0
Amreli,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,19.0,4.0,10.0,5.0,34.0,36.0,42.0,53.0,14.0,64.0,27.0,190.0,498.0
Amreli,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,8.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,14.0,25.0
Amreli,13.1,Number of Patients operated for cataract,TOTAL,24.0,78.0,29.0,103.0,104.0,81.0,87.0,0.0,83.0,200.0,93.0,121.0,1003.0
Amreli,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,24.0,78.0,29.0,103.0,104.0,81.0,87.0,0.0,83.0,200.0,93.0,121.0,1003.0
Amreli,13.3,Number of School children detected with Refractive errors,TOTAL,1016.0,1063.0,235.0,543.0,381.0,1414.0,422.0,114.0,777.0,506.0,661.0,838.0,7970.0
Amreli,13.4,Number of children provided free glasses,TOTAL,561.0,282.0,134.0,281.0,215.0,1154.0,261.0,84.0,683.0,516.0,366.0,848.0,5385.0
Amreli,13.5,Number of eyes collected through eye donation,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0,5.0,11.0
Amreli,13.6,Number of eyes utilised for corneal transplant,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0
Amreli,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,8.0,9.0,9.0,10.0,10.0,11.0,7.0,7.0,10.0,10.0,9.0,-1.0
Amreli,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,4.0,6.0,6.0,4.0,5.0,5.0,3.0,4.0,3.0,5.0,6.0,6.0,-1.0
Amreli,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,464.0,397.0,384.0,335.0,400.0,328.0,369.0,379.0,360.0,371.0,361.0,385.0,-1.0
Amreli,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,14.0,14.0,15.0,14.0,17.0,16.0,17.0,13.0,12.0,14.0,14.0,14.0,-1.0
Amreli,14.05,Number of RKS meetings held during the month,TOTAL,10.0,7.0,19.0,14.0,15.0,14.0,11.0,10.0,14.0,13.0,12.0,23.0,162.0
Amreli,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,24.0,25.0,27.0,22.0,26.0,23.0,24.0,20.0,22.0,20.0,23.0,24.0,-1.0
Amreli,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,361.0,941.0,1934.0,326.0,1729.0,1930.0,2545.0,1293.0,210.0,314.0,303.0,1631.0,13517.0
Amreli,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,9.0,10.0,11.0,9.0,11.0,11.0,9.0,8.0,8.0,10.0,10.0,10.0,-1.0
Amreli,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,2.0,4.0,-1.0
Amreli,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,523.0,549.0,587.0,967.0,717.0,866.0,645.0,391.0,449.0,658.0,795.0,578.0,7725.0
Amreli,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1917.0,2608.0,2330.0,2794.0,3604.0,3497.0,2780.0,1545.0,1551.0,2248.0,2783.0,1236.0,28893.0
Amreli,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,585.0,677.0,531.0,1075.0,742.0,770.0,650.0,427.0,488.0,850.0,866.0,959.0,8620.0
Amreli,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2673.0,3586.0,3381.0,3516.0,4537.0,4604.0,3828.0,2159.0,2144.0,3177.0,4205.0,1712.0,39522.0
Amreli,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1108.0,1226.0,1118.0,2042.0,1459.0,1636.0,1295.0,818.0,937.0,1508.0,1661.0,1537.0,16345.0
Amreli,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4590.0,6194.0,5711.0,6310.0,8141.0,8101.0,6608.0,3704.0,3695.0,5425.0,6988.0,2948.0,68415.0
Amreli,14.10.2.a,Number of death cases of Inpatient males,TOTAL,26.0,15.0,11.0,25.0,22.0,20.0,30.0,1.0,10.0,29.0,21.0,30.0,240.0
Amreli,14.10.2.b,Number of death cases of Inpatient females,TOTAL,9.0,10.0,10.0,9.0,13.0,13.0,18.0,1.0,3.0,19.0,14.0,13.0,132.0
Amreli,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,35.0,25.0,21.0,34.0,35.0,33.0,48.0,2.0,13.0,48.0,35.0,43.0,372.0
Amreli,14.11,In-Patient Head Count at midnight,TOTAL,2005.0,1944.0,1688.0,2303.0,2841.0,6148.0,4307.0,1680.0,1266.0,2061.0,5154.0,861.0,32258.0
Amreli,14.12.1,OPD attendance (All),TOTAL,81639.0,97030.0,89715.0,105958.0,107423.0,127725.0,105159.0,93254.0,85438.0,96278.0,126898.0,114633.0,1231150.0
Amreli,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,123.0,139.0,87.0,84.0,111.0,80.0,626.0,40.0,23.0,142.0,150.0,108.0,1713.0
Amreli,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,35.0,20.0,0.0,0.0,24.0,39.0,42.0,160.0
Amreli,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,268.0,375.0,148.0,148.0,130.0,204.0,162.0,199.0,213.0,271.0,212.0,154.0,2484.0
Amreli,14.14.a,Number of patients given AYUSH treatment,TOTAL,455.0,460.0,238.0,676.0,923.0,1050.0,2426.0,2236.0,3074.0,1812.0,5431.0,3418.0,22199.0
Amreli,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,717.0,880.0,1560.0,1548.0,1331.0,1510.0,1348.0,1201.0,1288.0,721.0,1542.0,1413.0,15059.0
Amreli,14.14.c,Number of Adolescents counselled,TOTAL,238.0,35.0,42.0,35.0,48.0,72.0,69.0,60.0,70.0,67.0,98.0,69.0,903.0
Amreli,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8954.0,7491.0,8825.0,6785.0,9218.0,10668.0,8723.0,7119.0,6996.0,7928.0,9714.0,12022.0,104443.0
Amreli,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,157.0,183.0,202.0,270.0,203.0,236.0,204.0,114.0,51.0,125.0,194.0,208.0,2147.0
Amreli,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,572.0,683.0,524.0,467.0,478.0,591.0,528.0,475.0,466.0,428.0,562.0,492.0,6266.0
Amreli,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,7.0,4.0,6.0,6.0,12.0,3.0,0.0,0.0,4.0,9.0,2.0,57.0
Amreli,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,613.0,737.0,776.0,566.0,545.0,670.0,513.0,561.0,443.0,652.0,699.0,718.0,7493.0
Amreli,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,2.0,2.0,3.0,2.0,7.0,3.0,1.0,0.0,3.0,6.0,1.0,32.0
Amreli,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,758.0,860.0,626.0,751.0,674.0,881.0,611.0,625.0,474.0,596.0,489.0,733.0,8078.0
Amreli,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,3.0
Amreli,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1943.0,2280.0,1926.0,1784.0,1697.0,2142.0,1652.0,1661.0,1383.0,1676.0,1750.0,1943.0,21837.0
Amreli,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,6.0,9.0,6.0,9.0,8.0,21.0,6.0,1.0,0.0,8.0,15.0,3.0,92.0
Amreli,15.2,Number of Widal tests conducted,Number tested,1030.0,893.0,649.0,653.0,888.0,1361.0,696.0,153.0,392.0,587.0,1437.0,1612.0,10351.0
Amreli,15.3.a,Number of VDRL tests conducted on males,Number tested,118.0,120.0,145.0,131.0,168.0,30.0,26.0,0.0,0.0,14.0,82.0,15.0,849.0
Amreli,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,73.0,100.0,104.0,124.0,78.0,59.0,211.0,0.0,0.0,50.0,57.0,63.0,919.0
Amreli,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,78.0,137.0,88.0,113.0,134.0,310.0,137.0,0.0,0.0,317.0,388.0,402.0,2104.0
Amreli,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,269.0,357.0,337.0,368.0,380.0,399.0,374.0,0.0,0.0,381.0,527.0,480.0,3872.0
Amreli,15.4.1,Number of blood smears examined for Malaria,TOTAL,8000.0,10966.0,7513.0,14641.0,15510.0,19604.0,11184.0,12266.0,10890.0,10028.0,18085.0,14267.0,152954.0
Amreli,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,35.0,55.0,48.0,50.0,89.0,85.0,62.0,43.0,40.0,17.0,10.0,12.0,546.0
Amreli,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,2.0,5.0,5.0,13.0,17.0,33.0,29.0,30.0,13.0,3.0,1.0,153.0
Amreli,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,8610.0,5230.0,7580.0,9970.0,15770.0,,,,,2770.0,10580.0,8130.0,68640.0
Amreli,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,10000.0,10000.0,15000.0,0.0,,,,,12500.0,0.0,2500.0,50000.0
Amreli,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3380.0,7650.0,7610.0,9200.0,8800.0,,,,,10040.0,2450.0,3930.0,53060.0
Amreli,16.1.1,Stock position of DPT vaccines,5. Total Stock,5230.0,7580.0,9970.0,15770.0,6970.0,0.0,0.0,0.0,0.0,5230.0,8130.0,6700.0,65580.0
Amreli,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1310.0,5130.0,10370.0,15720.0,19320.0,,,,,10610.0,10610.0,15300.0,88370.0
Amreli,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,6000.0,8000.0,10000.0,15000.0,0.0,,,,,20000.0,0.0,9000.0,68000.0
Amreli,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2180.0,2760.0,4650.0,11400.0,8900.0,,,,,25480.0,6380.0,5740.0,67490.0
Amreli,16.1.1A,Stock Position of Pentavalent,5. Total Stock,5130.0,10370.0,15720.0,19320.0,10420.0,0.0,0.0,0.0,0.0,5130.0,4230.0,18560.0,88880.0
Amreli,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,56600.0,42800.0,25720.0,18930.0,9100.0,,,,,31260.0,10860.0,13160.0,208430.0
Amreli,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,10000.0,10140.0,17000.0,,,,,0.0,250000.0,30000.0,317140.0
Amreli,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,13800.0,17080.0,16790.0,19970.0,10400.0,,,,,11540.0,247700.0,5620.0,342900.0
Amreli,16.1.2,Stock position of OPV vaccines,5. Total Stock,42800.0,25720.0,18930.0,9100.0,15700.0,0.0,0.0,0.0,0.0,19720.0,13160.0,37540.0,182670.0
Amreli,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,12330.0,8790.0,11590.0,12240.0,19990.0,,,,,8290.0,20210.0,15450.0,108890.0
Amreli,16.1.3,Stock position of TT vaccines,2. Stocks Received,5000.0,10000.0,10000.0,20000.0,0.0,,,,,20000.0,0.0,10000.0,75000.0
Amreli,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.3,Stock position of TT vaccines,4. Stock Distributed,8540.0,7200.0,9350.0,12250.0,10800.0,,,,,19500.0,4760.0,5980.0,78380.0
Amreli,16.1.3,Stock position of TT vaccines,5. Total Stock,8790.0,11590.0,12240.0,19990.0,9190.0,0.0,0.0,0.0,0.0,8790.0,15450.0,19470.0,105510.0
Amreli,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,22450.0,17850.0,23850.0,19550.0,22700.0,,,,,5280.0,19350.0,10530.0,141560.0
Amreli,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,10000.0,0.0,10000.0,0.0,,,,,15000.0,0.0,5000.0,40000.0
Amreli,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4600.0,4000.0,4300.0,6850.0,7750.0,,,,,2430.0,8820.0,4420.0,43170.0
Amreli,16.1.5,Stock position of BCG vaccines,5. Total Stock,17850.0,23850.0,19550.0,22700.0,14950.0,0.0,0.0,0.0,0.0,17850.0,10530.0,11110.0,138390.0
Amreli,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,550.0,3305.0,5850.0,9840.0,13140.0,,,,,4985.0,11470.0,7555.0,56695.0
Amreli,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,8000.0,10000.0,10000.0,0.0,,,,,12000.0,0.0,5000.0,50000.0
Amreli,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2245.0,5455.0,6010.0,6700.0,7050.0,,,,,13680.0,3915.0,4480.0,49535.0
Amreli,16.1.6,Stock position of Measles vaccines,5. Total Stock,3305.0,5850.0,9840.0,13140.0,6090.0,0.0,0.0,0.0,0.0,3305.0,7555.0,8075.0,57160.0
Amreli,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,550.0,50.0,1870.0,1170.0,3620.0,,,,,3890.0,5600.0,4230.0,20980.0
Amreli,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,2100.0,0.0,3000.0,0.0,,,,,2400.0,9850.0,0.0,17350.0
Amreli,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,500.0,280.0,700.0,550.0,530.0,,,,,6240.0,0.0,1130.0,9930.0
Amreli,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,50.0,1870.0,1170.0,3620.0,3090.0,0.0,0.0,0.0,0.0,50.0,15450.0,3100.0,28400.0
Amreli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,5270.0,4420.0,4320.0,4170.0,250.0,,,,,18950.0,12500.0,10550.0,60430.0
Amreli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,18000.0,,,,,0.0,0.0,0.0,18000.0
Amreli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,850.0,100.0,150.0,3920.0,150.0,,,,,6450.0,8080.0,600.0,20300.0
Amreli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,4420.0,4320.0,4170.0,250.0,18100.0,0.0,0.0,0.0,0.0,12500.0,4420.0,9950.0,58130.0
Amreli,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,30000.0,0.0,,,,,42000.0,42000.0,30000.0,144000.0
Amreli,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,125760.0,0.0,453600.0,,,,,0.0,0.0,0.0,579360.0
Amreli,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,95760.0,30000.0,0.0,,,,,0.0,12000.0,30000.0,167760.0
Amreli,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,30000.0,0.0,453600.0,0.0,0.0,0.0,0.0,42000.0,30000.0,0.0,555600.0
Amreli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,5400.0,0.0,,,,,62400.0,24000.0,6000.0,97800.0
Amreli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,51000.0,0.0,1000.0,,,,,0.0,0.0,0.0,52000.0
Amreli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,45600.0,5400.0,600.0,,,,,38400.0,18000.0,0.0,108000.0
Amreli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,5400.0,0.0,400.0,0.0,0.0,0.0,0.0,24000.0,6000.0,6000.0,41800.0
Amreli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,100.0,100.0,100.0,100.0,100.0,,,,,100.0,100.0,100.0,800.0
Amreli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,4500.0,,,,,0.0,0.0,0.0,4500.0
Amreli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,100.0,100.0,100.0,100.0,4600.0,0.0,0.0,0.0,0.0,100.0,100.0,100.0,5300.0
Amreli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1100.0,1100.0,1100.0,1100.0,45.0,,,,,1100.0,45.0,,5590.0
Amreli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,,0.0
Amreli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,,0.0
Amreli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,1055.0,0.0,,,,,1055.0,45.0,,2155.0
Amreli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1100.0,1100.0,1100.0,45.0,45.0,0.0,0.0,0.0,0.0,45.0,0.0,0.0,3435.0
Amreli,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,43000.0,31000.0,31000.0,105000.0
Amreli,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,4438000.0,0.0,4438000.0
Amreli,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,0.0,4438000.0,11000.0,4449000.0
Amreli,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,43000.0,31000.0,20000.0,94000.0
Amreli,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,120.0,190.0,190.0,500.0
Amreli,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,37900.0,0.0,37900.0
Amreli,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,120.0,37900.0,190.0,38210.0
Amreli,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,190.0,0.0,190.0
Amreli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amreli,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,148.0,148.0,98.0,98.0,96.0,,,,,2734.0,1434.0,650.0,5406.0
Amreli,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,50.0,0.0,2.0,0.0,,,,,1300.0,784.0,0.0,2136.0
Amreli,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,148.0,98.0,98.0,96.0,96.0,0.0,0.0,0.0,0.0,1434.0,650.0,650.0,3270.0
Amreli,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,20500.0,20500.0,25000.0,35000.0,6300.0,,,,,27000.0,6250.0,6250.0,146800.0
Amreli,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,5000.0,10000.0,1300.0,15000.0,,,,,0.0,2450.0,0.0,33750.0
Amreli,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,500.0,0.0,30000.0,0.0,,,,,6500.0,2450.0,600.0,40050.0
Amreli,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,20500.0,25000.0,35000.0,6300.0,21300.0,0.0,0.0,0.0,0.0,20500.0,6250.0,5650.0,140500.0
Amreli,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7700.0,6500.0,5200.0,30900.0,11500.0,,,,,200.0,4200.0,4000.0,70200.0
Amreli,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,26400.0,0.0,0.0,,,,,0.0,0.0,0.0,26400.0
Amreli,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1200.0,1300.0,700.0,19400.0,1700.0,,,,,0.0,200.0,900.0,25400.0
Amreli,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,6500.0,5200.0,30900.0,11500.0,9800.0,0.0,0.0,0.0,0.0,200.0,4000.0,3100.0,71200.0
Amreli,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,5000.0,4800.0,4800.0,4800.0,1000.0,,,,,0.0,144000.0,144000.0,308400.0
Amreli,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,276000.0,0.0,0.0,276000.0
Amreli,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,200.0,0.0,0.0,3800.0,300.0,,,,,271200.0,129600.0,52000.0,457100.0
Amreli,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,4800.0,4800.0,4800.0,1000.0,700.0,0.0,0.0,0.0,0.0,4800.0,14400.0,92000.0,127300.0
Amreli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,10000.0,10000.0,10000.0,10000.0,1200.0,,,,,200.0,0.0,0.0,41400.0
Amreli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Amreli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,8800.0,400.0,,,,,200.0,0.0,0.0,9400.0
Amreli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,10000.0,10000.0,10000.0,1200.0,800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32000.0
Amreli,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,,2.0,,,,,2.0,,,,5.0
Amreli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,1.0,,,,,1.0,,,,,3.0
Amreli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Amreli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,1.0,1.0,,,,,1.0,,,,,3.0
Amreli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,5.0,5.0,8.0,2.0,3.0,5.0,4.0,2.0,1.0,1.0,1.0,39.0
Amreli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Amreli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,5.0,5.0,8.0,2.0,3.0,5.0,4.0,2.0,1.0,1.0,1.0,39.0
Amreli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,8.0,3.0,8.0,7.0,2.0,6.0,3.0,2.0,3.0,4.0,,3.0,49.0
Amreli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,2.0,,,,2.0,2.0,,,1.0,7.0
Amreli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,8.0,3.0,8.0,9.0,2.0,6.0,3.0,4.0,5.0,4.0,,4.0,56.0
Amreli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,8.0,7.0,2.0,9.0,6.0,3.0,3.0,7.0,15.0,3.0,2.0,69.0
Amreli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,,2.0,,2.0,1.0,1.0,,,2.0,9.0
Amreli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,8.0,8.0,2.0,11.0,6.0,5.0,4.0,8.0,15.0,3.0,4.0,78.0
Amreli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,,,,1.0,1.0,1.0,,,4.0
Amreli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,1.0,,,,,,,,,2.0
Amreli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,1.0,1.0,,,,1.0,1.0,1.0,,,6.0
Amreli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Amreli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Amreli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,1.0,,,,1.0
Amreli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Amreli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Amreli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Amreli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Amreli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Amreli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Amreli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,6.0,5.0,1.0,1.0,2.0,,3.0,4.0,2.0,7.0,3.0,2.0,36.0
Amreli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,1.0,1.0,4.0,,,,1.0,4.0,,12.0
Amreli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,7.0,5.0,1.0,2.0,3.0,4.0,3.0,4.0,2.0,8.0,7.0,2.0,48.0
Amreli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Amreli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Amreli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Amreli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,1.0,,,1.0,,1.0,,1.0,4.0
Amreli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,,,,1.0,1.0,,,,3.0
Amreli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,,1.0,,,2.0,1.0,1.0,,1.0,7.0
Amreli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,3.0,3.0,2.0,1.0,,3.0,1.0,,2.0,,,16.0
Amreli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,5.0,3.0,3.0,6.0,6.0,2.0,2.0,2.0,3.0,5.0,,1.0,38.0
Amreli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,6.0,6.0,6.0,8.0,7.0,2.0,5.0,3.0,3.0,7.0,,1.0,54.0
Amreli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Amreli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Amreli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,1.0,,,,,,,,1.0
Amreli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,,1.0,,,,,,,1.0,3.0
Amreli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Amreli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,1.0,1.0,,,,,,,1.0,4.0
Amreli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Amreli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,1.0,,,,1.0,2.0
Amreli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Amreli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,1.0,,,1.0,1.0,3.0
Amreli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Amreli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,5.0,5.0,4.0,7.0,7.0,6.0,3.0,1.0,5.0,4.0,7.0,59.0
Amreli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,12.0,10.0,13.0,9.0,16.0,15.0,13.0,9.0,15.0,17.0,11.0,13.0,153.0
Amreli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,18.0,15.0,18.0,13.0,23.0,22.0,19.0,12.0,16.0,22.0,15.0,20.0,213.0
Amreli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,2.0,2.0,1.0,,,,,,,,,7.0
Amreli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,5.0,2.0,2.0,4.0,,,,,,1.0,,15.0
Amreli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,3.0,7.0,4.0,3.0,4.0,,,,,,1.0,,22.0
Amreli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Amreli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Amreli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Amreli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Amreli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Amreli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Amreli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,1.0,,1.0,,,,,,,3.0
Amreli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Amreli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,1.0,,1.0,,,,,,,3.0
Amreli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Amreli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Amreli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,,,,,,,,,1.0
Amreli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Amreli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Amreli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Amreli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,,2.0,1.0,,2.0,,,,,,7.0
Amreli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Amreli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,,2.0,1.0,,2.0,,,,,,7.0
Amreli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,1.0,,3.0,,,,,,4.0
Amreli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,2.0,4.0,4.0,4.0,2.0,,2.0,3.0,1.0,1.0,2.0,28.0
Amreli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,1.0,1.0,1.0,4.0,1.0,1.0,1.0,,,,,11.0
Amreli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,3.0,5.0,5.0,9.0,3.0,4.0,3.0,3.0,1.0,1.0,2.0,43.0
Amreli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Amreli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,8.0,3.0,4.0,5.0,7.0,4.0,3.0,2.0,3.0,1.0,1.0,,41.0
Amreli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,,1.0,,1.0,1.0,,,1.0,1.0,,6.0
Amreli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,8.0,4.0,4.0,6.0,7.0,5.0,4.0,2.0,3.0,3.0,2.0,,48.0
Amreli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Amreli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,,1.0,,1.0,1.0,,,,,,4.0
Amreli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Amreli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,,1.0,,2.0,1.0,,,,,,5.0
Amreli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Amreli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,1.0,,,,1.0,,,,2.0
Amreli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,2.0,,,,,2.0
Amreli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,1.0,1.0,,,2.0,1.0,,,,5.0
Amreli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Amreli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,1.0,,2.0,,1.0,,1.0,2.0,,,8.0
Amreli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,1.0,,1.0,,,1.0,,1.0,2.0,1.0,,8.0
Amreli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,2.0,1.0,1.0,2.0,2.0,,2.0,,2.0,4.0,1.0,,17.0
Amreli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,2.0,,1.0,2.0,,,,,1.0,1.0,8.0
Amreli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,10.0,7.0,4.0,5.0,9.0,5.0,5.0,4.0,9.0,6.0,11.0,15.0,90.0
Amreli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,21.0,32.0,27.0,19.0,35.0,37.0,41.0,31.0,28.0,26.0,27.0,18.0,342.0
Amreli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,31.0,40.0,33.0,24.0,45.0,44.0,46.0,35.0,37.0,32.0,39.0,34.0,440.0
Anand,1.1,Total number of pregnant women Registered for ANC,TOTAL,3800.0,3498.0,4076.0,3255.0,3118.0,3241.0,2687.0,3145.0,3181.0,3382.0,3670.0,3342.0,40395.0
Anand,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3246.0,2933.0,3097.0,2640.0,2458.0,2696.0,2213.0,2333.0,2459.0,2575.0,2695.0,2388.0,31733.0
Anand,1.2,Number of Pregnant women registered under JSY,TOTAL,1227.0,1351.0,1437.0,1203.0,1223.0,1402.0,930.0,1136.0,1320.0,1357.0,1373.0,1299.0,15258.0
Anand,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2427.0,2532.0,2900.0,2952.0,2913.0,3077.0,2647.0,2579.0,2295.0,2398.0,2409.0,2238.0,31367.0
Anand,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2659.0,2486.0,2758.0,2073.0,2031.0,1937.0,1952.0,1969.0,2159.0,2251.0,2594.0,3283.0,28152.0
Anand,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2543.0,2868.0,3369.0,2879.0,2942.0,2914.0,2460.0,2496.0,2670.0,2878.0,2857.0,3418.0,34294.0
Anand,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2768.0,2800.0,3173.0,2915.0,3199.0,3089.0,2958.0,2975.0,2999.0,2915.0,3238.0,3530.0,36559.0
Anand,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,68.0,59.0,151.0,95.0,43.0,35.0,29.0,40.0,35.0,39.0,53.0,48.0,695.0
Anand,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Anand,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3112.0,3513.0,3802.0,3831.0,3794.0,3883.0,3272.0,3369.0,3446.0,3192.0,3627.0,3756.0,42597.0
Anand,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,89.0,85.0,0.0,4.0,3.0,22.0,16.0,2.0,12.0,23.0,17.0,42.0,315.0
Anand,1.8,Number of pregnancy test kits used at SC level,TOTAL,798.0,753.0,979.0,889.0,1220.0,1186.0,1130.0,1061.0,1060.0,1124.0,1229.0,1379.0,12808.0
Anand,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,3.0,5.0,8.0,0.0,1.0,4.0,4.0,1.0,0.0,1.0,0.0,28.0
Anand,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,3.0,4.0,2.0,9.0,2.0,10.0,11.0,5.0,7.0,4.0,2.0,0.0,59.0
Anand,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,4.0,7.0,7.0,17.0,2.0,11.0,15.0,9.0,8.0,4.0,3.0,0.0,87.0
Anand,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,4.0,5.0,6.0,14.0,2.0,13.0,12.0,8.0,5.0,4.0,3.0,0.0,76.0
Anand,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,0.0,1.0,0.0,3.0,7.0,0.0,0.0,1.0,0.0,0.0,13.0
Anand,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,994.0,1046.0,946.0,1061.0,1430.0,1623.0,1625.0,1464.0,1457.0,1266.0,973.0,1047.0,14932.0
Anand,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,809.0,836.0,742.0,884.0,1149.0,1380.0,1436.0,1221.0,1091.0,1078.0,836.0,846.0,12308.0
Anand,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,68.0,108.0,142.0,106.0,57.0,52.0,46.0,56.0,44.0,76.0,76.0,73.0,904.0
Anand,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,24.0,13.0,1.0,4.0,0.0,4.0,1.0,0.0,2.0,0.0,0.0,0.0,49.0
Anand,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1160.0,1231.0,1157.0,1187.0,1672.0,1691.0,1612.0,1518.0,1329.0,1387.0,1854.0,1835.0,17633.0
Anand,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,3.0,0.0,0.0,0.0,0.0,0.0,5.0
Anand,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,63.0,56.0,75.0,52.0,62.0,59.0,52.0,29.0,36.0,55.0,40.0,36.0,615.0
Anand,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,9.0,9.0,9.0,14.0,12.0,11.0,20.0,20.0,10.0,10.0,9.0,5.0,138.0
Anand,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anand,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,72.0,65.0,84.0,66.0,74.0,72.0,75.0,49.0,46.0,65.0,49.0,41.0,758.0
Anand,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,264.0,189.0,194.0,202.0,271.0,274.0,335.0,285.0,328.0,363.0,365.0,512.0,3582.0
Anand,4.1.1.a,Number of male live births,TOTAL,1134.0,1210.0,1086.0,1188.0,1574.0,1674.0,1704.0,1546.0,1593.0,1335.0,1503.0,1466.0,17013.0
Anand,4.1.1.b,Number of female live births,TOTAL,983.0,1043.0,996.0,1055.0,1392.0,1578.0,1560.0,1390.0,1345.0,1273.0,1406.0,1362.0,15383.0
Anand,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2117.0,2253.0,2082.0,2243.0,2966.0,3252.0,3264.0,2936.0,2938.0,2608.0,2909.0,2828.0,32396.0
Anand,4.1.2,Number of still births,TOTAL,41.0,39.0,37.0,31.0,51.0,76.0,49.0,49.0,40.0,46.0,32.0,40.0,531.0
Anand,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,65.0,107.0,91.0,76.0,82.0,100.0,77.0,94.0,86.0,81.0,84.0,199.0,1142.0
Anand,4.2.1,Number of Newborns weighed at birth,TOTAL,2075.0,2258.0,2117.0,2301.0,3064.0,3276.0,3437.0,3018.0,2755.0,2547.0,2847.0,2905.0,32600.0
Anand,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,355.0,205.0,188.0,283.0,327.0,426.0,638.0,562.0,309.0,264.0,204.0,214.0,3975.0
Anand,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2059.0,2188.0,2038.0,2145.0,2935.0,3123.0,3278.0,2913.0,2906.0,2685.0,2616.0,2822.0,31708.0
Anand,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,10.0,7.0,12.0,18.0,17.0,22.0,28.0,17.0,20.0,12.0,18.0,181.0
Anand,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,89.0,88.0,157.0,115.0,155.0,165.0,205.0,198.0,145.0,155.0,103.0,122.0,1697.0
Anand,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,4.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Anand,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anand,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,89.0,98.0,168.0,127.0,176.0,182.0,227.0,226.0,162.0,175.0,115.0,140.0,1885.0
Anand,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,382.0,314.0,304.0,483.0,443.0,513.0,561.0,640.0,417.0,445.0,352.0,423.0,5277.0
Anand,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,66.0,28.0,19.0,25.0,31.0,7.0,12.0,27.0,0.0,33.0,1.0,20.0,269.0
Anand,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1215.0,1221.0,1141.0,1355.0,1484.0,1791.0,1770.0,1800.0,1681.0,711.0,497.0,473.0,15139.0
Anand,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,39.0,23.0,36.0,40.0,30.0,36.0,25.0,18.0,16.0,31.0,22.0,21.0,337.0
Anand,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1873.0,2130.0,2020.0,2337.0,3178.0,3482.0,3613.0,2973.0,3051.0,3065.0,3263.0,3306.0,34291.0
Anand,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1388.0,1751.0,2164.0,1934.0,2231.0,2656.0,2727.0,2438.0,2247.0,2691.0,3004.0,2953.0,28184.0
Anand,6.3,PNC maternal complications attended,TOTAL,1.0,0.0,3.0,1.0,4.0,118.0,3.0,161.0,163.0,153.0,102.0,149.0,858.0
Anand,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,42.0,25.0,16.0,18.0,11.0,7.0,5.0,1.0,3.0,11.0,8.0,14.0,161.0
Anand,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Anand,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,42.0,25.0,16.0,18.0,11.0,7.0,5.0,1.0,4.0,11.0,8.0,14.0,162.0
Anand,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Anand,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,43.0,125.0,94.0,127.0,119.0,112.0,82.0,73.0,77.0,67.0,93.0,50.0,1062.0
Anand,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,77.0,193.0,202.0,245.0,300.0,306.0,178.0,109.0,215.0,171.0,217.0,145.0,2358.0
Anand,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,120.0,318.0,296.0,372.0,419.0,418.0,260.0,182.0,292.0,238.0,310.0,195.0,3420.0
Anand,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,1.0,4.0,1.0,2.0,6.0,3.0,2.0,20.0
Anand,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,3.0,0.0,1.0,2.0,0.0,8.0,0.0,0.0,3.0,0.0,17.0
Anand,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anand,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,3.0,0.0,1.0,3.0,4.0,9.0,2.0,6.0,6.0,2.0,37.0
Anand,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0
Anand,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,3.0,7.0,7.0,10.0,47.0,51.0,23.0,231.0,623.0,281.0,122.0,127.0,1532.0
Anand,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,19.0,119.0,103.0,162.0,138.0,178.0,43.0,571.0,870.0,654.0,531.0,107.0,3495.0
Anand,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,27.0,14.0,15.0,78.0,16.0,2.0,5.0,10.0,4.0,7.0,0.0,,178.0
Anand,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anand,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,49.0,140.0,125.0,250.0,201.0,231.0,71.0,812.0,1497.0,942.0,653.0,234.0,5205.0
Anand,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,135.0,60.0,114.0,391.0,500.0,90.0,1129.0,662.0,0.0,14.0,16.0,613.0,3724.0
Anand,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,8.0,13.0,6.0,17.0,25.0,39.0,18.0,89.0,125.0,80.0,33.0,51.0,504.0
Anand,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,30.0,12.0,11.0,29.0,10.0,9.0,1.0,155.0,14.0,166.0,7.0,2.0,446.0
Anand,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3.0
Anand,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anand,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,40.0,25.0,18.0,46.0,35.0,48.0,19.0,244.0,139.0,246.0,40.0,53.0,953.0
Anand,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,4.0,34.0,6.0,104.0,224.0,14.0,114.0,23.0,0.0,0.0,0.0,216.0,739.0
Anand,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,1.0,0.0,15.0,6.0,4.0,5.0,52.0,24.0,26.0,11.0,45.0,189.0
Anand,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,9.0,4.0,0.0,0.0,1.0,0.0,1.0,15.0
Anand,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anand,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,1.0,0.0,15.0,6.0,13.0,9.0,52.0,24.0,27.0,11.0,46.0,204.0
Anand,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,1.0,0.0,0.0,28.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,36.0
Anand,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,743.0,874.0,996.0,1099.0,1305.0,1032.0,1035.0,980.0,864.0,886.0,1083.0,672.0,11569.0
Anand,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,296.0,276.0,414.0,525.0,557.0,314.0,408.0,383.0,319.0,376.0,344.0,634.0,4846.0
Anand,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,26.0,32.0,30.0,37.0,20.0,4.0,2.0,54.0,9.0,216.0,152.0,166.0,748.0
Anand,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,38.0,18.0,16.0,54.0,47.0,23.0,22.0,20.0,29.0,4.0,0.0,,271.0
Anand,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anand,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1103.0,1200.0,1456.0,1715.0,1929.0,1373.0,1467.0,1437.0,1221.0,1482.0,1579.0,1472.0,17434.0
Anand,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,37.0,9.0,14.0,39.0,38.0,20.0,108.0,27.0,34.0,37.0,57.0,62.0,482.0
Anand,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,30.0,21.0,36.0,26.0,80.0,90.0,1014.0,730.0,63.0,90.0,14.0,305.0,2499.0
Anand,9.06,Number of IUCD removals,TOTAL,187.0,883.0,251.0,253.0,387.0,345.0,318.0,264.0,329.0,285.0,373.0,259.0,4134.0
Anand,9.07,Number of Oral Pills cycles distributed,TOTAL,1919.0,1772.0,1232.0,2178.0,4579.0,3454.0,4965.0,3680.0,3490.0,3581.0,4521.0,5987.0,41358.0
Anand,9.08,Number of Condom pieces distributed,TOTAL,38468.0,30671.0,17618.0,14615.0,85683.0,73060.0,100498.0,77518.0,80480.0,71640.0,71217.0,91468.0,752936.0
Anand,9.09,Number of Centchroman (weekly) pills given,TOTAL,3.0,14.0,0.0,0.0,350.0,0.0,31.0,0.0,81.0,4.0,44.0,50.0,577.0
Anand,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,95.0,33.0,20.0,35.0,19.0,15.0,17.0,65.0,33.0,43.0,58.0,467.0,900.0
Anand,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,18.0,2.0,0.0,13.0,5.0,4.0,2.0,45.0
Anand,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,9.11.2.b,Number of failures following female sterilization,TOTAL,3.0,5.0,0.0,0.0,2.0,1.0,2.0,0.0,0.0,5.0,1.0,1.0,20.0
Anand,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,5.0,6.0,7.0,8.0,8.0,8.0,6.0,6.0,5.0,7.0,5.0,-1.0
Anand,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2015.0,2350.0,2668.0,2083.0,3035.0,3461.0,3290.0,3332.0,3114.0,3099.0,2666.0,2941.0,34054.0
Anand,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,12.0,0.0,4.0,0.0,0.0,0.0,11.0,4.0,31.0
Anand,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,9.0,6.0,16.0
Anand,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,9.0,0.0,1.0,0.0,0.0,0.0,11.0,12.0,33.0
Anand,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1815.0,2312.0,2501.0,2241.0,2474.0,2433.0,3052.0,3261.0,3340.0,2975.0,2715.0,2937.0,32056.0
Anand,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2100.0,2234.0,2510.0,2198.0,2477.0,2143.0,2558.0,2824.0,3340.0,3332.0,2915.0,3230.0,31861.0
Anand,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2410.0,2573.0,2563.0,2229.0,2415.0,2661.0,2490.0,2368.0,2931.0,3175.0,2993.0,3493.0,32301.0
Anand,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1690.0,2007.0,2020.0,1941.0,2594.0,2741.0,2771.0,2471.0,2359.0,2484.0,2174.0,2185.0,27437.0
Anand,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1782.0,2297.0,2503.0,2268.0,2465.0,2471.0,3062.0,3195.0,3274.0,3022.0,2716.0,3079.0,32134.0
Anand,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2078.0,2288.0,2532.0,2170.0,2476.0,2158.0,2539.0,2782.0,3271.0,3072.0,2913.0,3306.0,31585.0
Anand,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2425.0,2564.0,2585.0,2177.0,2431.0,2675.0,2471.0,2314.0,2912.0,3160.0,3006.0,3549.0,32269.0
Anand,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,703.0,712.0,695.0,844.0,1145.0,1354.0,1340.0,1061.0,936.0,1090.0,1017.0,857.0,11754.0
Anand,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,12.0,32.0,30.0,0.0,0.0,0.0,0.0,0.0,74.0
Anand,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,32.0,30.0,0.0,0.0,0.0,0.0,0.0,62.0
Anand,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,32.0,30.0,0.0,0.0,0.0,0.0,0.0,62.0
Anand,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2133.0,3190.0,3367.0,3252.0,3248.0,3280.0,2847.0,2571.0,2579.0,2599.0,2554.0,3093.0,34713.0
Anand,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2110.0,2166.0,2925.0,2345.0,2485.0,2334.0,2083.0,2239.0,2480.0,2400.0,2720.0,2984.0,29271.0
Anand,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1144.0,1688.0,1765.0,1696.0,1670.0,1669.0,1527.0,1415.0,1283.0,1345.0,1370.0,1698.0,18270.0
Anand,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1001.0,1433.0,1518.0,1495.0,1509.0,1558.0,1294.0,1185.0,1095.0,1218.0,1278.0,1480.0,16064.0
Anand,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2145.0,3121.0,3283.0,3191.0,3179.0,3227.0,2821.0,2600.0,2378.0,2563.0,2648.0,3178.0,34334.0
Anand,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2287.0,2340.0,3016.0,2412.0,2443.0,2473.0,2123.0,2318.0,2484.0,2415.0,2748.0,3072.0,30131.0
Anand,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2273.0,2335.0,3027.0,2392.0,2455.0,2465.0,2115.0,2253.0,2419.0,2395.0,2733.0,3139.0,30001.0
Anand,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,9.0
Anand,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1104.0,1097.0,1451.0,1168.0,1142.0,1259.0,947.0,1084.0,1101.0,1056.0,1163.0,1405.0,13977.0
Anand,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,885.0,951.0,1303.0,1016.0,1029.0,1056.0,895.0,997.0,1008.0,887.0,1133.0,1236.0,12396.0
Anand,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1989.0,2048.0,2754.0,2184.0,2171.0,2315.0,1842.0,2081.0,2109.0,1943.0,2296.0,2641.0,26373.0
Anand,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,600.0,825.0,1654.0,2823.0,4411.0,4738.0,1670.0,1802.0,2204.0,1758.0,1518.0,1961.0,25964.0
Anand,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,462.0,538.0,1061.0,3075.0,4989.0,4499.0,1485.0,1725.0,1948.0,1702.0,1265.0,1738.0,24487.0
Anand,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1112.0,1059.0,2155.0,3306.0,4674.0,3938.0,2435.0,1856.0,2072.0,1707.0,1473.0,2095.0,27882.0
Anand,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,0.0,0.0,1.0,1.0,11.0,0.0,0.0,0.0,1.0,0.0,15.0
Anand,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,8.0
Anand,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,4.0,5.0,0.0,1.0,0.0,0.0,0.0,2.0,12.0
Anand,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1561.0,1489.0,1493.0,1486.0,1549.0,1516.0,1541.0,1498.0,1566.0,1456.0,1545.0,1554.0,18254.0
Anand,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1535.0,1441.0,1475.0,1436.0,1505.0,1484.0,1479.0,1472.0,1535.0,1412.0,1510.0,1522.0,17806.0
Anand,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1417.0,1375.0,1378.0,1404.0,1409.0,1458.0,1426.0,1388.0,1421.0,1312.0,1404.0,1427.0,16819.0
Anand,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2121.0,2756.0,2539.0,2495.0,2378.0,2102.0,1704.0,1495.0,1148.0,1619.0,4692.0,2312.0,27361.0
Anand,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1476.0,53.0,47.0,59.0,642.0,184.0,103.0,69.0,20.0,202.0,7675.0,2037.0,12567.0
Anand,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1293.0,42.0,32.0,42.0,668.0,163.0,89.0,62.0,9.0,193.0,7997.0,1998.0,12588.0
Anand,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,10.0,0.0,0.0,2.0,5.0,0.0,0.0,0.0,0.0,17.0
Anand,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1109.0,933.0,942.0,927.0,1304.0,902.0,1107.0,1578.0,1671.0,1498.0,1358.0,1349.0,14678.0
Anand,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,9.0,6.0,2.0,1.0,13.0,1.0,1.0,0.0,0.0,1.0,4.0,38.0
Anand,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,4.0,4.0,0.0,13.0
Anand,13.1,Number of Patients operated for cataract,TOTAL,445.0,1295.0,1413.0,3924.0,1706.0,2088.0,2026.0,3230.0,3698.0,3431.0,243.0,2644.0,26143.0
Anand,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,445.0,1294.0,1413.0,3920.0,1703.0,2087.0,2023.0,3226.0,3691.0,3421.0,243.0,2639.0,26105.0
Anand,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,15.0,748.0,1611.0,673.0,231.0,1672.0,3781.0,388.0,3676.0,12795.0
Anand,13.4,Number of children provided free glasses,TOTAL,611.0,0.0,0.0,0.0,714.0,1620.0,856.0,231.0,1656.0,3740.0,388.0,2152.0,11968.0
Anand,13.5,Number of eyes collected through eye donation,TOTAL,4.0,0.0,0.0,0.0,10.0,4.0,2.0,4.0,4.0,1.0,0.0,0.0,29.0
Anand,13.6,Number of eyes utilised for corneal transplant,TOTAL,1.0,0.0,0.0,0.0,7.0,1.0,2.0,1.0,1.0,1.0,0.0,0.0,14.0
Anand,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,7.0,7.0,7.0,6.0,7.0,7.0,8.0,7.0,5.0,6.0,-1.0
Anand,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,13.0,13.0,15.0,13.0,14.0,20.0,13.0,16.0,13.0,16.0,15.0,12.0,-1.0
Anand,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,94.0,85.0,109.0,66.0,70.0,79.0,82.0,83.0,82.0,79.0,83.0,96.0,-1.0
Anand,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,10.0,10.0,10.0,10.0,11.0,11.0,10.0,10.0,11.0,9.0,9.0,10.0,-1.0
Anand,14.05,Number of RKS meetings held during the month,TOTAL,6.0,10.0,24.0,8.0,4.0,16.0,4.0,9.0,14.0,17.0,13.0,16.0,141.0
Anand,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,35.0,29.0,35.0,31.0,28.0,40.0,34.0,34.0,31.0,28.0,29.0,30.0,-1.0
Anand,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,153.0,228.0,241.0,318.0,347.0,334.0,219.0,342.0,465.0,495.0,297.0,417.0,3856.0
Anand,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,5.0,6.0,5.0,2.0,4.0,5.0,7.0,4.0,3.0,2.0,-1.0
Anand,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,7.0,74.0,5.0,7.0,-1.0
Anand,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,441.0,415.0,330.0,411.0,415.0,548.0,429.0,374.0,311.0,427.0,325.0,198.0,4624.0
Anand,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1003.0,1242.0,996.0,1095.0,1367.0,1606.0,1123.0,978.0,987.0,831.0,1141.0,1142.0,13511.0
Anand,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,511.0,544.0,617.0,315.0,988.0,895.0,534.0,432.0,368.0,492.0,426.0,261.0,6383.0
Anand,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2809.0,3134.0,2576.0,2840.0,3615.0,3852.0,3015.0,2780.0,2841.0,3055.0,2649.0,2809.0,35975.0
Anand,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,952.0,959.0,947.0,726.0,1403.0,1443.0,963.0,806.0,679.0,919.0,751.0,459.0,11007.0
Anand,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3812.0,4376.0,3572.0,3935.0,4982.0,5458.0,4138.0,3758.0,3828.0,3886.0,3790.0,3951.0,49486.0
Anand,14.10.2.a,Number of death cases of Inpatient males,TOTAL,4.0,1.0,3.0,2.0,5.0,5.0,1.0,3.0,2.0,4.0,4.0,5.0,39.0
Anand,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,4.0,1.0,1.0,1.0,3.0,5.0,4.0,6.0,2.0,2.0,1.0,34.0
Anand,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,8.0,5.0,4.0,3.0,6.0,8.0,6.0,7.0,8.0,6.0,6.0,6.0,73.0
Anand,14.11,In-Patient Head Count at midnight,TOTAL,2715.0,1766.0,2848.0,2148.0,3508.0,2135.0,1979.0,2403.0,886.0,1176.0,1209.0,1626.0,24399.0
Anand,14.12.1,OPD attendance (All),TOTAL,52942.0,54829.0,59352.0,62740.0,76571.0,93133.0,57751.0,55886.0,57998.0,50913.0,73176.0,76379.0,771670.0
Anand,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,344.0,287.0,266.0,387.0,298.0,387.0,188.0,529.0,562.0,690.0,486.0,347.0,4771.0
Anand,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,25.0,0.0,0.0,0.0,3.0,52.0,9.0,25.0,27.0,48.0,66.0,36.0,291.0
Anand,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,167.0,237.0,183.0,206.0,214.0,113.0,95.0,72.0,122.0,127.0,180.0,141.0,1857.0
Anand,14.14.a,Number of patients given AYUSH treatment,TOTAL,3208.0,2529.0,2470.0,1378.0,2438.0,2131.0,1535.0,1780.0,2292.0,1795.0,2299.0,2565.0,26420.0
Anand,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,339.0,330.0,327.0,123.0,274.0,288.0,264.0,148.0,111.0,20.0,25.0,28.0,2277.0
Anand,14.14.c,Number of Adolescents counselled,TOTAL,55.0,47.0,105.0,80.0,62.0,52.0,45.0,17.0,14.0,74.0,58.0,56.0,665.0
Anand,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,10164.0,10409.0,12465.0,14871.0,11534.0,19681.0,10553.0,11503.0,12271.0,12120.0,13749.0,12674.0,151994.0
Anand,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,359.0,501.0,563.0,819.0,786.0,957.0,613.0,745.0,609.0,361.0,380.0,331.0,7024.0
Anand,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,559.0,674.0,622.0,707.0,727.0,610.0,612.0,654.0,515.0,504.0,545.0,470.0,7199.0
Anand,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,19.0,29.0,22.0,10.0,7.0,9.0,8.0,10.0,8.0,4.0,15.0,148.0
Anand,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,430.0,588.0,736.0,638.0,669.0,524.0,514.0,576.0,571.0,426.0,484.0,508.0,6664.0
Anand,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,11.0,14.0,6.0,3.0,2.0,11.0,14.0,8.0,2.0,3.0,8.0,83.0
Anand,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1879.0,1696.0,2312.0,1961.0,2110.0,2373.0,1612.0,1806.0,1757.0,1646.0,1574.0,2170.0,22896.0
Anand,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,28.0,93.0,36.0,0.0,0.0,13.0,17.0,15.0,42.0,0.0,12.0,256.0
Anand,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2868.0,2958.0,3670.0,3306.0,3506.0,3507.0,2738.0,3036.0,2843.0,2576.0,2603.0,3148.0,36759.0
Anand,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8.0,58.0,136.0,64.0,13.0,9.0,33.0,39.0,33.0,52.0,7.0,35.0,487.0
Anand,15.2,Number of Widal tests conducted,Number tested,373.0,467.0,790.0,654.0,764.0,1086.0,893.0,651.0,569.0,348.0,653.0,781.0,8029.0
Anand,15.3.a,Number of VDRL tests conducted on males,Number tested,119.0,150.0,87.0,122.0,120.0,102.0,70.0,93.0,84.0,49.0,33.0,42.0,1071.0
Anand,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,190.0,173.0,155.0,250.0,211.0,281.0,135.0,129.0,151.0,182.0,91.0,96.0,2044.0
Anand,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,562.0,392.0,590.0,606.0,481.0,696.0,371.0,483.0,349.0,492.0,292.0,266.0,5580.0
Anand,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,871.0,715.0,832.0,978.0,812.0,1079.0,576.0,705.0,584.0,723.0,416.0,404.0,8695.0
Anand,15.4.1,Number of blood smears examined for Malaria,TOTAL,26833.0,30910.0,30054.0,32279.0,42779.0,48677.0,28473.0,24035.0,24862.0,18799.0,25558.0,25651.0,358910.0
Anand,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,18.0,32.0,29.0,30.0,42.0,56.0,24.0,14.0,4.0,4.0,3.0,18.0,274.0
Anand,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,2.0,3.0,4.0,4.0,1.0,1.0,1.0,0.0,0.0,16.0
Anand,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,4250.0,700.0,200.0,100.0,0.0,0.0,1100.0,1500.0,2400.0,2100.0,14900.0,,27250.0
Anand,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,2500.0,5000.0,10600.0,15000.0,7500.0,2500.0,6500.0,4000.0,15000.0,0.0,,68600.0
Anand,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3550.0,3000.0,5100.0,10700.0,15000.0,6400.0,2100.0,5600.0,4300.0,2200.0,10400.0,,68350.0
Anand,16.1.1,Stock position of DPT vaccines,5. Total Stock,700.0,200.0,100.0,0.0,0.0,1100.0,1500.0,2400.0,2100.0,14900.0,4500.0,0.0,27500.0
Anand,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,100.0,1800.0,4900.0,11300.0,11900.0,12700.0,11700.0,8700.0,10600.0,7100.0,17700.0,,98500.0
Anand,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,13200.0,15000.0,15000.0,12000.0,12000.0,6000.0,0.0,12000.0,6000.0,18000.0,0.0,,109200.0
Anand,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,11500.0,11900.0,8600.0,11400.0,11200.0,7000.0,3000.0,10100.0,9500.0,7400.0,12800.0,,104400.0
Anand,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1800.0,4900.0,11300.0,11900.0,12700.0,11700.0,8700.0,10600.0,7100.0,17700.0,4900.0,0.0,103300.0
Anand,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,11440.0,0.0,4500.0,5600.0,3400.0,4800.0,0.0,0.0,3800.0,3200.0,20000.0,,56740.0
Anand,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,20000.0,15000.0,20000.0,20000.0,7000.0,7000.0,17000.0,20000.0,411000.0,390000.0,,927000.0
Anand,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,11440.0,15500.0,13900.0,22200.0,18600.0,11800.0,7000.0,13200.0,20600.0,394200.0,407900.0,,936340.0
Anand,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,4500.0,5600.0,3400.0,4800.0,0.0,0.0,3800.0,3200.0,20000.0,2100.0,0.0,47400.0
Anand,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,7000.0,200.0,3200.0,2300.0,2300.0,5900.0,11900.0,18200.0,19100.0,14100.0,24300.0,,108500.0
Anand,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,15000.0,10000.0,20000.0,20000.0,15000.0,10000.0,10000.0,5000.0,15000.0,0.0,,120000.0
Anand,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6800.0,12000.0,10900.0,20000.0,16400.0,9000.0,3700.0,9100.0,10000.0,4800.0,13200.0,,115900.0
Anand,16.1.3,Stock position of TT vaccines,5. Total Stock,200.0,3200.0,2300.0,2300.0,5900.0,11900.0,18200.0,19100.0,14100.0,24300.0,11100.0,0.0,112600.0
Anand,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3600.0,4700.0,4900.0,5200.0,1400.0,1900.0,8000.0,4800.0,7900.0,13100.0,19800.0,,75300.0
Anand,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5500.0,5000.0,5000.0,2000.0,6000.0,10000.0,0.0,10000.0,10000.0,10000.0,0.0,,63500.0
Anand,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4400.0,4800.0,4700.0,5800.0,5500.0,3900.0,3200.0,6900.0,4800.0,3300.0,6900.0,,54200.0
Anand,16.1.5,Stock position of BCG vaccines,5. Total Stock,4700.0,4900.0,5200.0,1400.0,1900.0,8000.0,4800.0,7900.0,13100.0,19800.0,12900.0,0.0,84600.0
Anand,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,50.0,0.0,0.0,3600.0,0.0,2200.0,1250.0,550.0,100.0,8950.0,18750.0,,35450.0
Anand,16.1.6,Stock position of Measles vaccines,2. Stocks Received,7000.0,5250.0,15000.0,10000.0,11000.0,5000.0,2000.0,8000.0,15000.0,15000.0,0.0,,93250.0
Anand,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,7050.0,5250.0,11400.0,13600.0,8800.0,5950.0,2700.0,8450.0,6150.0,5200.0,8950.0,,83500.0
Anand,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,3600.0,0.0,2200.0,1250.0,550.0,100.0,8950.0,18750.0,9800.0,0.0,45200.0
Anand,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,15400.0,14600.0,14150.0,13850.0,12050.0,11000.0,8950.0,8350.0,7150.0,5950.0,5500.0,,116950.0
Anand,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Anand,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,800.0,450.0,300.0,1800.0,1050.0,2050.0,600.0,1200.0,1200.0,450.0,2600.0,,12500.0
Anand,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,14600.0,14150.0,13850.0,12050.0,11000.0,8950.0,8350.0,7150.0,5950.0,5500.0,2900.0,0.0,104450.0
Anand,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Anand,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Anand,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Anand,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Anand,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Anand,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Anand,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Anand,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Anand,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Anand,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Anand,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Anand,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Anand,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Anand,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Anand,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Anand,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Anand,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Anand,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Anand,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Anand,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Anand,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Anand,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Anand,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Anand,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Anand,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Anand,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Anand,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Anand,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Anand,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Anand,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Anand,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Anand,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Anand,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Anand,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Anand,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Anand,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Anand,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Anand,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Anand,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Anand,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Anand,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Anand,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Anand,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Anand,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Anand,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Anand,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Anand,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Anand,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Anand,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Anand,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Anand,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Anand,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Anand,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Anand,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Anand,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Anand,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Anand,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Anand,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Anand,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anand,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,1.0,4.0,4.0,5.0,4.0,6.0,,4.0,,3.0,32.0
Anand,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Anand,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Anand,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Anand,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,3.0,6.0,2.0,3.0,8.0,7.0,5.0,4.0,4.0,6.0,1.0,2.0,51.0
Anand,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,2.0,,,,1.0,,,1.0,,,,,4.0
Anand,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,5.0,6.0,2.0,3.0,9.0,7.0,5.0,5.0,4.0,6.0,1.0,2.0,55.0
Anand,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,9.0,10.0,8.0,13.0,12.0,8.0,10.0,12.0,12.0,9.0,3.0,110.0
Anand,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,2.0,,,1.0,1.0,5.0,1.0,2.0,2.0,1.0,1.0,1.0,17.0
Anand,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,6.0,9.0,10.0,9.0,14.0,17.0,9.0,12.0,14.0,13.0,10.0,4.0,127.0
Anand,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,10.0,3.0,11.0,6.0,7.0,12.0,10.0,10.0,8.0,11.0,15.0,6.0,109.0
Anand,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,2.0,2.0,1.0,,3.0,,2.0,3.0,4.0,4.0,1.0,2.0,24.0
Anand,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,12.0,5.0,12.0,6.0,10.0,12.0,12.0,13.0,12.0,15.0,16.0,8.0,133.0
Anand,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,2.0,,,,,,2.0
Anand,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Anand,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,2.0,,,,,,2.0
Anand,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Anand,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Anand,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Anand,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Anand,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Anand,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Anand,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Anand,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Anand,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Anand,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,13.0,10.0,8.0,7.0,7.0,9.0,16.0,6.0,8.0,8.0,4.0,11.0,107.0
Anand,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,3.0,3.0,1.0,,1.0,,5.0,,1.0,1.0,2.0,1.0,18.0
Anand,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,16.0,13.0,9.0,7.0,8.0,9.0,21.0,6.0,9.0,9.0,6.0,12.0,125.0
Anand,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Anand,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,2.0,,2.0
Anand,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,2.0,,2.0
Anand,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,1.0,2.0,2.0,2.0,,,1.0,1.0,9.0
Anand,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,1.0,,,,2.0,1.0,,,5.0
Anand,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,,2.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,14.0
Anand,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,1.0,,,1.0,,,2.0
Anand,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,1.0,1.0,,2.0,1.0,,5.0,3.0,4.0,1.0,19.0
Anand,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,2.0,1.0,6.0,3.0,2.0,1.0,5.0,1.0,6.0,,27.0
Anand,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,3.0,2.0,6.0,5.0,4.0,1.0,10.0,5.0,10.0,1.0,48.0
Anand,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Anand,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Anand,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Anand,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,1.0,,,,,1.0,,2.0
Anand,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,4.0,2.0,1.0,,7.0
Anand,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,1.0,,,4.0,2.0,2.0,,9.0
Anand,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,1.0,2.0,1.0,4.0
Anand,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Anand,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,1.0,2.0,1.0,4.0
Anand,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,2.0,3.0,3.0,,2.0,3.0,2.0,4.0,3.0,1.0,5.0,31.0
Anand,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,2.0,2.0,,2.0,4.0,1.0,4.0,6.0,7.0,3.0,32.0
Anand,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,2.0,5.0,5.0,,4.0,7.0,3.0,8.0,9.0,8.0,8.0,63.0
Anand,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Anand,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,2.0,,,,,,,,2.0
Anand,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Anand,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,,,2.0,,,,,,1.0,,4.0
Anand,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Anand,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Anand,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Anand,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Anand,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Anand,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Anand,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Anand,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Anand,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Anand,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Anand,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Anand,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,1.0,,,,,,1.0
Anand,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Anand,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Anand,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Anand,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,,1.0,,2.0,1.0,,,2.0,,7.0
Anand,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Anand,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,,1.0,,2.0,1.0,,,2.0,,7.0
Anand,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,1.0,2.0,,,,,1.0,,,4.0
Anand,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,2.0,1.0,2.0,1.0,,4.0,,1.0,,4.0,1.0,18.0
Anand,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,1.0,1.0,,1.0,,,2.0,1.0,,6.0
Anand,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,2.0,1.0,4.0,4.0,,5.0,,1.0,3.0,5.0,1.0,28.0
Anand,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,3.0,2.0,,1.0,,,1.0,4.0,2.0,,13.0
Anand,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Anand,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,3.0,2.0,,1.0,1.0,,1.0,4.0,2.0,,14.0
Anand,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,,1.0,,,,,,,2.0
Anand,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Anand,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Anand,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,2.0,,2.0,,,,,,,4.0
Anand,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,4.0,,,4.0
Anand,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,,,,,2.0,1.0,,,1.0,,,5.0
Anand,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,,,,,2.0,1.0,,,5.0,,,9.0
Anand,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Anand,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,,,4.0,,,2.0,,,,,7.0
Anand,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,1.0,,,,2.0,,1.0,,,4.0
Anand,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,,,1.0,4.0,,,4.0,,1.0,,,11.0
Anand,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,,,2.0,1.0,2.0,,2.0,,1.0,9.0
Anand,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,4.0,10.0,1.0,11.0,7.0,9.0,16.0,18.0,16.0,8.0,8.0,8.0,116.0
Anand,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,11.0,25.0,16.0,30.0,32.0,29.0,35.0,42.0,55.0,27.0,28.0,26.0,356.0
Anand,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,16.0,35.0,17.0,41.0,39.0,40.0,52.0,62.0,71.0,37.0,36.0,35.0,481.0
Aravalli,1.1,Total number of pregnant women Registered for ANC,TOTAL,2143.0,2428.0,2521.0,2441.0,2283.0,2277.0,2241.0,2344.0,2306.0,2530.0,2342.0,2204.0,28060.0
Aravalli,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1805.0,2047.0,2118.0,2114.0,1997.0,2040.0,2017.0,2073.0,2015.0,2201.0,2107.0,1918.0,24452.0
Aravalli,1.2,Number of Pregnant women registered under JSY,TOTAL,931.0,1055.0,1084.0,1206.0,1230.0,1212.0,1052.0,1196.0,1156.0,1226.0,984.0,845.0,13177.0
Aravalli,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1748.0,1958.0,2118.0,2075.0,2109.0,2071.0,1938.0,2117.0,2037.0,2076.0,2063.0,1818.0,24128.0
Aravalli,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1823.0,2010.0,2018.0,2047.0,1945.0,1881.0,1917.0,1954.0,1905.0,2070.0,1940.0,1903.0,23413.0
Aravalli,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2198.0,2216.0,2425.0,2350.0,2306.0,2337.0,2224.0,2098.0,2353.0,2224.0,2467.0,2341.0,27539.0
Aravalli,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2070.0,2209.0,2471.0,2296.0,2225.0,2293.0,2207.0,2193.0,2178.0,2350.0,2198.0,2119.0,26809.0
Aravalli,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,8.0,2.0,80.0,2.0,0.0,0.0,22.0,14.0,1.0,0.0,129.0
Aravalli,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1360.0,1676.0,1592.0,1715.0,1534.0,1742.0,1641.0,1723.0,1762.0,1852.0,1678.0,1562.0,19837.0
Aravalli,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,15.0,50.0,34.0,14.0,9.0,32.0,12.0,28.0,26.0,39.0,24.0,31.0,314.0
Aravalli,1.8,Number of pregnancy test kits used at SC level,TOTAL,580.0,588.0,718.0,1126.0,1152.0,1141.0,931.0,1057.0,887.0,1068.0,986.0,930.0,11164.0
Aravalli,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,8.0,22.0,7.0,3.0,2.0,3.0,6.0,1.0,5.0,0.0,2.0,3.0,62.0
Aravalli,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,1.0,1.0,0.0,0.0,6.0
Aravalli,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,8.0,22.0,7.0,3.0,2.0,3.0,7.0,4.0,6.0,1.0,2.0,3.0,68.0
Aravalli,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,8.0,21.0,7.0,3.0,2.0,3.0,7.0,4.0,6.0,1.0,2.0,3.0,67.0
Aravalli,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,5.0,0.0,0.0,0.0,1.0,1.0,3.0,2.0,1.0,0.0,0.0,14.0
Aravalli,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,799.0,974.0,930.0,1008.0,1147.0,1034.0,1018.0,1061.0,1007.0,952.0,831.0,1055.0,11816.0
Aravalli,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2.0,10.0,15.0,21.0,32.0,71.0,18.0,33.0,34.0,21.0,16.0,137.0,410.0
Aravalli,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,101.0,163.0,108.0,255.0,185.0,338.0,122.0,86.0,131.0,263.0,145.0,162.0,2059.0
Aravalli,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,5.0,0.0,0.0,9.0
Aravalli,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1044.0,1372.0,1114.0,1017.0,1155.0,1102.0,1169.0,1247.0,1162.0,1189.0,1207.0,1237.0,14015.0
Aravalli,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,65.0,52.0,16.0,133.0
Aravalli,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Aravalli,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,10.0,12.0,10.0,29.0,18.0,10.0,15.0,30.0,18.0,18.0,14.0,12.0,196.0
Aravalli,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aravalli,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,10.0,12.0,10.0,29.0,19.0,10.0,15.0,30.0,18.0,18.0,14.0,12.0,197.0
Aravalli,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,3.0,34.0,51.0,70.0,45.0,55.0,55.0,27.0,27.0,29.0,19.0,26.0,441.0
Aravalli,4.1.1.a,Number of male live births,TOTAL,955.0,1194.0,1047.0,1082.0,1171.0,1039.0,1109.0,1089.0,1104.0,1037.0,1006.0,1135.0,12968.0
Aravalli,4.1.1.b,Number of female live births,TOTAL,839.0,1069.0,950.0,919.0,1014.0,1011.0,1008.0,1038.0,987.0,1004.0,966.0,1077.0,11882.0
Aravalli,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1794.0,2263.0,1997.0,2001.0,2185.0,2050.0,2117.0,2127.0,2091.0,2041.0,1972.0,2212.0,24850.0
Aravalli,4.1.2,Number of still births,TOTAL,30.0,37.0,29.0,45.0,47.0,37.0,29.0,39.0,27.0,34.0,33.0,26.0,413.0
Aravalli,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,153.0,170.0,167.0,177.0,180.0,165.0,193.0,227.0,226.0,162.0,173.0,188.0,2181.0
Aravalli,4.2.1,Number of Newborns weighed at birth,TOTAL,1793.0,2263.0,1997.0,2001.0,2195.0,2054.0,2117.0,2126.0,2091.0,2038.0,1973.0,2212.0,24860.0
Aravalli,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,145.0,225.0,184.0,160.0,196.0,168.0,161.0,152.0,221.0,138.0,153.0,193.0,2096.0
Aravalli,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1767.0,2202.0,1976.0,1927.0,2139.0,2001.0,2061.0,2101.0,2067.0,1983.0,1924.0,2126.0,24274.0
Aravalli,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,1.0,1.0,1.0,6.0,9.0,5.0,3.0,10.0,5.0,7.0,5.0,53.0
Aravalli,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,12.0,0.0,0.0,0.0,14.0
Aravalli,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aravalli,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,1.0,1.0,1.0,6.0,10.0,5.0,4.0,22.0,5.0,7.0,5.0,67.0
Aravalli,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,30.0,34.0,46.0,52.0,0.0,27.0,11.0,31.0,13.0,244.0
Aravalli,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,72.0,52.0,32.0,20.0,26.0,6.0,24.0,22.0,38.0,44.0,46.0,47.0,429.0
Aravalli,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,144.0,117.0,73.0,36.0,30.0,28.0,66.0,46.0,41.0,47.0,49.0,66.0,743.0
Aravalli,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,2.0,9.0,1.0,1.0,2.0,0.0,16.0
Aravalli,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1228.0,1482.0,1171.0,1259.0,1560.0,1521.0,1550.0,1587.0,1541.0,1383.0,1519.0,1602.0,17403.0
Aravalli,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1013.0,1377.0,1117.0,1242.0,1391.0,1249.0,1365.0,1105.0,1324.0,1511.0,1375.0,1590.0,15659.0
Aravalli,6.3,PNC maternal complications attended,TOTAL,5.0,19.0,9.0,1.0,10.0,3.0,4.0,3.0,5.0,3.0,1.0,7.0,70.0
Aravalli,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2.0,6.0,2.0,0.0,0.0,1.0,2.0,1.0,1.0,1.0,3.0,1.0,20.0
Aravalli,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2.0,6.0,2.0,0.0,0.0,1.0,2.0,1.0,1.0,1.0,3.0,1.0,20.0
Aravalli,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,1.0,3.0,0.0,2.0,3.0,2.0,2.0,1.0,0.0,0.0,14.0
Aravalli,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,476.0,583.0,494.0,570.0,465.0,510.0,527.0,554.0,513.0,503.0,537.0,437.0,6169.0
Aravalli,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,568.0,678.0,592.0,698.0,618.0,659.0,649.0,672.0,606.0,640.0,657.0,528.0,7565.0
Aravalli,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1044.0,1261.0,1086.0,1268.0,1083.0,1169.0,1176.0,1226.0,1119.0,1143.0,1194.0,965.0,13734.0
Aravalli,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,94.0,94.0
Aravalli,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0
Aravalli,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aravalli,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0
Aravalli,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,0.0,12.0
Aravalli,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,7.0,0.0,1.0,0.0,10.0,3.0,8.0,590.0,776.0,548.0,232.0,53.0,2228.0
Aravalli,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,29.0,18.0,19.0,42.0,4.0,7.0,4.0,81.0,419.0,259.0,70.0,54.0,1006.0
Aravalli,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aravalli,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,36.0,18.0,20.0,42.0,14.0,10.0,12.0,671.0,1195.0,807.0,302.0,107.0,3234.0
Aravalli,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,9.0,39.0,2.0,9.0,4.0,243.0,6.0,43.0,611.0,679.0,604.0,129.0,2378.0
Aravalli,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,1.0,5.0,4.0,12.0,32.0,24.0,141.0,319.0,217.0,228.0,88.0,1071.0
Aravalli,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aravalli,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,1.0,5.0,4.0,12.0,32.0,24.0,141.0,319.0,217.0,228.0,88.0,1071.0
Aravalli,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,259.0,300.0,315.0,343.0,415.0,405.0,338.0,507.0,617.0,569.0,812.0,489.0,5369.0
Aravalli,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aravalli,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,31.0,0.0,17.0,7.0,6.0,8.0,6.0,1.0,4.0,0.0,1.0,0.0,81.0
Aravalli,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,799.0,883.0,990.0,975.0,1006.0,1067.0,979.0,1137.0,1087.0,1262.0,1236.0,982.0,12403.0
Aravalli,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,207.0,171.0,187.0,185.0,224.0,212.0,247.0,248.0,232.0,250.0,339.0,228.0,2730.0
Aravalli,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,90.0,62.0,98.0,129.0,119.0,105.0,80.0,49.0,60.0,38.0,37.0,45.0,912.0
Aravalli,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,15.0,30.0,49.0,69.0,0.0,1.0,36.0,0.0,16.0,3.0,10.0,1.0,230.0
Aravalli,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aravalli,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1111.0,1146.0,1324.0,1358.0,1349.0,1385.0,1342.0,1434.0,1395.0,1553.0,1622.0,1256.0,16275.0
Aravalli,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,253.0,461.0,436.0,527.0,507.0,444.0,683.0,180.0,1053.0,284.0,1314.0,206.0,6348.0
Aravalli,9.06,Number of IUCD removals,TOTAL,139.0,126.0,153.0,162.0,186.0,169.0,163.0,183.0,211.0,177.0,218.0,192.0,2079.0
Aravalli,9.07,Number of Oral Pills cycles distributed,TOTAL,2707.0,1791.0,2239.0,2887.0,3320.0,3971.0,3691.0,3027.0,3918.0,3092.0,4279.0,3097.0,38019.0
Aravalli,9.08,Number of Condom pieces distributed,TOTAL,15014.0,14254.0,12588.0,14926.0,23481.0,36030.0,34230.0,28088.0,31017.0,21321.0,15837.0,17592.0,264378.0
Aravalli,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,223.0,219.0,323.0,364.0,293.0,378.0,363.0,319.0,335.0,336.0,472.0,277.0,3902.0
Aravalli,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,1.0,2.0,3.0,3.0,2.0,1.0,1.0,1.0,2.0,3.0,2.0,-1.0
Aravalli,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1709.0,2059.0,1947.0,2005.0,2167.0,2025.0,2146.0,2025.0,1939.0,1900.0,1944.0,2118.0,23984.0
Aravalli,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1922.0,1932.0,1940.0,1944.0,2057.0,1984.0,2080.0,1984.0,2195.0,1999.0,1946.0,1897.0,23880.0
Aravalli,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1831.0,1961.0,1936.0,1956.0,2023.0,1964.0,2060.0,1920.0,2136.0,2000.0,2055.0,1964.0,23806.0
Aravalli,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1870.0,1957.0,1976.0,1918.0,2034.0,1871.0,1982.0,1988.0,2037.0,1985.0,2086.0,2063.0,23767.0
Aravalli,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1495.0,1714.0,1568.0,1714.0,1881.0,1753.0,1851.0,1905.0,1805.0,1748.0,1866.0,1826.0,21126.0
Aravalli,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1922.0,1932.0,1940.0,1944.0,2057.0,1984.0,2080.0,1984.0,2195.0,1999.0,1946.0,1897.0,23880.0
Aravalli,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1831.0,1961.0,1936.0,1956.0,2023.0,1964.0,2060.0,1920.0,2136.0,2000.0,2055.0,1964.0,23806.0
Aravalli,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1870.0,1957.0,1976.0,1918.0,2034.0,1871.0,1982.0,1988.0,2037.0,1985.0,2086.0,2063.0,23767.0
Aravalli,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,333.0,433.0,446.0,461.0,709.0,619.0,636.0,731.0,734.0,733.0,1425.0,1624.0,8884.0
Aravalli,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,7.0
Aravalli,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1734.0,1995.0,2017.0,2031.0,1977.0,1900.0,1992.0,1994.0,2025.0,1922.0,1995.0,2016.0,23598.0
Aravalli,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1672.0,1834.0,1971.0,1933.0,1907.0,1887.0,1966.0,2173.0,1997.0,1953.0,1944.0,2019.0,23256.0
Aravalli,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,898.0,1016.0,1046.0,1039.0,965.0,963.0,997.0,989.0,1022.0,972.0,1015.0,1052.0,11974.0
Aravalli,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,826.0,942.0,921.0,954.0,939.0,932.0,933.0,951.0,958.0,919.0,930.0,951.0,11156.0
Aravalli,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1724.0,1958.0,1967.0,1993.0,1904.0,1895.0,1930.0,1940.0,1980.0,1891.0,1945.0,2003.0,23130.0
Aravalli,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1682.0,1832.0,1958.0,1922.0,1918.0,1890.0,1960.0,2164.0,1999.0,1950.0,1940.0,2005.0,23220.0
Aravalli,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1681.0,1832.0,1959.0,1922.0,1918.0,1891.0,1960.0,2164.0,1999.0,1950.0,1940.0,2005.0,23221.0
Aravalli,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,151.0,169.0,211.0,33.0,79.0,89.0,63.0,60.0,95.0,83.0,50.0,102.0,1185.0
Aravalli,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,146.0,153.0,197.0,41.0,67.0,79.0,49.0,56.0,90.0,83.0,48.0,87.0,1096.0
Aravalli,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,297.0,322.0,408.0,74.0,146.0,168.0,112.0,116.0,185.0,166.0,98.0,189.0,2281.0
Aravalli,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,874.0,969.0,1345.0,1569.0,2670.0,3819.0,1749.0,2117.0,2421.0,1679.0,1638.0,1232.0,22082.0
Aravalli,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,882.0,864.0,1311.0,1603.0,2911.0,3574.0,1750.0,2181.0,2627.0,1498.0,1790.0,1410.0,22401.0
Aravalli,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1012.0,1045.0,1392.0,1625.0,2712.0,3583.0,1736.0,2084.0,2568.0,1387.0,1618.0,1496.0,22258.0
Aravalli,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,923.0,964.0,978.0,974.0,996.0,998.0,1028.0,1010.0,1021.0,1002.0,1054.0,1025.0,11973.0
Aravalli,10.4.2,Number of Immunisation sessions held during the month,TOTAL,918.0,964.0,976.0,971.0,996.0,998.0,1028.0,1010.0,1021.0,1002.0,1053.0,1025.0,11962.0
Aravalli,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,904.0,941.0,961.0,958.0,976.0,982.0,1016.0,1004.0,1007.0,988.0,1042.0,1016.0,11795.0
Aravalli,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1722.0,2008.0,2035.0,2020.0,1993.0,1864.0,1931.0,1947.0,1995.0,1916.0,2100.0,2072.0,23603.0
Aravalli,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,5512.0,4.0,3.0,214.0,3175.0,5237.0,227.0,523.0,100.0,0.0,6212.0,2141.0,23348.0
Aravalli,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,5174.0,0.0,0.0,214.0,3378.0,5098.0,257.0,626.0,122.0,0.0,5650.0,1898.0,22417.0
Aravalli,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2641.0,2830.0,2793.0,3260.0,3643.0,3248.0,2900.0,2603.0,2517.0,2298.0,2335.0,2365.0,33433.0
Aravalli,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,141.0,127.0,115.0,174.0,182.0,131.0,155.0,155.0,153.0,179.0,221.0,201.0,1934.0
Aravalli,13.1,Number of Patients operated for cataract,TOTAL,243.0,130.0,85.0,135.0,232.0,192.0,150.0,301.0,418.0,488.0,401.0,415.0,3190.0
Aravalli,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,243.0,130.0,71.0,135.0,232.0,191.0,149.0,301.0,418.0,488.0,401.0,415.0,3174.0
Aravalli,13.3,Number of School children detected with Refractive errors,TOTAL,771.0,39.0,30.0,285.0,449.0,1955.0,1173.0,695.0,2686.0,22386.0,7533.0,693.0,38695.0
Aravalli,13.4,Number of children provided free glasses,TOTAL,161.0,39.0,19.0,108.0,239.0,380.0,485.0,332.0,611.0,694.0,406.0,383.0,3857.0
Aravalli,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,0.0,16.0
Aravalli,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,0.0,16.0
Aravalli,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,3.0,3.0,4.0,4.0,3.0,3.0,4.0,4.0,4.0,4.0,3.0,-1.0
Aravalli,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,2.0,2.0,4.0,6.0,6.0,7.0,4.0,6.0,6.0,7.0,8.0,-1.0
Aravalli,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,416.0,402.0,355.0,367.0,426.0,392.0,414.0,385.0,462.0,472.0,431.0,461.0,-1.0
Aravalli,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,11.0,11.0,11.0,11.0,10.0,10.0,10.0,10.0,10.0,8.0,10.0,6.0,-1.0
Aravalli,14.05,Number of RKS meetings held during the month,TOTAL,12.0,11.0,21.0,14.0,19.0,18.0,16.0,17.0,15.0,12.0,15.0,15.0,185.0
Aravalli,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,26.0,26.0,27.0,27.0,29.0,29.0,29.0,26.0,24.0,25.0,26.0,26.0,-1.0
Aravalli,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,161.0,199.0,155.0,190.0,225.0,126.0,74.0,90.0,116.0,128.0,126.0,119.0,1709.0
Aravalli,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,2.0,1.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Aravalli,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,7.0,7.0,7.0,7.0,7.0,7.0,7.0,2.0,7.0,7.0,7.0,7.0,-1.0
Aravalli,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,162.0,156.0,85.0,159.0,125.0,181.0,151.0,35.0,90.0,85.0,106.0,102.0,1437.0
Aravalli,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,848.0,803.0,1153.0,949.0,1115.0,1364.0,846.0,759.0,1086.0,908.0,1026.0,767.0,11624.0
Aravalli,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,239.0,205.0,59.0,149.0,151.0,221.0,231.0,64.0,142.0,99.0,146.0,76.0,1782.0
Aravalli,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1102.0,1042.0,1634.0,1392.0,1425.0,1721.0,1169.0,1260.0,2408.0,1829.0,1674.0,1471.0,18127.0
Aravalli,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,401.0,361.0,144.0,308.0,276.0,402.0,382.0,99.0,232.0,184.0,252.0,178.0,3219.0
Aravalli,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1950.0,1845.0,2787.0,2341.0,2540.0,3085.0,2015.0,2019.0,3494.0,2737.0,2700.0,2238.0,29751.0
Aravalli,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,6.0,6.0,2.0,1.0,3.0,0.0,1.0,1.0,0.0,1.0,2.0,26.0
Aravalli,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,1.0,0.0,1.0,1.0,3.0,0.0,0.0,0.0,1.0,3.0,2.0,15.0
Aravalli,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,6.0,7.0,6.0,3.0,2.0,6.0,0.0,1.0,1.0,1.0,4.0,4.0,41.0
Aravalli,14.11,In-Patient Head Count at midnight,TOTAL,2741.0,3417.0,3172.0,3365.0,3286.0,4056.0,2072.0,2445.0,2100.0,2551.0,2815.0,1865.0,33885.0
Aravalli,14.12.1,OPD attendance (All),TOTAL,42021.0,52941.0,50060.0,53691.0,62122.0,79007.0,54191.0,52855.0,55701.0,53048.0,68914.0,61997.0,686548.0
Aravalli,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,132.0,99.0,69.0,54.0,119.0,95.0,80.0,145.0,155.0,195.0,89.0,170.0,1402.0
Aravalli,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,1.0,5.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,9.0
Aravalli,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,38.0,37.0,58.0,43.0,24.0,29.0,29.0,240.0,474.0,444.0,208.0,47.0,1671.0
Aravalli,14.14.a,Number of patients given AYUSH treatment,TOTAL,4205.0,4661.0,4685.0,5639.0,5891.0,6442.0,5633.0,5873.0,7303.0,4321.0,5357.0,5267.0,65277.0
Aravalli,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,247.0,210.0,230.0,35.0,192.0,268.0,165.0,205.0,164.0,10.0,21.0,256.0,2003.0
Aravalli,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5445.0,5406.0,6283.0,6081.0,5501.0,6298.0,4826.0,5324.0,5893.0,4896.0,6292.0,5547.0,67792.0
Aravalli,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,476.0,225.0,226.0,524.0,540.0,494.0,425.0,414.0,472.0,522.0,596.0,677.0,5591.0
Aravalli,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,406.0,403.0,318.0,332.0,377.0,411.0,265.0,299.0,318.0,189.0,240.0,246.0,3804.0
Aravalli,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,2.0,1.0,6.0,3.0,2.0,2.0,3.0,3.0,5.0,4.0,1.0,35.0
Aravalli,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,176.0,227.0,254.0,263.0,190.0,260.0,196.0,169.0,186.0,152.0,214.0,174.0,2461.0
Aravalli,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,3.0,4.0,2.0,1.0,0.0,1.0,0.0,0.0,1.0,3.0,2.0,19.0
Aravalli,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,749.0,859.0,1489.0,1419.0,1386.0,1551.0,1120.0,1298.0,1050.0,1121.0,1470.0,1507.0,15019.0
Aravalli,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,3.0,0.0,69.0,3.0,2.0,73.0,78.0,17.0,14.0,260.0
Aravalli,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1331.0,1489.0,2061.0,2014.0,1953.0,2222.0,1581.0,1766.0,1554.0,1462.0,1924.0,1927.0,21284.0
Aravalli,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5.0,5.0,6.0,11.0,4.0,71.0,6.0,5.0,76.0,84.0,24.0,17.0,314.0
Aravalli,15.2,Number of Widal tests conducted,Number tested,439.0,409.0,393.0,723.0,1011.0,1482.0,736.0,504.0,569.0,424.0,788.0,657.0,8135.0
Aravalli,15.3.a,Number of VDRL tests conducted on males,Number tested,17.0,11.0,14.0,20.0,14.0,16.0,12.0,25.0,68.0,32.0,25.0,17.0,271.0
Aravalli,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,23.0,12.0,20.0,27.0,23.0,19.0,12.0,29.0,46.0,53.0,19.0,12.0,295.0
Aravalli,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,194.0,216.0,85.0,221.0,196.0,290.0,189.0,254.0,286.0,279.0,310.0,304.0,2824.0
Aravalli,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,234.0,239.0,119.0,268.0,233.0,325.0,213.0,308.0,400.0,364.0,354.0,333.0,3390.0
Aravalli,15.4.1,Number of blood smears examined for Malaria,TOTAL,14592.0,14055.0,19737.0,19153.0,23272.0,27741.0,20310.0,17533.0,15850.0,12240.0,16846.0,12487.0,213816.0
Aravalli,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,6.0,7.0,18.0,22.0,22.0,34.0,18.0,18.0,6.0,3.0,1.0,450.0,605.0
Aravalli,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,4.0,0.0,0.0,1.0,7.0,14.0,9.0,1.0,0.0,0.0,0.0,37.0
Aravalli,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.3,Stock position of TT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Aravalli,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Aravalli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aravalli,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,1.0,,,,,,,1.0
Aravalli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,2.0,,,1.0,,,,2.0,,,6.0
Aravalli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Aravalli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,2.0,,,1.0,,,,2.0,,,6.0
Aravalli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,4.0,7.0,5.0,5.0,2.0,4.0,7.0,1.0,4.0,4.0,1.0,1.0,45.0
Aravalli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Aravalli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,4.0,7.0,5.0,5.0,2.0,4.0,7.0,1.0,4.0,4.0,1.0,1.0,45.0
Aravalli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,10.0,6.0,3.0,2.0,4.0,13.0,11.0,11.0,16.0,8.0,6.0,10.0,100.0
Aravalli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,3.0,1.0,,1.0,,,,,6.0
Aravalli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,10.0,7.0,3.0,2.0,7.0,14.0,11.0,12.0,16.0,8.0,6.0,10.0,106.0
Aravalli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,5.0,7.0,7.0,4.0,11.0,5.0,7.0,6.0,2.0,8.0,3.0,3.0,68.0
Aravalli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,2.0,,,1.0,1.0,3.0,2.0,2.0,,,,,11.0
Aravalli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,7.0,7.0,7.0,5.0,12.0,8.0,9.0,8.0,2.0,8.0,3.0,3.0,79.0
Aravalli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,3.0,2.0,,3.0,2.0,2.0,1.0,1.0,1.0,,16.0
Aravalli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aravalli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,3.0,2.0,,3.0,2.0,2.0,1.0,1.0,1.0,,16.0
Aravalli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,1.0,1.0,,2.0
Aravalli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aravalli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,1.0,1.0,,2.0
Aravalli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Aravalli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aravalli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,,,,,,,,,,1.0
Aravalli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Aravalli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aravalli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Aravalli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,2.0,3.0,2.0,1.0,3.0,3.0,2.0,3.0,1.0,3.0,2.0,27.0
Aravalli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,1.0,,,3.0,,,,,1.0,2.0,8.0
Aravalli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,3.0,4.0,2.0,1.0,6.0,3.0,2.0,3.0,1.0,4.0,4.0,35.0
Aravalli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Aravalli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Aravalli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Aravalli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,1.0,,2.0,1.0,1.0,,,1.0,,6.0
Aravalli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Aravalli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,1.0,1.0,2.0,1.0,1.0,,,1.0,,7.0
Aravalli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,2.0,3.0,4.0,2.0,2.0,,,,1.0,,15.0
Aravalli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,5.0,11.0,4.0,6.0,3.0,,7.0,1.0,8.0,46.0
Aravalli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,,3.0,8.0,15.0,6.0,8.0,3.0,,7.0,2.0,8.0,61.0
Aravalli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Aravalli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Aravalli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Aravalli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,,,2.0,2.0,,,,,1.0,6.0
Aravalli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,2.0,,,1.0,,,,,,3.0
Aravalli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,,2.0,,2.0,3.0,,,,,1.0,9.0
Aravalli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Aravalli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Aravalli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,1.0,,,,,,,,,1.0
Aravalli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,4.0,2.0,4.0,2.0,3.0,2.0,,2.0,,,2.0,1.0,22.0
Aravalli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,2.0,2.0,6.0,5.0,1.0,1.0,,1.0,,,,20.0
Aravalli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,6.0,4.0,6.0,8.0,8.0,3.0,1.0,2.0,1.0,,2.0,1.0,42.0
Aravalli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Aravalli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,1.0,,1.0,1.0,,,1.0,,,4.0
Aravalli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Aravalli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,1.0,,2.0,1.0,,,2.0,,,6.0
Aravalli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Aravalli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Aravalli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,1.0,,,,1.0
Aravalli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Aravalli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Aravalli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Aravalli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Aravalli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Aravalli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Aravalli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Aravalli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Aravalli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,1.0,,,1.0
Aravalli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Aravalli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Aravalli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Aravalli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,1.0,,,1.0,,1.0,,1.0,5.0
Aravalli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Aravalli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,1.0,,,1.0,,1.0,,1.0,5.0
Aravalli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,2.0,,,,1.0,,,,,,5.0
Aravalli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,2.0,,3.0,4.0,4.0,2.0,2.0,,,,,20.0
Aravalli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,1.0,2.0,,,1.0,,,,,4.0
Aravalli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,3.0,2.0,4.0,6.0,4.0,3.0,3.0,,,,,29.0
Aravalli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,1.0,1.0,1.0,,1.0,3.0,,,,2.0,,10.0
Aravalli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Aravalli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,1.0,1.0,1.0,,1.0,3.0,,,,2.0,,10.0
Aravalli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Aravalli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Aravalli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,,1.0,,,,,,,,2.0
Aravalli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Aravalli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,,,,,,,,,,1.0,,2.0
Aravalli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,,,,,,,,,,,,4.0
Aravalli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,5.0,,,,,1.0,,,,,1.0,,7.0
Aravalli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Aravalli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,1.0,1.0,,,,1.0,,,,3.0
Aravalli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,1.0,1.0,,,,6.0,,3.0,,11.0
Aravalli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,2.0,2.0,,,,7.0,,3.0,,14.0
Aravalli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Aravalli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,2.0,3.0,6.0,1.0,,1.0,,1.0,,3.0,1.0,20.0
Aravalli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,3.0,7.0,3.0,19.0,5.0,21.0,11.0,13.0,6.0,5.0,6.0,1.0,100.0
Aravalli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,5.0,9.0,6.0,25.0,6.0,21.0,12.0,13.0,8.0,5.0,9.0,2.0,121.0
Banas Kantha,1.1,Total number of pregnant women Registered for ANC,TOTAL,7441.0,6763.0,6641.0,7107.0,6948.0,7074.0,6343.0,7013.0,7317.0,7889.0,7371.0,6234.0,84141.0
Banas Kantha,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5584.0,5049.0,4861.0,5119.0,5020.0,4996.0,4497.0,5055.0,5379.0,5863.0,5702.0,4940.0,62065.0
Banas Kantha,1.2,Number of Pregnant women registered under JSY,TOTAL,2279.0,2090.0,2029.0,2212.0,2188.0,2241.0,1768.0,2535.0,2468.0,2664.0,2609.0,2378.0,27461.0
Banas Kantha,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5124.0,5105.0,5058.0,5181.0,5293.0,5396.0,5237.0,5447.0,5547.0,5753.0,5724.0,5113.0,63978.0
Banas Kantha,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,5385.0,5017.0,4984.0,5295.0,5077.0,5198.0,4845.0,5247.0,5333.0,5752.0,5534.0,4862.0,62529.0
Banas Kantha,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6353.0,6687.0,6394.0,6616.0,6875.0,6715.0,6585.0,6789.0,6974.0,7262.0,7526.0,7002.0,81778.0
Banas Kantha,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6295.0,5781.0,6273.0,5798.0,6163.0,6441.0,5930.0,6207.0,6393.0,6678.0,6709.0,6509.0,75177.0
Banas Kantha,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,117.0,109.0,91.0,152.0,147.0,183.0,132.0,184.0,195.0,238.0,204.0,188.0,1940.0
Banas Kantha,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,1.0,0.0,0.0,4.0,2.0,0.0,1.0,10.0,5.0,5.0,4.0,32.0
Banas Kantha,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3689.0,3740.0,3658.0,3531.0,3549.0,3892.0,3849.0,3530.0,3959.0,3625.0,3969.0,3681.0,44672.0
Banas Kantha,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,72.0,67.0,71.0,82.0,112.0,190.0,93.0,98.0,172.0,167.0,118.0,177.0,1419.0
Banas Kantha,1.8,Number of pregnancy test kits used at SC level,TOTAL,1235.0,1285.0,1299.0,1411.0,1455.0,1450.0,1339.0,1348.0,1412.0,2130.0,2225.0,2109.0,18698.0
Banas Kantha,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,96.0,71.0,101.0,81.0,79.0,77.0,62.0,75.0,67.0,49.0,52.0,35.0,845.0
Banas Kantha,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,89.0,90.0,82.0,97.0,85.0,84.0,68.0,92.0,73.0,93.0,85.0,43.0,981.0
Banas Kantha,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,185.0,161.0,183.0,178.0,164.0,161.0,130.0,167.0,140.0,142.0,137.0,78.0,1826.0
Banas Kantha,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,169.0,148.0,178.0,158.0,141.0,144.0,127.0,151.0,134.0,139.0,132.0,58.0,1679.0
Banas Kantha,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,8.0,21.0,28.0,23.0,18.0,13.0,11.0,20.0,18.0,23.0,10.0,7.0,200.0
Banas Kantha,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1164.0,1271.0,1380.0,1624.0,1653.0,1974.0,1805.0,1962.0,1913.0,1706.0,2418.0,1935.0,20805.0
Banas Kantha,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,577.0,706.0,710.0,812.0,1011.0,1036.0,1018.0,988.0,966.0,911.0,834.0,858.0,10427.0
Banas Kantha,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,224.0,291.0,500.0,622.0,352.0,577.0,268.0,861.0,622.0,501.0,516.0,706.0,6040.0
Banas Kantha,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,30.0,35.0,23.0,2.0,7.0,33.0,26.0,16.0,36.0,80.0,52.0,26.0,366.0
Banas Kantha,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,4255.0,4481.0,4116.0,4360.0,5100.0,5009.0,4531.0,4870.0,4340.0,4486.0,4405.0,3901.0,53854.0
Banas Kantha,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,124.0,80.0,143.0,130.0,121.0,170.0,95.0,76.0,55.0,0.0,0.0,0.0,994.0
Banas Kantha,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,124.0,80.0,77.0,102.0,101.0,100.0,84.0,76.0,55.0,0.0,0.0,0.0,799.0
Banas Kantha,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,9.0,18.0,23.0,28.0,12.0,24.0,16.0,22.0,29.0,19.0,28.0,44.0,272.0
Banas Kantha,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,1.0,1.0,2.0,4.0,5.0,5.0,6.0,2.0,10.0,6.0,12.0,54.0
Banas Kantha,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banas Kantha,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,9.0,19.0,24.0,30.0,16.0,29.0,21.0,28.0,31.0,29.0,34.0,56.0,326.0
Banas Kantha,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,185.0,168.0,177.0,168.0,206.0,267.0,208.0,218.0,191.0,202.0,144.0,132.0,2266.0
Banas Kantha,4.1.1.a,Number of male live births,TOTAL,2921.0,3030.0,2970.0,3274.0,3661.0,3721.0,3358.0,3598.0,3380.0,3328.0,3490.0,3025.0,39756.0
Banas Kantha,4.1.1.b,Number of female live births,TOTAL,2613.0,2813.0,2625.0,2830.0,3206.0,3368.0,3065.0,3337.0,2951.0,2948.0,3399.0,2826.0,35981.0
Banas Kantha,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5534.0,5843.0,5595.0,6104.0,6867.0,7089.0,6423.0,6935.0,6331.0,6276.0,6889.0,5851.0,75737.0
Banas Kantha,4.1.2,Number of still births,TOTAL,87.0,76.0,99.0,93.0,84.0,88.0,82.0,121.0,104.0,107.0,108.0,93.0,1142.0
Banas Kantha,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,93.0,109.0,90.0,110.0,92.0,106.0,105.0,123.0,162.0,205.0,153.0,103.0,1451.0
Banas Kantha,4.2.1,Number of Newborns weighed at birth,TOTAL,5522.0,5843.0,5570.0,6082.0,6850.0,7080.0,6412.0,6923.0,6310.0,6247.0,6888.0,5841.0,75568.0
Banas Kantha,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,310.0,404.0,365.0,442.0,493.0,759.0,452.0,516.0,514.0,360.0,313.0,297.0,5225.0
Banas Kantha,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,5518.0,5822.0,5561.0,6068.0,6821.0,7058.0,6378.0,6877.0,6179.0,6156.0,6870.0,5835.0,75143.0
Banas Kantha,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,54.0,10.0,34.0,53.0,76.0,75.0,83.0,68.0,50.0,54.0,64.0,41.0,662.0
Banas Kantha,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,25.0,42.0,26.0,21.0,32.0,53.0,37.0,38.0,50.0,46.0,67.0,41.0,478.0
Banas Kantha,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,9.0,7.0,5.0,14.0,16.0,15.0,12.0,5.0,14.0,1.0,2.0,100.0
Banas Kantha,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banas Kantha,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,79.0,61.0,67.0,79.0,122.0,144.0,135.0,118.0,105.0,114.0,132.0,84.0,1240.0
Banas Kantha,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,24.0,24.0,24.0,23.0,23.0,44.0,26.0,35.0,21.0,30.0,0.0,3.0,277.0
Banas Kantha,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,57.0,75.0,85.0,92.0,131.0,179.0,142.0,141.0,106.0,125.0,94.0,48.0,1275.0
Banas Kantha,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,37.0,28.0,32.0,31.0,38.0,79.0,56.0,67.0,42.0,44.0,22.0,4.0,480.0
Banas Kantha,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,55.0,75.0,83.0,82.0,134.0,165.0,147.0,128.0,106.0,127.0,88.0,64.0,1254.0
Banas Kantha,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,4.0,18.0,10.0,5.0,14.0,30.0,16.0,6.0,8.0,23.0,17.0,38.0,189.0
Banas Kantha,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,4838.0,5226.0,5109.0,5518.0,6532.0,6586.0,6154.0,6170.0,5930.0,5644.0,6451.0,5360.0,69518.0
Banas Kantha,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,4986.0,5313.0,5056.0,5513.0,6359.0,6560.0,6150.0,6338.0,6010.0,5647.0,6430.0,5133.0,69495.0
Banas Kantha,6.3,PNC maternal complications attended,TOTAL,13.0,8.0,9.0,9.0,8.0,15.0,24.0,15.0,16.0,14.0,7.0,4.0,142.0
Banas Kantha,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,31.0,37.0,13.0,16.0,7.0,17.0,17.0,19.0,19.0,28.0,9.0,21.0,234.0
Banas Kantha,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,12.0,1.0,0.0,2.0,3.0,1.0,3.0,1.0,0.0,0.0,10.0,11.0,44.0
Banas Kantha,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,43.0,38.0,13.0,18.0,10.0,18.0,20.0,20.0,19.0,28.0,19.0,32.0,278.0
Banas Kantha,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,208.0,154.0,268.0,293.0,230.0,238.0,212.0,216.0,266.0,229.0,219.0,303.0,2836.0
Banas Kantha,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,624.0,416.0,516.0,488.0,429.0,445.0,414.0,434.0,592.0,492.0,505.0,504.0,5859.0
Banas Kantha,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,832.0,570.0,784.0,781.0,659.0,683.0,626.0,650.0,858.0,721.0,724.0,807.0,8695.0
Banas Kantha,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Banas Kantha,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,4.0,2.0,1.0,1.0,9.0
Banas Kantha,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banas Kantha,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,4.0,2.0,1.0,1.0,11.0
Banas Kantha,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,57.0,49.0,80.0,125.0,158.0,214.0,131.0,528.0,1266.0,1053.0,434.0,143.0,4238.0
Banas Kantha,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,38.0,20.0,14.0,78.0,72.0,38.0,47.0,241.0,763.0,658.0,212.0,21.0,2202.0
Banas Kantha,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banas Kantha,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,95.0,69.0,94.0,203.0,230.0,252.0,178.0,769.0,2029.0,1711.0,646.0,164.0,6440.0
Banas Kantha,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,124.0,182.0,167.0,372.0,263.0,466.0,423.0,772.0,843.0,816.0,579.0,270.0,5277.0
Banas Kantha,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,16.0,23.0,12.0,49.0,24.0,33.0,35.0,35.0,48.0,51.0,16.0,23.0,365.0
Banas Kantha,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,12.0,6.0,4.0,10.0,15.0,20.0,5.0,25.0,24.0,28.0,31.0,6.0,186.0
Banas Kantha,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banas Kantha,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,28.0,29.0,16.0,59.0,39.0,53.0,40.0,60.0,72.0,79.0,47.0,29.0,551.0
Banas Kantha,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,583.0,844.0,963.0,2003.0,2284.0,2581.0,2295.0,2098.0,1910.0,1754.0,1713.0,1604.0,20632.0
Banas Kantha,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,3.0,10.0,0.0,1.0,1.0,2.0,2.0,0.0,0.0,0.0,0.0,19.0
Banas Kantha,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,3.0,0.0,3.0,4.0,4.0,3.0,2.0,3.0,3.0,7.0,4.0,0.0,36.0
Banas Kantha,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banas Kantha,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,3.0,3.0,13.0,4.0,5.0,4.0,4.0,5.0,3.0,7.0,4.0,0.0,55.0
Banas Kantha,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,1.0,4.0,0.0,0.0,0.0,4.0,2.0,0.0,4.0,0.0,0.0,3.0,18.0
Banas Kantha,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,2166.0,2514.0,2947.0,3343.0,3686.0,3691.0,3761.0,3652.0,3432.0,3407.0,2900.0,2150.0,37649.0
Banas Kantha,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,218.0,228.0,190.0,387.0,223.0,218.0,277.0,291.0,428.0,354.0,485.0,484.0,3783.0
Banas Kantha,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,43.0,35.0,71.0,64.0,63.0,92.0,72.0,66.0,64.0,78.0,46.0,61.0,755.0
Banas Kantha,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,16.0,11.0,6.0,16.0,14.0,11.0,13.0,13.0,7.0,4.0,0.0,5.0,116.0
Banas Kantha,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Banas Kantha,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,2443.0,2788.0,3214.0,3810.0,3986.0,4012.0,4123.0,4022.0,3931.0,3843.0,3431.0,2700.0,42303.0
Banas Kantha,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,5.0,12.0,4.0,0.0,4.0,2.0,35.0,62.0,86.0,97.0,98.0,41.0,446.0
Banas Kantha,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,396.0,347.0,312.0,453.0,439.0,295.0,164.0,519.0,583.0,623.0,893.0,650.0,5674.0
Banas Kantha,9.06,Number of IUCD removals,TOTAL,472.0,505.0,518.0,512.0,506.0,654.0,500.0,554.0,591.0,649.0,518.0,439.0,6418.0
Banas Kantha,9.07,Number of Oral Pills cycles distributed,TOTAL,3162.0,3298.0,2830.0,4766.0,5508.0,5573.0,6246.0,6602.0,8860.0,8421.0,6875.0,5696.0,67837.0
Banas Kantha,9.08,Number of Condom pieces distributed,TOTAL,22281.0,26207.0,29558.0,24652.0,30944.0,105091.0,86158.0,68856.0,72807.0,67798.0,60031.0,51370.0,645753.0
Banas Kantha,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,69.0,100.0,64.0,101.0,109.0,153.0,155.0,121.0,84.0,95.0,102.0,90.0,1243.0
Banas Kantha,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,3.0,4.0,5.0,4.0,6.0,3.0,6.0,6.0,7.0,7.0,6.0,-1.0
Banas Kantha,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5264.0,5530.0,5310.0,5573.0,6178.0,6365.0,6095.0,6442.0,6218.0,6136.0,6217.0,5715.0,71043.0
Banas Kantha,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,5781.0,5716.0,5398.0,5625.0,6085.0,6172.0,6266.0,6463.0,6390.0,6262.0,6148.0,5578.0,71884.0
Banas Kantha,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,5751.0,5650.0,5542.0,5317.0,5686.0,6175.0,6278.0,5983.0,6287.0,5955.0,6235.0,5777.0,70636.0
Banas Kantha,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,6029.0,5681.0,5465.0,5493.0,5549.0,5777.0,6083.0,5975.0,6142.0,6007.0,5712.0,5687.0,69600.0
Banas Kantha,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1457.0,1645.0,1879.0,1830.0,2566.0,2795.0,2530.0,2138.0,2072.0,2061.0,1845.0,1767.0,24585.0
Banas Kantha,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,5752.0,5719.0,5404.0,5621.0,6062.0,6185.0,6259.0,6450.0,6385.0,6302.0,6136.0,5579.0,71854.0
Banas Kantha,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5748.0,5623.0,5541.0,5392.0,5682.0,6098.0,6200.0,5985.0,6391.0,5968.0,6238.0,5720.0,70586.0
Banas Kantha,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,6019.0,5645.0,5464.0,5443.0,5540.0,5793.0,6110.0,5967.0,6166.0,6028.0,5727.0,5681.0,69583.0
Banas Kantha,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,692.0,970.0,1208.0,980.0,1580.0,1628.0,1568.0,1194.0,1154.0,1242.0,990.0,1103.0,14309.0
Banas Kantha,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5547.0,5671.0,5397.0,5462.0,5833.0,6035.0,5878.0,6078.0,5888.0,5651.0,5553.0,5323.0,68316.0
Banas Kantha,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4722.0,4888.0,4729.0,4826.0,5331.0,5372.0,5905.0,5731.0,5711.0,5346.0,5436.0,5136.0,63133.0
Banas Kantha,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2915.0,2918.0,2787.0,2859.0,3016.0,3107.0,3086.0,3213.0,3085.0,2930.0,2875.0,2743.0,35534.0
Banas Kantha,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2567.0,2579.0,2526.0,2479.0,2695.0,2725.0,2738.0,2794.0,2786.0,2683.0,2670.0,2523.0,31765.0
Banas Kantha,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5482.0,5497.0,5313.0,5338.0,5711.0,5832.0,5824.0,6007.0,5871.0,5613.0,5545.0,5266.0,67299.0
Banas Kantha,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,5052.0,5060.0,4967.0,5052.0,5402.0,5574.0,5772.0,5871.0,5800.0,5586.0,5528.0,5274.0,64938.0
Banas Kantha,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5052.0,5054.0,4967.0,5057.0,5401.0,5579.0,5745.0,5875.0,5802.0,5594.0,5509.0,5288.0,64923.0
Banas Kantha,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2256.0,2394.0,2315.0,2526.0,2697.0,2737.0,2775.0,2880.0,2818.0,2735.0,2697.0,2506.0,31336.0
Banas Kantha,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2083.0,2179.0,2020.0,2211.0,2401.0,2472.0,2494.0,2565.0,2571.0,2498.0,2450.0,2316.0,28260.0
Banas Kantha,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,4339.0,4573.0,4335.0,4737.0,5098.0,5209.0,5269.0,5445.0,5389.0,5233.0,5147.0,4822.0,59596.0
Banas Kantha,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,3386.0,3707.0,4175.0,5962.0,7056.0,6754.0,5228.0,5698.0,5751.0,4346.0,4807.0,4815.0,61685.0
Banas Kantha,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2986.0,2930.0,3624.0,6679.0,8585.0,7431.0,5369.0,5511.0,6254.0,4229.0,4965.0,4046.0,62609.0
Banas Kantha,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,4237.0,4415.0,4465.0,5263.0,5780.0,5573.0,5339.0,5542.0,5447.0,5185.0,5272.0,4137.0,60655.0
Banas Kantha,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,9.0,2.0,2.0,4.0,9.0,6.0,1.0,21.0,26.0,3.0,2.0,11.0,96.0
Banas Kantha,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,198.0,271.0,264.0,234.0,214.0,272.0,334.0,376.0,300.0,405.0,499.0,333.0,3700.0
Banas Kantha,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2654.0,2647.0,2638.0,2664.0,2717.0,2676.0,2737.0,2726.0,2711.0,2675.0,2724.0,2759.0,32328.0
Banas Kantha,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2580.0,2549.0,2535.0,2600.0,2596.0,2592.0,2645.0,2625.0,2645.0,2575.0,2629.0,2643.0,31214.0
Banas Kantha,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2437.0,2420.0,2387.0,2498.0,2474.0,2456.0,2512.0,2446.0,2570.0,2501.0,2531.0,2465.0,29697.0
Banas Kantha,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5400.0,5383.0,5223.0,5408.0,5849.0,5924.0,5823.0,6065.0,6350.0,5601.0,5659.0,5223.0,67908.0
Banas Kantha,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,18150.0,300.0,194.0,327.0,188.0,3026.0,264.0,15097.0,48019.0,103.0,159.0,154.0,85981.0
Banas Kantha,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,42614.0,301.0,325.0,290.0,374.0,3382.0,424.0,23655.0,88542.0,249.0,274.0,203.0,160633.0
Banas Kantha,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,30.0,12.0,28.0,8.0,3.0,25.0,7.0,6.0,3.0,3.0,23.0,16.0,164.0
Banas Kantha,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,5140.0,5750.0,5807.0,5875.0,6586.0,5840.0,4878.0,4884.0,6204.0,5711.0,5229.0,5124.0,67028.0
Banas Kantha,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,26.0,14.0,3.0,21.0,17.0,29.0,18.0,22.0,40.0,6.0,22.0,13.0,231.0
Banas Kantha,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,54.0,56.0,41.0,25.0,38.0,15.0,15.0,45.0,64.0,49.0,54.0,60.0,516.0
Banas Kantha,13.1,Number of Patients operated for cataract,TOTAL,310.0,393.0,350.0,330.0,509.0,364.0,273.0,430.0,335.0,438.0,445.0,398.0,4575.0
Banas Kantha,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,310.0,393.0,350.0,330.0,509.0,364.0,273.0,430.0,335.0,438.0,445.0,398.0,4575.0
Banas Kantha,13.3,Number of School children detected with Refractive errors,TOTAL,83.0,71.0,48.0,301.0,164.0,1241.0,125.0,1116.0,341.0,607.0,373.0,335.0,4805.0
Banas Kantha,13.4,Number of children provided free glasses,TOTAL,17.0,32.0,38.0,216.0,154.0,181.0,125.0,203.0,332.0,530.0,373.0,242.0,2443.0
Banas Kantha,13.5,Number of eyes collected through eye donation,TOTAL,4.0,4.0,4.0,0.0,1.0,0.0,2.0,2.0,3.0,0.0,1.0,0.0,21.0
Banas Kantha,13.6,Number of eyes utilised for corneal transplant,TOTAL,4.0,4.0,4.0,0.0,1.0,0.0,2.0,2.0,0.0,0.0,1.0,0.0,18.0
Banas Kantha,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,9.0,9.0,9.0,9.0,9.0,11.0,11.0,9.0,10.0,10.0,10.0,10.0,-1.0
Banas Kantha,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,9.0,7.0,9.0,8.0,12.0,9.0,9.0,12.0,10.0,10.0,12.0,10.0,-1.0
Banas Kantha,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2704.0,2115.0,2724.0,2914.0,2666.0,2738.0,2608.0,2481.0,2353.0,2556.0,2210.0,2091.0,-1.0
Banas Kantha,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,23.0,19.0,21.0,18.0,19.0,20.0,20.0,20.0,20.0,20.0,20.0,18.0,-1.0
Banas Kantha,14.05,Number of RKS meetings held during the month,TOTAL,13.0,16.0,44.0,28.0,30.0,34.0,28.0,27.0,36.0,27.0,31.0,39.0,353.0
Banas Kantha,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,60.0,59.0,61.0,58.0,58.0,61.0,59.0,56.0,55.0,57.0,56.0,54.0,-1.0
Banas Kantha,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,554.0,477.0,450.0,430.0,412.0,439.0,345.0,269.0,420.0,438.0,380.0,442.0,5056.0
Banas Kantha,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,15.0,14.0,11.0,12.0,14.0,13.0,12.0,12.0,12.0,11.0,11.0,13.0,-1.0
Banas Kantha,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,10.0,13.0,11.0,11.0,11.0,11.0,9.0,9.0,11.0,13.0,13.0,13.0,-1.0
Banas Kantha,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,810.0,1064.0,1026.0,1288.0,1314.0,1267.0,2353.0,1059.0,1147.0,1282.0,1185.0,1283.0,15078.0
Banas Kantha,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,4184.0,4853.0,4849.0,5169.0,5649.0,5436.0,8331.0,4446.0,4333.0,4119.0,6789.0,5415.0,63573.0
Banas Kantha,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,843.0,1071.0,1161.0,1170.0,1228.0,1079.0,2481.0,1237.0,1125.0,1111.0,1455.0,1245.0,15206.0
Banas Kantha,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5605.0,5287.0,5771.0,5852.0,6583.0,6249.0,8286.0,6311.0,7540.0,6658.0,9108.0,6873.0,80123.0
Banas Kantha,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1653.0,2135.0,2187.0,2458.0,2542.0,2346.0,4834.0,2296.0,2272.0,2393.0,2640.0,2528.0,30284.0
Banas Kantha,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9789.0,10140.0,10620.0,11021.0,12232.0,11685.0,16617.0,10757.0,11873.0,10777.0,15897.0,12288.0,143696.0
Banas Kantha,14.10.2.a,Number of death cases of Inpatient males,TOTAL,18.0,18.0,16.0,19.0,19.0,16.0,24.0,18.0,21.0,19.0,17.0,15.0,220.0
Banas Kantha,14.10.2.b,Number of death cases of Inpatient females,TOTAL,19.0,11.0,10.0,9.0,14.0,7.0,6.0,12.0,11.0,15.0,10.0,7.0,131.0
Banas Kantha,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,37.0,29.0,26.0,28.0,33.0,23.0,30.0,30.0,32.0,34.0,27.0,22.0,351.0
Banas Kantha,14.11,In-Patient Head Count at midnight,TOTAL,2435.0,3675.0,2553.0,4155.0,5071.0,4347.0,2533.0,4271.0,5321.0,7063.0,6382.0,8414.0,56220.0
Banas Kantha,14.12.1,OPD attendance (All),TOTAL,168508.0,158834.0,161952.0,176664.0,209735.0,223352.0,180630.0,183139.0,193814.0,162690.0,281741.0,243931.0,2344990.0
Banas Kantha,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,127.0,132.0,102.0,147.0,139.0,102.0,146.0,141.0,172.0,206.0,67.0,85.0,1566.0
Banas Kantha,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,5.0,7.0,2.0,6.0,6.0,5.0,7.0,1.0,9.0,9.0,4.0,13.0,74.0
Banas Kantha,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,495.0,458.0,378.0,573.0,512.0,501.0,438.0,1031.0,1073.0,1182.0,637.0,221.0,7499.0
Banas Kantha,14.14.a,Number of patients given AYUSH treatment,TOTAL,6295.0,5886.0,5764.0,6415.0,6880.0,6973.0,5592.0,5746.0,7170.0,8102.0,10076.0,12098.0,86997.0
Banas Kantha,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,525.0,486.0,677.0,725.0,726.0,717.0,496.0,653.0,705.0,713.0,546.0,638.0,7607.0
Banas Kantha,14.14.c,Number of Adolescents counselled,TOTAL,56.0,65.0,81.0,276.0,266.0,113.0,147.0,124.0,129.0,134.0,115.0,111.0,1617.0
Banas Kantha,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,16160.0,14891.0,14987.0,13971.0,15706.0,15394.0,12472.0,12536.0,17238.0,16923.0,19717.0,18910.0,188905.0
Banas Kantha,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1093.0,865.0,1054.0,942.0,1104.0,1262.0,797.0,704.0,931.0,986.0,1060.0,1078.0,11876.0
Banas Kantha,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2311.0,2699.0,2614.0,2849.0,2403.0,2816.0,2526.0,2192.0,2547.0,2159.0,2571.0,2763.0,30450.0
Banas Kantha,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,50.0,14.0,46.0,37.0,15.0,20.0,9.0,16.0,14.0,18.0,19.0,15.0,273.0
Banas Kantha,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1771.0,1798.0,2072.0,1859.0,1765.0,2105.0,1795.0,2018.0,2966.0,2243.0,2359.0,2028.0,24779.0
Banas Kantha,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,25.0,18.0,22.0,26.0,17.0,14.0,6.0,14.0,12.0,10.0,8.0,9.0,181.0
Banas Kantha,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2731.0,2927.0,3373.0,3449.0,3298.0,3897.0,3316.0,2941.0,2896.0,2808.0,3524.0,2972.0,38132.0
Banas Kantha,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,17.0,21.0,9.0,11.0,19.0,16.0,26.0,79.0,111.0,107.0,100.0,64.0,580.0
Banas Kantha,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6813.0,7424.0,8059.0,8157.0,7466.0,8818.0,7637.0,7151.0,8409.0,7210.0,8454.0,7763.0,93361.0
Banas Kantha,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,92.0,53.0,77.0,74.0,51.0,50.0,41.0,109.0,137.0,135.0,127.0,88.0,1034.0
Banas Kantha,15.2,Number of Widal tests conducted,Number tested,543.0,795.0,700.0,798.0,1095.0,1051.0,942.0,944.0,929.0,609.0,1573.0,1104.0,11083.0
Banas Kantha,15.3.a,Number of VDRL tests conducted on males,Number tested,171.0,195.0,206.0,249.0,74.0,241.0,183.0,227.0,184.0,179.0,253.0,1169.0,3331.0
Banas Kantha,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,270.0,225.0,261.0,269.0,115.0,219.0,161.0,254.0,286.0,193.0,251.0,245.0,2749.0
Banas Kantha,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,309.0,335.0,326.0,318.0,102.0,278.0,273.0,366.0,338.0,268.0,290.0,276.0,3479.0
Banas Kantha,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,750.0,755.0,793.0,836.0,291.0,738.0,617.0,847.0,808.0,640.0,794.0,1690.0,9559.0
Banas Kantha,15.4.1,Number of blood smears examined for Malaria,TOTAL,20816.0,21622.0,21493.0,23717.0,27207.0,30157.0,23680.0,24091.0,24492.0,18275.0,31139.0,26055.0,292744.0
Banas Kantha,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1043.0,170.0,79.0,92.0,72.0,148.0,883.0,45.0,36.0,98.0,207.0,17.0,2890.0
Banas Kantha,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,1.0,0.0,1.0,1.0,8.0,10.0,13.0,3.0,0.0,0.0,2.0,39.0
Banas Kantha,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,12100.0,300.0,150.0,3550.0,5500.0,3300.0,2200.0,5600.0,5100.0,8700.0,5000.0,7500.0,59000.0
Banas Kantha,16.1.1,Stock position of DPT vaccines,2. Stocks Received,11500.0,17500.0,22500.0,20000.0,15000.0,15000.0,20000.0,15000.0,20000.0,10000.0,15000.0,18000.0,199500.0
Banas Kantha,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,300.0,150.0,3550.0,5500.0,3300.0,2200.0,5600.0,5100.0,8700.0,5000.0,7500.0,3500.0,50400.0
Banas Kantha,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,23300.0,17650.0,19100.0,18050.0,17200.0,16100.0,16600.0,15500.0,16400.0,13700.0,12500.0,22000.0,208100.0
Banas Kantha,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,12000.0,4000.0,4500.0,13200.0,8500.0,15000.0,5500.0,12500.0,10500.0,13500.0,16500.0,9500.0,125200.0
Banas Kantha,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,42000.0,21000.0,30000.0,21000.0,24000.0,9000.0,24000.0,18000.0,21000.0,21000.0,12000.0,29000.0,272000.0
Banas Kantha,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,4000.0,4500.0,13200.0,8500.0,15000.0,5500.0,12500.0,10500.0,13500.0,16500.0,9500.0,10000.0,123200.0
Banas Kantha,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,50000.0,20500.0,21300.0,25700.0,17500.0,18500.0,17000.0,20000.0,18000.0,18000.0,19000.0,28500.0,274000.0
Banas Kantha,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1140.0,12500.0,11500.0,8900.0,4700.0,5700.0,5700.0,9700.0,24600.0,38200.0,2300.0,23500.0,148440.0
Banas Kantha,16.1.2,Stock position of OPV vaccines,2. Stocks Received,90000.0,40000.0,39000.0,35000.0,40000.0,40000.0,40000.0,54000.0,640000.0,13000.0,640000.0,40000.0,1711000.0
Banas Kantha,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,12500.0,11500.0,8900.0,4700.0,5700.0,5700.0,9700.0,24600.0,38200.0,2300.0,23500.0,15300.0,162600.0
Banas Kantha,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,78640.0,41000.0,41600.0,39200.0,39000.0,40000.0,36000.0,39100.0,626400.0,48900.0,618800.0,48200.0,1696840.0
Banas Kantha,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2300.0,23800.0,21800.0,27000.0,16600.0,27100.0,17100.0,29400.0,23600.0,27400.0,14400.0,22900.0,253400.0
Banas Kantha,16.1.3,Stock position of TT vaccines,2. Stocks Received,80000.0,20000.0,30000.0,20000.0,32000.0,16000.0,32000.0,15000.0,22500.0,10000.0,30000.0,30000.0,337500.0
Banas Kantha,16.1.3,Stock position of TT vaccines,3. Unusable Stock,23800.0,21800.0,27000.0,16600.0,27100.0,17100.0,29400.0,23600.0,27400.0,14400.0,22900.0,16000.0,267100.0
Banas Kantha,16.1.3,Stock position of TT vaccines,4. Stock Distributed,58500.0,22000.0,24800.0,30400.0,21500.0,26000.0,19700.0,20800.0,18700.0,23000.0,21500.0,36900.0,323800.0
Banas Kantha,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,5220.0,4500.0,4070.0,5200.0,5420.0,5720.0,5220.0,4120.0,3770.0,3820.0,2320.0,0.0,49380.0
Banas Kantha,16.1.5,Stock position of BCG vaccines,2. Stocks Received,25000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,0.0,30000.0,145000.0
Banas Kantha,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,4500.0,4070.0,5200.0,5420.0,5720.0,5220.0,4120.0,3770.0,3820.0,2320.0,0.0,6200.0,50360.0
Banas Kantha,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,25720.0,10430.0,8870.0,9780.0,9700.0,10500.0,11100.0,10350.0,9950.0,11500.0,2320.0,23800.0,144020.0
Banas Kantha,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,9150.0,150.0,6750.0,12250.0,6500.0,3750.0,5500.0,8000.0,9150.0,7500.0,5750.0,11250.0,85700.0
Banas Kantha,16.1.6,Stock position of Measles vaccines,2. Stocks Received,14000.0,20000.0,20000.0,10000.0,10000.0,15000.0,15000.0,14150.0,10000.0,10000.0,15000.0,20000.0,173150.0
Banas Kantha,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,150.0,6750.0,12250.0,6500.0,3750.0,5500.0,8000.0,9150.0,7500.0,5750.0,11250.0,11000.0,87550.0
Banas Kantha,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,23000.0,13400.0,14500.0,15750.0,12750.0,13250.0,12500.0,13000.0,11650.0,11750.0,9500.0,20250.0,171300.0
Banas Kantha,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,10000.0,8000.0,7700.0,6800.0,6250.0,5250.0,4500.0,3850.0,3200.0,2950.0,2000.0,900.0,61400.0
Banas Kantha,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,1200.0
Banas Kantha,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,8000.0,7700.0,6800.0,6250.0,5250.0,4500.0,3850.0,3200.0,2950.0,2000.0,900.0,900.0,52300.0
Banas Kantha,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2000.0,300.0,900.0,550.0,1000.0,750.0,650.0,650.0,250.0,950.0,1100.0,1200.0,10300.0
Banas Kantha,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,221.0,21.0,21.0,21.0,21.0,21.0,3021.0,21.0,0.0,21.0,21.0,21.0,3431.0
Banas Kantha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,5700.0,0.0,24000.0,0.0,12000.0,8400.0,0.0,0.0,0.0,0.0,0.0,0.0,50100.0
Banas Kantha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,21.0,21.0,21.0,21.0,21.0,3021.0,21.0,0.0,0.0,21.0,21.0,21.0,3210.0
Banas Kantha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,5900.0,0.0,24000.0,0.0,12000.0,5400.0,3000.0,21.0,0.0,0.0,0.0,0.0,50321.0
Banas Kantha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,115920.0,10080.0,10080.0,10080.0,0.0,0.0,146160.0
Banas Kantha,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,50400.0,0.0,423360.0,252000.0,0.0,60000.0,0.0,0.0,0.0,0.0,785760.0
Banas Kantha,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,115920.0,10080.0,10080.0,10080.0,0.0,0.0,0.0,146160.0
Banas Kantha,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,50400.0,0.0,423360.0,136080.0,105840.0,60000.0,0.0,10080.0,0.0,0.0,785760.0
Banas Kantha,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,8500.0,5000.0,0.0,13800.0,4200.0,4200.0,4200.0,300.0,0.0,40200.0
Banas Kantha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,42000.0,0.0,0.0,30000.0,0.0,70000.0,0.0,24600.0,0.0,0.0,166600.0
Banas Kantha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,8500.0,5000.0,0.0,13800.0,4200.0,4200.0,4200.0,300.0,0.0,0.0,40200.0
Banas Kantha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,33500.0,3500.0,5000.0,16200.0,9600.0,70000.0,0.0,28500.0,300.0,0.0,166600.0
Banas Kantha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,5000.0,0.0,0.0,0.0,4500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9500.0
Banas Kantha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,5000.0,0.0,0.0,0.0,4500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9500.0
Banas Kantha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3336.0,7736.0,7736.0,7736.0,6736.0,6736.0,6736.0,6236.0,4036.0,1536.0,9200.0,8500.0,76260.0
Banas Kantha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,15000.0
Banas Kantha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,7736.0,7736.0,7736.0,6736.0,6736.0,6736.0,6236.0,4036.0,1536.0,9200.0,8500.0,8500.0,81424.0
Banas Kantha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,600.0,0.0,0.0,1000.0,0.0,0.0,500.0,2200.0,2500.0,2336.0,700.0,0.0,9836.0
Banas Kantha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,725.0,625.0,625.0,475.0,475.0,75.0,2200.0,2100.0,1900.0,1100.0,650.0,6525.0,17475.0
Banas Kantha,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,2500.0,0.0,0.0,0.0,0.0,6500.0,0.0,9000.0
Banas Kantha,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,625.0,625.0,475.0,475.0,75.0,2200.0,2100.0,1900.0,1100.0,650.0,6525.0,4125.0,20875.0
Banas Kantha,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,100.0,0.0,150.0,0.0,400.0,375.0,100.0,200.0,800.0,450.0,625.0,2400.0,5600.0
Banas Kantha,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,13125.0,15625.0,15625.0,20125.0,19475.0,19475.0,19475.0,19475.0,18200.0,15850.0,14200.0,21600.0,212250.0
Banas Kantha,16.3.02,Stock Position of Gloves,2. Stocks Received,3500.0,0.0,4500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7800.0,0.0,15800.0
Banas Kantha,16.3.02,Stock Position of Gloves,3. Unusable Stock,15625.0,15625.0,20125.0,19475.0,19475.0,19475.0,19475.0,18200.0,15850.0,14200.0,21600.0,21600.0,220725.0
Banas Kantha,16.3.02,Stock Position of Gloves,4. Stock Distributed,1000.0,0.0,0.0,650.0,0.0,0.0,0.0,1275.0,2350.0,1650.0,400.0,0.0,7325.0
Banas Kantha,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,1400.0,1400.0,1200.0,1200.0,1200.0,1200.0,200.0,10200.0,17100.0,16700.0,15900.0,0.0,67700.0
Banas Kantha,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,7000.0,0.0,0.0,0.0,0.0,17000.0
Banas Kantha,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,1400.0,1200.0,1200.0,1200.0,1200.0,200.0,0.0,17100.0,16700.0,15900.0,0.0,0.0,56100.0
Banas Kantha,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,200.0,0.0,0.0,0.0,11000.0,200.0,100.0,400.0,800.0,15900.0,0.0,28600.0
Banas Kantha,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,85.0,91.0,90.0,110.0,103.0,123.0,121.0,121.0,99.0,72.0,56.0,52.0,1123.0
Banas Kantha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,10.0,0.0,20.0,0.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Banas Kantha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,91.0,90.0,110.0,103.0,123.0,121.0,121.0,99.0,72.0,56.0,52.0,50.0,1088.0
Banas Kantha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,4.0,1.0,0.0,7.0,0.0,2.0,0.0,22.0,27.0,16.0,4.0,2.0,85.0
Banas Kantha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,1820000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1820000.0
Banas Kantha,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,1820000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1820000.0
Banas Kantha,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,8900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8900.0
Banas Kantha,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,8900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8900.0
Banas Kantha,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8500.0,0.0,0.0,0.0,0.0,8500.0
Banas Kantha,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8500.0,0.0,0.0,0.0,0.0,8500.0
Banas Kantha,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,92981.0,100531.0,125531.0,124031.0,40031.0,86431.0,160181.0,153071.0,338571.0,333881.0,369357.0,366157.0,2290754.0
Banas Kantha,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,10000.0,25000.0,0.0,10000.0,60000.0,288500.0,10000.0,185500.0,0.0,42700.0,0.0,0.0,631700.0
Banas Kantha,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,100531.0,125531.0,124031.0,40031.0,86431.0,160181.0,153071.0,338571.0,333881.0,369357.0,366157.0,266381.0,2464154.0
Banas Kantha,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,2450.0,0.0,1500.0,94000.0,13600.0,214750.0,17110.0,0.0,4690.0,7224.0,3200.0,99776.0,458300.0
Banas Kantha,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7430.0,8130.0
Banas Kantha,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,9900.0,0.0,49500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26400.0,0.0,85800.0
Banas Kantha,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7430.0,2590.0,10720.0
Banas Kantha,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,9200.0,700.0,49500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18970.0,4840.0,83210.0
Banas Kantha,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,304000.0,0.0,200000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,504000.0
Banas Kantha,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,304000.0,0.0,200000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,504000.0
Banas Kantha,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2900.0,2900.0
Banas Kantha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,20000.0
Banas Kantha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2900.0,900.0,3800.0
Banas Kantha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7100.0,2000.0,19100.0
Banas Kantha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Banas Kantha,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,1.0,1.0,,1.0,8.0,2.0,1.0,3.0,1.0,3.0,3.0,27.0
Banas Kantha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,2.0,2.0,2.0,,,,2.0,,1.0,1.0,2.0,13.0
Banas Kantha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,1.0,,,,,,,,,,1.0
Banas Kantha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,2.0,3.0,2.0,,,,2.0,,1.0,1.0,2.0,14.0
Banas Kantha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,8.0,14.0,24.0,14.0,24.0,20.0,16.0,24.0,18.0,25.0,10.0,11.0,208.0
Banas Kantha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,1.0,,2.0,,2.0,5.0,1.0,1.0,2.0,,,,14.0
Banas Kantha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,9.0,14.0,26.0,14.0,26.0,25.0,17.0,25.0,20.0,25.0,10.0,11.0,222.0
Banas Kantha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,44.0,59.0,60.0,51.0,41.0,52.0,33.0,42.0,58.0,46.0,28.0,22.0,536.0
Banas Kantha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,5.0,5.0,8.0,3.0,5.0,6.0,7.0,7.0,7.0,3.0,7.0,,63.0
Banas Kantha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,49.0,64.0,68.0,54.0,46.0,58.0,40.0,49.0,65.0,49.0,35.0,22.0,599.0
Banas Kantha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,35.0,61.0,57.0,68.0,45.0,44.0,57.0,46.0,35.0,49.0,40.0,34.0,571.0
Banas Kantha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,9.0,4.0,13.0,8.0,6.0,6.0,7.0,5.0,4.0,8.0,12.0,4.0,86.0
Banas Kantha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,44.0,65.0,70.0,76.0,51.0,50.0,64.0,51.0,39.0,57.0,52.0,38.0,657.0
Banas Kantha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,5.0,3.0,6.0,4.0,2.0,13.0,5.0,4.0,7.0,7.0,,4.0,60.0
Banas Kantha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,2.0,5.0,,1.0,,1.0,,10.0
Banas Kantha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,5.0,4.0,6.0,4.0,2.0,15.0,10.0,4.0,8.0,7.0,1.0,4.0,70.0
Banas Kantha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,1.0,,,,,,,1.0,,,2.0
Banas Kantha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Banas Kantha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,1.0,,1.0,,,,,1.0,,,3.0
Banas Kantha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,3.0,,1.0,,1.0,2.0,,2.0,1.0,,1.0,,11.0
Banas Kantha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,4.0,,3.0,,1.0,2.0,,,,11.0
Banas Kantha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,3.0,1.0,1.0,4.0,1.0,5.0,,3.0,3.0,,1.0,,22.0
Banas Kantha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Banas Kantha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Banas Kantha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Banas Kantha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,29.0,29.0,28.0,13.0,23.0,35.0,24.0,24.0,32.0,30.0,22.0,17.0,306.0
Banas Kantha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,22.0,11.0,16.0,11.0,13.0,16.0,11.0,12.0,11.0,12.0,9.0,4.0,148.0
Banas Kantha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,51.0,40.0,44.0,24.0,36.0,51.0,35.0,36.0,43.0,42.0,31.0,21.0,454.0
Banas Kantha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Banas Kantha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Banas Kantha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,2.0,2.0,1.0,,2.0,2.0,,,,,,9.0
Banas Kantha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,2.0,2.0,1.0,,2.0,2.0,,,,,,9.0
Banas Kantha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Banas Kantha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,11.0,9.0,9.0,,5.0,4.0,3.0,3.0,9.0,10.0,6.0,4.0,73.0
Banas Kantha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,3.0,1.0,2.0,3.0,4.0,2.0,1.0,,4.0,,2.0,4.0,26.0
Banas Kantha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,14.0,10.0,11.0,3.0,9.0,6.0,4.0,3.0,13.0,11.0,8.0,8.0,100.0
Banas Kantha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,1.0,,1.0,,1.0,3.0,,1.0,3.0,1.0,2.0,,13.0
Banas Kantha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,8.0,13.0,21.0,18.0,20.0,15.0,19.0,13.0,19.0,22.0,22.0,18.0,208.0
Banas Kantha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,35.0,54.0,34.0,32.0,46.0,48.0,56.0,33.0,58.0,44.0,49.0,50.0,539.0
Banas Kantha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,44.0,67.0,56.0,50.0,67.0,66.0,75.0,47.0,80.0,67.0,73.0,68.0,760.0
Banas Kantha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Banas Kantha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Banas Kantha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Banas Kantha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,1.0,,,,,,1.0
Banas Kantha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,9.0,9.0,3.0,2.0,2.0,1.0,2.0,6.0,6.0,5.0,6.0,3.0,54.0
Banas Kantha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,64.0,47.0,64.0,45.0,64.0,39.0,54.0,38.0,44.0,45.0,83.0,40.0,627.0
Banas Kantha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,75.0,52.0,84.0,74.0,67.0,81.0,96.0,62.0,78.0,108.0,99.0,78.0,954.0
Banas Kantha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,148.0,108.0,151.0,121.0,133.0,121.0,152.0,106.0,128.0,158.0,188.0,121.0,1635.0
Banas Kantha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Banas Kantha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,1.0,1.0,1.0,1.0,2.0,2.0,1.0,2.0,,1.0,,12.0
Banas Kantha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,,,,1.0,2.0,,,,,,,4.0
Banas Kantha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,1.0,1.0,1.0,2.0,4.0,3.0,1.0,2.0,,1.0,,17.0
Banas Kantha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,1.0,,,1.0,,1.0,,,2.0,1.0,2.0,9.0
Banas Kantha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,26.0,31.0,28.0,20.0,26.0,35.0,31.0,26.0,30.0,51.0,53.0,25.0,382.0
Banas Kantha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,35.0,42.0,35.0,33.0,40.0,47.0,51.0,38.0,52.0,50.0,63.0,40.0,526.0
Banas Kantha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,62.0,74.0,63.0,53.0,67.0,82.0,83.0,64.0,82.0,103.0,117.0,67.0,917.0
Banas Kantha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,,1.0,,1.0,,2.0,,2.0,,2.0,9.0
Banas Kantha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,6.0,2.0,4.0,8.0,2.0,6.0,11.0,2.0,3.0,8.0,8.0,9.0,69.0
Banas Kantha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,6.0,5.0,5.0,14.0,3.0,10.0,9.0,3.0,9.0,8.0,14.0,12.0,98.0
Banas Kantha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,12.0,8.0,9.0,23.0,5.0,17.0,20.0,7.0,12.0,18.0,22.0,23.0,176.0
Banas Kantha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Banas Kantha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Banas Kantha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Banas Kantha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Banas Kantha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Banas Kantha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Banas Kantha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Banas Kantha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,1.0,1.0
Banas Kantha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Banas Kantha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,,,,,,2.0,1.0,4.0
Banas Kantha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Banas Kantha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,,,,,,2.0,1.0,4.0
Banas Kantha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Banas Kantha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,1.0,1.0,1.0,,,2.0,1.0,1.0,8.0
Banas Kantha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Banas Kantha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,1.0,1.0,1.0,,,2.0,1.0,1.0,8.0
Banas Kantha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Banas Kantha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Banas Kantha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Banas Kantha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Banas Kantha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Banas Kantha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,6.0,3.0,4.0,5.0,5.0,3.0,4.0,2.0,2.0,4.0,2.0,41.0
Banas Kantha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Banas Kantha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,6.0,3.0,4.0,5.0,5.0,3.0,4.0,2.0,2.0,4.0,2.0,41.0
Banas Kantha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,7.0,3.0,3.0,,3.0,3.0,2.0,3.0,4.0,1.0,3.0,34.0
Banas Kantha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,19.0,26.0,32.0,24.0,17.0,30.0,28.0,25.0,30.0,13.0,32.0,30.0,306.0
Banas Kantha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,4.0,3.0,2.0,1.0,3.0,2.0,,2.0,3.0,4.0,2.0,28.0
Banas Kantha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,23.0,37.0,38.0,29.0,18.0,36.0,33.0,27.0,35.0,20.0,37.0,35.0,368.0
Banas Kantha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,1.0,2.0,,,,,,,3.0
Banas Kantha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,14.0,11.0,9.0,6.0,10.0,23.0,13.0,15.0,8.0,13.0,14.0,21.0,157.0
Banas Kantha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,3.0,3.0,,,2.0,3.0,1.0,1.0,14.0
Banas Kantha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,14.0,11.0,9.0,7.0,14.0,28.0,13.0,15.0,10.0,16.0,15.0,22.0,174.0
Banas Kantha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,1.0,,1.0,3.0,,,,,6.0
Banas Kantha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,3.0,2.0,1.0,4.0,4.0,3.0,,,1.0,,18.0
Banas Kantha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,,,,3.0,4.0,1.0,1.0,,2.0,,1.0,13.0
Banas Kantha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,,3.0,2.0,5.0,8.0,6.0,7.0,,2.0,1.0,1.0,37.0
Banas Kantha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,2.0,,,,1.0,,2.0,1.0,2.0,1.0,1.0,11.0
Banas Kantha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,5.0,8.0,4.0,3.0,4.0,15.0,5.0,7.0,2.0,4.0,8.0,3.0,68.0
Banas Kantha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,6.0,5.0,12.0,5.0,4.0,7.0,3.0,6.0,5.0,5.0,5.0,12.0,75.0
Banas Kantha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,12.0,15.0,16.0,8.0,8.0,23.0,8.0,15.0,8.0,11.0,14.0,16.0,154.0
Banas Kantha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,1.0,,,2.0,1.0,,,1.0,,6.0
Banas Kantha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,20.0,8.0,5.0,5.0,6.0,14.0,12.0,6.0,6.0,,15.0,2.0,99.0
Banas Kantha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,18.0,11.0,10.0,9.0,13.0,24.0,26.0,10.0,5.0,3.0,10.0,2.0,141.0
Banas Kantha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,39.0,19.0,15.0,15.0,19.0,38.0,40.0,17.0,11.0,3.0,26.0,4.0,246.0
Banas Kantha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,10.0,6.0,4.0,4.0,5.0,6.0,5.0,3.0,7.0,5.0,7.0,4.0,66.0
Banas Kantha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,68.0,62.0,53.0,41.0,57.0,61.0,63.0,59.0,61.0,77.0,58.0,41.0,701.0
Banas Kantha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,204.0,169.0,187.0,159.0,160.0,202.0,227.0,171.0,211.0,211.0,228.0,168.0,2297.0
Banas Kantha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,282.0,237.0,244.0,204.0,222.0,269.0,295.0,233.0,279.0,293.0,293.0,213.0,3064.0
Bharuch,1.1,Total number of pregnant women Registered for ANC,TOTAL,3415.0,3203.0,3351.0,2848.0,2807.0,3024.0,2667.0,2914.0,2801.0,2962.0,3039.0,2974.0,36005.0
Bharuch,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2588.0,2357.0,2477.0,2239.0,2054.0,2229.0,2050.0,2311.0,2162.0,2426.0,2435.0,2413.0,27741.0
Bharuch,1.2,Number of Pregnant women registered under JSY,TOTAL,1047.0,909.0,1096.0,998.0,921.0,935.0,890.0,879.0,823.0,934.0,950.0,903.0,11285.0
Bharuch,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2416.0,2343.0,2599.0,2517.0,2364.0,2649.0,2364.0,2431.0,2464.0,2674.0,2597.0,2659.0,30077.0
Bharuch,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2164.0,1955.0,2067.0,1886.0,1847.0,1822.0,1702.0,1932.0,1934.0,1967.0,2151.0,2029.0,23456.0
Bharuch,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2659.0,2724.0,2678.0,2674.0,2437.0,2798.0,2422.0,2416.0,2515.0,2587.0,2584.0,3094.0,31588.0
Bharuch,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2726.0,2729.0,2592.0,2593.0,2643.0,2906.0,2597.0,2653.0,2699.0,2694.0,2718.0,2568.0,32118.0
Bharuch,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,36.0,29.0,119.0,24.0,68.0,21.0,28.0,27.0,43.0,40.0,45.0,79.0,559.0
Bharuch,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,7.0,1.0,0.0,0.0,0.0,10.0
Bharuch,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1863.0,2007.0,2084.0,2163.0,2056.0,2241.0,1957.0,2191.0,1781.0,1750.0,1865.0,1933.0,23891.0
Bharuch,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,96.0,49.0,61.0,29.0,27.0,34.0,27.0,27.0,24.0,17.0,19.0,36.0,446.0
Bharuch,1.8,Number of pregnancy test kits used at SC level,TOTAL,174.0,192.0,244.0,562.0,600.0,744.0,593.0,726.0,612.0,827.0,875.0,826.0,6975.0
Bharuch,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,11.0,8.0,8.0,8.0,1.0,1.0,3.0,7.0,7.0,5.0,3.0,2.0,64.0
Bharuch,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,19.0,13.0,8.0,13.0,6.0,11.0,5.0,4.0,3.0,2.0,4.0,4.0,92.0
Bharuch,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,30.0,21.0,16.0,21.0,7.0,12.0,8.0,11.0,10.0,7.0,7.0,6.0,156.0
Bharuch,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,28.0,21.0,13.0,20.0,7.0,11.0,8.0,11.0,10.0,6.0,7.0,6.0,148.0
Bharuch,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,2.0,1.0,2.0,0.0,1.0,1.0,4.0,1.0,1.0,5.0,0.0,19.0
Bharuch,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,991.0,1271.0,1112.0,1168.0,1238.0,1337.0,1408.0,1422.0,1422.0,1335.0,1126.0,1156.0,14986.0
Bharuch,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,680.0,635.0,609.0,575.0,516.0,623.0,633.0,614.0,576.0,559.0,483.0,470.0,6973.0
Bharuch,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,18.0,21.0,20.0,28.0,4.0,2.0,6.0,14.0,24.0,12.0,48.0,23.0,220.0
Bharuch,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,14.0,0.0,0.0,3.0,0.0,0.0,0.0,1.0,0.0,18.0
Bharuch,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bharuch,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,924.0,1078.0,971.0,828.0,1158.0,1131.0,1069.0,1016.0,1002.0,989.0,903.0,824.0,11893.0
Bharuch,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,24.0,23.0,28.0,21.0,23.0,12.0,37.0,40.0,40.0,31.0,32.0,26.0,337.0
Bharuch,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,4.0,5.0,6.0,0.0,10.0,5.0,1.0,17.0,17.0,5.0,12.0,7.0,89.0
Bharuch,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bharuch,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,28.0,28.0,34.0,21.0,33.0,17.0,38.0,57.0,57.0,36.0,44.0,33.0,426.0
Bharuch,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,130.0,126.0,125.0,27.0,121.0,142.0,104.0,86.0,137.0,132.0,74.0,65.0,1269.0
Bharuch,4.1.1.a,Number of male live births,TOTAL,1033.0,1194.0,1180.0,1077.0,1294.0,1280.0,1286.0,1282.0,1313.0,1222.0,1063.0,1044.0,14268.0
Bharuch,4.1.1.b,Number of female live births,TOTAL,898.0,1182.0,915.0,963.0,1072.0,1169.0,1162.0,1152.0,1105.0,1112.0,948.0,912.0,12590.0
Bharuch,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1931.0,2376.0,2095.0,2040.0,2366.0,2449.0,2448.0,2434.0,2418.0,2334.0,2011.0,1956.0,26858.0
Bharuch,4.1.2,Number of still births,TOTAL,18.0,37.0,16.0,26.0,52.0,49.0,52.0,38.0,32.0,42.0,32.0,36.0,430.0
Bharuch,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,33.0,27.0,38.0,23.0,46.0,33.0,30.0,26.0,39.0,41.0,36.0,28.0,400.0
Bharuch,4.2.1,Number of Newborns weighed at birth,TOTAL,1925.0,2359.0,2072.0,1904.0,2248.0,2429.0,2420.0,2434.0,2274.0,2259.0,1995.0,1950.0,26269.0
Bharuch,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,174.0,320.0,278.0,270.0,363.0,430.0,452.0,450.0,343.0,379.0,302.0,276.0,4037.0
Bharuch,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1903.0,2301.0,2040.0,1880.0,2205.0,2320.0,2350.0,2412.0,2221.0,2242.0,1953.0,1875.0,25702.0
Bharuch,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Bharuch,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,17.0,30.0,18.0,16.0,14.0,35.0,16.0,17.0,8.0,3.0,17.0,23.0,214.0
Bharuch,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,38.0,170.0,124.0,97.0,0.0,57.0,135.0,210.0,322.0,176.0,252.0,144.0,1725.0
Bharuch,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bharuch,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,55.0,200.0,142.0,113.0,14.0,92.0,151.0,227.0,331.0,179.0,269.0,167.0,1940.0
Bharuch,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,82.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,83.0
Bharuch,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,43.0,118.0,63.0,31.0,44.0,115.0,73.0,126.0,278.0,86.0,186.0,71.0,1234.0
Bharuch,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,2.0,2.0,2.0,1.0,2.0,1.0,1.0,0.0,1.0,0.0,12.0
Bharuch,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,23.0,282.0,91.0,91.0,211.0,304.0,338.0,386.0,344.0,374.0,310.0,324.0,3078.0
Bharuch,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,14.0,15.0,12.0,14.0,1.0,14.0,15.0,14.0,14.0,6.0,23.0,9.0,151.0
Bharuch,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1914.0,2119.0,1916.0,1915.0,2315.0,2500.0,2374.0,2352.0,2409.0,2312.0,1993.0,1889.0,26008.0
Bharuch,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1415.0,1289.0,1241.0,1116.0,1572.0,1350.0,1565.0,1401.0,1404.0,1603.0,1483.0,1057.0,16496.0
Bharuch,6.3,PNC maternal complications attended,TOTAL,93.0,70.0,57.0,39.0,87.0,10.0,20.0,51.0,32.0,57.0,33.0,47.0,596.0
Bharuch,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,11.0,23.0,25.0,16.0,21.0,9.0,11.0,8.0,21.0,16.0,23.0,21.0,205.0
Bharuch,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,10.0
Bharuch,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,11.0,23.0,25.0,16.0,21.0,9.0,11.0,8.0,31.0,16.0,23.0,21.0,215.0
Bharuch,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,8.0,11.0,8.0,0.0,0.0,0.0,0.0,27.0
Bharuch,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,134.0,182.0,142.0,150.0,186.0,212.0,172.0,201.0,162.0,91.0,154.0,135.0,1921.0
Bharuch,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,235.0,274.0,311.0,245.0,284.0,373.0,273.0,349.0,390.0,230.0,371.0,330.0,3665.0
Bharuch,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,369.0,456.0,453.0,395.0,470.0,585.0,445.0,550.0,552.0,321.0,525.0,465.0,5586.0
Bharuch,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,33.0,3.0,26.0,0.0,20.0,0.0,0.0,5.0,0.0,0.0,0.0,87.0
Bharuch,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bharuch,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,56.0,25.0,61.0,105.0,101.0,85.0,85.0,510.0,351.0,174.0,147.0,144.0,1844.0
Bharuch,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,72.0,43.0,80.0,131.0,103.0,139.0,110.0,711.0,386.0,373.0,317.0,130.0,2595.0
Bharuch,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,25.0,22.0,19.0,8.0,13.0,14.0,19.0,39.0,40.0,33.0,27.0,101.0,360.0
Bharuch,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bharuch,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,153.0,90.0,160.0,244.0,217.0,238.0,214.0,1260.0,777.0,580.0,491.0,375.0,4799.0
Bharuch,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bharuch,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,4.0
Bharuch,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,4.0,3.0,5.0,3.0,2.0,2.0,3.0,4.0,0.0,3.0,0.0,0.0,29.0
Bharuch,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bharuch,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,4.0,3.0,5.0,3.0,2.0,2.0,3.0,4.0,4.0,3.0,0.0,0.0,33.0
Bharuch,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,626.0,659.0,794.0,938.0,791.0,930.0,854.0,853.0,856.0,757.0,698.0,494.0,9250.0
Bharuch,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,48.0,47.0,55.0,74.0,60.0,46.0,62.0,68.0,55.0,52.0,74.0,65.0,706.0
Bharuch,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,12.0,13.0,22.0,6.0,18.0,10.0,7.0,18.0,14.0,11.0,15.0,23.0,169.0
Bharuch,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,19.0,10.0,26.0,18.0,19.0,20.0,15.0,21.0,25.0,16.0,20.0,29.0,238.0
Bharuch,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bharuch,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,705.0,729.0,897.0,1036.0,888.0,1006.0,938.0,960.0,950.0,836.0,807.0,611.0,10363.0
Bharuch,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,39.0,10.0,12.0,2.0,4.0,0.0,0.0,0.0,1.0,4.0,5.0,2.0,79.0
Bharuch,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.06,Number of IUCD removals,TOTAL,407.0,189.0,194.0,179.0,181.0,192.0,156.0,188.0,151.0,191.0,186.0,221.0,2435.0
Bharuch,9.07,Number of Oral Pills cycles distributed,TOTAL,2531.0,2098.0,1539.0,1394.0,1311.0,2530.0,2269.0,2628.0,2314.0,2963.0,2571.0,2698.0,26846.0
Bharuch,9.08,Number of Condom pieces distributed,TOTAL,20925.0,17198.0,18653.0,26383.0,18149.0,28373.0,18293.0,18069.0,21051.0,17625.0,36941.0,27578.0,269238.0
Bharuch,9.09,Number of Centchroman (weekly) pills given,TOTAL,5.0,0.0,2.0,1.0,16.0,2.0,75.0,35.0,80.0,2.0,91.0,45.0,354.0
Bharuch,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,4.0,3.0,14.0,40.0,38.0,21.0,45.0,84.0,45.0,23.0,43.0,22.0,382.0
Bharuch,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Bharuch,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,9.12,Number of Institutions having NSV trained doctors,TOTAL,13.0,13.0,16.0,12.0,11.0,7.0,12.0,10.0,9.0,7.0,6.0,2.0,-1.0
Bharuch,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2237.0,2486.0,2427.0,2396.0,2617.0,3157.0,2849.0,2997.0,2721.0,2868.0,2395.0,2416.0,31566.0
Bharuch,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2259.0,2159.0,2347.0,2360.0,2246.0,2545.0,2428.0,2909.0,2689.0,2797.0,2576.0,2453.0,29768.0
Bharuch,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2411.0,2205.0,2242.0,2436.0,2241.0,2496.0,2300.0,2460.0,2766.0,2645.0,2785.0,2540.0,29527.0
Bharuch,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2414.0,2299.0,2344.0,2325.0,2349.0,3021.0,2506.0,2368.0,2480.0,2753.0,2637.0,2744.0,30240.0
Bharuch,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1674.0,1923.0,1756.0,1814.0,1998.0,2269.0,2024.0,2209.0,2146.0,2251.0,1887.0,1796.0,23747.0
Bharuch,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2259.0,2165.0,2334.0,2356.0,2291.0,2556.0,2428.0,2870.0,2691.0,2797.0,2640.0,2463.0,29850.0
Bharuch,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2411.0,2203.0,2238.0,2432.0,2262.0,2496.0,2300.0,2448.0,2772.0,2647.0,2791.0,2540.0,29540.0
Bharuch,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2414.0,2305.0,2330.0,2318.0,2362.0,3021.0,2506.0,2427.0,2502.0,2752.0,2624.0,2751.0,30312.0
Bharuch,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,406.0,458.0,378.0,587.0,635.0,540.0,446.0,652.0,686.0,559.0,562.0,525.0,6434.0
Bharuch,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,85.0,21.0,106.0
Bharuch,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,66.0,0.0,66.0
Bharuch,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,112.0,120.0,0.0,232.0
Bharuch,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2204.0,2401.0,2613.0,2301.0,2354.0,2995.0,2554.0,2498.0,2303.0,2421.0,2421.0,2613.0,29678.0
Bharuch,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2105.0,2104.0,2088.0,2069.0,1874.0,2095.0,1835.0,2013.0,2001.0,2002.0,2069.0,2367.0,24622.0
Bharuch,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1165.0,1316.0,1373.0,1428.0,1200.0,1527.0,1317.0,1303.0,1172.0,1304.0,1240.0,1387.0,15732.0
Bharuch,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1044.0,1124.0,1243.0,1182.0,1124.0,1428.0,1157.0,1171.0,1082.0,1164.0,1166.0,1231.0,14116.0
Bharuch,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2209.0,2440.0,2616.0,2610.0,2324.0,2955.0,2474.0,2474.0,2254.0,2468.0,2406.0,2618.0,29848.0
Bharuch,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2105.0,2111.0,2150.0,2028.0,1923.0,2243.0,1962.0,2165.0,2149.0,2122.0,2224.0,2566.0,25748.0
Bharuch,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2132.0,2111.0,2150.0,2026.0,1926.0,2241.0,1962.0,2165.0,2149.0,2122.0,2216.0,2566.0,25766.0
Bharuch,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,176.0,133.0,48.0,23.0,55.0,81.0,331.0,676.0,691.0,384.0,352.0,453.0,3403.0
Bharuch,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,146.0,130.0,39.0,20.0,41.0,75.0,233.0,192.0,175.0,468.0,475.0,248.0,2242.0
Bharuch,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,322.0,263.0,87.0,43.0,96.0,156.0,564.0,868.0,866.0,852.0,827.0,701.0,5645.0
Bharuch,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,331.0,464.0,513.0,1434.0,3763.0,4510.0,1019.0,972.0,1893.0,788.0,947.0,1850.0,18484.0
Bharuch,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,244.0,175.0,394.0,1165.0,4550.0,5553.0,1357.0,1107.0,2404.0,901.0,1054.0,1275.0,20179.0
Bharuch,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1189.0,1371.0,1897.0,2576.0,3589.0,3727.0,3194.0,2045.0,2375.0,1380.0,1745.0,1769.0,26857.0
Bharuch,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,4.0,0.0,0.0,0.0,1.0,2.0,2.0,0.0,2.0,3.0,2.0,16.0
Bharuch,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,2.0,7.0,16.0,42.0,61.0,55.0,92.0,93.0,93.0,80.0,83.0,628.0
Bharuch,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1180.0,1165.0,1160.0,1172.0,1135.0,1164.0,1179.0,1173.0,1176.0,1166.0,1159.0,1172.0,14001.0
Bharuch,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1171.0,1158.0,1164.0,1168.0,1132.0,1159.0,1175.0,1172.0,1174.0,1155.0,1155.0,1171.0,13954.0
Bharuch,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1113.0,1085.0,1103.0,1120.0,1070.0,1084.0,1109.0,1111.0,1110.0,1089.0,1093.0,1112.0,13199.0
Bharuch,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2165.0,2368.0,2569.0,2275.0,2302.0,2861.0,2353.0,2373.0,2135.0,2271.0,2297.0,3085.0,29054.0
Bharuch,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,9754.0,27.0,43.0,11.0,556.0,8125.0,0.0,3509.0,4901.0,18.0,2759.0,7234.0,36937.0
Bharuch,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,10032.0,27.0,10.0,0.0,698.0,7654.0,0.0,3937.0,4776.0,0.0,2508.0,6838.0,36480.0
Bharuch,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,8.0,0.0,13.0
Bharuch,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2597.0,2441.0,2560.0,3264.0,4334.0,4379.0,4048.0,4460.0,4515.0,4556.0,4666.0,4437.0,46257.0
Bharuch,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,5.0,15.0,21.0,10.0,15.0,92.0,5.0,7.0,6.0,7.0,0.0,18.0,201.0
Bharuch,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,45.0,56.0,67.0,120.0,132.0,224.0,105.0,167.0,343.0,113.0,152.0,121.0,1645.0
Bharuch,13.1,Number of Patients operated for cataract,TOTAL,128.0,128.0,125.0,153.0,79.0,89.0,79.0,120.0,77.0,52.0,4.0,16.0,1050.0
Bharuch,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,126.0,126.0,127.0,155.0,76.0,87.0,76.0,117.0,75.0,48.0,6.0,13.0,1032.0
Bharuch,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,568.0,1115.0,18195.0,100.0,167.0,48866.0,3487.0,72457.0,288878.0,433833.0
Bharuch,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,13.0,15.0,93.0,631.0,0.0,67.0,516.0,3429.0,897.0,4206.0,9867.0
Bharuch,13.5,Number of eyes collected through eye donation,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,2.0,10.0
Bharuch,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,5.0,5.0,5.0,4.0,4.0,4.0,3.0,4.0,4.0,5.0,-1.0
Bharuch,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,15.0,13.0,14.0,12.0,12.0,10.0,13.0,13.0,9.0,8.0,8.0,6.0,-1.0
Bharuch,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,423.0,443.0,489.0,467.0,526.0,590.0,482.0,531.0,542.0,569.0,545.0,553.0,-1.0
Bharuch,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,8.0,8.0,8.0,8.0,9.0,8.0,8.0,7.0,8.0,8.0,8.0,-1.0
Bharuch,14.05,Number of RKS meetings held during the month,TOTAL,7.0,8.0,16.0,11.0,4.0,14.0,7.0,11.0,121.0,9.0,10.0,22.0,240.0
Bharuch,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,29.0,32.0,33.0,29.0,27.0,29.0,29.0,28.0,24.0,22.0,25.0,24.0,-1.0
Bharuch,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,175.0,151.0,109.0,137.0,154.0,156.0,78.0,95.0,153.0,94.0,94.0,82.0,1478.0
Bharuch,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,5.0,5.0,4.0,4.0,4.0,4.0,3.0,2.0,2.0,2.0,3.0,-1.0
Bharuch,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,7.0,13.0,12.0,11.0,13.0,14.0,14.0,14.0,8.0,8.0,8.0,5.0,-1.0
Bharuch,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1189.0,214.0,198.0,1195.0,162.0,806.0,165.0,266.0,378.0,190.0,269.0,4253.0,9285.0
Bharuch,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3958.0,661.0,662.0,3661.0,762.0,1048.0,398.0,763.0,798.0,641.0,1079.0,1825.0,16256.0
Bharuch,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1260.0,290.0,230.0,958.0,342.0,238.0,180.0,241.0,331.0,388.0,283.0,4406.0,9147.0
Bharuch,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4906.0,1808.0,1573.0,4302.0,883.0,1418.0,1126.0,2340.0,1521.0,1634.0,1506.0,2373.0,25390.0
Bharuch,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2449.0,504.0,428.0,2153.0,504.0,1044.0,345.0,507.0,709.0,578.0,552.0,8659.0,18432.0
Bharuch,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,8864.0,2469.0,2235.0,7963.0,1645.0,2466.0,1524.0,3103.0,2319.0,2275.0,2585.0,4198.0,41646.0
Bharuch,14.10.2.a,Number of death cases of Inpatient males,TOTAL,10.0,21.0,11.0,11.0,0.0,23.0,17.0,14.0,14.0,11.0,10.0,14.0,156.0
Bharuch,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,8.0,4.0,2.0,1.0,7.0,5.0,3.0,7.0,4.0,7.0,6.0,57.0
Bharuch,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,13.0,29.0,15.0,13.0,1.0,30.0,22.0,17.0,21.0,15.0,17.0,20.0,213.0
Bharuch,14.11,In-Patient Head Count at midnight,TOTAL,3010.0,3197.0,2900.0,2919.0,3193.0,3011.0,2705.0,2947.0,2237.0,2424.0,2733.0,1204.0,32480.0
Bharuch,14.12.1,OPD attendance (All),TOTAL,45095.0,49293.0,50016.0,51548.0,59807.0,72799.0,46617.0,56229.0,58854.0,57113.0,63425.0,64917.0,675713.0
Bharuch,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,97.0,51.0,66.0,72.0,99.0,92.0,49.0,489.0,66.0,74.0,73.0,5320.0,6548.0
Bharuch,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,23.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0
Bharuch,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,110.0,111.0,151.0,140.0,147.0,235.0,173.0,417.0,419.0,261.0,234.0,200.0,2598.0
Bharuch,14.14.a,Number of patients given AYUSH treatment,TOTAL,1850.0,1713.0,2195.0,1889.0,1485.0,1084.0,1324.0,1698.0,2476.0,2917.0,3502.0,3791.0,25924.0
Bharuch,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,743.0,62.0,60.0,63.0,61.0,52.0,341.0,489.0,42.0,55.0,48.0,53.0,2069.0
Bharuch,14.14.c,Number of Adolescents counselled,TOTAL,119.0,134.0,185.0,223.0,20.0,29.0,8.0,319.0,479.0,125.0,149.0,126.0,1916.0
Bharuch,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6638.0,6418.0,7650.0,7609.0,8087.0,7988.0,6526.0,7650.0,6786.0,6819.0,7864.0,6140.0,86175.0
Bharuch,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,336.0,394.0,330.0,286.0,317.0,325.0,194.0,314.0,258.0,332.0,260.0,246.0,3592.0
Bharuch,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,524.0,541.0,720.0,692.0,796.0,878.0,523.0,797.0,701.0,614.0,823.0,566.0,8175.0
Bharuch,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,15.0,15.0,16.0,21.0,29.0,6.0,4.0,15.0,11.0,5.0,16.0,4.0,157.0
Bharuch,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,400.0,369.0,375.0,417.0,480.0,778.0,248.0,432.0,599.0,515.0,502.0,382.0,5497.0
Bharuch,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,7.0,13.0,11.0,17.0,35.0,29.0,1.0,7.0,9.0,3.0,6.0,2.0,140.0
Bharuch,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1392.0,1264.0,1625.0,1237.0,1288.0,1109.0,823.0,835.0,729.0,903.0,1075.0,1089.0,13369.0
Bharuch,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,17.0,56.0,72.0,73.0,44.0,24.0,0.0,54.0,28.0,2.0,0.0,2.0,372.0
Bharuch,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2316.0,2174.0,2720.0,2346.0,2564.0,2765.0,1594.0,2064.0,2029.0,2032.0,2400.0,2037.0,27041.0
Bharuch,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,39.0,84.0,99.0,111.0,108.0,59.0,5.0,76.0,48.0,10.0,22.0,8.0,669.0
Bharuch,15.2,Number of Widal tests conducted,Number tested,197.0,335.0,223.0,219.0,532.0,456.0,318.0,365.0,228.0,248.0,463.0,478.0,4062.0
Bharuch,15.3.a,Number of VDRL tests conducted on males,Number tested,88.0,133.0,70.0,94.0,300.0,112.0,62.0,168.0,33.0,66.0,75.0,16.0,1217.0
Bharuch,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,80.0,157.0,110.0,109.0,9.0,174.0,86.0,424.0,306.0,115.0,189.0,18.0,1777.0
Bharuch,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,313.0,619.0,431.0,229.0,99.0,282.0,259.0,360.0,326.0,478.0,360.0,368.0,4124.0
Bharuch,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,481.0,909.0,611.0,432.0,408.0,568.0,407.0,952.0,665.0,659.0,624.0,402.0,7118.0
Bharuch,15.4.1,Number of blood smears examined for Malaria,TOTAL,8032.0,9260.0,19549.0,17416.0,16698.0,16625.0,7840.0,8865.0,8282.0,7189.0,10256.0,10724.0,140736.0
Bharuch,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,30.0,39.0,48.0,60.0,82.0,115.0,53.0,22.0,24.0,227.0,15.0,11.0,726.0
Bharuch,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,5.0,4.0,3.0,16.0,20.0,25.0,7.0,7.0,20.0,13.0,1.0,1.0,122.0
Bharuch,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3300.0,5300.0,6900.0,19370.0,16700.0,20700.0,15650.0,10950.0,18650.0,16650.0,16650.0,,150820.0
Bharuch,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,5000.0,5000.0,15500.0,0.0,20000.0,0.0,12000.0,10000.0,5000.0,0.0,,82500.0
Bharuch,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Bharuch,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,8000.0,3400.0,4900.0,6860.0,13250.0,14300.0,4700.0,4300.0,11900.0,5000.0,4350.0,,80960.0
Bharuch,16.1.1,Stock position of DPT vaccines,5. Total Stock,5300.0,6900.0,7000.0,28010.0,3450.0,26400.0,10950.0,18650.0,16750.0,16650.0,12300.0,0.0,152360.0
Bharuch,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,9100.0,6600.0,16000.0,21690.0,9950.0,18820.0,11400.0,10150.0,12700.0,127010.0,20350.0,,263770.0
Bharuch,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,6000.0,17000.0,0.0,16000.0,0.0,21000.0,0.0,9000.0,19000.0,,9000.0,,97000.0
Bharuch,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,8500.0,7600.0,12700.0,9380.0,8250.0,8450.0,1250.0,6450.0,10300.0,,7050.0,,79930.0
Bharuch,16.1.1A,Stock Position of Pentavalent,5. Total Stock,6600.0,16000.0,3300.0,28310.0,1700.0,31370.0,10150.0,12700.0,21400.0,127010.0,22300.0,0.0,280840.0
Bharuch,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,34280.0,50360.0,43860.0,60600.0,47900.0,68800.0,33100.0,31800.0,17300.0,,14080.0,,402080.0
Bharuch,16.1.2,Stock position of OPV vaccines,2. Stocks Received,62000.0,9000.0,9000.0,47000.0,0.0,30000.0,0.0,12000.0,33000.0,,310000.0,,512000.0
Bharuch,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,45920.0,15500.0,28760.0,19680.0,20200.0,21700.0,1300.0,26500.0,24700.0,,310240.0,,514500.0
Bharuch,16.1.2,Stock position of OPV vaccines,5. Total Stock,50360.0,43860.0,24100.0,87920.0,27700.0,77100.0,31800.0,17300.0,25600.0,0.0,13840.0,0.0,399580.0
Bharuch,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,9200.0,25000.0,39000.0,44890.0,20850.0,36050.0,18800.0,11000.0,14650.0,,21050.0,,240490.0
Bharuch,16.1.3,Stock position of TT vaccines,2. Stocks Received,30000.0,20000.0,0.0,15000.0,0.0,21000.0,0.0,10000.0,17500.0,,10000.0,,123500.0
Bharuch,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.3,Stock position of TT vaccines,4. Stock Distributed,14200.0,6000.0,13650.0,11620.0,11900.0,12300.0,7800.0,6350.0,11300.0,,8150.0,,103270.0
Bharuch,16.1.3,Stock position of TT vaccines,5. Total Stock,25000.0,39000.0,25350.0,48270.0,8950.0,44750.0,11000.0,14650.0,20850.0,0.0,22900.0,0.0,260720.0
Bharuch,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,400.0,5000.0,5600.0,6100.0,5350.0,7450.0,3790.0,0.0,2200.0,,7520.0,,43410.0
Bharuch,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,5000.0,0.0,10000.0,0.0,10000.0,0.0,6000.0,11500.0,,6000.0,,58500.0
Bharuch,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,5400.0,4400.0,5350.0,4280.0,5030.0,5250.0,3790.0,3800.0,6280.0,,6050.0,,49630.0
Bharuch,16.1.5,Stock position of BCG vaccines,5. Total Stock,5000.0,5600.0,250.0,11820.0,320.0,12200.0,0.0,2200.0,7420.0,0.0,7470.0,0.0,52280.0
Bharuch,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5705.0,2155.0,4155.0,17300.0,17050.0,19900.0,11900.0,8250.0,8050.0,,11500.0,,105965.0
Bharuch,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,7000.0,15000.0,15000.0,0.0,10000.0,0.0,5000.0,15000.0,,0.0,,67000.0
Bharuch,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3550.0,5000.0,8650.0,6100.0,7300.0,7410.0,3650.0,5200.0,5500.0,,4750.0,,57110.0
Bharuch,16.1.6,Stock position of Measles vaccines,5. Total Stock,2155.0,4155.0,10505.0,26200.0,9750.0,22490.0,8250.0,8050.0,17550.0,0.0,6750.0,0.0,115855.0
Bharuch,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,7470.0,7170.0,6570.0,11580.0,6020.0,10000.0,5020.0,4570.0,4270.0,,2950.0,,65620.0
Bharuch,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,300.0,0.0,0.0,0.0,0.0,750.0,,0.0,,1050.0
Bharuch,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Bharuch,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,300.0,600.0,0.0,910.0,500.0,710.0,450.0,300.0,1150.0,,600.0,,5520.0
Bharuch,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,7170.0,6570.0,6570.0,10970.0,5520.0,9290.0,4570.0,4270.0,3870.0,0.0,2350.0,0.0,61150.0
Bharuch,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,,,,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,,,0.0,0.0,,,0.0,0.0,,,,0.0
Bharuch,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bharuch,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,6600.0,6600.0,2733.0,0.0,2305.0,0.0,4300.0,4300.0,,,,26838.0
Bharuch,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6600.0,0.0,0.0,0.0,0.0,16500.0,0.0,0.0,0.0,,,,23100.0
Bharuch,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bharuch,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,3600.0,428.0,0.0,0.0,0.0,0.0,0.0,,,,4028.0
Bharuch,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,6600.0,6600.0,3000.0,2305.0,0.0,18805.0,0.0,4300.0,4300.0,0.0,0.0,0.0,45910.0
Bharuch,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,54000.0,36400.0,36400.0,142775.0,0.0,93775.0,0.0,90000.0,90000.0,,,,543350.0
Bharuch,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,48000.0,0.0,0.0,0.0,0.0,100000.0,0.0,0.0,50000.0,,,,198000.0
Bharuch,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bharuch,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,65600.0,0.0,36400.0,49000.0,0.0,0.0,0.0,0.0,30000.0,,,,181000.0
Bharuch,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,36400.0,36400.0,0.0,93775.0,0.0,193775.0,0.0,90000.0,110000.0,0.0,0.0,0.0,560350.0
Bharuch,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,24200.0,24200.0,24200.0,59480.0,17200.0,58330.0,0.0,14200.0,14200.0,,,,236010.0
Bharuch,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bharuch,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bharuch,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,6500.0,1150.0,0.0,0.0,0.0,0.0,3000.0,,,,10650.0
Bharuch,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,24200.0,24200.0,17700.0,58330.0,17200.0,58330.0,0.0,14200.0,11200.0,0.0,0.0,0.0,225360.0
Bharuch,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,2.0,1.0,2.0,1.0,5.0,3.0,2.0,,,,,17.0
Bharuch,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bharuch,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bharuch,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Bharuch,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,5.0,3.0,2.0,1.0,4.0,2.0,1.0,2.0,5.0,1.0,1.0,,27.0
Bharuch,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,1.0,,,1.0,,,,,,,2.0
Bharuch,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,5.0,3.0,3.0,1.0,4.0,3.0,1.0,2.0,5.0,1.0,1.0,,29.0
Bharuch,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,7.0,3.0,2.0,5.0,10.0,5.0,5.0,3.0,4.0,5.0,7.0,3.0,59.0
Bharuch,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,3.0,3.0,1.0,5.0,2.0,1.0,2.0,1.0,,19.0
Bharuch,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,8.0,3.0,2.0,8.0,13.0,6.0,10.0,5.0,5.0,7.0,8.0,3.0,78.0
Bharuch,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,7.0,3.0,4.0,2.0,1.0,4.0,1.0,2.0,,,26.0
Bharuch,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,3.0,,,1.0,,1.0,,2.0,3.0,,10.0
Bharuch,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,1.0,10.0,3.0,4.0,3.0,1.0,5.0,1.0,4.0,3.0,,36.0
Bharuch,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,3.0,,,2.0,3.0,2.0,2.0,3.0,3.0,3.0,2.0,24.0
Bharuch,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,,,1.0,,,,2.0
Bharuch,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,4.0,,,2.0,3.0,2.0,2.0,4.0,3.0,3.0,2.0,26.0
Bharuch,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bharuch,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bharuch,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Bharuch,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,1.0,,,1.0,,,1.0,1.0,,1.0,,6.0
Bharuch,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,,,,,,,2.0,,,3.0
Bharuch,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,2.0,,,1.0,,,1.0,1.0,2.0,1.0,,9.0
Bharuch,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bharuch,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bharuch,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bharuch,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,6.0,6.0,5.0,4.0,3.0,3.0,3.0,4.0,3.0,2.0,4.0,3.0,46.0
Bharuch,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,3.0,3.0,2.0,3.0,1.0,3.0,,4.0,2.0,,23.0
Bharuch,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,7.0,7.0,8.0,7.0,5.0,6.0,4.0,7.0,3.0,6.0,6.0,3.0,69.0
Bharuch,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bharuch,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,,,2.0,,,3.0
Bharuch,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Bharuch,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,,,,,,2.0,,,3.0
Bharuch,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bharuch,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,12.0,4.0,6.0,9.0,7.0,7.0,6.0,9.0,8.0,5.0,9.0,85.0
Bharuch,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,3.0,2.0,,2.0,2.0,2.0,1.0,2.0,6.0,,2.0,3.0,25.0
Bharuch,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,6.0,14.0,4.0,8.0,11.0,9.0,8.0,8.0,15.0,8.0,7.0,12.0,110.0
Bharuch,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,1.0,,,,,1.0,,,,2.0
Bharuch,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,6.0,5.0,9.0,7.0,8.0,11.0,12.0,9.0,8.0,4.0,10.0,6.0,95.0
Bharuch,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,4.0,10.0,13.0,6.0,12.0,17.0,24.0,8.0,17.0,20.0,13.0,18.0,162.0
Bharuch,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,10.0,15.0,22.0,14.0,20.0,28.0,36.0,17.0,26.0,24.0,23.0,24.0,259.0
Bharuch,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bharuch,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Bharuch,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,2.0,,,,,,,,,,,,2.0
Bharuch,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,2.0,,,,,,,,,,1.0,,3.0
Bharuch,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Bharuch,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,6.0,3.0,5.0,6.0,7.0,4.0,9.0,10.0,3.0,8.0,4.0,67.0
Bharuch,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,9.0,6.0,4.0,16.0,6.0,20.0,16.0,14.0,7.0,14.0,15.0,12.0,139.0
Bharuch,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,11.0,12.0,7.0,21.0,12.0,27.0,20.0,23.0,17.0,17.0,23.0,16.0,206.0
Bharuch,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bharuch,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,1.0,,,1.0,,1.0,1.0,5.0
Bharuch,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Bharuch,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,,2.0,,,1.0,,1.0,1.0,6.0
Bharuch,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,1.0,,,,,,2.0
Bharuch,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,19.0,14.0,10.0,12.0,16.0,22.0,17.0,16.0,18.0,14.0,14.0,13.0,185.0
Bharuch,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,7.0,12.0,13.0,16.0,14.0,31.0,26.0,19.0,18.0,23.0,21.0,16.0,216.0
Bharuch,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,26.0,26.0,24.0,28.0,30.0,53.0,44.0,35.0,36.0,37.0,35.0,29.0,403.0
Bharuch,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,1.0,1.0,,,,,,,1.0,,4.0
Bharuch,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,3.0,3.0,4.0,4.0,4.0,4.0,3.0,4.0,2.0,6.0,3.0,,40.0
Bharuch,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,5.0,1.0,5.0,8.0,4.0,5.0,3.0,5.0,6.0,5.0,48.0
Bharuch,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,3.0,5.0,10.0,6.0,9.0,12.0,7.0,9.0,5.0,11.0,10.0,5.0,92.0
Bharuch,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bharuch,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,1.0,,,,1.0,,,2.0
Bharuch,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bharuch,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,1.0,,,,1.0,,,2.0
Bharuch,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bharuch,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Bharuch,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bharuch,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Bharuch,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bharuch,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,,1.0,1.0,,,,,,3.0
Bharuch,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bharuch,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,1.0,,1.0,1.0,,,,,,3.0
Bharuch,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bharuch,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,3.0,,,1.0,,,,,,,5.0
Bharuch,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bharuch,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,3.0,,,1.0,,,,,,,5.0
Bharuch,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bharuch,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Bharuch,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bharuch,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Bharuch,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bharuch,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,2.0,2.0,,1.0,1.0,1.0,,,1.0,1.0,1.0,11.0
Bharuch,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bharuch,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,2.0,2.0,,1.0,1.0,1.0,,,1.0,1.0,1.0,11.0
Bharuch,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,2.0,1.0,2.0,1.0,3.0,,,,,1.0,,12.0
Bharuch,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,10.0,14.0,17.0,19.0,7.0,25.0,19.0,10.0,13.0,19.0,16.0,22.0,191.0
Bharuch,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,1.0,8.0,1.0,2.0,3.0,2.0,1.0,4.0,3.0,2.0,2.0,30.0
Bharuch,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,13.0,17.0,26.0,22.0,10.0,31.0,21.0,11.0,17.0,22.0,19.0,24.0,233.0
Bharuch,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Bharuch,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,3.0,4.0,7.0,7.0,8.0,13.0,6.0,10.0,6.0,6.0,7.0,80.0
Bharuch,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,1.0,,2.0,2.0,1.0,1.0,,1.0,,9.0
Bharuch,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,3.0,5.0,8.0,7.0,10.0,15.0,7.0,11.0,6.0,7.0,7.0,89.0
Bharuch,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,2.0,,,,,1.0,,,,,3.0
Bharuch,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,2.0,,3.0,4.0,2.0,1.0,1.0,,1.0,,14.0
Bharuch,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,1.0,,,2.0,,1.0,,,,,2.0,7.0
Bharuch,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,1.0,4.0,,5.0,4.0,3.0,2.0,1.0,,1.0,2.0,24.0
Bharuch,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,2.0,,,,2.0
Bharuch,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,3.0,1.0,3.0,1.0,9.0,4.0,8.0,12.0,6.0,6.0,4.0,57.0
Bharuch,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,1.0,,5.0,5.0,7.0,6.0,6.0,10.0,8.0,,6.0,55.0
Bharuch,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,4.0,1.0,8.0,6.0,16.0,10.0,14.0,24.0,14.0,6.0,10.0,114.0
Bharuch,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,1.0,1.0,,1.0,,,,,3.0
Bharuch,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,5.0,9.0,11.0,10.0,7.0,9.0,4.0,7.0,13.0,6.0,9.0,92.0
Bharuch,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,5.0,6.0,7.0,6.0,14.0,8.0,14.0,6.0,5.0,8.0,8.0,10.0,97.0
Bharuch,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,7.0,11.0,16.0,17.0,25.0,16.0,23.0,11.0,12.0,21.0,14.0,19.0,192.0
Bharuch,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,1.0,2.0,1.0,,1.0,1.0,,2.0,2.0,1.0,3.0,15.0
Bharuch,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,32.0,24.0,46.0,40.0,43.0,50.0,62.0,48.0,57.0,59.0,51.0,42.0,554.0
Bharuch,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,71.0,92.0,89.0,71.0,98.0,141.0,111.0,104.0,133.0,126.0,111.0,113.0,1260.0
Bharuch,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,104.0,117.0,137.0,112.0,141.0,192.0,174.0,152.0,192.0,187.0,163.0,158.0,1829.0
Bhavnagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,4914.0,4655.0,4766.0,5550.0,4622.0,4830.0,5115.0,4793.0,5196.0,4937.0,4615.0,4421.0,58414.0
Bhavnagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4183.0,3843.0,4008.0,4036.0,3782.0,3919.0,3690.0,3908.0,3860.0,3808.0,3661.0,3453.0,46151.0
Bhavnagar,1.2,Number of Pregnant women registered under JSY,TOTAL,1072.0,993.0,1044.0,1189.0,1233.0,1324.0,981.0,1144.0,1291.0,1387.0,1168.0,1561.0,14387.0
Bhavnagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4293.0,4292.0,4219.0,4277.0,4110.0,4165.0,3937.0,4057.0,4269.0,3873.0,4122.0,3961.0,49575.0
Bhavnagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3330.0,3322.0,3392.0,3393.0,3199.0,3344.0,3143.0,3332.0,3123.0,3123.0,2754.0,3061.0,38516.0
Bhavnagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4017.0,4110.0,4280.0,4554.0,4094.0,4274.0,4269.0,4146.0,4276.0,3842.0,3825.0,3844.0,49531.0
Bhavnagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4895.0,4923.0,5078.0,5797.0,4873.0,5205.0,5381.0,4988.0,4940.0,4871.0,4664.0,4829.0,60444.0
Bhavnagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,891.0,875.0,910.0,895.0,864.0,919.0,782.0,913.0,939.0,976.0,812.0,1124.0,10900.0
Bhavnagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6.0,6.0,9.0,7.0,42.0,3.0,3.0,4.0,3.0,20.0,23.0,6.0,132.0
Bhavnagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2466.0,1966.0,2283.0,2248.0,1989.0,2139.0,2023.0,1805.0,1871.0,1947.0,1703.0,1904.0,24344.0
Bhavnagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,49.0,35.0,82.0,70.0,62.0,60.0,75.0,39.0,93.0,117.0,55.0,51.0,788.0
Bhavnagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,67.0,194.0,186.0,223.0,250.0,255.0,283.0,260.0,390.0,274.0,245.0,230.0,2857.0
Bhavnagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,56.0,67.0,89.0,59.0,68.0,58.0,70.0,45.0,46.0,33.0,29.0,30.0,650.0
Bhavnagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,34.0,55.0,46.0,38.0,52.0,44.0,55.0,59.0,27.0,35.0,18.0,20.0,483.0
Bhavnagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,90.0,122.0,135.0,97.0,120.0,102.0,125.0,104.0,73.0,68.0,47.0,50.0,1133.0
Bhavnagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,45.0,64.0,48.0,39.0,66.0,53.0,83.0,71.0,46.0,56.0,40.0,33.0,644.0
Bhavnagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,6.0,1.0,6.0,2.0,4.0,8.0,3.0,4.0,19.0,17.0,71.0
Bhavnagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1339.0,1382.0,1385.0,1475.0,5002.0,1571.0,1690.0,1572.0,1614.0,1515.0,3876.0,1573.0,23994.0
Bhavnagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,839.0,1008.0,925.0,928.0,4558.0,918.0,1394.0,1075.0,1088.0,982.0,3286.0,813.0,17814.0
Bhavnagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,248.0,242.0,296.0,194.0,247.0,256.0,269.0,259.0,333.0,243.0,258.0,288.0,3133.0
Bhavnagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,19.0,39.0,23.0,23.0,128.0,4.0,55.0,12.0,47.0,77.0,50.0,30.0,507.0
Bhavnagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,32.0,0.0,15.0,40.0,30.0,0.0,10.0,26.0,0.0,1.0,2.0,156.0
Bhavnagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,2323.0,1912.0,2207.0,2156.0,2264.0,2421.0,2311.0,2435.0,1953.0,1785.0,1786.0,1618.0,25171.0
Bhavnagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,6.0,0.0,0.0,12.0,0.0,0.0,22.0
Bhavnagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,12.0,0.0,0.0,18.0
Bhavnagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,11.0
Bhavnagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,14.0,19.0,30.0,23.0,13.0,37.0,0.0,27.0,11.0,20.0,31.0,36.0,261.0
Bhavnagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,93.0,93.0,96.0,102.0,182.0,103.0,103.0,132.0,113.0,183.0,184.0,98.0,1482.0
Bhavnagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhavnagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,112.0,112.0,126.0,125.0,195.0,140.0,109.0,159.0,124.0,203.0,215.0,134.0,1754.0
Bhavnagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,63.0,88.0,79.0,81.0,83.0,87.0,94.0,75.0,121.0,54.0,44.0,327.0,1196.0
Bhavnagar,4.1.1.a,Number of male live births,TOTAL,2239.0,2281.0,2199.0,5088.0,2421.0,2506.0,2463.0,2487.0,2267.0,2303.0,1930.0,1934.0,30118.0
Bhavnagar,4.1.1.b,Number of female live births,TOTAL,1871.0,1972.0,1990.0,3991.0,2206.0,2238.0,2163.0,2241.0,2087.0,2045.0,1718.0,1796.0,26318.0
Bhavnagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4110.0,4253.0,4189.0,9079.0,4627.0,4744.0,4626.0,4728.0,4354.0,4348.0,3648.0,3730.0,56436.0
Bhavnagar,4.1.2,Number of still births,TOTAL,76.0,62.0,58.0,63.0,71.0,69.0,79.0,69.0,82.0,69.0,65.0,52.0,815.0
Bhavnagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,130.0,107.0,146.0,143.0,129.0,147.0,114.0,124.0,301.0,296.0,107.0,105.0,1849.0
Bhavnagar,4.2.1,Number of Newborns weighed at birth,TOTAL,4834.0,4350.0,4367.0,4662.0,5084.0,5544.0,5219.0,5316.0,5123.0,4618.0,3410.0,3874.0,56401.0
Bhavnagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,403.0,334.0,383.0,434.0,447.0,607.0,432.0,495.0,330.0,368.0,238.0,274.0,4745.0
Bhavnagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4362.0,4232.0,4217.0,4170.0,4437.0,4968.0,4655.0,4835.0,4733.0,4773.0,3466.0,3666.0,52514.0
Bhavnagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,2.0,2.0,1.0,4.0,4.0,2.0,2.0,0.0,0.0,0.0,1.0,0.0,18.0
Bhavnagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,55.0,32.0,12.0,10.0,14.0,16.0,10.0,41.0,48.0,6.0,4.0,12.0,260.0
Bhavnagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,104.0,0.0,119.0,137.0,141.0,130.0,141.0,153.0,113.0,126.0,132.0,0.0,1296.0
Bhavnagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhavnagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,161.0,34.0,132.0,151.0,159.0,148.0,153.0,194.0,161.0,132.0,137.0,12.0,1574.0
Bhavnagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,42.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,46.0
Bhavnagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,346.0,304.0,259.0,283.0,242.0,257.0,416.0,410.0,381.0,320.0,226.0,123.0,3567.0
Bhavnagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,45.0,5.0,11.0,10.0,17.0,5.0,4.0,4.0,165.0,7.0,3.0,1.0,277.0
Bhavnagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,656.0,556.0,537.0,583.0,617.0,665.0,747.0,674.0,610.0,592.0,574.0,229.0,7040.0
Bhavnagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,50.0,66.0,58.0,72.0,78.0,97.0,77.0,81.0,73.0,97.0,82.0,0.0,831.0
Bhavnagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3618.0,3572.0,3528.0,3514.0,3980.0,4245.0,4056.0,4028.0,4232.0,3947.0,2431.0,2452.0,43603.0
Bhavnagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,3517.0,3310.0,3380.0,3412.0,3909.0,4162.0,3836.0,3767.0,3909.0,3608.0,2692.0,2471.0,41973.0
Bhavnagar,6.3,PNC maternal complications attended,TOTAL,597.0,547.0,533.0,467.0,527.0,722.0,587.0,42.0,46.0,79.0,32.0,75.0,4254.0
Bhavnagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,204.0,193.0,218.0,175.0,164.0,150.0,143.0,103.0,110.0,79.0,158.0,107.0,1804.0
Bhavnagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,586.0,685.0,627.0,671.0,663.0,711.0,748.0,618.0,713.0,858.0,696.0,838.0,8414.0
Bhavnagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,790.0,878.0,845.0,846.0,827.0,861.0,891.0,721.0,823.0,937.0,854.0,945.0,10218.0
Bhavnagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,14.0,14.0,15.0,20.0,10.0,13.0,14.0,26.0,25.0,27.0,13.0,15.0,206.0
Bhavnagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,31.0,66.0,46.0,63.0,60.0,86.0,68.0,65.0,70.0,50.0,81.0,39.0,725.0
Bhavnagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,200.0,183.0,179.0,197.0,163.0,204.0,142.0,129.0,198.0,147.0,137.0,156.0,2035.0
Bhavnagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,231.0,249.0,225.0,260.0,223.0,290.0,210.0,194.0,268.0,197.0,218.0,195.0,2760.0
Bhavnagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,455.0,1.0,4.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,464.0
Bhavnagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,2.0,0.0,8.0,2.0,0.0,1.0,0.0,3.0,0.0,0.0,0.0,16.0
Bhavnagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,1.0,0.0,3.0,5.0,5.0,3.0,4.0,1.0,3.0,0.0,0.0,25.0
Bhavnagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Bhavnagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhavnagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,3.0,0.0,11.0,7.0,5.0,4.0,5.0,4.0,3.0,0.0,0.0,42.0
Bhavnagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,2.0,8.0,9.0,8.0,8.0,7.0,8.0,8.0,5.0,7.0,7.0,7.0,84.0
Bhavnagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,3.0,3.0,7.0,1.0,6.0,0.0,0.0,0.0,0.0,7.0,0.0,27.0
Bhavnagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,29.0,21.0,27.0,64.0,10.0,37.0,44.0,0.0,34.0,18.0,0.0,0.0,284.0
Bhavnagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,7.0,32.0,10.0,23.0,13.0,11.0,7.0,36.0,48.0,51.0,7.0,10.0,255.0
Bhavnagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhavnagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,36.0,56.0,40.0,94.0,24.0,54.0,51.0,36.0,82.0,69.0,14.0,10.0,566.0
Bhavnagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,7.0,32.0,10.0,18.0,13.0,11.0,7.0,37.0,48.0,11.0,7.0,5.0,206.0
Bhavnagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,121.0,84.0,72.0,82.0,56.0,86.0,132.0,156.0,266.0,137.0,109.0,90.0,1391.0
Bhavnagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,164.0,111.0,63.0,108.0,134.0,131.0,131.0,216.0,223.0,199.0,264.0,276.0,2020.0
Bhavnagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,5.0,9.0
Bhavnagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhavnagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,285.0,195.0,135.0,190.0,190.0,217.0,263.0,372.0,489.0,336.0,377.0,371.0,3420.0
Bhavnagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,4.0,15.0,46.0,25.0,20.0,31.0,11.0,29.0,44.0,31.0,15.0,0.0,271.0
Bhavnagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,9.0,9.0,17.0,4.0,5.0,12.0,4.0,38.0,20.0,8.0,5.0,14.0,145.0
Bhavnagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,5.0,11.0,5.0,10.0,8.0,9.0,5.0,25.0,3.0,4.0,0.0,5.0,90.0
Bhavnagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhavnagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,18.0,35.0,68.0,39.0,33.0,52.0,20.0,92.0,67.0,43.0,20.0,19.0,506.0
Bhavnagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,93.0,165.0,127.0,117.0,128.0,136.0,98.0,204.0,181.0,174.0,129.0,113.0,1665.0
Bhavnagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,935.0,1019.0,1108.0,1116.0,1086.0,1150.0,1153.0,1232.0,1284.0,1273.0,1024.0,996.0,13376.0
Bhavnagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,90.0,87.0,65.0,87.0,94.0,118.0,69.0,78.0,73.0,69.0,68.0,52.0,950.0
Bhavnagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,58.0,72.0,33.0,38.0,25.0,32.0,32.0,39.0,32.0,27.0,25.0,23.0,436.0
Bhavnagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,27.0,38.0,20.0,18.0,29.0,17.0,20.0,38.0,31.0,25.0,25.0,32.0,320.0
Bhavnagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhavnagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1110.0,1216.0,1226.0,1259.0,1234.0,1317.0,1274.0,1387.0,1420.0,1394.0,1142.0,1103.0,15082.0
Bhavnagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,129.0,91.0,55.0,71.0,27.0,28.0,64.0,67.0,38.0,54.0,60.0,81.0,765.0
Bhavnagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,142.0,244.0,231.0,209.0,222.0,206.0,165.0,235.0,187.0,204.0,181.0,285.0,2511.0
Bhavnagar,9.06,Number of IUCD removals,TOTAL,210.0,248.0,228.0,235.0,223.0,226.0,221.0,259.0,282.0,286.0,286.0,245.0,2949.0
Bhavnagar,9.07,Number of Oral Pills cycles distributed,TOTAL,2755.0,2585.0,3425.0,4181.0,5127.0,6132.0,6394.0,6552.0,6292.0,6147.0,6481.0,4572.0,60643.0
Bhavnagar,9.08,Number of Condom pieces distributed,TOTAL,44278.0,44357.0,44860.0,46478.0,39507.0,43244.0,44433.0,58891.0,55207.0,68048.0,78765.0,85332.0,653400.0
Bhavnagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,3.0,4.0,0.0,52.0,36.0,20.0,24.0,17.0,10.0,3.0,50.0,6.0,225.0
Bhavnagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,9.0,13.0,22.0,32.0,62.0,59.0,40.0,45.0,81.0,81.0,32.0,45.0,521.0
Bhavnagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,4.0,0.0,0.0,3.0,28.0,36.0
Bhavnagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,16.0,23.0,31.0,42.0,37.0,54.0,8.0,9.0,30.0,24.0,0.0,33.0,307.0
Bhavnagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Bhavnagar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,2.0
Bhavnagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,13.0,10.0,13.0,14.0,11.0,10.0,10.0,10.0,10.0,12.0,13.0,11.0,-1.0
Bhavnagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4421.0,4221.0,4054.0,4187.0,4340.0,4721.0,4477.0,4420.0,4074.0,4013.0,3599.0,3378.0,49905.0
Bhavnagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1106.0,1055.0,1061.0,1098.0,1102.0,973.0,1104.0,1139.0,351.0,403.0,288.0,230.0,9910.0
Bhavnagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1047.0,1042.0,1052.0,1031.0,1099.0,963.0,1102.0,1086.0,352.0,370.0,264.0,225.0,9633.0
Bhavnagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1022.0,1012.0,1050.0,1112.0,1052.0,986.0,1088.0,1071.0,306.0,351.0,252.0,227.0,9529.0
Bhavnagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3531.0,3201.0,3167.0,3260.0,3184.0,3512.0,3437.0,3244.0,3543.0,3539.0,3152.0,3014.0,39784.0
Bhavnagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3395.0,3019.0,3127.0,3186.0,3191.0,3242.0,3229.0,3086.0,3485.0,3319.0,3034.0,3048.0,38361.0
Bhavnagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3285.0,3072.0,3123.0,3084.0,3094.0,3284.0,3061.0,3068.0,3447.0,3271.0,2983.0,3091.0,37863.0
Bhavnagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2777.0,2604.0,2716.0,2754.0,3077.0,3138.0,2997.0,2950.0,2475.0,2553.0,2170.0,2463.0,32674.0
Bhavnagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4165.0,3868.0,3862.0,3995.0,4064.0,4388.0,4269.0,4048.0,3884.0,3725.0,3377.0,3143.0,46788.0
Bhavnagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3980.0,3697.0,3785.0,3790.0,3974.0,3957.0,4027.0,3847.0,3829.0,3528.0,3246.0,3230.0,44890.0
Bhavnagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3893.0,3696.0,3776.0,3794.0,3814.0,3965.0,3929.0,3802.0,3744.0,3467.0,3205.0,3385.0,44470.0
Bhavnagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,939.0,930.0,975.0,972.0,1266.0,1236.0,1368.0,1413.0,1206.0,1392.0,1223.0,1790.0,14710.0
Bhavnagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,493.0,433.0,271.0,235.0,176.0,245.0,304.0,323.0,230.0,224.0,188.0,202.0,3324.0
Bhavnagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,290.0,279.0,169.0,139.0,175.0,125.0,111.0,209.0,134.0,169.0,126.0,100.0,2026.0
Bhavnagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,298.0,260.0,88.0,179.0,162.0,214.0,92.0,217.0,131.0,111.0,163.0,167.0,2082.0
Bhavnagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3840.0,3850.0,3942.0,3970.0,4000.0,4188.0,3836.0,3626.0,3627.0,3492.0,3266.0,3076.0,44713.0
Bhavnagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2283.0,2193.0,2419.0,2508.0,2546.0,2654.0,2973.0,2599.0,2318.0,2597.0,2534.0,2632.0,30256.0
Bhavnagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2204.0,2139.0,2304.0,2289.0,2477.0,2488.0,2342.0,1963.0,1933.0,1947.0,1638.0,1580.0,25304.0
Bhavnagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1700.0,1906.0,1875.0,1955.0,2023.0,2040.0,2047.0,1691.0,1743.0,1668.0,1452.0,1406.0,21506.0
Bhavnagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3904.0,4045.0,4179.0,4244.0,4500.0,4528.0,4389.0,3654.0,3676.0,3615.0,3090.0,2986.0,46810.0
Bhavnagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3365.0,3198.0,3446.0,3468.0,3578.0,3956.0,3504.0,3515.0,3223.0,3101.0,2984.0,3085.0,40423.0
Bhavnagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3372.0,3182.0,3446.0,3460.0,3561.0,3817.0,3514.0,3486.0,3207.0,3128.0,2978.0,3062.0,40213.0
Bhavnagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1561.0,1706.0,1788.0,1671.0,1712.0,1839.0,1812.0,1709.0,1666.0,1656.0,1469.0,783.0,19372.0
Bhavnagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1407.0,1590.0,1564.0,1455.0,1591.0,1702.0,1488.0,1682.0,1503.0,1588.0,1313.0,720.0,17603.0
Bhavnagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2968.0,3296.0,3352.0,3126.0,3303.0,3541.0,3300.0,3391.0,3169.0,3244.0,2782.0,1503.0,36975.0
Bhavnagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1648.0,1436.0,1603.0,1969.0,2694.0,3705.0,2375.0,2371.0,2513.0,2399.0,2599.0,2383.0,27695.0
Bhavnagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1921.0,1682.0,1959.0,2603.0,3233.0,4727.0,2560.0,2543.0,3040.0,2628.0,2790.0,2462.0,32148.0
Bhavnagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2394.0,2286.0,2818.0,2991.0,3822.0,3836.0,3074.0,2764.0,3253.0,2882.0,2860.0,2578.0,35558.0
Bhavnagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,9.0,7.0,7.0,7.0,9.0,9.0,10.0,8.0,7.0,5.0,3.0,3.0,84.0
Bhavnagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,168.0,139.0,174.0,145.0,135.0,129.0,132.0,124.0,143.0,109.0,122.0,116.0,1636.0
Bhavnagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1497.0,1576.0,1552.0,1682.0,1659.0,1660.0,1734.0,1603.0,1709.0,1692.0,1722.0,1656.0,19742.0
Bhavnagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1462.0,1539.0,1521.0,1594.0,1613.0,1612.0,1665.0,1575.0,1683.0,1601.0,1636.0,1627.0,19128.0
Bhavnagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1324.0,1353.0,1322.0,1449.0,1455.0,1467.0,1517.0,1444.0,1543.0,1477.0,1504.0,1471.0,17326.0
Bhavnagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3460.0,3442.0,3707.0,3760.0,4368.0,3892.0,3729.0,3559.0,3440.0,3191.0,4210.0,3458.0,44216.0
Bhavnagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1251.0,840.0,1228.0,1325.0,23449.0,4497.0,1502.0,1318.0,661.0,864.0,25127.0,9725.0,71787.0
Bhavnagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,811.0,343.0,725.0,755.0,25669.0,4097.0,1236.0,928.0,244.0,822.0,26868.0,9166.0,71664.0
Bhavnagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,11.0,4.0,3.0,1.0,4.0,1.0,0.0,0.0,0.0,24.0
Bhavnagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Bhavnagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,4.0
Bhavnagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Bhavnagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,43.0,21.0,41.0,4.0,17.0,3.0,60.0,16.0,25.0,308.0,22.0,96.0,656.0
Bhavnagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2816.0,2738.0,2567.0,2813.0,3545.0,3340.0,3843.0,3452.0,3451.0,3525.0,3403.0,3157.0,38650.0
Bhavnagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,107.0,11.0,3.0,1.0,2.0,7.0,55.0,3.0,51.0,14.0,2.0,2.0,258.0
Bhavnagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,153.0,90.0,99.0,131.0,127.0,173.0,173.0,191.0,195.0,153.0,221.0,199.0,1905.0
Bhavnagar,13.1,Number of Patients operated for cataract,TOTAL,62.0,65.0,63.0,73.0,69.0,110.0,63.0,121.0,122.0,109.0,118.0,83.0,1058.0
Bhavnagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,91.0,63.0,61.0,76.0,67.0,108.0,61.0,116.0,2.0,105.0,106.0,79.0,935.0
Bhavnagar,13.3,Number of School children detected with Refractive errors,TOTAL,9.0,9.0,446.0,167.0,556.0,1941.0,634.0,1225.0,498.0,1150.0,320.0,1013.0,7968.0
Bhavnagar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,424.0,112.0,265.0,319.0,270.0,299.0,305.0,323.0,301.0,984.0,3602.0
Bhavnagar,13.5,Number of eyes collected through eye donation,TOTAL,4.0,0.0,2.0,0.0,10.0,6.0,14.0,8.0,2.0,8.0,5.0,8.0,67.0
Bhavnagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,4.0,0.0,2.0,0.0,10.0,6.0,14.0,8.0,2.0,8.0,5.0,8.0,67.0
Bhavnagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,7.0,7.0,9.0,7.0,6.0,8.0,8.0,6.0,6.0,7.0,-1.0
Bhavnagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,9.0,9.0,8.0,10.0,9.0,8.0,10.0,11.0,8.0,9.0,11.0,9.0,-1.0
Bhavnagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,660.0,682.0,729.0,681.0,1058.0,906.0,1076.0,1135.0,1455.0,1438.0,1616.0,1372.0,-1.0
Bhavnagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,15.0,14.0,12.0,15.0,14.0,14.0,11.0,13.0,12.0,12.0,14.0,15.0,-1.0
Bhavnagar,14.05,Number of RKS meetings held during the month,TOTAL,4.0,6.0,17.0,17.0,12.0,17.0,5.0,13.0,11.0,21.0,6.0,14.0,143.0
Bhavnagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,29.0,26.0,19.0,27.0,26.0,28.0,25.0,23.0,26.0,23.0,29.0,27.0,-1.0
Bhavnagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,183.0,224.0,182.0,164.0,245.0,145.0,48.0,76.0,55.0,1783.0,2514.0,2276.0,7895.0
Bhavnagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,3.0,4.0,3.0,3.0,5.0,3.0,5.0,4.0,4.0,5.0,6.0,-1.0
Bhavnagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,529.0,242.0,1.0,2.0,1.0,1.0,2.0,1.0,0.0,0.0,256.0,-1.0
Bhavnagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,939.0,910.0,874.0,963.0,1133.0,1256.0,1234.0,897.0,785.0,200.0,177.0,251.0,9619.0
Bhavnagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3485.0,2569.0,2190.0,2427.0,2830.0,2850.0,2165.0,2342.0,2182.0,424.0,454.0,753.0,24671.0
Bhavnagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,846.0,875.0,785.0,864.0,1095.0,1273.0,1616.0,908.0,902.0,196.0,199.0,347.0,9906.0
Bhavnagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4126.0,3866.0,3243.0,3593.0,3819.0,4341.0,2951.0,3351.0,3534.0,1751.0,1787.0,2725.0,39087.0
Bhavnagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1785.0,1785.0,1659.0,1827.0,2228.0,2529.0,2850.0,1805.0,1687.0,396.0,376.0,598.0,19525.0
Bhavnagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7611.0,6435.0,5433.0,6020.0,6649.0,7191.0,5116.0,5693.0,5716.0,2175.0,2241.0,3478.0,63758.0
Bhavnagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,5.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,4.0,18.0
Bhavnagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,4.0
Bhavnagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,6.0,5.0,2.0,0.0,0.0,0.0,1.0,1.0,2.0,0.0,0.0,5.0,22.0
Bhavnagar,14.11,In-Patient Head Count at midnight,TOTAL,1758.0,1366.0,1260.0,1545.0,1255.0,1418.0,1315.0,1057.0,1261.0,939.0,1043.0,1399.0,15616.0
Bhavnagar,14.12.1,OPD attendance (All),TOTAL,113269.0,117043.0,114118.0,136525.0,143130.0,157414.0,118606.0,124400.0,128051.0,121502.0,156964.0,112501.0,1543523.0
Bhavnagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,105.0,81.0,74.0,94.0,72.0,89.0,33.0,145.0,141.0,121.0,61.0,139.0,1155.0
Bhavnagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,48.0,5.0,0.0,0.0,1.0,54.0
Bhavnagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,365.0,314.0,304.0,246.0,284.0,354.0,327.0,308.0,332.0,330.0,354.0,353.0,3871.0
Bhavnagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,1420.0,403.0,2560.0,1415.0,1460.0,1528.0,2227.0,2537.0,4654.0,4286.0,3711.0,4403.0,30604.0
Bhavnagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,528.0,520.0,573.0,573.0,413.0,570.0,799.0,847.0,768.0,670.0,756.0,933.0,7950.0
Bhavnagar,14.14.c,Number of Adolescents counselled,TOTAL,52.0,7.0,6.0,17.0,4.0,1.0,1.0,145.0,1.0,11.0,0.0,0.0,245.0
Bhavnagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7822.0,15708.0,15714.0,17149.0,16923.0,16932.0,14075.0,16071.0,16380.0,16783.0,17071.0,15583.0,186211.0
Bhavnagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,143.0,1928.0,1701.0,1837.0,1903.0,2138.0,1583.0,1882.0,1695.0,2063.0,2025.0,1503.0,20401.0
Bhavnagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1487.0,1525.0,1520.0,1665.0,1747.0,1791.0,1564.0,1682.0,1863.0,1633.0,1906.0,1028.0,19411.0
Bhavnagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,26.0,20.0,16.0,25.0,20.0,23.0,25.0,20.0,28.0,33.0,24.0,20.0,280.0
Bhavnagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1203.0,1349.0,1410.0,1540.0,1219.0,1485.0,1413.0,1616.0,1557.0,1259.0,1597.0,1326.0,16974.0
Bhavnagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,26.0,11.0,50.0,17.0,16.0,17.0,9.0,19.0,12.0,11.0,15.0,14.0,217.0
Bhavnagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1684.0,1818.0,1942.0,1734.0,1627.0,1797.0,1318.0,1389.0,1408.0,1206.0,1308.0,1865.0,19096.0
Bhavnagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,23.0,15.0,56.0,6.0,42.0,42.0,13.0,7.0,147.0,1.0,118.0,107.0,577.0
Bhavnagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4374.0,4692.0,4872.0,4939.0,4593.0,5073.0,4295.0,4687.0,4828.0,4098.0,4811.0,4219.0,55481.0
Bhavnagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,75.0,46.0,122.0,48.0,78.0,82.0,47.0,46.0,187.0,45.0,157.0,141.0,1074.0
Bhavnagar,15.2,Number of Widal tests conducted,Number tested,305.0,1000.0,1003.0,1028.0,1305.0,1301.0,871.0,1109.0,1004.0,796.0,1426.0,1367.0,12515.0
Bhavnagar,15.3.a,Number of VDRL tests conducted on males,Number tested,138.0,453.0,625.0,283.0,373.0,427.0,346.0,485.0,438.0,423.0,290.0,103.0,4384.0
Bhavnagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,208.0,385.0,375.0,460.0,285.0,454.0,280.0,423.0,525.0,439.0,461.0,456.0,4751.0
Bhavnagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,456.0,388.0,469.0,570.0,362.0,457.0,525.0,598.0,526.0,284.0,424.0,580.0,5639.0
Bhavnagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,802.0,1226.0,1469.0,1313.0,1020.0,1338.0,1151.0,1506.0,1489.0,1146.0,1175.0,1139.0,14774.0
Bhavnagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,7955.0,9392.0,9627.0,9229.0,13477.0,46264.0,44373.0,41652.0,11566.0,8634.0,13567.0,13684.0,229420.0
Bhavnagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,142.0,18.0,28.0,30.0,26.0,50.0,241.0,32.0,28.0,13.0,13.0,13.0,634.0
Bhavnagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,2.0,0.0,2.0,1.0,1.0,5.0,6.0,2.0,0.0,0.0,0.0,21.0
Bhavnagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,11710.0,4810.0,4650.0,6050.0,10380.0,5830.0,7900.0,5700.0,8350.0,7650.0,6700.0,2200.0,81930.0
Bhavnagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,5000.0,5000.0,10000.0,10150.0,5000.0,10000.0,5000.0,5000.0,5000.0,5000.0,,10000.0,75150.0
Bhavnagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,0.0,0.0,,,,,0.0,,,,0.0
Bhavnagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,11900.0,5160.0,8600.0,5820.0,9550.0,7930.0,7200.0,2350.0,5700.0,5950.0,4500.0,6450.0,81110.0
Bhavnagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,4810.0,4650.0,6050.0,10380.0,5830.0,7900.0,5700.0,8350.0,7650.0,6700.0,2200.0,5750.0,75970.0
Bhavnagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,19770.0,27920.0,14100.0,24600.0,27650.0,21450.0,10250.0,11900.0,15000.0,18450.0,19050.0,9650.0,219790.0
Bhavnagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,28000.0,3000.0,21000.0,9300.0,6000.0,,9000.0,9000.0,15000.0,12000.0,,15000.0,127300.0
Bhavnagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bhavnagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,19850.0,16820.0,10500.0,6250.0,12200.0,11200.0,7350.0,5900.0,11550.0,11400.0,9400.0,16230.0,138650.0
Bhavnagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,27920.0,14100.0,24600.0,27650.0,21450.0,10250.0,11900.0,15000.0,18450.0,19050.0,9650.0,8420.0,208440.0
Bhavnagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,35080.0,28780.0,16780.0,3180.0,,20560.0,2360.0,7160.0,23120.0,2960.0,8360.0,39080.0,187420.0
Bhavnagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,17000.0,11000.0,10000.0,20500.0,38000.0,5000.0,20000.0,31500.0,396000.0,10000.0,405000.0,,964000.0
Bhavnagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bhavnagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,23300.0,23000.0,23600.0,23680.0,17440.0,23200.0,15200.0,15540.0,416160.0,4600.0,374280.0,14500.0,974500.0
Bhavnagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,28780.0,16780.0,3180.0,0.0,20560.0,2360.0,7160.0,23120.0,2960.0,8360.0,39080.0,24580.0,176920.0
Bhavnagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,20950.0,30450.0,23450.0,25750.0,34250.0,28950.0,21650.0,15850.0,11100.0,14950.0,17370.0,8680.0,253400.0
Bhavnagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,30000.0,7500.0,15000.0,20000.0,10000.0,10000.0,,,15000.0,16000.0,,10000.0,133500.0
Bhavnagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bhavnagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,20500.0,14500.0,12700.0,11500.0,15300.0,17300.0,5800.0,4750.0,7650.0,13580.0,8690.0,15060.0,147330.0
Bhavnagar,16.1.3,Stock position of TT vaccines,5. Total Stock,30450.0,23450.0,25750.0,34250.0,28950.0,21650.0,15850.0,11100.0,18450.0,17370.0,8680.0,3620.0,239570.0
Bhavnagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,0.0,,,,0.0
Bhavnagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,0.0,,,,0.0
Bhavnagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,0.0,,,,0.0
Bhavnagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,0.0,,,,0.0
Bhavnagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,11760.0,8310.0,8500.0,3900.0,9190.0,5890.0,9270.0,14070.0,14620.0,10620.0,12570.0,5570.0,114270.0
Bhavnagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,6000.0,9000.0,2500.0,10000.0,5000.0,10000.0,10000.0,5000.0,5000.0,10000.0,,5000.0,77500.0
Bhavnagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Bhavnagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,9450.0,8810.0,7100.0,4710.0,8300.0,6620.0,5200.0,4450.0,8620.0,8050.0,7000.0,7600.0,85910.0
Bhavnagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,8310.0,8500.0,3900.0,9190.0,5890.0,9270.0,14070.0,14620.0,11000.0,12570.0,5570.0,2970.0,105860.0
Bhavnagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,7350.0,0.0,1250.0,6600.0,14200.0,11100.0,10750.0,13500.0,3720.0,10025.0,12225.0,4775.0,95495.0
Bhavnagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,15000.0,15000.0,15250.0,6000.0,5000.0,10000.0,,10000.0,9000.0,,5000.0,90250.0
Bhavnagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,,,0.0,,,,,,,,,0.0
Bhavnagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,7350.0,13750.0,9650.0,7650.0,9100.0,5350.0,7250.0,9780.0,3695.0,6800.0,7450.0,8050.0,95875.0
Bhavnagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,1250.0,6600.0,14200.0,11100.0,10750.0,13500.0,3720.0,10025.0,12225.0,4775.0,1725.0,89870.0
Bhavnagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,0.0,,,,0.0
Bhavnagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,0.0,,,,0.0
Bhavnagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,0.0,,,,0.0
Bhavnagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,0.0,,,,0.0
Bhavnagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1170.0,5950.0,5250.0,3650.0,5450.0,5750.0,4930.0,4730.0,3720.0,3270.0,2720.0,2570.0,49160.0
Bhavnagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,6000.0,0.0,0.0,1950.0,900.0,,,,2100.0,,,2100.0,13050.0
Bhavnagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,0.0,,,,0.0
Bhavnagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1220.0,700.0,1600.0,150.0,600.0,820.0,200.0,1010.0,2550.0,550.0,150.0,2650.0,12200.0
Bhavnagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5950.0,5250.0,3650.0,5450.0,5750.0,4930.0,4730.0,3720.0,3270.0,2720.0,2570.0,2020.0,50010.0
Bhavnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1800.0,1300.0,1100.0,450.0,550.0,4600.0,4500.0,3500.0,2300.0,2100.0,14400.0,4650.0,41250.0
Bhavnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,6000.0,6000.0,0.0,0.0,0.0,0.0,12600.0,0.0,9000.0,33600.0
Bhavnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,500.0,200.0,650.0,5900.0,1950.0,100.0,1000.0,1200.0,200.0,300.0,9750.0,13650.0,35400.0
Bhavnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1300.0,1100.0,450.0,550.0,4600.0,4500.0,3500.0,2300.0,2100.0,14400.0,4650.0,0.0,39450.0
Bhavnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,151200.0,115920.0,100800.0,85680.0,55440.0,35280.0,55440.0,599760.0
Bhavnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,50400.0,352800.0,0.0,0.0,0.0,0.0,0.0,75600.0,514080.0,992880.0
Bhavnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,50400.0,201600.0,35280.0,15120.0,15120.0,30240.0,20160.0,55440.0,569520.0,992880.0
Bhavnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,151200.0,115920.0,100800.0,85680.0,55440.0,35280.0,55440.0,0.0,599760.0
Bhavnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,1600.0,7000.0,4000.0,2800.0,400.0,0.0,0.0,9200.0,25000.0
Bhavnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,12000.0,15000.0,,0.0,0.0,0.0,0.0,78000.0,24000.0,129000.0
Bhavnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,10400.0,9600.0,3075.0,1200.0,2400.0,400.0,0.0,68800.0,33200.0,129075.0
Bhavnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,1600.0,7000.0,3925.0,2800.0,400.0,0.0,0.0,9200.0,0.0,24925.0
Bhavnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1500.0,1400.0,1400.0,1400.0,0.0,4500.0,3300.0,2400.0,2400.0,2400.0,2400.0,900.0,24000.0
Bhavnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0
Bhavnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,100.0,0.0,0.0,1400.0,0.0,1200.0,1100.0,0.0,0.0,0.0,1500.0,900.0,6200.0
Bhavnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1400.0,1400.0,1400.0,0.0,6000.0,3300.0,2200.0,2400.0,2400.0,2400.0,900.0,0.0,23800.0
Bhavnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,250.0,0.0,250.0,250.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4915.0,5665.0
Bhavnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4915.0,0.0,4915.0
Bhavnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,250.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4915.0,5165.0
Bhavnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,250.0,0.0,250.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4915.0,0.0,5415.0
Bhavnagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,250.0,0.0,4500.0,2425.0,950.0,825.0,250.0,200.0,0.0,4875.0,3825.0,18100.0
Bhavnagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,10000.0
Bhavnagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,2075.0,1475.0,125.0,575.0,50.0,200.0,125.0,1000.0,350.0,5975.0
Bhavnagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,250.0,5000.0,2425.0,950.0,825.0,250.0,200.0,0.0,4875.0,3875.0,3475.0,22125.0
Bhavnagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,850.0,225.0,0.0,7000.0,14125.0,8625.0,5550.0,5550.0,7100.0,11100.0,8625.0,625.0,69375.0
Bhavnagar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,7000.0,10000.0,0.0,0.0,0.0,400.0,4000.0,0.0,0.0,0.0,21400.0
Bhavnagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,625.0,225.0,0.0,2875.0,5500.0,3075.0,0.0,2450.0,0.0,2475.0,8000.0,0.0,25225.0
Bhavnagar,16.3.02,Stock Position of Gloves,5. Total Stock,225.0,0.0,7000.0,14125.0,8625.0,5550.0,5550.0,3500.0,11100.0,8625.0,625.0,625.0,65550.0
Bhavnagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,50000.0,27000.0,23400.0,20400.0,15400.0,4400.0,100.0,100.0,140800.0
Bhavnagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,50000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50000.0
Bhavnagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,23000.0,3600.0,3000.0,5000.0,11000.0,4300.0,0.0,0.0,49900.0
Bhavnagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,50000.0,27000.0,23400.0,20400.0,15400.0,4400.0,100.0,100.0,100.0,140900.0
Bhavnagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,205000.0,125000.0,66000.0,26000.0,73000.0,254000.0,517000.0,1495000.0,954000.0,324000.0,14000.0,5000.0,4058000.0
Bhavnagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,500000.0,406000.0,500000.0,1660000.0,0.0,790000.0,0.0,0.0,0.0,3856000.0
Bhavnagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,80000.0,59000.0,40000.0,453000.0,225000.0,237000.0,682000.0,541000.0,1420000.0,310000.0,9000.0,0.0,4056000.0
Bhavnagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,125000.0,66000.0,26000.0,73000.0,254000.0,517000.0,1495000.0,954000.0,324000.0,14000.0,5000.0,5000.0,3858000.0
Bhavnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,100.0,100.0,0.0,0.0,0.0,0.0,16400.0,2200.0,1400.0,1000.0,8500.0,2590.0,32290.0
Bhavnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,20000.0,0.0,0.0,0.0,15000.0,0.0,0.0,35000.0
Bhavnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,100.0,0.0,0.0,0.0,3600.0,14200.0,800.0,400.0,6600.0,5910.0,2100.0,33710.0
Bhavnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,100.0,0.0,0.0,0.0,0.0,16400.0,2200.0,1400.0,1000.0,9400.0,2590.0,490.0,33580.0
Bhavnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,1160.0,520.0,160.0,0.0,0.0,0.0,0.0,3600.0,3500.0,8940.0
Bhavnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0
Bhavnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,340.0,640.0,360.0,160.0,0.0,0.0,0.0,0.0,100.0,1020.0,2620.0
Bhavnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,1160.0,520.0,160.0,0.0,0.0,0.0,0.0,0.0,3500.0,2480.0,7820.0
Bhavnagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,828.0,778.0,753.0,703.0,403.0,20.0,10.0,0.0,0.0,5150.0,3400.0,1500.0,13545.0
Bhavnagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8300.0,0.0,0.0,0.0,8300.0
Bhavnagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,50.0,25.0,50.0,300.0,383.0,10.0,10.0,0.0,3150.0,1750.0,1900.0,400.0,8028.0
Bhavnagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,778.0,753.0,703.0,403.0,20.0,10.0,0.0,0.0,5150.0,3400.0,1500.0,1100.0,13817.0
Bhavnagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,21425.0,14500.0,39500.0,50500.0,35500.0,28500.0,33960.0,82500.0,64500.0,29000.0,31900.0,26400.0,458185.0
Bhavnagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,25000.0,15000.0,0.0,25000.0,19960.0,133040.0,0.0,0.0,2900.0,0.0,15860.0,236760.0
Bhavnagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,925.0,0.0,4000.0,15000.0,32000.0,14500.0,84500.0,18000.0,34500.0,500.0,5500.0,10800.0,220225.0
Bhavnagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,20500.0,39500.0,50500.0,35500.0,28500.0,33960.0,82500.0,64500.0,30000.0,31400.0,26400.0,31460.0,474720.0
Bhavnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1800.0,1300.0,400.0,200.0,3600.0,16700.0,15000.0,11300.0,9700.0,8600.0,5800.0,20200.0,94600.0
Bhavnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,0.0,,16500.0,16500.0,,,,0.0,,16500.0,16500.0,66000.0
Bhavnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,0.0,,0.0,,,,,0.0,,,,0.0
Bhavnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,500.0,900.0,200.0,13100.0,3400.0,1700.0,3700.0,1600.0,1100.0,2889.0,2100.0,24700.0,55889.0
Bhavnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1300.0,400.0,200.0,3600.0,16700.0,15000.0,11300.0,9700.0,8600.0,5711.0,20200.0,12000.0,104711.0
Bhavnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,25400.0,22400.0,44000.0,27400.0,2800.0,,,,0.0,178000.0,140000.0,126000.0,566000.0
Bhavnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,30000.0,3000.0,5000.0,,0.0,,,356000.0,,,80000.0,474000.0
Bhavnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,0.0,,0.0,,0.0,,,0.0,,,,0.0
Bhavnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,3000.0,8400.0,19600.0,29600.0,2800.0,0.0,,,178000.0,96324.0,14000.0,168000.0,519724.0
Bhavnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,22400.0,44000.0,27400.0,2800.0,0.0,0.0,0.0,0.0,178000.0,81676.0,126000.0,38000.0,520276.0
Bhavnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,,,0.0,,,43000.0,43000.0
Bhavnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,,,0.0,,,,0.0
Bhavnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,,,0.0,,,,0.0
Bhavnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,,,0.0,,,43000.0,43000.0
Bhavnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhavnagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,1.0,2.0,,,,,,3.0
Bhavnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bhavnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bhavnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Bhavnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,1.0,1.0,,2.0,,2.0,1.0,,,7.0
Bhavnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bhavnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,1.0,1.0,,2.0,,2.0,1.0,,,7.0
Bhavnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,,1.0,,1.0,1.0,,2.0,1.0,2.0,2.0,11.0
Bhavnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,3.0,,,1.0,,,,4.0
Bhavnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,1.0,,1.0,,4.0,1.0,,3.0,1.0,2.0,2.0,15.0
Bhavnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,1.0,1.0,3.0,1.0,6.0,2.0,4.0,2.0,2.0,,22.0
Bhavnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,,,,1.0,,1.0,1.0,,,4.0
Bhavnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,1.0,1.0,3.0,1.0,7.0,2.0,5.0,3.0,2.0,,26.0
Bhavnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Bhavnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
Bhavnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,,,,1.0,,,,2.0
Bhavnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhavnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Bhavnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,,,,,,,,,1.0
Bhavnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhavnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhavnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Bhavnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhavnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhavnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bhavnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,1.0,1.0,,1.0,1.0,1.0,3.0,2.0,1.0,2.0,14.0
Bhavnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhavnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,1.0,1.0,,1.0,1.0,1.0,3.0,2.0,1.0,2.0,14.0
Bhavnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bhavnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Bhavnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,1.0,,,,,1.0
Bhavnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,1.0,,1.0,,1.0,,1.0,,4.0
Bhavnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Bhavnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,2.0,,1.0,,1.0,,1.0,,5.0
Bhavnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,1.0,,,,,1.0,1.0,,,3.0
Bhavnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,2.0,2.0,2.0,1.0,3.0,6.0,5.0,3.0,3.0,4.0,5.0,36.0
Bhavnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,2.0,2.0,3.0,1.0,3.0,6.0,5.0,4.0,4.0,4.0,5.0,39.0
Bhavnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Bhavnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bhavnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,,,,,,,,,1.0
Bhavnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Bhavnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Bhavnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,,,,,,,,,,1.0
Bhavnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Bhavnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Bhavnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,1.0,,,1.0
Bhavnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,4.0,1.0,4.0,7.0,2.0,5.0,3.0,2.0,2.0,30.0
Bhavnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,1.0,5.0,6.0,5.0,8.0,3.0,4.0,8.0,2.0,8.0,51.0
Bhavnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,1.0,1.0,9.0,7.0,9.0,15.0,5.0,9.0,11.0,4.0,10.0,81.0
Bhavnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,1.0,3.0,,,,,4.0
Bhavnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,2.0,,2.0,1.0,4.0,2.0,2.0,2.0,15.0
Bhavnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,2.0,,3.0,4.0,4.0,2.0,2.0,2.0,19.0
Bhavnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bhavnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bhavnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bhavnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Bhavnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bhavnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Bhavnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,1.0,1.0,,,,,,,2.0
Bhavnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bhavnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,1.0,1.0,,,,,,,2.0
Bhavnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bhavnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Bhavnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,1.0,,1.0,1.0,,3.0
Bhavnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bhavnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,1.0,,1.0,1.0,,3.0
Bhavnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,1.0,,,,1.0,1.0,1.0,,4.0
Bhavnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,1.0,3.0,1.0,2.0,3.0,3.0,1.0,,,14.0
Bhavnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,1.0,1.0,,,,,,,2.0
Bhavnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,1.0,5.0,2.0,2.0,3.0,4.0,2.0,1.0,,20.0
Bhavnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,1.0,2.0,,1.0,3.0,4.0,4.0,2.0,1.0,2.0,3.0,24.0
Bhavnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Bhavnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,1.0,2.0,,1.0,3.0,4.0,4.0,2.0,1.0,2.0,4.0,25.0
Bhavnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,1.0,,1.0,1.0,1.0,1.0,,1.0,1.0,9.0
Bhavnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Bhavnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,1.0,1.0,,1.0,1.0,2.0,1.0,,1.0,1.0,10.0
Bhavnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Bhavnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,2.0,,,,1.0,,1.0,4.0
Bhavnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,2.0,,,,1.0,,1.0,4.0
Bhavnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Bhavnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,1.0,,2.0,2.0,1.0,1.0,7.0
Bhavnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,1.0,,3.0,,,1.0,,,5.0
Bhavnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,1.0,,4.0,,2.0,3.0,1.0,1.0,12.0
Bhavnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,2.0,,,,,1.0,1.0,,2.0,6.0
Bhavnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,6.0,2.0,5.0,1.0,5.0,3.0,5.0,5.0,4.0,4.0,4.0,45.0
Bhavnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,8.0,7.0,8.0,10.0,11.0,13.0,13.0,7.0,22.0,38.0,22.0,19.0,178.0
Bhavnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,9.0,13.0,10.0,17.0,12.0,18.0,16.0,12.0,28.0,43.0,26.0,25.0,229.0
Botad,1.1,Total number of pregnant women Registered for ANC,TOTAL,1503.0,1664.0,1831.0,1684.0,1548.0,1854.0,1440.0,1712.0,1712.0,1792.0,1713.0,1854.0,20307.0
Botad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,953.0,1014.0,1119.0,1027.0,896.0,1095.0,892.0,1055.0,1031.0,1143.0,1032.0,1199.0,12456.0
Botad,1.2,Number of Pregnant women registered under JSY,TOTAL,186.0,139.0,203.0,205.0,203.0,296.0,185.0,187.0,162.0,230.0,224.0,244.0,2464.0
Botad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,857.0,895.0,1042.0,970.0,832.0,988.0,840.0,1001.0,959.0,965.0,899.0,959.0,11207.0
Botad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,778.0,962.0,1037.0,1008.0,890.0,1036.0,881.0,953.0,890.0,938.0,936.0,1098.0,11407.0
Botad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1056.0,1124.0,1263.0,1326.0,1097.0,1324.0,1041.0,1221.0,1269.0,1259.0,1322.0,1588.0,14890.0
Botad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1136.0,1143.0,1365.0,1354.0,1215.0,1395.0,1099.0,1417.0,1372.0,1425.0,1375.0,1535.0,15831.0
Botad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,88.0,131.0,111.0,111.0,98.0,110.0,92.0,119.0,114.0,104.0,105.0,93.0,1276.0
Botad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,531.0,597.0,790.0,849.0,556.0,489.0,358.0,538.0,455.0,546.0,624.0,614.0,6947.0
Botad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2.0,0.0,2.0,8.0,9.0,12.0,29.0,3.0,7.0,11.0,5.0,3.0,91.0
Botad,1.8,Number of pregnancy test kits used at SC level,TOTAL,3.0,37.0,62.0,40.0,51.0,39.0,11.0,62.0,180.0,181.0,126.0,121.0,913.0
Botad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,4.0,13.0,3.0,4.0,12.0,21.0,9.0,42.0,54.0,38.0,40.0,36.0,276.0
Botad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,20.0,32.0,39.0,28.0,37.0,23.0,25.0,15.0,5.0,12.0,14.0,11.0,261.0
Botad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,24.0,45.0,42.0,32.0,49.0,44.0,34.0,57.0,59.0,50.0,54.0,47.0,537.0
Botad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,24.0,45.0,44.0,33.0,46.0,44.0,34.0,33.0,26.0,25.0,26.0,20.0,400.0
Botad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,2.0,5.0
Botad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,202.0,257.0,260.0,393.0,438.0,423.0,449.0,489.0,543.0,415.0,432.0,447.0,4748.0
Botad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,68.0,95.0,89.0,219.0,173.0,241.0,224.0,244.0,287.0,207.0,216.0,247.0,2310.0
Botad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,4.0,8.0,1.0,0.0,16.0,17.0,0.0,10.0,9.0,12.0,0.0,20.0,97.0
Botad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,12.0,21.0
Botad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,575.0,588.0,315.0,253.0,206.0,293.0,293.0,617.0,458.0,594.0,191.0,3408.0,7791.0
Botad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,6.0,5.0,10.0,1.0,2.0,7.0,1.0,7.0,6.0,5.0,2.0,6.0,58.0
Botad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Botad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Botad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,6.0,5.0,10.0,1.0,2.0,7.0,1.0,7.0,6.0,5.0,2.0,6.0,58.0
Botad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,4.1.1.a,Number of male live births,TOTAL,493.0,537.0,615.0,613.0,698.0,748.0,755.0,764.0,730.0,562.0,585.0,609.0,7709.0
Botad,4.1.1.b,Number of female live births,TOTAL,451.0,511.0,571.0,564.0,628.0,693.0,677.0,688.0,732.0,578.0,462.0,560.0,7115.0
Botad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,944.0,1048.0,1186.0,1177.0,1326.0,1441.0,1432.0,1452.0,1462.0,1140.0,1047.0,1169.0,14824.0
Botad,4.1.2,Number of still births,TOTAL,7.0,17.0,19.0,7.0,50.0,13.0,13.0,13.0,8.0,7.0,9.0,30.0,193.0
Botad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,42.0,60.0,44.0,55.0,51.0,69.0,41.0,62.0,42.0,50.0,52.0,109.0,677.0
Botad,4.2.1,Number of Newborns weighed at birth,TOTAL,942.0,878.0,1176.0,1234.0,1294.0,1434.0,1425.0,1469.0,1463.0,1141.0,1045.0,1325.0,14826.0
Botad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,38.0,37.0,39.0,46.0,64.0,40.0,68.0,70.0,63.0,47.0,52.0,89.0,653.0
Botad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,794.0,860.0,1136.0,1182.0,1239.0,1410.0,1387.0,1421.0,1415.0,1097.0,1030.0,1304.0,14275.0
Botad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,5.0,7.0,6.0,7.0,8.0,2.0,13.0,12.0,12.0,4.0,9.0,14.0,99.0
Botad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Botad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Botad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,5.0,7.0,6.0,7.0,8.0,2.0,13.0,12.0,12.0,4.0,9.0,14.0,99.0
Botad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,5.0,7.0,6.0,7.0,8.0,2.0,3.0,15.0,13.0,32.0,40.0,66.0,204.0
Botad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,0.0,4.0
Botad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,12.0,11.0,10.0,23.0,31.0,25.0,27.0,49.0,59.0,78.0,63.0,88.0,476.0
Botad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1169.0,1233.0,960.0,963.0,1078.0,1089.0,1139.0,1186.0,1189.0,965.0,923.0,1464.0,13358.0
Botad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,645.0,769.0,836.0,846.0,911.0,946.0,945.0,1013.0,985.0,873.0,860.0,1872.0,11501.0
Botad,6.3,PNC maternal complications attended,TOTAL,1.0,0.0,1.0,3.0,2.0,4.0,2.0,0.0,3.0,0.0,0.0,0.0,16.0
Botad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,7.0,9.0,3.0,5.0,9.0,1.0,4.0,8.0,5.0,8.0,5.0,65.0
Botad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1.0,7.0,9.0,3.0,5.0,9.0,1.0,4.0,8.0,5.0,8.0,5.0,65.0
Botad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,13.0,0.0,5.0,5.0,4.0,13.0,7.0,16.0,3.0,2.0,5.0,2.0,75.0
Botad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,60.0,8.0,21.0,37.0,57.0,73.0,55.0,95.0,74.0,79.0,69.0,88.0,716.0
Botad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,73.0,8.0,26.0,42.0,61.0,86.0,62.0,111.0,77.0,81.0,74.0,90.0,791.0
Botad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Botad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Botad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Botad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Botad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,6.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0
Botad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Botad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Botad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Botad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,16.0,6.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0
Botad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,19.0,10.0,18.0,11.0,4.0,10.0,8.0,0.0,13.0,14.0,19.0,17.0,143.0
Botad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,46.0,72.0,57.0,51.0,41.0,65.0,39.0,134.0,113.0,104.0,140.0,38.0,900.0
Botad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Botad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Botad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,65.0,82.0,75.0,62.0,45.0,75.0,47.0,134.0,126.0,118.0,159.0,55.0,1043.0
Botad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,13.0,35.0,50.0,54.0,39.0,53.0,38.0,67.0,75.0,65.0,132.0,371.0,992.0
Botad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Botad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,8.0,9.0,9.0,12.0,11.0,36.0,8.0,20.0,27.0,37.0,28.0,27.0,232.0
Botad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Botad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Botad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,8.0,9.0,10.0,12.0,11.0,36.0,8.0,20.0,27.0,37.0,28.0,27.0,233.0
Botad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,462.0,452.0,383.0,515.0,458.0,557.0,465.0,519.0,381.0,489.0,644.0,735.0,6060.0
Botad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,68.0,37.0,55.0,39.0,18.0,45.0,33.0,44.0,64.0,55.0,49.0,47.0,554.0
Botad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,34.0,53.0,59.0,47.0,34.0,33.0,45.0,49.0,70.0,35.0,29.0,41.0,529.0
Botad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Botad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Botad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,564.0,542.0,497.0,601.0,510.0,635.0,543.0,612.0,515.0,579.0,722.0,823.0,7143.0
Botad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,29.0,4.0,3.0,8.0,14.0,3.0,1.0,0.0,1.0,23.0,24.0,58.0,168.0
Botad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,46.0,82.0,44.0,67.0,18.0,33.0,0.0,88.0,45.0,0.0,0.0,423.0
Botad,9.06,Number of IUCD removals,TOTAL,107.0,117.0,116.0,115.0,124.0,121.0,110.0,137.0,118.0,115.0,146.0,211.0,1537.0
Botad,9.07,Number of Oral Pills cycles distributed,TOTAL,1163.0,951.0,1005.0,1136.0,1166.0,1375.0,1500.0,1314.0,1327.0,1230.0,1397.0,1786.0,15350.0
Botad,9.08,Number of Condom pieces distributed,TOTAL,44924.0,46596.0,59024.0,42923.0,49202.0,53543.0,62487.0,45340.0,45180.0,44649.0,45488.0,49950.0,589306.0
Botad,9.09,Number of Centchroman (weekly) pills given,TOTAL,40.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Botad,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,1.0,0.0,37.0,30.0,0.0,3.0,10.0,2.0,29.0,112.0
Botad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,9.0,3.0,30.0,1.0,18.0,10.0,46.0,14.0,35.0,38.0,28.0,233.0
Botad,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,1.0,1.0,2.0,0.0,5.0,0.0,0.0,1.0,0.0,0.0,0.0,11.0
Botad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,,4.0,4.0,1.0,4.0,4.0,5.0,4.0,3.0,3.0,6.0,-1.0
Botad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,975.0,993.0,1082.0,1069.0,1033.0,1280.0,1020.0,1156.0,1088.0,974.0,959.0,1560.0,13189.0
Botad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,78.0,61.0,55.0,4.0,5.0,15.0,12.0,0.0,19.0,7.0,33.0,48.0,337.0
Botad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,67.0,75.0,44.0,5.0,3.0,10.0,5.0,0.0,15.0,8.0,21.0,30.0,283.0
Botad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,62.0,73.0,48.0,6.0,3.0,10.0,6.0,0.0,18.0,7.0,14.0,29.0,276.0
Botad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,894.0,940.0,1009.0,1051.0,972.0,1191.0,1099.0,1160.0,1128.0,1113.0,1059.0,1057.0,12673.0
Botad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,967.0,865.0,926.0,959.0,948.0,996.0,1040.0,1045.0,1111.0,978.0,989.0,1019.0,11843.0
Botad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,909.0,909.0,924.0,954.0,933.0,998.0,958.0,1005.0,960.0,914.0,913.0,1291.0,11668.0
Botad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,500.0,462.0,552.0,538.0,628.0,627.0,619.0,603.0,699.0,632.0,509.0,634.0,7003.0
Botad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,878.0,946.0,1048.0,1045.0,936.0,1210.0,1119.0,1137.0,1103.0,1099.0,1018.0,1054.0,12593.0
Botad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,958.0,874.0,952.0,960.0,920.0,1020.0,1027.0,1036.0,1081.0,956.0,973.0,1018.0,11775.0
Botad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,892.0,901.0,919.0,958.0,903.0,971.0,940.0,993.0,941.0,905.0,900.0,1274.0,11497.0
Botad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,211.0,235.0,315.0,320.0,392.0,342.0,298.0,427.0,445.0,320.0,298.0,335.0,3938.0
Botad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,25.0,0.0,8.0,0.0,6.0,1.0,0.0,0.0,2.0,9.0,0.0,8.0,59.0
Botad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,5.0,0.0,7.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0
Botad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2.0,0.0,2.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Botad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,857.0,991.0,1022.0,1034.0,941.0,1030.0,892.0,925.0,907.0,870.0,915.0,1572.0,11956.0
Botad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,581.0,733.0,694.0,695.0,681.0,799.0,684.0,728.0,751.0,778.0,745.0,851.0,8720.0
Botad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,440.0,512.0,530.0,482.0,464.0,520.0,449.0,445.0,425.0,425.0,488.0,631.0,5811.0
Botad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,366.0,440.0,445.0,437.0,396.0,452.0,361.0,411.0,406.0,404.0,438.0,684.0,5240.0
Botad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,806.0,952.0,975.0,919.0,860.0,972.0,810.0,856.0,831.0,829.0,926.0,1315.0,11051.0
Botad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,698.0,772.0,874.0,787.0,751.0,919.0,762.0,847.0,836.0,828.0,761.0,940.0,9775.0
Botad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,697.0,772.0,873.0,786.0,750.0,918.0,757.0,844.0,836.0,821.0,756.0,929.0,9739.0
Botad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,4.0
Botad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,168.0,180.0,365.0,330.0,318.0,365.0,273.0,305.0,288.0,287.0,301.0,344.0,3524.0
Botad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,177.0,160.0,287.0,275.0,230.0,306.0,227.0,293.0,266.0,287.0,261.0,341.0,3110.0
Botad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,345.0,340.0,652.0,605.0,548.0,671.0,500.0,598.0,554.0,574.0,562.0,685.0,6634.0
Botad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,292.0,415.0,327.0,565.0,553.0,696.0,594.0,583.0,595.0,626.0,546.0,446.0,6238.0
Botad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,545.0,612.0,696.0,741.0,755.0,984.0,779.0,761.0,771.0,778.0,811.0,845.0,9078.0
Botad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,619.0,738.0,802.0,818.0,917.0,1153.0,815.0,929.0,991.0,915.0,933.0,971.0,10601.0
Botad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,3.0
Botad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Botad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,355.0,381.0,381.0,378.0,379.0,397.0,370.0,398.0,405.0,394.0,387.0,409.0,4634.0
Botad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,340.0,375.0,378.0,376.0,375.0,395.0,365.0,392.0,401.0,384.0,383.0,405.0,4569.0
Botad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,289.0,308.0,326.0,325.0,335.0,353.0,320.0,344.0,346.0,328.0,339.0,359.0,3972.0
Botad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,841.0,924.0,963.0,967.0,886.0,1012.0,865.0,856.0,766.0,766.0,886.0,1298.0,11030.0
Botad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,19.0,8.0,0.0,3205.0,565.0,16.0,0.0,0.0,0.0,3795.0,1838.0,9446.0
Botad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,7.0,0.0,3406.0,553.0,0.0,0.0,0.0,0.0,3775.0,1160.0,8901.0
Botad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,2.0,4.0,0.0,0.0,14.0
Botad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,499.0,406.0,480.0,653.0,649.0,766.0,581.0,618.0,593.0,619.0,662.0,631.0,7157.0
Botad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,17.0,8.0,0.0,2.0,0.0,0.0,0.0,0.0,13.0,0.0,0.0,40.0
Botad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,120.0,70.0,15.0,155.0,4.0,4.0,0.0,0.0,0.0,0.0,4.0,0.0,372.0
Botad,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Botad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Botad,13.3,Number of School children detected with Refractive errors,TOTAL,27.0,5.0,0.0,29.0,34.0,27.0,56.0,43.0,61.0,180.0,167.0,290.0,919.0
Botad,13.4,Number of children provided free glasses,TOTAL,27.0,0.0,0.0,22.0,27.0,22.0,23.0,40.0,117.0,137.0,142.0,130.0,687.0
Botad,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,112.0,0.0,0.0,0.0,0.0,0.0,0.0,112.0
Botad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,3.0,3.0,3.0,3.0,2.0,2.0,3.0,2.0,2.0,2.0,2.0,-1.0
Botad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,1.0,1.0,-1.0
Botad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,186.0,164.0,143.0,151.0,159.0,154.0,155.0,167.0,159.0,152.0,174.0,168.0,-1.0
Botad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,6.0,6.0,6.0,5.0,6.0,5.0,6.0,6.0,5.0,5.0,6.0,-1.0
Botad,14.05,Number of RKS meetings held during the month,TOTAL,0.0,4.0,5.0,2.0,2.0,5.0,3.0,4.0,4.0,3.0,3.0,7.0,42.0
Botad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,13.0,10.0,11.0,11.0,12.0,14.0,13.0,13.0,12.0,11.0,12.0,12.0,-1.0
Botad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,21.0,36.0,88.0,122.0,119.0,54.0,87.0,56.0,39.0,79.0,74.0,79.0,854.0
Botad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,3.0,3.0,2.0,3.0,3.0,-1.0
Botad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Botad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,127.0,118.0,80.0,112.0,111.0,112.0,122.0,169.0,140.0,104.0,135.0,156.0,1486.0
Botad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,289.0,270.0,264.0,265.0,426.0,521.0,367.0,257.0,261.0,270.0,347.0,455.0,3992.0
Botad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,130.0,177.0,106.0,127.0,127.0,126.0,144.0,152.0,159.0,120.0,97.0,132.0,1597.0
Botad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,620.0,617.0,660.0,774.0,895.0,963.0,748.0,785.0,841.0,795.0,907.0,977.0,9582.0
Botad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,257.0,295.0,186.0,239.0,238.0,238.0,266.0,321.0,299.0,224.0,232.0,288.0,3083.0
Botad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,909.0,887.0,924.0,1039.0,1321.0,1484.0,1115.0,1042.0,1102.0,1065.0,1254.0,1432.0,13574.0
Botad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,8.0,5.0,3.0,6.0,9.0,4.0,3.0,4.0,2.0,7.0,1.0,52.0
Botad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,6.0,1.0,3.0,5.0,6.0,7.0,1.0,0.0,2.0,3.0,7.0,48.0
Botad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,7.0,14.0,6.0,6.0,11.0,15.0,11.0,4.0,4.0,4.0,10.0,8.0,100.0
Botad,14.11,In-Patient Head Count at midnight,TOTAL,850.0,933.0,835.0,1012.0,1176.0,1454.0,1180.0,1070.0,1035.0,992.0,1035.0,1269.0,12841.0
Botad,14.12.1,OPD attendance (All),TOTAL,19774.0,18205.0,20154.0,23058.0,26543.0,32527.0,22827.0,25312.0,26526.0,23402.0,34382.0,37819.0,310529.0
Botad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,7.0,5.0,11.0,2.0,4.0,7.0,2.0,7.0,6.0,5.0,1129.0,9.0,1194.0
Botad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,131.0,120.0,119.0,155.0,92.0,141.0,73.0,112.0,139.0,141.0,244.0,216.0,1683.0
Botad,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,1.0,8.0
Botad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Botad,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2300.0,2103.0,2784.0,2358.0,2397.0,2872.0,2231.0,2782.0,2474.0,2424.0,2697.0,3117.0,30539.0
Botad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,35.0,23.0,82.0,13.0,23.0,40.0,209.0,14.0,92.0,14.0,33.0,23.0,601.0
Botad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,241.0,297.0,281.0,349.0,186.0,340.0,298.0,612.0,251.0,175.0,300.0,301.0,3631.0
Botad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,43.0,1.0,18.0,0.0,3.0,2.0,2.0,2.0,2.0,0.0,0.0,1.0,74.0
Botad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,240.0,316.0,203.0,278.0,99.0,274.0,234.0,298.0,292.0,326.0,446.0,525.0,3531.0
Botad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,22.0,1.0,1.0,1.0,14.0,1.0,0.0,1.0,2.0,0.0,1.0,0.0,44.0
Botad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,526.0,589.0,810.0,568.0,595.0,786.0,623.0,738.0,734.0,646.0,657.0,785.0,8057.0
Botad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,25.0,1.0,5.0,10.0,3.0,92.0,92.0,138.0,113.0,112.0,57.0,111.0,759.0
Botad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1007.0,1202.0,1294.0,1195.0,880.0,1400.0,1155.0,1648.0,1277.0,1147.0,1403.0,1611.0,15219.0
Botad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,90.0,3.0,24.0,11.0,20.0,95.0,94.0,141.0,117.0,112.0,58.0,112.0,877.0
Botad,15.2,Number of Widal tests conducted,Number tested,194.0,143.0,507.0,503.0,411.0,467.0,329.0,148.0,186.0,164.0,394.0,474.0,3920.0
Botad,15.3.a,Number of VDRL tests conducted on males,Number tested,9.0,1.0,2.0,8.0,5.0,2.0,3.0,2.0,8.0,5.0,3.0,360.0,408.0
Botad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,24.0,16.0,5.0,12.0,4.0,41.0,14.0,60.0,15.0,73.0,14.0,6.0,284.0
Botad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,327.0,48.0,146.0,276.0,340.0,312.0,245.0,399.0,536.0,390.0,274.0,394.0,3687.0
Botad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,360.0,65.0,153.0,296.0,349.0,355.0,262.0,461.0,559.0,468.0,291.0,760.0,4379.0
Botad,15.4.1,Number of blood smears examined for Malaria,TOTAL,1634.0,2636.0,2515.0,1791.0,3471.0,4230.0,3883.0,3214.0,1772.0,1737.0,3833.0,2505.0,33221.0
Botad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,0.0,1.0,1.0,2.0,5.0,3.0,4.0,1.0,3.0,1.0,1.0,23.0
Botad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Botad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Botad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Botad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Botad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Botad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Botad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Botad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Botad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Botad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Botad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Botad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Botad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Botad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Botad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Botad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Botad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Botad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Botad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Botad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Botad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Botad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Botad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Botad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Botad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Botad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Botad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Botad,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Botad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Botad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Botad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Botad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Botad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Botad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Botad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Botad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Botad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Botad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Botad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Botad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Botad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Botad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Botad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Botad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Botad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Botad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Botad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Botad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Botad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Botad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Botad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Botad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Botad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Botad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Botad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Botad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,,,,,,,,,,1.0
Botad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Botad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Botad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Botad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,2.0,,,,,,,,,2.0
Botad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Botad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,2.0,,,,,,,,,2.0
Botad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,1.0,1.0,,,,,,,,,3.0
Botad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Botad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,1.0,1.0,1.0,,,,,,,,,3.0
Botad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,,1.0,,,1.0,,1.0,1.0,,,6.0
Botad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Botad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,1.0,,1.0,,,1.0,,1.0,1.0,,,6.0
Botad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Botad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Botad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Botad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Botad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Botad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Botad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Botad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Botad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Botad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Botad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Botad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Botad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,1.0,1.0,,1.0,3.0
Botad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Botad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,1.0,1.0,,2.0,4.0
Botad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Botad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,2.0,,,,,,,2.0
Botad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,2.0,1.0,,,,,,3.0
Botad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Botad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Botad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Botad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,1.0,,,,,3.0,,1.0,2.0,7.0
Botad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,2.0,4.0,4.0,3.0,5.0,1.0,1.0,1.0,1.0,22.0
Botad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,3.0,4.0,4.0,3.0,5.0,4.0,1.0,2.0,3.0,29.0
Botad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,1.0,1.0,,,,,,,,2.0
Botad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,2.0,3.0,,,2.0,,,,,7.0
Botad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,3.0,4.0,,,2.0,,,,,9.0
Botad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Botad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,,,,,1.0,,,,,2.0
Botad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,3.0,,,,,1.0,,1.0,,1.0,6.0
Botad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,4.0,,,,,2.0,1.0,1.0,,1.0,9.0
Botad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Botad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Botad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,,,,,,,,,1.0
Botad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,7.0,8.0,1.0,2.0,2.0,1.0,1.0,,1.0,23.0
Botad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,5.0,1.0,6.0,9.0,6.0,2.0,7.0,4.0,3.0,,43.0
Botad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,5.0,8.0,14.0,10.0,8.0,4.0,8.0,5.0,3.0,1.0,66.0
Botad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,1.0,,,,,,,,1.0,2.0
Botad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Botad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,1.0,,,,,,,,1.0,2.0
Botad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Botad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Botad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Botad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Botad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Botad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Botad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Botad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Botad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Botad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Botad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Botad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Botad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Botad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Botad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Botad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,1.0,,,1.0,,1.0,,3.0
Botad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Botad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,1.0,,,1.0,,1.0,,3.0
Botad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,2.0,1.0,,,,1.0,,4.0
Botad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,2.0,,,1.0,1.0,1.0,,2.0,,7.0
Botad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,1.0,,1.0,,1.0,,,,,3.0
Botad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,3.0,,3.0,2.0,2.0,1.0,,3.0,,14.0
Botad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,,1.0,8.0,4.0,2.0,2.0,,1.0,,19.0
Botad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Botad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,1.0,,1.0,8.0,4.0,2.0,2.0,1.0,1.0,,20.0
Botad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,1.0,,1.0,,,,2.0
Botad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Botad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Botad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,1.0,,1.0,,,,2.0
Botad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,2.0,,,,,,2.0
Botad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,1.0,,2.0,,8.0,,,1.0,,1.0,13.0
Botad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,1.0,,2.0,,10.0,,,1.0,,1.0,15.0
Botad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Botad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Botad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,2.0,,,,,1.0,,,3.0
Botad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,3.0,,,,,1.0,,,4.0
Botad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,1.0,,,,,,1.0,2.0
Botad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,5.0,2.0,2.0,6.0,1.0,1.0,3.0,20.0
Botad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,4.0,5.0,9.0,23.0,8.0,6.0,18.0,9.0,15.0,5.0,102.0
Botad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,4.0,5.0,9.0,29.0,10.0,8.0,24.0,10.0,16.0,9.0,124.0
Chhotaudepur,1.1,Total number of pregnant women Registered for ANC,TOTAL,2245.0,2274.0,2287.0,1918.0,1851.0,1793.0,1678.0,1808.0,1745.0,2168.0,2479.0,2060.0,24306.0
Chhotaudepur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1449.0,1514.0,1620.0,1411.0,1305.0,1250.0,1214.0,1338.0,1235.0,1566.0,1811.0,1485.0,17198.0
Chhotaudepur,1.2,Number of Pregnant women registered under JSY,TOTAL,1715.0,1676.0,1749.0,1419.0,1388.0,1321.0,1242.0,1365.0,1286.0,1588.0,1818.0,1401.0,17968.0
Chhotaudepur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1463.0,1583.0,1657.0,1467.0,1434.0,1446.0,1322.0,1561.0,1504.0,1620.0,1673.0,1503.0,18233.0
Chhotaudepur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1369.0,1341.0,1245.0,1257.0,1046.0,1059.0,1022.0,1083.0,1051.0,1212.0,1466.0,1248.0,14399.0
Chhotaudepur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1802.0,2083.0,2355.0,1964.0,1730.0,1745.0,1618.0,1606.0,1699.0,1651.0,2114.0,1962.0,22329.0
Chhotaudepur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2124.0,2072.0,2332.0,2235.0,2097.0,2055.0,1876.0,1778.0,1790.0,1960.0,2269.0,1996.0,24584.0
Chhotaudepur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,403.0,528.0,143.0,437.0,331.0,377.0,350.0,410.0,37.0,356.0,421.0,527.0,4320.0
Chhotaudepur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,3.0,3.0,0.0,10.0
Chhotaudepur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1323.0,1577.0,1661.0,1457.0,1141.0,1423.0,1092.0,1183.0,1260.0,1187.0,1218.0,1477.0,15999.0
Chhotaudepur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,128.0,69.0,96.0,47.0,35.0,53.0,28.0,34.0,57.0,50.0,39.0,22.0,658.0
Chhotaudepur,1.8,Number of pregnancy test kits used at SC level,TOTAL,91.0,141.0,154.0,135.0,123.0,136.0,87.0,157.0,134.0,176.0,190.0,165.0,1689.0
Chhotaudepur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,17.0,4.0,7.0,3.0,8.0,7.0,9.0,3.0,5.0,8.0,12.0,85.0
Chhotaudepur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,118.0,84.0,124.0,94.0,121.0,95.0,94.0,114.0,113.0,98.0,73.0,68.0,1196.0
Chhotaudepur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,120.0,101.0,128.0,101.0,124.0,103.0,101.0,123.0,116.0,103.0,81.0,80.0,1281.0
Chhotaudepur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,60.0,58.0,82.0,66.0,74.0,48.0,49.0,76.0,72.0,55.0,50.0,49.0,739.0
Chhotaudepur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,10.0,18.0,11.0,9.0,24.0,11.0,16.0,30.0,37.0,14.0,21.0,12.0,213.0
Chhotaudepur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,784.0,780.0,753.0,765.0,894.0,853.0,952.0,848.0,826.0,796.0,688.0,901.0,9840.0
Chhotaudepur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,516.0,499.0,543.0,541.0,573.0,443.0,613.0,581.0,543.0,416.0,366.0,427.0,6061.0
Chhotaudepur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,3.0,1.0,24.0,19.0,15.0,7.0,46.0,16.0,10.0,8.0,11.0,57.0,217.0
Chhotaudepur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,7.0,2.0,0.0,2.0,0.0,0.0,11.0,2.0,0.0,3.0,3.0,30.0
Chhotaudepur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chhotaudepur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,376.0,504.0,441.0,477.0,463.0,441.0,423.0,444.0,418.0,457.0,428.0,393.0,5265.0
Chhotaudepur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,19.0,10.0,10.0,27.0,14.0,23.0,43.0,13.0,26.0,19.0,32.0,27.0,263.0
Chhotaudepur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Chhotaudepur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhotaudepur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,19.0,10.0,10.0,27.0,14.0,23.0,43.0,13.0,26.0,19.0,32.0,27.0,263.0
Chhotaudepur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,7.0,12.0,17.0,15.0,20.0,11.0,9.0,17.0,15.0,12.0,13.0,15.0,163.0
Chhotaudepur,4.1.1.a,Number of male live births,TOTAL,686.0,803.0,844.0,770.0,803.0,747.0,783.0,799.0,829.0,687.0,642.0,709.0,9102.0
Chhotaudepur,4.1.1.b,Number of female live births,TOTAL,681.0,696.0,626.0,648.0,726.0,676.0,732.0,694.0,696.0,676.0,611.0,791.0,8253.0
Chhotaudepur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1367.0,1499.0,1470.0,1418.0,1529.0,1423.0,1515.0,1493.0,1525.0,1363.0,1253.0,1500.0,17355.0
Chhotaudepur,4.1.2,Number of still births,TOTAL,22.0,27.0,28.0,34.0,40.0,28.0,32.0,36.0,101.0,30.0,21.0,27.0,426.0
Chhotaudepur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,39.0,58.0,42.0,63.0,33.0,33.0,35.0,36.0,33.0,51.0,43.0,29.0,495.0
Chhotaudepur,4.2.1,Number of Newborns weighed at birth,TOTAL,1446.0,1537.0,1432.0,1407.0,1554.0,1431.0,1520.0,1543.0,1463.0,1443.0,1294.0,1343.0,17413.0
Chhotaudepur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,319.0,301.0,245.0,247.0,299.0,254.0,283.0,230.0,215.0,203.0,194.0,218.0,3008.0
Chhotaudepur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1418.0,1553.0,1354.0,1363.0,1525.0,1398.0,1471.0,1510.0,1392.0,1397.0,1249.0,1332.0,16962.0
Chhotaudepur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,9.0,0.0,0.0,5.0,18.0,53.0,12.0,25.0,28.0,20.0,13.0,1.0,184.0
Chhotaudepur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,63.0,59.0,95.0,69.0,82.0,111.0,136.0,100.0,82.0,70.0,75.0,74.0,1016.0
Chhotaudepur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chhotaudepur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhotaudepur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,72.0,59.0,95.0,74.0,100.0,164.0,148.0,125.0,110.0,90.0,88.0,75.0,1200.0
Chhotaudepur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,986.0,1544.0,927.0,1033.0,1094.0,1060.0,1587.0,1019.0,495.0,1011.0,1205.0,959.0,12920.0
Chhotaudepur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,10.0,2.0,9.0,5.0,4.0,1.0,4.0,12.0,5.0,20.0,39.0,96.0,207.0
Chhotaudepur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1088.0,1257.0,855.0,894.0,1002.0,236.0,1202.0,1074.0,931.0,572.0,1148.0,1025.0,11284.0
Chhotaudepur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,30.0,17.0,9.0,3.0,3.0,63.0,7.0,20.0,13.0,10.0,12.0,11.0,198.0
Chhotaudepur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,756.0,773.0,853.0,762.0,902.0,722.0,960.0,961.0,883.0,852.0,787.0,770.0,9981.0
Chhotaudepur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,666.0,664.0,709.0,734.0,946.0,636.0,792.0,949.0,834.0,802.0,574.0,643.0,8949.0
Chhotaudepur,6.3,PNC maternal complications attended,TOTAL,5.0,7.0,12.0,5.0,14.0,76.0,73.0,4.0,3.0,2.0,23.0,63.0,287.0
Chhotaudepur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,5.0,5.0,5.0,1.0,35.0,10.0,12.0,11.0,10.0,3.0,97.0
Chhotaudepur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,4.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,10.0,0.0,15.0
Chhotaudepur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,4.0,5.0,5.0,5.0,2.0,35.0,10.0,12.0,11.0,20.0,3.0,112.0
Chhotaudepur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Chhotaudepur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,50.0,52.0,73.0,47.0,36.0,32.0,24.0,70.0,42.0,33.0,23.0,32.0,514.0
Chhotaudepur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,95.0,99.0,132.0,97.0,109.0,97.0,82.0,89.0,91.0,97.0,87.0,105.0,1180.0
Chhotaudepur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,145.0,151.0,205.0,144.0,145.0,129.0,106.0,159.0,133.0,130.0,110.0,137.0,1694.0
Chhotaudepur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Chhotaudepur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chhotaudepur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhotaudepur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,3.0,0.0,3.0,0.0,6.0,6.0,0.0,52.0,48.0,30.0,19.0,0.0,167.0
Chhotaudepur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,6.0,6.0,15.0,0.0,3.0,0.0,258.0,1340.0,1048.0,472.0,24.0,3172.0
Chhotaudepur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chhotaudepur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhotaudepur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,3.0,6.0,9.0,15.0,6.0,9.0,0.0,310.0,1388.0,1078.0,491.0,24.0,3339.0
Chhotaudepur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,27.0,27.0,49.0,28.0,31.0,26.0,38.0,328.0,278.0,294.0,159.0,26.0,1311.0
Chhotaudepur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,4.0
Chhotaudepur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,0.0,19.0
Chhotaudepur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chhotaudepur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhotaudepur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,14.0,4.0,0.0,0.0,0.0,0.0,23.0
Chhotaudepur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,4.0
Chhotaudepur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,10.0,10.0,11.0,6.0,20.0,13.0,26.0,17.0,21.0,15.0,149.0
Chhotaudepur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chhotaudepur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhotaudepur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,10.0,10.0,12.0,6.0,21.0,14.0,26.0,17.0,22.0,15.0,153.0
Chhotaudepur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,291.0,367.0,410.0,396.0,429.0,442.0,424.0,457.0,483.0,482.0,389.0,226.0,4796.0
Chhotaudepur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,56.0,55.0,51.0,51.0,47.0,51.0,79.0,66.0,42.0,42.0,36.0,30.0,606.0
Chhotaudepur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,4.0,5.0,11.0,9.0,5.0,9.0,14.0,21.0,3.0,3.0,0.0,7.0,91.0
Chhotaudepur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chhotaudepur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhotaudepur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,351.0,427.0,472.0,456.0,481.0,502.0,517.0,544.0,528.0,527.0,425.0,263.0,5493.0
Chhotaudepur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,25.0,30.0,29.0,30.0,33.0,19.0,46.0,56.0,38.0,36.0,47.0,25.0,414.0
Chhotaudepur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,19.0,0.0,0.0,0.0,3.0,4.0,2.0,0.0,0.0,3.0,4.0,4.0,39.0
Chhotaudepur,9.06,Number of IUCD removals,TOTAL,149.0,171.0,160.0,85.0,107.0,171.0,166.0,190.0,193.0,215.0,193.0,219.0,2019.0
Chhotaudepur,9.07,Number of Oral Pills cycles distributed,TOTAL,1047.0,1091.0,1153.0,1000.0,1007.0,1173.0,1687.0,1076.0,1206.0,1320.0,1407.0,1049.0,14216.0
Chhotaudepur,9.08,Number of Condom pieces distributed,TOTAL,8054.0,5986.0,5561.0,4299.0,3737.0,5431.0,5637.0,5528.0,4124.0,8403.0,5220.0,3948.0,65928.0
Chhotaudepur,9.09,Number of Centchroman (weekly) pills given,TOTAL,131.0,10.0,138.0,12.0,13.0,5.0,83.0,1.0,45.0,45.0,19.0,233.0,735.0
Chhotaudepur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,2.0,0.0,0.0,0.0,2.0,7.0,0.0,33.0,15.0,1.0,1.0,61.0
Chhotaudepur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,22.0
Chhotaudepur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,5.0,11.0,6.0,2.0,6.0,4.0,15.0,32.0,41.0,21.0,19.0,1.0,163.0
Chhotaudepur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,9.12,Number of Institutions having NSV trained doctors,TOTAL,20.0,22.0,26.0,24.0,25.0,15.0,14.0,17.0,17.0,14.0,16.0,17.0,-1.0
Chhotaudepur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1627.0,1628.0,1926.0,1809.0,1975.0,1921.0,1913.0,2046.0,1913.0,2007.0,1712.0,1757.0,22234.0
Chhotaudepur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,177.0,222.0,101.0,140.0,188.0,30.0,29.0,33.0,47.0,37.0,39.0,11.0,1054.0
Chhotaudepur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,174.0,198.0,118.0,115.0,193.0,5.0,23.0,15.0,26.0,32.0,60.0,7.0,966.0
Chhotaudepur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,191.0,194.0,107.0,131.0,185.0,9.0,16.0,10.0,25.0,37.0,62.0,3.0,970.0
Chhotaudepur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1418.0,1220.0,1637.0,1491.0,1496.0,1622.0,1642.0,1649.0,1711.0,1909.0,1672.0,1570.0,19037.0
Chhotaudepur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1453.0,1172.0,1737.0,1546.0,1556.0,1651.0,1657.0,1618.0,1729.0,1736.0,1839.0,1675.0,19369.0
Chhotaudepur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1463.0,1136.0,1612.0,1601.0,1562.0,1617.0,1644.0,1636.0,1648.0,1774.0,1706.0,1843.0,19242.0
Chhotaudepur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1322.0,1345.0,1381.0,1453.0,1660.0,1503.0,1569.0,1620.0,1449.0,1653.0,1488.0,1312.0,17755.0
Chhotaudepur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1669.0,1687.0,1691.0,1647.0,1650.0,1723.0,1637.0,1670.0,1735.0,1936.0,1786.0,1626.0,20457.0
Chhotaudepur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1643.0,1709.0,1785.0,1643.0,1707.0,1732.0,1634.0,1631.0,1761.0,1736.0,1951.0,1782.0,20714.0
Chhotaudepur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1715.0,1653.0,1646.0,1710.0,1710.0,1663.0,1668.0,1636.0,1657.0,1789.0,1821.0,1917.0,20585.0
Chhotaudepur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,293.0,229.0,293.0,290.0,207.0,212.0,232.0,446.0,425.0,233.0,252.0,277.0,3389.0
Chhotaudepur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,81.0,7.0,8.0,22.0,14.0,40.0,37.0,20.0,44.0,220.0,206.0,36.0,735.0
Chhotaudepur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,15.0,2.0,24.0,3.0,15.0,23.0,23.0,25.0,15.0,10.0,21.0,2.0,178.0
Chhotaudepur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,142.0,37.0,63.0,107.0,54.0,70.0,43.0,99.0,119.0,66.0,57.0,49.0,906.0
Chhotaudepur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1511.0,1750.0,1837.0,1724.0,1736.0,1699.0,1525.0,1520.0,1553.0,1579.0,1576.0,1538.0,19548.0
Chhotaudepur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,618.0,762.0,885.0,783.0,941.0,895.0,891.0,940.0,1040.0,933.0,1103.0,1035.0,10826.0
Chhotaudepur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,772.0,886.0,941.0,850.0,850.0,821.0,758.0,775.0,799.0,819.0,806.0,761.0,9838.0
Chhotaudepur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,720.0,777.0,875.0,765.0,813.0,811.0,691.0,702.0,691.0,781.0,750.0,675.0,9051.0
Chhotaudepur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1492.0,1663.0,1816.0,1615.0,1663.0,1632.0,1449.0,1477.0,1490.0,1600.0,1556.0,1436.0,18889.0
Chhotaudepur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1359.0,1485.0,1560.0,1411.0,1519.0,1547.0,1463.0,1380.0,1484.0,1571.0,1617.0,1516.0,17912.0
Chhotaudepur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1328.0,1467.0,1535.0,1381.0,1506.0,1535.0,1449.0,1352.0,1441.0,1551.0,1615.0,1493.0,17653.0
Chhotaudepur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,267.0,287.0,304.0,299.0,370.0,419.0,434.0,357.0,379.0,360.0,376.0,389.0,4241.0
Chhotaudepur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,240.0,248.0,267.0,225.0,317.0,403.0,346.0,319.0,357.0,335.0,335.0,389.0,3781.0
Chhotaudepur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,507.0,535.0,571.0,524.0,687.0,822.0,780.0,676.0,736.0,695.0,711.0,778.0,8022.0
Chhotaudepur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,576.0,746.0,879.0,843.0,1872.0,1788.0,972.0,1059.0,1090.0,1050.0,1143.0,744.0,12762.0
Chhotaudepur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,727.0,804.0,971.0,1245.0,2884.0,3041.0,1574.0,1775.0,2162.0,1720.0,1944.0,1198.0,20045.0
Chhotaudepur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1337.0,1540.0,1678.0,1694.0,2777.0,2641.0,1683.0,1685.0,1850.0,1780.0,1554.0,1260.0,21479.0
Chhotaudepur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,11.0,1.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0
Chhotaudepur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,5.0,1.0,11.0,6.0,16.0,11.0,11.0,5.0,5.0,12.0,18.0,9.0,110.0
Chhotaudepur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1061.0,1020.0,1044.0,1025.0,1036.0,1017.0,1026.0,1008.0,1021.0,1007.0,1025.0,994.0,12284.0
Chhotaudepur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1007.0,1018.0,1037.0,1016.0,1024.0,1021.0,1013.0,984.0,1023.0,1001.0,1024.0,1006.0,12174.0
Chhotaudepur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,919.0,951.0,969.0,944.0,964.0,994.0,952.0,953.0,986.0,967.0,989.0,999.0,11587.0
Chhotaudepur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1452.0,1594.0,1743.0,1637.0,1702.0,1691.0,1368.0,1398.0,1500.0,1526.0,1837.0,1858.0,19306.0
Chhotaudepur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,364.0,189.0,119.0,51.0,19607.0,6463.0,111.0,146.0,175.0,150.0,14866.0,2933.0,45174.0
Chhotaudepur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,155.0,53.0,11.0,0.0,8016.0,5430.0,8.0,30.0,29.0,8.0,20846.0,3643.0,38229.0
Chhotaudepur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,21.0,35.0,0.0,0.0,0.0,11.0,14.0,51.0,0.0,4.0,25.0,1.0,162.0
Chhotaudepur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,582.0,623.0,701.0,815.0,1016.0,871.0,1267.0,683.0,701.0,612.0,492.0,562.0,8925.0
Chhotaudepur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,29.0,21.0,59.0,114.0,79.0,335.0,86.0,45.0,27.0,516.0,51.0,17.0,1379.0
Chhotaudepur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,11.0,28.0,13.0,17.0,209.0,38.0,16.0,3.0,8.0,12.0,31.0,32.0,418.0
Chhotaudepur,13.1,Number of Patients operated for cataract,TOTAL,83.0,103.0,152.0,323.0,257.0,269.0,220.0,224.0,258.0,298.0,635.0,439.0,3261.0
Chhotaudepur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,83.0,103.0,152.0,323.0,257.0,269.0,220.0,224.0,248.0,298.0,270.0,229.0,2676.0
Chhotaudepur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,218.0,456.0,2412.0,476.0,180.0,140.0,140.0,190.0,4212.0
Chhotaudepur,13.4,Number of children provided free glasses,TOTAL,0.0,1.0,0.0,0.0,166.0,456.0,648.0,476.0,180.0,140.0,140.0,190.0,2397.0
Chhotaudepur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,3.0,4.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,3.0,-1.0
Chhotaudepur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,27.0,28.0,30.0,27.0,31.0,26.0,28.0,24.0,25.0,26.0,24.0,27.0,-1.0
Chhotaudepur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,4044.0,4382.0,6450.0,5787.0,5638.0,6618.0,4336.0,5797.0,5766.0,5175.0,3959.0,5753.0,-1.0
Chhotaudepur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,8.0,8.0,8.0,7.0,8.0,8.0,7.0,8.0,8.0,8.0,8.0,-1.0
Chhotaudepur,14.05,Number of RKS meetings held during the month,TOTAL,5.0,2.0,16.0,9.0,8.0,11.0,9.0,14.0,14.0,20.0,23.0,30.0,161.0
Chhotaudepur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,32.0,33.0,34.0,31.0,33.0,28.0,30.0,31.0,29.0,24.0,33.0,32.0,-1.0
Chhotaudepur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,162.0,193.0,251.0,146.0,207.0,300.0,242.0,2382.0,2450.0,2082.0,2010.0,2402.0,12827.0
Chhotaudepur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,5.0,5.0,5.0,4.0,4.0,5.0,4.0,5.0,5.0,5.0,5.0,-1.0
Chhotaudepur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,6.0,7.0,7.0,6.0,6.0,6.0,6.0,6.0,8.0,100.0,10.0,8.0,-1.0
Chhotaudepur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,479.0,480.0,451.0,494.0,528.0,598.0,613.0,512.0,436.0,462.0,491.0,513.0,6057.0
Chhotaudepur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,843.0,853.0,719.0,813.0,911.0,945.0,870.0,823.0,879.0,741.0,977.0,816.0,10190.0
Chhotaudepur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,487.0,445.0,578.0,491.0,492.0,490.0,577.0,424.0,431.0,480.0,389.0,463.0,5747.0
Chhotaudepur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2326.0,2396.0,2181.0,2553.0,2709.0,2923.0,2408.0,2306.0,2871.0,2989.0,2761.0,3055.0,31478.0
Chhotaudepur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,966.0,925.0,1029.0,985.0,1020.0,1088.0,1190.0,936.0,867.0,942.0,880.0,976.0,11804.0
Chhotaudepur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3169.0,3249.0,2900.0,3366.0,3620.0,3868.0,3278.0,3129.0,3750.0,3730.0,3738.0,3871.0,41668.0
Chhotaudepur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,10.0,10.0,10.0,5.0,3.0,15.0,12.0,7.0,4.0,5.0,8.0,5.0,94.0
Chhotaudepur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,9.0,4.0,5.0,3.0,4.0,6.0,6.0,7.0,2.0,1.0,3.0,6.0,56.0
Chhotaudepur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,19.0,14.0,15.0,8.0,7.0,21.0,18.0,14.0,6.0,6.0,11.0,11.0,150.0
Chhotaudepur,14.11,In-Patient Head Count at midnight,TOTAL,5301.0,5963.0,5383.0,5656.0,6123.0,7251.0,5665.0,5257.0,4869.0,5759.0,6407.0,6245.0,69879.0
Chhotaudepur,14.12.1,OPD attendance (All),TOTAL,26834.0,31254.0,29886.0,27283.0,37324.0,44413.0,29784.0,26555.0,30578.0,29397.0,37737.0,38548.0,389593.0
Chhotaudepur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,310.0,17.0,35.0,11.0,23.0,29.0,51.0,18.0,33.0,1012.0,284.0,39.0,1862.0
Chhotaudepur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,101.0,107.0,104.0,112.0,103.0,104.0,99.0,481.0,1149.0,1181.0,528.0,332.0,4401.0
Chhotaudepur,14.14.a,Number of patients given AYUSH treatment,TOTAL,338.0,286.0,391.0,359.0,401.0,428.0,359.0,337.0,297.0,247.0,282.0,205.0,3930.0
Chhotaudepur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,65.0,89.0,316.0,68.0,67.0,1.0,55.0,119.0,78.0,111.0,124.0,123.0,1216.0
Chhotaudepur,14.14.c,Number of Adolescents counselled,TOTAL,0.0,307.0,0.0,248.0,149.0,127.0,112.0,193.0,153.0,243.0,0.0,399.0,1931.0
Chhotaudepur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4878.0,5926.0,5658.0,6271.0,6771.0,9696.0,8436.0,4638.0,6567.0,5733.0,7919.0,7060.0,79553.0
Chhotaudepur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,589.0,686.0,354.0,261.0,284.0,365.0,319.0,220.0,210.0,1224.0,1447.0,189.0,6148.0
Chhotaudepur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,394.0,354.0,635.0,605.0,575.0,556.0,502.0,423.0,430.0,604.0,551.0,526.0,6155.0
Chhotaudepur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,122.0,134.0,5.0,2.0,6.0,1.0,5.0,3.0,4.0,36.0,12.0,2.0,332.0
Chhotaudepur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,440.0,445.0,617.0,541.0,539.0,516.0,480.0,294.0,427.0,538.0,560.0,677.0,6074.0
Chhotaudepur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,98.0,135.0,5.0,7.0,28.0,2.0,22.0,7.0,1.0,52.0,3.0,2.0,362.0
Chhotaudepur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1379.0,1452.0,1569.0,1329.0,946.0,1344.0,1025.0,907.0,874.0,1234.0,896.0,1367.0,14322.0
Chhotaudepur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,42.0,80.0,26.0,81.0,33.0,2.0,16.0,14.0,1.0,24.0,1.0,3.0,323.0
Chhotaudepur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2213.0,2251.0,2821.0,2475.0,2060.0,2416.0,2007.0,1624.0,1731.0,2376.0,2007.0,2570.0,26551.0
Chhotaudepur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,262.0,349.0,36.0,90.0,67.0,5.0,43.0,24.0,6.0,112.0,16.0,7.0,1017.0
Chhotaudepur,15.2,Number of Widal tests conducted,Number tested,217.0,155.0,178.0,196.0,164.0,249.0,108.0,47.0,105.0,116.0,629.0,257.0,2421.0
Chhotaudepur,15.3.a,Number of VDRL tests conducted on males,Number tested,55.0,61.0,49.0,36.0,104.0,146.0,20.0,44.0,70.0,28.0,81.0,30.0,724.0
Chhotaudepur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,57.0,59.0,58.0,32.0,50.0,63.0,47.0,89.0,39.0,50.0,97.0,56.0,697.0
Chhotaudepur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,665.0,295.0,192.0,158.0,208.0,241.0,117.0,168.0,168.0,129.0,205.0,148.0,2694.0
Chhotaudepur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,777.0,415.0,299.0,226.0,362.0,450.0,184.0,301.0,277.0,207.0,383.0,234.0,4115.0
Chhotaudepur,15.4.1,Number of blood smears examined for Malaria,TOTAL,8767.0,8770.0,11021.0,10222.0,16191.0,15599.0,9735.0,9078.0,8088.0,8983.0,11093.0,10917.0,128464.0
Chhotaudepur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,53.0,76.0,443.0,185.0,110.0,404.0,65.0,112.0,395.0,76.0,23.0,44.0,1986.0
Chhotaudepur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,7.0,0.0,2.0,2.0,3.0,13.0,22.0,53.0,57.0,10.0,9.0,3.0,181.0
Chhotaudepur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Chhotaudepur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Chhotaudepur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Chhotaudepur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Chhotaudepur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhotaudepur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,,,,,,,1.0,2.0,,4.0
Chhotaudepur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Chhotaudepur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chhotaudepur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Chhotaudepur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,1.0,,3.0,,,1.0,,1.0,1.0,,7.0
Chhotaudepur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chhotaudepur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,1.0,,3.0,,,1.0,,1.0,1.0,,7.0
Chhotaudepur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,3.0,3.0,6.0,5.0,5.0,3.0,3.0,,,9.0,2.0,2.0,41.0
Chhotaudepur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,1.0,,,,1.0,,,,,,3.0
Chhotaudepur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,3.0,7.0,5.0,5.0,3.0,4.0,,,9.0,2.0,2.0,44.0
Chhotaudepur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,5.0,1.0,3.0,3.0,,10.0,10.0,4.0,,3.0,3.0,45.0
Chhotaudepur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,1.0,1.0,,3.0
Chhotaudepur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,6.0,1.0,3.0,3.0,,10.0,10.0,4.0,1.0,4.0,3.0,48.0
Chhotaudepur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,1.0,1.0,3.0,1.0,,,,1.0,,2.0,10.0
Chhotaudepur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Chhotaudepur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,1.0,1.0,3.0,1.0,,,1.0,1.0,,2.0,11.0
Chhotaudepur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,1.0,,,1.0
Chhotaudepur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chhotaudepur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,1.0,,,1.0
Chhotaudepur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,,,,,,,1.0
Chhotaudepur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chhotaudepur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,,,,,,,1.0
Chhotaudepur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chhotaudepur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chhotaudepur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Chhotaudepur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,5.0,3.0,3.0,4.0,1.0,3.0,1.0,,2.0,5.0,1.0,30.0
Chhotaudepur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,1.0,1.0,2.0,2.0,2.0,5.0,2.0,3.0,1.0,2.0,22.0
Chhotaudepur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,6.0,4.0,4.0,6.0,3.0,5.0,6.0,2.0,5.0,6.0,3.0,52.0
Chhotaudepur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,2.0,,,,,,,,2.0
Chhotaudepur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,1.0,,,,,,,,,,,2.0
Chhotaudepur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,1.0,,,2.0,,,,,,,,4.0
Chhotaudepur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,,,1.0,4.0,,,1.0,1.0,,1.0,9.0
Chhotaudepur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Chhotaudepur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,,1.0,1.0,4.0,,,1.0,1.0,,1.0,10.0
Chhotaudepur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,1.0,,,,,,,,1.0,3.0
Chhotaudepur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,2.0,,,,1.0,2.0,1.0,,,,1.0,7.0
Chhotaudepur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,3.0,,1.0,,1.0,2.0,1.0,,,,2.0,10.0
Chhotaudepur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Chhotaudepur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Chhotaudepur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,2.0,,,,,,,,2.0
Chhotaudepur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,2.0,1.0,,,,,,,3.0
Chhotaudepur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Chhotaudepur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Chhotaudepur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,,,,,2.0,,,,,,,4.0
Chhotaudepur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,,,,,2.0,,,,,,,5.0
Chhotaudepur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,,,1.0,,,,,,,,2.0
Chhotaudepur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,,,,,,,,,1.0,,,2.0
Chhotaudepur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,,,,1.0,,,,,1.0,,,4.0
Chhotaudepur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Chhotaudepur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Chhotaudepur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,1.0,,,,,,1.0
Chhotaudepur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Chhotaudepur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Chhotaudepur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Chhotaudepur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,3.0,,,,,1.0,,4.0
Chhotaudepur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,3.0,,,,,1.0,,4.0
Chhotaudepur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,2.0,,2.0
Chhotaudepur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,2.0,,2.0
Chhotaudepur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,,2.0,,,1.0,1.0,,,2.0,6.0,1.0,15.0
Chhotaudepur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,,,,1.0,,,,,2.0
Chhotaudepur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,,2.0,1.0,,1.0,1.0,1.0,,2.0,6.0,1.0,17.0
Chhotaudepur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,,1.0,,,,,,,2.0
Chhotaudepur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,,,1.0,,,,,,,2.0
Chhotaudepur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,,,,,,,1.0,,,,2.0
Chhotaudepur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,,,,,,,1.0,,,,2.0
Chhotaudepur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Chhotaudepur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,,,2.0,,,,,,1.0,,4.0
Chhotaudepur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Chhotaudepur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,,,,2.0,,,,,,1.0,,4.0
Chhotaudepur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Chhotaudepur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,3.0,5.0,7.0,6.0,5.0,4.0,,,,1.0,2.0,,33.0
Chhotaudepur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,2.0,2.0,12.0,5.0,10.0,3.0,,1.0,1.0,3.0,2.0,,41.0
Chhotaudepur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,5.0,7.0,19.0,11.0,15.0,8.0,,1.0,1.0,4.0,4.0,,75.0
Dahod,1.1,Total number of pregnant women Registered for ANC,TOTAL,5414.0,5633.0,5818.0,5939.0,5934.0,5678.0,5247.0,5411.0,5243.0,5500.0,5486.0,5439.0,66742.0
Dahod,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3506.0,3674.0,3795.0,3895.0,3788.0,3718.0,3455.0,3453.0,3430.0,3573.0,3545.0,3607.0,43439.0
Dahod,1.2,Number of Pregnant women registered under JSY,TOTAL,2958.0,2735.0,3049.0,3442.0,3613.0,3293.0,3210.0,4175.0,3194.0,3146.0,3185.0,3057.0,39057.0
Dahod,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3607.0,3828.0,3984.0,3959.0,3937.0,3978.0,3659.0,3803.0,3672.0,3810.0,3951.0,4067.0,46255.0
Dahod,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4102.0,4206.0,4370.0,4352.0,4444.0,4246.0,3937.0,4084.0,3912.0,4014.0,3996.0,4107.0,49770.0
Dahod,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5002.0,5442.0,5573.0,5733.0,5929.0,5801.0,5323.0,5133.0,5274.0,5184.0,5204.0,5737.0,65335.0
Dahod,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4558.0,4973.0,5003.0,5479.0,5470.0,5001.0,4676.0,4986.0,4862.0,4918.0,4713.0,5108.0,59747.0
Dahod,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,17.0,31.0,45.0,37.0,26.0,19.0,16.0,16.0,26.0,80.0,21.0,22.0,356.0
Dahod,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,7.0,3.0,0.0,3.0,3.0,3.0,10.0,63.0,14.0,25.0,11.0,0.0,142.0
Dahod,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2161.0,2411.0,2583.0,2753.0,2747.0,2755.0,2416.0,2177.0,2083.0,2292.0,2296.0,2758.0,29432.0
Dahod,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,163.0,93.0,97.0,219.0,255.0,257.0,186.0,204.0,209.0,280.0,214.0,324.0,2501.0
Dahod,1.8,Number of pregnancy test kits used at SC level,TOTAL,38.0,57.0,85.0,254.0,208.0,559.0,387.0,451.0,449.0,483.0,322.0,287.0,3580.0
Dahod,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,4.0,10.0,17.0,17.0,17.0,15.0,26.0,14.0,26.0,19.0,11.0,7.0,183.0
Dahod,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,23.0,30.0,39.0,33.0,45.0,45.0,63.0,81.0,55.0,53.0,54.0,44.0,565.0
Dahod,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,27.0,40.0,56.0,50.0,62.0,60.0,89.0,95.0,81.0,72.0,65.0,51.0,748.0
Dahod,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,38.0,35.0,33.0,55.0,46.0,46.0,60.0,70.0,56.0,52.0,50.0,40.0,581.0
Dahod,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,6.0,30.0,25.0,22.0,0.0,26.0,26.0,3.0,30.0,29.0,6.0,24.0,227.0
Dahod,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2498.0,2957.0,2720.0,3147.0,3095.0,2888.0,3114.0,2971.0,3572.0,2967.0,2592.0,2482.0,35003.0
Dahod,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1540.0,1469.0,1918.0,2352.0,2378.0,2301.0,2063.0,1979.0,3171.0,2302.0,1958.0,2236.0,25667.0
Dahod,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,274.0,620.0,452.0,623.0,418.0,474.0,701.0,269.0,654.0,333.0,265.0,63.0,5146.0
Dahod,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,68.0,51.0,411.0,584.0,350.0,312.0,503.0,134.0,87.0,85.0,78.0,15.0,2678.0
Dahod,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1865.0,1656.0,1612.0,1501.0,1904.0,1893.0,1552.0,1652.0,1299.0,1841.0,1833.0,1942.0,20550.0
Dahod,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,533.0,251.0,254.0,89.0,385.0,406.0,0.0,0.0,0.0,0.0,0.0,0.0,1918.0
Dahod,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,385.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,385.0
Dahod,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,5.0,9.0,11.0,7.0,18.0,2.0,5.0,0.0,4.0,0.0,0.0,3.0,64.0
Dahod,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,33.0,19.0,16.0,31.0,10.0,26.0,22.0,36.0,28.0,17.0,29.0,18.0,285.0
Dahod,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dahod,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,38.0,28.0,27.0,38.0,28.0,28.0,27.0,36.0,32.0,17.0,29.0,21.0,349.0
Dahod,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,4.0,2.0,0.0,0.0,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0
Dahod,4.1.1.a,Number of male live births,TOTAL,2252.0,2453.0,2352.0,2383.0,2644.0,2513.0,2437.0,2507.0,2617.0,2564.0,2351.0,2679.0,29752.0
Dahod,4.1.1.b,Number of female live births,TOTAL,2042.0,2269.0,2035.0,2185.0,2404.0,2320.0,2288.0,2261.0,2383.0,2410.0,2229.0,2359.0,27185.0
Dahod,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4294.0,4722.0,4387.0,4568.0,5048.0,4833.0,4725.0,4768.0,5000.0,4974.0,4580.0,5038.0,56937.0
Dahod,4.1.2,Number of still births,TOTAL,48.0,78.0,62.0,71.0,80.0,55.0,69.0,66.0,45.0,66.0,61.0,63.0,764.0
Dahod,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,87.0,118.0,93.0,99.0,104.0,90.0,108.0,105.0,121.0,105.0,79.0,43.0,1152.0
Dahod,4.2.1,Number of Newborns weighed at birth,TOTAL,4155.0,4461.0,4206.0,4318.0,4897.0,5045.0,4841.0,4258.0,5105.0,5084.0,4674.0,5224.0,56268.0
Dahod,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,263.0,424.0,248.0,390.0,423.0,376.0,413.0,523.0,553.0,389.0,331.0,557.0,4890.0
Dahod,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4164.0,4607.0,4432.0,4570.0,5190.0,5063.0,4892.0,4315.0,5120.0,5145.0,4702.0,5181.0,57381.0
Dahod,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,2.0,3.0,0.0,90.0,0.0,0.0,27.0,14.0,5.0,0.0,141.0
Dahod,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,41.0,0.0,5.0,0.0,1.0,0.0,100.0,68.0,28.0,6.0,249.0
Dahod,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,13.0,15.0,34.0,44.0,19.0,26.0,48.0,56.0,53.0,34.0,44.0,0.0,386.0
Dahod,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dahod,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,13.0,15.0,77.0,47.0,24.0,116.0,49.0,56.0,180.0,116.0,77.0,6.0,776.0
Dahod,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,403.0,553.0,585.0,506.0,204.0,215.0,189.0,145.0,157.0,80.0,145.0,731.0,3913.0
Dahod,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,76.0,0.0,0.0,84.0,0.0,0.0,1.0,161.0
Dahod,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1051.0,954.0,1431.0,1756.0,1862.0,1988.0,1980.0,1432.0,2309.0,718.0,964.0,2946.0,19391.0
Dahod,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,12.0,14.0,26.0,50.0,20.0,26.0,42.0,56.0,49.0,40.0,53.0,50.0,438.0
Dahod,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3616.0,3790.0,4048.0,3907.0,4360.0,5704.0,5381.0,5616.0,5741.0,5763.0,5362.0,5611.0,58899.0
Dahod,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,4082.0,4271.0,4878.0,4413.0,4586.0,5996.0,4987.0,5293.0,5328.0,5722.0,5231.0,5791.0,60578.0
Dahod,6.3,PNC maternal complications attended,TOTAL,3.0,20.0,16.0,17.0,11.0,1.0,1.0,7.0,83.0,3.0,3.0,1.0,166.0
Dahod,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,16.0,10.0,10.0,12.0,0.0,3.0,2.0,5.0,11.0,20.0,12.0,13.0,114.0
Dahod,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,36.0,3.0,5.0,0.0,0.0,39.0,0.0,0.0,3.0,2.0,18.0,0.0,106.0
Dahod,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,52.0,13.0,15.0,12.0,0.0,42.0,2.0,5.0,14.0,22.0,30.0,13.0,220.0
Dahod,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,199.0,185.0,184.0,197.0,105.0,121.0,122.0,87.0,97.0,91.0,136.0,153.0,1677.0
Dahod,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,383.0,345.0,359.0,371.0,392.0,395.0,346.0,313.0,389.0,412.0,406.0,393.0,4504.0
Dahod,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,582.0,530.0,543.0,568.0,497.0,516.0,468.0,400.0,486.0,503.0,542.0,546.0,6181.0
Dahod,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,18.0,1.0,20.0,0.0,0.0,42.0,19.0,16.0,21.0,7.0,11.0,155.0
Dahod,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Dahod,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,1.0,2.0,3.0,6.0,23.0,36.0,19.0,2.0,0.0,93.0
Dahod,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dahod,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,1.0,3.0,3.0,6.0,23.0,36.0,19.0,2.0,0.0,94.0
Dahod,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,1.0,2.0,9.0,15.0,11.0,20.0,9.0,134.0,128.0,84.0,31.0,9.0,453.0
Dahod,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,7.0,7.0,7.0,7.0,13.0,36.0,41.0,828.0,1794.0,1561.0,387.0,9.0,4697.0
Dahod,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,50.0,36.0,56.0,123.0,147.0,240.0,145.0,620.0,846.0,1035.0,432.0,93.0,3823.0
Dahod,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dahod,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,58.0,45.0,72.0,145.0,171.0,296.0,195.0,1582.0,2768.0,2680.0,850.0,111.0,8973.0
Dahod,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,16.0,22.0,21.0,26.0,35.0,54.0,35.0,55.0,133.0,1564.0,1256.0,1018.0,4235.0
Dahod,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,110.0,0.0,282.0,44.0,0.0,436.0
Dahod,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,11.0,10.0,3.0,13.0,1.0,0.0,0.0,28.0,6.0,2.0,1.0,2.0,77.0
Dahod,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dahod,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,11.0,10.0,3.0,13.0,1.0,0.0,0.0,138.0,6.0,284.0,45.0,2.0,513.0
Dahod,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,4.0,3.0,0.0,6.0,4.0,19.0,30.0,48.0,68.0,0.0,139.0,27.0,348.0
Dahod,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,15.0,0.0,21.0,37.0,0.0,0.0,34.0,109.0
Dahod,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,6.0
Dahod,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,13.0,18.0,8.0,14.0,5.0,0.0,7.0,0.0,3.0,0.0,0.0,2.0,70.0
Dahod,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dahod,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,16.0,18.0,8.0,16.0,5.0,15.0,7.0,21.0,40.0,0.0,0.0,39.0,185.0
Dahod,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,498.0,663.0,560.0,546.0,679.0,619.0,693.0,738.0,687.0,821.0,538.0,478.0,7520.0
Dahod,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,694.0,966.0,1084.0,1111.0,1097.0,1040.0,946.0,821.0,1011.0,1096.0,1018.0,1020.0,11904.0
Dahod,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,2.0,2.0,2.0,2.0,2.0,0.0,2.0,8.0,5.0,5.0,30.0
Dahod,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,35.0,48.0,46.0,47.0,35.0,37.0,40.0,25.0,32.0,34.0,19.0,24.0,422.0
Dahod,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dahod,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1227.0,1677.0,1692.0,1706.0,1813.0,1698.0,1681.0,1584.0,1732.0,1959.0,1580.0,1527.0,19876.0
Dahod,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,29.0,34.0,26.0,19.0,27.0,37.0,48.0,45.0,43.0,20.0,18.0,13.0,359.0
Dahod,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1754.0,1990.0,3744.0
Dahod,9.06,Number of IUCD removals,TOTAL,301.0,211.0,190.0,355.0,333.0,210.0,205.0,376.0,159.0,146.0,193.0,203.0,2882.0
Dahod,9.07,Number of Oral Pills cycles distributed,TOTAL,5382.0,5656.0,4927.0,5077.0,4045.0,4587.0,5625.0,8191.0,5836.0,4118.0,5621.0,6668.0,65733.0
Dahod,9.08,Number of Condom pieces distributed,TOTAL,28877.0,25245.0,30778.0,27804.0,21090.0,22669.0,27256.0,31748.0,31091.0,16562.0,24753.0,17504.0,305377.0
Dahod,9.09,Number of Centchroman (weekly) pills given,TOTAL,4154.0,254.0,2676.0,147.0,125.0,4.0,25.0,3.0,28.0,69.0,2.0,279.0,7766.0
Dahod,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,60.0,111.0,26.0,28.0,52.0,21.0,36.0,12.0,32.0,39.0,41.0,16.0,474.0
Dahod,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,0.0,0.0,16.0
Dahod,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,3.0
Dahod,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,9.0
Dahod,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,9.12,Number of Institutions having NSV trained doctors,TOTAL,20.0,20.0,19.0,18.0,19.0,51.0,44.0,45.0,59.0,63.0,56.0,57.0,-1.0
Dahod,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5211.0,5046.0,5065.0,5394.0,5630.0,5523.0,5601.0,5580.0,5460.0,5392.0,5338.0,5921.0,65161.0
Dahod,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,6.0,34.0,42.0
Dahod,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,6.0,26.0,36.0
Dahod,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,1.0,0.0,0.0,3.0,0.0,0.0,3.0,0.0,4.0,19.0,30.0
Dahod,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,4632.0,4802.0,4468.0,4786.0,4955.0,4958.0,4998.0,4882.0,4810.0,4973.0,4845.0,4427.0,57536.0
Dahod,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4532.0,4521.0,4597.0,4578.0,4973.0,4836.0,4948.0,4993.0,4803.0,4801.0,4906.0,4515.0,57003.0
Dahod,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,4465.0,4538.0,4419.0,4570.0,4692.0,4895.0,4806.0,5024.0,4729.0,4725.0,4639.0,4613.0,56115.0
Dahod,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,4310.0,4439.0,3966.0,3952.0,4456.0,4314.0,4411.0,4121.0,4739.0,4629.0,4714.0,4928.0,52979.0
Dahod,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4619.0,4759.0,4652.0,4646.0,5035.0,5145.0,5111.0,4922.0,4887.0,5021.0,4823.0,4621.0,58241.0
Dahod,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4562.0,4489.0,4740.0,4475.0,5144.0,5001.0,5015.0,4952.0,4890.0,4824.0,5015.0,4685.0,57792.0
Dahod,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4440.0,4512.0,4442.0,4427.0,4655.0,4967.0,4846.0,4851.0,4758.0,4683.0,4729.0,4668.0,55978.0
Dahod,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2213.0,2101.0,1748.0,2172.0,1850.0,1790.0,1926.0,1920.0,2053.0,2110.0,2011.0,2374.0,24268.0
Dahod,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,19.0,135.0,7.0,7.0,10.0,27.0,0.0,3.0,114.0,19.0,26.0,21.0,388.0
Dahod,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0,0.0,0.0,12.0,7.0,38.0
Dahod,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,12.0,1.0,33.0
Dahod,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3983.0,4313.0,4231.0,4399.0,4732.0,4717.0,4565.0,4507.0,4434.0,4432.0,4665.0,4919.0,53897.0
Dahod,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2898.0,3076.0,3203.0,3253.0,3534.0,3823.0,3733.0,3684.0,3812.0,3556.0,3848.0,3829.0,42249.0
Dahod,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1876.0,2044.0,2156.0,2120.0,2254.0,2289.0,2290.0,2101.0,2168.0,2291.0,2331.0,2395.0,26315.0
Dahod,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1725.0,1895.0,2002.0,1909.0,2055.0,2099.0,2171.0,2018.0,1980.0,2139.0,2119.0,2181.0,24293.0
Dahod,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3601.0,3939.0,4158.0,4029.0,4309.0,4388.0,4461.0,4119.0,4148.0,4430.0,4450.0,4576.0,50608.0
Dahod,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3440.0,3744.0,3774.0,3680.0,4074.0,4096.0,4184.0,4020.0,3890.0,4036.0,3985.0,4295.0,47218.0
Dahod,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3464.0,3706.0,3903.0,3593.0,4091.0,4097.0,4139.0,4007.0,3879.0,4028.0,3967.0,4290.0,47164.0
Dahod,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,2.0,8.0
Dahod,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,815.0,834.0,1008.0,688.0,985.0,965.0,985.0,1008.0,961.0,1051.0,918.0,976.0,11194.0
Dahod,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,764.0,761.0,920.0,645.0,928.0,914.0,941.0,937.0,894.0,971.0,851.0,923.0,10449.0
Dahod,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1579.0,1595.0,1928.0,1333.0,1913.0,1879.0,1926.0,1945.0,1855.0,2022.0,1769.0,1899.0,21643.0
Dahod,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,3107.0,3368.0,3175.0,2985.0,3435.0,3542.0,3602.0,3679.0,3431.0,3467.0,3283.0,3561.0,40635.0
Dahod,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,3048.0,3274.0,3431.0,3422.0,3597.0,3875.0,3574.0,3606.0,3477.0,3243.0,3530.0,3554.0,41631.0
Dahod,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,3252.0,3496.0,3680.0,3679.0,4088.0,4065.0,3857.0,3892.0,3797.0,3608.0,3754.0,3932.0,45100.0
Dahod,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,6.0,3.0,5.0,7.0,10.0,0.0,6.0,6.0,10.0,7.0,9.0,4.0,73.0
Dahod,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1523.0,1504.0,1521.0,1561.0,1591.0,1564.0,1618.0,1592.0,1614.0,1582.0,1547.0,1583.0,18800.0
Dahod,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1528.0,1491.0,1497.0,1524.0,1580.0,1555.0,1608.0,1591.0,1622.0,1577.0,1532.0,1558.0,18663.0
Dahod,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1482.0,1433.0,1446.0,1492.0,1523.0,1519.0,1560.0,1532.0,1571.0,1523.0,1490.0,1501.0,18072.0
Dahod,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3882.0,3922.0,4158.0,4189.0,4377.0,4489.0,4384.0,4366.0,4173.0,4006.0,4220.0,4969.0,51135.0
Dahod,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,4880.0,123.0,76.0,31.0,1491.0,1114.0,6453.0,4456.0,232.0,86.0,101.0,16808.0,35851.0
Dahod,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,5033.0,48.0,32.0,6.0,1514.0,1084.0,5609.0,5669.0,202.0,52.0,47.0,16845.0,36141.0
Dahod,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,3.0
Dahod,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,20.0,0.0,10.0,0.0,24.0,0.0,0.0,2.0,56.0
Dahod,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2760.0,2775.0,2859.0,5308.0,3861.0,3511.0,2621.0,2477.0,2322.0,2267.0,2129.0,2246.0,35136.0
Dahod,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,12.0,98.0,167.0,1067.0,1257.0,711.0,453.0,13.0,21.0,14.0,5.0,4.0,3822.0
Dahod,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,15.0,6.0,10.0,20.0,0.0,17.0,13.0,11.0,10.0,9.0,52.0,163.0
Dahod,13.1,Number of Patients operated for cataract,TOTAL,275.0,72.0,112.0,167.0,124.0,143.0,162.0,108.0,543.0,490.0,333.0,497.0,3026.0
Dahod,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,95.0,72.0,79.0,187.0,169.0,188.0,162.0,108.0,273.0,220.0,333.0,236.0,2122.0
Dahod,13.3,Number of School children detected with Refractive errors,TOTAL,41.0,0.0,26.0,90.0,133.0,187.0,69.0,70.0,333.0,202.0,75.0,70.0,1296.0
Dahod,13.4,Number of children provided free glasses,TOTAL,40.0,0.0,19.0,50.0,48.0,183.0,69.0,76.0,286.0,180.0,141.0,236.0,1328.0
Dahod,13.5,Number of eyes collected through eye donation,TOTAL,2.0,0.0,4.0,0.0,2.0,2.0,2.0,2.0,0.0,2.0,0.0,2.0,18.0
Dahod,13.6,Number of eyes utilised for corneal transplant,TOTAL,1.0,0.0,3.0,0.0,2.0,2.0,2.0,2.0,0.0,2.0,0.0,2.0,16.0
Dahod,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,10.0,8.0,7.0,7.0,5.0,16.0,17.0,18.0,17.0,18.0,19.0,19.0,-1.0
Dahod,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,22.0,20.0,22.0,22.0,20.0,45.0,38.0,39.0,48.0,55.0,49.0,47.0,-1.0
Dahod,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,667.0,687.0,800.0,685.0,848.0,574.0,653.0,709.0,665.0,663.0,807.0,653.0,-1.0
Dahod,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,17.0,17.0,16.0,16.0,15.0,24.0,24.0,25.0,24.0,25.0,25.0,25.0,-1.0
Dahod,14.05,Number of RKS meetings held during the month,TOTAL,9.0,7.0,15.0,6.0,11.0,12.0,10.0,16.0,19.0,14.0,15.0,16.0,150.0
Dahod,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,37.0,40.0,39.0,37.0,37.0,72.0,71.0,71.0,80.0,83.0,79.0,77.0,-1.0
Dahod,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,215.0,190.0,264.0,282.0,286.0,2410.0,4656.0,576.0,2397.0,457.0,381.0,279.0,12393.0
Dahod,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,13.0,11.0,11.0,10.0,9.0,17.0,19.0,19.0,17.0,16.0,18.0,19.0,-1.0
Dahod,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,9.0,15.0,12.0,13.0,10.0,12.0,10.0,9.0,125.0,10.0,55.0,20.0,-1.0
Dahod,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,667.0,457.0,423.0,890.0,489.0,561.0,475.0,408.0,254.0,214.0,134.0,515.0,5487.0
Dahod,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1896.0,1733.0,1491.0,1555.0,2336.0,2971.0,2913.0,2442.0,1607.0,1162.0,1229.0,3259.0,24594.0
Dahod,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,646.0,374.0,343.0,1024.0,537.0,551.0,492.0,442.0,310.0,238.0,165.0,486.0,5608.0
Dahod,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3901.0,3772.0,3753.0,4675.0,6126.0,6229.0,5533.0,5027.0,4914.0,4632.0,3986.0,5008.0,57556.0
Dahod,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1313.0,831.0,766.0,1914.0,1026.0,1112.0,967.0,850.0,564.0,452.0,299.0,1001.0,11095.0
Dahod,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5797.0,5505.0,5244.0,6230.0,8462.0,9200.0,8446.0,7469.0,6521.0,5794.0,5215.0,8267.0,82150.0
Dahod,14.10.2.a,Number of death cases of Inpatient males,TOTAL,18.0,16.0,26.0,16.0,29.0,26.0,27.0,20.0,17.0,18.0,11.0,31.0,255.0
Dahod,14.10.2.b,Number of death cases of Inpatient females,TOTAL,11.0,15.0,8.0,10.0,8.0,21.0,22.0,11.0,14.0,6.0,6.0,28.0,160.0
Dahod,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,29.0,31.0,34.0,26.0,37.0,47.0,49.0,31.0,31.0,24.0,17.0,59.0,415.0
Dahod,14.11,In-Patient Head Count at midnight,TOTAL,7703.0,6597.0,6356.0,7065.0,7236.0,7271.0,6380.0,5426.0,3791.0,4457.0,3760.0,4399.0,70441.0
Dahod,14.12.1,OPD attendance (All),TOTAL,81138.0,84103.0,85977.0,95702.0,123632.0,155570.0,105393.0,95124.0,97010.0,104661.0,119552.0,103573.0,1251435.0
Dahod,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,157.0,145.0,175.0,233.0,191.0,207.0,133.0,190.0,111.0,75.0,131.0,343.0,2091.0
Dahod,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,24.0,12.0,0.0,0.0,38.0,41.0,6.0,8.0,17.0,21.0,16.0,25.0,208.0
Dahod,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,234.0,222.0,292.0,390.0,364.0,480.0,204.0,1360.0,2606.0,2547.0,998.0,259.0,9956.0
Dahod,14.14.a,Number of patients given AYUSH treatment,TOTAL,312.0,325.0,345.0,385.0,749.0,556.0,191.0,222.0,580.0,1524.0,2028.0,641.0,7858.0
Dahod,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,118.0,793.0,294.0,258.0,266.0,106.0,222.0,273.0,737.0,182.0,369.0,585.0,4203.0
Dahod,14.14.c,Number of Adolescents counselled,TOTAL,248.0,188.0,182.0,237.0,92.0,206.0,173.0,121.0,288.0,95.0,169.0,267.0,2266.0
Dahod,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,13035.0,13478.0,17978.0,14462.0,14505.0,14111.0,12160.0,12120.0,12238.0,11085.0,11923.0,11787.0,158882.0
Dahod,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,737.0,672.0,618.0,697.0,1225.0,1053.0,773.0,676.0,749.0,558.0,567.0,693.0,9018.0
Dahod,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1282.0,1303.0,1365.0,1436.0,1526.0,1392.0,1400.0,1573.0,1166.0,669.0,1204.0,1535.0,15851.0
Dahod,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,14.0,184.0,18.0,19.0,22.0,301.0,70.0,37.0,65.0,52.0,59.0,10.0,851.0
Dahod,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1559.0,1784.0,1981.0,1756.0,1840.0,1792.0,1566.0,1740.0,2026.0,1025.0,1191.0,1264.0,19524.0
Dahod,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,9.0,214.0,26.0,285.0,14.0,44.0,21.0,42.0,20.0,14.0,43.0,7.0,739.0
Dahod,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2445.0,1985.0,2803.0,2813.0,2695.0,2535.0,2194.0,2722.0,2509.0,2057.0,2095.0,3339.0,30192.0
Dahod,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,9.0,579.0,67.0,249.0,28.0,80.0,124.0,46.0,8.0,3.0,4.0,0.0,1197.0
Dahod,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,5286.0,5072.0,6149.0,6005.0,6061.0,5719.0,5160.0,6035.0,5701.0,3751.0,4490.0,6138.0,65567.0
Dahod,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,32.0,977.0,111.0,553.0,64.0,425.0,215.0,125.0,93.0,69.0,106.0,17.0,2787.0
Dahod,15.2,Number of Widal tests conducted,Number tested,309.0,365.0,203.0,320.0,336.0,1133.0,963.0,471.0,342.0,245.0,404.0,306.0,5397.0
Dahod,15.3.a,Number of VDRL tests conducted on males,Number tested,78.0,354.0,380.0,333.0,30.0,90.0,68.0,453.0,64.0,75.0,106.0,353.0,2384.0
Dahod,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,162.0,106.0,274.0,125.0,174.0,247.0,166.0,108.0,215.0,255.0,477.0,228.0,2537.0
Dahod,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,334.0,821.0,1054.0,735.0,1079.0,1108.0,815.0,796.0,504.0,654.0,897.0,1184.0,9981.0
Dahod,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,574.0,1281.0,1708.0,1193.0,1283.0,1445.0,1049.0,1357.0,783.0,984.0,1480.0,1765.0,14902.0
Dahod,15.4.1,Number of blood smears examined for Malaria,TOTAL,23362.0,34532.0,47204.0,44792.0,49662.0,63213.0,43952.0,32346.0,27708.0,23041.0,32326.0,24139.0,446277.0
Dahod,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,666.0,1061.0,333.0,578.0,776.0,775.0,922.0,343.0,290.0,74.0,86.0,74.0,5978.0
Dahod,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,16.0,10.0,11.0,27.0,36.0,200.0,215.0,159.0,169.0,28.0,16.0,36.0,923.0
Dahod,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,0.0,0.0,390.0,200.0,2530.0,4070.0,3400.0,5460.0,5110.0,5640.0,10770.0,2850.0,40420.0
Dahod,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,10000.0,7500.0,15000.0,15000.0,10000.0,12000.0,12000.0,12000.0,12500.0,0.0,22000.0,128000.0
Dahod,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,0.0,9610.0,7690.0,12670.0,13460.0,10670.0,9940.0,12350.0,11470.0,7370.0,7920.0,18880.0,122030.0
Dahod,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,390.0,200.0,2530.0,4070.0,3400.0,5460.0,5110.0,5640.0,10770.0,2850.0,5970.0,46390.0
Dahod,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3180.0,0.0,2820.0,1980.0,3480.0,4390.0,1600.0,7450.0,5460.0,5950.0,12390.0,1840.0,50540.0
Dahod,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,12000.0,21000.0,18000.0,24000.0,15000.0,21000.0,18000.0,21000.0,18000.0,0.0,27000.0,195000.0
Dahod,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,3180.0,9180.0,21840.0,16500.0,23090.0,17790.0,15150.0,19990.0,20510.0,11560.0,10550.0,20690.0,190030.0
Dahod,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,2820.0,1980.0,3480.0,4390.0,1600.0,7450.0,5460.0,5950.0,12390.0,1840.0,8150.0,55510.0
Dahod,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,12740.0,17500.0,5100.0,4400.0,2220.0,4000.0,4220.0,9360.0,8360.0,7060.0,1060.0,0.0,76020.0
Dahod,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,20000.0,36000.0,28000.0,30000.0,31000.0,22000.0,22000.0,27000.0,0.0,0.0,57000.0,293000.0
Dahod,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,15240.0,32400.0,36700.0,30180.0,28220.0,30780.0,16860.0,23000.0,28300.0,6000.0,1060.0,42860.0,291600.0
Dahod,16.1.2,Stock position of OPV vaccines,5. Total Stock,17500.0,5100.0,4400.0,2220.0,4000.0,4220.0,9360.0,8360.0,7060.0,1060.0,0.0,14140.0,77420.0
Dahod,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,3050.0,1760.0,2440.0,6270.0,3540.0,4380.0,0.0,5520.0,7200.0,5810.0,12330.0,4540.0,56840.0
Dahod,16.1.3,Stock position of TT vaccines,2. Stocks Received,16500.0,20000.0,25000.0,25000.0,24000.0,25000.0,16680.0,25000.0,20000.0,20000.0,5000.0,40000.0,262180.0
Dahod,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.3,Stock position of TT vaccines,4. Stock Distributed,17790.0,19320.0,21170.0,27730.0,23160.0,29380.0,11160.0,23320.0,21390.0,13480.0,12790.0,27010.0,247700.0
Dahod,16.1.3,Stock position of TT vaccines,5. Total Stock,1760.0,2440.0,6270.0,3540.0,4380.0,0.0,5520.0,7200.0,5810.0,12330.0,4540.0,17530.0,71320.0
Dahod,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2120.0,1720.0,200.0,410.0,720.0,660.0,220.0,2100.0,1490.0,2800.0,6600.0,8540.0,27580.0
Dahod,16.1.5,Stock position of BCG vaccines,2. Stocks Received,8000.0,8500.0,8500.0,9000.0,9000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,20000.0,123000.0
Dahod,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,8400.0,10020.0,8290.0,8690.0,9060.0,10440.0,8120.0,10610.0,8690.0,6200.0,8060.0,20510.0,117090.0
Dahod,16.1.5,Stock position of BCG vaccines,5. Total Stock,1720.0,200.0,410.0,720.0,660.0,220.0,2100.0,1490.0,2800.0,6600.0,8540.0,8030.0,33490.0
Dahod,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,520.0,0.0,1230.0,360.0,760.0,375.0,480.0,6110.0,3865.0,4875.0,8050.0,950.0,27575.0
Dahod,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,8000.0,15000.0,12000.0,10000.0,10000.0,15000.0,12500.0,15000.0,10000.0,0.0,23000.0,130500.0
Dahod,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,520.0,6770.0,15870.0,11600.0,10385.0,9895.0,9370.0,14745.0,13990.0,6825.0,7100.0,20460.0,127530.0
Dahod,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,1230.0,360.0,760.0,375.0,480.0,6110.0,3865.0,4875.0,8050.0,950.0,3490.0,30545.0
Dahod,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,6500.0,5640.0,1890.0,1920.0,5070.0,6760.0,8550.0,6740.0,5030.0,5150.0,3310.0,5830.0,62390.0
Dahod,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1500.0,0.0,5000.0,5100.0,3600.0,6000.0,0.0,0.0,3100.0,0.0,6000.0,2400.0,32700.0
Dahod,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2360.0,3750.0,4970.0,1950.0,1910.0,4210.0,1810.0,1710.0,2980.0,1840.0,3480.0,4510.0,35480.0
Dahod,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5640.0,1890.0,1920.0,5070.0,6760.0,8550.0,6740.0,5030.0,5150.0,3310.0,5830.0,3720.0,59610.0
Dahod,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,17000.0,14400.0,11227.0,8800.0,6300.0,6200.0,3500.0,2300.0,9500.0,9150.0,8450.0,7250.0,104077.0
Dahod,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7200.0,0.0,0.0,0.0,0.0,7200.0
Dahod,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,2600.0,3173.0,2427.0,2500.0,100.0,2700.0,1200.0,0.0,350.0,700.0,1200.0,700.0,17650.0
Dahod,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,14400.0,11227.0,8800.0,6300.0,6200.0,3500.0,2300.0,9500.0,9150.0,8450.0,7250.0,6550.0,93627.0
Dahod,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,95685.0,40820.0,12460.0,53060.0,46755.0,336755.0,112905.0,45855.0,99855.0,94300.0,82740.0,66405.0,1087595.0
Dahod,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,50400.0,0.0,300000.0,0.0,0.0,54000.0,0.0,0.0,0.0,0.0,404400.0
Dahod,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,54865.0,28360.0,9800.0,6305.0,10000.0,223850.0,67050.0,0.0,5555.0,11560.0,16335.0,3535.0,437215.0
Dahod,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,40820.0,12460.0,53060.0,46755.0,336755.0,112905.0,45855.0,99855.0,94300.0,82740.0,66405.0,62870.0,1054780.0
Dahod,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,20754.0,11720.0,2000.0,19000.0,16800.0,45800.0,21000.0,10460.0,140460.0,124240.0,107540.0,87000.0,606774.0
Dahod,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,18000.0,0.0,30000.0,0.0,0.0,130000.0,0.0,0.0,0.0,0.0,178000.0
Dahod,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,9034.0,9720.0,1000.0,2200.0,1000.0,24800.0,10540.0,0.0,16220.0,16700.0,20540.0,9140.0,120894.0
Dahod,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,11720.0,2000.0,19000.0,16800.0,45800.0,21000.0,10460.0,140460.0,124240.0,107540.0,87000.0,77860.0,663880.0
Dahod,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3248.0,2832.0,314.0,280.0,280.0,280.0,130.0,0.0,7960.0,6882.0,6594.0,5224.0,34024.0
Dahod,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7960.0,0.0,0.0,0.0,0.0,7960.0
Dahod,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,416.0,2518.0,34.0,0.0,0.0,150.0,130.0,0.0,1078.0,288.0,1370.0,696.0,6680.0
Dahod,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,2832.0,314.0,280.0,280.0,280.0,130.0,0.0,7960.0,6882.0,6594.0,5224.0,4528.0,35304.0
Dahod,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,7227.0,7227.0,7227.0,6300.0,6300.0,5300.0,5300.0,4800.0,6965.0,4400.0,3700.0,1000.0,65746.0
Dahod,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4465.0,0.0,0.0,0.0,0.0,4465.0
Dahod,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,927.0,0.0,1000.0,0.0,500.0,2300.0,2565.0,700.0,2700.0,300.0,10992.0
Dahod,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,7227.0,7227.0,6300.0,6300.0,5300.0,5300.0,4800.0,6965.0,4400.0,3700.0,1000.0,700.0,59219.0
Dahod,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,1375.0,125.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0
Dahod,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,3250.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3250.0
Dahod,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,1875.0,1250.0,125.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3250.0
Dahod,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,1375.0,125.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0
Dahod,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,247.0,102.0,212.0,327.0,313.0,386.0,236.0,114.0,47.0,32.0,10.0,71.0,2097.0
Dahod,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,240.0,220.0,140.0,200.0,0.0,0.0,0.0,100.0,25.0,120.0,300.0,1345.0
Dahod,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.02,Stock Position of Gloves,4. Stock Distributed,145.0,130.0,105.0,154.0,127.0,150.0,122.0,67.0,115.0,47.0,59.0,114.0,1335.0
Dahod,16.3.02,Stock Position of Gloves,5. Total Stock,102.0,212.0,327.0,313.0,386.0,236.0,114.0,47.0,32.0,10.0,71.0,257.0,2107.0
Dahod,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7100.0,1800.0,200.0,200.0,0.0,9300.0
Dahod,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,3000.0,0.0,0.0,0.0,13000.0
Dahod,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,2900.0,5300.0,4600.0,0.0,200.0,0.0,13000.0
Dahod,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,7100.0,1800.0,200.0,200.0,0.0,0.0,9300.0
Dahod,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,26.0,23.0,23.0,23.0,16.0,11.0,11.0,108.0,92.0,69.0,56.0,0.0,458.0
Dahod,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,100.0
Dahod,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,3.0,0.0,0.0,7.0,5.0,0.0,3.0,16.0,23.0,13.0,7.0,0.0,77.0
Dahod,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,23.0,23.0,23.0,16.0,11.0,11.0,108.0,92.0,69.0,56.0,49.0,0.0,481.0
Dahod,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,255000.0,152000.0,132000.0,742000.0,362000.0,67000.0,413000.0,707000.0,206000.0,187700.0,1348000.0,608000.0,5179700.0
Dahod,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,42000.0,0.0,800000.0,0.0,0.0,798000.0,800000.0,0.0,0.0,1700000.0,0.0,0.0,4140000.0
Dahod,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,145000.0,20000.0,190000.0,380000.0,295000.0,452000.0,506000.0,501000.0,18300.0,539700.0,740000.0,505000.0,4292000.0
Dahod,16.3.07,Stock Position of IFA Tablets,5. Total Stock,152000.0,132000.0,742000.0,362000.0,67000.0,413000.0,707000.0,206000.0,187700.0,1348000.0,608000.0,103000.0,5027700.0
Dahod,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,21200.0,19700.0,15600.0,8500.0,2700.0,200.0,200.0,200.0,200.0,200.0,0.0,68700.0
Dahod,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,21600.0,3200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24800.0
Dahod,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,400.0,4700.0,4100.0,7100.0,5800.0,2500.0,0.0,0.0,0.0,0.0,200.0,0.0,24800.0
Dahod,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,21200.0,19700.0,15600.0,8500.0,2700.0,200.0,200.0,200.0,200.0,200.0,0.0,0.0,68700.0
Dahod,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3290.0,900.0,0.0,0.0,0.0,4190.0
Dahod,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,6590.0,0.0,0.0,0.0,0.0,0.0,6590.0
Dahod,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,3300.0,2390.0,900.0,0.0,0.0,0.0,6590.0
Dahod,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,3290.0,900.0,0.0,0.0,0.0,0.0,4190.0
Dahod,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,797.0,797.0,212.0,924.0,714.0,209.0,14.0,14.0,0.0,0.0,4060.0,1810.0,9551.0
Dahod,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,835.0,0.0,0.0,0.0,0.0,0.0,0.0,5350.0,0.0,2169.0,8354.0
Dahod,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,585.0,123.0,210.0,505.0,195.0,0.0,14.0,0.0,1290.0,2250.0,2375.0,7547.0
Dahod,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,797.0,212.0,924.0,714.0,209.0,14.0,14.0,0.0,0.0,4060.0,1810.0,1604.0,10358.0
Dahod,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,261475.0,217500.0,115500.0,80500.0,35500.0,23000.0,33500.0,49385.0,24400.0,20000.0,99500.0,68500.0,1028760.0
Dahod,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,25000.0,0.0,0.0,7500.0,35000.0,48385.0,0.0,3500.0,89000.0,0.0,46500.0,254885.0
Dahod,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,43975.0,127000.0,35000.0,45000.0,20000.0,24500.0,32500.0,24985.0,7900.0,9500.0,31000.0,22500.0,423860.0
Dahod,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,217500.0,115500.0,80500.0,35500.0,23000.0,33500.0,49385.0,24400.0,20000.0,99500.0,68500.0,92500.0,859785.0
Dahod,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1400.0,800.0,600.0,26400.0,7000.0,6200.0,5200.0,14600.0,12300.0,5800.0,4700.0,2900.0,87900.0
Dahod,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6600.0,0.0,33000.0,0.0,0.0,0.0,9900.0,0.0,0.0,0.0,0.0,0.0,49500.0
Dahod,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,7200.0,200.0,7200.0,19400.0,800.0,1000.0,500.0,2300.0,6500.0,1100.0,1800.0,2900.0,50900.0
Dahod,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,800.0,600.0,26400.0,7000.0,6200.0,5200.0,14600.0,12300.0,5800.0,4700.0,2900.0,0.0,86500.0
Dahod,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,125150.0,125150.0,184000.0,89500.0,89500.0,86100.0,66100.0,54100.0,100600.0,34200.0,22000.0,16000.0,992400.0
Dahod,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,60000.0,60000.0,0.0,0.0,0.0,0.0,70000.0,0.0,0.0,0.0,60000.0,250000.0
Dahod,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,1150.0,154500.0,0.0,3400.0,20000.0,12000.0,23500.0,66400.0,12200.0,6000.0,14000.0,313150.0
Dahod,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,125150.0,184000.0,89500.0,89500.0,86100.0,66100.0,54100.0,100600.0,34200.0,22000.0,16000.0,62000.0,929250.0
Dahod,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,9100.0,9100.0,8900.0,700.0,700.0,500.0,500.0,500.0,500.0,0.0,0.0,0.0,30500.0
Dahod,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dahod,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,200.0,8200.0,0.0,200.0,0.0,0.0,0.0,500.0,0.0,0.0,0.0,9100.0
Dahod,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,9100.0,8900.0,700.0,700.0,500.0,500.0,500.0,500.0,0.0,0.0,0.0,0.0,21400.0
Dahod,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,5.0,1.0,4.0,7.0,5.0,7.0,5.0,5.0,1.0,1.0,3.0,4.0,48.0
Dahod,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,3.0,3.0,1.0,,1.0,5.0,1.0,2.0,2.0,1.0,1.0,21.0
Dahod,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,1.0,,,,1.0,,,,,,2.0
Dahod,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,3.0,4.0,1.0,,1.0,6.0,1.0,2.0,2.0,1.0,1.0,23.0
Dahod,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,5.0,4.0,13.0,12.0,6.0,5.0,9.0,7.0,11.0,6.0,5.0,6.0,89.0
Dahod,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,1.0,2.0
Dahod,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,5.0,4.0,13.0,13.0,6.0,5.0,9.0,7.0,11.0,6.0,5.0,7.0,91.0
Dahod,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,8.0,22.0,14.0,18.0,29.0,37.0,28.0,28.0,49.0,39.0,22.0,23.0,317.0
Dahod,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,2.0,2.0,1.0,2.0,1.0,1.0,,,2.0,12.0
Dahod,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,8.0,23.0,14.0,20.0,31.0,38.0,30.0,29.0,50.0,39.0,22.0,25.0,329.0
Dahod,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,13.0,2.0,6.0,11.0,18.0,15.0,8.0,12.0,16.0,10.0,12.0,12.0,135.0
Dahod,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,2.0,2.0,,1.0,1.0,,,,,1.0,7.0
Dahod,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,13.0,2.0,8.0,13.0,18.0,16.0,9.0,12.0,16.0,10.0,12.0,13.0,142.0
Dahod,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,7.0,14.0,8.0,2.0,10.0,13.0,12.0,6.0,4.0,2.0,9.0,2.0,89.0
Dahod,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,5.0,,,,2.0,3.0,5.0,,1.0,,,1.0,17.0
Dahod,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,12.0,14.0,8.0,2.0,12.0,16.0,17.0,6.0,5.0,2.0,9.0,3.0,106.0
Dahod,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,1.0,1.0,,,,,,2.0
Dahod,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Dahod,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,1.0,1.0,,1.0,,,,3.0
Dahod,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,,1.0,1.0,,,3.0,,,,1.0,7.0
Dahod,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,,1.0,1.0,,2.0,,,,5.0
Dahod,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,,2.0,1.0,1.0,1.0,3.0,2.0,,,1.0,12.0
Dahod,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,1.0,,1.0,1.0,,,3.0
Dahod,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,1.0,1.0,,,,,,2.0
Dahod,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,1.0,2.0,,1.0,1.0,,,5.0
Dahod,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,8.0,13.0,7.0,9.0,3.0,11.0,6.0,13.0,9.0,6.0,5.0,13.0,103.0
Dahod,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,4.0,4.0,8.0,8.0,13.0,13.0,10.0,25.0,7.0,8.0,5.0,7.0,112.0
Dahod,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,12.0,17.0,15.0,17.0,16.0,24.0,16.0,38.0,16.0,14.0,10.0,20.0,215.0
Dahod,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Dahod,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,1.0,1.0,,,,,2.0
Dahod,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Dahod,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,1.0,1.0,1.0,,,,3.0
Dahod,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Dahod,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,8.0,3.0,8.0,7.0,6.0,5.0,5.0,8.0,9.0,3.0,8.0,73.0
Dahod,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,1.0,1.0,2.0,5.0,2.0,3.0,2.0,4.0,2.0,6.0,3.0,33.0
Dahod,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,5.0,9.0,4.0,10.0,12.0,8.0,9.0,7.0,12.0,11.0,9.0,11.0,107.0
Dahod,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,2.0,1.0,1.0,,1.0,1.0,,1.0,1.0,1.0,9.0
Dahod,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,5.0,6.0,4.0,5.0,3.0,7.0,3.0,4.0,4.0,6.0,4.0,4.0,55.0
Dahod,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,5.0,9.0,6.0,2.0,7.0,17.0,9.0,13.0,10.0,11.0,11.0,8.0,108.0
Dahod,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,10.0,15.0,12.0,8.0,11.0,24.0,13.0,18.0,14.0,18.0,16.0,13.0,172.0
Dahod,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Dahod,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,1.0,1.0,,1.0,1.0,,,,4.0
Dahod,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,1.0,4.0,,,1.0,1.0,1.0,2.0,,,2.0,3.0,15.0
Dahod,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,4.0,,,3.0,2.0,1.0,3.0,1.0,,2.0,3.0,20.0
Dahod,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,1.0,2.0,,1.0,1.0,1.0,2.0,,,,9.0
Dahod,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,,3.0,5.0,2.0,,4.0,1.0,6.0,1.0,1.0,,25.0
Dahod,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,7.0,2.0,4.0,3.0,1.0,6.0,8.0,2.0,4.0,6.0,5.0,9.0,57.0
Dahod,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,10.0,2.0,8.0,10.0,3.0,7.0,13.0,4.0,12.0,7.0,6.0,9.0,91.0
Dahod,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Dahod,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,,2.0,,,,1.0,1.0,,1.0,2.0,1.0,11.0
Dahod,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Dahod,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,4.0,,2.0,,,,1.0,2.0,,1.0,2.0,1.0,13.0
Dahod,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,,1.0,,1.0,,,,2.0,,1.0,,6.0
Dahod,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,7.0,11.0,6.0,9.0,8.0,8.0,10.0,7.0,6.0,5.0,5.0,8.0,90.0
Dahod,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,15.0,11.0,7.0,2.0,7.0,4.0,12.0,7.0,13.0,7.0,6.0,5.0,96.0
Dahod,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,23.0,22.0,14.0,11.0,16.0,12.0,22.0,14.0,21.0,12.0,12.0,13.0,192.0
Dahod,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,,1.0,,,,,,,,,,2.0
Dahod,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,1.0,3.0,1.0,3.0,2.0,1.0,,2.0,3.0,1.0,18.0
Dahod,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,2.0,1.0,,,3.0,4.0,1.0,1.0,1.0,4.0,,18.0
Dahod,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,3.0,3.0,3.0,1.0,6.0,6.0,2.0,1.0,3.0,7.0,1.0,38.0
Dahod,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dahod,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Dahod,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dahod,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Dahod,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dahod,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,1.0,1.0,,1.0,,,,,3.0
Dahod,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dahod,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,1.0,1.0,,1.0,,,,,3.0
Dahod,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dahod,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,2.0,,1.0,,,1.0,,,4.0
Dahod,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dahod,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,2.0,,1.0,,,1.0,,,4.0
Dahod,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dahod,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,1.0,1.0,1.0,,,,,1.0,5.0
Dahod,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dahod,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,1.0,1.0,1.0,,,,,1.0,5.0
Dahod,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dahod,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Dahod,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dahod,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Dahod,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dahod,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,4.0,2.0,,2.0,4.0,6.0,2.0,2.0,3.0,5.0,2.0,2.0,34.0
Dahod,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Dahod,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,4.0,2.0,,2.0,4.0,6.0,2.0,2.0,3.0,5.0,2.0,2.0,34.0
Dahod,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,3.0,1.0,4.0,5.0,,1.0,,1.0,2.0,1.0,1.0,,19.0
Dahod,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,14.0,11.0,12.0,12.0,13.0,12.0,9.0,18.0,8.0,9.0,16.0,15.0,149.0
Dahod,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,2.0,,1.0,1.0,6.0,2.0,2.0,1.0,,2.0,2.0,22.0
Dahod,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,20.0,14.0,16.0,18.0,14.0,19.0,11.0,21.0,11.0,10.0,19.0,17.0,190.0
Dahod,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,,,,,,,2.0,,,,3.0
Dahod,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,2.0,6.0,5.0,3.0,4.0,9.0,2.0,2.0,2.0,6.0,6.0,49.0
Dahod,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,1.0,2.0,,2.0,,3.0,1.0,,,,1.0,11.0
Dahod,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,3.0,8.0,5.0,5.0,4.0,12.0,3.0,4.0,2.0,6.0,7.0,63.0
Dahod,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,2.0,,6.0,2.0,1.0,3.0,1.0,,,,,15.0
Dahod,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,2.0,3.0,2.0,2.0,4.0,1.0,3.0,3.0,1.0,,,21.0
Dahod,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,,,,,5.0,,,,,,,6.0
Dahod,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,4.0,3.0,8.0,4.0,10.0,4.0,4.0,3.0,1.0,,,42.0
Dahod,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Dahod,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,,,,,1.0,1.0,4.0,5.0,2.0,3.0,1.0,18.0
Dahod,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,1.0,2.0,,2.0,2.0,2.0,1.0,,,,11.0
Dahod,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,1.0,2.0,2.0,,3.0,3.0,6.0,6.0,2.0,3.0,1.0,30.0
Dahod,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Dahod,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,3.0,4.0,1.0,1.0,5.0,2.0,3.0,4.0,1.0,,,25.0
Dahod,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,2.0,2.0,1.0,,1.0,2.0,,1.0,1.0,2.0,,14.0
Dahod,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,6.0,6.0,2.0,1.0,6.0,4.0,3.0,5.0,2.0,2.0,,40.0
Dahod,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,2.0,3.0,1.0,1.0,7.0,4.0,3.0,2.0,2.0,2.0,3.0,33.0
Dahod,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,10.0,15.0,25.0,26.0,23.0,31.0,23.0,25.0,21.0,23.0,22.0,21.0,265.0
Dahod,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,32.0,48.0,54.0,37.0,61.0,84.0,84.0,75.0,71.0,77.0,68.0,47.0,738.0
Dahod,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,45.0,65.0,82.0,64.0,85.0,122.0,111.0,103.0,94.0,102.0,92.0,71.0,1036.0
Devbhumi Dwarka,1.1,Total number of pregnant women Registered for ANC,TOTAL,1409.0,1321.0,1376.0,1270.0,1187.0,1316.0,1202.0,1252.0,1295.0,1546.0,1191.0,1482.0,15847.0
Devbhumi Dwarka,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1245.0,1124.0,1145.0,1053.0,1006.0,1096.0,1020.0,1132.0,1091.0,1328.0,1042.0,1210.0,13492.0
Devbhumi Dwarka,1.2,Number of Pregnant women registered under JSY,TOTAL,238.0,206.0,272.0,266.0,185.0,265.0,188.0,240.0,191.0,235.0,205.0,207.0,2698.0
Devbhumi Dwarka,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1218.0,1025.0,1173.0,1092.0,1070.0,1127.0,1060.0,1155.0,1198.0,1374.0,1052.0,1186.0,13730.0
Devbhumi Dwarka,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1310.0,1248.0,1357.0,1231.0,1167.0,1293.0,1163.0,1232.0,1249.0,1481.0,1205.0,1446.0,15382.0
Devbhumi Dwarka,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1211.0,1309.0,1243.0,1267.0,1239.0,1185.0,1241.0,1261.0,1218.0,1384.0,1300.0,1307.0,15165.0
Devbhumi Dwarka,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1249.0,1195.0,1237.0,1178.0,1263.0,1174.0,1060.0,1213.0,1165.0,1266.0,975.0,1165.0,14140.0
Devbhumi Dwarka,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,1.0,0.0,10.0,4.0,16.0,2.0,1.0,1.0,0.0,6.0,0.0,0.0,41.0
Devbhumi Dwarka,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Devbhumi Dwarka,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1073.0,921.0,995.0,994.0,918.0,1160.0,866.0,849.0,887.0,1030.0,778.0,743.0,11214.0
Devbhumi Dwarka,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,3.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,2.0,2.0,1.0,12.0
Devbhumi Dwarka,1.8,Number of pregnancy test kits used at SC level,TOTAL,296.0,252.0,284.0,255.0,206.0,253.0,259.0,197.0,241.0,240.0,243.0,247.0,2973.0
Devbhumi Dwarka,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,11.0,20.0,13.0,19.0,26.0,30.0,13.0,28.0,15.0,19.0,16.0,17.0,227.0
Devbhumi Dwarka,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,25.0,17.0,13.0,10.0,23.0,15.0,22.0,18.0,16.0,23.0,15.0,17.0,214.0
Devbhumi Dwarka,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,36.0,37.0,26.0,29.0,49.0,45.0,35.0,46.0,31.0,42.0,31.0,34.0,441.0
Devbhumi Dwarka,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,36.0,36.0,25.0,27.0,46.0,45.0,35.0,45.0,29.0,36.0,30.0,31.0,421.0
Devbhumi Dwarka,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,2.0,1.0,0.0,2.0,1.0,4.0,3.0,1.0,1.0,4.0,1.0,22.0
Devbhumi Dwarka,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,459.0,382.0,448.0,375.0,483.0,494.0,467.0,550.0,551.0,464.0,371.0,329.0,5373.0
Devbhumi Dwarka,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,367.0,296.0,308.0,269.0,305.0,349.0,350.0,350.0,407.0,359.0,256.0,204.0,3820.0
Devbhumi Dwarka,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,2.0,1.0,2.0,2.0,3.0,5.0,5.0,3.0,3.0,26.0
Devbhumi Dwarka,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Devbhumi Dwarka,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,497.0,636.0,608.0,543.0,685.0,623.0,607.0,631.0,578.0,719.0,484.0,532.0,7143.0
Devbhumi Dwarka,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,2.0,0.0,11.0,0.0,1.0,3.0,0.0,1.0,1.0,0.0,0.0,3.0,22.0
Devbhumi Dwarka,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,17.0,16.0,15.0,22.0,30.0,13.0,24.0,13.0,20.0,21.0,9.0,,200.0
Devbhumi Dwarka,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Devbhumi Dwarka,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,19.0,16.0,26.0,22.0,31.0,16.0,24.0,14.0,21.0,21.0,9.0,3.0,222.0
Devbhumi Dwarka,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,49.0,67.0,88.0,57.0,69.0,71.0,49.0,79.0,93.0,92.0,63.0,55.0,832.0
Devbhumi Dwarka,4.1.1.a,Number of male live births,TOTAL,541.0,516.0,555.0,493.0,651.0,619.0,579.0,616.0,596.0,627.0,438.0,448.0,6679.0
Devbhumi Dwarka,4.1.1.b,Number of female live births,TOTAL,445.0,521.0,512.0,456.0,563.0,526.0,528.0,607.0,554.0,610.0,448.0,442.0,6212.0
Devbhumi Dwarka,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,986.0,1037.0,1067.0,949.0,1214.0,1145.0,1107.0,1223.0,1150.0,1237.0,886.0,890.0,12891.0
Devbhumi Dwarka,4.1.2,Number of still births,TOTAL,14.0,25.0,20.0,11.0,19.0,24.0,14.0,9.0,16.0,15.0,14.0,16.0,197.0
Devbhumi Dwarka,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,7.0,16.0,31.0,13.0,25.0,14.0,21.0,13.0,22.0,10.0,13.0,13.0,198.0
Devbhumi Dwarka,4.2.1,Number of Newborns weighed at birth,TOTAL,986.0,1036.0,1067.0,946.0,1211.0,1143.0,1107.0,1209.0,1118.0,1171.0,885.0,888.0,12767.0
Devbhumi Dwarka,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,62.0,45.0,43.0,50.0,52.0,59.0,56.0,85.0,69.0,72.0,36.0,53.0,682.0
Devbhumi Dwarka,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,967.0,1022.0,1028.0,890.0,1143.0,1109.0,1080.0,1130.0,1099.0,1136.0,846.0,852.0,12302.0
Devbhumi Dwarka,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,3.0,1.0,1.0,0.0,0.0,0.0,0.0,6.0
Devbhumi Dwarka,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,6.0,5.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Devbhumi Dwarka,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,0.0,15.0,,,0.0,,0.0,,,,,15.0
Devbhumi Dwarka,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Devbhumi Dwarka,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,6.0,20.0,0.0,2.0,3.0,1.0,1.0,0.0,0.0,0.0,0.0,33.0
Devbhumi Dwarka,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Devbhumi Dwarka,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,2.0,2.0,1.0,2.0,9.0
Devbhumi Dwarka,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,1.0,0.0,2.0,3.0,2.0,1.0,2.0,2.0,1.0,2.0,16.0
Devbhumi Dwarka,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,949.0,1026.0,1082.0,936.0,1212.0,1151.0,1112.0,1122.0,1159.0,1239.0,895.0,899.0,12782.0
Devbhumi Dwarka,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,917.0,982.0,826.0,862.0,1042.0,990.0,962.0,984.0,1019.0,1121.0,787.0,777.0,11269.0
Devbhumi Dwarka,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,9.0,0.0,30.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,40.0
Devbhumi Dwarka,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,12.0,8.0,0.0,4.0,4.0,10.0,10.0,0.0,12.0,7.0,0.0,0.0,67.0
Devbhumi Dwarka,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,12.0,8.0,0.0,4.0,4.0,10.0,10.0,0.0,12.0,7.0,0.0,0.0,67.0
Devbhumi Dwarka,7.2,Number of MTPs conducted at Private Facilities,TOTAL,7.0,12.0,7.0,5.0,8.0,2.0,0.0,0.0,0.0,0.0,1.0,2.0,44.0
Devbhumi Dwarka,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,2.0,2.0,2.0,2.0,5.0,15.0,6.0,0.0,10.0,8.0,11.0,63.0
Devbhumi Dwarka,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,57.0,69.0,67.0,80.0,87.0,62.0,90.0,109.0,107.0,101.0,97.0,102.0,1028.0
Devbhumi Dwarka,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,57.0,71.0,69.0,82.0,89.0,67.0,105.0,115.0,107.0,111.0,105.0,113.0,1091.0
Devbhumi Dwarka,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Devbhumi Dwarka,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,0.0,,,,0.0,,0.0,,0.0,,1.0,1.0
Devbhumi Dwarka,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Devbhumi Dwarka,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
Devbhumi Dwarka,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,59.0,51.0,37.0,45.0,42.0,80.0,80.0,184.0,307.0,328.0,149.0,118.0,1480.0
Devbhumi Dwarka,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,34.0,43.0,32.0,17.0,31.0,43.0,42.0,84.0,141.0,118.0,101.0,79.0,765.0
Devbhumi Dwarka,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Devbhumi Dwarka,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,93.0,94.0,69.0,62.0,73.0,123.0,122.0,268.0,448.0,446.0,250.0,197.0,2245.0
Devbhumi Dwarka,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,1.0,6.0,11.0,16.0,24.0,31.0,14.0,15.0,21.0,12.0,2.0,12.0,165.0
Devbhumi Dwarka,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,0.0,,0.0,0.0,0.0,,0.0,,0.0,,,0.0
Devbhumi Dwarka,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Devbhumi Dwarka,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,,0.0,0.0,,1.0
Devbhumi Dwarka,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Devbhumi Dwarka,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Devbhumi Dwarka,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,566.0,672.0,704.0,641.0,692.0,714.0,759.0,827.0,767.0,715.0,647.0,592.0,8296.0
Devbhumi Dwarka,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,23.0,11.0,2.0,2.0,6.0,3.0,5.0,0.0,4.0,0.0,4.0,4.0,64.0
Devbhumi Dwarka,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,10.0
Devbhumi Dwarka,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,59.0,107.0,28.0,0.0,60.0,25.0,33.0,41.0,49.0,47.0,28.0,,477.0
Devbhumi Dwarka,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Devbhumi Dwarka,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,648.0,790.0,734.0,643.0,760.0,742.0,797.0,868.0,820.0,762.0,679.0,604.0,8847.0
Devbhumi Dwarka,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,12.0,0.0,0.0,3.0,19.0
Devbhumi Dwarka,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.06,Number of IUCD removals,TOTAL,122.0,121.0,127.0,119.0,151.0,153.0,139.0,181.0,186.0,157.0,147.0,165.0,1768.0
Devbhumi Dwarka,9.07,Number of Oral Pills cycles distributed,TOTAL,2399.0,1699.0,1842.0,1768.0,1876.0,2054.0,2037.0,2498.0,2446.0,2479.0,2434.0,2298.0,25830.0
Devbhumi Dwarka,9.08,Number of Condom pieces distributed,TOTAL,22525.0,28611.0,32670.0,25478.0,31027.0,34633.0,34688.0,36520.0,32637.0,35008.0,33286.0,29064.0,376147.0
Devbhumi Dwarka,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,4.0,0.0,2.0,80.0,2.0,78.0,83.0,249.0
Devbhumi Dwarka,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,2.0,0.0,2.0,2.0,17.0,15.0,16.0,1355.0,7.0,1419.0,1358.0,4193.0
Devbhumi Dwarka,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Devbhumi Dwarka,9.12,Number of Institutions having NSV trained doctors,TOTAL,13.0,13.0,12.0,13.0,13.0,12.0,13.0,13.0,12.0,11.0,13.0,12.0,-1.0
Devbhumi Dwarka,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1126.0,1253.0,1374.0,1154.0,1318.0,1454.0,1305.0,1477.0,1369.0,1514.0,1134.0,1136.0,15614.0
Devbhumi Dwarka,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1094.0,1137.0,1226.0,1195.0,1190.0,1293.0,1325.0,1401.0,1344.0,1366.0,1318.0,1128.0,15017.0
Devbhumi Dwarka,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1051.0,1099.0,1143.0,1216.0,1170.0,1198.0,1284.0,1310.0,1313.0,1410.0,1291.0,1262.0,14747.0
Devbhumi Dwarka,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1137.0,1207.0,1189.0,1206.0,1189.0,1152.0,1177.0,1331.0,1271.0,1390.0,1270.0,1273.0,14792.0
Devbhumi Dwarka,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,940.0,1044.0,1050.0,958.0,1129.0,1215.0,1091.0,1316.0,1138.0,1369.0,949.0,929.0,13128.0
Devbhumi Dwarka,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1119.0,1156.0,1220.0,1212.0,1192.0,1314.0,1331.0,1418.0,1354.0,1368.0,1341.0,1137.0,15162.0
Devbhumi Dwarka,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1078.0,1116.0,1168.0,1226.0,1176.0,1198.0,1292.0,1334.0,1325.0,1417.0,1305.0,1270.0,14905.0
Devbhumi Dwarka,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1164.0,1220.0,1238.0,1212.0,1198.0,1159.0,1140.0,1337.0,1292.0,1418.0,1290.0,1296.0,14964.0
Devbhumi Dwarka,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,467.0,458.0,503.0,474.0,412.0,618.0,416.0,700.0,585.0,455.0,360.0,386.0,5834.0
Devbhumi Dwarka,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Devbhumi Dwarka,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1150.0,1177.0,1267.0,1270.0,1180.0,1294.0,1344.0,1152.0,1124.0,1210.0,1114.0,1237.0,14519.0
Devbhumi Dwarka,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,893.0,1044.0,1005.0,1166.0,870.0,1071.0,916.0,1083.0,998.0,984.0,920.0,976.0,11926.0
Devbhumi Dwarka,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,565.0,632.0,689.0,673.0,601.0,690.0,674.0,581.0,608.0,599.0,577.0,597.0,7486.0
Devbhumi Dwarka,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,572.0,534.0,556.0,575.0,556.0,599.0,650.0,563.0,514.0,526.0,525.0,602.0,6772.0
Devbhumi Dwarka,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1137.0,1166.0,1245.0,1248.0,1157.0,1289.0,1324.0,1144.0,1122.0,1125.0,1102.0,1199.0,14258.0
Devbhumi Dwarka,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1065.0,1056.0,1191.0,1182.0,1010.0,1067.0,1064.0,1078.0,1113.0,1122.0,1051.0,1141.0,13140.0
Devbhumi Dwarka,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1072.0,1058.0,1193.0,1185.0,1008.0,1067.0,1066.0,1085.0,1111.0,1052.0,1068.0,1153.0,13118.0
Devbhumi Dwarka,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,383.0,413.0,362.0,352.0,315.0,357.0,346.0,355.0,375.0,434.0,346.0,373.0,4411.0
Devbhumi Dwarka,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,397.0,375.0,327.0,335.0,318.0,324.0,341.0,307.0,324.0,373.0,314.0,332.0,4067.0
Devbhumi Dwarka,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,780.0,788.0,689.0,687.0,633.0,681.0,687.0,662.0,699.0,807.0,660.0,705.0,8478.0
Devbhumi Dwarka,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,360.0,368.0,365.0,552.0,612.0,1113.0,584.0,573.0,787.0,908.0,1061.0,767.0,8050.0
Devbhumi Dwarka,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,278.0,368.0,318.0,655.0,668.0,853.0,542.0,590.0,1259.0,866.0,1128.0,655.0,8180.0
Devbhumi Dwarka,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,442.0,491.0,503.0,675.0,779.0,909.0,764.0,630.0,1041.0,886.0,916.0,665.0,8701.0
Devbhumi Dwarka,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Devbhumi Dwarka,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,600.0,621.0,613.0,594.0,614.0,615.0,623.0,624.0,618.0,618.0,632.0,636.0,7408.0
Devbhumi Dwarka,10.4.2,Number of Immunisation sessions held during the month,TOTAL,598.0,617.0,612.0,590.0,612.0,612.0,615.0,623.0,618.0,615.0,618.0,636.0,7366.0
Devbhumi Dwarka,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,314.0,351.0,350.0,375.0,395.0,385.0,390.0,385.0,404.0,404.0,401.0,448.0,4602.0
Devbhumi Dwarka,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1133.0,1159.0,1245.0,1245.0,1156.0,1297.0,1314.0,1138.0,1111.0,1202.0,1092.0,1207.0,14299.0
Devbhumi Dwarka,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,4568.0,11.0,0.0,0.0,157.0,5761.0,0.0,0.0,0.0,0.0,0.0,5324.0,15821.0
Devbhumi Dwarka,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,4402.0,0.0,0.0,0.0,157.0,5852.0,0.0,0.0,0.0,0.0,0.0,5462.0,15873.0
Devbhumi Dwarka,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Devbhumi Dwarka,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1070.0,1223.0,1315.0,1310.0,1719.0,1366.0,1495.0,1426.0,1876.0,1696.0,1774.0,1760.0,18030.0
Devbhumi Dwarka,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,1.0,3.0,1.0,0.0,4.0,9.0,3.0,1.0,3.0,8.0,11.0,46.0
Devbhumi Dwarka,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,3.0,17.0,27.0,5.0,4.0,28.0,9.0,10.0,4.0,13.0,19.0,16.0,155.0
Devbhumi Dwarka,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Devbhumi Dwarka,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,9.0,10.0,10.0,10.0,10.0,9.0,10.0,10.0,9.0,8.0,9.0,9.0,-1.0
Devbhumi Dwarka,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,15.0,15.0,50.0,20.0,9.0,4.0,13.0,17.0,10.0,11.0,9.0,26.0,-1.0
Devbhumi Dwarka,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,2.0,3.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Devbhumi Dwarka,14.05,Number of RKS meetings held during the month,TOTAL,5.0,2.0,5.0,4.0,4.0,5.0,1.0,1.0,3.0,3.0,4.0,3.0,40.0
Devbhumi Dwarka,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,13.0,14.0,16.0,15.0,15.0,14.0,15.0,15.0,15.0,13.0,14.0,14.0,-1.0
Devbhumi Dwarka,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,3.0,2.0,42.0,5.0,27.0,25.0,4.0,16.0,27.0,27.0,1.0,2.0,181.0
Devbhumi Dwarka,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Devbhumi Dwarka,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Devbhumi Dwarka,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,63.0,70.0,289.0,128.0,133.0,169.0,111.0,102.0,121.0,74.0,100.0,99.0,1459.0
Devbhumi Dwarka,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,214.0,235.0,726.0,318.0,370.0,402.0,200.0,237.0,332.0,131.0,233.0,327.0,3725.0
Devbhumi Dwarka,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,72.0,100.0,244.0,135.0,136.0,157.0,99.0,131.0,176.0,85.0,101.0,118.0,1554.0
Devbhumi Dwarka,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,568.0,579.0,1537.0,742.0,794.0,964.0,649.0,714.0,776.0,544.0,862.0,920.0,9649.0
Devbhumi Dwarka,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,135.0,170.0,533.0,263.0,269.0,326.0,210.0,233.0,297.0,159.0,201.0,217.0,3013.0
Devbhumi Dwarka,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,782.0,814.0,2263.0,1060.0,1164.0,1366.0,849.0,951.0,1108.0,675.0,1095.0,1247.0,13374.0
Devbhumi Dwarka,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,10.0,9.0,3.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,5.0,34.0
Devbhumi Dwarka,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,1.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.0,9.0
Devbhumi Dwarka,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,11.0,11.0,4.0,0.0,0.0,0.0,0.0,7.0,1.0,2.0,7.0,43.0
Devbhumi Dwarka,14.11,In-Patient Head Count at midnight,TOTAL,659.0,737.0,720.0,510.0,658.0,596.0,488.0,832.0,962.0,439.0,751.0,925.0,8277.0
Devbhumi Dwarka,14.12.1,OPD attendance (All),TOTAL,25346.0,23791.0,34821.0,30034.0,30331.0,33855.0,28778.0,26958.0,29191.0,26154.0,34224.0,38274.0,361757.0
Devbhumi Dwarka,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,47.0,16.0,71.0,16.0,8.0,0.0,0.0,86.0,116.0,50.0,39.0,31.0,480.0
Devbhumi Dwarka,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0,0.0,0.0,0.0,45.0
Devbhumi Dwarka,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,16.0,2.0,37.0,51.0,37.0,32.0,87.0,0.0,52.0,91.0,56.0,461.0
Devbhumi Dwarka,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,14.14.c,Number of Adolescents counselled,TOTAL,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,11.0,11.0,10.0,9.0,113.0
Devbhumi Dwarka,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2115.0,2645.0,2747.0,3041.0,3252.0,3280.0,2762.0,2377.0,3126.0,2872.0,2923.0,3266.0,34406.0
Devbhumi Dwarka,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,5.0,33.0,24.0,44.0,41.0,30.0,18.0,25.0,63.0,37.0,30.0,28.0,378.0
Devbhumi Dwarka,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,200.0,454.0,257.0,198.0,178.0,228.0,134.0,213.0,178.0,106.0,99.0,189.0,2434.0
Devbhumi Dwarka,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,4.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,7.0
Devbhumi Dwarka,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,363.0,691.0,465.0,335.0,202.0,375.0,258.0,329.0,293.0,126.0,116.0,388.0,3941.0
Devbhumi Dwarka,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Devbhumi Dwarka,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,359.0,644.0,373.0,319.0,211.0,338.0,312.0,211.0,261.0,466.0,206.0,247.0,3947.0
Devbhumi Dwarka,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,24.0,21.0,21.0,14.0,16.0,16.0,20.0,27.0,15.0,20.0,18.0,30.0,242.0
Devbhumi Dwarka,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,922.0,1789.0,1095.0,852.0,591.0,941.0,704.0,753.0,732.0,698.0,421.0,824.0,10322.0
Devbhumi Dwarka,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,24.0,27.0,21.0,15.0,16.0,18.0,21.0,27.0,15.0,20.0,18.0,30.0,252.0
Devbhumi Dwarka,15.2,Number of Widal tests conducted,Number tested,150.0,124.0,68.0,38.0,51.0,121.0,82.0,48.0,17.0,11.0,32.0,82.0,824.0
Devbhumi Dwarka,15.3.a,Number of VDRL tests conducted on males,Number tested,13.0,55.0,21.0,12.0,8.0,5.0,0.0,6.0,0.0,0.0,58.0,10.0,188.0
Devbhumi Dwarka,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,14.0,41.0,27.0,18.0,15.0,18.0,0.0,11.0,0.0,0.0,16.0,12.0,172.0
Devbhumi Dwarka,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,161.0,447.0,115.0,131.0,110.0,18.0,0.0,40.0,0.0,0.0,0.0,84.0,1106.0
Devbhumi Dwarka,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,188.0,543.0,163.0,161.0,133.0,41.0,0.0,57.0,0.0,0.0,74.0,106.0,1466.0
Devbhumi Dwarka,15.4.1,Number of blood smears examined for Malaria,TOTAL,2860.0,2686.0,2747.0,3855.0,3528.0,3350.0,3971.0,2304.0,3953.0,2333.0,3368.0,2883.0,37838.0
Devbhumi Dwarka,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,6.0,11.0,9.0,10.0,9.0,11.0,15.0,5.0,9.0,2.0,1.0,2.0,90.0
Devbhumi Dwarka,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,2.0,0.0,0.0,1.0,1.0,1.0,3.0,4.0,1.0,0.0,0.0,14.0
Devbhumi Dwarka,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.3,Stock position of TT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Devbhumi Dwarka,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,1.0,,,,1.0,2.0,1.0,2.0,4.0,4.0,1.0,17.0
Devbhumi Dwarka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,,,,3.0,1.0,,,,,5.0
Devbhumi Dwarka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Devbhumi Dwarka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,,,3.0,1.0,,,,,5.0
Devbhumi Dwarka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,2.0,3.0,,2.0,3.0,1.0,4.0,3.0,3.0,1.0,1.0,25.0
Devbhumi Dwarka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Devbhumi Dwarka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,2.0,3.0,,2.0,3.0,1.0,4.0,3.0,3.0,1.0,1.0,25.0
Devbhumi Dwarka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,3.0,1.0,1.0,3.0,1.0,3.0,3.0,,3.0,1.0,2.0,22.0
Devbhumi Dwarka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,2.0,,,3.0
Devbhumi Dwarka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,3.0,1.0,1.0,3.0,1.0,3.0,3.0,,5.0,1.0,2.0,25.0
Devbhumi Dwarka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,7.0,3.0,9.0,5.0,5.0,6.0,7.0,5.0,1.0,7.0,4.0,7.0,66.0
Devbhumi Dwarka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Devbhumi Dwarka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,7.0,3.0,9.0,5.0,5.0,6.0,7.0,5.0,1.0,7.0,4.0,7.0,66.0
Devbhumi Dwarka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,,,,,,1.0,1.0,,,3.0
Devbhumi Dwarka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Devbhumi Dwarka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,,1.0,,,,1.0,1.0,,,4.0
Devbhumi Dwarka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,1.0,,,,,,1.0,,,1.0,3.0
Devbhumi Dwarka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Devbhumi Dwarka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,1.0,,,,,,1.0,,,1.0,3.0
Devbhumi Dwarka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,1.0,,,1.0,,1.0,1.0,5.0
Devbhumi Dwarka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,1.0,,,,,,,,,,2.0
Devbhumi Dwarka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,2.0,,,1.0,,,1.0,,1.0,1.0,7.0
Devbhumi Dwarka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Devbhumi Dwarka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Devbhumi Dwarka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,1.0,,,1.0
Devbhumi Dwarka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,4.0,5.0,5.0,6.0,2.0,3.0,8.0,5.0,,10.0,3.0,7.0,58.0
Devbhumi Dwarka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,5.0,2.0,,9.0,4.0,1.0,2.0,4.0,2.0,1.0,32.0
Devbhumi Dwarka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,6.0,10.0,8.0,2.0,12.0,12.0,6.0,2.0,14.0,5.0,8.0,90.0
Devbhumi Dwarka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Devbhumi Dwarka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,1.0,,1.0
Devbhumi Dwarka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Devbhumi Dwarka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,,1.0,2.0,,1.0,1.0,3.0,,,,9.0
Devbhumi Dwarka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,,,,,1.0,1.0,,,3.0
Devbhumi Dwarka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,2.0,,1.0,2.0,,1.0,1.0,4.0,1.0,,,13.0
Devbhumi Dwarka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Devbhumi Dwarka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,3.0,2.0,1.0,,5.0,1.0,,3.0,6.0,2.0,24.0
Devbhumi Dwarka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,6.0,9.0,2.0,7.0,5.0,4.0,3.0,6.0,5.0,3.0,10.0,4.0,64.0
Devbhumi Dwarka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,6.0,10.0,5.0,9.0,6.0,4.0,8.0,7.0,5.0,7.0,16.0,6.0,89.0
Devbhumi Dwarka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Devbhumi Dwarka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,,,,,,,,,,,,1.0
Devbhumi Dwarka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Devbhumi Dwarka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,2.0,,,,,,1.0,,3.0
Devbhumi Dwarka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,1.0,1.0,,,,,,1.0,1.0,5.0
Devbhumi Dwarka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,1.0,1.0,3.0,,,,,,2.0,1.0,9.0
Devbhumi Dwarka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Devbhumi Dwarka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,1.0,,,,,,,,2.0
Devbhumi Dwarka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,,,,,,,,1.0,,,,2.0
Devbhumi Dwarka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,,1.0,,1.0,,,,1.0,,1.0,,5.0
Devbhumi Dwarka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Devbhumi Dwarka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,9.0,9.0,12.0,9.0,11.0,5.0,6.0,13.0,5.0,13.0,7.0,7.0,106.0
Devbhumi Dwarka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,16.0,16.0,7.0,13.0,11.0,19.0,10.0,17.0,13.0,22.0,15.0,17.0,176.0
Devbhumi Dwarka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,25.0,25.0,20.0,22.0,22.0,24.0,16.0,30.0,18.0,35.0,22.0,24.0,283.0
Devbhumi Dwarka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,2.0,,,1.0,,1.0,,3.0,2.0,1.0,1.0,11.0
Devbhumi Dwarka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,1.0,2.0,,3.0,1.0,2.0,3.0,,12.0
Devbhumi Dwarka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,,,2.0,2.0,1.0,3.0,4.0,4.0,4.0,1.0,23.0
Devbhumi Dwarka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,2.0,2.0,,,,,,,,,,4.0
Devbhumi Dwarka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,2.0,2.0,,,,,,,,,,4.0
Devbhumi Dwarka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,2.0,2.0,,4.0,1.0,,,,,,,9.0
Devbhumi Dwarka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,2.0,2.0,,4.0,1.0,,,,,,,9.0
Devbhumi Dwarka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,4.0,,1.0,,1.0,1.0,,,1.0,,9.0
Devbhumi Dwarka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,3.0,10.0,1.0,7.0,4.0,4.0,9.0,5.0,8.0,5.0,5.0,64.0
Devbhumi Dwarka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,2.0,2.0,1.0,,1.0,,1.0,2.0,1.0,1.0,,12.0
Devbhumi Dwarka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,6.0,16.0,2.0,8.0,5.0,5.0,11.0,7.0,9.0,7.0,5.0,85.0
Devbhumi Dwarka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Devbhumi Dwarka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,6.0,6.0,2.0,5.0,4.0,10.0,6.0,6.0,6.0,3.0,4.0,62.0
Devbhumi Dwarka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,1.0,,1.0,,,2.0,,,,,2.0,7.0
Devbhumi Dwarka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,5.0,7.0,6.0,3.0,5.0,4.0,12.0,6.0,6.0,6.0,3.0,6.0,69.0
Devbhumi Dwarka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,,1.0,,,1.0,,,,3.0
Devbhumi Dwarka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,3.0,,1.0,,,,1.0,,,,5.0
Devbhumi Dwarka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Devbhumi Dwarka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,,3.0,,1.0,1.0,,,2.0,,,,9.0
Devbhumi Dwarka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Devbhumi Dwarka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,1.0,,2.0,1.0,1.0,,,1.0,,2.0,9.0
Devbhumi Dwarka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,4.0,,,3.0,1.0,3.0,5.0,4.0,3.0,3.0,,26.0
Devbhumi Dwarka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,6.0,1.0,,5.0,2.0,4.0,5.0,4.0,4.0,3.0,2.0,36.0
Devbhumi Dwarka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,1.0,,1.0,,,1.0,,4.0
Devbhumi Dwarka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,10.0,10.0,6.0,3.0,3.0,12.0,1.0,9.0,7.0,8.0,12.0,81.0
Devbhumi Dwarka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,3.0,14.0,14.0,12.0,7.0,3.0,9.0,6.0,11.0,13.0,4.0,13.0,109.0
Devbhumi Dwarka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,25.0,24.0,18.0,10.0,7.0,21.0,8.0,20.0,20.0,13.0,25.0,194.0
Devbhumi Dwarka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,3.0,1.0,1.0,1.0,,,1.0,,,,,10.0
Devbhumi Dwarka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,12.0,8.0,16.0,8.0,23.0,23.0,16.0,9.0,10.0,4.0,10.0,9.0,148.0
Devbhumi Dwarka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,39.0,47.0,48.0,24.0,38.0,52.0,41.0,37.0,47.0,71.0,36.0,30.0,510.0
Devbhumi Dwarka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,54.0,58.0,65.0,33.0,62.0,75.0,57.0,47.0,57.0,75.0,46.0,39.0,668.0
Gandhinagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,3348.0,3690.0,3436.0,3313.0,3033.0,3206.0,3084.0,2433.0,2417.0,2856.0,2916.0,3121.0,36853.0
Gandhinagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2682.0,2982.0,2781.0,2581.0,2397.0,2466.0,2651.0,2009.0,1956.0,2369.0,2397.0,2363.0,29634.0
Gandhinagar,1.2,Number of Pregnant women registered under JSY,TOTAL,394.0,444.0,628.0,572.0,476.0,553.0,355.0,432.0,620.0,426.0,562.0,539.0,6001.0
Gandhinagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2589.0,2885.0,2663.0,2657.0,2754.0,2751.0,2866.0,2329.0,2111.0,2369.0,2304.0,3386.0,31664.0
Gandhinagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2742.0,3113.0,2958.0,2765.0,2546.0,2550.0,2623.0,2084.0,2017.0,2400.0,2499.0,2593.0,30890.0
Gandhinagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2752.0,2964.0,2999.0,2969.0,2803.0,2682.0,2911.0,2578.0,1985.0,2128.0,2420.0,2996.0,32187.0
Gandhinagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2548.0,2815.0,2639.0,2500.0,2479.0,2402.0,2262.0,2157.0,1917.0,2023.0,2345.0,2575.0,28662.0
Gandhinagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,49.0,39.0,79.0,49.0,47.0,48.0,62.0,55.0,57.0,61.0,46.0,45.0,637.0
Gandhinagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,4.0,6.0,3.0,1.0,0.0,8.0,14.0,0.0,0.0,9.0,5.0,53.0
Gandhinagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1574.0,1876.0,1937.0,1899.0,1755.0,1720.0,1724.0,1390.0,1425.0,1680.0,1601.0,1535.0,20116.0
Gandhinagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,40.0,53.0,46.0,31.0,57.0,33.0,24.0,27.0,20.0,11.0,20.0,75.0,437.0
Gandhinagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,137.0,155.0,181.0,252.0,325.0,264.0,292.0,271.0,243.0,346.0,340.0,384.0,3190.0
Gandhinagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,1.0,3.0,3.0,2.0,1.0,1.0,1.0,0.0,3.0,0.0,0.0,16.0
Gandhinagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,3.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Gandhinagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1.0,1.0,3.0,6.0,3.0,1.0,1.0,1.0,0.0,3.0,0.0,0.0,20.0
Gandhinagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,10.0,0.0,1.0,1.0,1.0,1.0,0.0,2.0,0.0,1.0,0.0,1.0,18.0
Gandhinagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,15.0,10.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,40.0
Gandhinagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,989.0,977.0,1181.0,1172.0,1293.0,1238.0,1345.0,1428.0,1018.0,990.0,617.0,1131.0,13379.0
Gandhinagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,514.0,595.0,599.0,705.0,784.0,738.0,811.0,600.0,595.0,938.0,568.0,778.0,8225.0
Gandhinagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,97.0,182.0,202.0,143.0,99.0,292.0,94.0,78.0,128.0,35.0,112.0,63.0,1525.0
Gandhinagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,32.0,45.0,35.0,34.0,23.0,27.0,23.0,25.0,24.0,12.0,15.0,18.0,313.0
Gandhinagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,21.0,16.0,3.0,20.0,0.0,2.0,0.0,2.0,0.0,3.0,10.0,4.0,81.0
Gandhinagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1562.0,1923.0,1635.0,1630.0,1779.0,1781.0,1935.0,1436.0,1177.0,1322.0,1162.0,1168.0,18510.0
Gandhinagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,46.0,0.0,0.0,47.0,66.0,52.0,58.0,105.0,374.0
Gandhinagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,0.0,0.0,0.0,11.0
Gandhinagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,18.0,26.0,30.0,27.0,30.0,29.0,36.0,14.0,20.0,12.0,17.0,63.0,322.0
Gandhinagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,31.0,15.0,15.0,14.0,22.0,18.0,21.0,17.0,9.0,6.0,11.0,9.0,188.0
Gandhinagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,88.0,118.0,129.0,134.0,153.0,130.0,153.0,214.0,155.0,132.0,10.0,116.0,1532.0
Gandhinagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gandhinagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,137.0,159.0,174.0,175.0,205.0,177.0,210.0,245.0,184.0,150.0,38.0,188.0,2042.0
Gandhinagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,280.0,326.0,268.0,303.0,285.0,267.0,304.0,427.0,195.0,175.0,172.0,163.0,3165.0
Gandhinagar,4.1.1.a,Number of male live births,TOTAL,1409.0,1609.0,1565.0,1557.0,1701.0,1697.0,1855.0,1559.0,1263.0,1247.0,1036.0,1276.0,17774.0
Gandhinagar,4.1.1.b,Number of female live births,TOTAL,1213.0,1380.0,1357.0,1362.0,1519.0,1538.0,1595.0,1444.0,1156.0,1131.0,908.0,1133.0,15736.0
Gandhinagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2622.0,2989.0,2922.0,2919.0,3220.0,3235.0,3450.0,3003.0,2419.0,2378.0,1944.0,2409.0,33510.0
Gandhinagar,4.1.2,Number of still births,TOTAL,32.0,37.0,32.0,20.0,30.0,26.0,46.0,47.0,21.0,24.0,8.0,27.0,350.0
Gandhinagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,102.0,46.0,28.0,42.0,34.0,44.0,19.0,48.0,29.0,48.0,24.0,38.0,502.0
Gandhinagar,4.2.1,Number of Newborns weighed at birth,TOTAL,2600.0,3041.0,2227.0,2367.0,2546.0,2449.0,2555.0,2529.0,1976.0,1973.0,1564.0,1919.0,27746.0
Gandhinagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,193.0,270.0,177.0,214.0,230.0,208.0,275.0,350.0,236.0,220.0,135.0,220.0,2728.0
Gandhinagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1725.0,1847.0,1778.0,1911.0,2053.0,2329.0,2497.0,2271.0,1794.0,1853.0,1518.0,1844.0,23420.0
Gandhinagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gandhinagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,5.0,9.0,14.0,9.0,19.0,20.0,18.0,14.0,16.0,34.0,9.0,31.0,198.0
Gandhinagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,74.0,113.0,91.0,123.0,146.0,130.0,199.0,324.0,8.0,137.0,108.0,120.0,1573.0
Gandhinagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gandhinagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,79.0,122.0,106.0,132.0,165.0,150.0,217.0,338.0,24.0,171.0,117.0,151.0,1772.0
Gandhinagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,124.0,95.0,100.0,119.0,113.0,45.0,98.0,51.0,24.0,62.0,52.0,34.0,917.0
Gandhinagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,243.0,261.0,240.0,333.0,322.0,275.0,380.0,438.0,110.0,289.0,210.0,139.0,3240.0
Gandhinagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,14.0,5.0,10.0,3.0,17.0,2.0,17.0,21.0,1.0,22.0,12.0,11.0,135.0
Gandhinagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,170.0,425.0,279.0,298.0,339.0,226.0,278.0,379.0,150.0,452.0,168.0,263.0,3427.0
Gandhinagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,53.0,81.0,88.0,0.0,93.0,125.0,70.0,185.0,3.0,45.0,22.0,12.0,777.0
Gandhinagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1471.0,1981.0,2184.0,2266.0,2439.0,2099.0,2413.0,2482.0,1805.0,1989.0,1648.0,1819.0,24596.0
Gandhinagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1355.0,2042.0,1856.0,1741.0,2028.0,1993.0,1999.0,1632.0,1613.0,1780.0,1568.0,1554.0,21161.0
Gandhinagar,6.3,PNC maternal complications attended,TOTAL,14.0,20.0,6.0,16.0,29.0,16.0,3.0,0.0,0.0,82.0,37.0,47.0,270.0
Gandhinagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,37.0,5.0,0.0,24.0,11.0,13.0,24.0,32.0,39.0,42.0,39.0,28.0,294.0
Gandhinagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,26.0,36.0,0.0,11.0,7.0,19.0,0.0,19.0,21.0,18.0,25.0,31.0,213.0
Gandhinagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,63.0,41.0,0.0,35.0,18.0,32.0,24.0,51.0,60.0,60.0,64.0,59.0,507.0
Gandhinagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,58.0,15.0,19.0,7.0,17.0,11.0,9.0,12.0,3.0,14.0,4.0,7.0,176.0
Gandhinagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,274.0,363.0,340.0,428.0,208.0,262.0,409.0,550.0,255.0,360.0,376.0,284.0,4109.0
Gandhinagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,368.0,451.0,435.0,448.0,243.0,280.0,391.0,529.0,305.0,421.0,433.0,371.0,4675.0
Gandhinagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,642.0,814.0,775.0,876.0,451.0,542.0,800.0,1079.0,560.0,781.0,809.0,655.0,8784.0
Gandhinagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,13.0,0.0,0.0,20.0,0.0,0.0,33.0
Gandhinagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,6.0,0.0,3.0,0.0,0.0,0.0,2.0,4.0,2.0,2.0,3.0,2.0,24.0
Gandhinagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,4.0
Gandhinagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gandhinagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,6.0,0.0,4.0,1.0,0.0,0.0,4.0,4.0,2.0,2.0,3.0,2.0,28.0
Gandhinagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,5.0,1.0,0.0,4.0,0.0,2.0,2.0,1.0,1.0,1.0,2.0,19.0
Gandhinagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,111.0,119.0,122.0,135.0,31.0,52.0,82.0,34.0,75.0,77.0,63.0,61.0,962.0
Gandhinagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,20.0,0.0,0.0,35.0,41.0,22.0,0.0,187.0,187.0,0.0,44.0,536.0
Gandhinagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,12.0,14.0,18.0,10.0,17.0,12.0,10.0,27.0,22.0,32.0,46.0,33.0,253.0
Gandhinagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gandhinagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,123.0,153.0,140.0,145.0,83.0,105.0,114.0,61.0,284.0,296.0,109.0,138.0,1751.0
Gandhinagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,30.0,40.0,38.0,60.0,65.0,134.0,158.0,165.0,161.0,146.0,156.0,216.0,1369.0
Gandhinagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,389.0,367.0,357.0,338.0,164.0,182.0,250.0,221.0,234.0,219.0,254.0,336.0,3311.0
Gandhinagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,11.0,4.0,14.0,35.0,8.0,0.0,2.0,13.0,18.0,2.0,15.0,9.0,131.0
Gandhinagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,4.0,23.0,21.0,1.0,4.0,1.0,6.0,3.0,13.0,1.0,16.0,94.0
Gandhinagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gandhinagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,401.0,375.0,394.0,394.0,173.0,186.0,253.0,240.0,255.0,234.0,270.0,361.0,3536.0
Gandhinagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,407.0,561.0,570.0,498.0,623.0,793.0,817.0,762.0,732.0,785.0,779.0,718.0,8045.0
Gandhinagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,260.0,225.0,204.0,205.0,262.0,110.0,187.0,187.0,180.0,181.0,180.0,180.0,2361.0
Gandhinagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,29.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,110.0,0.0,143.0
Gandhinagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,11.0,13.0,23.0,11.0,17.0,17.0,9.0,16.0,4.0,10.0,0.0,12.0,143.0
Gandhinagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gandhinagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,300.0,242.0,227.0,216.0,279.0,127.0,196.0,203.0,184.0,191.0,290.0,192.0,2647.0
Gandhinagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,5.0,2.0,11.0,6.0,3.0,1.0,14.0,5.0,10.0,10.0,2.0,3.0,72.0
Gandhinagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,615.0,772.0,750.0,805.0,796.0,768.0,821.0,788.0,652.0,777.0,727.0,553.0,8824.0
Gandhinagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,698.0,645.0,621.0,649.0,374.0,347.0,457.0,327.0,336.0,330.0,404.0,479.0,5667.0
Gandhinagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,13.0,7.0,16.0,9.0,25.0,12.0,16.0,15.0,18.0,17.0,7.0,12.0,167.0
Gandhinagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,31.0,47.0,32.0,76.0,48.0,49.0,19.0,30.0,20.0,35.0,11.0,40.0,438.0
Gandhinagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gandhinagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1357.0,1471.0,1419.0,1539.0,1243.0,1176.0,1313.0,1160.0,1026.0,1159.0,1149.0,1084.0,15096.0
Gandhinagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,42.0,102.0,55.0,30.0,51.0,88.0,34.0,47.0,44.0,59.0,83.0,98.0,733.0
Gandhinagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,595.0,677.0,665.0,681.0,696.0,933.0,818.0,849.0,882.0,960.0,1061.0,968.0,9785.0
Gandhinagar,9.06,Number of IUCD removals,TOTAL,362.0,372.0,298.0,352.0,306.0,355.0,304.0,318.0,280.0,294.0,295.0,327.0,3863.0
Gandhinagar,9.07,Number of Oral Pills cycles distributed,TOTAL,9735.0,7137.0,7321.0,8128.0,7409.0,7047.0,5879.0,5679.0,5449.0,5708.0,5622.0,6703.0,81817.0
Gandhinagar,9.08,Number of Condom pieces distributed,TOTAL,77607.0,77874.0,80744.0,111836.0,111607.0,106017.0,93633.0,85452.0,78793.0,109932.0,95053.0,140353.0,1168901.0
Gandhinagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,52.0,135.0,1.0,7.0,11.0,2.0,0.0,0.0,0.0,0.0,1237.0,352.0,1797.0
Gandhinagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,81.0,57.0,54.0,76.0,69.0,33.0,45.0,37.0,29.0,30.0,20.0,21.0,552.0
Gandhinagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,8.0,21.0,2.0,0.0,0.0,0.0,0.0,0.0,31.0
Gandhinagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,4.0,0.0,5.0,12.0,51.0,75.0,58.0,35.0,46.0,13.0,299.0
Gandhinagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,3.0
Gandhinagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,16.0,19.0,17.0,18.0,18.0,16.0,14.0,14.0,13.0,13.0,14.0,15.0,-1.0
Gandhinagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2671.0,3067.0,2719.0,2753.0,2965.0,3095.0,3293.0,3038.0,2471.0,2381.0,2348.0,2561.0,33362.0
Gandhinagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,25.0,28.0,36.0,46.0,37.0,32.0,43.0,14.0,53.0,30.0,38.0,64.0,446.0
Gandhinagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,26.0,66.0,28.0,21.0,25.0,12.0,34.0,21.0,37.0,28.0,49.0,46.0,393.0
Gandhinagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,21.0,31.0,28.0,14.0,30.0,8.0,18.0,17.0,42.0,26.0,40.0,234.0,509.0
Gandhinagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2552.0,2926.0,2671.0,2509.0,2636.0,2636.0,2774.0,2553.0,2214.0,2228.0,2272.0,2507.0,30478.0
Gandhinagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2539.0,2869.0,2653.0,2461.0,2597.0,2601.0,2677.0,2568.0,2262.0,2054.0,2295.0,2450.0,30026.0
Gandhinagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2568.0,2878.0,2601.0,2461.0,2563.0,2608.0,2701.0,2497.0,2266.0,1926.0,2070.0,2382.0,29521.0
Gandhinagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2406.0,2787.0,2218.0,2524.0,2751.0,2901.0,3017.0,2665.0,2296.0,2313.0,2152.0,2383.0,30413.0
Gandhinagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2584.0,2909.0,2598.0,2611.0,2680.0,2654.0,2771.0,2554.0,2385.0,2236.0,2264.0,2562.0,30808.0
Gandhinagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2561.0,2865.0,2601.0,2544.0,2615.0,2587.0,2671.0,2585.0,2286.0,2057.0,2311.0,2444.0,30127.0
Gandhinagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2589.0,2867.0,2548.0,2517.0,2561.0,2551.0,2639.0,2419.0,2226.0,1896.0,1985.0,2338.0,29136.0
Gandhinagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1222.0,1474.0,1420.0,1595.0,1637.0,1660.0,1778.0,1804.0,1437.0,1493.0,1364.0,1498.0,18382.0
Gandhinagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,50.0,12.0,25.0,49.0,43.0,27.0,0.0,7.0,10.0,11.0,13.0,84.0,331.0
Gandhinagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,8.0,9.0,24.0,4.0,3.0,10.0,0.0,2.0,2.0,0.0,0.0,37.0,99.0
Gandhinagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4.0,7.0,26.0,4.0,4.0,11.0,5.0,10.0,10.0,0.0,11.0,50.0,142.0
Gandhinagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2478.0,2902.0,2700.0,2742.0,2690.0,2661.0,2763.0,2308.0,2054.0,2027.0,2332.0,2557.0,30214.0
Gandhinagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1605.0,1917.0,2091.0,2033.0,1953.0,1744.0,1883.0,1644.0,1683.0,1776.0,1849.0,2186.0,22364.0
Gandhinagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1368.0,1549.0,1398.0,1382.0,1438.0,1342.0,1378.0,1124.0,1104.0,1052.0,1176.0,1308.0,15619.0
Gandhinagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1206.0,1408.0,1274.0,1300.0,1242.0,1215.0,1240.0,1033.0,967.0,935.0,1049.0,1190.0,14059.0
Gandhinagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2574.0,2957.0,2672.0,2682.0,2680.0,2557.0,2618.0,2157.0,2071.0,1987.0,2225.0,2498.0,29678.0
Gandhinagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2437.0,2702.0,2452.0,2549.0,2444.0,2331.0,2593.0,2038.0,2018.0,1984.0,2096.0,2542.0,28186.0
Gandhinagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2421.0,2685.0,2424.0,2529.0,2425.0,2322.0,2592.0,2030.0,1977.0,1977.0,2088.0,2542.0,28012.0
Gandhinagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,1.0,1.0,0.0,0.0,8.0
Gandhinagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1162.0,1246.0,1110.0,1140.0,1136.0,1109.0,1253.0,1014.0,998.0,999.0,1038.0,1238.0,13443.0
Gandhinagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1036.0,1097.0,1047.0,1025.0,992.0,1039.0,1178.0,959.0,925.0,914.0,908.0,1149.0,12269.0
Gandhinagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2198.0,2343.0,2157.0,2165.0,2128.0,2148.0,2431.0,1973.0,1923.0,1913.0,1946.0,2387.0,25712.0
Gandhinagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1422.0,1480.0,1493.0,2283.0,2073.0,2407.0,1708.0,1863.0,1773.0,1951.0,2640.0,2957.0,24050.0
Gandhinagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1327.0,1394.0,1430.0,2282.0,2079.0,2365.0,1685.0,1754.0,2140.0,2138.0,2489.0,2658.0,23741.0
Gandhinagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1478.0,1629.0,1522.0,1986.0,2052.0,1783.0,1991.0,1953.0,1783.0,2080.0,2360.0,2627.0,23244.0
Gandhinagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,5.0
Gandhinagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,4.0,7.0
Gandhinagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1117.0,1150.0,1136.0,1119.0,1100.0,1121.0,1130.0,1127.0,1105.0,1114.0,1097.0,1155.0,13471.0
Gandhinagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1109.0,1148.0,1136.0,1121.0,1098.0,1121.0,1130.0,1129.0,1106.0,1102.0,1096.0,1157.0,13453.0
Gandhinagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1094.0,1124.0,1105.0,1083.0,1087.0,1099.0,1107.0,1111.0,1073.0,1055.0,1060.0,1105.0,13103.0
Gandhinagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2440.0,2693.0,2670.0,2670.0,2660.0,2525.0,2505.0,2210.0,1927.0,1860.0,2066.0,2448.0,28674.0
Gandhinagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,5571.0,68.0,73.0,28.0,2216.0,10505.0,317.0,17.0,39.0,12.0,205.0,5299.0,24350.0
Gandhinagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,5691.0,10.0,7.0,5.0,2505.0,11234.0,279.0,4.0,10.0,0.0,187.0,6008.0,25940.0
Gandhinagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,16.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,20.0
Gandhinagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,9.0,4.0,1.0,19.0,18.0,10.0,12.0,8.0,7.0,5.0,16.0,111.0
Gandhinagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,800.0,727.0,747.0,1318.0,1427.0,1129.0,1169.0,939.0,919.0,966.0,993.0,1032.0,12166.0
Gandhinagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,12.0,12.0,7.0,6.0,32.0,7.0,12.0,18.0,9.0,9.0,9.0,5.0,138.0
Gandhinagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,123.0,192.0,154.0,197.0,364.0,457.0,336.0,206.0,248.0,251.0,368.0,237.0,3133.0
Gandhinagar,13.1,Number of Patients operated for cataract,TOTAL,1671.0,845.0,617.0,671.0,657.0,572.0,676.0,889.0,912.0,998.0,967.0,868.0,10343.0
Gandhinagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,535.0,844.0,616.0,670.0,656.0,572.0,675.0,889.0,911.0,998.0,966.0,801.0,9133.0
Gandhinagar,13.3,Number of School children detected with Refractive errors,TOTAL,45.0,3.0,58.0,993.0,324.0,121.0,262.0,545.0,437.0,680.0,1457.0,437.0,5362.0
Gandhinagar,13.4,Number of children provided free glasses,TOTAL,45.0,3.0,58.0,262.0,324.0,121.0,262.0,545.0,437.0,680.0,1449.0,437.0,4623.0
Gandhinagar,13.5,Number of eyes collected through eye donation,TOTAL,5.0,7.0,2.0,2.0,4.0,0.0,2.0,8.0,6.0,4.0,8.0,4.0,52.0
Gandhinagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,5.0,7.0,2.0,2.0,4.0,0.0,2.0,8.0,0.0,4.0,0.0,4.0,38.0
Gandhinagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,9.0,9.0,8.0,10.0,9.0,7.0,8.0,9.0,8.0,6.0,8.0,8.0,-1.0
Gandhinagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,11.0,8.0,8.0,9.0,11.0,10.0,8.0,9.0,9.0,8.0,8.0,12.0,-1.0
Gandhinagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,450.0,480.0,489.0,584.0,482.0,602.0,524.0,474.0,465.0,506.0,487.0,543.0,-1.0
Gandhinagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,13.0,13.0,13.0,14.0,13.0,13.0,12.0,13.0,13.0,11.0,13.0,12.0,-1.0
Gandhinagar,14.05,Number of RKS meetings held during the month,TOTAL,12.0,12.0,12.0,11.0,9.0,8.0,9.0,9.0,9.0,14.0,12.0,15.0,132.0
Gandhinagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,28.0,27.0,26.0,26.0,24.0,26.0,21.0,22.0,22.0,21.0,22.0,26.0,-1.0
Gandhinagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,600.0,854.0,598.0,674.0,88.0,94.0,677.0,89.0,663.0,765.0,125.0,141.0,5368.0
Gandhinagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,11.0,10.0,11.0,9.0,7.0,7.0,8.0,10.0,8.0,8.0,7.0,8.0,-1.0
Gandhinagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,8.0,305.0,7.0,7.0,7.0,7.0,4.0,6.0,5.0,4.0,3.0,4.0,-1.0
Gandhinagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1419.0,1323.0,1521.0,2231.0,1647.0,665.0,719.0,846.0,320.0,552.0,892.0,2469.0,14604.0
Gandhinagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3915.0,3744.0,3479.0,3987.0,3839.0,1824.0,4032.0,3093.0,670.0,1419.0,762.0,5680.0,36444.0
Gandhinagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1123.0,1176.0,1206.0,1617.0,1426.0,620.0,775.0,784.0,305.0,460.0,586.0,1587.0,11665.0
Gandhinagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5272.0,5407.0,5421.0,6066.0,6217.0,3234.0,6092.0,4194.0,1480.0,2726.0,2231.0,7207.0,55547.0
Gandhinagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2542.0,2499.0,2727.0,3848.0,3073.0,1285.0,1494.0,1630.0,625.0,1012.0,1478.0,4056.0,26269.0
Gandhinagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9187.0,9151.0,8900.0,10053.0,10056.0,5058.0,10124.0,7287.0,2150.0,4145.0,2993.0,12887.0,91991.0
Gandhinagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,30.0,36.0,43.0,21.0,35.0,41.0,41.0,78.0,8.0,43.0,5.0,41.0,422.0
Gandhinagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,22.0,19.0,16.0,17.0,26.0,19.0,17.0,50.0,4.0,27.0,4.0,29.0,250.0
Gandhinagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,52.0,55.0,59.0,38.0,61.0,60.0,58.0,128.0,12.0,70.0,9.0,70.0,672.0
Gandhinagar,14.11,In-Patient Head Count at midnight,TOTAL,11394.0,9924.0,10109.0,500.0,589.0,475.0,586.0,648.0,534.0,443.0,663.0,808.0,36673.0
Gandhinagar,14.12.1,OPD attendance (All),TOTAL,85970.0,79200.0,85610.0,82476.0,98316.0,93575.0,84424.0,119804.0,84428.0,83047.0,120634.0,119122.0,1136606.0
Gandhinagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,345.0,2408.0,345.0,561.0,479.0,451.0,44.0,1078.0,554.0,584.0,109.0,112.0,7070.0
Gandhinagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,40.0,30.0,23.0,33.0,284.0,298.0,52.0,77.0,837.0
Gandhinagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,285.0,256.0,342.0,498.0,409.0,473.0,196.0,1057.0,907.0,670.0,331.0,282.0,5706.0
Gandhinagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,1657.0,1745.0,1261.0,890.0,1681.0,1722.0,1605.0,2004.0,2009.0,1948.0,4646.0,2156.0,23324.0
Gandhinagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,94.0,121.0,114.0,136.0,569.0,55.0,52.0,108.0,62.0,91.0,44.0,114.0,1560.0
Gandhinagar,14.14.c,Number of Adolescents counselled,TOTAL,70.0,120.0,94.0,109.0,107.0,71.0,67.0,63.0,90.0,220.0,70.0,78.0,1159.0
Gandhinagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9149.0,4533.0,11880.0,9902.0,9823.0,10522.0,10178.0,4695.0,8857.0,8368.0,11699.0,11672.0,111278.0
Gandhinagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,420.0,165.0,502.0,490.0,455.0,463.0,405.0,154.0,307.0,259.0,385.0,345.0,4350.0
Gandhinagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,507.0,560.0,424.0,667.0,439.0,532.0,447.0,732.0,409.0,400.0,367.0,306.0,5790.0
Gandhinagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,10.0,9.0,15.0,12.0,8.0,26.0,12.0,26.0,13.0,10.0,7.0,3.0,151.0
Gandhinagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,373.0,331.0,310.0,311.0,318.0,399.0,336.0,1213.0,488.0,361.0,347.0,203.0,4990.0
Gandhinagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,7.0,3.0,11.0,8.0,7.0,10.0,5.0,15.0,6.0,7.0,2.0,0.0,81.0
Gandhinagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2127.0,2262.0,2359.0,2377.0,2269.0,2439.0,1788.0,2976.0,1796.0,1832.0,2006.0,1585.0,25816.0
Gandhinagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,1.0,1.0,1.0,1.0,7.0,6.0,7.0,8.0,4.0,0.0,0.0,37.0
Gandhinagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3007.0,3153.0,3093.0,3355.0,3026.0,3370.0,2571.0,4921.0,2693.0,2593.0,2720.0,2094.0,36596.0
Gandhinagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,18.0,13.0,27.0,21.0,16.0,43.0,23.0,48.0,27.0,21.0,9.0,3.0,269.0
Gandhinagar,15.2,Number of Widal tests conducted,Number tested,349.0,299.0,261.0,377.0,474.0,397.0,121.0,470.0,195.0,134.0,262.0,355.0,3694.0
Gandhinagar,15.3.a,Number of VDRL tests conducted on males,Number tested,159.0,149.0,140.0,240.0,127.0,146.0,0.0,284.0,129.0,127.0,126.0,105.0,1732.0
Gandhinagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,116.0,116.0,98.0,80.0,53.0,107.0,0.0,231.0,118.0,117.0,129.0,171.0,1336.0
Gandhinagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,307.0,371.0,336.0,352.0,356.0,377.0,5.0,685.0,291.0,254.0,309.0,494.0,4137.0
Gandhinagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,582.0,636.0,574.0,672.0,536.0,630.0,5.0,1200.0,538.0,498.0,564.0,770.0,7205.0
Gandhinagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,18344.0,18742.0,18057.0,18027.0,24333.0,26006.0,20429.0,23116.0,16776.0,14446.0,28357.0,19483.0,246116.0
Gandhinagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,56.0,67.0,72.0,63.0,130.0,115.0,8.0,105.0,24.0,13.0,566.0,14.0,1233.0
Gandhinagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,0.0,0.0,1.0,35.0,23.0,2.0,29.0,16.0,1.0,0.0,1.0,110.0
Gandhinagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,5000.0,8000.0,3500.0,7000.0,10000.0,8000.0,13000.0,10500.0,7000.0,13500.0,10000.0,7500.0,103000.0
Gandhinagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,7500.0,,7500.0,7500.0,0.0,15000.0,0.0,0.0,10000.0,0.0,0.0,6000.0,53500.0
Gandhinagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4500.0,4500.0,4000.0,4500.0,2000.0,10000.0,2500.0,3500.0,3500.0,3500.0,2500.0,6500.0,51500.0
Gandhinagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,8000.0,3500.0,7000.0,10000.0,8000.0,13000.0,10500.0,7000.0,13500.0,10000.0,7500.0,7000.0,105000.0
Gandhinagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,6500.0,12500.0,4500.0,11000.0,8500.0,5500.0,12000.0,9500.0,2000.0,9500.0,3000.0,1000.0,85500.0
Gandhinagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,12000.0,,12000.0,6000.0,0.0,15000.0,0.0,0.0,12000.0,0.0,0.0,18000.0,75000.0
Gandhinagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,6000.0,8000.0,5500.0,8500.0,3000.0,8500.0,2500.0,7500.0,4500.0,6500.0,2000.0,8500.0,71000.0
Gandhinagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,12500.0,4500.0,11000.0,8500.0,5500.0,12000.0,9500.0,2000.0,9500.0,3000.0,1000.0,10500.0,89500.0
Gandhinagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,61060.0,70300.0,58800.0,40800.0,37300.0,28300.0,31800.0,25800.0,11300.0,89100.0,45500.0,49000.0,549060.0
Gandhinagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20740.0,,,10000.0,0.0,20000.0,0.0,0.0,296000.0,46000.0,240000.0,0.0,632740.0
Gandhinagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,11500.0,11500.0,18000.0,13500.0,9000.0,16500.0,6000.0,14500.0,218200.0,89600.0,236500.0,14000.0,658800.0
Gandhinagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,70300.0,58800.0,40800.0,37300.0,28300.0,31800.0,25800.0,11300.0,89100.0,45500.0,49000.0,35000.0,523000.0
Gandhinagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,7000.0,20500.0,12000.0,16000.0,17500.0,14000.0,22500.0,19500.0,12000.0,21000.0,13500.0,9500.0,185000.0
Gandhinagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,,10000.0,10000.0,0.0,22000.0,0.0,0.0,15000.0,0.0,0.0,15000.0,92000.0
Gandhinagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6500.0,8500.0,6000.0,8500.0,3500.0,13500.0,3000.0,7500.0,6000.0,7500.0,4000.0,9000.0,83500.0
Gandhinagar,16.1.3,Stock position of TT vaccines,5. Total Stock,20500.0,12000.0,16000.0,17500.0,14000.0,22500.0,19500.0,12000.0,21000.0,13500.0,9500.0,15500.0,193500.0
Gandhinagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gandhinagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Gandhinagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gandhinagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2550.0,5450.0,2550.0,4750.0,5050.0,3650.0,9450.0,7450.0,3250.0,10850.0,7050.0,5050.0,67100.0
Gandhinagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,6000.0,,5000.0,4000.0,0.0,10000.0,0.0,0.0,10000.0,0.0,0.0,10000.0,45000.0
Gandhinagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,3100.0,2900.0,2800.0,3700.0,1400.0,4200.0,2000.0,4200.0,2400.0,3800.0,2000.0,3200.0,35700.0
Gandhinagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,5450.0,2550.0,4750.0,5050.0,3650.0,9450.0,7450.0,3250.0,10850.0,7050.0,5050.0,11850.0,76400.0
Gandhinagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,16000.0,18250.0,13750.0,17750.0,17250.0,14500.0,18500.0,15750.0,15500.0,16500.0,22250.0,19000.0,205000.0
Gandhinagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,6750.0,,10000.0,5000.0,0.0,10000.0,0.0,5000.0,5000.0,10000.0,0.0,0.0,51750.0
Gandhinagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4250.0,4500.0,6000.0,5500.0,2750.0,6000.0,2750.0,5250.0,4000.0,4250.0,3250.0,5000.0,53500.0
Gandhinagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,18500.0,13750.0,17750.0,17250.0,14500.0,18500.0,15750.0,15500.0,16500.0,22250.0,19000.0,14000.0,203250.0
Gandhinagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gandhinagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Gandhinagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gandhinagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,4200.0,3900.0,6000.0,6000.0,5700.0,5700.0,5400.0,5100.0,4800.0,4500.0,3900.0,3900.0,59100.0
Gandhinagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,3000.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0
Gandhinagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,300.0,900.0,,300.0,0.0,300.0,300.0,300.0,300.0,600.0,0.0,600.0,3900.0
Gandhinagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3900.0,6000.0,6000.0,5700.0,5700.0,5400.0,5100.0,4800.0,4500.0,3900.0,3900.0,3300.0,58200.0
Gandhinagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gandhinagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,0.0,,0.0,,,,,0.0
Gandhinagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,,100800.0,287280.0,,0.0,0.0,0.0,0.0,0.0,0.0,1507800.0,1895880.0
Gandhinagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gandhinagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,100800.0,287280.0,,0.0,,0.0,,,,1507800.0,1895880.0
Gandhinagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Gandhinagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,0.0,9600.0,,0.0,0.0,0.0,0.0,0.0,0.0,48000.0,57600.0
Gandhinagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gandhinagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,9600.0,,0.0,,0.0,,,,48000.0,57600.0
Gandhinagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gandhinagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,0.0,,0.0,,,,,0.0
Gandhinagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gandhinagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,0.0,,0.0,,,,,0.0
Gandhinagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gandhinagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,,0.0,,0.0,,0.0,,,,,0.0
Gandhinagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gandhinagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,,0.0,,0.0,,0.0,,,,,0.0
Gandhinagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gandhinagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,,0.0,,0.0,,0.0,,,,,0.0
Gandhinagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,,0.0,,,,0.0,,,,,0.0
Gandhinagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,,,0.0,,,,0.0,,,,,0.0
Gandhinagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,,,0.0,,,,0.0,,,,,0.0
Gandhinagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,,,0.0,,,,0.0,,,,,0.0
Gandhinagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,,,0.0,,,,0.0,,,,,0.0
Gandhinagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,,,0.0,,,,0.0,,,,,0.0
Gandhinagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,,,0.0,,,,0.0,,,,,0.0
Gandhinagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Gandhinagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,,,0.0,,,,0.0,,,,,0.0
Gandhinagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gandhinagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,,0.0,,,,0.0,,,,,0.0
Gandhinagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gandhinagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,,0.0,,,,0.0,,,,,0.0
Gandhinagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Gandhinagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,,0.0,,,,0.0,,,,,0.0
Gandhinagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gandhinagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Gandhinagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gandhinagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Gandhinagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,1.0,,,,,1.0
Gandhinagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,4.0,3.0,,,2.0,1.0,4.0,,,2.0,,17.0
Gandhinagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gandhinagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,4.0,3.0,,,2.0,1.0,4.0,,,2.0,,17.0
Gandhinagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,3.0,2.0,2.0,1.0,8.0,4.0,3.0,2.0,,1.0,1.0,28.0
Gandhinagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,2.0,,,3.0
Gandhinagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,4.0,2.0,2.0,1.0,8.0,4.0,3.0,2.0,2.0,1.0,1.0,31.0
Gandhinagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,2.0,1.0,,,3.0,,8.0,1.0,4.0,1.0,,21.0
Gandhinagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,1.0,3.0,,,,1.0,,,6.0
Gandhinagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,3.0,1.0,,1.0,6.0,,8.0,1.0,5.0,1.0,,27.0
Gandhinagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Gandhinagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gandhinagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,1.0,,,,,,1.0
Gandhinagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gandhinagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gandhinagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Gandhinagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gandhinagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
Gandhinagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,,,,,,,,,,1.0
Gandhinagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gandhinagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gandhinagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Gandhinagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,1.0,,2.0,1.0,3.0,,,,,1.0,9.0
Gandhinagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,,,,1.0,1.0,,,,,2.0,6.0
Gandhinagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,2.0,1.0,,2.0,2.0,4.0,,,,,3.0,15.0
Gandhinagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Gandhinagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,1.0,1.0,,3.0,,,,1.0,2.0,1.0,10.0
Gandhinagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,1.0,,1.0,2.0
Gandhinagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,1.0,1.0,,3.0,,,,2.0,2.0,2.0,12.0
Gandhinagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,,,,1.0,,3.0,,,,5.0
Gandhinagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,2.0,1.0,4.0,4.0,2.0,6.0,1.0,,,20.0
Gandhinagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,1.0,2.0,1.0,4.0,5.0,2.0,9.0,1.0,,,25.0
Gandhinagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Gandhinagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Gandhinagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Gandhinagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,1.0,,,,,,1.0
Gandhinagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,,,1.0,2.0,4.0,2.0,1.0,1.0,1.0,1.0,14.0
Gandhinagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,2.0,3.0,5.0,3.0,2.0,5.0,2.0,4.0,,26.0
Gandhinagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,1.0,,2.0,4.0,7.0,7.0,4.0,6.0,3.0,5.0,1.0,40.0
Gandhinagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,1.0,,,1.0,,,,2.0
Gandhinagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,1.0,,3.0,,,,,4.0
Gandhinagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,2.0,,3.0,1.0,,,,6.0
Gandhinagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Gandhinagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Gandhinagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Gandhinagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,1.0,,,,1.0
Gandhinagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Gandhinagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Gandhinagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,,,,1.0,,,,2.0,,,4.0
Gandhinagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,,,,1.0,,,,2.0,,,4.0
Gandhinagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Gandhinagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,1.0,1.0,,,2.0,2.0,1.0,7.0
Gandhinagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Gandhinagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,1.0,1.0,,,3.0,2.0,2.0,9.0
Gandhinagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,1.0,1.0,,1.0,,,3.0,,1.0,7.0
Gandhinagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Gandhinagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,1.0,1.0,,1.0,,,3.0,1.0,1.0,8.0
Gandhinagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Gandhinagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,1.0,,,,,1.0
Gandhinagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Gandhinagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,1.0,,,,,,1.0,2.0
Gandhinagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,1.0,,,,,,1.0,2.0
Gandhinagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Gandhinagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,1.0,2.0,,,,3.0
Gandhinagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,1.0,,,,,1.0,1.0,,,,,4.0
Gandhinagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,1.0,,,,,1.0,2.0,2.0,,,,7.0
Gandhinagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,1.0,1.0,,,2.0
Gandhinagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,9.0,6.0,6.0,3.0,8.0,8.0,11.0,11.0,4.0,12.0,8.0,6.0,92.0
Gandhinagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,20.0,19.0,17.0,14.0,26.0,24.0,31.0,32.0,20.0,25.0,31.0,27.0,286.0
Gandhinagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,29.0,25.0,23.0,17.0,34.0,32.0,42.0,43.0,25.0,38.0,39.0,33.0,380.0
Gir Somnath,1.1,Total number of pregnant women Registered for ANC,TOTAL,2283.0,2151.0,2116.0,2103.0,2147.0,2339.0,2026.0,2273.0,2001.0,2039.0,2134.0,1940.0,25552.0
Gir Somnath,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2087.0,1960.0,1918.0,1881.0,1890.0,2070.0,1825.0,2017.0,1803.0,1859.0,1931.0,1769.0,23010.0
Gir Somnath,1.2,Number of Pregnant women registered under JSY,TOTAL,907.0,919.0,902.0,956.0,964.0,1129.0,976.0,1082.0,887.0,1012.0,1040.0,944.0,11718.0
Gir Somnath,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2029.0,1945.0,1912.0,1849.0,1869.0,2050.0,1774.0,1968.0,1832.0,1852.0,1930.0,1807.0,22817.0
Gir Somnath,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2194.0,2057.0,2051.0,1997.0,2065.0,2263.0,1946.0,2158.0,1961.0,1966.0,2099.0,1886.0,24643.0
Gir Somnath,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2089.0,2004.0,2116.0,1973.0,2040.0,2251.0,2031.0,2110.0,1997.0,1948.0,1981.0,1878.0,24418.0
Gir Somnath,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1801.0,1600.0,1617.0,1569.0,1580.0,1621.0,1400.0,1562.0,1384.0,1451.0,1484.0,1369.0,18438.0
Gir Somnath,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,196.0,177.0,171.0,169.0,169.0,199.0,157.0,165.0,187.0,100.0,115.0,70.0,1875.0
Gir Somnath,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,12.0,10.0,12.0,0.0,0.0,0.0,0.0,12.0,0.0,46.0
Gir Somnath,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,757.0,753.0,805.0,790.0,771.0,837.0,641.0,704.0,651.0,590.0,611.0,603.0,8513.0
Gir Somnath,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,4.0,5.0,5.0,3.0,5.0,3.0,3.0,2.0,3.0,3.0,4.0,44.0
Gir Somnath,1.8,Number of pregnancy test kits used at SC level,TOTAL,349.0,289.0,149.0,207.0,198.0,430.0,627.0,569.0,511.0,371.0,482.0,520.0,4702.0
Gir Somnath,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,43.0,32.0,40.0,51.0,86.0,79.0,94.0,74.0,63.0,57.0,56.0,65.0,740.0
Gir Somnath,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,64.0,62.0,52.0,39.0,53.0,49.0,49.0,50.0,44.0,41.0,57.0,40.0,600.0
Gir Somnath,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,107.0,94.0,92.0,90.0,139.0,128.0,143.0,124.0,107.0,98.0,113.0,105.0,1340.0
Gir Somnath,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,103.0,92.0,87.0,79.0,136.0,134.0,132.0,122.0,102.0,94.0,113.0,102.0,1296.0
Gir Somnath,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,8.0,9.0,10.0,3.0,2.0,4.0,4.0,6.0,6.0,6.0,10.0,4.0,72.0
Gir Somnath,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,922.0,841.0,611.0,872.0,1060.0,1054.0,966.0,961.0,889.0,850.0,858.0,827.0,10711.0
Gir Somnath,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,675.0,580.0,402.0,618.0,586.0,654.0,550.0,605.0,542.0,506.0,599.0,527.0,6844.0
Gir Somnath,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,148.0,188.0,160.0,141.0,141.0,314.0,225.0,181.0,208.0,118.0,143.0,174.0,2141.0
Gir Somnath,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,70.0,63.0,48.0,35.0,15.0,18.0,17.0,7.0,10.0,38.0,8.0,14.0,343.0
Gir Somnath,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,3.0,7.0,5.0,4.0,2.0,5.0,4.0,3.0,3.0,2.0,4.0,4.0,46.0
Gir Somnath,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1034.0,880.0,1011.0,903.0,836.0,1116.0,1030.0,1105.0,994.0,1115.0,969.0,932.0,11925.0
Gir Somnath,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,0.0,6.0
Gir Somnath,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,47.0,35.0,15.0,52.0,92.0,82.0,91.0,73.0,35.0,9.0,23.0,27.0,581.0
Gir Somnath,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,4.0,12.0,17.0,7.0,9.0,12.0,9.0,4.0,9.0,11.0,9.0,13.0,116.0
Gir Somnath,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gir Somnath,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,51.0,47.0,32.0,59.0,101.0,94.0,100.0,77.0,44.0,23.0,35.0,40.0,703.0
Gir Somnath,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,8.0,41.0,18.0,25.0,34.0,42.0,12.0,9.0,17.0,26.0,51.0,27.0,310.0
Gir Somnath,4.1.1.a,Number of male live births,TOTAL,1114.0,1006.0,903.0,971.0,1098.0,1136.0,1097.0,1098.0,961.0,1010.0,950.0,863.0,12207.0
Gir Somnath,4.1.1.b,Number of female live births,TOTAL,895.0,928.0,843.0,834.0,1083.0,1077.0,1047.0,1100.0,864.0,872.0,854.0,818.0,11215.0
Gir Somnath,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2009.0,1934.0,1746.0,1805.0,2181.0,2213.0,2144.0,2198.0,1825.0,1882.0,1804.0,1681.0,23422.0
Gir Somnath,4.1.2,Number of still births,TOTAL,37.0,34.0,27.0,27.0,36.0,33.0,45.0,31.0,53.0,41.0,32.0,50.0,446.0
Gir Somnath,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,36.0,38.0,41.0,31.0,43.0,40.0,53.0,38.0,41.0,42.0,34.0,34.0,471.0
Gir Somnath,4.2.1,Number of Newborns weighed at birth,TOTAL,1590.0,1191.0,1230.0,1086.0,1263.0,1302.0,1234.0,1362.0,1230.0,1350.0,1227.0,1096.0,15161.0
Gir Somnath,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,133.0,59.0,72.0,53.0,90.0,87.0,92.0,134.0,125.0,82.0,62.0,85.0,1074.0
Gir Somnath,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1546.0,1155.0,1162.0,1040.0,1210.0,1264.0,1168.0,1415.0,1157.0,1249.0,1179.0,1048.0,14593.0
Gir Somnath,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,6.0,6.0,9.0,3.0,6.0,4.0,6.0,9.0,18.0,6.0,5.0,6.0,84.0
Gir Somnath,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,15.0,15.0,23.0,23.0,69.0,55.0,57.0,6.0,12.0,16.0,15.0,17.0,323.0
Gir Somnath,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gir Somnath,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,21.0,21.0,32.0,26.0,75.0,59.0,63.0,15.0,30.0,22.0,20.0,23.0,407.0
Gir Somnath,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,105.0,103.0,115.0,87.0,108.0,104.0,115.0,60.0,107.0,107.0,85.0,92.0,1188.0
Gir Somnath,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,15.0,23.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,15.0,0.0,54.0
Gir Somnath,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,115.0,88.0,109.0,100.0,156.0,139.0,146.0,98.0,107.0,107.0,90.0,96.0,1351.0
Gir Somnath,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,8.0,2.0,4.0,3.0,3.0,2.0,1.0,2.0,0.0,1.0,5.0,33.0
Gir Somnath,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1380.0,1526.0,1553.0,1450.0,1535.0,1493.0,1545.0,1739.0,1552.0,1509.0,2974.0,2301.0,20557.0
Gir Somnath,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1562.0,1656.0,1674.0,1550.0,1770.0,1712.0,1720.0,1845.0,1611.0,1645.0,3091.0,2360.0,22196.0
Gir Somnath,6.3,PNC maternal complications attended,TOTAL,11.0,3.0,15.0,2.0,6.0,5.0,7.0,1.0,12.0,0.0,0.0,0.0,62.0
Gir Somnath,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,8.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,11.0
Gir Somnath,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,8.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,11.0
Gir Somnath,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,19.0,24.0,27.0,30.0,38.0,49.0,45.0,31.0,35.0,37.0,61.0,37.0,433.0
Gir Somnath,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,68.0,86.0,96.0,103.0,145.0,124.0,91.0,94.0,92.0,85.0,119.0,120.0,1223.0
Gir Somnath,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,87.0,110.0,123.0,133.0,183.0,173.0,136.0,125.0,127.0,122.0,180.0,157.0,1656.0
Gir Somnath,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Gir Somnath,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Gir Somnath,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gir Somnath,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Gir Somnath,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,7.0,13.0,7.0,2.0,6.0,5.0,6.0,14.0,6.0,13.0,53.0,85.0,217.0
Gir Somnath,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,27.0,12.0,21.0,33.0,20.0,32.0,20.0,44.0,57.0,63.0,33.0,7.0,369.0
Gir Somnath,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,52.0,32.0,36.0,55.0,30.0,56.0,29.0,68.0,89.0,78.0,52.0,35.0,612.0
Gir Somnath,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gir Somnath,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,86.0,57.0,64.0,90.0,56.0,93.0,55.0,126.0,152.0,154.0,138.0,127.0,1198.0
Gir Somnath,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,91.0,37.0,14.0,18.0,11.0,19.0,9.0,47.0,12.0,0.0,0.0,0.0,258.0
Gir Somnath,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,170.0,66.0,101.0,79.0,88.0,128.0,52.0,221.0,273.0,250.0,218.0,184.0,1830.0
Gir Somnath,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gir Somnath,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,261.0,103.0,115.0,97.0,99.0,147.0,61.0,268.0,285.0,250.0,218.0,184.0,2088.0
Gir Somnath,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,15.0,15.0,7.0,6.0,15.0,6.0,11.0,25.0,39.0,107.0,80.0,49.0,375.0
Gir Somnath,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0
Gir Somnath,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gir Somnath,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0
Gir Somnath,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,782.0,873.0,970.0,929.0,1123.0,1094.0,985.0,1015.0,871.0,844.0,686.0,765.0,10937.0
Gir Somnath,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,82.0,113.0,74.0,88.0,77.0,70.0,67.0,91.0,95.0,77.0,71.0,50.0,955.0
Gir Somnath,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,58.0,45.0,17.0,10.0,17.0,8.0,13.0,9.0,19.0,15.0,15.0,24.0,250.0
Gir Somnath,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4.0,5.0,4.0,4.0,2.0,8.0,2.0,8.0,6.0,6.0,7.0,4.0,60.0
Gir Somnath,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gir Somnath,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,926.0,1036.0,1065.0,1031.0,1219.0,1180.0,1067.0,1123.0,991.0,942.0,779.0,843.0,12202.0
Gir Somnath,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,62.0,51.0,86.0,46.0,31.0,69.0,58.0,34.0,43.0,7.0,1.0,59.0,547.0
Gir Somnath,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.06,Number of IUCD removals,TOTAL,220.0,208.0,205.0,184.0,155.0,164.0,155.0,181.0,146.0,139.0,149.0,131.0,2037.0
Gir Somnath,9.07,Number of Oral Pills cycles distributed,TOTAL,3667.0,2541.0,2625.0,2553.0,2684.0,2487.0,2663.0,2455.0,2495.0,2389.0,2532.0,2413.0,31504.0
Gir Somnath,9.08,Number of Condom pieces distributed,TOTAL,29772.0,15992.0,15193.0,15421.0,14963.0,13073.0,16459.0,17491.0,18011.0,18681.0,19990.0,19229.0,214275.0
Gir Somnath,9.09,Number of Centchroman (weekly) pills given,TOTAL,24.0,14.0,21.0,7.0,9.0,3.0,2.0,5.0,3.0,70.0,52.0,3.0,213.0
Gir Somnath,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,11.0,9.0,19.0,7.0,10.0,8.0,1.0,2.0,0.0,1.0,1.0,4.0,73.0
Gir Somnath,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,15.0,8.0,11.0,18.0,5.0,15.0,8.0,13.0,13.0,43.0,27.0,9.0,185.0
Gir Somnath,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Gir Somnath,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,8.0,11.0,8.0,7.0,9.0,6.0,9.0,8.0,8.0,6.0,4.0,-1.0
Gir Somnath,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2039.0,1882.0,1895.0,1799.0,2015.0,2061.0,2020.0,2086.0,1900.0,1875.0,1800.0,2609.0,23981.0
Gir Somnath,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,348.0,0.0,0.0,0.0,0.0,19.0,22.0,14.0,19.0,22.0,17.0,0.0,461.0
Gir Somnath,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,19.0,16.0,17.0,20.0,16.0,12.0,0.0,100.0
Gir Somnath,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,15.0,12.0,9.0,22.0,19.0,11.0,0.0,88.0
Gir Somnath,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1844.0,1924.0,1895.0,1804.0,1842.0,1876.0,1889.0,1954.0,1944.0,1863.0,1679.0,1705.0,22219.0
Gir Somnath,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1847.0,1856.0,1920.0,1826.0,1803.0,1879.0,1820.0,1922.0,1883.0,1844.0,1710.0,1695.0,22005.0
Gir Somnath,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1865.0,1857.0,1843.0,1823.0,1816.0,1925.0,1813.0,1906.0,1870.0,1828.0,1758.0,1779.0,22083.0
Gir Somnath,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1957.0,1703.0,1706.0,1674.0,1828.0,1812.0,1771.0,1931.0,1783.0,1870.0,1775.0,2465.0,22275.0
Gir Somnath,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1897.0,1979.0,2075.0,1906.0,1937.0,1971.0,2001.0,2148.0,2025.0,1938.0,1789.0,1845.0,23511.0
Gir Somnath,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1930.0,1910.0,2029.0,1929.0,1875.0,1956.0,1919.0,2024.0,1990.0,1929.0,1766.0,1742.0,22999.0
Gir Somnath,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1926.0,1903.0,1925.0,1911.0,1889.0,1976.0,1922.0,2021.0,1962.0,1911.0,1826.0,1824.0,22996.0
Gir Somnath,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1434.0,984.0,1146.0,983.0,897.0,1129.0,1205.0,1265.0,1218.0,1208.0,1115.0,1679.0,14263.0
Gir Somnath,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,14.0,8.0,36.0
Gir Somnath,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1822.0,1915.0,1951.0,1805.0,1835.0,1972.0,1922.0,2007.0,1947.0,1806.0,1755.0,1757.0,22494.0
Gir Somnath,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1569.0,1682.0,1679.0,1572.0,1612.0,1766.0,1698.0,1789.0,1692.0,1632.0,1673.0,1684.0,20048.0
Gir Somnath,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,884.0,931.0,964.0,893.0,921.0,1008.0,970.0,944.0,934.0,887.0,890.0,875.0,11101.0
Gir Somnath,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,859.0,897.0,920.0,856.0,901.0,949.0,895.0,969.0,865.0,865.0,847.0,876.0,10699.0
Gir Somnath,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1743.0,1828.0,1884.0,1749.0,1822.0,1957.0,1865.0,1913.0,1799.0,1752.0,1737.0,1751.0,21800.0
Gir Somnath,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1760.0,1758.0,1846.0,1739.0,1736.0,1891.0,1804.0,1918.0,1811.0,1733.0,1724.0,1722.0,21442.0
Gir Somnath,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1754.0,1751.0,1849.0,1737.0,1727.0,1879.0,1803.0,1909.0,1809.0,1731.0,1723.0,1723.0,21395.0
Gir Somnath,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,713.0,722.0,762.0,694.0,703.0,772.0,761.0,772.0,728.0,640.0,683.0,763.0,8713.0
Gir Somnath,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,686.0,694.0,734.0,686.0,689.0,722.0,698.0,750.0,717.0,668.0,689.0,704.0,8437.0
Gir Somnath,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1399.0,1416.0,1496.0,1380.0,1392.0,1494.0,1459.0,1522.0,1445.0,1308.0,1372.0,1467.0,17150.0
Gir Somnath,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,493.0,557.0,585.0,1020.0,4102.0,6236.0,1321.0,1344.0,2190.0,743.0,918.0,1249.0,20758.0
Gir Somnath,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,412.0,463.0,567.0,1124.0,4090.0,6580.0,1235.0,1244.0,2105.0,642.0,534.0,1178.0,20174.0
Gir Somnath,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,550.0,570.0,591.0,1014.0,3276.0,5794.0,1317.0,1195.0,1734.0,726.0,687.0,1172.0,18626.0
Gir Somnath,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,7.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,10.0
Gir Somnath,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,6.0,5.0,0.0,0.0,0.0,1.0,15.0,0.0,0.0,0.0,0.0,4.0,31.0
Gir Somnath,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,918.0,877.0,924.0,900.0,897.0,942.0,909.0,908.0,939.0,904.0,883.0,915.0,10916.0
Gir Somnath,10.4.2,Number of Immunisation sessions held during the month,TOTAL,905.0,873.0,917.0,890.0,879.0,940.0,891.0,895.0,920.0,894.0,868.0,907.0,10779.0
Gir Somnath,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,804.0,767.0,835.0,811.0,828.0,863.0,825.0,826.0,848.0,821.0,794.0,848.0,9870.0
Gir Somnath,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1710.0,1763.0,1768.0,1679.0,1688.0,1865.0,1801.0,1876.0,1744.0,1708.0,1543.0,1617.0,20762.0
Gir Somnath,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1907.0,98.0,110.0,529.0,67.0,75.0,118.0,120.0,109.0,81.0,86.0,9768.0,13068.0
Gir Somnath,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,23325.0,30.0,53.0,877.0,16.0,43.0,24.0,25.0,35.0,39.0,69.0,10291.0,34827.0
Gir Somnath,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,16.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,5.0,3.0,1.0,0.0,28.0
Gir Somnath,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1150.0,1069.0,1138.0,1168.0,1257.0,1156.0,996.0,991.0,1125.0,1242.0,1299.0,1217.0,13808.0
Gir Somnath,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,10.0,5.0,2.0,5.0,7.0,7.0,6.0,9.0,8.0,53.0,6.0,10.0,128.0
Gir Somnath,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,25.0,69.0,78.0,85.0,34.0,53.0,32.0,8.0,4.0,15.0,15.0,12.0,430.0
Gir Somnath,13.1,Number of Patients operated for cataract,TOTAL,399.0,19.0,12.0,23.0,22.0,20.0,0.0,8.0,16.0,13.0,9.0,16.0,557.0
Gir Somnath,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,21.0,19.0,12.0,23.0,22.0,20.0,0.0,8.0,16.0,13.0,9.0,13.0,176.0
Gir Somnath,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,1450.0,216.0,23.0,6.0,0.0,189.0,274.0,182.0,213.0,2553.0
Gir Somnath,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,32.0,17.0,23.0,6.0,165.0,599.0,75.0,65.0,15.0,997.0
Gir Somnath,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,165.0,410.0,75.0,0.0,0.0,650.0
Gir Somnath,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,4.0,4.0,4.0,3.0,4.0,3.0,4.0,4.0,5.0,5.0,3.0,-1.0
Gir Somnath,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,8.0,8.0,7.0,7.0,10.0,8.0,5.0,6.0,6.0,6.0,7.0,-1.0
Gir Somnath,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,105.0,127.0,123.0,133.0,139.0,193.0,185.0,167.0,180.0,171.0,185.0,149.0,-1.0
Gir Somnath,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,8.0,7.0,7.0,7.0,8.0,8.0,8.0,8.0,9.0,9.0,7.0,-1.0
Gir Somnath,14.05,Number of RKS meetings held during the month,TOTAL,7.0,5.0,13.0,7.0,13.0,11.0,9.0,6.0,9.0,8.0,7.0,12.0,107.0
Gir Somnath,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,16.0,16.0,19.0,19.0,20.0,23.0,22.0,23.0,22.0,22.0,19.0,20.0,-1.0
Gir Somnath,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,130.0,102.0,65.0,91.0,42.0,60.0,33.0,47.0,44.0,47.0,33.0,31.0,725.0
Gir Somnath,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,5.0,5.0,5.0,3.0,4.0,3.0,5.0,5.0,6.0,6.0,4.0,-1.0
Gir Somnath,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,5.0,5.0,5.0,5.0,223.0,5.0,3.0,3.0,5.0,3.0,3.0,-1.0
Gir Somnath,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,370.0,146.0,155.0,176.0,204.0,161.0,148.0,159.0,145.0,192.0,164.0,200.0,2220.0
Gir Somnath,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,598.0,813.0,854.0,1110.0,1557.0,1312.0,918.0,976.0,989.0,1453.0,1138.0,1537.0,13255.0
Gir Somnath,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,638.0,168.0,172.0,139.0,173.0,329.0,189.0,199.0,171.0,141.0,166.0,197.0,2682.0
Gir Somnath,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1320.0,1313.0,1740.0,1996.0,2544.0,1981.0,1509.0,1973.0,1850.0,2153.0,2019.0,2411.0,22809.0
Gir Somnath,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1008.0,314.0,327.0,315.0,377.0,490.0,337.0,358.0,316.0,333.0,330.0,397.0,4902.0
Gir Somnath,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1918.0,2126.0,2594.0,3106.0,4101.0,3293.0,2427.0,2949.0,2839.0,3606.0,3157.0,3948.0,36064.0
Gir Somnath,14.10.2.a,Number of death cases of Inpatient males,TOTAL,10.0,10.0,4.0,3.0,13.0,5.0,3.0,12.0,16.0,5.0,9.0,13.0,103.0
Gir Somnath,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,2.0,1.0,1.0,15.0,4.0,2.0,2.0,4.0,3.0,5.0,3.0,44.0
Gir Somnath,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12.0,12.0,5.0,4.0,28.0,9.0,5.0,14.0,20.0,8.0,14.0,16.0,147.0
Gir Somnath,14.11,In-Patient Head Count at midnight,TOTAL,1985.0,1937.0,2065.0,2060.0,2152.0,2230.0,2289.0,782.0,2508.0,2414.0,2386.0,2716.0,25524.0
Gir Somnath,14.12.1,OPD attendance (All),TOTAL,46096.0,37020.0,41638.0,46467.0,46963.0,62758.0,33831.0,43433.0,43605.0,38642.0,44530.0,57192.0,542175.0
Gir Somnath,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,63.0,1006.0,89.0,74.0,63.0,101.0,36.0,75.0,95.0,175.0,50.0,69.0,1896.0
Gir Somnath,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,256.0,169.0,208.0,218.0,265.0,210.0,211.0,248.0,272.0,203.0,239.0,254.0,2753.0
Gir Somnath,14.14.a,Number of patients given AYUSH treatment,TOTAL,1153.0,1062.0,1307.0,1199.0,990.0,1078.0,948.0,923.0,1310.0,1010.0,1137.0,959.0,13076.0
Gir Somnath,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,22.0,12.0,5.0,15.0,10.0,10.0,20.0,22.0,19.0,18.0,153.0
Gir Somnath,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5029.0,4122.0,4798.0,4109.0,4020.0,4038.0,3473.0,4389.0,4167.0,3951.0,4413.0,5034.0,51543.0
Gir Somnath,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,111.0,73.0,67.0,58.0,87.0,81.0,88.0,95.0,70.0,73.0,60.0,58.0,921.0
Gir Somnath,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,339.0,295.0,325.0,360.0,380.0,417.0,367.0,287.0,330.0,316.0,385.0,443.0,4244.0
Gir Somnath,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,8.0,6.0,3.0,6.0,7.0,8.0,3.0,29.0,0.0,3.0,1.0,4.0,78.0
Gir Somnath,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,508.0,355.0,426.0,429.0,403.0,596.0,413.0,592.0,677.0,581.0,617.0,562.0,6159.0
Gir Somnath,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,1.0,2.0,6.0,24.0,6.0,4.0,1.0,1.0,0.0,1.0,0.0,48.0
Gir Somnath,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,611.0,645.0,634.0,652.0,670.0,983.0,659.0,843.0,796.0,613.0,611.0,674.0,8391.0
Gir Somnath,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,2.0,66.0,0.0,17.0,0.0,0.0,0.0,0.0,0.0,86.0
Gir Somnath,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1458.0,1295.0,1385.0,1441.0,1453.0,1996.0,1439.0,1722.0,1803.0,1510.0,1613.0,1679.0,18794.0
Gir Somnath,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,10.0,7.0,6.0,14.0,97.0,14.0,24.0,30.0,1.0,3.0,2.0,4.0,212.0
Gir Somnath,15.2,Number of Widal tests conducted,Number tested,36.0,40.0,30.0,38.0,70.0,32.0,57.0,20.0,16.0,9.0,14.0,19.0,381.0
Gir Somnath,15.3.a,Number of VDRL tests conducted on males,Number tested,30.0,20.0,22.0,20.0,19.0,25.0,30.0,21.0,21.0,22.0,23.0,21.0,274.0
Gir Somnath,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,84.0,59.0,70.0,56.0,81.0,108.0,99.0,58.0,58.0,43.0,40.0,127.0,883.0
Gir Somnath,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,33.0,29.0,37.0,70.0,70.0,111.0,112.0,91.0,177.0,74.0,69.0,155.0,1028.0
Gir Somnath,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,147.0,108.0,129.0,146.0,170.0,244.0,241.0,170.0,256.0,139.0,132.0,303.0,2185.0
Gir Somnath,15.4.1,Number of blood smears examined for Malaria,TOTAL,7378.0,13174.0,9759.0,10856.0,12432.0,14734.0,10478.0,11854.0,10287.0,10274.0,12473.0,13753.0,137452.0
Gir Somnath,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,10.0,12.0,13.0,20.0,16.0,30.0,261.0,4.0,8.0,7.0,9.0,5.0,395.0
Gir Somnath,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,7.0,1.0,1.0,1.0,15.0
Gir Somnath,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.3,Stock position of TT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gir Somnath,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,1.0,,,,,,,,,1.0,,4.0
Gir Somnath,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,,,,,,,,,,,1.0
Gir Somnath,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gir Somnath,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,1.0,,,,,,,,,,,1.0
Gir Somnath,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,1.0,1.0,1.0,,1.0,2.0,4.0,3.0,2.0,3.0,2.0,22.0
Gir Somnath,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gir Somnath,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,1.0,1.0,1.0,,1.0,2.0,4.0,3.0,2.0,3.0,2.0,22.0
Gir Somnath,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,1.0,1.0,2.0,2.0,,3.0,7.0,4.0,2.0,,4.0,28.0
Gir Somnath,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,2.0,,,3.0
Gir Somnath,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,1.0,1.0,2.0,2.0,,4.0,7.0,4.0,4.0,,4.0,31.0
Gir Somnath,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,4.0,5.0,2.0,7.0,6.0,8.0,3.0,4.0,4.0,1.0,5.0,51.0
Gir Somnath,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,,2.0,,,2.0,,,,2.0,7.0
Gir Somnath,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,4.0,5.0,2.0,9.0,6.0,8.0,5.0,4.0,4.0,1.0,7.0,58.0
Gir Somnath,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,1.0,1.0,,,,,,,,3.0
Gir Somnath,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gir Somnath,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,1.0,1.0,,,,,,,,3.0
Gir Somnath,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gir Somnath,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gir Somnath,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Gir Somnath,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,,,,,,,1.0
Gir Somnath,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gir Somnath,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,,,,,,,1.0
Gir Somnath,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Gir Somnath,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gir Somnath,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,1.0,,,,,,1.0
Gir Somnath,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,4.0,1.0,3.0,,6.0,5.0,5.0,2.0,2.0,5.0,5.0,41.0
Gir Somnath,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,1.0,,,1.0,2.0,2.0,1.0,1.0,1.0,,10.0
Gir Somnath,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,5.0,2.0,3.0,,7.0,7.0,7.0,3.0,3.0,6.0,5.0,51.0
Gir Somnath,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Gir Somnath,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Gir Somnath,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Gir Somnath,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,2.0,,,,,1.0,2.0,1.0,,1.0,7.0
Gir Somnath,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,1.0,,,,2.0,,1.0,,5.0
Gir Somnath,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,2.0,,1.0,,,1.0,4.0,1.0,1.0,1.0,12.0
Gir Somnath,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,1.0,,2.0,,2.0,1.0,6.0
Gir Somnath,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,5.0,4.0,,4.0,4.0,4.0,4.0,2.0,5.0,5.0,3.0,40.0
Gir Somnath,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,5.0,4.0,,4.0,4.0,5.0,4.0,4.0,5.0,7.0,4.0,46.0
Gir Somnath,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Gir Somnath,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Gir Somnath,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Gir Somnath,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Gir Somnath,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Gir Somnath,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,,,1.0,,,,,,,2.0
Gir Somnath,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Gir Somnath,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Gir Somnath,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Gir Somnath,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Gir Somnath,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,2.0,2.0,2.0,2.0,3.0,3.0,6.0,5.0,2.0,3.0,4.0,35.0
Gir Somnath,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,11.0,13.0,6.0,6.0,6.0,6.0,7.0,9.0,8.0,11.0,11.0,13.0,107.0
Gir Somnath,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,12.0,15.0,8.0,8.0,8.0,9.0,10.0,15.0,13.0,13.0,14.0,18.0,143.0
Gir Somnath,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,,,,,,,,,2.0,3.0
Gir Somnath,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,1.0,,,,,1.0,1.0,2.0,,,5.0
Gir Somnath,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,1.0,,,,,1.0,1.0,2.0,,2.0,8.0
Gir Somnath,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Gir Somnath,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Gir Somnath,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,1.0,,,,1.0
Gir Somnath,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Gir Somnath,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Gir Somnath,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Gir Somnath,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Gir Somnath,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Gir Somnath,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Gir Somnath,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,1.0,,,,1.0
Gir Somnath,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Gir Somnath,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Gir Somnath,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,1.0,1.0
Gir Somnath,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Gir Somnath,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Gir Somnath,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Gir Somnath,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,6.0,4.0,3.0,2.0,1.0,3.0,2.0,10.0,7.0,1.0,,39.0
Gir Somnath,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,,3.0,,1.0,,,,1.0,,1.0,7.0
Gir Somnath,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,7.0,5.0,6.0,2.0,2.0,3.0,2.0,10.0,8.0,1.0,1.0,47.0
Gir Somnath,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,3.0,1.0,,2.0,2.0,1.0,1.0,1.0,1.0,2.0,2.0,17.0
Gir Somnath,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,1.0,1.0,,,,,1.0,1.0,,1.0,6.0
Gir Somnath,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,4.0,2.0,1.0,2.0,2.0,1.0,1.0,2.0,2.0,2.0,3.0,23.0
Gir Somnath,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Gir Somnath,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,2.0,,2.0
Gir Somnath,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,1.0,,,,2.0,,3.0
Gir Somnath,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Gir Somnath,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,1.0,1.0,,,1.0,2.0,,,1.0,6.0
Gir Somnath,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,1.0,1.0,,,1.0,2.0,,,2.0,7.0
Gir Somnath,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,,,,1.0,,,,,,2.0
Gir Somnath,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,1.0,,,1.0,,,2.0,,2.0,,1.0,9.0
Gir Somnath,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,2.0,1.0,1.0,3.0,1.0,2.0,,4.0,2.0,16.0
Gir Somnath,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,2.0,1.0,1.0,2.0,2.0,1.0,4.0,3.0,2.0,2.0,4.0,3.0,27.0
Gir Somnath,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Gir Somnath,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,2.0,5.0,4.0,,1.0,3.0,,2.0,3.0,3.0,2.0,27.0
Gir Somnath,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,6.0,5.0,6.0,5.0,5.0,13.0,3.0,10.0,13.0,14.0,4.0,9.0,93.0
Gir Somnath,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,8.0,7.0,11.0,9.0,5.0,14.0,6.0,10.0,15.0,17.0,7.0,11.0,120.0
Jamnagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,2856.0,3023.0,3071.0,3362.0,2968.0,2989.0,2762.0,3110.0,2900.0,3208.0,2377.0,2315.0,34941.0
Jamnagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2460.0,2523.0,2520.0,2891.0,2532.0,2531.0,2319.0,2650.0,2387.0,2507.0,2127.0,2003.0,29450.0
Jamnagar,1.2,Number of Pregnant women registered under JSY,TOTAL,347.0,393.0,370.0,329.0,372.0,433.0,299.0,358.0,302.0,355.0,379.0,339.0,4276.0
Jamnagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2292.0,2448.0,2453.0,2783.0,2611.0,2583.0,2410.0,2724.0,2390.0,2422.0,2103.0,1964.0,29183.0
Jamnagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2270.0,2399.0,2405.0,2747.0,2576.0,2552.0,2316.0,2759.0,2246.0,2497.0,2163.0,2028.0,28958.0
Jamnagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2155.0,2229.0,2441.0,2848.0,2699.0,2540.0,2644.0,2866.0,2849.0,2398.0,2270.0,2104.0,30043.0
Jamnagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4743.0,5228.0,4919.0,5150.0,4937.0,4968.0,4940.0,4799.0,4902.0,5210.0,4576.0,4169.0,58541.0
Jamnagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,9.0,36.0,24.0,29.0,17.0,14.0,25.0,22.0,5.0,4.0,14.0,19.0,218.0
Jamnagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,8.0,2.0,5.0,6.0,5.0,6.0,6.0,0.0,0.0,0.0,0.0,38.0
Jamnagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,920.0,939.0,981.0,1341.0,1145.0,1346.0,1153.0,1216.0,1204.0,1333.0,1337.0,1061.0,13976.0
Jamnagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,3.0,3.0,0.0,2.0,3.0,6.0,10.0,21.0,3.0,1.0,8.0,0.0,60.0
Jamnagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,84.0,76.0,93.0,97.0,126.0,103.0,108.0,101.0,109.0,84.0,140.0,112.0,1233.0
Jamnagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,23.0,49.0,60.0,46.0,45.0,45.0,33.0,39.0,79.0,54.0,43.0,12.0,528.0
Jamnagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,50.0,28.0,19.0,13.0,22.0,33.0,41.0,30.0,23.0,24.0,14.0,10.0,307.0
Jamnagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,73.0,77.0,79.0,59.0,67.0,78.0,74.0,69.0,102.0,78.0,57.0,22.0,835.0
Jamnagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,57.0,70.0,47.0,51.0,63.0,69.0,63.0,57.0,92.0,75.0,46.0,22.0,712.0
Jamnagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,5.0,10.0,10.0,11.0,23.0,11.0,8.0,5.0,24.0,0.0,7.0,0.0,114.0
Jamnagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1616.0,1544.0,1394.0,1700.0,1917.0,1970.0,1847.0,2151.0,2111.0,2174.0,1710.0,1714.0,21848.0
Jamnagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,993.0,1136.0,1074.0,1394.0,1466.0,1564.0,1398.0,1685.0,1647.0,1640.0,1389.0,1521.0,16907.0
Jamnagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,51.0,76.0,77.0,87.0,73.0,86.0,45.0,6.0,15.0,10.0,14.0,12.0,552.0
Jamnagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,1.0,0.0,28.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0
Jamnagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,656.0,771.0,837.0,889.0,914.0,845.0,800.0,802.0,777.0,961.0,664.0,792.0,9708.0
Jamnagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Jamnagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,217.0,183.0,131.0,132.0,146.0,174.0,201.0,213.0,207.0,272.0,156.0,163.0,2195.0
Jamnagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,217.0,183.0,131.0,112.0,173.0,146.0,164.0,175.0,172.0,195.0,127.0,159.0,1954.0
Jamnagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamnagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,434.0,366.0,262.0,244.0,319.0,320.0,365.0,388.0,379.0,467.0,283.0,322.0,4149.0
Jamnagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,88.0,98.0,118.0,73.0,106.0,118.0,96.0,90.0,84.0,96.0,79.0,72.0,1118.0
Jamnagar,4.1.1.a,Number of male live births,TOTAL,1225.0,1205.0,1197.0,1367.0,1478.0,1544.0,1421.0,1583.0,1551.0,1593.0,1242.0,1332.0,16738.0
Jamnagar,4.1.1.b,Number of female live births,TOTAL,1077.0,1120.0,1099.0,1233.0,1360.0,1376.0,1263.0,1416.0,1416.0,1605.0,1184.0,1181.0,15330.0
Jamnagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2302.0,2325.0,2296.0,2600.0,2838.0,2920.0,2684.0,2999.0,2967.0,3198.0,2426.0,2513.0,32068.0
Jamnagar,4.1.2,Number of still births,TOTAL,60.0,84.0,40.0,92.0,71.0,89.0,86.0,74.0,56.0,74.0,45.0,43.0,814.0
Jamnagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,134.0,51.0,182.0,134.0,164.0,122.0,114.0,182.0,100.0,97.0,99.0,99.0,1478.0
Jamnagar,4.2.1,Number of Newborns weighed at birth,TOTAL,2304.0,2290.0,2295.0,2592.0,2831.0,2843.0,1867.0,2933.0,2976.0,3199.0,2509.0,2512.0,31151.0
Jamnagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,312.0,304.0,241.0,319.0,381.0,292.0,361.0,315.0,339.0,370.0,226.0,267.0,3727.0
Jamnagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1618.0,1647.0,1668.0,1909.0,1896.0,1880.0,1683.0,1839.0,1813.0,2129.0,1855.0,1706.0,21643.0
Jamnagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,20.0,16.0,18.0,17.0,7.0,33.0,46.0,50.0,24.0,32.0,24.0,34.0,321.0
Jamnagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,378.0,375.0,548.0,620.0,469.0,437.0,481.0,492.0,454.0,435.0,541.0,379.0,5609.0
Jamnagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamnagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,398.0,391.0,566.0,637.0,476.0,470.0,527.0,542.0,478.0,467.0,565.0,413.0,5930.0
Jamnagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,2.0,14.0,3.0,0.0,10.0,1.0,10.0,7.0,17.0,11.0,7.0,8.0,90.0
Jamnagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,14.0,13.0,7.0,8.0,2.0,22.0,29.0,19.0,23.0,18.0,8.0,14.0,177.0
Jamnagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,14.0,13.0,9.0,9.0,12.0,23.0,23.0,29.0,23.0,18.0,8.0,14.0,195.0
Jamnagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2227.0,2291.0,2196.0,2231.0,2649.0,2772.0,2619.0,2720.0,2890.0,3073.0,2756.0,2862.0,31286.0
Jamnagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1987.0,2015.0,1744.0,2069.0,2320.0,2554.0,2424.0,2538.0,2730.0,2706.0,2390.0,2566.0,28043.0
Jamnagar,6.3,PNC maternal complications attended,TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Jamnagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,133.0,154.0,119.0,136.0,175.0,135.0,140.0,165.0,233.0,239.0,149.0,175.0,1953.0
Jamnagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,48.0,49.0,49.0,58.0,3.0,32.0,52.0,82.0,16.0,13.0,34.0,95.0,531.0
Jamnagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,181.0,203.0,168.0,194.0,178.0,167.0,192.0,247.0,249.0,252.0,183.0,270.0,2484.0
Jamnagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,6.0,8.0,5.0,13.0,1.0,6.0,4.0,2.0,1.0,6.0,3.0,2.0,57.0
Jamnagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,42.0,41.0,35.0,38.0,36.0,41.0,25.0,40.0,44.0,32.0,3.0,43.0,420.0
Jamnagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,315.0,371.0,332.0,449.0,402.0,382.0,368.0,405.0,439.0,370.0,368.0,376.0,4577.0
Jamnagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,357.0,412.0,367.0,487.0,438.0,423.0,393.0,445.0,483.0,402.0,371.0,419.0,4997.0
Jamnagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,7.0
Jamnagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,3.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,9.0
Jamnagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,1.0,0.0,2.0,0.0,1.0,18.0,0.0,2.0,1.0,1.0,2.0,29.0
Jamnagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamnagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4.0,1.0,2.0,3.0,0.0,1.0,18.0,0.0,4.0,2.0,8.0,2.0,45.0
Jamnagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Jamnagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,63.0,87.0,150.0
Jamnagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,128.0,162.0,110.0,122.0,111.0,209.0,185.0,267.0,459.0,674.0,337.0,195.0,2959.0
Jamnagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,36.0,37.0,37.0,33.0,22.0,36.0,32.0,99.0,131.0,183.0,106.0,79.0,831.0
Jamnagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamnagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,164.0,199.0,147.0,155.0,133.0,245.0,217.0,366.0,590.0,857.0,506.0,361.0,3940.0
Jamnagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,6.0,14.0,19.0,30.0,53.0,52.0,34.0,79.0,77.0,103.0,9.0,28.0,504.0
Jamnagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamnagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,6.0,5.0,5.0,1.0,3.0,7.0,6.0,7.0,6.0,5.0,2.0,54.0
Jamnagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamnagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,6.0,5.0,5.0,1.0,3.0,7.0,6.0,7.0,6.0,5.0,2.0,54.0
Jamnagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,735.0,816.0,903.0,1088.0,955.0,917.0,906.0,828.0,795.0,712.0,669.0,667.0,9991.0
Jamnagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,21.0,37.0,29.0,29.0,20.0,34.0,38.0,53.0,24.0,21.0,319.0,268.0,893.0
Jamnagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,547.0,490.0,508.0,501.0,190.0,571.0,565.0,669.0,540.0,629.0,13.0,10.0,5233.0
Jamnagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,72.0,84.0,45.0,95.0,110.0,94.0,71.0,104.0,121.0,228.0,96.0,74.0,1194.0
Jamnagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamnagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1375.0,1427.0,1485.0,1713.0,1275.0,1616.0,1580.0,1654.0,1480.0,1590.0,1097.0,1019.0,17311.0
Jamnagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,16.0,31.0,11.0,7.0,0.0,4.0,3.0,6.0,12.0,8.0,22.0,20.0,140.0
Jamnagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,70.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,0.0,0.0,81.0
Jamnagar,9.06,Number of IUCD removals,TOTAL,186.0,137.0,186.0,234.0,159.0,369.0,161.0,210.0,156.0,180.0,231.0,194.0,2403.0
Jamnagar,9.07,Number of Oral Pills cycles distributed,TOTAL,5926.0,6450.0,6018.0,5430.0,6474.0,9274.0,6784.0,7892.0,6316.0,6096.0,2652.0,2953.0,72265.0
Jamnagar,9.08,Number of Condom pieces distributed,TOTAL,72789.0,70489.0,61538.0,45174.0,39608.0,72305.0,78192.0,79977.0,72615.0,69337.0,31200.0,33322.0,726546.0
Jamnagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,1.0,4000.0,0.0,0.0,3.0,3.0,1.0,1.0,8.0,1.0,4018.0
Jamnagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,17.0,11.0,1.0,1.0,9.0,20.0,4.0,9.0,17.0,12.0,10.0,19.0,130.0
Jamnagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Jamnagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,3.0
Jamnagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,3.0
Jamnagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,29.0,32.0,32.0,33.0,31.0,32.0,33.0,33.0,29.0,31.0,28.0,30.0,-1.0
Jamnagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2821.0,3257.0,3056.0,3297.0,3246.0,3445.0,3364.0,3503.0,3383.0,3659.0,2311.0,10111.0,45453.0
Jamnagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,118.0,137.0,134.0,125.0,118.0,155.0,122.0,167.0,0.0,0.0,209.0,139.0,1424.0
Jamnagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,114.0,88.0,90.0,115.0,81.0,99.0,108.0,95.0,0.0,0.0,138.0,107.0,1035.0
Jamnagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,78.0,117.0,78.0,82.0,101.0,77.0,80.0,99.0,0.0,0.0,123.0,115.0,950.0
Jamnagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2168.0,2472.0,2360.0,2395.0,2191.0,2639.0,2376.0,2570.0,2517.0,2637.0,2148.0,4167.0,30640.0
Jamnagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2192.0,2325.0,2284.0,2407.0,2149.0,2434.0,2329.0,2345.0,2381.0,2333.0,2095.0,3715.0,28989.0
Jamnagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2173.0,2406.0,2283.0,2439.0,2249.0,2510.0,2300.0,2366.0,2357.0,2317.0,2008.0,3686.0,29094.0
Jamnagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2871.0,3240.0,3065.0,3253.0,3235.0,3008.0,3437.0,3623.0,3326.0,3722.0,1694.0,9966.0,44440.0
Jamnagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2178.0,2464.0,2310.0,2398.0,2209.0,2636.0,2374.0,2567.0,2486.0,2635.0,2141.0,4177.0,30575.0
Jamnagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2228.0,2313.0,2238.0,2416.0,2128.0,2432.0,2330.0,2347.0,2387.0,2342.0,2103.0,3721.0,28985.0
Jamnagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2175.0,2400.0,2269.0,2457.0,2243.0,2511.0,2281.0,2346.0,2349.0,2294.0,1993.0,3674.0,28992.0
Jamnagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,647.0,1208.0,1268.0,1331.0,1623.0,1772.0,2072.0,1958.0,1869.0,1810.0,1296.0,1147.0,18001.0
Jamnagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2224.0,2407.0,2484.0,2532.0,2217.0,2715.0,2314.0,2311.0,2229.0,2189.0,1848.0,3886.0,29356.0
Jamnagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1699.0,1750.0,1873.0,2030.0,1794.0,1866.0,1964.0,1914.0,1408.0,1402.0,1626.0,2886.0,22212.0
Jamnagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1075.0,1166.0,1211.0,1206.0,1119.0,1267.0,1081.0,1099.0,1044.0,1108.0,895.0,2026.0,14297.0
Jamnagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,987.0,1083.0,1129.0,1106.0,1047.0,1141.0,1068.0,1064.0,886.0,852.0,851.0,1658.0,12872.0
Jamnagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2062.0,2249.0,2340.0,2312.0,2166.0,2408.0,2149.0,2163.0,1930.0,1960.0,1746.0,3684.0,27169.0
Jamnagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1963.0,2039.0,2223.0,2333.0,1880.0,2059.0,2089.0,2061.0,2103.0,2043.0,1829.0,3263.0,25885.0
Jamnagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1963.0,2046.0,2223.0,2333.0,1880.0,2059.0,2090.0,2068.0,2101.0,2039.0,1828.0,3262.0,25892.0
Jamnagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,507.0,525.0,572.0,614.0,758.0,754.0,972.0,841.0,616.0,620.0,622.0,466.0,7867.0
Jamnagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,470.0,440.0,529.0,540.0,688.0,721.0,884.0,772.0,584.0,565.0,562.0,442.0,7197.0
Jamnagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,977.0,965.0,1101.0,1154.0,1446.0,1475.0,1856.0,1613.0,1200.0,1185.0,1184.0,908.0,15064.0
Jamnagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,944.0,927.0,1026.0,1252.0,2952.0,2444.0,1948.0,1378.0,1613.0,1295.0,1765.0,1537.0,19081.0
Jamnagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1027.0,928.0,1050.0,1291.0,3209.0,2194.0,1939.0,1323.0,1547.0,1456.0,1856.0,1497.0,19317.0
Jamnagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1062.0,755.0,1085.0,1248.0,2741.0,1774.0,1644.0,1347.0,1301.0,1232.0,1816.0,1340.0,17345.0
Jamnagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1081.0,1079.0,1067.0,1058.0,1069.0,1066.0,1063.0,1063.0,1058.0,1068.0,990.0,989.0,12651.0
Jamnagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1064.0,1078.0,1061.0,1047.0,1061.0,1059.0,1056.0,1054.0,1047.0,1063.0,980.0,990.0,12560.0
Jamnagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,876.0,889.0,584.0,880.0,877.0,887.0,896.0,907.0,914.0,931.0,852.0,870.0,10363.0
Jamnagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2456.0,2406.0,2503.0,2434.0,2691.0,2791.0,2569.0,2193.0,2158.0,2210.0,1866.0,1946.0,28223.0
Jamnagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,7840.0,2804.0,499.0,406.0,4006.0,7117.0,2171.0,443.0,246.0,274.0,773.0,7366.0,33945.0
Jamnagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,8605.0,13.0,120.0,25.0,3146.0,16077.0,2604.0,84.0,86.0,90.0,615.0,7544.0,39009.0
Jamnagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,3.0
Jamnagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1387.0,1430.0,1488.0,1400.0,1834.0,1609.0,1455.0,1477.0,1717.0,1622.0,1634.0,1644.0,18697.0
Jamnagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,140.0,0.0,0.0,141.0
Jamnagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,23.0,78.0,90.0,100.0,90.0,67.0,71.0,64.0,123.0,191.0,227.0,206.0,1330.0
Jamnagar,13.1,Number of Patients operated for cataract,TOTAL,25.0,37.0,68.0,83.0,61.0,69.0,40.0,52.0,101.0,75.0,61.0,17.0,689.0
Jamnagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,25.0,37.0,68.0,83.0,61.0,69.0,40.0,52.0,101.0,75.0,61.0,17.0,689.0
Jamnagar,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,13.5,Number of eyes collected through eye donation,TOTAL,6.0,6.0,6.0,8.0,14.0,20.0,4.0,10.0,10.0,10.0,6.0,14.0,114.0
Jamnagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,4.0,5.0,5.0,5.0,7.0,-1.0
Jamnagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,27.0,25.0,26.0,26.0,25.0,27.0,26.0,26.0,25.0,22.0,22.0,23.0,-1.0
Jamnagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,232.0,232.0,189.0,227.0,234.0,222.0,204.0,228.0,197.0,240.0,186.0,180.0,-1.0
Jamnagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,6.0,6.0,6.0,6.0,6.0,6.0,5.0,6.0,6.0,6.0,8.0,-1.0
Jamnagar,14.05,Number of RKS meetings held during the month,TOTAL,6.0,3.0,4.0,3.0,2.0,2.0,3.0,3.0,3.0,4.0,2.0,7.0,42.0
Jamnagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,37.0,37.0,36.0,37.0,36.0,38.0,38.0,37.0,37.0,35.0,35.0,37.0,-1.0
Jamnagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,79.0,59.0,52.0,24.0,29.0,71.0,96.0,90.0,63.0,73.0,55.0,52.0,743.0
Jamnagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,8.0,8.0,8.0,8.0,8.0,8.0,8.0,7.0,8.0,8.0,9.0,11.0,-1.0
Jamnagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Jamnagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,7490.0,7310.0,7821.0,8412.0,9221.0,8752.0,7946.0,8085.0,8898.0,8816.0,9337.0,9180.0,101268.0
Jamnagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,18062.0,19728.0,20621.0,20775.0,21134.0,22129.0,20617.0,21233.0,19526.0,19333.0,20494.0,21677.0,245329.0
Jamnagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,5496.0,5875.0,5799.0,6252.0,6849.0,6381.0,5829.0,6288.0,7027.0,7031.0,7315.0,7241.0,77383.0
Jamnagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,22585.0,24748.0,25817.0,26957.0,25504.0,30451.0,24727.0,26589.0,24931.0,24751.0,25412.0,26324.0,308796.0
Jamnagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,12986.0,13185.0,13620.0,14664.0,16070.0,15133.0,13775.0,14373.0,15925.0,15847.0,16652.0,16421.0,178651.0
Jamnagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,40647.0,44476.0,46438.0,47732.0,46638.0,52580.0,45344.0,47822.0,44457.0,44084.0,45906.0,48001.0,554125.0
Jamnagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,77.0,88.0,82.0,75.0,82.0,97.0,84.0,64.0,70.0,88.0,73.0,79.0,959.0
Jamnagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,65.0,71.0,63.0,60.0,65.0,74.0,77.0,56.0,74.0,72.0,61.0,69.0,807.0
Jamnagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,142.0,159.0,145.0,135.0,147.0,171.0,161.0,120.0,144.0,160.0,134.0,148.0,1766.0
Jamnagar,14.11,In-Patient Head Count at midnight,TOTAL,599.0,511.0,524.0,639.0,834.0,925.0,588.0,936.0,644.0,1032.0,910.0,1107.0,9249.0
Jamnagar,14.12.1,OPD attendance (All),TOTAL,96374.0,97579.0,106749.0,114984.0,117139.0,124548.0,107323.0,112264.0,113309.0,112328.0,122831.0,134683.0,1360111.0
Jamnagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,480.0,551.0,537.0,564.0,589.0,614.0,464.0,539.0,668.0,642.0,593.0,503.0,6744.0
Jamnagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2669.0,2106.0,1860.0,1968.0,2015.0,2162.0,2164.0,2034.0,2002.0,2246.0,1927.0,1915.0,25068.0
Jamnagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,12.0
Jamnagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,286.0,0.0,335.0,275.0,261.0,301.0,312.0,262.0,192.0,0.0,0.0,0.0,2224.0
Jamnagar,14.14.c,Number of Adolescents counselled,TOTAL,2133.0,1836.0,1825.0,1901.0,1869.0,1942.0,2035.0,1940.0,2044.0,1516.0,2039.0,2076.0,23156.0
Jamnagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5088.0,3378.0,3652.0,5680.0,3793.0,4141.0,5550.0,3986.0,4299.0,5603.0,4257.0,4440.0,53867.0
Jamnagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,231.0,273.0,294.0,373.0,324.0,263.0,196.0,233.0,396.0,275.0,215.0,28.0,3101.0
Jamnagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,609.0,567.0,650.0,679.0,506.0,725.0,668.0,586.0,465.0,421.0,396.0,351.0,6623.0
Jamnagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,1.0,2.0,2.0,3.0,3.0,2.0,3.0,2.0,2.0,0.0,0.0,21.0
Jamnagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,389.0,324.0,529.0,382.0,290.0,303.0,229.0,246.0,272.0,209.0,249.0,165.0,3587.0
Jamnagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,5.0,21.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,1.0,0.0,35.0
Jamnagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,386.0,325.0,353.0,409.0,216.0,325.0,291.0,296.0,320.0,245.0,235.0,295.0,3696.0
Jamnagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,12.0,12.0,42.0,38.0,11.0,20.0,25.0,20.0,10.0,11.0,13.0,9.0,223.0
Jamnagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1384.0,1216.0,1532.0,1470.0,1012.0,1353.0,1188.0,1128.0,1057.0,875.0,880.0,811.0,13906.0
Jamnagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,15.0,18.0,65.0,41.0,15.0,24.0,28.0,23.0,13.0,14.0,14.0,9.0,279.0
Jamnagar,15.2,Number of Widal tests conducted,Number tested,0.0,10.0,14.0,3.0,3.0,4.0,4.0,3.0,1.0,3.0,3.0,0.0,48.0
Jamnagar,15.3.a,Number of VDRL tests conducted on males,Number tested,156.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,156.0
Jamnagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,96.0,3.0,3.0,4.0,2.0,3.0,3.0,3.0,0.0,0.0,0.0,0.0,117.0
Jamnagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,62.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,64.0
Jamnagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,314.0,3.0,3.0,4.0,2.0,3.0,3.0,3.0,0.0,2.0,0.0,0.0,337.0
Jamnagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,10841.0,12082.0,15449.0,17947.0,20344.0,21730.0,15932.0,18198.0,15849.0,13290.0,15127.0,14611.0,191400.0
Jamnagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,28.0,30.0,58.0,41.0,50.0,63.0,63.0,55.0,40.0,26.0,23.0,18.0,495.0
Jamnagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,11.0,4.0,1.0,7.0,23.0,33.0,25.0,20.0,5.0,1.0,0.0,132.0
Jamnagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,8660.0,5860.0,3800.0,5300.0,10900.0,13250.0,14050.0,16550.0,19700.0,14300.0,16600.0,21720.0,150690.0
Jamnagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2500.0,2500.0,5000.0,10000.0,10000.0,12500.0,10000.0,10000.0,0.0,10000.0,10000.0,0.0,82500.0
Jamnagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,5300.0,4560.0,6900.0,4400.0,7650.0,11700.0,7500.0,6850.0,5400.0,7700.0,4880.0,6120.0,78960.0
Jamnagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,5860.0,3800.0,1900.0,10900.0,13250.0,14050.0,16550.0,19700.0,14300.0,16600.0,21720.0,15600.0,154230.0
Jamnagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,15040.0,18780.0,10230.0,14850.0,12000.0,15450.0,12000.0,7650.0,16100.0,302400.0,16050.0,20000.0,460550.0
Jamnagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,12000.0,0.0,12000.0,6000.0,12000.0,9000.0,0.0,15000.0,12000.0,0.0,9000.0,6000.0,93000.0
Jamnagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,9200.0,8550.0,16230.0,8850.0,8550.0,8200.0,4350.0,6550.0,10100.0,279760.0,5050.0,7500.0,372890.0
Jamnagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,17840.0,10230.0,6000.0,12000.0,15450.0,16250.0,7650.0,16100.0,18000.0,22640.0,20000.0,18500.0,180660.0
Jamnagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,49560.0,39700.0,24000.0,27200.0,29300.0,30800.0,30900.0,20100.0,31500.0,302400.0,22640.0,42940.0,651040.0
Jamnagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,20000.0,20000.0,20000.0,20000.0,10000.0,30000.0,290000.0,0.0,280000.0,0.0,690000.0
Jamnagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,9860.0,15700.0,34700.0,17900.0,18500.0,19900.0,20800.0,18600.0,19100.0,279760.0,259700.0,10900.0,725420.0
Jamnagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,39700.0,24000.0,9300.0,29300.0,30800.0,30900.0,20100.0,31500.0,302400.0,22640.0,42940.0,32040.0,615620.0
Jamnagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,19550.0,18000.0,18700.0,30550.0,25250.0,25550.0,26200.0,30300.0,29050.0,25750.0,19160.0,24760.0,292820.0
Jamnagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,15000.0,10000.0,20000.0,0.0,10000.0,10000.0,12000.0,16000.0,10000.0,10000.0,10000.0,0.0,123000.0
Jamnagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,16550.0,9300.0,11150.0,5300.0,9700.0,9350.0,7900.0,17250.0,13300.0,16590.0,4400.0,5400.0,126190.0
Jamnagar,16.1.3,Stock position of TT vaccines,5. Total Stock,18000.0,18700.0,27550.0,25250.0,25550.0,26200.0,30300.0,29050.0,25750.0,19160.0,24760.0,19360.0,289630.0
Jamnagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18000.0,0.0,0.0,18000.0
Jamnagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0,0.0,0.0,9000.0
Jamnagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10950.0,0.0,0.0,10950.0
Jamnagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16050.0,0.0,0.0,16050.0
Jamnagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,5020.0,6950.0,6980.0,7520.0,8250.0,12700.0,17950.0,18150.0,15500.0,17000.0,16650.0,18700.0,151370.0
Jamnagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,4500.0,4500.0,4500.0,4500.0,9000.0,9000.0,4500.0,4500.0,4500.0,4500.0,4500.0,4500.0,63000.0
Jamnagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2570.0,4470.0,7730.0,3770.0,4550.0,3750.0,4300.0,7150.0,3000.0,4850.0,2450.0,3590.0,52180.0
Jamnagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,6950.0,6980.0,3750.0,8250.0,12700.0,17950.0,18150.0,15500.0,17000.0,16650.0,18700.0,19610.0,162190.0
Jamnagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,8620.0,5520.0,3200.0,5050.0,5000.0,4000.0,10450.0,9950.0,5450.0,10300.0,7350.0,11400.0,86290.0
Jamnagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,2500.0,5000.0,5000.0,4000.0,15000.0,7500.0,2500.0,10000.0,5000.0,10000.0,5000.0,74500.0
Jamnagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,6100.0,4820.0,7900.0,5050.0,5000.0,8550.0,8000.0,7500.0,5150.0,7950.0,5950.0,6700.0,78670.0
Jamnagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,5520.0,3200.0,300.0,5000.0,4000.0,10450.0,9950.0,4950.0,10300.0,7350.0,11400.0,9700.0,82120.0
Jamnagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5080.0,8080.0,4220.0,7220.0,6720.0,6220.0,6220.0,7470.0,5450.0,2400.0,5150.0,2050.0,66280.0
Jamnagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,0.0,3000.0,0.0,3000.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,12000.0
Jamnagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,3860.0,500.0,500.0,3500.0,0.0,1750.0,2020.0,3050.0,250.0,0.0,350.0,15780.0
Jamnagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,8080.0,4220.0,6720.0,6720.0,6220.0,6220.0,7470.0,5450.0,2400.0,2150.0,5150.0,1700.0,62500.0
Jamnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,150.0,1050.0,1050.0,1050.0,1050.0,1050.0,1050.0,1050.0,1100.0,750.0,750.0,750.0,10850.0
Jamnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,15600.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,6300.0,0.0,0.0,27900.0
Jamnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,14700.0,0.0,0.0,0.0,0.0,0.0,0.0,5950.0,250.0,6300.0,0.0,0.0,27200.0
Jamnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1050.0,1050.0,1050.0,1050.0,1050.0,1050.0,1050.0,1100.0,850.0,750.0,750.0,750.0,11550.0
Jamnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,18480.0,0.0,0.0,0.0,44100.0,0.0,0.0,0.0,0.0,0.0,0.0,62580.0
Jamnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,50400.0,0.0,0.0,100800.0,252000.0,0.0,0.0,0.0,0.0,86160.0,0.0,0.0,489360.0
Jamnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,31920.0,18480.0,0.0,100800.0,207900.0,4100.0,0.0,0.0,0.0,86160.0,0.0,0.0,449360.0
Jamnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,18480.0,0.0,0.0,0.0,44100.0,40000.0,0.0,0.0,0.0,0.0,0.0,0.0,102580.0
Jamnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,220.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,6220.0
Jamnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,6000.0,0.0,0.0,30000.0,0.0,0.0,0.0,60000.0,0.0,0.0,0.0,0.0,96000.0
Jamnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,5780.0,220.0,0.0,30000.0,0.0,0.0,0.0,54000.0,6000.0,0.0,0.0,0.0,96000.0
Jamnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,220.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,6220.0
Jamnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2000.0,120.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2120.0
Jamnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,1880.0,120.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Jamnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,120.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,120.0
Jamnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4200.0,8622.0,8422.0,7900.0,12250.0,12250.0,12250.0,9950.0,5950.0,0.0,5150.0,5150.0,92094.0
Jamnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,4422.0,0.0,0.0,4350.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8772.0
Jamnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,200.0,522.0,0.0,0.0,0.0,2300.0,4000.0,500.0,0.0,0.0,0.0,7522.0
Jamnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,8622.0,8422.0,7900.0,12250.0,12250.0,12250.0,9950.0,5950.0,5450.0,0.0,5150.0,5150.0,93344.0
Jamnagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,8.0,8.0,88.0,88.0,88.0,82.0,82.0,53.0,4.0,4.0,2.0,2.0,509.0
Jamnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,80.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,85.0
Jamnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,6.0,0.0,29.0,49.0,0.0,2.0,0.0,3.0,89.0
Jamnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,8.0,88.0,88.0,88.0,82.0,82.0,53.0,4.0,4.0,2.0,2.0,4.0,505.0
Jamnagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,500000.0,21000.0,0.0,0.0,298000.0,121000.0,,0.0,0.0,0.0,0.0,0.0,940000.0
Jamnagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,298000.0,700000.0,0.0,300000.0,0.0,0.0,0.0,0.0,0.0,1298000.0
Jamnagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,479000.0,21000.0,0.0,0.0,877000.0,121000.0,300000.0,0.0,0.0,0.0,0.0,0.0,1798000.0
Jamnagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,21000.0,0.0,0.0,298000.0,121000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,440000.0
Jamnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Jamnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,2280.0,0.0,0.0,0.0,4280.0
Jamnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,1950.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Jamnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,50.0,0.0,0.0,0.0,2280.0,0.0,0.0,0.0,2330.0
Jamnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,186.0,0.0,0.0,0.0,286.0
Jamnagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,1400.0,1900.0,0.0,0.0,0.0,0.0,3300.0
Jamnagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,1300.0,1814.0,186.0,0.0,0.0,0.0,3300.0
Jamnagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,100.0,186.0,0.0,0.0,0.0,0.0,286.0
Jamnagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,16000.0,0.0,4000.0,0.0,0.0,0.0,20000.0
Jamnagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,51000.0,0.0,51000.0,0.0,0.0,0.0,0.0,102000.0
Jamnagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,35000.0,16000.0,47000.0,4000.0,0.0,0.0,0.0,102000.0
Jamnagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,16000.0,0.0,4000.0,0.0,0.0,0.0,0.0,20000.0
Jamnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,500.0,500.0,500.0,300.0,200.0,200.0,200.0,200.0,200.0,0.0,0.0,0.0,2800.0
Jamnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,26400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26400.0
Jamnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,200.0,26500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26700.0
Jamnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,500.0,500.0,300.0,200.0,200.0,200.0,200.0,200.0,200.0,0.0,0.0,0.0,2500.0
Jamnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,200000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200000.0
Jamnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,200000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200000.0
Jamnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamnagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,1.0,1.0,,,1.0,,1.0,1.0,,,,6.0
Jamnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jamnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jamnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Jamnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,,,,,,1.0,,1.0,1.0,2.0,6.0
Jamnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jamnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,,,,,,1.0,,1.0,1.0,2.0,6.0
Jamnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,6.0,7.0,8.0,5.0,2.0,6.0,4.0,,2.0,7.0,9.0,60.0
Jamnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,3.0,,,4.0
Jamnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,6.0,7.0,8.0,5.0,2.0,7.0,4.0,,5.0,7.0,9.0,64.0
Jamnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,6.0,14.0,8.0,5.0,8.0,12.0,14.0,9.0,8.0,5.0,10.0,103.0
Jamnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jamnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,6.0,14.0,8.0,5.0,8.0,12.0,14.0,9.0,8.0,5.0,10.0,103.0
Jamnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,1.0,1.0,,,,1.0,2.0,,5.0
Jamnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,1.0,1.0,,,,1.0,2.0,,5.0
Jamnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jamnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Jamnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jamnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Jamnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jamnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Jamnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,4.0,4.0,5.0,2.0,3.0,5.0,3.0,2.0,5.0,4.0,7.0,4.0,48.0
Jamnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,1.0,1.0,,,1.0,1.0,1.0,1.0,,,7.0
Jamnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,5.0,6.0,3.0,3.0,5.0,4.0,3.0,6.0,5.0,7.0,4.0,55.0
Jamnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Jamnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Jamnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Jamnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,1.0,,1.0,1.0,1.0,1.0,1.0,1.0,,1.0,8.0
Jamnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,,,,,,1.0,,1.0,,,,4.0
Jamnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,,1.0,,1.0,1.0,2.0,1.0,2.0,1.0,,1.0,12.0
Jamnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,,1.0,,1.0,3.0,,,,1.0,1.0,9.0
Jamnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,5.0,,,2.0,,2.0,,1.0,2.0,3.0,16.0
Jamnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,2.0,5.0,1.0,,3.0,3.0,2.0,,1.0,3.0,4.0,25.0
Jamnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Jamnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Jamnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Jamnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,,,,1.0,,,,1.0,1.0,4.0
Jamnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,2.0,1.0,,2.0,2.0,3.0,1.0,,4.0,7.0,1.0,25.0
Jamnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,3.0,1.0,,2.0,2.0,4.0,1.0,,4.0,8.0,2.0,29.0
Jamnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Jamnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Jamnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,1.0,,,,,,1.0
Jamnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,2.0,,,,,,2.0
Jamnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,6.0,8.0,6.0,8.0,6.0,7.0,7.0,13.0,3.0,6.0,5.0,12.0,87.0
Jamnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,4.0,18.0,9.0,4.0,13.0,16.0,13.0,10.0,13.0,18.0,13.0,19.0,150.0
Jamnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,10.0,26.0,15.0,12.0,19.0,23.0,22.0,23.0,16.0,24.0,18.0,31.0,239.0
Jamnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,1.0,,1.0,,,2.0
Jamnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,2.0,,3.0,1.0,,1.0,2.0,9.0
Jamnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,2.0,,4.0,1.0,1.0,1.0,2.0,11.0
Jamnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Jamnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Jamnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Jamnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Jamnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Jamnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Jamnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,1.0,,1.0,2.0
Jamnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Jamnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,1.0,,1.0,2.0
Jamnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Jamnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Jamnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,,,,,,,1.0
Jamnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Jamnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Jamnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Jamnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,,,2.0,1.0,1.0,2.0,1.0,4.0,,4.0,16.0
Jamnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Jamnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,,,2.0,1.0,1.0,2.0,1.0,4.0,,4.0,16.0
Jamnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,,,1.0,,,,,1.0,2.0,6.0
Jamnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,3.0,9.0,1.0,3.0,8.0,5.0,5.0,3.0,7.0,7.0,10.0,64.0
Jamnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,2.0,1.0,1.0,1.0,2.0,2.0,2.0,,1.0,3.0,1.0,16.0
Jamnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,6.0,11.0,2.0,4.0,11.0,7.0,7.0,3.0,8.0,11.0,13.0,86.0
Jamnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,,,,,,,,,1.0,,2.0
Jamnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,3.0,7.0,1.0,5.0,4.0,1.0,2.0,2.0,7.0,3.0,2.0,41.0
Jamnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,,,2.0,1.0,1.0,,1.0,,2.0,1.0,9.0
Jamnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,6.0,3.0,7.0,1.0,7.0,5.0,2.0,2.0,3.0,7.0,6.0,3.0,52.0
Jamnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Jamnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,,,1.0,1.0,,,,,,,3.0
Jamnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Jamnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,,1.0,1.0,1.0,,,,,,,4.0
Jamnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Jamnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,1.0,1.0,2.0,1.0,2.0,2.0,,1.0,1.0,,11.0
Jamnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,2.0,2.0,2.0,3.0,,1.0,3.0,3.0,,,,16.0
Jamnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,2.0,3.0,3.0,5.0,1.0,4.0,5.0,3.0,1.0,1.0,,28.0
Jamnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Jamnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,4.0,,2.0,5.0,6.0,1.0,2.0,2.0,,2.0,25.0
Jamnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,2.0,6.0,3.0,2.0,7.0,5.0,2.0,7.0,8.0,1.0,3.0,48.0
Jamnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,2.0,10.0,3.0,4.0,12.0,11.0,3.0,9.0,11.0,1.0,5.0,74.0
Jamnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,1.0,,1.0,,2.0,1.0,,5.0
Jamnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,3.0,5.0,9.0,4.0,2.0,3.0,3.0,9.0,11.0,8.0,7.0,11.0,75.0
Jamnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,24.0,16.0,20.0,21.0,34.0,39.0,13.0,25.0,28.0,24.0,35.0,39.0,318.0
Jamnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,27.0,21.0,29.0,25.0,36.0,43.0,16.0,35.0,39.0,34.0,43.0,50.0,398.0
Junagadh,1.1,Total number of pregnant women Registered for ANC,TOTAL,2822.0,2721.0,2940.0,2893.0,2669.0,3191.0,2819.0,3352.0,2529.0,2381.0,2696.0,2271.0,33284.0
Junagadh,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2040.0,1863.0,2007.0,1711.0,1939.0,2024.0,2063.0,2130.0,1790.0,1639.0,1887.0,1498.0,22591.0
Junagadh,1.2,Number of Pregnant women registered under JSY,TOTAL,538.0,449.0,568.0,537.0,487.0,584.0,527.0,469.0,448.0,437.0,553.0,443.0,6040.0
Junagadh,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2166.0,2233.0,2278.0,2604.0,2129.0,2626.0,2189.0,1881.0,2003.0,1743.0,1974.0,1608.0,25434.0
Junagadh,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1971.0,1874.0,2068.0,1846.0,1615.0,1953.0,1767.0,1632.0,1444.0,1468.0,1784.0,1427.0,20849.0
Junagadh,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1869.0,1995.0,1995.0,2048.0,1709.0,1859.0,1990.0,1578.0,1713.0,1470.0,1832.0,1671.0,21729.0
Junagadh,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1663.0,1812.0,1835.0,1789.0,1716.0,1983.0,1707.0,1843.0,1371.0,1482.0,1846.0,1542.0,20589.0
Junagadh,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,25.0,38.0,29.0,35.0,37.0,40.0,26.0,43.0,18.0,23.0,21.0,20.0,355.0
Junagadh,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,10.0,30.0,4.0,15.0,12.0,35.0,18.0,18.0,20.0,5.0,9.0,0.0,176.0
Junagadh,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1029.0,1039.0,1266.0,1114.0,1046.0,1185.0,1030.0,903.0,872.0,832.0,1077.0,1393.0,12786.0
Junagadh,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,54.0,133.0,78.0,262.0,43.0,137.0,48.0,50.0,14.0,2.0,22.0,11.0,854.0
Junagadh,1.8,Number of pregnancy test kits used at SC level,TOTAL,721.0,685.0,597.0,558.0,539.0,744.0,694.0,857.0,758.0,784.0,916.0,844.0,8697.0
Junagadh,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,10.0,2.0,2.0,9.0,15.0,5.0,6.0,7.0,8.0,7.0,1.0,3.0,75.0
Junagadh,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,7.0,13.0,12.0,14.0,7.0,6.0,15.0,11.0,7.0,3.0,16.0,8.0,119.0
Junagadh,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,17.0,15.0,14.0,23.0,22.0,11.0,21.0,18.0,15.0,10.0,17.0,11.0,194.0
Junagadh,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,16.0,14.0,14.0,23.0,18.0,11.0,21.0,14.0,14.0,10.0,15.0,10.0,180.0
Junagadh,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,1.0,0.0,0.0,2.0,5.0,4.0,0.0,4.0,0.0,0.0,16.0
Junagadh,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,799.0,900.0,863.0,826.0,973.0,920.0,1024.0,1014.0,1115.0,965.0,834.0,914.0,11147.0
Junagadh,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,556.0,574.0,571.0,554.0,677.0,560.0,732.0,692.0,772.0,761.0,646.0,748.0,7843.0
Junagadh,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,299.0,331.0,324.0,324.0,164.0,158.0,127.0,118.0,184.0,125.0,193.0,140.0,2487.0
Junagadh,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,14.0,16.0,13.0,19.0,7.0,17.0,19.0,18.0,49.0,33.0,43.0,22.0,270.0
Junagadh,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,12.0,16.0
Junagadh,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,786.0,736.0,641.0,688.0,919.0,837.0,851.0,732.0,786.0,622.0,621.0,707.0,8926.0
Junagadh,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,1.0,13.0,6.0,3.0,1.0,2.0,0.0,3.0,1.0,3.0,2.0,3.0,38.0
Junagadh,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,150.0,151.0,174.0,155.0,169.0,171.0,165.0,163.0,152.0,145.0,115.0,107.0,1817.0
Junagadh,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Junagadh,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,151.0,164.0,180.0,158.0,170.0,173.0,165.0,166.0,153.0,148.0,117.0,110.0,1855.0
Junagadh,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,62.0,67.0,70.0,45.0,134.0,60.0,71.0,75.0,63.0,65.0,100.0,93.0,905.0
Junagadh,4.1.1.a,Number of male live births,TOTAL,929.0,935.0,902.0,891.0,1017.0,928.0,1025.0,925.0,1043.0,844.0,778.0,869.0,11086.0
Junagadh,4.1.1.b,Number of female live births,TOTAL,870.0,885.0,847.0,789.0,903.0,888.0,894.0,860.0,906.0,770.0,715.0,787.0,10114.0
Junagadh,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1799.0,1820.0,1749.0,1680.0,1920.0,1816.0,1919.0,1785.0,1949.0,1614.0,1493.0,1656.0,21200.0
Junagadh,4.1.2,Number of still births,TOTAL,18.0,24.0,27.0,9.0,27.0,10.0,24.0,23.0,27.0,16.0,14.0,19.0,238.0
Junagadh,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,37.0,38.0,47.0,24.0,42.0,30.0,65.0,31.0,23.0,36.0,37.0,35.0,445.0
Junagadh,4.2.1,Number of Newborns weighed at birth,TOTAL,1331.0,1646.0,1476.0,1412.0,1711.0,1428.0,1589.0,1458.0,1643.0,1444.0,1342.0,1513.0,17993.0
Junagadh,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,89.0,163.0,116.0,135.0,161.0,162.0,169.0,144.0,166.0,110.0,71.0,102.0,1588.0
Junagadh,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1236.0,1323.0,1442.0,1230.0,1517.0,1277.0,1476.0,1346.0,1452.0,1428.0,1329.0,1452.0,16508.0
Junagadh,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,5.0,5.0,3.0,3.0,4.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,23.0
Junagadh,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,80.0,86.0,86.0,94.0,100.0,110.0,126.0,109.0,137.0,134.0,82.0,90.0,1234.0
Junagadh,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,12.0,13.0,11.0,15.0,25.0,42.0,18.0,30.0,35.0,184.0,160.0,157.0,702.0
Junagadh,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Junagadh,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,97.0,104.0,100.0,112.0,129.0,152.0,145.0,140.0,172.0,318.0,243.0,247.0,1959.0
Junagadh,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,565.0,513.0,426.0,475.0,574.0,186.0,591.0,585.0,213.0,352.0,110.0,199.0,4789.0
Junagadh,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,13.0,31.0,9.0,9.0,12.0,20.0,22.0,20.0,21.0,6.0,13.0,14.0,190.0
Junagadh,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,585.0,545.0,498.0,547.0,617.0,204.0,731.0,716.0,236.0,373.0,587.0,224.0,5863.0
Junagadh,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,65.0,61.0,74.0,96.0,72.0,42.0,92.0,86.0,115.0,97.0,86.0,90.0,976.0
Junagadh,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1409.0,1401.0,1413.0,1294.0,1578.0,1372.0,1616.0,1600.0,1694.0,1590.0,1444.0,1728.0,18139.0
Junagadh,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1379.0,1327.0,1443.0,1319.0,1457.0,1430.0,1535.0,1290.0,1443.0,1593.0,1159.0,1362.0,16737.0
Junagadh,6.3,PNC maternal complications attended,TOTAL,11.0,2.0,2.0,2.0,1.0,1.0,1.0,3.0,1.0,18.0,17.0,9.0,68.0
Junagadh,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,10.0,4.0,7.0,3.0,2.0,9.0,6.0,6.0,5.0,52.0
Junagadh,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
Junagadh,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,1.0,10.0,4.0,7.0,3.0,2.0,9.0,6.0,6.0,6.0,54.0
Junagadh,7.2,Number of MTPs conducted at Private Facilities,TOTAL,5.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Junagadh,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,37.0,11.0,20.0,20.0,11.0,3.0,10.0,10.0,12.0,11.0,15.0,23.0,183.0
Junagadh,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,115.0,127.0,119.0,74.0,63.0,47.0,49.0,54.0,60.0,72.0,74.0,65.0,919.0
Junagadh,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,152.0,138.0,139.0,94.0,74.0,50.0,59.0,64.0,72.0,83.0,89.0,88.0,1102.0
Junagadh,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,16.0,14.0,17.0,15.0,19.0,21.0,22.0,17.0,20.0,19.0,22.0,18.0,220.0
Junagadh,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,3.0,1.0,1.0,0.0,0.0,1.0,7.0
Junagadh,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Junagadh,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Junagadh,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,3.0,1.0,1.0,0.0,1.0,1.0,8.0
Junagadh,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Junagadh,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,34.0,26.0,32.0,43.0,18.0,42.0,30.0,73.0,77.0,61.0,39.0,24.0,499.0
Junagadh,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,146.0,109.0,105.0,149.0,81.0,164.0,136.0,215.0,522.0,499.0,250.0,104.0,2480.0
Junagadh,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Junagadh,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,180.0,135.0,137.0,192.0,99.0,206.0,166.0,288.0,599.0,560.0,289.0,128.0,2979.0
Junagadh,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,32.0,27.0,30.0,26.0,34.0,42.0,32.0,44.0,42.0,30.0,37.0,34.0,410.0
Junagadh,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Junagadh,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,5.0,0.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Junagadh,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Junagadh,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Junagadh,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Junagadh,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1051.0,1175.0,1233.0,1363.0,1215.0,1392.0,1257.0,1134.0,1130.0,989.0,904.0,801.0,13644.0
Junagadh,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,73.0,88.0,64.0,83.0,98.0,68.0,10.0,27.0,30.0,16.0,16.0,15.0,588.0
Junagadh,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,76.0,63.0,41.0,51.0,42.0,52.0,50.0,40.0,39.0,51.0,46.0,47.0,598.0
Junagadh,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,9.0,10.0,20.0,41.0,20.0,41.0,11.0,18.0,50.0,40.0,15.0,23.0,298.0
Junagadh,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Junagadh,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1209.0,1336.0,1358.0,1538.0,1375.0,1553.0,1328.0,1219.0,1249.0,1096.0,981.0,886.0,15128.0
Junagadh,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,31.0,8.0,5.0,49.0,21.0,41.0,71.0,19.0,14.0,22.0,30.0,15.0,326.0
Junagadh,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,89.0,0.0,0.0,131.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,220.0
Junagadh,9.06,Number of IUCD removals,TOTAL,252.0,234.0,250.0,256.0,231.0,239.0,183.0,236.0,230.0,214.0,484.0,220.0,3029.0
Junagadh,9.07,Number of Oral Pills cycles distributed,TOTAL,6235.0,5010.0,6195.0,4471.0,4159.0,4318.0,3789.0,4539.0,4609.0,4848.0,4834.0,5368.0,58375.0
Junagadh,9.08,Number of Condom pieces distributed,TOTAL,35431.0,66566.0,54625.0,39909.0,37838.0,36343.0,37631.0,43128.0,42450.0,41793.0,40701.0,51360.0,527775.0
Junagadh,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,2.0,30.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,34.0
Junagadh,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,15.0,8.0,8.0,11.0,11.0,14.0,5.0,5.0,5.0,1.0,3.0,1.0,87.0
Junagadh,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Junagadh,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,3.0,1.0,0.0,0.0,0.0,4.0,0.0,6.0,1.0,16.0
Junagadh,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,9.12,Number of Institutions having NSV trained doctors,TOTAL,9.0,7.0,9.0,9.0,9.0,11.0,10.0,9.0,9.0,9.0,11.0,11.0,-1.0
Junagadh,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1906.0,1803.0,1920.0,1795.0,1967.0,1864.0,1978.0,1932.0,2096.0,1916.0,1786.0,1874.0,22837.0
Junagadh,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0,26.0,0.0,0.0,51.0
Junagadh,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,14.0,33.0,0.0,1.0,49.0
Junagadh,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,33.0,0.0,1.0,42.0
Junagadh,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1400.0,1552.0,1671.0,1554.0,1546.0,1297.0,1333.0,1509.0,1463.0,1469.0,1543.0,1454.0,17791.0
Junagadh,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1412.0,1477.0,1624.0,1555.0,1527.0,1299.0,1313.0,1332.0,1534.0,1414.0,1637.0,1453.0,17577.0
Junagadh,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1472.0,1549.0,1631.0,1587.0,1492.0,1253.0,1276.0,1337.0,1364.0,1437.0,1546.0,1572.0,17516.0
Junagadh,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1830.0,1762.0,1903.0,1472.0,2013.0,1886.0,2039.0,1951.0,2139.0,1920.0,1742.0,1875.0,22532.0
Junagadh,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1706.0,1620.0,1733.0,1650.0,1641.0,1619.0,1672.0,1573.0,1552.0,1502.0,1589.0,1514.0,19371.0
Junagadh,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1708.0,1523.0,1696.0,1625.0,1604.0,1644.0,1617.0,1372.0,1604.0,1462.0,1679.0,1507.0,19041.0
Junagadh,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1765.0,1591.0,1660.0,1661.0,1547.0,1563.0,1600.0,1387.0,1424.0,1474.0,1593.0,1627.0,18892.0
Junagadh,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,923.0,793.0,657.0,936.0,919.0,1053.0,1221.0,1121.0,1315.0,1190.0,1009.0,1373.0,12510.0
Junagadh,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,225.0,25.0,24.0,0.0,14.0,4.0,0.0,7.0,299.0
Junagadh,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,246.0,28.0,0.0,0.0,12.0,5.0,1.0,14.0,306.0
Junagadh,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,240.0,0.0,0.0,0.0,9.0,16.0,0.0,9.0,274.0
Junagadh,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1701.0,1615.0,1947.0,1801.0,1595.0,1776.0,1665.0,1405.0,1320.0,1364.0,1543.0,1434.0,19166.0
Junagadh,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1251.0,1364.0,1304.0,1285.0,1099.0,1363.0,1217.0,1237.0,1193.0,1163.0,1192.0,1209.0,14877.0
Junagadh,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,842.0,802.0,976.0,839.0,769.0,844.0,824.0,710.0,655.0,674.0,818.0,715.0,9468.0
Junagadh,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,709.0,723.0,803.0,785.0,677.0,748.0,697.0,600.0,560.0,626.0,776.0,621.0,8325.0
Junagadh,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1551.0,1525.0,1779.0,1624.0,1446.0,1592.0,1521.0,1310.0,1215.0,1300.0,1594.0,1336.0,17793.0
Junagadh,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1679.0,1677.0,1717.0,1685.0,1533.0,1655.0,1608.0,1317.0,1371.0,1354.0,1530.0,1401.0,18527.0
Junagadh,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1672.0,1669.0,1702.0,1690.0,1544.0,1652.0,1610.0,1317.0,1378.0,1347.0,1524.0,1395.0,18500.0
Junagadh,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,424.0,463.0,467.0,484.0,397.0,413.0,407.0,307.0,352.0,372.0,597.0,343.0,5026.0
Junagadh,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,345.0,393.0,391.0,367.0,350.0,344.0,309.0,273.0,302.0,301.0,523.0,306.0,4204.0
Junagadh,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,769.0,856.0,858.0,851.0,747.0,757.0,716.0,580.0,654.0,673.0,1120.0,649.0,9230.0
Junagadh,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,174.0,134.0,217.0,6071.0,5170.0,1860.0,254.0,366.0,155.0,38.0,138.0,136.0,14713.0
Junagadh,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,85.0,56.0,135.0,7247.0,5600.0,2095.0,280.0,286.0,199.0,33.0,104.0,121.0,16241.0
Junagadh,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,83.0,67.0,127.0,8284.0,5036.0,1410.0,448.0,379.0,193.0,27.0,86.0,116.0,16256.0
Junagadh,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,6.0,2.0,5.0,5.0,1.0,0.0,4.0,3.0,0.0,2.0,28.0
Junagadh,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,1.0,5.0,16.0,11.0,3.0,1.0,3.0,0.0,0.0,0.0,3.0,45.0
Junagadh,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1059.0,1014.0,1093.0,1074.0,1015.0,1061.0,1060.0,938.0,948.0,923.0,1048.0,956.0,12189.0
Junagadh,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1055.0,1013.0,1092.0,1068.0,1011.0,1046.0,1042.0,935.0,944.0,915.0,1043.0,948.0,12112.0
Junagadh,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,879.0,938.0,1024.0,1002.0,947.0,990.0,980.0,890.0,897.0,871.0,975.0,906.0,11299.0
Junagadh,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1582.0,1408.0,1791.0,1480.0,1682.0,1648.0,1536.0,1244.0,1110.0,1221.0,1509.0,1362.0,17573.0
Junagadh,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2173.0,71.0,31.0,10.0,1680.0,50.0,40.0,36.0,24.0,30.0,161.0,8158.0,12464.0
Junagadh,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,2120.0,17.0,0.0,0.0,761.0,8.0,20.0,0.0,0.0,0.0,93.0,7287.0,10306.0
Junagadh,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,7.0
Junagadh,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,4.0,5.0,0.0,0.0,11.0,12.0,24.0,13.0,0.0,0.0,18.0,86.0,173.0
Junagadh,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1545.0,1742.0,1732.0,1751.0,1770.0,1459.0,1425.0,1461.0,1454.0,1294.0,1490.0,1550.0,18673.0
Junagadh,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,32.0,17.0,17.0,5.0,5.0,0.0,2.0,5.0,2.0,3.0,2.0,7.0,97.0
Junagadh,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,2.0,77.0,46.0,113.0,83.0,98.0,113.0,91.0,95.0,0.0,73.0,122.0,913.0
Junagadh,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,88.0,55.0,68.0,211.0
Junagadh,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,86.0,55.0,66.0,207.0
Junagadh,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,8.0,141.0,54.0,65.0,58.0,58.0,43.0,198.0,1058.0,445.0,567.0,2695.0
Junagadh,13.4,Number of children provided free glasses,TOTAL,35.0,8.0,61.0,86.0,82.0,58.0,58.0,43.0,211.0,1058.0,445.0,567.0,2712.0
Junagadh,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0,8.0,30.0
Junagadh,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,3.0
Junagadh,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,6.0,6.0,6.0,6.0,7.0,9.0,7.0,7.0,7.0,6.0,5.0,-1.0
Junagadh,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,9.0,6.0,6.0,8.0,9.0,9.0,7.0,8.0,7.0,9.0,9.0,9.0,-1.0
Junagadh,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,257.0,249.0,271.0,358.0,274.0,264.0,262.0,272.0,261.0,261.0,238.0,262.0,-1.0
Junagadh,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,10.0,7.0,10.0,11.0,11.0,12.0,13.0,11.0,11.0,11.0,9.0,9.0,-1.0
Junagadh,14.05,Number of RKS meetings held during the month,TOTAL,5.0,6.0,24.0,9.0,4.0,16.0,5.0,4.0,17.0,6.0,5.0,20.0,121.0
Junagadh,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,24.0,25.0,25.0,28.0,26.0,27.0,30.0,28.0,28.0,30.0,28.0,26.0,-1.0
Junagadh,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,218.0,250.0,251.0,250.0,256.0,233.0,141.0,215.0,284.0,248.0,246.0,206.0,2798.0
Junagadh,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,3.0,3.0,4.0,5.0,4.0,3.0,4.0,4.0,4.0,-1.0
Junagadh,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,8.0,9.0,13.0,9.0,13.0,8.0,10.0,10.0,11.0,10.0,8.0,8.0,-1.0
Junagadh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,594.0,522.0,481.0,457.0,559.0,659.0,563.0,448.0,837.0,533.0,1523.0,1491.0,8667.0
Junagadh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1627.0,1779.0,2246.0,1660.0,1983.0,1907.0,1975.0,2101.0,5051.0,1791.0,4515.0,5684.0,32319.0
Junagadh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,672.0,577.0,487.0,439.0,541.0,642.0,628.0,487.0,1076.0,483.0,2163.0,985.0,9180.0
Junagadh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2470.0,2433.0,2593.0,2509.0,2679.0,3069.0,2872.0,2949.0,7600.0,2916.0,6041.0,7560.0,45691.0
Junagadh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1266.0,1099.0,968.0,896.0,1100.0,1301.0,1191.0,935.0,1913.0,1016.0,3686.0,2476.0,17847.0
Junagadh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4097.0,4212.0,4839.0,4169.0,4662.0,4976.0,4847.0,5050.0,12651.0,4707.0,10556.0,13244.0,78010.0
Junagadh,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,1.0,0.0,0.0,2.0,1.0,0.0,1.0,0.0,1.0,56.0,51.0,113.0
Junagadh,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,21.0,23.0,48.0
Junagadh,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,2.0,0.0,1.0,3.0,1.0,1.0,1.0,0.0,1.0,77.0,74.0,161.0
Junagadh,14.11,In-Patient Head Count at midnight,TOTAL,1181.0,803.0,681.0,800.0,866.0,850.0,717.0,794.0,781.0,698.0,8027.0,8400.0,24598.0
Junagadh,14.12.1,OPD attendance (All),TOTAL,69043.0,77747.0,77834.0,89402.0,95623.0,103679.0,90668.0,82472.0,89089.0,81344.0,140364.0,141377.0,1138642.0
Junagadh,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,39.0,73.0,30.0,76.0,34.0,76.0,38.0,102.0,163.0,100.0,367.0,151.0,1249.0
Junagadh,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,11.0,18.0,16.0,23.0,9.0,14.0,9.0,15.0,11.0,22.0,0.0,0.0,148.0
Junagadh,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,229.0,253.0,224.0,232.0,206.0,268.0,243.0,307.0,383.0,337.0,529.0,329.0,3540.0
Junagadh,14.14.a,Number of patients given AYUSH treatment,TOTAL,1284.0,1310.0,1257.0,1305.0,1552.0,1691.0,1500.0,1337.0,1371.0,1741.0,2284.0,1697.0,18329.0
Junagadh,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,128.0,142.0,270.0
Junagadh,14.14.c,Number of Adolescents counselled,TOTAL,59.0,61.0,55.0,57.0,58.0,35.0,38.0,2798.0,44.0,44.0,50.0,54.0,3353.0
Junagadh,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5923.0,6314.0,7304.0,7034.0,6517.0,7464.0,5330.0,6631.0,6138.0,6571.0,10619.0,12856.0,88701.0
Junagadh,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,55.0,53.0,77.0,87.0,77.0,67.0,33.0,63.0,72.0,68.0,312.0,312.0,1276.0
Junagadh,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,843.0,909.0,1200.0,1091.0,946.0,1026.0,810.0,866.0,842.0,924.0,1053.0,1018.0,11528.0
Junagadh,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,2.0,3.0,3.0,1.0,2.0,5.0,5.0,1.0,15.0,8.0,12.0,59.0
Junagadh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,561.0,674.0,705.0,732.0,595.0,681.0,557.0,711.0,776.0,876.0,1242.0,1217.0,9327.0
Junagadh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,2.0,0.0,1.0,1.0,1.0,2.0,2.0,0.0,8.0,7.0,5.0,29.0
Junagadh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1184.0,1221.0,1589.0,1357.0,1229.0,1384.0,1095.0,1170.0,1165.0,1543.0,1710.0,1926.0,16573.0
Junagadh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,39.0,52.0,68.0,39.0,33.0,66.0,69.0,40.0,61.0,36.0,32.0,71.0,606.0
Junagadh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2588.0,2804.0,3494.0,3180.0,2770.0,3091.0,2462.0,2747.0,2783.0,3343.0,4005.0,4161.0,37428.0
Junagadh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,41.0,56.0,71.0,43.0,35.0,69.0,76.0,47.0,62.0,59.0,47.0,88.0,694.0
Junagadh,15.2,Number of Widal tests conducted,Number tested,121.0,80.0,73.0,90.0,93.0,94.0,46.0,12.0,17.0,16.0,499.0,767.0,1908.0
Junagadh,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,1.0,0.0,0.0,6.0,4.0,5.0,112.0,96.0,224.0
Junagadh,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,24.0,0.0,1.0,0.0,11.0,0.0,0.0,0.0,84.0,55.0,175.0
Junagadh,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,112.0,142.0,222.0,173.0,138.0,123.0,61.0,42.0,27.0,83.0,604.0,596.0,2323.0
Junagadh,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,112.0,142.0,246.0,173.0,140.0,123.0,72.0,48.0,31.0,88.0,800.0,747.0,2722.0
Junagadh,15.4.1,Number of blood smears examined for Malaria,TOTAL,18295.0,22901.0,17358.0,19527.0,25773.0,27527.0,20229.0,20352.0,18840.0,16938.0,24975.0,25438.0,258153.0
Junagadh,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,21.0,30.0,37.0,56.0,49.0,59.0,44.0,72.0,78.0,16.0,12.0,757.0,1231.0
Junagadh,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,1.0,0.0,3.0,7.0,10.0,25.0,6.0,0.0,2.0,54.0
Junagadh,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,10330.0,570.0,12320.0,19690.0,48340.0,41300.0,4400.0,17190.0,9520.0,8320.0,12270.0,5830.0,190080.0
Junagadh,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1000.0,7500.0,15000.0,45000.0,10000.0,0.0,20000.0,0.0,5000.0,10000.0,,10000.0,123500.0
Junagadh,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Junagadh,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,10760.0,6630.0,7630.0,16350.0,17040.0,16550.0,7210.0,7670.0,6200.0,5550.0,6940.0,4820.0,113350.0
Junagadh,16.1.1,Stock position of DPT vaccines,5. Total Stock,570.0,1440.0,19690.0,48340.0,41300.0,24750.0,17190.0,9520.0,8320.0,12770.0,5330.0,11010.0,200230.0
Junagadh,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,17340.0,1200.0,35500.0,32475.0,35600.0,39290.0,8170.0,8070.0,11330.0,8860.0,13700.0,8630.0,220165.0
Junagadh,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,24000.0,9000.0,15000.0,15000.0,0.0,12000.0,15000.0,9000.0,15000.0,4500.0,15000.0,133500.0
Junagadh,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Junagadh,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,16140.0,9390.0,12025.0,11870.0,11310.0,11860.0,12100.0,11740.0,11470.0,10160.0,9570.0,11360.0,138995.0
Junagadh,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1200.0,15810.0,32475.0,35605.0,39290.0,27430.0,8070.0,11330.0,8860.0,13700.0,8630.0,12270.0,214670.0
Junagadh,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,51500.0,24720.0,54960.0,59800.0,64800.0,65220.0,6880.0,18900.0,7600.0,12280.0,2000.0,37900.0,406560.0
Junagadh,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,20000.0,30000.0,30000.0,25000.0,0.0,40000.0,15000.0,30000.0,0.0,41000.0,0.0,231000.0
Junagadh,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Junagadh,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,26780.0,23420.0,25160.0,25000.0,24580.0,27320.0,27980.0,26300.0,25320.0,10280.0,5100.0,10900.0,258140.0
Junagadh,16.1.2,Stock position of OPV vaccines,5. Total Stock,24720.0,21300.0,59800.0,64800.0,65220.0,37900.0,18900.0,7600.0,12280.0,2000.0,37900.0,27000.0,379420.0
Junagadh,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,22840.0,8060.0,37320.0,65840.0,96220.0,88580.0,30190.0,22830.0,11670.0,11330.0,17720.0,8860.0,421460.0
Junagadh,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,20000.0,40000.0,60000.0,20000.0,0.0,0.0,0.0,10000.0,15000.0,,15000.0,180000.0
Junagadh,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Junagadh,16.1.3,Stock position of TT vaccines,4. Stock Distributed,14780.0,9630.0,11480.0,29620.0,27640.0,26540.0,7360.0,11160.0,10340.0,8610.0,8860.0,11350.0,177370.0
Junagadh,16.1.3,Stock position of TT vaccines,5. Total Stock,8060.0,18430.0,65840.0,96220.0,88580.0,62040.0,22830.0,11670.0,11330.0,17720.0,8860.0,12510.0,424090.0
Junagadh,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,0.0,,,,,,0.0,,0.0,,,0.0
Junagadh,16.1.4,Stock position of DT vaccines,2. Stocks Received,,0.0,,,,,,0.0,,0.0,,,0.0
Junagadh,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,0.0,,,,,,0.0,,0.0,,,0.0
Junagadh,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,0.0,,,,,,0.0,,0.0,,,0.0
Junagadh,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,13860.0,7520.0,18290.0,19030.0,20290.0,27420.0,10950.0,11090.0,5450.0,6820.0,8070.0,9500.0,158290.0
Junagadh,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,6500.0,6500.0,6500.0,13000.0,0.0,6000.0,0.0,6500.0,6500.0,6500.0,6500.0,64500.0
Junagadh,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Junagadh,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6340.0,4690.0,5760.0,5240.0,5870.0,6030.0,5860.0,5640.0,5130.0,5250.0,5070.0,5260.0,66140.0
Junagadh,16.1.5,Stock position of BCG vaccines,5. Total Stock,7520.0,9330.0,19030.0,20290.0,27420.0,21390.0,11090.0,5450.0,6820.0,8070.0,9500.0,10740.0,156650.0
Junagadh,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,13400.0,4545.0,17520.0,18835.0,19980.0,16705.0,1000.0,6800.0,1000.0,8115.0,5050.0,7200.0,120150.0
Junagadh,16.1.6,Stock position of Measles vaccines,2. Stocks Received,750.0,10000.0,10000.0,10000.0,5000.0,5000.0,15000.0,2500.0,15000.0,5000.0,10000.0,10000.0,98250.0
Junagadh,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Junagadh,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,9605.0,7805.0,8685.0,8855.0,8275.0,9715.0,9200.0,8300.0,7885.0,8065.0,7850.0,7850.0,102090.0
Junagadh,16.1.6,Stock position of Measles vaccines,5. Total Stock,4545.0,6740.0,18835.0,19980.0,16705.0,11990.0,6800.0,1000.0,8115.0,5050.0,7200.0,9350.0,116310.0
Junagadh,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,0.0,,,,,,0.0,,0.0,,,0.0
Junagadh,16.1.7,Stock position of JE vaccines,2. Stocks Received,,0.0,,,,,,0.0,,0.0,,,0.0
Junagadh,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,0.0,,,,,,0.0,,0.0,,,0.0
Junagadh,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,0.0,,,,,,0.0,,0.0,,,0.0
Junagadh,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,280.0,160.0,5430.0,7550.0,9600.0,11390.0,7410.0,0.0,8430.0,6190.0,5370.0,4830.0,66640.0
Junagadh,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,730.0,3000.0,3000.0,3000.0,3000.0,0.0,3000.0,0.0,0.0,0.0,,0.0,15730.0
Junagadh,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Junagadh,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,850.0,760.0,880.0,950.0,1210.0,1170.0,910.0,0.0,2240.0,820.0,540.0,840.0,11170.0
Junagadh,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,160.0,2400.0,7550.0,9600.0,11390.0,10220.0,9500.0,0.0,6190.0,5370.0,4830.0,3990.0,71200.0
Junagadh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,18350.0,16650.0,13900.0,12800.0,9350.0,9150.0,6800.0,6300.0,12550.0,11550.0,21550.0,21450.0,160400.0
Junagadh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0,0.0,12000.0,,0.0,21000.0
Junagadh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,1700.0,2750.0,1100.0,3450.0,200.0,2350.0,500.0,2750.0,1000.0,2000.0,100.0,1550.0,19450.0
Junagadh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,16650.0,13900.0,12800.0,9350.0,9150.0,6800.0,6300.0,12550.0,11550.0,21550.0,21450.0,19900.0,161950.0
Junagadh,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,1854.0,1854.0,1854.0,1854.0,1800.0,1800.0,389880.0,164424.0,384420.0,164841.0,152427.0,115191.0,1382199.0
Junagadh,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,388080.0,0.0,378000.0,0.0,151200.0,,0.0,917280.0
Junagadh,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,54.0,0.0,0.0,225456.0,158004.0,219579.0,163614.0,37236.0,111882.0,915825.0
Junagadh,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,1854.0,1854.0,1854.0,1800.0,1800.0,389880.0,164424.0,384420.0,164841.0,152427.0,115191.0,3309.0,1383654.0
Junagadh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,322.0,322.0,322.0,322.0,300.0,300.0,48300.0,20972.0,61820.0,27429.0,97634.0,73666.0,331709.0
Junagadh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,48000.0,0.0,60000.0,0.0,96000.0,,0.0,204000.0
Junagadh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,22.0,0.0,0.0,27328.0,19152.0,34391.0,25795.0,23968.0,72556.0,203212.0
Junagadh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,322.0,322.0,322.0,300.0,300.0,48300.0,20972.0,61820.0,27429.0,97634.0,73666.0,1110.0,332497.0
Junagadh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,536.0,536.0,536.0,536.0,530.0,530.0,430.0,430.0,130.0,30.0,30.0,,4254.0
Junagadh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Junagadh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Junagadh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,6.0,0.0,100.0,0.0,300.0,100.0,0.0,,,506.0
Junagadh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,536.0,536.0,536.0,530.0,530.0,430.0,430.0,130.0,30.0,30.0,30.0,0.0,3748.0
Junagadh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4700.0,4600.0,4400.0,3700.0,3300.0,3200.0,2800.0,2700.0,2500.0,1400.0,5500.0,,38800.0
Junagadh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,,,5000.0
Junagadh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Junagadh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,200.0,700.0,400.0,100.0,400.0,100.0,200.0,1100.0,900.0,400.0,,4500.0
Junagadh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4700.0,4400.0,3700.0,3300.0,3200.0,2800.0,2700.0,2500.0,1400.0,5500.0,5100.0,0.0,39300.0
Junagadh,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,5.0,5.0,1155.0,2155.0,225.0,225.0,225.0,225.0,125.0,75.0,50.0,50.0,4520.0
Junagadh,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,1250.0,2125.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,3375.0
Junagadh,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,100.0,1125.0,1930.0,0.0,0.0,0.0,100.0,50.0,25.0,,40.0,3370.0
Junagadh,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,5.0,1155.0,2155.0,225.0,225.0,225.0,225.0,125.0,75.0,50.0,50.0,10.0,4525.0
Junagadh,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,11225.0,8900.0,20175.0,14400.0,7675.0,23875.0,11475.0,11425.0,9250.0,8550.0,8550.0,8250.0,143750.0
Junagadh,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,11375.0,3500.0,0.0,17250.0,0.0,0.0,0.0,0.0,0.0,,0.0,32125.0
Junagadh,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.02,Stock Position of Gloves,4. Stock Distributed,2325.0,100.0,9275.0,6725.0,1050.0,12400.0,50.0,2175.0,700.0,0.0,300.0,400.0,35500.0
Junagadh,16.3.02,Stock Position of Gloves,5. Total Stock,8900.0,20175.0,14400.0,7675.0,23875.0,11475.0,11425.0,9250.0,8550.0,8550.0,8250.0,7850.0,140375.0
Junagadh,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,57.0,46.0,112.0
Junagadh,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,57.0,,0.0,57.0
Junagadh,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,29.0,40.0
Junagadh,16.3.03,Stock Position of MVA Syringes,5. Total Stock,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,57.0,46.0,17.0,129.0
Junagadh,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,8500.0,7500.0,18600.0,3100.0,3100.0,13100.0,7700.0,4700.0,4700.0,32500.0,5900.0,5900.0,115300.0
Junagadh,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,14100.0,0.0,0.0,10000.0,4400.0,0.0,0.0,38000.0,0.0,,0.0,66500.0
Junagadh,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,1000.0,3000.0,15500.0,0.0,0.0,9800.0,3000.0,0.0,10200.0,26600.0,,2100.0,71200.0
Junagadh,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,7500.0,18600.0,3100.0,3100.0,13100.0,7700.0,4700.0,4700.0,32500.0,5900.0,5900.0,3800.0,110600.0
Junagadh,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Junagadh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,1.0,0.0,0.0,19.0,8.0,3.0,3.0,0.0,0.0,0.0,7.0,0.0,41.0
Junagadh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,70.0,,5.0,105.0
Junagadh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,11.0,11.0,5.0,0.0,3.0,0.0,0.0,63.0,2.0,0.0,95.0
Junagadh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,1.0,0.0,19.0,8.0,3.0,3.0,0.0,0.0,0.0,7.0,5.0,5.0,51.0
Junagadh,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,918600.0,918600.0,916600.0,272600.0,1316600.0,1310600.0,3726200.0,5181400.0,384000.0,193000.0,193000.0,2172000.0,17503200.0
Junagadh,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,1266000.0,0.0,3622000.0,1500000.0,0.0,0.0,0.0,1979000.0,0.0,8367000.0
Junagadh,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,2000.0,644000.0,222000.0,6000.0,1206400.0,44800.0,4797400.0,191000.0,0.0,,1997000.0,9110600.0
Junagadh,16.3.07,Stock Position of IFA Tablets,5. Total Stock,918600.0,916600.0,272600.0,1316600.0,1310600.0,3726200.0,5181400.0,384000.0,193000.0,193000.0,2172000.0,175000.0,16759600.0
Junagadh,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,445.0,395.0,365.0,365.0,365.0,365.0,3365.0,3365.0,470.0,50.0,6350.0,52340.0,68240.0
Junagadh,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,6300.0,52340.0,0.0,61640.0
Junagadh,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,50.0,30.0,0.0,0.0,0.0,0.0,0.0,2895.0,420.0,0.0,6350.0,50840.0,60585.0
Junagadh,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,395.0,365.0,365.0,365.0,365.0,3365.0,3365.0,470.0,50.0,6350.0,52340.0,1500.0,69295.0
Junagadh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,30.0,0.0,0.0,400.0,620.0,520.0,520.0,350.0,330.0,280.0,260.0,200.0,3510.0
Junagadh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,400.0,3600.0,0.0,0.0,0.0,0.0,0.0,0.0,,4400.0,8400.0
Junagadh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,3380.0,100.0,0.0,170.0,20.0,50.0,20.0,60.0,4450.0,8250.0
Junagadh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,30.0,0.0,400.0,620.0,520.0,520.0,350.0,330.0,280.0,260.0,200.0,150.0,3660.0
Junagadh,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,18.0,18.0,18.0,13.0,13.0,13.0,13.0,13.0,6.0,206.0,1196.0,1058.0,2585.0
Junagadh,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,3581.0,,0.0,3781.0
Junagadh,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,5.0,0.0,0.0,0.0,0.0,7.0,0.0,2591.0,138.0,912.0,3653.0
Junagadh,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,18.0,18.0,13.0,13.0,13.0,13.0,13.0,6.0,206.0,1196.0,1058.0,146.0,2713.0
Junagadh,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,50120.0,15820.0,15120.0,34620.0,18520.0,21760.0,80900.0,154220.0,31500.0,16200.0,15700.0,15200.0,469680.0
Junagadh,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,20000.0,0.0,5000.0,59880.0,76120.0,0.0,0.0,0.0,,10000.0,171000.0
Junagadh,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,34300.0,700.0,500.0,16100.0,1760.0,740.0,2800.0,122720.0,15300.0,500.0,500.0,2000.0,197920.0
Junagadh,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,15820.0,15120.0,34620.0,18520.0,21760.0,80900.0,154220.0,31500.0,16200.0,15700.0,15200.0,23200.0,442760.0
Junagadh,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,100.0,100.0,30.0,10290.0,4120.0,3910.0,3600.0,2800.0,2300.0,1300.0,17000.0,16100.0,61650.0
Junagadh,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,33000.0,0.0,0.0,0.0,0.0,0.0,0.0,16500.0,,0.0,49500.0
Junagadh,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,70.0,22740.0,6170.0,210.0,310.0,800.0,500.0,1000.0,800.0,900.0,1200.0,34700.0
Junagadh,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,100.0,30.0,10290.0,4120.0,3910.0,3600.0,2800.0,2300.0,1300.0,17000.0,16100.0,14900.0,76450.0
Junagadh,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,24200.0,24200.0,23800.0,23400.0,22000.0,22000.0,22000.0,19000.0,13000.0,10400.0,9200.0,6600.0,219800.0
Junagadh,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,400.0,400.0,1400.0,0.0,0.0,3000.0,6000.0,2600.0,1200.0,2600.0,4800.0,22400.0
Junagadh,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,24200.0,23800.0,23400.0,22000.0,22000.0,22000.0,19000.0,13000.0,10400.0,9200.0,6600.0,1800.0,197400.0
Junagadh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,300.0,300.0,300.0,3080.0,1370.0,1340.0,1340.0,1000.0,1000.0,700.0,600.0,500.0,11830.0
Junagadh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,6000.0
Junagadh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Junagadh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,3220.0,1710.0,30.0,0.0,340.0,0.0,300.0,100.0,100.0,400.0,6200.0
Junagadh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,300.0,300.0,3080.0,1370.0,1340.0,1340.0,1000.0,1000.0,700.0,600.0,500.0,100.0,11630.0
Junagadh,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,2.0,2.0,2.0,2.0,1.0,,2.0,,,,12.0
Junagadh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,1.0,,,,,,,2.0
Junagadh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,,,,,1.0
Junagadh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,2.0,1.0,,,,,,,3.0
Junagadh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,1.0,,1.0,2.0,1.0,2.0,3.0,1.0,3.0,1.0,,16.0
Junagadh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Junagadh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,1.0,,2.0,2.0,1.0,2.0,3.0,1.0,3.0,1.0,,17.0
Junagadh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,1.0,1.0,1.0,,3.0,,1.0,4.0,8.0,5.0,1.0,27.0
Junagadh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,1.0,1.0,,,,1.0,,1.0,,4.0
Junagadh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,1.0,1.0,2.0,1.0,3.0,,1.0,5.0,8.0,6.0,1.0,31.0
Junagadh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,3.0,2.0,2.0,3.0,2.0,4.0,2.0,5.0,2.0,4.0,3.0,36.0
Junagadh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,1.0,1.0,1.0,1.0,,,1.0,,1.0,7.0
Junagadh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,5.0,3.0,2.0,3.0,4.0,3.0,5.0,2.0,5.0,3.0,4.0,4.0,43.0
Junagadh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,1.0,,,,,,,,2.0
Junagadh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Junagadh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,1.0,,,,,,,,2.0
Junagadh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,1.0,1.0,,,,,,,,2.0
Junagadh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Junagadh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,1.0,,,,,,,,2.0
Junagadh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,,,,1.0,,2.0
Junagadh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Junagadh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,,,,,,,1.0,,2.0
Junagadh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Junagadh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Junagadh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Junagadh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,,,5.0,1.0,,1.0,2.0,2.0,4.0,3.0,3.0,23.0
Junagadh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,,,1.0,,,,,,,2.0
Junagadh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,,,5.0,1.0,1.0,1.0,2.0,2.0,4.0,3.0,3.0,25.0
Junagadh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Junagadh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,1.0,,,,1.0,2.0
Junagadh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,1.0,,,,1.0,2.0
Junagadh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,1.0,2.0,,3.0
Junagadh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,,,,1.0,2.0,,,,4.0
Junagadh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,,,,,1.0,2.0,1.0,2.0,,7.0
Junagadh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,2.0,,2.0,1.0,1.0,,,,,6.0
Junagadh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,13.0,6.0,9.0,7.0,11.0,4.0,6.0,6.0,3.0,7.0,3.0,5.0,80.0
Junagadh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,13.0,6.0,9.0,9.0,11.0,6.0,7.0,7.0,3.0,7.0,3.0,5.0,86.0
Junagadh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Junagadh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Junagadh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Junagadh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Junagadh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Junagadh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,1.0,,,,,,,,,1.0
Junagadh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Junagadh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Junagadh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,,,,,,,,,1.0
Junagadh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Junagadh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,7.0,2.0,2.0,1.0,9.0,4.0,14.0,11.0,12.0,6.0,10.0,11.0,89.0
Junagadh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,17.0,13.0,21.0,7.0,21.0,15.0,32.0,31.0,34.0,24.0,19.0,24.0,258.0
Junagadh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,24.0,15.0,23.0,8.0,30.0,19.0,46.0,42.0,46.0,31.0,29.0,35.0,348.0
Junagadh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Junagadh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,1.0,,2.0,,1.0,,1.0,5.0
Junagadh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,3.0,1.0,1.0,2.0,,,3.0,,,11.0
Junagadh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,,3.0,1.0,2.0,2.0,2.0,1.0,4.0,,1.0,17.0
Junagadh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Junagadh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Junagadh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Junagadh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Junagadh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Junagadh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,1.0,,,,,,,,,1.0
Junagadh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Junagadh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Junagadh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,,,,,,,,,,1.0
Junagadh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Junagadh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Junagadh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,,,,,,,,,1.0
Junagadh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Junagadh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Junagadh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Junagadh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,4.0,,,,,2.0,1.0,2.0,9.0
Junagadh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Junagadh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,4.0,,,,,2.0,1.0,2.0,9.0
Junagadh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Junagadh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,3.0,3.0,1.0,2.0,2.0,2.0,6.0,1.0,1.0,1.0,,22.0
Junagadh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,2.0,,2.0,,,4.0,3.0,,,,,12.0
Junagadh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,5.0,3.0,3.0,2.0,2.0,7.0,9.0,1.0,1.0,1.0,,35.0
Junagadh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,1.0,4.0,4.0,2.0,3.0,2.0,2.0,1.0,2.0,,3.0,28.0
Junagadh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,2.0,,,2.0,,,,,,1.0,1.0,6.0
Junagadh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,3.0,4.0,4.0,4.0,3.0,2.0,2.0,1.0,2.0,1.0,4.0,34.0
Junagadh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,,1.0,,,,,2.0
Junagadh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Junagadh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,,,1.0,,1.0,,,,,3.0
Junagadh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,1.0,,1.0,,,,,2.0
Junagadh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,1.0,,,,,1.0,2.0
Junagadh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,,2.0,1.0,,2.0,1.0,2.0,,,,1.0,10.0
Junagadh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,,2.0,1.0,,3.0,2.0,3.0,,,,2.0,14.0
Junagadh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Junagadh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,4.0,5.0,,2.0,3.0,4.0,2.0,3.0,1.0,1.0,26.0
Junagadh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,4.0,3.0,1.0,5.0,6.0,3.0,,4.0,10.0,2.0,4.0,,42.0
Junagadh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,3.0,5.0,10.0,6.0,5.0,3.0,8.0,12.0,5.0,5.0,1.0,68.0
Junagadh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,,,,,,1.0,,,,2.0
Junagadh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,10.0,5.0,4.0,1.0,9.0,3.0,6.0,9.0,6.0,3.0,3.0,3.0,62.0
Junagadh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,31.0,19.0,15.0,22.0,24.0,32.0,15.0,29.0,27.0,34.0,26.0,25.0,299.0
Junagadh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,41.0,24.0,20.0,23.0,33.0,35.0,21.0,38.0,34.0,37.0,29.0,28.0,363.0
Kachchh,1.1,Total number of pregnant women Registered for ANC,TOTAL,5281.0,4863.0,5565.0,5103.0,5173.0,5708.0,4365.0,4973.0,4459.0,4564.0,4538.0,4396.0,58988.0
Kachchh,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3704.0,3601.0,3790.0,3453.0,3445.0,3550.0,2810.0,3614.0,3031.0,3227.0,3142.0,2998.0,40365.0
Kachchh,1.2,Number of Pregnant women registered under JSY,TOTAL,1088.0,997.0,1072.0,1012.0,968.0,1138.0,939.0,1109.0,985.0,1046.0,1051.0,1105.0,12510.0
Kachchh,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4015.0,3616.0,4187.0,3765.0,4078.0,3962.0,3741.0,3994.0,3581.0,3428.0,3507.0,3465.0,45339.0
Kachchh,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3998.0,4085.0,4243.0,4212.0,4357.0,4807.0,3756.0,4286.0,3718.0,3621.0,3646.0,3497.0,48226.0
Kachchh,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4143.0,4105.0,4174.0,4254.0,4418.0,4873.0,4278.0,4353.0,3841.0,3574.0,3631.0,3618.0,49262.0
Kachchh,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4799.0,4347.0,4846.0,5110.0,5180.0,5177.0,5043.0,5109.0,4816.0,4455.0,4426.0,4313.0,57621.0
Kachchh,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,194.0,98.0,98.0,108.0,166.0,100.0,128.0,136.0,106.0,76.0,74.0,81.0,1365.0
Kachchh,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,9.0,21.0,2.0,33.0,3.0,16.0,12.0,17.0,8.0,1.0,0.0,123.0
Kachchh,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2359.0,1764.0,1882.0,1856.0,1972.0,2119.0,1917.0,2517.0,2329.0,2397.0,2334.0,2547.0,25993.0
Kachchh,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,54.0,70.0,58.0,76.0,99.0,103.0,67.0,35.0,37.0,77.0,43.0,59.0,778.0
Kachchh,1.8,Number of pregnancy test kits used at SC level,TOTAL,1147.0,415.0,207.0,422.0,857.0,1035.0,628.0,686.0,586.0,592.0,636.0,705.0,7916.0
Kachchh,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,151.0,144.0,171.0,56.0,67.0,18.0,10.0,7.0,7.0,10.0,6.0,12.0,659.0
Kachchh,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,439.0,71.0,134.0,44.0,81.0,20.0,17.0,35.0,15.0,20.0,23.0,21.0,920.0
Kachchh,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,590.0,215.0,305.0,100.0,148.0,38.0,27.0,42.0,22.0,30.0,29.0,33.0,1579.0
Kachchh,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,494.0,147.0,137.0,72.0,82.0,30.0,24.0,30.0,17.0,60.0,31.0,32.0,1156.0
Kachchh,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,483.0,105.0,167.0,53.0,61.0,9.0,9.0,12.0,6.0,5.0,7.0,8.0,925.0
Kachchh,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2048.0,2077.0,1668.0,1823.0,2274.0,2051.0,1934.0,1594.0,1399.0,1332.0,1175.0,1078.0,20453.0
Kachchh,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1647.0,1502.0,1284.0,1387.0,1920.0,1531.0,1456.0,867.0,835.0,804.0,685.0,722.0,14640.0
Kachchh,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,192.0,247.0,225.0,201.0,237.0,123.0,59.0,130.0,133.0,179.0,143.0,121.0,1990.0
Kachchh,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,110.0,77.0,156.0,75.0,63.0,9.0,20.0,29.0,26.0,13.0,3.0,5.0,586.0
Kachchh,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,2.0,2.0,0.0,0.0,10.0
Kachchh,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1736.0,1459.0,2059.0,1646.0,1826.0,2126.0,1651.0,1140.0,1201.0,805.0,480.0,510.0,16639.0
Kachchh,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,43.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,43.0
Kachchh,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,21.0,20.0,36.0,38.0,28.0,20.0,15.0,0.0,0.0,0.0,178.0
Kachchh,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,13.0,16.0
Kachchh,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,28.0,52.0,26.0,35.0,46.0,15.0,43.0,33.0,44.0,47.0,21.0,0.0,390.0
Kachchh,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,16.0,22.0,19.0,22.0,22.0,17.0,15.0,91.0,87.0,10.0,14.0,20.0,355.0
Kachchh,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kachchh,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,44.0,74.0,45.0,57.0,68.0,35.0,58.0,124.0,131.0,57.0,35.0,33.0,761.0
Kachchh,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,78.0,110.0,154.0,191.0,208.0,182.0,113.0,127.0,114.0,27.0,22.0,17.0,1343.0
Kachchh,4.1.1.a,Number of male live births,TOTAL,1741.0,2118.0,1909.0,1925.0,1921.0,2038.0,1749.0,1477.0,1490.0,1273.0,958.0,954.0,19553.0
Kachchh,4.1.1.b,Number of female live births,TOTAL,1733.0,1882.0,1734.0,1715.0,1845.0,1807.0,1618.0,1296.0,1328.0,1158.0,886.0,770.0,17772.0
Kachchh,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3474.0,4000.0,3643.0,3640.0,3766.0,3845.0,3367.0,2773.0,2818.0,2431.0,1844.0,1724.0,37325.0
Kachchh,4.1.2,Number of still births,TOTAL,93.0,102.0,208.0,153.0,83.0,85.0,52.0,39.0,48.0,29.0,19.0,35.0,946.0
Kachchh,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,148.0,122.0,208.0,116.0,116.0,91.0,59.0,67.0,55.0,64.0,61.0,72.0,1179.0
Kachchh,4.2.1,Number of Newborns weighed at birth,TOTAL,4009.0,4031.0,3894.0,3663.0,3830.0,3241.0,2766.0,2796.0,2694.0,2437.0,1981.0,2008.0,37350.0
Kachchh,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,738.0,322.0,459.0,407.0,354.0,351.0,251.0,299.0,293.0,235.0,162.0,189.0,4060.0
Kachchh,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,7989.0,4118.0,3862.0,3545.0,3961.0,3871.0,3427.0,2531.0,2566.0,2427.0,2040.0,2054.0,42391.0
Kachchh,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,2.0,2.0,3.0,0.0,0.0,5.0,0.0,0.0,1.0,0.0,2.0,16.0
Kachchh,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,120.0,75.0,73.0,89.0,110.0,60.0,20.0,72.0,30.0,28.0,48.0,72.0,797.0
Kachchh,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,18.0,25.0,24.0,30.0,12.0,24.0,20.0,8.0,12.0,20.0,21.0,24.0,238.0
Kachchh,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kachchh,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,139.0,102.0,99.0,122.0,122.0,84.0,45.0,80.0,42.0,49.0,69.0,98.0,1051.0
Kachchh,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,2.0,0.0,2.0,0.0,0.0,2.0,0.0,2.0,2.0,0.0,0.0,0.0,10.0
Kachchh,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,551.0,798.0,774.0,850.0,994.0,768.0,745.0,864.0,803.0,797.0,433.0,484.0,8861.0
Kachchh,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,109.0,143.0,4.0,153.0,283.0,136.0,12.0,97.0,238.0,5.0,2.0,8.0,1190.0
Kachchh,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,523.0,801.0,768.0,736.0,589.0,671.0,530.0,686.0,756.0,769.0,466.0,493.0,7788.0
Kachchh,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,14.0,27.0,16.0,56.0,20.0,9.0,13.0,17.0,9.0,21.0,14.0,11.0,227.0
Kachchh,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3420.0,3705.0,4197.0,3743.0,4144.0,3979.0,3513.0,3771.0,3318.0,3268.0,2809.0,3202.0,43069.0
Kachchh,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,3377.0,3330.0,3675.0,3454.0,3919.0,3853.0,3560.0,3840.0,3415.0,3449.0,2926.0,3172.0,41970.0
Kachchh,6.3,PNC maternal complications attended,TOTAL,5.0,31.0,303.0,245.0,5.0,66.0,55.0,28.0,13.0,210.0,3.0,8.0,972.0
Kachchh,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,6.0,1.0,1.0,4.0,3.0,3.0,7.0,20.0,17.0,4.0,0.0,2.0,68.0
Kachchh,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,2.0,0.0,0.0,0.0,1.0,0.0,15.0,64.0,0.0,0.0,0.0,0.0,82.0
Kachchh,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,8.0,1.0,1.0,4.0,4.0,3.0,22.0,84.0,17.0,4.0,0.0,2.0,150.0
Kachchh,7.2,Number of MTPs conducted at Private Facilities,TOTAL,1.0,0.0,2.0,5.0,0.0,0.0,0.0,2.0,2.0,1.0,0.0,0.0,13.0
Kachchh,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,37.0,32.0,43.0,58.0,20.0,43.0,30.0,73.0,50.0,61.0,74.0,61.0,582.0
Kachchh,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,62.0,83.0,73.0,109.0,67.0,167.0,126.0,165.0,122.0,85.0,141.0,101.0,1301.0
Kachchh,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,99.0,115.0,116.0,167.0,87.0,210.0,156.0,238.0,172.0,146.0,215.0,162.0,1883.0
Kachchh,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,5.0,0.0,5.0,0.0,12.0,7.0,0.0,0.0,35.0,0.0,0.0,64.0
Kachchh,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,246.0,0.0,246.0
Kachchh,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,98.0,0.0,0.0,0.0,0.0,0.0,98.0
Kachchh,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,0.0,0.0,0.0,4.0
Kachchh,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kachchh,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,98.0,1.0,3.0,0.0,246.0,0.0,348.0
Kachchh,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,0.0,0.0,0.0,4.0
Kachchh,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,60.0,41.0,39.0,63.0,36.0,63.0,42.0,57.0,111.0,258.0,0.0,147.0,917.0
Kachchh,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,312.0,291.0,224.0,206.0,143.0,299.0,97.0,668.0,904.0,497.0,426.0,153.0,4220.0
Kachchh,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,79.0,67.0,40.0,16.0,25.0,60.0,14.0,222.0,265.0,233.0,213.0,16.0,1250.0
Kachchh,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kachchh,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,451.0,399.0,303.0,285.0,204.0,422.0,153.0,947.0,1280.0,988.0,639.0,316.0,6387.0
Kachchh,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,88.0,41.0,71.0,51.0,57.0,109.0,63.0,60.0,190.0,268.0,245.0,312.0,1555.0
Kachchh,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,7.0,37.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,44.0
Kachchh,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,7.0,7.0,32.0,26.0,4.0,53.0,23.0,14.0,22.0,0.0,11.0,0.0,199.0
Kachchh,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,19.0,0.0,0.0,0.0,21.0
Kachchh,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kachchh,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,7.0,7.0,39.0,63.0,4.0,53.0,23.0,16.0,41.0,0.0,11.0,0.0,264.0
Kachchh,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,59.0,19.0,31.0,56.0,19.0,41.0,58.0,22.0,91.0,56.0,5.0,0.0,457.0
Kachchh,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,4.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,14.0
Kachchh,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2.0,4.0,1.0,1.0,7.0,2.0,12.0,9.0,43.0,0.0,0.0,0.0,81.0
Kachchh,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kachchh,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,4.0,5.0,8.0,7.0,2.0,12.0,9.0,43.0,0.0,0.0,3.0,95.0
Kachchh,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,36.0,0.0,27.0,0.0,0.0,11.0,0.0,8.0,43.0,0.0,0.0,0.0,125.0
Kachchh,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1006.0,644.0,674.0,901.0,759.0,752.0,585.0,629.0,554.0,617.0,524.0,374.0,8019.0
Kachchh,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,124.0,93.0,239.0,276.0,104.0,289.0,174.0,249.0,234.0,431.0,394.0,270.0,2877.0
Kachchh,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,23.0,26.0,21.0,24.0,10.0,31.0,21.0,21.0,13.0,13.0,17.0,16.0,236.0
Kachchh,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,5.0,11.0,8.0,13.0,11.0,10.0,10.0,24.0,38.0,10.0,10.0,20.0,170.0
Kachchh,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kachchh,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1158.0,774.0,942.0,1214.0,884.0,1082.0,790.0,923.0,839.0,1071.0,945.0,680.0,11302.0
Kachchh,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,387.0,72.0,106.0,93.0,90.0,89.0,59.0,87.0,111.0,122.0,114.0,116.0,1446.0
Kachchh,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,130.0,40.0,161.0,77.0,51.0,14.0,34.0,67.0,288.0,293.0,136.0,0.0,1291.0
Kachchh,9.06,Number of IUCD removals,TOTAL,246.0,310.0,255.0,273.0,299.0,327.0,234.0,362.0,291.0,294.0,321.0,312.0,3524.0
Kachchh,9.07,Number of Oral Pills cycles distributed,TOTAL,4857.0,4910.0,4858.0,4983.0,5430.0,5658.0,4732.0,5665.0,5104.0,5134.0,5040.0,5855.0,62226.0
Kachchh,9.08,Number of Condom pieces distributed,TOTAL,22034.0,20225.0,18750.0,19135.0,23903.0,21348.0,21163.0,21701.0,22046.0,22385.0,23330.0,22083.0,258103.0
Kachchh,9.09,Number of Centchroman (weekly) pills given,TOTAL,970.0,523.0,336.0,299.0,1083.0,153.0,21.0,22.0,183.0,1030.0,243.0,17.0,4880.0
Kachchh,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,301.0,166.0,197.0,86.0,81.0,91.0,116.0,313.0,87.0,66.0,84.0,45.0,1633.0
Kachchh,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,4.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,3.0,14.0
Kachchh,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,17.0,13.0,5.0,17.0,19.0,3.0,5.0,29.0,65.0,34.0,70.0,138.0,415.0
Kachchh,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,7.0
Kachchh,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kachchh,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,7.0,13.0,11.0,13.0,9.0,10.0,10.0,13.0,11.0,12.0,11.0,-1.0
Kachchh,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4235.0,4073.0,4724.0,3921.0,4562.0,5623.0,4840.0,4633.0,3869.0,3654.0,3543.0,3548.0,51225.0
Kachchh,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,410.0,51.0,449.0,245.0,14.0,876.0,39.0,297.0,52.0,25.0,78.0,782.0,3318.0
Kachchh,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,404.0,266.0,478.0,228.0,20.0,637.0,21.0,340.0,44.0,13.0,69.0,769.0,3289.0
Kachchh,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,682.0,295.0,550.0,248.0,15.0,842.0,22.0,341.0,48.0,15.0,70.0,768.0,3896.0
Kachchh,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3946.0,3977.0,3710.0,3365.0,4009.0,4451.0,3646.0,4026.0,3942.0,3507.0,3338.0,3519.0,45436.0
Kachchh,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3614.0,3523.0,3630.0,3212.0,3869.0,4010.0,3600.0,3748.0,3670.0,3454.0,3410.0,3531.0,43271.0
Kachchh,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,4011.0,3392.0,3831.0,3375.0,3918.0,4357.0,3552.0,3806.0,3694.0,3423.0,3370.0,3651.0,44380.0
Kachchh,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3078.0,3263.0,3749.0,2830.0,3711.0,3775.0,3511.0,3248.0,2821.0,2998.0,2613.0,2792.0,38389.0
Kachchh,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3985.0,3769.0,3855.0,3434.0,3984.0,4507.0,3669.0,3908.0,3817.0,3531.0,3414.0,3643.0,45516.0
Kachchh,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3868.0,3727.0,3828.0,3347.0,3810.0,3994.0,3594.0,3822.0,3654.0,3455.0,3446.0,3676.0,44221.0
Kachchh,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4274.0,3960.0,4093.0,3358.0,3884.0,4326.0,3549.0,3463.0,3662.0,3437.0,3390.0,3806.0,45202.0
Kachchh,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1686.0,1555.0,1567.0,1363.0,1875.0,1892.0,2136.0,1830.0,1204.0,1407.0,1186.0,1145.0,18846.0
Kachchh,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,617.0,364.0,496.0,284.0,149.0,7.0,88.0,142.0,175.0,119.0,48.0,0.0,2489.0
Kachchh,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,529.0,215.0,277.0,284.0,140.0,0.0,5.0,0.0,4.0,2.0,0.0,0.0,1456.0
Kachchh,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,519.0,213.0,273.0,284.0,140.0,0.0,5.0,2.0,0.0,0.0,0.0,0.0,1436.0
Kachchh,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7065.0,3713.0,4106.0,3555.0,3875.0,4457.0,3469.0,3671.0,3244.0,3043.0,3143.0,3459.0,46800.0
Kachchh,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,6134.0,2760.0,2730.0,2412.0,2506.0,2983.0,2601.0,2587.0,2341.0,2354.0,2429.0,2471.0,34308.0
Kachchh,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,2.0,10.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,21.0
Kachchh,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2364.0,2240.0,2144.0,1954.0,2277.0,2628.0,2076.0,2123.0,1929.0,1811.0,1805.0,1922.0,25273.0
Kachchh,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2150.0,2156.0,2002.0,1832.0,2152.0,2451.0,1890.0,1909.0,1789.0,1734.0,1637.0,1839.0,23541.0
Kachchh,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4514.0,4396.0,4146.0,3786.0,4429.0,5079.0,3966.0,4032.0,3718.0,3545.0,3442.0,3761.0,48814.0
Kachchh,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3685.0,3343.0,3516.0,2840.0,3482.0,3637.0,3003.0,3364.0,2949.0,2655.0,2998.0,3106.0,38578.0
Kachchh,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3594.0,3204.0,3458.0,2764.0,3334.0,3578.0,2986.0,3346.0,2921.0,2643.0,2981.0,2917.0,37726.0
Kachchh,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,2.0,1.0,0.0,19.0,1.0,1.0,0.0,1.0,0.0,9.0,4.0,18.0,56.0
Kachchh,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,385.0,479.0,762.0,811.0,787.0,777.0,808.0,678.0,777.0,742.0,813.0,1023.0,8842.0
Kachchh,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,344.0,457.0,721.0,688.0,704.0,714.0,743.0,643.0,763.0,690.0,760.0,908.0,8135.0
Kachchh,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,729.0,936.0,1483.0,1499.0,1491.0,1491.0,1551.0,1321.0,1540.0,1432.0,1573.0,1931.0,16977.0
Kachchh,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,798.0,1173.0,1402.0,1164.0,1467.0,2601.0,2004.0,1985.0,3237.0,2579.0,1132.0,1913.0,21455.0
Kachchh,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1128.0,1240.0,1730.0,1450.0,1770.0,3973.0,2559.0,2352.0,3924.0,2862.0,1532.0,2365.0,26885.0
Kachchh,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1993.0,1948.0,2219.0,2112.0,2520.0,3456.0,2901.0,2375.0,3172.0,2259.0,2094.0,1691.0,28740.0
Kachchh,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,47.0,9.0,5.0,5.0,28.0,13.0,13.0,17.0,8.0,3.0,6.0,6.0,160.0
Kachchh,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,4.0
Kachchh,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,43.0,12.0,53.0,46.0,74.0,46.0,73.0,55.0,43.0,41.0,37.0,43.0,566.0
Kachchh,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1685.0,1633.0,1889.0,1712.0,1798.0,1879.0,1674.0,1695.0,1636.0,1617.0,1682.0,1640.0,20540.0
Kachchh,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1569.0,1552.0,1793.0,1624.0,1706.0,1737.0,1596.0,1620.0,1548.0,1412.0,1539.0,1562.0,19258.0
Kachchh,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1292.0,1315.0,1405.0,1448.0,1512.0,1514.0,1396.0,1447.0,1381.0,1241.0,1417.0,1454.0,16822.0
Kachchh,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3413.0,3640.0,3844.0,3471.0,4138.0,3809.0,3475.0,3479.0,3239.0,3063.0,3032.0,3235.0,41838.0
Kachchh,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,7829.0,364.0,707.0,480.0,3593.0,2204.0,920.0,2374.0,18914.0,2707.0,1726.0,1234.0,43052.0
Kachchh,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,7602.0,235.0,186.0,155.0,2123.0,1794.0,337.0,2413.0,19506.0,1904.0,1304.0,661.0,38220.0
Kachchh,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,5.0,6.0,0.0,0.0,16.0
Kachchh,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Kachchh,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,689.0,157.0,238.0,119.0,87.0,12.0,35.0,11.0,8.0,12.0,17.0,10.0,1395.0
Kachchh,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1976.0,2344.0,2255.0,2180.0,3579.0,2817.0,2285.0,2594.0,2535.0,2363.0,2291.0,2271.0,29490.0
Kachchh,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,628.0,430.0,478.0,255.0,135.0,178.0,153.0,38.0,10.0,17.0,57.0,439.0,2818.0
Kachchh,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,2.0,4.0,0.0,30.0,0.0,0.0,0.0,38.0,120.0,221.0,153.0,55.0,623.0
Kachchh,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,73.0,228.0,3015.0,655.0,59.0,0.0,96.0,496.0,4622.0
Kachchh,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,138.0,363.0,172.0,21.0,503.0,496.0,1693.0
Kachchh,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,10.0,11.0,10.0,8.0,11.0,12.0,12.0,12.0,10.0,11.0,10.0,10.0,-1.0
Kachchh,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,14.0,13.0,15.0,15.0,12.0,14.0,15.0,13.0,13.0,11.0,14.0,14.0,-1.0
Kachchh,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,392.0,384.0,440.0,491.0,423.0,432.0,511.0,488.0,513.0,437.0,456.0,466.0,-1.0
Kachchh,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,14.0,14.0,13.0,9.0,13.0,13.0,14.0,14.0,13.0,14.0,11.0,13.0,-1.0
Kachchh,14.05,Number of RKS meetings held during the month,TOTAL,6.0,7.0,14.0,2082019.0,15.0,10.0,6.0,7.0,11.0,81.0,6.0,19.0,2082201.0
Kachchh,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,43.0,38.0,41.0,35.0,37.0,43.0,44.0,43.0,44.0,43.0,36.0,40.0,-1.0
Kachchh,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,244.0,420.0,342.0,261.0,318.0,307.0,290.0,321.0,360.0,350.0,271.0,457.0,3941.0
Kachchh,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,11.0,10.0,8.0,6.0,9.0,12.0,12.0,12.0,9.0,12.0,10.0,10.0,-1.0
Kachchh,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,7.0,6.0,6.0,2.0,186.0,52.0,26.0,135.0,300.0,402.0,215.0,37.0,-1.0
Kachchh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,323.0,308.0,825.0,297.0,408.0,615.0,446.0,394.0,411.0,541.0,391.0,372.0,5331.0
Kachchh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1147.0,1162.0,883.0,810.0,1549.0,1141.0,1229.0,1185.0,1114.0,1130.0,1907.0,1294.0,14551.0
Kachchh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,521.0,415.0,356.0,297.0,444.0,675.0,526.0,520.0,1136.0,570.0,824.0,424.0,6708.0
Kachchh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2615.0,2513.0,2342.0,1762.0,3051.0,2824.0,2752.0,3164.0,3580.0,3454.0,2987.0,2543.0,33587.0
Kachchh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,844.0,723.0,1181.0,594.0,852.0,1290.0,972.0,914.0,1547.0,1111.0,1215.0,796.0,12039.0
Kachchh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3762.0,3675.0,3225.0,2572.0,4600.0,3965.0,3981.0,4349.0,4694.0,4584.0,4894.0,3837.0,48138.0
Kachchh,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,1.0,2.0,1.0,3.0,2.0,1.0,2.0,0.0,2.0,1.0,0.0,15.0
Kachchh,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,3.0,2.0,1.0,2.0,0.0,1.0,2.0,0.0,0.0,0.0,2.0,13.0
Kachchh,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,4.0,4.0,2.0,5.0,2.0,2.0,4.0,0.0,2.0,1.0,2.0,28.0
Kachchh,14.11,In-Patient Head Count at midnight,TOTAL,1840.0,1700.0,2375.0,740.0,2054.0,2445.0,2101.0,1808.0,1728.0,1620.0,1796.0,2287.0,22494.0
Kachchh,14.12.1,OPD attendance (All),TOTAL,57927.0,65553.0,68091.0,55882.0,73332.0,89146.0,70222.0,75291.0,76274.0,75090.0,137751.0,99311.0,943870.0
Kachchh,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,153.0,94.0,89.0,20.0,105.0,121.0,16.0,124.0,127.0,4037.0,5747.0,41.0,10674.0
Kachchh,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,4.0,12.0,17.0,2.0,31.0,40.0,15.0,23.0,4.0,70.0,11.0,17.0,246.0
Kachchh,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,141.0,583.0,316.0,242.0,221.0,254.0,184.0,434.0,442.0,373.0,352.0,251.0,3793.0
Kachchh,14.14.a,Number of patients given AYUSH treatment,TOTAL,433.0,200.0,33.0,456.0,537.0,1.0,1.0,1.0,115.0,0.0,1.0,342.0,2120.0
Kachchh,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32.0,32.0
Kachchh,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,9.0,0.0,12.0,25.0,9.0,0.0,11.0,66.0
Kachchh,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8106.0,7991.0,8850.0,7255.0,9376.0,8682.0,7723.0,8126.0,9802.0,8511.0,9740.0,9130.0,103292.0
Kachchh,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,154.0,225.0,238.0,103.0,236.0,239.0,203.0,276.0,1067.0,172.0,156.0,110.0,3179.0
Kachchh,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1103.0,1255.0,933.0,424.0,795.0,1264.0,714.0,1049.0,1165.0,1174.0,1153.0,674.0,11703.0
Kachchh,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,27.0,10.0,9.0,5.0,4.0,9.0,5.0,12.0,8.0,6.0,7.0,50.0,152.0
Kachchh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,793.0,598.0,732.0,280.0,584.0,866.0,761.0,977.0,1147.0,2823.0,851.0,413.0,10825.0
Kachchh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,8.0,4.0,3.0,3.0,0.0,3.0,3.0,7.0,3.0,5.0,2.0,11.0,52.0
Kachchh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1324.0,1355.0,1493.0,732.0,1223.0,1558.0,941.0,1469.0,1025.0,3236.0,1422.0,1179.0,16957.0
Kachchh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,51.0,0.0,1.0,12.0,0.0,1.0,2.0,7.0,41.0,4.0,3.0,34.0,156.0
Kachchh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3220.0,3208.0,3158.0,1436.0,2602.0,3688.0,2416.0,3495.0,3337.0,7233.0,3426.0,2266.0,39485.0
Kachchh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,86.0,14.0,13.0,20.0,4.0,13.0,10.0,26.0,52.0,15.0,12.0,95.0,360.0
Kachchh,15.2,Number of Widal tests conducted,Number tested,310.0,327.0,498.0,50.0,561.0,630.0,294.0,348.0,272.0,308.0,509.0,365.0,4472.0
Kachchh,15.3.a,Number of VDRL tests conducted on males,Number tested,60.0,6.0,2.0,0.0,107.0,23.0,314.0,369.0,415.0,321.0,5.0,1.0,1623.0
Kachchh,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,97.0,96.0,22.0,8.0,155.0,22.0,98.0,31.0,91.0,117.0,131.0,166.0,1034.0
Kachchh,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,151.0,134.0,259.0,244.0,312.0,115.0,102.0,134.0,170.0,141.0,108.0,113.0,1983.0
Kachchh,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,308.0,236.0,283.0,252.0,574.0,160.0,514.0,534.0,676.0,579.0,244.0,280.0,4640.0
Kachchh,15.4.1,Number of blood smears examined for Malaria,TOTAL,16824.0,16124.0,14965.0,14473.0,20551.0,21684.0,19032.0,17904.0,21061.0,17370.0,26715.0,15050.0,221753.0
Kachchh,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,157.0,44.0,28.0,45.0,74.0,83.0,41.0,666.0,24.0,11.0,962.0,2.0,2137.0
Kachchh,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,5.0,4.0,2.0,2.0,2.0,5.0,10.0,22.0,13.0,4.0,0.0,0.0,69.0
Kachchh,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Kachchh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Kachchh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Kachchh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Kachchh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kachchh,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,,,,,,5.0,,1.0,,,7.0
Kachchh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,1.0,,,1.0
Kachchh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kachchh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,1.0,,,1.0
Kachchh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,2.0,,3.0,3.0,2.0,1.0,3.0,1.0,3.0,3.0,1.0,23.0
Kachchh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kachchh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,2.0,,3.0,3.0,2.0,1.0,3.0,1.0,3.0,3.0,1.0,23.0
Kachchh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,5.0,4.0,4.0,3.0,5.0,3.0,5.0,2.0,7.0,3.0,5.0,48.0
Kachchh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,,3.0,1.0,1.0,,1.0,,1.0,8.0
Kachchh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,6.0,4.0,4.0,3.0,8.0,4.0,6.0,2.0,8.0,3.0,6.0,56.0
Kachchh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,4.0,3.0,1.0,1.0,1.0,2.0,4.0,1.0,3.0,2.0,,24.0
Kachchh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,2.0,,,,,,,,1.0,1.0,4.0
Kachchh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,4.0,5.0,1.0,1.0,1.0,2.0,4.0,1.0,3.0,3.0,1.0,28.0
Kachchh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,1.0,,,1.0,1.0,2.0,,5.0
Kachchh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Kachchh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,1.0,,1.0,1.0,1.0,2.0,,6.0
Kachchh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kachchh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kachchh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Kachchh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,1.0,1.0,,1.0,,1.0,2.0,,,,1.0,8.0
Kachchh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,1.0,,,1.0,2.0
Kachchh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,1.0,,1.0,,1.0,2.0,1.0,,,2.0,10.0
Kachchh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
Kachchh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kachchh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,1.0,,,,,,,,,,,1.0
Kachchh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,1.0,4.0,,2.0,2.0,2.0,1.0,2.0,3.0,2.0,2.0,22.0
Kachchh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,2.0,,,1.0,,1.0,1.0,1.0,2.0,1.0,9.0
Kachchh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,1.0,6.0,,2.0,3.0,2.0,2.0,3.0,4.0,4.0,3.0,31.0
Kachchh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Kachchh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Kachchh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,,,,,,,,,,1.0
Kachchh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Kachchh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,,1.0,1.0,,,1.0,1.0,,1.0,,6.0
Kachchh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,1.0,,,1.0,1.0,,1.0,,4.0
Kachchh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,1.0,,1.0,2.0,,,2.0,2.0,,2.0,,11.0
Kachchh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,2.0,2.0,,,,,,1.0,1.0,1.0,1.0,8.0
Kachchh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,5.0,5.0,,1.0,3.0,,4.0,1.0,4.0,3.0,5.0,32.0
Kachchh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,7.0,7.0,,1.0,3.0,,4.0,2.0,5.0,4.0,6.0,40.0
Kachchh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Kachchh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Kachchh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,1.0,,,,1.0
Kachchh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Kachchh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Kachchh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Kachchh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,1.0,,1.0,,,,,1.0,,1.0,,4.0
Kachchh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kachchh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,1.0,,1.0,,,,,1.0,,1.0,,4.0
Kachchh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Kachchh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,2.0,2.0,2.0,4.0,2.0,1.0,3.0,2.0,1.0,2.0,1.0,27.0
Kachchh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,2.0,3.0,2.0,4.0,3.0,3.0,3.0,7.0,1.0,2.0,1.0,34.0
Kachchh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,9.0,4.0,5.0,4.0,8.0,5.0,4.0,6.0,9.0,2.0,4.0,2.0,62.0
Kachchh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Kachchh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,1.0,,,1.0,1.0,,,,3.0
Kachchh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,,1.0,1.0,,1.0,,2.0,,,,1.0,7.0
Kachchh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,,1.0,1.0,1.0,1.0,1.0,3.0,1.0,,,1.0,11.0
Kachchh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kachchh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kachchh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kachchh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Kachchh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kachchh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Kachchh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Kachchh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kachchh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,1.0,,,,,1.0
Kachchh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Kachchh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kachchh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,1.0,,,,,1.0
Kachchh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kachchh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kachchh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kachchh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,,1.0,,,,1.0,,,,,4.0
Kachchh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kachchh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,,1.0,,,,1.0,,,,,4.0
Kachchh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Kachchh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,,2.0,1.0,3.0,1.0,2.0,1.0,,,,,12.0
Kachchh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,1.0,1.0,,,,,,,,,3.0
Kachchh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,,3.0,2.0,3.0,1.0,2.0,2.0,,,,,16.0
Kachchh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,3.0,1.0,2.0,,2.0,1.0,1.0,1.0,1.0,3.0,,19.0
Kachchh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,1.0,,,,1.0,,,,3.0
Kachchh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,3.0,1.0,3.0,1.0,2.0,1.0,1.0,2.0,1.0,3.0,,22.0
Kachchh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Kachchh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Kachchh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Kachchh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kachchh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,,,1.0,,1.0,2.0,,2.0,,,7.0
Kachchh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,,,1.0,,1.0,2.0,,2.0,,,7.0
Kachchh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Kachchh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,,1.0,,,,,,2.0,2.0,,6.0
Kachchh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,1.0,,2.0,1.0,,1.0,3.0,,3.0,2.0,,13.0
Kachchh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,1.0,,3.0,1.0,,1.0,3.0,,5.0,4.0,,19.0
Kachchh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Kachchh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,4.0,4.0,1.0,1.0,2.0,2.0,1.0,1.0,4.0,2.0,1.0,1.0,24.0
Kachchh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,7.0,7.0,15.0,3.0,9.0,4.0,8.0,7.0,4.0,4.0,9.0,5.0,82.0
Kachchh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,12.0,11.0,16.0,4.0,11.0,6.0,9.0,8.0,8.0,6.0,10.0,6.0,107.0
Kheda,1.1,Total number of pregnant women Registered for ANC,TOTAL,3957.0,4446.0,5765.0,4686.0,4467.0,4432.0,4256.0,4460.0,4160.0,4564.0,4441.0,4401.0,54035.0
Kheda,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3402.0,3762.0,4727.0,3892.0,3808.0,3767.0,3604.0,3851.0,3619.0,3923.0,3889.0,3875.0,46119.0
Kheda,1.2,Number of Pregnant women registered under JSY,TOTAL,782.0,768.0,875.0,913.0,941.0,922.0,854.0,902.0,897.0,994.0,957.0,1000.0,10805.0
Kheda,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3281.0,3745.0,4501.0,4483.0,4322.0,4129.0,4239.0,3901.0,3834.0,3978.0,4344.0,4617.0,49374.0
Kheda,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3070.0,3612.0,4352.0,3739.0,3706.0,3389.0,3385.0,3427.0,3326.0,3626.0,3691.0,3641.0,42964.0
Kheda,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3441.0,4198.0,5172.0,4638.0,4520.0,4444.0,4197.0,4226.0,3961.0,4109.0,4043.0,5015.0,51964.0
Kheda,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2818.0,3243.0,3856.0,3567.0,3645.0,3968.0,3802.0,3623.0,3437.0,3865.0,3955.0,4170.0,43949.0
Kheda,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,49.0,57.0,47.0,40.0,55.0,33.0,45.0,70.0,52.0,21.0,33.0,22.0,524.0
Kheda,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,1.0,0.0,2.0,19.0,17.0,1.0,4.0,13.0,16.0,21.0,94.0
Kheda,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1778.0,2009.0,2693.0,2557.0,2693.0,2823.0,2659.0,2720.0,2667.0,2367.0,2331.0,2334.0,29631.0
Kheda,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,35.0,126.0,94.0,151.0,67.0,53.0,41.0,34.0,43.0,19.0,12.0,22.0,697.0
Kheda,1.8,Number of pregnancy test kits used at SC level,TOTAL,565.0,1024.0,907.0,1101.0,854.0,828.0,1061.0,981.0,988.0,1021.0,1144.0,1233.0,11707.0
Kheda,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,17.0,13.0,17.0,11.0,12.0,15.0,25.0,8.0,16.0,7.0,1.0,2.0,144.0
Kheda,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,1.0,1.0,7.0
Kheda,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,17.0,13.0,19.0,11.0,12.0,15.0,25.0,9.0,16.0,9.0,2.0,3.0,151.0
Kheda,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,16.0,13.0,17.0,7.0,7.0,15.0,15.0,7.0,1.0,4.0,1.0,2.0,105.0
Kheda,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,2.0,1.0,2.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,9.0
Kheda,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,594.0,734.0,831.0,782.0,960.0,1136.0,1079.0,1169.0,1125.0,983.0,919.0,861.0,11173.0
Kheda,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,412.0,413.0,420.0,386.0,440.0,553.0,521.0,665.0,659.0,516.0,509.0,511.0,6005.0
Kheda,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2.0,1.0,2.0,37.0,5.0,5.0,12.0,9.0,24.0,4.0,10.0,13.0,124.0
Kheda,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,6.0,6.0,10.0,7.0,7.0,16.0,13.0,11.0,10.0,10.0,12.0,10.0,118.0
Kheda,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,6.0
Kheda,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,2045.0,2605.0,3408.0,2872.0,3309.0,3174.0,3252.0,3036.0,2721.0,2831.0,2584.0,2838.0,34675.0
Kheda,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,19.0,25.0,12.0,0.0,17.0,39.0,0.0,0.0,0.0,0.0,0.0,0.0,112.0
Kheda,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,15.0,22.0
Kheda,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,2.0,3.0,8.0,7.0,10.0,6.0,7.0,0.0,6.0,6.0,7.0,4.0,66.0
Kheda,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,15.0,28.0,32.0,33.0,30.0,41.0,30.0,33.0,19.0,18.0,34.0,19.0,332.0
Kheda,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kheda,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,17.0,31.0,40.0,40.0,40.0,47.0,37.0,33.0,32.0,24.0,41.0,38.0,420.0
Kheda,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,85.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,95.0,0.0,74.0,230.0,484.0
Kheda,4.1.1.a,Number of male live births,TOTAL,1337.0,1793.0,2198.0,1904.0,2224.0,2182.0,2201.0,2252.0,1898.0,1926.0,1768.0,1945.0,23628.0
Kheda,4.1.1.b,Number of female live births,TOTAL,1294.0,1580.0,2048.0,1729.0,2007.0,2102.0,2134.0,2052.0,1984.0,1896.0,1754.0,1822.0,22402.0
Kheda,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2631.0,3373.0,4246.0,3633.0,4231.0,4284.0,4335.0,4304.0,3882.0,3822.0,3522.0,3767.0,46030.0
Kheda,4.1.2,Number of still births,TOTAL,34.0,51.0,44.0,60.0,66.0,52.0,53.0,52.0,50.0,75.0,46.0,49.0,632.0
Kheda,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,87.0,114.0,147.0,143.0,135.0,74.0,75.0,77.0,62.0,59.0,94.0,79.0,1146.0
Kheda,4.2.1,Number of Newborns weighed at birth,TOTAL,2371.0,3018.0,4214.0,3460.0,4074.0,4131.0,4140.0,4041.0,3686.0,3458.0,2936.0,3602.0,43131.0
Kheda,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,138.0,268.0,213.0,294.0,336.0,429.0,377.0,330.0,365.0,291.0,263.0,411.0,3715.0
Kheda,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2333.0,2913.0,4163.0,3368.0,3985.0,4014.0,4067.0,4009.0,3619.0,3400.0,2908.0,3577.0,42356.0
Kheda,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3.0,2.0,25.0,22.0,6.0,4.0,16.0,0.0,46.0,33.0,5.0,0.0,162.0
Kheda,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,81.0,51.0,57.0,65.0,97.0,132.0,131.0,181.0,121.0,101.0,107.0,86.0,1210.0
Kheda,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,26.0,55.0,57.0,63.0,62.0,86.0,76.0,77.0,56.0,41.0,68.0,58.0,725.0
Kheda,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kheda,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,110.0,108.0,139.0,150.0,165.0,222.0,223.0,258.0,223.0,175.0,180.0,144.0,2097.0
Kheda,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,110.0,108.0,123.0,149.0,165.0,178.0,199.0,197.0,203.0,175.0,206.0,175.0,1988.0
Kheda,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,3.0,2.0,3.0,1.0,2.0,1.0,97.0,94.0,99.0,67.0,369.0
Kheda,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,110.0,108.0,139.0,149.0,165.0,223.0,223.0,258.0,223.0,175.0,211.0,221.0,2205.0
Kheda,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,17.0,32.0,45.0,7.0,124.0,40.0,30.0,46.0,28.0,24.0,20.0,11.0,424.0
Kheda,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2114.0,2766.0,3442.0,3519.0,3930.0,3996.0,3930.0,3913.0,3432.0,3382.0,3240.0,3674.0,41338.0
Kheda,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2263.0,2746.0,3497.0,3397.0,3178.0,2778.0,2721.0,2969.0,2620.0,2480.0,2164.0,2733.0,33546.0
Kheda,6.3,PNC maternal complications attended,TOTAL,6.0,14.0,0.0,0.0,1.0,9.0,0.0,0.0,67.0,4.0,7.0,10.0,118.0
Kheda,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,25.0,28.0,31.0,25.0,24.0,21.0,17.0,28.0,23.0,17.0,40.0,34.0,313.0
Kheda,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kheda,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,25.0,28.0,31.0,25.0,25.0,21.0,17.0,28.0,23.0,17.0,40.0,34.0,314.0
Kheda,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,3.0,2.0,1.0,2.0,1.0,1.0,1.0,0.0,0.0,2.0,2.0,15.0
Kheda,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,206.0,173.0,368.0,237.0,216.0,306.0,260.0,234.0,266.0,302.0,316.0,314.0,3198.0
Kheda,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,311.0,342.0,800.0,396.0,307.0,428.0,342.0,389.0,416.0,398.0,464.0,454.0,5047.0
Kheda,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,517.0,515.0,1168.0,633.0,523.0,734.0,602.0,623.0,682.0,700.0,780.0,768.0,8245.0
Kheda,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,53.0,86.0,105.0,10.0,18.0,61.0,10.0,10.0,10.0,0.0,10.0,104.0,477.0
Kheda,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,8.0,0.0,12.0
Kheda,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Kheda,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,1.0,2.0,4.0,1.0,0.0,1.0,5.0,1.0,0.0,2.0,18.0
Kheda,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kheda,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,2.0,2.0,4.0,1.0,2.0,3.0,6.0,1.0,8.0,2.0,32.0
Kheda,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,2.0,4.0,0.0,3.0,0.0,0.0,15.0,27.0,1.0,12.0,2.0,2.0,68.0
Kheda,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,46.0,37.0,40.0,105.0,123.0,107.0,167.0,1283.0,1194.0,964.0,578.0,324.0,4968.0
Kheda,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,12.0,1.0,51.0,1.0,353.0,333.0,0.0,100.0,33.0,884.0
Kheda,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,13.0,12.0,11.0,9.0,24.0,28.0,18.0,11.0,49.0,28.0,32.0,19.0,254.0
Kheda,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kheda,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,59.0,49.0,51.0,126.0,148.0,186.0,186.0,1647.0,1576.0,992.0,710.0,376.0,6106.0
Kheda,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,79.0,140.0,192.0,251.0,191.0,274.0,448.0,1365.0,1250.0,1017.0,955.0,597.0,6759.0
Kheda,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,21.0,30.0,47.0,103.0,98.0,80.0,75.0,222.0,340.0,229.0,120.0,150.0,1515.0
Kheda,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,6.0,9.0,8.0,7.0,7.0,16.0,4.0,18.0,35.0,38.0,33.0,18.0,199.0
Kheda,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,14.0,10.0,2.0,9.0,6.0,16.0,12.0,6.0,6.0,18.0,14.0,8.0,121.0
Kheda,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kheda,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,41.0,49.0,57.0,119.0,111.0,112.0,91.0,246.0,381.0,285.0,167.0,176.0,1835.0
Kheda,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,46.0,61.0,107.0,152.0,135.0,216.0,228.0,615.0,316.0,365.0,204.0,172.0,2617.0
Kheda,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Kheda,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,4.0,2.0,3.0,3.0,0.0,0.0,1.0,0.0,0.0,2.0,3.0,2.0,20.0
Kheda,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,15.0,9.0,10.0,10.0,7.0,2.0,10.0,4.0,14.0,10.0,4.0,96.0
Kheda,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kheda,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,5.0,17.0,12.0,13.0,10.0,7.0,3.0,10.0,4.0,16.0,13.0,9.0,119.0
Kheda,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,5.0,6.0,0.0,8.0,2.0,2.0,108.0,0.0,0.0,0.0,0.0,0.0,131.0
Kheda,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,964.0,1326.0,1258.0,1221.0,1326.0,1426.0,1522.0,1671.0,1546.0,1521.0,1355.0,1208.0,16344.0
Kheda,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,502.0,822.0,1051.0,1245.0,889.0,729.0,663.0,833.0,688.0,506.0,561.0,435.0,8924.0
Kheda,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,23.0,34.0,105.0,47.0,40.0,26.0,70.0,74.0,73.0,72.0,82.0,86.0,732.0
Kheda,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,45.0,70.0,74.0,63.0,74.0,70.0,87.0,78.0,98.0,104.0,132.0,131.0,1026.0
Kheda,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kheda,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1534.0,2252.0,2488.0,2576.0,2329.0,2251.0,2342.0,2656.0,2405.0,2203.0,2130.0,1860.0,27026.0
Kheda,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,56.0,56.0,57.0,158.0,42.0,58.0,73.0,56.0,56.0,52.0,93.0,59.0,816.0
Kheda,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,631.0,506.0,746.0,1115.0,1153.0,997.0,1184.0,358.0,190.0,155.0,93.0,140.0,7268.0
Kheda,9.06,Number of IUCD removals,TOTAL,493.0,588.0,607.0,674.0,472.0,455.0,505.0,437.0,532.0,474.0,480.0,503.0,6220.0
Kheda,9.07,Number of Oral Pills cycles distributed,TOTAL,2398.0,2290.0,2421.0,3846.0,2976.0,3495.0,4427.0,3478.0,3525.0,3736.0,3676.0,2592.0,38860.0
Kheda,9.08,Number of Condom pieces distributed,TOTAL,25337.0,19305.0,20164.0,34527.0,10199.0,41232.0,72406.0,48093.0,29465.0,22327.0,22115.0,13160.0,358330.0
Kheda,9.09,Number of Centchroman (weekly) pills given,TOTAL,26.0,39.0,471.0,350.0,2.0,12.0,10.0,140.0,11.0,116.0,144.0,230.0,1551.0
Kheda,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,35.0,8.0,6.0,22.0,2.0,10.0,43.0,65.0,51.0,61.0,44.0,31.0,378.0
Kheda,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,29.0,39.0
Kheda,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,9.11.2.b,Number of failures following female sterilization,TOTAL,3.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,5.0
Kheda,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,5.0,3.0,5.0,5.0,9.0,8.0,8.0,13.0,8.0,10.0,14.0,-1.0
Kheda,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3236.0,3933.0,4987.0,4530.0,4645.0,4046.0,4799.0,4373.0,4139.0,4454.0,4138.0,4501.0,51781.0
Kheda,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,110.0,134.0,105.0,102.0,0.0,5.0,20.0,60.0,1.0,537.0
Kheda,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,119.0,118.0,98.0,95.0,0.0,2.0,17.0,49.0,1.0,499.0
Kheda,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,127.0,138.0,92.0,96.0,0.0,3.0,21.0,63.0,1.0,541.0
Kheda,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2791.0,3511.0,4125.0,3711.0,3824.0,3722.0,3855.0,4082.0,4011.0,4015.0,3773.0,3847.0,45267.0
Kheda,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2920.0,3467.0,4004.0,3662.0,3773.0,3795.0,3666.0,3819.0,3910.0,3941.0,3767.0,3960.0,44684.0
Kheda,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3110.0,3892.0,4478.0,3742.0,3960.0,3991.0,3892.0,3724.0,3896.0,3862.0,3700.0,3770.0,46017.0
Kheda,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1729.0,2068.0,2834.0,2578.0,2970.0,3022.0,3018.0,3125.0,2904.0,2975.0,2597.0,2672.0,32492.0
Kheda,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2904.0,3397.0,4140.0,3797.0,3958.0,3824.0,3947.0,4074.0,3999.0,3976.0,3778.0,3799.0,45593.0
Kheda,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2995.0,3353.0,4001.0,3769.0,3891.0,3901.0,3767.0,3771.0,3830.0,3868.0,3821.0,3875.0,44842.0
Kheda,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3278.0,3743.0,4494.0,3933.0,4137.0,4098.0,4068.0,3725.0,3798.0,3828.0,3673.0,3798.0,46573.0
Kheda,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,487.0,749.0,857.0,834.0,1012.0,1643.0,1644.0,1719.0,1530.0,1592.0,1393.0,1543.0,15003.0
Kheda,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,11.0,9.0,7.0,28.0,15.0,19.0,17.0,12.0,52.0,32.0,7.0,7.0,216.0
Kheda,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7.0,0.0,17.0,30.0,14.0,11.0,26.0,9.0,8.0,20.0,9.0,9.0,160.0
Kheda,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,27.0,12.0,18.0,21.0,15.0,4.0,8.0,8.0,43.0,6.0,9.0,171.0
Kheda,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2862.0,3851.0,4681.0,4289.0,4207.0,4047.0,3867.0,3648.0,3521.0,3627.0,3680.0,3771.0,46051.0
Kheda,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2361.0,3038.0,3553.0,3521.0,3367.0,3522.0,3335.0,3479.0,3066.0,3145.0,3338.0,3468.0,39193.0
Kheda,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,5.0,19.0,29.0
Kheda,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1492.0,1958.0,2400.0,2167.0,2136.0,2146.0,1972.0,1884.0,1839.0,1885.0,1892.0,1949.0,23720.0
Kheda,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1363.0,1866.0,2262.0,2022.0,1998.0,1925.0,1840.0,1752.0,1693.0,1714.0,1774.0,1839.0,22048.0
Kheda,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2855.0,3824.0,4662.0,4189.0,4134.0,4071.0,3812.0,3636.0,3532.0,3599.0,3666.0,3788.0,45768.0
Kheda,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2665.0,3152.0,4025.0,3742.0,3828.0,3673.0,3776.0,3683.0,3488.0,3601.0,3468.0,3901.0,43002.0
Kheda,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2629.0,3137.0,3994.0,3720.0,3828.0,3639.0,3735.0,3636.0,3448.0,3553.0,3423.0,3826.0,42568.0
Kheda,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,4.0
Kheda,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1290.0,1526.0,1958.0,1896.0,1816.0,1766.0,1789.0,1758.0,1624.0,1721.0,1669.0,1867.0,20680.0
Kheda,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1205.0,1413.0,1835.0,1791.0,1720.0,1583.0,1629.0,1565.0,1521.0,1558.0,1558.0,1732.0,19110.0
Kheda,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2495.0,2939.0,3793.0,3687.0,3536.0,3349.0,3418.0,3323.0,3145.0,3279.0,3227.0,3599.0,39790.0
Kheda,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1131.0,1325.0,1710.0,1725.0,1902.0,2122.0,1923.0,2026.0,2119.0,2078.0,2318.0,2335.0,22714.0
Kheda,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1255.0,1420.0,1953.0,1998.0,2310.0,2468.0,2238.0,2270.0,2252.0,2323.0,2539.0,2797.0,25823.0
Kheda,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2169.0,2588.0,3108.0,3238.0,3172.0,2984.0,2914.0,2870.0,2794.0,2849.0,2863.0,3084.0,34633.0
Kheda,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Kheda,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1322.0,1574.0,2001.0,1764.0,1727.0,1769.0,1781.0,1758.0,1757.0,1715.0,1778.0,1843.0,20789.0
Kheda,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1297.0,1566.0,2003.0,1756.0,1723.0,1764.0,1770.0,1751.0,1753.0,1713.0,1774.0,1843.0,20713.0
Kheda,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1238.0,1485.0,1921.0,1640.0,1677.0,1712.0,1736.0,1727.0,1716.0,1689.0,1745.0,1813.0,20099.0
Kheda,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2770.0,3542.0,4554.0,4010.0,3932.0,3989.0,3811.0,3585.0,3411.0,3601.0,3739.0,3883.0,44827.0
Kheda,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,189.0,68.0,67.0,86.0,4866.0,133.0,110.0,112.0,120.0,106.0,4783.0,1374.0,12014.0
Kheda,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,145.0,2.0,0.0,5.0,4694.0,52.0,123.0,17.0,16.0,0.0,4560.0,1231.0,10845.0
Kheda,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,0.0,8.0,0.0,0.0,0.0,1.0,13.0,19.0,3.0,1.0,10.0,58.0
Kheda,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1247.0,1883.0,1911.0,1659.0,1962.0,1984.0,1918.0,2004.0,2040.0,2038.0,2287.0,1920.0,22853.0
Kheda,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,10.0,4.0,2.0,2.0,0.0,0.0,0.0,1.0,4.0,24.0,47.0
Kheda,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,8.0,6.0,2.0,2.0,6.0,10.0,10.0,11.0,18.0,16.0,76.0,45.0,210.0
Kheda,13.1,Number of Patients operated for cataract,TOTAL,98.0,83.0,82.0,100.0,115.0,272.0,171.0,130.0,158.0,144.0,140.0,132.0,1625.0
Kheda,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,98.0,83.0,82.0,100.0,115.0,165.0,171.0,130.0,158.0,144.0,140.0,107.0,1493.0
Kheda,13.3,Number of School children detected with Refractive errors,TOTAL,604.0,605.0,0.0,38.0,51.0,220.0,251.0,451.0,33755.0,39780.0,47677.0,43955.0,167387.0
Kheda,13.4,Number of children provided free glasses,TOTAL,604.0,605.0,0.0,0.0,0.0,0.0,0.0,0.0,610.0,170.0,862.0,943.0,3794.0
Kheda,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,4.0,4.0,4.0,4.0,5.0,5.0,6.0,3.0,4.0,4.0,4.0,-1.0
Kheda,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,16.0,13.0,14.0,13.0,15.0,14.0,15.0,12.0,16.0,18.0,14.0,18.0,-1.0
Kheda,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1724.0,672.0,922.0,872.0,881.0,733.0,756.0,743.0,757.0,817.0,827.0,844.0,-1.0
Kheda,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,8.0,7.0,9.0,8.0,8.0,9.0,9.0,7.0,8.0,10.0,9.0,-1.0
Kheda,14.05,Number of RKS meetings held during the month,TOTAL,17.0,17.0,16.0,23.0,19.0,13.0,14.0,10.0,15.0,12.0,14.0,17.0,187.0
Kheda,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,22.0,21.0,24.0,18.0,21.0,15.0,17.0,14.0,16.0,21.0,17.0,21.0,-1.0
Kheda,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,24.0,18.0,16.0,53.0,10.0,15.0,16.0,42.0,21.0,18.0,49.0,56.0,338.0
Kheda,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,5.0,3.0,3.0,4.0,7.0,6.0,5.0,4.0,6.0,6.0,5.0,-1.0
Kheda,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,4.0,5.0,4.0,5.0,4.0,4.0,4.0,4.0,3.0,4.0,4.0,-1.0
Kheda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,327.0,313.0,380.0,293.0,376.0,593.0,314.0,156.0,297.0,181.0,457.0,721.0,4408.0
Kheda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1098.0,1213.0,1543.0,1230.0,1353.0,1307.0,1306.0,817.0,1192.0,736.0,1238.0,1156.0,14189.0
Kheda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,375.0,340.0,398.0,343.0,458.0,1270.0,323.0,218.0,393.0,294.0,493.0,794.0,5699.0
Kheda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2008.0,2425.0,3055.0,2666.0,2874.0,2629.0,2868.0,2556.0,3335.0,2299.0,3028.0,2535.0,32278.0
Kheda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,702.0,653.0,778.0,636.0,834.0,1863.0,637.0,374.0,690.0,475.0,950.0,1515.0,10107.0
Kheda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3106.0,3638.0,4598.0,3896.0,4227.0,3936.0,4174.0,3373.0,4527.0,3035.0,4266.0,3691.0,46467.0
Kheda,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,8.0,5.0,6.0,7.0,5.0,7.0,3.0,13.0,7.0,5.0,14.0,85.0
Kheda,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,1.0,2.0,4.0,1.0,4.0,3.0,2.0,6.0,4.0,1.0,3.0,33.0
Kheda,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,7.0,9.0,7.0,10.0,8.0,9.0,10.0,5.0,19.0,11.0,6.0,17.0,118.0
Kheda,14.11,In-Patient Head Count at midnight,TOTAL,599.0,1085.0,1606.0,1244.0,2158.0,315.0,1235.0,1618.0,1184.0,1121.0,1485.0,1522.0,15172.0
Kheda,14.12.1,OPD attendance (All),TOTAL,40035.0,56175.0,71654.0,66847.0,69996.0,77726.0,58712.0,49499.0,54248.0,43907.0,70264.0,72411.0,731474.0
Kheda,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,141.0,129.0,133.0,164.0,102.0,159.0,92.0,55.0,491.0,284.0,212.0,139.0,2101.0
Kheda,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,207.0,155.0,230.0,115.0,189.0,277.0,230.0,490.0,385.0,194.0,330.0,268.0,3070.0
Kheda,14.14.a,Number of patients given AYUSH treatment,TOTAL,1616.0,747.0,935.0,773.0,820.0,796.0,914.0,1352.0,1536.0,1422.0,2383.0,1801.0,15095.0
Kheda,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,252.0,270.0,486.0,397.0,341.0,319.0,236.0,388.0,336.0,327.0,341.0,391.0,4084.0
Kheda,14.14.c,Number of Adolescents counselled,TOTAL,424.0,127.0,682.0,17.0,76.0,10.0,187.0,62.0,1.0,71.0,50.0,50.0,1757.0
Kheda,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,12128.0,10770.0,13448.0,14334.0,11843.0,15818.0,12188.0,10929.0,13853.0,8977.0,18626.0,12764.0,155678.0
Kheda,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,462.0,380.0,550.0,593.0,421.0,474.0,2768.0,433.0,431.0,418.0,8722.0,400.0,16052.0
Kheda,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,381.0,366.0,706.0,493.0,492.0,626.0,475.0,482.0,830.0,348.0,603.0,608.0,6410.0
Kheda,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,13.0,20.0,36.0,25.0,29.0,32.0,20.0,22.0,15.0,23.0,25.0,24.0,284.0
Kheda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,265.0,391.0,456.0,470.0,348.0,400.0,391.0,358.0,544.0,455.0,512.0,590.0,5180.0
Kheda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,7.0,18.0,21.0,13.0,12.0,9.0,10.0,10.0,10.0,7.0,8.0,11.0,136.0
Kheda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1432.0,1554.0,2525.0,1894.0,1397.0,1637.0,1049.0,1314.0,1283.0,1160.0,1597.0,1878.0,18720.0
Kheda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,42.0,33.0,12.0,10.0,10.0,28.0,3.0,4.0,2.0,3.0,45.0,11.0,203.0
Kheda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2078.0,2311.0,3687.0,2857.0,2237.0,2663.0,1915.0,2154.0,2657.0,1963.0,2712.0,3076.0,30310.0
Kheda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,62.0,71.0,69.0,48.0,51.0,69.0,33.0,36.0,27.0,33.0,78.0,46.0,623.0
Kheda,15.2,Number of Widal tests conducted,Number tested,224.0,416.0,403.0,533.0,605.0,617.0,557.0,429.0,300.0,249.0,622.0,591.0,5546.0
Kheda,15.3.a,Number of VDRL tests conducted on males,Number tested,127.0,184.0,361.0,169.0,232.0,252.0,186.0,149.0,162.0,114.0,217.0,237.0,2390.0
Kheda,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,112.0,178.0,269.0,181.0,174.0,218.0,162.0,142.0,167.0,121.0,266.0,283.0,2273.0
Kheda,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,371.0,339.0,813.0,488.0,402.0,546.0,363.0,410.0,335.0,260.0,529.0,527.0,5383.0
Kheda,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,610.0,701.0,1443.0,838.0,808.0,1016.0,711.0,701.0,664.0,495.0,1012.0,1047.0,10046.0
Kheda,15.4.1,Number of blood smears examined for Malaria,TOTAL,21600.0,24580.0,30087.0,26483.0,39020.0,42610.0,28134.0,24101.0,20846.0,15993.0,29760.0,30319.0,333533.0
Kheda,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,7.0,18.0,28.0,41.0,46.0,57.0,14.0,9.0,198.0,1.0,4.0,1.0,424.0
Kheda,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,5.0,1.0,0.0,0.0,0.0,0.0,8.0
Kheda,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,11000.0,2750.0,3080.0,80.0,4650.0,12300.0,16400.0,19700.0,13500.0,3150.0,8550.0,950.0,96110.0
Kheda,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2500.0,7500.0,7500.0,12500.0,15000.0,15000.0,12000.0,4000.0,0.0,12000.0,0.0,23500.0,111500.0
Kheda,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,10750.0,7170.0,10500.0,7930.0,7350.0,10900.0,8700.0,10200.0,10350.0,6600.0,7600.0,9050.0,107100.0
Kheda,16.1.1,Stock position of DPT vaccines,5. Total Stock,2750.0,3080.0,80.0,4650.0,12300.0,16400.0,19700.0,13500.0,3150.0,8550.0,950.0,15400.0,100510.0
Kheda,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,16550.0,9900.0,15550.0,29600.0,22650.0,15750.0,7650.0,37350.0,20950.0,7300.0,25950.0,13050.0,222250.0
Kheda,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,6000.0,21000.0,27000.0,6000.0,3000.0,6000.0,39000.0,2000.0,0.0,30000.0,0.0,15000.0,155000.0
Kheda,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,12650.0,15350.0,12950.0,12950.0,9900.0,14100.0,9300.0,18400.0,13650.0,11350.0,12900.0,14200.0,157700.0
Kheda,16.1.1A,Stock Position of Pentavalent,5. Total Stock,9900.0,15550.0,29600.0,22650.0,15750.0,7650.0,37350.0,20950.0,7300.0,25950.0,13050.0,13850.0,219550.0
Kheda,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,5600.0,13280.0,45780.0,30680.0,26880.0,43480.0,20080.0,8380.0,15540.0,25530.0,20130.0,36730.0,292090.0
Kheda,16.1.2,Stock position of OPV vaccines,2. Stocks Received,30000.0,60000.0,15000.0,20000.0,40000.0,5000.0,7000.0,17000.0,447000.0,30000.0,450000.0,25000.0,1146000.0
Kheda,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,22320.0,27500.0,30100.0,23800.0,23400.0,28400.0,18700.0,9840.0,437010.0,35400.0,433400.0,28800.0,1118670.0
Kheda,16.1.2,Stock position of OPV vaccines,5. Total Stock,13280.0,45780.0,30680.0,26880.0,43480.0,20080.0,8380.0,15540.0,25530.0,20130.0,36730.0,32930.0,319420.0
Kheda,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,18850.0,5430.0,38180.0,42530.0,31030.0,30730.0,34780.0,32930.0,38130.0,22680.0,34550.0,20450.0,350270.0
Kheda,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,50000.0,20000.0,4000.0,12000.0,20000.0,10000.0,20000.0,0.0,24000.0,0.0,25000.0,185000.0
Kheda,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.1.3,Stock position of TT vaccines,4. Stock Distributed,13420.0,17250.0,15650.0,15500.0,12300.0,15950.0,11850.0,14800.0,15450.0,12130.0,14100.0,15070.0,173470.0
Kheda,16.1.3,Stock position of TT vaccines,5. Total Stock,5430.0,38180.0,42530.0,31030.0,30730.0,34780.0,32930.0,38130.0,22680.0,34550.0,20450.0,30380.0,361800.0
Kheda,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,10000.0,15700.0,17100.0,14350.0,10750.0,9200.0,20150.0,16200.0,17200.0,8450.0,20800.0,13250.0,173150.0
Kheda,16.1.5,Stock position of BCG vaccines,2. Stocks Received,14000.0,10000.0,5000.0,2500.0,5000.0,20000.0,5000.0,10000.0,0.0,20000.0,0.0,15000.0,106500.0
Kheda,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,8300.0,8600.0,15050.0,6100.0,6550.0,9050.0,8950.0,7920.0,8750.0,7650.0,7550.0,8000.0,102470.0
Kheda,16.1.5,Stock position of BCG vaccines,5. Total Stock,15700.0,17100.0,7050.0,10750.0,9200.0,20150.0,16200.0,18280.0,8450.0,20800.0,13250.0,20250.0,177180.0
Kheda,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,7080.0,680.0,500.0,4950.0,3400.0,8800.0,8475.0,13125.0,15205.0,6310.0,18960.0,10460.0,97945.0
Kheda,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1500.0,5000.0,19500.0,7500.0,12500.0,10000.0,10000.0,10000.0,0.0,20000.0,0.0,15000.0,111000.0
Kheda,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,7900.0,5180.0,15050.0,9050.0,7100.0,10325.0,5350.0,7920.0,8895.0,7350.0,8500.0,8700.0,101320.0
Kheda,16.1.6,Stock position of Measles vaccines,5. Total Stock,680.0,500.0,4950.0,3400.0,8800.0,8475.0,13125.0,15205.0,6310.0,18960.0,10460.0,16760.0,107625.0
Kheda,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,21530.0,21060.0,20160.0,18910.0,17160.0,15860.0,13910.0,12910.0,10710.0,8760.0,7310.0,5840.0,174120.0
Kheda,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,470.0,900.0,1250.0,1750.0,1300.0,1950.0,1000.0,2200.0,1950.0,1450.0,1470.0,1300.0,16990.0
Kheda,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,21060.0,20160.0,18910.0,17160.0,15860.0,13910.0,12910.0,10710.0,8760.0,7310.0,5840.0,4540.0,157130.0
Kheda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3600.0,1800.0,600.0,11400.0,3000.0,3000.0,0.0,0.0,0.0,0.0,12600.0,8950.0,44950.0
Kheda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,18600.0,0.0,0.0,0.0,0.0,0.0,0.0,12600.0,0.0,0.0,31200.0
Kheda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,1800.0,1200.0,7800.0,8400.0,0.0,3000.0,0.0,0.0,0.0,0.0,3650.0,1200.0,27050.0
Kheda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1800.0,600.0,11400.0,3000.0,3000.0,0.0,0.0,0.0,0.0,12600.0,8950.0,7750.0,49100.0
Kheda,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,12000.0,0.0,0.0,30000.0,24000.0,435360.0,35280.0,10080.0,40080.0,10080.0,52080.0,18000.0,666960.0
Kheda,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,42000.0,0.0,423360.0,0.0,0.0,30000.0,0.0,42000.0,0.0,186480.0,723840.0
Kheda,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,12000.0,0.0,12000.0,6000.0,12000.0,400080.0,25200.0,0.0,30000.0,0.0,34080.0,6000.0,537360.0
Kheda,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,30000.0,24000.0,435360.0,35280.0,10080.0,40080.0,10080.0,52080.0,18000.0,198480.0,853440.0
Kheda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3000.0,1800.0,600.0,41400.0,15400.0,26400.0,2400.0,2400.0,7400.0,4400.0,4400.0,2400.0,112000.0
Kheda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,47000.0,0.0,12000.0,0.0,0.0,5000.0,0.0,0.0,0.0,37500.0,101500.0
Kheda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1200.0,1200.0,6200.0,26000.0,1000.0,24000.0,0.0,0.0,3000.0,0.0,2000.0,0.0,64600.0
Kheda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1800.0,600.0,41400.0,15400.0,26400.0,2400.0,2400.0,7400.0,4400.0,4400.0,2400.0,39900.0,148900.0
Kheda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,600.0,300.0,300.0,300.0,300.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,2100.0
Kheda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,300.0,0.0,0.0,0.0,0.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0
Kheda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,300.0,300.0,300.0,300.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0
Kheda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3500.0,3400.0,3300.0,3300.0,2700.0,2400.0,2000.0,300.0,8200.0,3398.0,2298.0,598.0,35394.0
Kheda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9100.0,0.0,0.0,0.0,10000.0,19100.0
Kheda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,100.0,100.0,100.0,600.0,300.0,400.0,1700.0,1200.0,4802.0,1100.0,1700.0,398.0,12500.0
Kheda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3400.0,3300.0,3200.0,2700.0,2400.0,2000.0,300.0,8200.0,3398.0,2298.0,598.0,10200.0,41994.0
Kheda,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,6.0,12.0
Kheda,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0,0.0,45.0
Kheda,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,39.0,0.0,45.0
Kheda,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,6.0,12.0
Kheda,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,23000.0,18000.0,8000.0,80000.0,4000.0,4000.0,61500.0,7000.0,7000.0,7000.0,5000.0,13000.0,237500.0
Kheda,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,200000.0,0.0,0.0,890000.0,0.0,0.0,0.0,0.0,5063000.0,3000.0,6156000.0
Kheda,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,5000.0,1000.0,128000.0,76000.0,0.0,832500.0,54500.0,0.0,0.0,2000.0,5055000.0,3000.0,6157000.0
Kheda,16.3.07,Stock Position of IFA Tablets,5. Total Stock,18000.0,17000.0,80000.0,4000.0,4000.0,61500.0,7000.0,7000.0,7000.0,5000.0,13000.0,13000.0,236500.0
Kheda,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24000.0,24000.0
Kheda,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28000.0,0.0,28000.0
Kheda,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,0.0,4000.0
Kheda,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24000.0,24000.0,48000.0
Kheda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kheda,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,237.0,187.0,187.0,187.0,87.0,87.0,37.0,37.0,37.0,27.0,4627.0,165.0,5902.0
Kheda,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4600.0,0.0,0.0,4600.0
Kheda,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,50.0,0.0,0.0,100.0,0.0,50.0,0.0,0.0,0.0,0.0,4462.0,0.0,4662.0
Kheda,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,187.0,187.0,187.0,87.0,87.0,37.0,37.0,37.0,37.0,4627.0,165.0,165.0,5840.0
Kheda,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,500.0,0.0,0.0,0.0,0.0,39000.0,39500.0
Kheda,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,96000.0,0.0,106000.0
Kheda,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,9500.0,500.0,0.0,0.0,0.0,57000.0,0.0,67000.0
Kheda,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,500.0,0.0,0.0,0.0,0.0,39000.0,39000.0,78500.0
Kheda,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3800.0,8000.0,6200.0,52800.0,47700.0,43000.0,32300.0,25200.0,17700.0,7600.0,3600.0,10900.0,258800.0
Kheda,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,13200.0,0.0,52800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9900.0,0.0,75900.0
Kheda,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,9000.0,1800.0,52800.0,5100.0,4700.0,10700.0,7100.0,7500.0,10100.0,4000.0,2600.0,5600.0,121000.0
Kheda,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8000.0,6200.0,6200.0,47700.0,43000.0,32300.0,25200.0,17700.0,7600.0,3600.0,10900.0,5300.0,213700.0
Kheda,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,400.0,56000.0,50200.0,30000.0,17600.0,129600.0,32400.0,29400.0,95200.0,131500.0,116700.0,139100.0,828100.0
Kheda,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,78000.0,0.0,0.0,0.0,120000.0,0.0,0.0,69000.0,60000.0,0.0,42000.0,0.0,369000.0
Kheda,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Kheda,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,22400.0,5800.0,0.0,12400.0,8000.0,97200.0,3000.0,3200.0,23700.0,14800.0,19600.0,30200.0,240300.0
Kheda,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,56000.0,50200.0,50200.0,17600.0,129600.0,32400.0,29400.0,95200.0,131500.0,116700.0,139100.0,108900.0,956800.0
Kheda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,6400.0,2900.0,2400.0,8800.0,6900.0,5100.0,600.0,600.0,20600.0,15700.0,14400.0,12900.0,97300.0
Kheda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,20000.0,0.0,0.0,0.0,0.0,30000.0
Kheda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,600.0,0.0,0.0,,,,600.0
Kheda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3500.0,500.0,10000.0,1900.0,1800.0,4500.0,0.0,,4900.0,1300.0,1500.0,2800.0,32700.0
Kheda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2900.0,2400.0,2400.0,6900.0,5100.0,600.0,0.0,20600.0,15700.0,14400.0,12900.0,10100.0,94000.0
Kheda,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Kheda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kheda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kheda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Kheda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,3.0,2.0,4.0,2.0,,7.0,2.0,6.0,1.0,2.0,,2.0,31.0
Kheda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kheda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,3.0,2.0,4.0,2.0,,7.0,2.0,6.0,1.0,2.0,,2.0,31.0
Kheda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,3.0,2.0,1.0,1.0,2.0,8.0,4.0,6.0,5.0,,2.0,2.0,36.0
Kheda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,1.0,1.0,2.0,,,,,4.0
Kheda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,2.0,1.0,1.0,2.0,9.0,5.0,8.0,5.0,,2.0,2.0,40.0
Kheda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,9.0,4.0,3.0,5.0,3.0,2.0,5.0,1.0,,,,33.0
Kheda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kheda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,9.0,4.0,3.0,5.0,3.0,2.0,5.0,1.0,,,,33.0
Kheda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kheda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kheda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Kheda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kheda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kheda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Kheda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kheda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kheda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Kheda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kheda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kheda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kheda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,2.0,3.0,,2.0,4.0,1.0,2.0,,,,,17.0
Kheda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,,1.0,,,1.0,2.0,1.0,,,2.0,,9.0
Kheda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,2.0,4.0,,2.0,5.0,3.0,3.0,,,2.0,,26.0
Kheda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Kheda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Kheda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Kheda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Kheda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,1.0,1.0,,,2.0
Kheda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,1.0,1.0,,,2.0
Kheda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Kheda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Kheda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Kheda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Kheda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Kheda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kheda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,1.0,,,,1.0
Kheda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Kheda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,1.0,,,1.0
Kheda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Kheda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Kheda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kheda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kheda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kheda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Kheda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kheda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Kheda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Kheda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kheda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Kheda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Kheda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kheda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Kheda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kheda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kheda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kheda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Kheda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kheda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,1.0,1.0
Kheda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Kheda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Kheda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Kheda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Kheda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Kheda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Kheda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Kheda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Kheda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Kheda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Kheda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Kheda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Kheda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Kheda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Mahesana,1.1,Total number of pregnant women Registered for ANC,TOTAL,4197.0,3817.0,3903.0,3565.0,3105.0,2960.0,3015.0,3467.0,3269.0,3598.0,3658.0,3344.0,41898.0
Mahesana,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3807.0,3426.0,3434.0,3128.0,2679.0,2578.0,2683.0,3086.0,2963.0,3253.0,3335.0,2982.0,37354.0
Mahesana,1.2,Number of Pregnant women registered under JSY,TOTAL,874.0,861.0,1059.0,818.0,776.0,793.0,669.0,904.0,818.0,920.0,908.0,893.0,10293.0
Mahesana,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3659.0,3506.0,3484.0,3265.0,3051.0,3080.0,2963.0,3176.0,3039.0,3186.0,3282.0,3193.0,38884.0
Mahesana,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3759.0,3441.0,3485.0,3232.0,2824.0,2667.0,2743.0,3103.0,2983.0,3193.0,3381.0,3055.0,37866.0
Mahesana,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3457.0,3769.0,3497.0,3440.0,3011.0,2888.0,2988.0,2943.0,3199.0,3368.0,3410.0,3297.0,39267.0
Mahesana,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3427.0,3169.0,3319.0,3254.0,2969.0,2981.0,2815.0,3009.0,2816.0,3002.0,3050.0,2896.0,36707.0
Mahesana,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,15.0,37.0,44.0,26.0,23.0,25.0,18.0,29.0,10.0,6.0,4.0,5.0,242.0
Mahesana,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,1.0,6.0,0.0,3.0,3.0,0.0,0.0,1.0,14.0
Mahesana,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2971.0,3100.0,3158.0,2842.0,2497.0,2301.0,2290.0,2395.0,2484.0,2589.0,2579.0,2655.0,31861.0
Mahesana,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,101.0,58.0,104.0,92.0,77.0,110.0,64.0,54.0,49.0,52.0,69.0,61.0,891.0
Mahesana,1.8,Number of pregnancy test kits used at SC level,TOTAL,1018.0,1300.0,1203.0,1188.0,1138.0,1169.0,1031.0,1216.0,1341.0,1278.0,1294.0,1070.0,14246.0
Mahesana,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,4.0
Mahesana,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1.0,2.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,11.0
Mahesana,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1.0,3.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,3.0,2.0,1.0,15.0
Mahesana,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,3.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,3.0,2.0,1.0,12.0
Mahesana,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mahesana,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,914.0,1015.0,980.0,1127.0,1159.0,1295.0,1163.0,1103.0,1180.0,1106.0,891.0,860.0,12793.0
Mahesana,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,590.0,628.0,623.0,690.0,728.0,591.0,587.0,577.0,591.0,514.0,455.0,478.0,7052.0
Mahesana,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,117.0,110.0,138.0,169.0,166.0,190.0,122.0,121.0,132.0,120.0,111.0,199.0,1695.0
Mahesana,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,9.0,5.0,6.0,26.0,18.0,13.0,26.0,22.0,5.0,9.0,10.0,9.0,158.0
Mahesana,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1921.0,2056.0,1861.0,1679.0,2152.0,2049.0,2038.0,2238.0,1885.0,1944.0,1732.0,1866.0,23421.0
Mahesana,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,48.0,25.0,37.0,134.0,44.0,56.0,50.0,55.0,42.0,53.0,64.0,38.0,646.0
Mahesana,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,24.0,13.0,22.0,21.0,19.0,30.0,32.0,32.0,22.0,32.0,46.0,32.0,325.0
Mahesana,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,41.0,44.0,55.0,39.0,46.0,51.0,49.0,35.0,67.0,55.0,31.0,37.0,550.0
Mahesana,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,18.0,24.0,30.0,26.0,29.0,28.0,27.0,21.0,27.0,32.0,18.0,19.0,299.0
Mahesana,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahesana,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,59.0,68.0,85.0,65.0,75.0,79.0,76.0,56.0,94.0,87.0,49.0,56.0,849.0
Mahesana,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,287.0,278.0,276.0,269.0,342.0,295.0,320.0,317.0,312.0,222.0,266.0,200.0,3384.0
Mahesana,4.1.1.a,Number of male live births,TOTAL,1473.0,1620.0,1491.0,1440.0,1747.0,1716.0,1661.0,1703.0,1610.0,1592.0,1341.0,1395.0,18789.0
Mahesana,4.1.1.b,Number of female live births,TOTAL,1329.0,1407.0,1309.0,1318.0,1515.0,1567.0,1499.0,1616.0,1396.0,1405.0,1238.0,1308.0,16907.0
Mahesana,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2802.0,3027.0,2800.0,2758.0,3262.0,3283.0,3160.0,3319.0,3006.0,2997.0,2579.0,2703.0,35696.0
Mahesana,4.1.2,Number of still births,TOTAL,62.0,55.0,58.0,60.0,65.0,69.0,52.0,43.0,65.0,71.0,55.0,43.0,698.0
Mahesana,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,60.0,68.0,74.0,38.0,36.0,35.0,31.0,47.0,38.0,45.0,28.0,32.0,532.0
Mahesana,4.2.1,Number of Newborns weighed at birth,TOTAL,2800.0,3027.0,2800.0,2758.0,3262.0,3283.0,3160.0,3315.0,3005.0,2997.0,2577.0,2702.0,35686.0
Mahesana,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,288.0,354.0,291.0,280.0,373.0,406.0,386.0,386.0,414.0,422.0,297.0,292.0,4189.0
Mahesana,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2411.0,2750.0,2522.0,2492.0,2895.0,2949.0,2927.0,2983.0,2722.0,2725.0,2336.0,2513.0,32225.0
Mahesana,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,1.0,2.0,0.0,5.0,1.0,7.0,1.0,3.0,0.0,20.0
Mahesana,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,12.0,18.0,4.0,11.0,10.0,9.0,13.0,11.0,12.0,12.0,8.0,3.0,123.0
Mahesana,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,26.0,87.0,46.0,53.0,65.0,68.0,84.0,30.0,34.0,40.0,26.0,25.0,584.0
Mahesana,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahesana,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,38.0,105.0,50.0,65.0,77.0,77.0,102.0,42.0,53.0,53.0,37.0,28.0,727.0
Mahesana,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,59.0,60.0,51.0,62.0,92.0,60.0,75.0,46.0,53.0,76.0,62.0,56.0,752.0
Mahesana,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,66.0,116.0,89.0,106.0,124.0,80.0,103.0,61.0,91.0,81.0,70.0,61.0,1048.0
Mahesana,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,33.0,52.0,44.0,35.0,57.0,26.0,48.0,22.0,24.0,15.0,13.0,16.0,385.0
Mahesana,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,69.0,137.0,77.0,120.0,169.0,85.0,107.0,45.0,61.0,64.0,48.0,43.0,1025.0
Mahesana,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,24.0,42.0,20.0,32.0,42.0,51.0,34.0,28.0,26.0,18.0,25.0,21.0,363.0
Mahesana,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2834.0,3040.0,2818.0,2791.0,3212.0,3205.0,3160.0,3305.0,3053.0,3022.0,2623.0,2715.0,35778.0
Mahesana,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2350.0,2402.0,2482.0,2359.0,2641.0,2596.0,2748.0,2941.0,2623.0,2479.0,2048.0,2008.0,29677.0
Mahesana,6.3,PNC maternal complications attended,TOTAL,6.0,6.0,76.0,25.0,74.0,67.0,64.0,25.0,26.0,33.0,23.0,24.0,449.0
Mahesana,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,9.0,13.0,11.0,3.0,7.0,7.0,2.0,9.0,13.0,9.0,7.0,13.0,103.0
Mahesana,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Mahesana,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,9.0,14.0,11.0,3.0,7.0,8.0,2.0,9.0,13.0,9.0,7.0,13.0,105.0
Mahesana,7.2,Number of MTPs conducted at Private Facilities,TOTAL,61.0,65.0,52.0,48.0,21.0,50.0,35.0,58.0,14.0,11.0,7.0,16.0,438.0
Mahesana,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,148.0,179.0,194.0,202.0,176.0,184.0,260.0,195.0,255.0,222.0,213.0,232.0,2460.0
Mahesana,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,408.0,518.0,531.0,411.0,430.0,453.0,546.0,467.0,468.0,452.0,486.0,474.0,5644.0
Mahesana,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,556.0,697.0,725.0,613.0,606.0,637.0,806.0,662.0,723.0,674.0,699.0,706.0,8104.0
Mahesana,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,2.0,2.0,1.0,7.0,14.0,7.0,3.0,8.0,44.0
Mahesana,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahesana,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,2.0,2.0,1.0,7.0,14.0,7.0,3.0,8.0,44.0
Mahesana,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Mahesana,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,69.0,52.0,91.0,131.0,85.0,118.0,99.0,400.0,641.0,474.0,255.0,31.0,2446.0
Mahesana,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,180.0,128.0,134.0,162.0,164.0,169.0,155.0,570.0,801.0,718.0,395.0,176.0,3752.0
Mahesana,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahesana,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,249.0,180.0,225.0,293.0,249.0,287.0,254.0,970.0,1442.0,1192.0,650.0,207.0,6198.0
Mahesana,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,213.0,201.0,180.0,259.0,270.0,236.0,250.0,265.0,261.0,396.0,445.0,501.0,3477.0
Mahesana,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,9.0,10.0,10.0,18.0,10.0,31.0,0.0,53.0,96.0,0.0,63.0,3.0,303.0
Mahesana,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,13.0,9.0,19.0,28.0,6.0,8.0,2.0,2.0,25.0,11.0,14.0,16.0,153.0
Mahesana,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahesana,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,22.0,19.0,29.0,46.0,16.0,39.0,2.0,55.0,121.0,11.0,77.0,19.0,456.0
Mahesana,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,190.0,268.0,272.0,325.0,412.0,385.0,471.0,471.0,510.0,578.0,494.0,434.0,4810.0
Mahesana,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,2.0,4.0,3.0,7.0,10.0,3.0,9.0,15.0,13.0,17.0,9.0,93.0
Mahesana,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahesana,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,2.0,4.0,3.0,7.0,10.0,3.0,9.0,15.0,13.0,17.0,9.0,93.0
Mahesana,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,45.0,29.0,70.0,58.0,85.0,97.0,161.0,122.0,142.0,186.0,156.0,161.0,1312.0
Mahesana,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,2063.0,2247.0,2297.0,2332.0,2228.0,2293.0,2238.0,2440.0,2383.0,2285.0,2121.0,1703.0,26630.0
Mahesana,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,86.0,103.0,129.0,153.0,93.0,115.0,138.0,146.0,176.0,117.0,126.0,112.0,1494.0
Mahesana,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,14.0,17.0,18.0,15.0,15.0,17.0,15.0,12.0,23.0,22.0,25.0,20.0,213.0
Mahesana,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,159.0,183.0,211.0,186.0,161.0,117.0,67.0,86.0,49.0,66.0,26.0,51.0,1362.0
Mahesana,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahesana,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,2322.0,2550.0,2655.0,2686.0,2497.0,2542.0,2458.0,2684.0,2631.0,2490.0,2298.0,1886.0,29699.0
Mahesana,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,65.0,53.0,75.0,22.0,69.0,25.0,28.0,57.0,18.0,37.0,11.0,20.0,480.0
Mahesana,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,626.0,660.0,696.0,731.0,801.0,793.0,761.0,770.0,736.0,994.0,1178.0,1127.0,9873.0
Mahesana,9.06,Number of IUCD removals,TOTAL,559.0,546.0,653.0,590.0,634.0,588.0,590.0,735.0,653.0,732.0,748.0,753.0,7781.0
Mahesana,9.07,Number of Oral Pills cycles distributed,TOTAL,11748.0,10677.0,11948.0,12943.0,13584.0,13490.0,13774.0,12696.0,13945.0,14200.0,13249.0,12457.0,154711.0
Mahesana,9.08,Number of Condom pieces distributed,TOTAL,179404.0,121767.0,104767.0,98569.0,133435.0,143932.0,152491.0,130539.0,128733.0,125496.0,114534.0,130755.0,1564422.0
Mahesana,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,10.0,5.0,21.0,20.0,22.0,11.0,9.0,7.0,2.0,1.0,0.0,2.0,110.0
Mahesana,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Mahesana,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,9.12,Number of Institutions having NSV trained doctors,TOTAL,13.0,11.0,12.0,11.0,14.0,18.0,18.0,18.0,19.0,15.0,14.0,14.0,-1.0
Mahesana,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2659.0,2748.0,2768.0,2740.0,2932.0,2845.0,3041.0,3371.0,3281.0,3132.0,2576.0,2546.0,34639.0
Mahesana,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2.0,3.0,0.0,0.0,8.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Mahesana,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,12.0,2.0,0.0,1.0,8.0,2.0,1.0,1.0,1.0,1.0,0.0,1.0,30.0
Mahesana,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4.0,3.0,2.0,1.0,8.0,1.0,1.0,0.0,0.0,1.0,2.0,0.0,23.0
Mahesana,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3005.0,2882.0,2813.0,2992.0,2883.0,3110.0,3192.0,3407.0,3281.0,3337.0,2989.0,2866.0,36757.0
Mahesana,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3024.0,2927.0,2857.0,2893.0,2839.0,2864.0,2999.0,3088.0,3276.0,3183.0,3172.0,3148.0,36270.0
Mahesana,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3152.0,3008.0,3014.0,2847.0,2859.0,2968.0,2839.0,3125.0,3113.0,3118.0,3033.0,3174.0,36250.0
Mahesana,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2152.0,2253.0,2211.0,2460.0,2689.0,2590.0,2742.0,2854.0,2889.0,2651.0,2204.0,2130.0,29825.0
Mahesana,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3012.0,2881.0,2820.0,3001.0,2888.0,3101.0,3202.0,3407.0,3283.0,3359.0,2996.0,2891.0,36841.0
Mahesana,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3036.0,2927.0,2872.0,2892.0,2838.0,2842.0,2995.0,3097.0,3280.0,3183.0,3177.0,3166.0,36305.0
Mahesana,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3159.0,3015.0,3027.0,2847.0,2854.0,2945.0,2836.0,3118.0,3102.0,3122.0,3036.0,3184.0,36245.0
Mahesana,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,615.0,619.0,617.0,687.0,688.0,745.0,842.0,878.0,974.0,839.0,677.0,712.0,8893.0
Mahesana,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,13.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Mahesana,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,1.0,4.0,2.0,1.0,1.0,1.0,1.0,0.0,0.0,11.0
Mahesana,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,2.0,1.0,3.0,1.0,1.0,0.0,0.0,1.0,2.0,0.0,11.0
Mahesana,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2987.0,3373.0,3386.0,3271.0,3221.0,3065.0,3020.0,2999.0,2780.0,2953.0,2855.0,3124.0,37034.0
Mahesana,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2863.0,2836.0,2847.0,2825.0,2646.0,2702.0,2747.0,2682.0,2784.0,2930.0,2808.0,2927.0,33597.0
Mahesana,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1549.0,1753.0,1750.0,1681.0,1703.0,1616.0,1581.0,1531.0,1434.0,1555.0,1546.0,1570.0,19269.0
Mahesana,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1372.0,1561.0,1541.0,1489.0,1464.0,1356.0,1389.0,1341.0,1248.0,1358.0,1277.0,1455.0,16851.0
Mahesana,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2921.0,3314.0,3291.0,3170.0,3167.0,2972.0,2970.0,2872.0,2682.0,2913.0,2823.0,3025.0,36120.0
Mahesana,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2954.0,2889.0,2907.0,2776.0,2708.0,2688.0,2750.0,2699.0,2760.0,2932.0,2800.0,2931.0,33794.0
Mahesana,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2949.0,2888.0,2925.0,2765.0,2690.0,2680.0,2741.0,2697.0,2751.0,2933.0,2800.0,2899.0,33718.0
Mahesana,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,216.0,178.0,185.0,69.0,93.0,93.0,86.0,77.0,90.0,121.0,74.0,158.0,1440.0
Mahesana,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,204.0,173.0,184.0,72.0,84.0,92.0,78.0,77.0,94.0,101.0,71.0,137.0,1367.0
Mahesana,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,420.0,351.0,369.0,141.0,177.0,185.0,164.0,154.0,184.0,222.0,145.0,295.0,2807.0
Mahesana,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1346.0,1558.0,1798.0,4131.0,7989.0,3673.0,2096.0,2047.0,2682.0,1630.0,2198.0,1397.0,32545.0
Mahesana,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1145.0,1258.0,1515.0,5617.0,10606.0,4707.0,1558.0,2267.0,2789.0,1765.0,1934.0,1060.0,36221.0
Mahesana,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1540.0,1771.0,1915.0,4578.0,7885.0,3092.0,2327.0,3092.0,2729.0,1591.0,2377.0,1212.0,34109.0
Mahesana,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,0.0,1.0,0.0,2.0,1.0,0.0,7.0
Mahesana,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,6.0
Mahesana,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1497.0,1486.0,1452.0,1463.0,1454.0,1466.0,1543.0,1478.0,1516.0,1560.0,1565.0,1583.0,18063.0
Mahesana,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1494.0,1478.0,1445.0,1451.0,1450.0,1464.0,1535.0,1479.0,1516.0,1549.0,1553.0,1557.0,17971.0
Mahesana,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1471.0,1459.0,1428.0,1431.0,1429.0,1406.0,1475.0,1450.0,1486.0,1522.0,1537.0,1527.0,17621.0
Mahesana,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2813.0,3113.0,3148.0,3115.0,4121.0,2966.0,2880.0,2817.0,2642.0,2785.0,2722.0,2979.0,36101.0
Mahesana,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,199.0,49.0,19.0,24.0,10480.0,3330.0,18.0,33.0,30.0,35.0,10050.0,8369.0,32636.0
Mahesana,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,105.0,48.0,0.0,16.0,10556.0,3185.0,0.0,16.0,0.0,0.0,8387.0,8485.0,30798.0
Mahesana,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,1.0,0.0,0.0,16.0,0.0,0.0,17.0,7.0,0.0,0.0,6.0,49.0
Mahesana,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1193.0,1466.0,1408.0,1459.0,2041.0,1676.0,1325.0,1310.0,1179.0,1233.0,1310.0,1272.0,16872.0
Mahesana,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,7.0,3.0,1.0,6.0,1.0,1.0,0.0,0.0,0.0,2.0,2.0,24.0
Mahesana,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,156.0,31.0,30.0,38.0,57.0,256.0,171.0,185.0,158.0,151.0,313.0,265.0,1811.0
Mahesana,13.1,Number of Patients operated for cataract,TOTAL,489.0,529.0,307.0,558.0,699.0,477.0,354.0,559.0,591.0,683.0,681.0,525.0,6452.0
Mahesana,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,489.0,359.0,264.0,397.0,497.0,476.0,354.0,557.0,590.0,679.0,661.0,499.0,5822.0
Mahesana,13.3,Number of School children detected with Refractive errors,TOTAL,37.0,26.0,49.0,107.0,175.0,132.0,69.0,133.0,31878.0,12920.0,2460.0,372.0,48358.0
Mahesana,13.4,Number of children provided free glasses,TOTAL,62.0,19.0,32.0,14.0,144.0,192.0,65.0,140.0,800.0,1447.0,1046.0,236.0,4197.0
Mahesana,13.5,Number of eyes collected through eye donation,TOTAL,3.0,4.0,0.0,2.0,7.0,2.0,4.0,2.0,5.0,4.0,5.0,4.0,42.0
Mahesana,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,4.0,0.0,2.0,6.0,1.0,4.0,2.0,5.0,4.0,5.0,4.0,37.0
Mahesana,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,8.0,8.0,7.0,8.0,6.0,4.0,5.0,6.0,6.0,5.0,-1.0
Mahesana,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,10.0,9.0,10.0,9.0,10.0,15.0,15.0,17.0,14.0,12.0,10.0,9.0,-1.0
Mahesana,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,588.0,561.0,665.0,596.0,613.0,566.0,577.0,602.0,582.0,553.0,615.0,653.0,-1.0
Mahesana,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,17.0,18.0,19.0,18.0,17.0,18.0,16.0,17.0,17.0,18.0,17.0,16.0,-1.0
Mahesana,14.05,Number of RKS meetings held during the month,TOTAL,6.0,9.0,38.0,16.0,14.0,21.0,8.0,15.0,27.0,18.0,13.0,26.0,211.0
Mahesana,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,35.0,30.0,34.0,32.0,30.0,37.0,32.0,36.0,34.0,32.0,32.0,32.0,-1.0
Mahesana,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,479.0,498.0,448.0,455.0,474.0,435.0,456.0,360.0,532.0,570.0,509.0,424.0,5640.0
Mahesana,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,6.0,7.0,7.0,5.0,6.0,4.0,5.0,5.0,8.0,8.0,7.0,-1.0
Mahesana,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,12.0,11.0,12.0,10.0,9.0,11.0,10.0,12.0,12.0,9.0,10.0,9.0,-1.0
Mahesana,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,510.0,600.0,443.0,462.0,764.0,874.0,473.0,674.0,709.0,814.0,835.0,824.0,7982.0
Mahesana,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2872.0,2885.0,2776.0,2865.0,3650.0,3248.0,1940.0,2262.0,2409.0,2487.0,2747.0,2792.0,32933.0
Mahesana,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,417.0,528.0,376.0,427.0,556.0,704.0,380.0,539.0,674.0,640.0,863.0,905.0,7009.0
Mahesana,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3918.0,3930.0,3873.0,3968.0,5138.0,4816.0,3043.0,4018.0,4583.0,4068.0,4378.0,4198.0,49931.0
Mahesana,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,927.0,1128.0,819.0,889.0,1320.0,1578.0,853.0,1213.0,1383.0,1454.0,1698.0,1729.0,14991.0
Mahesana,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6790.0,6815.0,6649.0,6833.0,8788.0,8064.0,4983.0,6280.0,6992.0,6555.0,7125.0,6990.0,82864.0
Mahesana,14.10.2.a,Number of death cases of Inpatient males,TOTAL,26.0,31.0,30.0,18.0,39.0,23.0,30.0,26.0,30.0,22.0,31.0,39.0,345.0
Mahesana,14.10.2.b,Number of death cases of Inpatient females,TOTAL,18.0,21.0,14.0,11.0,10.0,14.0,14.0,17.0,16.0,13.0,19.0,17.0,184.0
Mahesana,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,44.0,52.0,44.0,29.0,49.0,37.0,44.0,43.0,46.0,35.0,50.0,56.0,529.0
Mahesana,14.11,In-Patient Head Count at midnight,TOTAL,2516.0,2803.0,2445.0,2612.0,3006.0,3390.0,2633.0,2781.0,2649.0,2733.0,3041.0,2740.0,33349.0
Mahesana,14.12.1,OPD attendance (All),TOTAL,130740.0,125661.0,124175.0,140480.0,167194.0,181721.0,138673.0,136344.0,194423.0,129010.0,211806.0,181001.0,1861228.0
Mahesana,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,414.0,290.0,372.0,497.0,371.0,421.0,324.0,783.0,895.0,823.0,694.0,524.0,6408.0
Mahesana,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,12.0,19.0,25.0,29.0,23.0,23.0,11.0,14.0,31.0,21.0,18.0,16.0,242.0
Mahesana,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,451.0,505.0,562.0,925.0,995.0,881.0,720.0,881.0,1484.0,1045.0,1119.0,984.0,10552.0
Mahesana,14.14.a,Number of patients given AYUSH treatment,TOTAL,7555.0,7036.0,7602.0,8406.0,8224.0,9160.0,7483.0,7747.0,9381.0,9159.0,9709.0,9669.0,101131.0
Mahesana,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1666.0,1837.0,2173.0,2250.0,2010.0,2031.0,1682.0,1688.0,2030.0,1920.0,1673.0,1980.0,22940.0
Mahesana,14.14.c,Number of Adolescents counselled,TOTAL,181.0,185.0,231.0,185.0,207.0,219.0,151.0,214.0,316.0,297.0,273.0,212.0,2671.0
Mahesana,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,13232.0,15217.0,17196.0,19248.0,14202.0,13979.0,11827.0,12367.0,13365.0,13434.0,15917.0,13892.0,173876.0
Mahesana,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,250.0,245.0,257.0,265.0,355.0,329.0,276.0,296.0,315.0,348.0,338.0,411.0,3685.0
Mahesana,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2215.0,2431.0,2402.0,2298.0,2245.0,2640.0,2060.0,2418.0,2586.0,2485.0,2519.0,2384.0,28683.0
Mahesana,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,14.0,14.0,23.0,33.0,38.0,36.0,42.0,19.0,23.0,16.0,20.0,26.0,304.0
Mahesana,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1650.0,1703.0,1835.0,1971.0,1803.0,2112.0,1707.0,1869.0,1934.0,1954.0,2206.0,2061.0,22805.0
Mahesana,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,10.0,10.0,7.0,12.0,9.0,12.0,11.0,25.0,6.0,7.0,5.0,11.0,125.0
Mahesana,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3094.0,2686.0,3042.0,2749.0,2339.0,2364.0,2058.0,2579.0,2566.0,2695.0,2662.0,2813.0,31647.0
Mahesana,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,269.0,158.0,219.0,258.0,282.0,184.0,178.0,190.0,140.0,123.0,150.0,113.0,2264.0
Mahesana,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6959.0,6820.0,7279.0,7018.0,6387.0,7116.0,5825.0,6866.0,7086.0,7134.0,7387.0,7258.0,83135.0
Mahesana,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,293.0,182.0,249.0,303.0,329.0,232.0,231.0,234.0,169.0,146.0,175.0,150.0,2693.0
Mahesana,15.2,Number of Widal tests conducted,Number tested,1021.0,1113.0,993.0,1177.0,980.0,1308.0,955.0,772.0,836.0,791.0,1335.0,1266.0,12547.0
Mahesana,15.3.a,Number of VDRL tests conducted on males,Number tested,323.0,887.0,425.0,307.0,249.0,497.0,309.0,453.0,507.0,419.0,431.0,633.0,5440.0
Mahesana,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,376.0,482.0,224.0,286.0,213.0,322.0,262.0,266.0,389.0,278.0,385.0,299.0,3782.0
Mahesana,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2471.0,2407.0,2673.0,2496.0,1934.0,2105.0,1899.0,2442.0,2374.0,2446.0,2446.0,2537.0,28230.0
Mahesana,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,3170.0,3776.0,3322.0,3089.0,2396.0,2924.0,2470.0,3161.0,3270.0,3143.0,3262.0,3469.0,37452.0
Mahesana,15.4.1,Number of blood smears examined for Malaria,TOTAL,29974.0,35063.0,41218.0,35579.0,44921.0,47245.0,34567.0,29441.0,27836.0,24711.0,37097.0,28911.0,416563.0
Mahesana,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,68.0,93.0,89.0,69.0,127.0,168.0,114.0,38.0,29.0,11.0,14.0,205.0,1025.0
Mahesana,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,1.0,7.0,5.0,10.0,9.0,10.0,11.0,2.0,2.0,0.0,0.0,57.0
Mahesana,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,13220.0,6620.0,7370.0,4800.0,100.0,10350.0,9870.0,6070.0,5070.0,5870.0,9620.0,6920.0,85880.0
Mahesana,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,7500.0,5000.0,7500.0,15000.0,10000.0,0.0,5000.0,5000.0,10000.0,0.0,10000.0,75000.0
Mahesana,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,6600.0,6750.0,7570.0,12200.0,4750.0,10480.0,3800.0,6000.0,4200.0,6250.0,2700.0,7800.0,79100.0
Mahesana,16.1.1,Stock position of DPT vaccines,5. Total Stock,6620.0,7370.0,4800.0,100.0,10350.0,9870.0,6070.0,5070.0,5870.0,9620.0,6920.0,9120.0,81780.0
Mahesana,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,14000.0,8700.0,10150.0,8700.0,6700.0,10500.0,17200.0,9100.0,6000.0,3550.0,10150.0,6900.0,111650.0
Mahesana,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,7000.0,9000.0,11000.0,9000.0,9000.0,15000.0,0.0,6000.0,6000.0,18000.0,0.0,23400.0,113400.0
Mahesana,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,12300.0,7550.0,12450.0,11000.0,5200.0,8300.0,8100.0,9100.0,8450.0,11400.0,3250.0,14300.0,111400.0
Mahesana,16.1.1A,Stock Position of Pentavalent,5. Total Stock,8700.0,10150.0,8700.0,6700.0,10500.0,17200.0,9100.0,6000.0,3550.0,10150.0,6900.0,16000.0,113650.0
Mahesana,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,12600.0,12600.0,94140.0,55140.0,31340.0,15400.0,25600.0,4900.0,2500.0,8500.0,22900.0,14400.0,300020.0
Mahesana,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,101040.0,0.0,0.0,0.0,30000.0,0.0,20000.0,27000.0,35400.0,0.0,29700.0,243140.0
Mahesana,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,0.0,19500.0,39000.0,23800.0,15940.0,19800.0,20700.0,22400.0,21000.0,21000.0,8500.0,4600.0,216240.0
Mahesana,16.1.2,Stock position of OPV vaccines,5. Total Stock,12600.0,94140.0,55140.0,31340.0,15400.0,25600.0,4900.0,2500.0,8500.0,22900.0,14400.0,39500.0,326920.0
Mahesana,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,14350.0,16850.0,18450.0,20370.0,1330.0,12630.0,21830.0,13030.0,13530.0,15030.0,25130.0,22630.0,195160.0
Mahesana,16.1.3,Stock position of TT vaccines,2. Stocks Received,15000.0,10000.0,15000.0,7500.0,20000.0,28000.0,0.0,10000.0,10000.0,22500.0,0.0,15000.0,153000.0
Mahesana,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.3,Stock position of TT vaccines,4. Stock Distributed,12500.0,8400.0,13080.0,26540.0,8700.0,18800.0,8800.0,9500.0,8500.0,12400.0,2500.0,14700.0,144420.0
Mahesana,16.1.3,Stock position of TT vaccines,5. Total Stock,16850.0,18450.0,20370.0,1330.0,12630.0,21830.0,13030.0,13530.0,15030.0,25130.0,22630.0,22930.0,203740.0
Mahesana,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,13680.0,13460.0,13240.0,12110.0,13490.0,16240.0,20520.0,15040.0,14420.0,15420.0,27700.0,25400.0,200720.0
Mahesana,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,5000.0,7000.0,6000.0,5230.0,10000.0,0.0,5000.0,6000.0,20000.0,0.0,10000.0,79230.0
Mahesana,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,5220.0,5220.0,8130.0,4620.0,2480.0,5720.0,5480.0,5620.0,5000.0,7720.0,2300.0,6400.0,63910.0
Mahesana,16.1.5,Stock position of BCG vaccines,5. Total Stock,13460.0,13240.0,12110.0,13490.0,16240.0,20520.0,15040.0,14420.0,15420.0,27700.0,25400.0,29000.0,216040.0
Mahesana,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3245.0,5095.0,2595.0,7250.0,5070.0,9900.0,11250.0,4150.0,4150.0,6950.0,13700.0,10850.0,84205.0
Mahesana,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,5000.0,20000.0,5000.0,10000.0,8000.0,0.0,10000.0,10000.0,15000.0,0.0,10000.0,103000.0
Mahesana,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,8150.0,7500.0,15345.0,7180.0,5170.0,6650.0,7100.0,6750.0,6750.0,8250.0,2850.0,9750.0,91445.0
Mahesana,16.1.6,Stock position of Measles vaccines,5. Total Stock,5095.0,2595.0,7250.0,5070.0,9900.0,11250.0,4150.0,7400.0,7400.0,13700.0,10850.0,11100.0,95760.0
Mahesana,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,6470.0,6050.0,5950.0,5720.0,3790.0,3140.0,2330.0,1310.0,1360.0,960.0,590.0,250.0,37920.0
Mahesana,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,700.0,0.0,300.0,0.0,1380.0,2380.0
Mahesana,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,420.0,100.0,230.0,1930.0,650.0,810.0,1020.0,650.0,400.0,670.0,340.0,870.0,8090.0
Mahesana,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,6050.0,5950.0,5720.0,3790.0,3140.0,2330.0,1310.0,1360.0,960.0,590.0,250.0,760.0,32210.0
Mahesana,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,5510.0,5310.0,350.0,8150.0,3400.0,1050.0,1050.0,1050.0,1050.0,1050.0,1050.0,150.0,29170.0
Mahesana,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,24000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7436.0,31436.0
Mahesana,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,200.0,5310.0,16200.0,4750.0,2350.0,0.0,0.0,0.0,0.0,0.0,900.0,0.0,29710.0
Mahesana,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,5310.0,0.0,8150.0,3400.0,1050.0,1050.0,1050.0,1050.0,1050.0,1050.0,150.0,7586.0,30896.0
Mahesana,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,105840.0,840.0,0.0,0.0,1996620.0,494700.0,272940.0,76380.0,76380.0,780.0,780.0,551666.0,3576926.0
Mahesana,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,2087340.0,0.0,0.0,0.0,0.0,0.0,0.0,625986.0,614280.0,3327606.0
Mahesana,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,105000.0,840.0,0.0,90720.0,1501920.0,221760.0,196560.0,0.0,75600.0,0.0,75100.0,917520.0,3185020.0
Mahesana,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,840.0,0.0,0.0,1996620.0,494700.0,272940.0,76380.0,76380.0,780.0,780.0,551666.0,248426.0,3719512.0
Mahesana,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,18600.0,15600.0,1200.0,1200.0,1200.0,600.0,600.0,600.0,0.0,39600.0
Mahesana,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,63600.0,54000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60000.0,177600.0
Mahesana,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,45000.0,57000.0,14400.0,0.0,0.0,600.0,0.0,0.0,600.0,600.0,118200.0
Mahesana,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,18600.0,15600.0,1200.0,1200.0,1200.0,600.0,600.0,600.0,0.0,59400.0,99000.0
Mahesana,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,100.0,2100.0
Mahesana,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,2000.0
Mahesana,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1900.0,0.0,1900.0
Mahesana,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,100.0,100.0,2200.0
Mahesana,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3017.0,2817.0,2717.0,1300.0,900.0,5500.0,5200.0,4700.0,3400.0,1000.0,1000.0,9300.0,40851.0
Mahesana,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,15000.0
Mahesana,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,200.0,100.0,1417.0,400.0,400.0,300.0,500.0,1300.0,2400.0,0.0,1700.0,0.0,8717.0
Mahesana,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,2817.0,2717.0,1300.0,900.0,5500.0,5200.0,4700.0,3400.0,1000.0,1000.0,9300.0,9300.0,47134.0
Mahesana,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,1200.0,775.0,200.0,2300.0,100.0,100.0,100.0,100.0,3500.0,8375.0
Mahesana,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,1825.0,0.0,0.0,2500.0,0.0,0.0,0.0,0.0,3750.0,0.0,8075.0
Mahesana,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,625.0,425.0,575.0,400.0,2200.0,0.0,0.0,0.0,350.0,200.0,4775.0
Mahesana,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,1200.0,775.0,200.0,2300.0,100.0,100.0,100.0,100.0,3500.0,3300.0,11675.0
Mahesana,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,8500.0,7875.0,11950.0,6000.0,4775.0,4400.0,450.0,350.0,350.0,350.0,5850.0,50850.0
Mahesana,16.3.02,Stock Position of Gloves,2. Stocks Received,10000.0,0.0,14000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8000.0,0.0,32000.0
Mahesana,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.02,Stock Position of Gloves,4. Stock Distributed,1500.0,800.0,9925.0,5950.0,1225.0,375.0,3950.0,100.0,0.0,0.0,2500.0,0.0,26325.0
Mahesana,16.3.02,Stock Position of Gloves,5. Total Stock,8500.0,7700.0,11950.0,6000.0,4775.0,4400.0,450.0,350.0,350.0,350.0,5850.0,5850.0,56525.0
Mahesana,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,1800.0,1800.0,0.0,0.0,0.0,14800.0,300.0,300.0,0.0,0.0,0.0,19000.0
Mahesana,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,2000.0,0.0,0.0,0.0,0.0,14800.0,10000.0,0.0,0.0,0.0,0.0,0.0,26800.0
Mahesana,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,200.0,0.0,1800.0,0.0,0.0,0.0,24500.0,0.0,300.0,0.0,0.0,0.0,26800.0
Mahesana,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,1800.0,1800.0,0.0,0.0,0.0,14800.0,300.0,300.0,0.0,0.0,0.0,0.0,19000.0
Mahesana,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,75.0,75.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150.0
Mahesana,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,75.0,75.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150.0
Mahesana,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,4.0,4.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0
Mahesana,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,4.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0
Mahesana,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,9.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0
Mahesana,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,4.0,4.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0
Mahesana,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,120000.0,80000.0,40000.0,10000.0,361000.0,951000.0,38000.0,257000.0,424000.0,2197000.0,1977000.0,2004000.0,8459000.0
Mahesana,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,1655000.0,930000.0,0.0,250000.0,250000.0,1773000.0,0.0,320000.0,632000.0,5810000.0
Mahesana,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,40000.0,40000.0,30000.0,1304000.0,340000.0,913000.0,31000.0,83000.0,0.0,220000.0,293000.0,1777000.0,5071000.0
Mahesana,16.3.07,Stock Position of IFA Tablets,5. Total Stock,80000.0,40000.0,10000.0,361000.0,951000.0,38000.0,257000.0,424000.0,2197000.0,1977000.0,2004000.0,859000.0,9198000.0
Mahesana,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,6000.0,3200.0,200.0,200.0,1100.0,1100.0,32500.0,44300.0
Mahesana,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,8500.0,0.0,0.0,0.0,900.0,0.0,31400.0,15600.0,56400.0
Mahesana,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,2500.0,2800.0,3000.0,0.0,0.0,0.0,0.0,15300.0,23600.0
Mahesana,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,6000.0,3200.0,200.0,200.0,1100.0,1100.0,32500.0,32800.0,77100.0
Mahesana,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mahesana,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,3000.0
Mahesana,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,3000.0
Mahesana,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,100.0,100.0,100.0,0.0,0.0,0.0,0.0,4050.0,4050.0,1500.0,1050.0,290.0,11240.0
Mahesana,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,2550.0,450.0,760.0,0.0,3860.0
Mahesana,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,100.0,100.0,0.0,0.0,0.0,0.0,0.0,4050.0,1500.0,1050.0,290.0,290.0,7380.0
Mahesana,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,29000.0,37000.0,60350.0,48850.0,23850.0,66350.0,123350.0,140350.0,151350.0,149350.0,88350.0,37500.0,955650.0
Mahesana,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,10000.0,0.0,0.0,0.0,50000.0,57000.0,21500.0,94000.0,0.0,0.0,0.0,0.0,232500.0
Mahesana,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,2000.0,6000.0,11500.0,25000.0,7500.0,0.0,4500.0,83000.0,2000.0,61000.0,50850.0,1000.0,254350.0
Mahesana,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,37000.0,31000.0,48850.0,23850.0,66350.0,123350.0,140350.0,151350.0,149350.0,88350.0,37500.0,36500.0,933800.0
Mahesana,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2000.0,1800.0,1300.0,12100.0,9500.0,8300.0,8000.0,8000.0,7800.0,2300.0,2300.0,1800.0,65200.0
Mahesana,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,33000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33000.0
Mahesana,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,200.0,500.0,22200.0,2600.0,1200.0,300.0,0.0,200.0,5500.0,0.0,500.0,0.0,33200.0
Mahesana,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1800.0,1300.0,12100.0,9500.0,8300.0,8000.0,8000.0,7800.0,2300.0,2300.0,1800.0,1800.0,65000.0
Mahesana,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,200000.0,408000.0,374000.0,32000.0,18000.0,2000.0,2000.0,2000.0,2000.0,2000.0,20000.0,2000.0,1064000.0
Mahesana,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,220000.0,0.0,150000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,370000.0
Mahesana,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,12000.0,34000.0,492000.0,14000.0,16000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,568000.0
Mahesana,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,408000.0,374000.0,32000.0,18000.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,20000.0,2000.0,866000.0
Mahesana,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1600.0,1600.0,1600.0,17600.0,17600.0,15500.0,7300.0,7000.0,7000.0,4500.0,4500.0,4500.0,90300.0
Mahesana,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0
Mahesana,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahesana,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,4000.0,0.0,2100.0,8200.0,300.0,0.0,2500.0,0.0,0.0,0.0,17100.0
Mahesana,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1600.0,1600.0,17600.0,17600.0,15500.0,7300.0,7000.0,7000.0,4500.0,4500.0,4500.0,4500.0,93200.0
Mahesana,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,1.0,3.0,2.0,4.0,,1.0,3.0,,,4.0,1.0,21.0
Mahesana,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,2.0,,,1.0,2.0,,,1.0,,,6.0
Mahesana,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,,1.0
Mahesana,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,2.0,,,1.0,2.0,,,1.0,,,7.0
Mahesana,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,4.0,4.0,,1.0,2.0,5.0,2.0,5.0,3.0,7.0,5.0,4.0,42.0
Mahesana,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,1.0,,,1.0,,,1.0,,,,3.0
Mahesana,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,4.0,4.0,1.0,1.0,2.0,6.0,2.0,5.0,4.0,7.0,5.0,4.0,45.0
Mahesana,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,6.0,11.0,14.0,9.0,5.0,6.0,10.0,4.0,11.0,12.0,7.0,7.0,102.0
Mahesana,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,3.0,1.0,,1.0,1.0,1.0,1.0,1.0,1.0,3.0,2.0,,15.0
Mahesana,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,9.0,12.0,14.0,10.0,6.0,7.0,11.0,5.0,12.0,15.0,9.0,7.0,117.0
Mahesana,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,6.0,10.0,22.0,8.0,8.0,11.0,8.0,9.0,10.0,10.0,4.0,6.0,112.0
Mahesana,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,3.0,3.0,3.0,,,1.0,1.0,,3.0,4.0,,,18.0
Mahesana,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,9.0,13.0,25.0,8.0,8.0,12.0,9.0,9.0,13.0,14.0,4.0,6.0,130.0
Mahesana,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,,,,3.0,1.0,3.0,,1.0,2.0,11.0
Mahesana,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Mahesana,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,2.0,,,,,3.0,1.0,3.0,,1.0,2.0,12.0
Mahesana,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mahesana,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mahesana,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Mahesana,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,2.0,,,1.0,,,,,,4.0
Mahesana,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Mahesana,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,1.0,2.0,,,1.0,,,,,,5.0
Mahesana,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mahesana,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mahesana,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Mahesana,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,9.0,11.0,2.0,3.0,3.0,8.0,10.0,4.0,8.0,8.0,2.0,7.0,75.0
Mahesana,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,3.0,2.0,4.0,4.0,1.0,,,1.0,1.0,2.0,,1.0,19.0
Mahesana,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,12.0,13.0,6.0,7.0,4.0,8.0,10.0,5.0,9.0,10.0,2.0,8.0,94.0
Mahesana,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Mahesana,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,,1.0,,,1.0,1.0,,4.0
Mahesana,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,,,1.0,,,,2.0,,4.0
Mahesana,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,1.0,,2.0,,,1.0,3.0,,8.0
Mahesana,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,1.0,1.0,1.0,,,,,1.0,4.0
Mahesana,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,10.0,8.0,8.0,4.0,2.0,4.0,9.0,2.0,6.0,6.0,12.0,6.0,77.0
Mahesana,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,4.0,,2.0,1.0,3.0,3.0,3.0,2.0,2.0,3.0,8.0,33.0
Mahesana,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,12.0,12.0,8.0,6.0,4.0,8.0,13.0,5.0,8.0,8.0,15.0,15.0,114.0
Mahesana,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,1.0,,,,,,1.0,,,,1.0,1.0,4.0
Mahesana,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,15.0,15.0,7.0,10.0,10.0,13.0,12.0,12.0,15.0,15.0,20.0,16.0,160.0
Mahesana,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,44.0,69.0,57.0,28.0,42.0,56.0,41.0,54.0,61.0,64.0,53.0,66.0,635.0
Mahesana,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,60.0,84.0,64.0,38.0,52.0,69.0,54.0,66.0,76.0,79.0,74.0,83.0,799.0
Mahesana,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Mahesana,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,2.0,,,,,,1.0,,1.0,,4.0
Mahesana,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Mahesana,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,2.0,,,,,,1.0,,1.0,,4.0
Mahesana,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Mahesana,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,2.0,3.0,2.0,2.0,2.0,3.0,,1.0,,1.0,,18.0
Mahesana,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,10.0,3.0,2.0,2.0,3.0,3.0,2.0,,,4.0,1.0,,30.0
Mahesana,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,12.0,5.0,5.0,4.0,5.0,5.0,5.0,,1.0,4.0,2.0,,48.0
Mahesana,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Mahesana,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,5.0,3.0,,2.0,3.0,,,2.0,1.0,3.0,1.0,20.0
Mahesana,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Mahesana,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,5.0,3.0,,2.0,3.0,,,2.0,1.0,3.0,1.0,20.0
Mahesana,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,1.0,1.0,1.0,1.0,,1.0,,,,1.0,3.0,9.0
Mahesana,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,32.0,38.0,29.0,20.0,29.0,26.0,16.0,28.0,34.0,29.0,31.0,22.0,334.0
Mahesana,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,24.0,39.0,24.0,26.0,41.0,48.0,26.0,20.0,30.0,40.0,35.0,32.0,385.0
Mahesana,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,56.0,78.0,54.0,47.0,71.0,74.0,43.0,48.0,64.0,69.0,67.0,57.0,728.0
Mahesana,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,,2.0,,2.0,1.0,,3.0,,1.0,1.0,11.0
Mahesana,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,8.0,5.0,6.0,5.0,7.0,7.0,5.0,6.0,3.0,6.0,3.0,63.0
Mahesana,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,12.0,7.0,6.0,5.0,6.0,5.0,5.0,2.0,8.0,9.0,4.0,71.0
Mahesana,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,4.0,21.0,12.0,14.0,10.0,15.0,13.0,10.0,11.0,11.0,16.0,8.0,145.0
Mahesana,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Mahesana,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Mahesana,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Mahesana,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Mahesana,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Mahesana,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Mahesana,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Mahesana,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Mahesana,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Mahesana,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,,1.0,,,,,,,,2.0
Mahesana,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Mahesana,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,,1.0,,,,,,,,2.0
Mahesana,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Mahesana,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,2.0,,,1.0,1.0,,,4.0
Mahesana,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Mahesana,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,2.0,,,1.0,1.0,,,4.0
Mahesana,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Mahesana,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Mahesana,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Mahesana,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Mahesana,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Mahesana,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,2.0,1.0,2.0,2.0,3.0,2.0,2.0,2.0,3.0,1.0,3.0,23.0
Mahesana,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Mahesana,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,2.0,1.0,2.0,2.0,3.0,2.0,2.0,2.0,3.0,1.0,3.0,23.0
Mahesana,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,7.0,1.0,2.0,1.0,1.0,2.0,1.0,2.0,,,,,17.0
Mahesana,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,23.0,30.0,18.0,22.0,17.0,22.0,24.0,12.0,22.0,22.0,21.0,17.0,250.0
Mahesana,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,7.0,6.0,4.0,2.0,1.0,3.0,3.0,1.0,2.0,10.0,2.0,6.0,47.0
Mahesana,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,37.0,37.0,24.0,25.0,19.0,27.0,28.0,15.0,24.0,32.0,23.0,23.0,314.0
Mahesana,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Mahesana,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,9.0,6.0,12.0,8.0,12.0,8.0,10.0,6.0,6.0,4.0,14.0,11.0,106.0
Mahesana,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,3.0,1.0,,1.0,1.0,2.0,3.0,3.0,,1.0,1.0,,16.0
Mahesana,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,12.0,8.0,12.0,9.0,13.0,10.0,13.0,9.0,6.0,5.0,15.0,11.0,123.0
Mahesana,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Mahesana,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,2.0,,2.0,,3.0,2.0,,,1.0,,,10.0
Mahesana,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,2.0,,1.0,,,,,,3.0
Mahesana,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,2.0,,2.0,2.0,3.0,3.0,1.0,,1.0,,,14.0
Mahesana,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Mahesana,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,2.0,2.0,1.0,4.0,2.0,7.0,3.0,2.0,2.0,7.0,5.0,37.0
Mahesana,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,6.0,1.0,6.0,3.0,4.0,3.0,4.0,5.0,2.0,3.0,2.0,39.0
Mahesana,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,9.0,3.0,7.0,7.0,6.0,10.0,7.0,7.0,4.0,10.0,7.0,77.0
Mahesana,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,1.0,,,,,,1.0,,,2.0
Mahesana,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,16.0,10.0,10.0,13.0,11.0,9.0,8.0,9.0,15.0,12.0,13.0,14.0,140.0
Mahesana,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,11.0,20.0,14.0,13.0,11.0,8.0,14.0,8.0,7.0,9.0,15.0,13.0,143.0
Mahesana,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,27.0,30.0,24.0,27.0,22.0,17.0,22.0,17.0,22.0,22.0,28.0,27.0,285.0
Mahesana,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,2.0,2.0,2.0,2.0,2.0,,4.0,1.0,1.0,2.0,3.0,23.0
Mahesana,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,44.0,42.0,40.0,29.0,43.0,37.0,43.0,29.0,41.0,46.0,45.0,58.0,497.0
Mahesana,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,159.0,156.0,181.0,119.0,166.0,125.0,139.0,206.0,172.0,214.0,187.0,167.0,1991.0
Mahesana,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,205.0,200.0,223.0,150.0,211.0,164.0,182.0,239.0,214.0,261.0,234.0,228.0,2511.0
Mahisagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,2216.0,2036.0,2525.0,2437.0,2460.0,2331.0,2183.0,2089.0,2006.0,2206.0,2084.0,1897.0,26470.0
Mahisagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1592.0,1560.0,2085.0,1955.0,1797.0,1842.0,1754.0,1717.0,1630.0,1762.0,1672.0,1406.0,20772.0
Mahisagar,1.2,Number of Pregnant women registered under JSY,TOTAL,966.0,891.0,1047.0,1061.0,984.0,973.0,911.0,985.0,878.0,1108.0,987.0,851.0,11642.0
Mahisagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1573.0,1595.0,1869.0,1764.0,1891.0,1894.0,1816.0,1745.0,1712.0,1809.0,1715.0,1710.0,21093.0
Mahisagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1895.0,1757.0,2097.0,2039.0,1941.0,1916.0,1790.0,1884.0,1837.0,1928.0,1834.0,1627.0,22545.0
Mahisagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2133.0,2089.0,2195.0,2365.0,2332.0,2318.0,2154.0,2041.0,2129.0,2003.0,2203.0,2021.0,25983.0
Mahisagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1851.0,1739.0,1919.0,1984.0,2218.0,2028.0,1937.0,1979.0,1990.0,1858.0,1973.0,1960.0,23436.0
Mahisagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,89.0,7.0,13.0,12.0,8.0,9.0,0.0,0.0,33.0,40.0,4.0,5.0,220.0
Mahisagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,5.0,7.0,5.0,3.0,0.0,0.0,26.0
Mahisagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,752.0,461.0,744.0,725.0,700.0,722.0,796.0,749.0,736.0,781.0,716.0,670.0,8552.0
Mahisagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,6.0,15.0,24.0,20.0,29.0,16.0,11.0,9.0,20.0,10.0,19.0,15.0,194.0
Mahisagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,27.0,7.0,47.0,44.0,25.0,46.0,108.0,95.0,94.0,133.0,114.0,96.0,836.0
Mahisagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,36.0,19.0,15.0,19.0,33.0,25.0,27.0,21.0,12.0,15.0,22.0,8.0,252.0
Mahisagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,8.0,6.0,0.0,9.0,4.0,10.0,13.0,19.0,12.0,7.0,11.0,4.0,103.0
Mahisagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,44.0,25.0,15.0,28.0,37.0,35.0,40.0,40.0,24.0,22.0,33.0,12.0,355.0
Mahisagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,47.0,19.0,14.0,23.0,24.0,29.0,30.0,21.0,14.0,14.0,21.0,10.0,266.0
Mahisagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,6.0,11.0,2.0,5.0,9.0,8.0,8.0,13.0,6.0,7.0,8.0,3.0,86.0
Mahisagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,499.0,496.0,570.0,537.0,624.0,514.0,440.0,371.0,515.0,557.0,557.0,421.0,6101.0
Mahisagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,244.0,297.0,373.0,389.0,500.0,450.0,420.0,288.0,472.0,394.0,395.0,326.0,4548.0
Mahisagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,55.0,70.0,97.0,142.0,150.0,86.0,71.0,102.0,118.0,99.0,106.0,90.0,1186.0
Mahisagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,6.0,0.0,1.0,34.0,14.0,0.0,4.0,5.0,0.0,7.0,0.0,0.0,71.0
Mahisagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,2.0,8.0,0.0,63.0,14.0,2.0,0.0,8.0,0.0,0.0,97.0
Mahisagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1026.0,894.0,1052.0,1032.0,1184.0,1200.0,1260.0,989.0,1282.0,1322.0,1042.0,1124.0,13407.0
Mahisagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,300.0,312.0,326.0,335.0,325.0,400.0,371.0,396.0,338.0,342.0,3445.0
Mahisagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,4.0,8.0,3.0,11.0,27.0,6.0,7.0,4.0,5.0,4.0,4.0,2.0,85.0
Mahisagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,2.0,0.0,0.0,0.0,6.0,3.0,0.0,7.0,0.0,0.0,0.0,18.0
Mahisagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,10.0,6.0,5.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,24.0
Mahisagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahisagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,14.0,16.0,8.0,12.0,27.0,12.0,10.0,4.0,12.0,6.0,4.0,2.0,127.0
Mahisagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,10.0,10.0,10.0,10.0,40.0,88.0,62.0,10.0,6.0,12.0,6.0,10.0,274.0
Mahisagar,4.1.1.a,Number of male live births,TOTAL,875.0,777.0,951.0,1034.0,1058.0,978.0,980.0,891.0,1073.0,964.0,904.0,787.0,11272.0
Mahisagar,4.1.1.b,Number of female live births,TOTAL,771.0,688.0,850.0,867.0,994.0,916.0,857.0,734.0,940.0,876.0,819.0,753.0,10065.0
Mahisagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1646.0,1465.0,1801.0,1901.0,2052.0,1894.0,1837.0,1625.0,2013.0,1840.0,1723.0,1540.0,21337.0
Mahisagar,4.1.2,Number of still births,TOTAL,37.0,43.0,47.0,48.0,62.0,35.0,35.0,51.0,38.0,40.0,60.0,44.0,540.0
Mahisagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,33.0,50.0,54.0,65.0,63.0,82.0,69.0,62.0,41.0,67.0,66.0,56.0,708.0
Mahisagar,4.2.1,Number of Newborns weighed at birth,TOTAL,1126.0,1622.0,1694.0,1771.0,2357.0,1715.0,1711.0,1898.0,1808.0,1746.0,1551.0,1529.0,20528.0
Mahisagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,102.0,140.0,151.0,126.0,191.0,175.0,143.0,182.0,142.0,125.0,106.0,80.0,1663.0
Mahisagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1078.0,1611.0,1628.0,1703.0,2295.0,1645.0,1629.0,1829.0,1765.0,1662.0,1620.0,1452.0,19917.0
Mahisagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,1.0,0.0,6.0,2.0,3.0,10.0,11.0,2.0,0.0,4.0,0.0,39.0
Mahisagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,40.0,40.0,0.0,38.0,34.0,13.0,0.0,1.0,166.0
Mahisagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,2.0,0.0,1.0,1.0,1.0,0.0,5.0,2.0,2.0,0.0,1.0,15.0
Mahisagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahisagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,3.0,0.0,7.0,43.0,44.0,10.0,54.0,38.0,15.0,4.0,2.0,220.0
Mahisagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,16.0,17.0,18.0,17.0,13.0,24.0,15.0,51.0,28.0,26.0,39.0,34.0,298.0
Mahisagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,10.0,8.0,11.0,11.0,5.0,13.0,10.0,16.0,26.0,13.0,13.0,17.0,153.0
Mahisagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,13.0,107.0,79.0,139.0,91.0,140.0,79.0,145.0,87.0,64.0,102.0,106.0,1152.0
Mahisagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1149.0,1149.0,1258.0,1226.0,1460.0,1379.0,1194.0,1311.0,1492.0,1256.0,1160.0,1047.0,15081.0
Mahisagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,987.0,1043.0,1120.0,1042.0,1315.0,1186.0,1096.0,1172.0,1395.0,1031.0,1046.0,926.0,13359.0
Mahisagar,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,6.0,7.0,10.0,7.0,6.0,37.0
Mahisagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,6.0
Mahisagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0
Mahisagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,8.0
Mahisagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,48.0,50.0,53.0,107.0,32.0,31.0,14.0,41.0,41.0,26.0,44.0,26.0,513.0
Mahisagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,225.0,257.0,272.0,304.0,217.0,225.0,220.0,256.0,204.0,255.0,264.0,264.0,2963.0
Mahisagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,273.0,307.0,325.0,411.0,249.0,256.0,234.0,297.0,245.0,281.0,308.0,290.0,3476.0
Mahisagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,23.0,30.0,23.0,34.0,31.0,0.0,28.0,32.0,25.0,0.0,13.0,34.0,273.0
Mahisagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,2.0,0.0,8.0
Mahisagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahisagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,2.0,0.0,8.0
Mahisagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,5.0,0.0,8.0
Mahisagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,2.0,0.0,1.0,3.0,5.0,6.0,3.0,4.0,44.0,31.0,18.0,0.0,117.0
Mahisagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,15.0,20.0,144.0,166.0,140.0,40.0,27.0,552.0
Mahisagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,36.0,6.0,14.0,22.0,19.0,66.0,52.0,470.0,1042.0,765.0,313.0,46.0,2851.0
Mahisagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahisagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,38.0,6.0,15.0,25.0,24.0,87.0,75.0,618.0,1252.0,936.0,371.0,73.0,3520.0
Mahisagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,12.0,0.0,0.0,6.0,3.0,7.0,27.0,255.0,418.0,413.0,267.0,83.0,1491.0
Mahisagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,9.0,0.0,0.0,2.0,2.0,2.0,14.0,118.0,164.0,125.0,73.0,2.0,511.0
Mahisagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,4.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Mahisagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahisagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,13.0,3.0,0.0,2.0,2.0,2.0,14.0,118.0,164.0,125.0,73.0,2.0,518.0
Mahisagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,1.0,2.0,2.0,2.0,10.0,7.0,12.0,94.0,94.0,121.0,124.0,43.0,512.0
Mahisagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,2.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Mahisagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,52.0,0.0,0.0,0.0,52.0
Mahisagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahisagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,52.0,0.0,0.0,0.0,57.0
Mahisagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,455.0,464.0,513.0,527.0,578.0,576.0,628.0,641.0,583.0,591.0,586.0,491.0,6633.0
Mahisagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,13.0,31.0,15.0,20.0,21.0,26.0,17.0,41.0,56.0,30.0,40.0,24.0,334.0
Mahisagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,27.0,6.0,8.0,2.0,3.0,0.0,0.0,4.0,4.0,6.0,2.0,3.0,65.0
Mahisagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,10.0,6.0,6.0,10.0,11.0,9.0,5.0,4.0,3.0,5.0,7.0,2.0,78.0
Mahisagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahisagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,505.0,507.0,542.0,559.0,613.0,611.0,650.0,690.0,646.0,632.0,635.0,520.0,7110.0
Mahisagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,24.0,19.0,30.0,24.0,26.0,27.0,29.0,7.0,27.0,12.0,12.0,10.0,247.0
Mahisagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,52.0,205.0,253.0,250.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,760.0
Mahisagar,9.06,Number of IUCD removals,TOTAL,141.0,114.0,183.0,64.0,96.0,145.0,229.0,209.0,85.0,79.0,109.0,101.0,1555.0
Mahisagar,9.07,Number of Oral Pills cycles distributed,TOTAL,1444.0,1426.0,2029.0,1616.0,2138.0,2799.0,2649.0,2514.0,1775.0,1518.0,2018.0,1387.0,23313.0
Mahisagar,9.08,Number of Condom pieces distributed,TOTAL,5095.0,7664.0,2501.0,1589.0,7533.0,7188.0,6482.0,4903.0,4899.0,4800.0,9090.0,5076.0,66820.0
Mahisagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,2.0,0.0,10.0,43.0,90.0,0.0,20.0,15.0,8.0,0.0,20.0,208.0
Mahisagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,2.0,2.0,4.0,7.0,2.0,7.0,2.0,3.0,0.0,0.0,0.0,22.0,51.0
Mahisagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mahisagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,2.0,2.0,0.0,0.0,1.0,2.0,2.0,2.0,12.0,8.0,3.0,0.0,34.0
Mahisagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,0.0,3.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,8.0
Mahisagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,12.0,12.0,8.0,8.0,11.0,12.0,10.0,15.0,10.0,9.0,7.0,8.0,-1.0
Mahisagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1744.0,1887.0,1939.0,2022.0,2154.0,2146.0,2016.0,2082.0,2155.0,1980.0,1908.0,1834.0,23867.0
Mahisagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,394.0,447.0,256.0,320.0,361.0,379.0,302.0,400.0,380.0,201.0,169.0,222.0,3831.0
Mahisagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,448.0,406.0,317.0,335.0,350.0,372.0,291.0,354.0,369.0,218.0,171.0,189.0,3820.0
Mahisagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,460.0,447.0,309.0,383.0,482.0,481.0,370.0,429.0,385.0,333.0,206.0,176.0,4461.0
Mahisagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1381.0,1493.0,1743.0,1548.0,1741.0,1538.0,1526.0,1618.0,1542.0,1693.0,1657.0,1445.0,18925.0
Mahisagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1507.0,1469.0,1707.0,1578.0,1672.0,1601.0,1559.0,1559.0,1650.0,1621.0,1707.0,1564.0,19194.0
Mahisagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1628.0,1590.0,1734.0,1745.0,1680.0,1744.0,1716.0,1639.0,1711.0,1784.0,1742.0,1658.0,20371.0
Mahisagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1525.0,1422.0,1578.0,1519.0,1785.0,1699.0,1669.0,1752.0,1697.0,1639.0,1614.0,1405.0,19304.0
Mahisagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1694.0,1765.0,1816.0,1666.0,1750.0,1784.0,1867.0,1886.0,1843.0,1893.0,1839.0,1571.0,21374.0
Mahisagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1867.0,1718.0,1816.0,1695.0,1692.0,1794.0,1897.0,1868.0,1934.0,1865.0,1891.0,1715.0,21752.0
Mahisagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2077.0,1910.0,1837.0,1990.0,1759.0,1917.0,1885.0,1891.0,1924.0,1951.0,1888.0,1795.0,22824.0
Mahisagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,181.0,145.0,175.0,170.0,214.0,190.0,238.0,190.0,203.0,170.0,203.0,159.0,2238.0
Mahisagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,122.0,66.0,99.0,83.0,88.0,96.0,42.0,99.0,48.0,8.0,0.0,15.0,766.0
Mahisagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,90.0,83.0,88.0,87.0,99.0,87.0,39.0,83.0,40.0,19.0,0.0,36.0,751.0
Mahisagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,103.0,91.0,122.0,137.0,223.0,82.0,71.0,77.0,42.0,8.0,0.0,4.0,960.0
Mahisagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1826.0,1883.0,1877.0,2008.0,2027.0,2126.0,1905.0,1960.0,1956.0,1808.0,1862.0,1768.0,23006.0
Mahisagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,870.0,908.0,923.0,1034.0,1071.0,1232.0,1313.0,1251.0,1342.0,1243.0,1127.0,1119.0,13433.0
Mahisagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,855.0,911.0,868.0,981.0,1210.0,1134.0,1057.0,966.0,1067.0,840.0,1011.0,859.0,11759.0
Mahisagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,846.0,799.0,825.0,924.0,1108.0,950.0,863.0,886.0,854.0,771.0,904.0,714.0,10444.0
Mahisagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1701.0,1710.0,1693.0,1905.0,2318.0,2084.0,1920.0,1852.0,1921.0,1611.0,1915.0,1573.0,22203.0
Mahisagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1327.0,1458.0,1414.0,1458.0,1546.0,1590.0,1654.0,1602.0,1594.0,1692.0,1768.0,1608.0,18711.0
Mahisagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1327.0,1448.0,1382.0,1445.0,1532.0,1587.0,1626.0,1595.0,1598.0,1693.0,1753.0,1589.0,18575.0
Mahisagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,6.0
Mahisagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,323.0,295.0,363.0,312.0,467.0,344.0,336.0,364.0,400.0,283.0,338.0,291.0,4116.0
Mahisagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,300.0,279.0,314.0,260.0,394.0,314.0,302.0,307.0,344.0,264.0,289.0,261.0,3628.0
Mahisagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,623.0,574.0,677.0,572.0,861.0,658.0,638.0,671.0,744.0,547.0,627.0,552.0,7744.0
Mahisagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,675.0,848.0,1227.0,1387.0,1817.0,1819.0,1203.0,1348.0,1208.0,1156.0,1118.0,791.0,14597.0
Mahisagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,807.0,955.0,1040.0,1407.0,2046.0,2137.0,1403.0,1448.0,1552.0,1088.0,1238.0,956.0,16077.0
Mahisagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1387.0,1446.0,1571.0,1687.0,1564.0,1653.0,1557.0,1609.0,1422.0,1477.0,1425.0,1076.0,17874.0
Mahisagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,2.0,2.0,2.0,2.0,0.0,1.0,0.0,0.0,2.0,0.0,1.0,14.0
Mahisagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,24.0,32.0,42.0,59.0,48.0,57.0,53.0,68.0,75.0,50.0,55.0,47.0,610.0
Mahisagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1081.0,1046.0,1052.0,1086.0,1030.0,1054.0,1057.0,1040.0,1071.0,1008.0,1056.0,1045.0,12626.0
Mahisagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1064.0,1038.0,1033.0,1075.0,1024.0,1047.0,1044.0,1027.0,1065.0,1004.0,1047.0,1034.0,12502.0
Mahisagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,935.0,924.0,946.0,976.0,920.0,988.0,967.0,939.0,953.0,932.0,966.0,937.0,11383.0
Mahisagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1658.0,1546.0,1676.0,1619.0,1803.0,1943.0,1752.0,1819.0,1760.0,1609.0,1626.0,1482.0,20293.0
Mahisagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,3559.0,150.0,399.0,111.0,722.0,286.0,138.0,963.0,370.0,1784.0,588.0,318.0,9388.0
Mahisagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,3747.0,101.0,333.0,15.0,809.0,159.0,89.0,913.0,274.0,1571.0,643.0,367.0,9021.0
Mahisagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,52.0,42.0,0.0,50.0,174.0,72.0,70.0,64.0,79.0,4.0,0.0,14.0,621.0
Mahisagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1295.0,1309.0,1341.0,1116.0,1335.0,1336.0,1371.0,1075.0,907.0,827.0,917.0,822.0,13651.0
Mahisagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,5.0,0.0,3.0,4.0,3.0,0.0,0.0,12.0,6.0,0.0,0.0,0.0,33.0
Mahisagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,40.0,46.0,72.0,0.0,0.0,0.0,0.0,30.0,0.0,0.0,15.0,14.0,217.0
Mahisagar,13.1,Number of Patients operated for cataract,TOTAL,97.0,186.0,102.0,183.0,261.0,277.0,237.0,412.0,433.0,388.0,341.0,373.0,3290.0
Mahisagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,97.0,184.0,39.0,183.0,261.0,277.0,237.0,412.0,433.0,382.0,239.0,309.0,3053.0
Mahisagar,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,2.0,0.0,1040.0,1091.0,1153.0,1570.0,5188.0,5465.0,5276.0,2246.0,4115.0,27146.0
Mahisagar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,10.0,60.0,60.0,80.0,232.0,405.0,341.0,63.0,120.0,1371.0
Mahisagar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,4.0,4.0,4.0,-1.0
Mahisagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,8.0,7.0,8.0,9.0,9.0,12.0,8.0,14.0,9.0,9.0,8.0,7.0,-1.0
Mahisagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,211.0,256.0,239.0,263.0,234.0,1102.0,1438.0,956.0,1899.0,911.0,953.0,1292.0,-1.0
Mahisagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,6.0,6.0,5.0,6.0,5.0,6.0,7.0,7.0,7.0,6.0,7.0,-1.0
Mahisagar,14.05,Number of RKS meetings held during the month,TOTAL,2.0,1.0,8.0,5.0,4.0,6.0,5.0,5.0,11.0,6.0,4.0,14.0,71.0
Mahisagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,21.0,22.0,20.0,18.0,23.0,20.0,19.0,26.0,22.0,19.0,19.0,20.0,-1.0
Mahisagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,263.0,235.0,219.0,223.0,221.0,229.0,241.0,244.0,258.0,261.0,260.0,229.0,2883.0
Mahisagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Mahisagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,6.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,7.0,7.0,7.0,-1.0
Mahisagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,136.0,167.0,212.0,295.0,307.0,326.0,311.0,278.0,181.0,297.0,313.0,469.0,3292.0
Mahisagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1460.0,1400.0,1952.0,1640.0,2176.0,2555.0,1973.0,1448.0,1019.0,821.0,1686.0,2085.0,20215.0
Mahisagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,167.0,167.0,191.0,234.0,261.0,334.0,363.0,294.0,242.0,307.0,352.0,508.0,3420.0
Mahisagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2509.0,1983.0,3239.0,2791.0,3401.0,3616.0,2621.0,2704.0,3544.0,2582.0,2535.0,2354.0,33879.0
Mahisagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,303.0,334.0,403.0,529.0,568.0,660.0,674.0,572.0,423.0,604.0,665.0,977.0,6712.0
Mahisagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3969.0,3383.0,5191.0,4431.0,5577.0,6171.0,4594.0,4152.0,4563.0,3403.0,4221.0,4439.0,54094.0
Mahisagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,3.0,2.0,2.0,3.0,3.0,1.0,1.0,2.0,4.0,2.0,0.0,24.0
Mahisagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,2.0,1.0,1.0,0.0,1.0,3.0,2.0,1.0,2.0,1.0,1.0,16.0
Mahisagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,2.0,5.0,3.0,3.0,3.0,4.0,4.0,3.0,3.0,6.0,3.0,1.0,40.0
Mahisagar,14.11,In-Patient Head Count at midnight,TOTAL,3750.0,2675.0,3088.0,3942.0,4395.0,4612.0,3606.0,3125.0,3771.0,3586.0,3750.0,3778.0,44078.0
Mahisagar,14.12.1,OPD attendance (All),TOTAL,29902.0,30621.0,32975.0,37490.0,46115.0,58222.0,42668.0,39735.0,38122.0,36200.0,42337.0,46547.0,480934.0
Mahisagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,34.0,37.0,14.0,6.0,6.0,13.0,30.0,474.0,574.0,618.0,186.0,31.0,2023.0
Mahisagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,5.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.0,2.0,21.0
Mahisagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,108.0,52.0,80.0,31.0,83.0,98.0,155.0,448.0,771.0,423.0,276.0,183.0,2708.0
Mahisagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,603.0,1241.0,836.0,923.0,740.0,913.0,860.0,1159.0,1255.0,1178.0,1524.0,1429.0,12661.0
Mahisagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,98.0,99.0,30.0,12.0,18.0,20.0,18.0,21.0,18.0,18.0,20.0,21.0,393.0
Mahisagar,14.14.c,Number of Adolescents counselled,TOTAL,15.0,17.0,7.0,36.0,49.0,3.0,0.0,15.0,58.0,14.0,57.0,32.0,303.0
Mahisagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4794.0,4145.0,4775.0,6463.0,5879.0,7143.0,6105.0,6081.0,6193.0,5119.0,6177.0,6437.0,69311.0
Mahisagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,235.0,166.0,200.0,248.0,187.0,220.0,186.0,205.0,200.0,192.0,196.0,231.0,2466.0
Mahisagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,288.0,327.0,134.0,273.0,338.0,412.0,310.0,346.0,436.0,224.0,269.0,364.0,3721.0
Mahisagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,10.0,5.0,6.0,0.0,2.0,12.0,0.0,6.0,8.0,1.0,0.0,2.0,52.0
Mahisagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,231.0,204.0,92.0,289.0,225.0,188.0,218.0,236.0,263.0,161.0,222.0,331.0,2660.0
Mahisagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,5.0,0.0,3.0,11.0,0.0,188.0,0.0,4.0,6.0,1.0,0.0,1.0,219.0
Mahisagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,421.0,346.0,482.0,586.0,459.0,398.0,270.0,278.0,361.0,277.0,249.0,423.0,4550.0
Mahisagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,32.0,28.0,70.0,32.0,0.0,23.0,0.0,15.0,11.0,0.0,0.0,0.0,211.0
Mahisagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,940.0,877.0,708.0,1148.0,1022.0,998.0,798.0,860.0,1060.0,662.0,740.0,1118.0,10931.0
Mahisagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,47.0,33.0,79.0,43.0,2.0,223.0,0.0,25.0,25.0,2.0,0.0,3.0,482.0
Mahisagar,15.2,Number of Widal tests conducted,Number tested,195.0,131.0,277.0,197.0,259.0,331.0,333.0,312.0,177.0,122.0,291.0,333.0,2958.0
Mahisagar,15.3.a,Number of VDRL tests conducted on males,Number tested,7.0,7.0,9.0,3.0,3.0,3.0,2.0,2.0,2.0,0.0,24.0,8.0,70.0
Mahisagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,64.0,76.0,88.0,77.0,48.0,44.0,41.0,47.0,59.0,57.0,67.0,76.0,744.0
Mahisagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,70.0,94.0,106.0,174.0,104.0,66.0,89.0,96.0,81.0,106.0,33.0,126.0,1145.0
Mahisagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,141.0,177.0,203.0,254.0,155.0,113.0,132.0,145.0,142.0,163.0,124.0,210.0,1959.0
Mahisagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,6067.0,8127.0,8041.0,7656.0,11223.0,14189.0,8795.0,6484.0,5436.0,4672.0,7511.0,7006.0,95207.0
Mahisagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,11.0,20.0,15.0,17.0,95.0,52.0,10.0,5.0,7.0,2.0,4.0,323.0,561.0
Mahisagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,4.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,3.0,1.0,2.0,16.0
Mahisagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Mahisagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Mahisagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Mahisagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Mahisagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahisagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,1.0,1.0,,,,,,,,3.0
Mahisagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,2.0,,,,,,,,,,,1.0,3.0
Mahisagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mahisagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,2.0,,,,,,,,,,,1.0,3.0
Mahisagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,2.0,,,,,,,,,,2.0
Mahisagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mahisagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,2.0,,,,,,,,,,2.0
Mahisagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,5.0,7.0,2.0,5.0,6.0,3.0,5.0,8.0,4.0,6.0,2.0,,53.0
Mahisagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mahisagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,5.0,7.0,2.0,5.0,6.0,3.0,5.0,8.0,4.0,6.0,2.0,,53.0
Mahisagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,1.0,,2.0,,1.0,2.0,,1.0,,,8.0
Mahisagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,1.0,,,1.0,,2.0,,2.0,,6.0
Mahisagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,1.0,1.0,2.0,,2.0,2.0,2.0,1.0,2.0,,14.0
Mahisagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Mahisagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mahisagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,,,,,,,,1.0
Mahisagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,,,,,,,,1.0,,,2.0
Mahisagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mahisagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,,,,,,,1.0,,,2.0
Mahisagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mahisagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mahisagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Mahisagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mahisagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mahisagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Mahisagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,1.0,,1.0,2.0,,,2.0,,2.0,1.0,9.0
Mahisagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,,,1.0,,1.0,,,,,,4.0
Mahisagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,1.0,1.0,,2.0,2.0,1.0,,2.0,,2.0,1.0,13.0
Mahisagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Mahisagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Mahisagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Mahisagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,2.0,2.0,1.0,2.0,3.0,1.0,,,1.0,1.0,14.0
Mahisagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,1.0,,,2.0,,,,1.0,,5.0
Mahisagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,3.0,3.0,1.0,2.0,5.0,1.0,,,2.0,1.0,19.0
Mahisagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,2.0,1.0,,,,1.0,,1.0,,1.0,,6.0
Mahisagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,1.0,,3.0,1.0,3.0,1.0,1.0,2.0,1.0,14.0
Mahisagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,2.0,2.0,1.0,,3.0,2.0,3.0,2.0,1.0,3.0,1.0,20.0
Mahisagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Mahisagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Mahisagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,1.0,,,,,,,1.0
Mahisagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Mahisagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,,,1.0,,1.0,,,,,3.0
Mahisagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,2.0,1.0,,,,3.0
Mahisagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,,,,2.0,,3.0,1.0,,,,7.0
Mahisagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Mahisagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Mahisagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,1.0,,,,,,,,,1.0
Mahisagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,4.0,7.0,2.0,,2.0,1.0,1.0,,2.0,2.0,2.0,26.0
Mahisagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,5.0,4.0,7.0,2.0,2.0,5.0,5.0,9.0,7.0,3.0,3.0,3.0,55.0
Mahisagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,8.0,8.0,14.0,4.0,2.0,7.0,6.0,10.0,7.0,5.0,5.0,5.0,81.0
Mahisagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Mahisagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Mahisagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,1.0,,,,1.0,,2.0
Mahisagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Mahisagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Mahisagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Mahisagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Mahisagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Mahisagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Mahisagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Mahisagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Mahisagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,1.0,,,,,1.0
Mahisagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Mahisagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Mahisagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Mahisagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Mahisagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Mahisagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Mahisagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,3.0,1.0,3.0,,2.0,,1.0,1.0,1.0,,13.0
Mahisagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Mahisagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,3.0,1.0,3.0,,2.0,,1.0,1.0,1.0,,13.0
Mahisagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,,,2.0,,,2.0,2.0,,1.0,3.0,,11.0
Mahisagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,1.0,,1.0,,2.0,2.0,,,,6.0
Mahisagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,,,3.0,,1.0,2.0,4.0,2.0,1.0,3.0,,17.0
Mahisagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,,,,1.0,1.0,1.0,3.0,,,1.0,,9.0
Mahisagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Mahisagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,,,,1.0,1.0,1.0,3.0,,,1.0,1.0,10.0
Mahisagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,2.0,,2.0,,,,,,,,1.0,5.0
Mahisagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Mahisagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,2.0,,3.0,,,,,,,,1.0,6.0
Mahisagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Mahisagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,,1.0,,,,,,,,,,2.0
Mahisagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,,1.0,,,,,,,,,,2.0
Mahisagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Mahisagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Mahisagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Mahisagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,1.0,,1.0,,,,,,,,,2.0
Mahisagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,,2.0,1.0,,,,1.0,1.0,,,6.0
Mahisagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,9.0,9.0,10.0,3.0,5.0,7.0,9.0,8.0,6.0,13.0,3.0,3.0,85.0
Mahisagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,23.0,24.0,29.0,13.0,13.0,16.0,16.0,18.0,17.0,32.0,21.0,21.0,243.0
Mahisagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,32.0,34.0,39.0,18.0,19.0,23.0,25.0,26.0,24.0,46.0,24.0,24.0,334.0
Morbi,1.1,Total number of pregnant women Registered for ANC,TOTAL,1430.0,1683.0,1908.0,1907.0,1456.0,1668.0,1545.0,1662.0,1557.0,1625.0,1528.0,1822.0,19791.0
Morbi,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1058.0,1167.0,1282.0,1277.0,954.0,1089.0,1082.0,1211.0,1141.0,1199.0,1159.0,1321.0,13940.0
Morbi,1.2,Number of Pregnant women registered under JSY,TOTAL,170.0,234.0,238.0,324.0,245.0,402.0,345.0,332.0,315.0,233.0,267.0,351.0,3456.0
Morbi,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1003.0,1090.0,1278.0,1345.0,1131.0,1172.0,1134.0,1257.0,1302.0,1271.0,1128.0,1311.0,14422.0
Morbi,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1025.0,1286.0,1468.0,1457.0,1087.0,1258.0,1149.0,1272.0,1214.0,1233.0,1197.0,1459.0,15105.0
Morbi,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1373.0,1354.0,1691.0,1733.0,1349.0,1440.0,1338.0,1456.0,1332.0,1360.0,1383.0,1502.0,17311.0
Morbi,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1222.0,1405.0,1471.0,1482.0,1383.0,1475.0,1342.0,1357.0,1377.0,1398.0,1363.0,1493.0,16768.0
Morbi,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,18.0,6.0,8.0,2.0,40.0,4.0,37.0,35.0,8.0,1.0,1.0,3.0,163.0
Morbi,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,4.0,24.0,1.0,0.0,1.0,0.0,0.0,0.0,30.0
Morbi,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,679.0,756.0,959.0,1001.0,668.0,851.0,712.0,718.0,811.0,733.0,712.0,787.0,9387.0
Morbi,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,8.0,6.0,8.0,3.0,1.0,1.0,2.0,2.0,7.0,6.0,10.0,6.0,60.0
Morbi,1.8,Number of pregnancy test kits used at SC level,TOTAL,405.0,447.0,433.0,445.0,456.0,507.0,475.0,459.0,436.0,471.0,439.0,462.0,5435.0
Morbi,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,6.0,13.0,19.0,15.0,20.0,18.0,15.0,21.0,26.0,25.0,15.0,27.0,220.0
Morbi,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,18.0,26.0,32.0,34.0,33.0,32.0,25.0,14.0,34.0,35.0,44.0,35.0,362.0
Morbi,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,24.0,39.0,51.0,49.0,53.0,50.0,40.0,35.0,60.0,60.0,59.0,62.0,582.0
Morbi,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,24.0,39.0,51.0,49.0,52.0,48.0,40.0,35.0,60.0,60.0,59.0,61.0,578.0
Morbi,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,4.0
Morbi,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,306.0,392.0,507.0,455.0,579.0,618.0,578.0,659.0,680.0,469.0,479.0,523.0,6245.0
Morbi,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,254.0,359.0,394.0,401.0,477.0,518.0,509.0,584.0,598.0,394.0,407.0,449.0,5344.0
Morbi,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,4.0,5.0,4.0,0.0,1.0,1.0,6.0,0.0,1.0,2.0,35.0,59.0
Morbi,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,4.0,3.0,1.0,0.0,1.0,2.0,6.0,0.0,1.0,2.0,5.0,25.0
Morbi,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,577.0,942.0,1160.0,1054.0,1036.0,1119.0,1167.0,1137.0,1092.0,1108.0,902.0,1060.0,12354.0
Morbi,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,13.0,26.0,22.0,13.0,29.0,27.0,44.0,16.0,24.0,18.0,12.0,25.0,269.0
Morbi,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,13.0,26.0,0.0,0.0,0.0,9.0,0.0,10.0,1.0,18.0,11.0,0.0,88.0
Morbi,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,6.0,14.0,20.0,6.0,8.0,15.0,18.0,12.0,19.0,6.0,14.0,10.0,148.0
Morbi,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,4.0,2.0,0.0,6.0,12.0,3.0,3.0,1.0,2.0,0.0,0.0,0.0,33.0
Morbi,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morbi,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,10.0,16.0,20.0,12.0,20.0,18.0,21.0,13.0,21.0,6.0,14.0,10.0,181.0
Morbi,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,21.0,25.0,47.0,27.0,30.0,27.0,44.0,63.0,73.0,74.0,28.0,56.0,515.0
Morbi,4.1.1.a,Number of male live births,TOTAL,481.0,716.0,882.0,802.0,895.0,922.0,890.0,895.0,926.0,827.0,752.0,849.0,9837.0
Morbi,4.1.1.b,Number of female live births,TOTAL,410.0,634.0,835.0,749.0,761.0,831.0,884.0,932.0,905.0,805.0,679.0,785.0,9210.0
Morbi,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,891.0,1350.0,1717.0,1551.0,1656.0,1753.0,1774.0,1827.0,1831.0,1632.0,1431.0,1634.0,19047.0
Morbi,4.1.2,Number of still births,TOTAL,10.0,11.0,20.0,9.0,21.0,15.0,21.0,13.0,12.0,9.0,16.0,17.0,174.0
Morbi,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,27.0,45.0,66.0,45.0,50.0,44.0,37.0,36.0,41.0,36.0,44.0,58.0,529.0
Morbi,4.2.1,Number of Newborns weighed at birth,TOTAL,776.0,1350.0,1717.0,1553.0,1656.0,1685.0,1772.0,1827.0,1825.0,1633.0,1429.0,1630.0,18853.0
Morbi,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,61.0,42.0,95.0,86.0,117.0,199.0,119.0,104.0,133.0,110.0,63.0,91.0,1220.0
Morbi,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,772.0,1331.0,1678.0,1539.0,1624.0,1705.0,1752.0,1803.0,1788.0,1598.0,1412.0,1615.0,18617.0
Morbi,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,10.0,3.0,32.0,26.0,4.0,6.0,4.0,5.0,12.0,14.0,9.0,5.0,130.0
Morbi,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,13.0,7.0,9.0,21.0,25.0,13.0,21.0,10.0,7.0,5.0,12.0,5.0,148.0
Morbi,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morbi,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,23.0,10.0,41.0,47.0,29.0,19.0,25.0,15.0,19.0,19.0,21.0,10.0,278.0
Morbi,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,14.0,7.0,36.0,39.0,25.0,14.0,21.0,10.0,9.0,5.0,12.0,5.0,197.0
Morbi,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,7.0,0.0,0.0,20.0,12.0,10.0,0.0,17.0,0.0,0.0,0.0,66.0
Morbi,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,20.0,10.0,41.0,27.0,29.0,19.0,25.0,15.0,19.0,13.0,89.0,8.0,315.0
Morbi,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Morbi,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,810.0,1332.0,1666.0,1533.0,1520.0,1691.0,1645.0,1754.0,1644.0,1557.0,1421.0,1621.0,18194.0
Morbi,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,686.0,1270.0,1176.0,1440.0,1444.0,1609.0,1615.0,1355.0,1246.0,1069.0,1389.0,1543.0,15842.0
Morbi,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,4.0,0.0,6.0,0.0,12.0
Morbi,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Morbi,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Morbi,7.2,Number of MTPs conducted at Private Facilities,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Morbi,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,5.0,1.0,6.0,5.0,0.0,0.0,2.0,3.0,0.0,1.0,1.0,3.0,27.0
Morbi,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,20.0,57.0,41.0,55.0,117.0,69.0,77.0,77.0,57.0,59.0,51.0,52.0,732.0
Morbi,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,25.0,58.0,47.0,60.0,117.0,69.0,79.0,80.0,57.0,60.0,52.0,55.0,759.0
Morbi,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,27.0,0.0,0.0,64.0,53.0,0.0,0.0,39.0,0.0,30.0,75.0,0.0,288.0
Morbi,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Morbi,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Morbi,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morbi,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0
Morbi,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,9.0,0.0,0.0,9.0,20.0
Morbi,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,48.0,27.0,15.0,32.0,40.0,51.0,42.0,110.0,369.0,420.0,373.0,119.0,1646.0
Morbi,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,58.0,43.0,20.0,54.0,29.0,35.0,40.0,142.0,249.0,262.0,160.0,65.0,1157.0
Morbi,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morbi,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,106.0,70.0,35.0,86.0,69.0,86.0,82.0,254.0,627.0,682.0,533.0,193.0,2823.0
Morbi,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,19.0,20.0,8.0,9.0,9.0,5.0,10.0,18.0,0.0,0.0,1.0,0.0,99.0
Morbi,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morbi,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,5.0,1.0,1.0,4.0,5.0,11.0,10.0,0.0,3.0,1.0,2.0,7.0,50.0
Morbi,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morbi,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,5.0
Morbi,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,454.0,497.0,590.0,640.0,537.0,564.0,695.0,647.0,623.0,558.0,444.0,357.0,6606.0
Morbi,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,42.0,61.0,57.0,30.0,29.0,27.0,20.0,61.0,98.0,17.0,19.0,30.0,491.0
Morbi,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,21.0,14.0,26.0,42.0,52.0,13.0,31.0,14.0,2.0,35.0,31.0,26.0,307.0
Morbi,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,30.0,21.0,36.0,41.0,12.0,25.0,40.0,14.0,17.0,40.0,34.0,60.0,370.0
Morbi,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morbi,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,547.0,593.0,709.0,753.0,630.0,629.0,786.0,736.0,740.0,650.0,528.0,473.0,7774.0
Morbi,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,5.0,4.0,1.0,5.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,18.0
Morbi,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,57.0,80.0,86.0,72.0,102.0,109.0,60.0,47.0,47.0,115.0,69.0,0.0,844.0
Morbi,9.06,Number of IUCD removals,TOTAL,58.0,65.0,102.0,92.0,87.0,84.0,88.0,94.0,107.0,69.0,78.0,77.0,1001.0
Morbi,9.07,Number of Oral Pills cycles distributed,TOTAL,2455.0,1713.0,1475.0,1412.0,1653.0,1611.0,1658.0,1633.0,1639.0,2485.0,1474.0,2056.0,21264.0
Morbi,9.08,Number of Condom pieces distributed,TOTAL,22231.0,18625.0,10941.0,14290.0,28577.0,25077.0,34798.0,23085.0,20471.0,22762.0,10830.0,10900.0,242587.0
Morbi,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,340.0,340.0,0.0,0.0,50.0,0.0,0.0,0.0,2.0,0.0,0.0,732.0
Morbi,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,10.0,12.0,10.0,16.0,2.0,2.0,16.0,28.0,18.0,13.0,19.0,8.0,154.0
Morbi,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,5.0,4.0,3.0,4.0,4.0,4.0,4.0,4.0,3.0,3.0,3.0,-1.0
Morbi,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,893.0,1195.0,1618.0,1558.0,1497.0,1681.0,1540.0,1680.0,1616.0,1617.0,1353.0,1439.0,17687.0
Morbi,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Morbi,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1081.0,1368.0,1495.0,1708.0,1486.0,1624.0,1666.0,1701.0,1687.0,1603.0,1673.0,1642.0,18734.0
Morbi,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1111.0,1348.0,1530.0,1463.0,1520.0,1482.0,1480.0,1577.0,1604.0,1531.0,1640.0,1676.0,17962.0
Morbi,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1131.0,1285.0,1649.0,1555.0,1479.0,1520.0,1482.0,1502.0,1515.0,1506.0,1512.0,1755.0,17891.0
Morbi,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,675.0,889.0,1171.0,1081.0,1246.0,1439.0,1339.0,1447.0,1407.0,1496.0,1216.0,1324.0,14730.0
Morbi,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1081.0,1372.0,1501.0,1708.0,1486.0,1624.0,1663.0,1698.0,2084.0,1604.0,1674.0,1642.0,19137.0
Morbi,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1111.0,1226.0,1530.0,1473.0,1523.0,1484.0,1480.0,1572.0,1604.0,1535.0,1640.0,1686.0,17864.0
Morbi,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1126.0,1280.0,1649.0,1555.0,1481.0,1518.0,1486.0,1502.0,1515.0,1506.0,1512.0,1755.0,17885.0
Morbi,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,468.0,474.0,577.0,633.0,695.0,705.0,748.0,792.0,780.0,709.0,651.0,773.0,8005.0
Morbi,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Morbi,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1099.0,1291.0,1774.0,1760.0,1622.0,1582.0,1504.0,1504.0,1390.0,1383.0,1383.0,1514.0,17806.0
Morbi,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1164.0,1275.0,1577.0,1509.0,1368.0,1400.0,1368.0,1472.0,1385.0,1398.0,1407.0,1632.0,16955.0
Morbi,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,552.0,670.0,902.0,892.0,824.0,789.0,753.0,745.0,696.0,694.0,688.0,765.0,8970.0
Morbi,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,523.0,606.0,821.0,787.0,776.0,754.0,710.0,731.0,658.0,659.0,660.0,682.0,8367.0
Morbi,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1075.0,1276.0,1723.0,1679.0,1600.0,1543.0,1463.0,1476.0,1354.0,1353.0,1348.0,1447.0,17337.0
Morbi,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1201.0,1279.0,1617.0,1576.0,1422.0,1393.0,1378.0,1450.0,1422.0,1403.0,1412.0,1625.0,17178.0
Morbi,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1195.0,1279.0,1617.0,1577.0,1422.0,1393.0,1378.0,1439.0,1422.0,1403.0,1408.0,1625.0,17158.0
Morbi,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,331.0,388.0,465.0,469.0,471.0,443.0,459.0,415.0,419.0,404.0,429.0,467.0,5160.0
Morbi,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,273.0,338.0,416.0,437.0,422.0,415.0,381.0,426.0,375.0,362.0,385.0,430.0,4660.0
Morbi,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,604.0,726.0,881.0,906.0,893.0,858.0,840.0,841.0,794.0,766.0,814.0,897.0,9820.0
Morbi,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,650.0,854.0,1204.0,1362.0,1656.0,1803.0,1536.0,1144.0,1241.0,1334.0,1070.0,1238.0,15092.0
Morbi,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,683.0,812.0,1148.0,1380.0,1625.0,2031.0,1510.0,1093.0,1203.0,1188.0,1096.0,1138.0,14907.0
Morbi,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,783.0,916.0,1192.0,1206.0,1420.0,1482.0,1098.0,1139.0,1416.0,1268.0,1098.0,1084.0,14102.0
Morbi,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,11.0,11.0,6.0,0.0,2.0,0.0,0.0,30.0
Morbi,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,612.0,660.0,725.0,692.0,666.0,691.0,691.0,685.0,691.0,647.0,684.0,750.0,8194.0
Morbi,10.4.2,Number of Immunisation sessions held during the month,TOTAL,546.0,620.0,691.0,707.0,607.0,645.0,651.0,648.0,675.0,609.0,655.0,738.0,7792.0
Morbi,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,489.0,540.0,607.0,564.0,549.0,561.0,568.0,580.0,614.0,545.0,590.0,669.0,6876.0
Morbi,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1096.0,1302.0,1753.0,1733.0,1607.0,1576.0,1501.0,1506.0,1390.0,1360.0,1377.0,1546.0,17747.0
Morbi,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,995.0,0.0,0.0,0.0,3509.0,2133.0,26.0,1354.0,307.0,23.0,3654.0,2598.0,14599.0
Morbi,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,932.0,0.0,0.0,0.0,3607.0,2141.0,49.0,1167.0,297.0,0.0,3600.0,2547.0,14340.0
Morbi,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,13.0,0.0,0.0,23.0
Morbi,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,731.0,887.0,897.0,920.0,1152.0,1126.0,890.0,989.0,1096.0,937.0,888.0,1051.0,11564.0
Morbi,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,7.0,17.0,26.0,8.0,45.0,53.0,23.0,35.0,42.0,21.0,6.0,11.0,294.0
Morbi,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,22.0,0.0,16.0,0.0,94.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,132.0
Morbi,13.1,Number of Patients operated for cataract,TOTAL,104.0,0.0,62.0,212.0,212.0,24.0,190.0,190.0,190.0,197.0,0.0,112.0,1493.0
Morbi,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,104.0,0.0,62.0,212.0,212.0,24.0,190.0,190.0,190.0,197.0,0.0,112.0,1493.0
Morbi,13.3,Number of School children detected with Refractive errors,TOTAL,27.0,0.0,11.0,36.0,741.0,118.0,115.0,199.0,525.0,291.0,12.0,130.0,2205.0
Morbi,13.4,Number of children provided free glasses,TOTAL,4.0,0.0,0.0,26.0,119.0,110.0,107.0,183.0,263.0,248.0,11.0,83.0,1154.0
Morbi,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Morbi,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,2.0,2.0,,1.0,2.0,1.0,1.0,3.0,2.0,2.0,4.0,-1.0
Morbi,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,27.0,34.0,46.0,66.0,35.0,72.0,74.0,33.0,84.0,83.0,77.0,81.0,-1.0
Morbi,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,4.0,5.0,5.0,5.0,4.0,5.0,5.0,6.0,5.0,5.0,5.0,-1.0
Morbi,14.05,Number of RKS meetings held during the month,TOTAL,2.0,1.0,12.0,3.0,2.0,5.0,4.0,2.0,11.0,3.0,4.0,12.0,61.0
Morbi,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,10.0,10.0,10.0,10.0,11.0,8.0,9.0,7.0,7.0,7.0,9.0,-1.0
Morbi,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,43.0,63.0,99.0,97.0,87.0,22.0,7.0,60.0,38.0,57.0,62.0,73.0,708.0
Morbi,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,1.0,,,,,,,1.0,1.0,-1.0
Morbi,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Morbi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,184.0,232.0,212.0,259.0,253.0,339.0,288.0,284.0,306.0,307.0,471.0,350.0,3485.0
Morbi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,441.0,637.0,567.0,488.0,660.0,819.0,666.0,588.0,569.0,473.0,515.0,656.0,7079.0
Morbi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,193.0,198.0,221.0,241.0,235.0,320.0,324.0,328.0,317.0,300.0,707.0,277.0,3661.0
Morbi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,800.0,1086.0,876.0,901.0,1109.0,1186.0,1003.0,1203.0,1480.0,1258.0,1131.0,1168.0,13201.0
Morbi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,377.0,430.0,433.0,500.0,488.0,659.0,612.0,612.0,623.0,607.0,1178.0,627.0,7146.0
Morbi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1241.0,1723.0,1443.0,1389.0,1769.0,2005.0,1669.0,1791.0,2049.0,1731.0,1646.0,1824.0,20280.0
Morbi,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,9.0,0.0,0.0,2.0,2.0,2.0,0.0,1.0,0.0,1.0,0.0,17.0
Morbi,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,3.0
Morbi,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,9.0,0.0,1.0,2.0,3.0,2.0,0.0,2.0,0.0,1.0,0.0,20.0
Morbi,14.11,In-Patient Head Count at midnight,TOTAL,326.0,673.0,497.0,371.0,760.0,968.0,1269.0,759.0,681.0,1208.0,1038.0,1196.0,9746.0
Morbi,14.12.1,OPD attendance (All),TOTAL,45286.0,43236.0,48181.0,44298.0,60190.0,62949.0,69341.0,48014.0,62723.0,52622.0,65315.0,69123.0,671278.0
Morbi,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,64.0,70.0,88.0,76.0,75.0,62.0,80.0,62.0,65.0,73.0,86.0,132.0,933.0
Morbi,14.14.a,Number of patients given AYUSH treatment,TOTAL,1212.0,1019.0,1737.0,925.0,1308.0,2888.0,2212.0,1834.0,1837.0,1686.0,2637.0,2308.0,21603.0
Morbi,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,14.14.c,Number of Adolescents counselled,TOTAL,492.0,480.0,472.0,479.0,477.0,479.0,500.0,476.0,501.0,45.0,487.0,473.0,5361.0
Morbi,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2304.0,2510.0,2511.0,2704.0,2783.0,2173.0,2970.0,1684.0,2098.0,2294.0,2456.0,2629.0,29116.0
Morbi,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,30.0,35.0,46.0,33.0,42.0,26.0,31.0,41.0,36.0,58.0,30.0,78.0,486.0
Morbi,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,372.0,345.0,472.0,528.0,591.0,616.0,572.0,562.0,403.0,217.0,272.0,421.0,5371.0
Morbi,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,6.0,6.0,3.0,5.0,3.0,3.0,7.0,4.0,3.0,4.0,5.0,50.0
Morbi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,360.0,481.0,679.0,804.0,604.0,718.0,1238.0,737.0,832.0,544.0,597.0,825.0,8419.0
Morbi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,2.0,4.0,1.0,1.0,1.0,1.0,1.0,2.0,3.0,5.0,2.0,24.0
Morbi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,280.0,451.0,484.0,466.0,428.0,494.0,1054.0,465.0,429.0,328.0,311.0,465.0,5655.0
Morbi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,2.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,6.0
Morbi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1012.0,1277.0,1635.0,1798.0,1623.0,1828.0,2864.0,1764.0,1664.0,1089.0,1180.0,1711.0,19445.0
Morbi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,9.0,12.0,5.0,7.0,4.0,4.0,9.0,6.0,6.0,9.0,7.0,80.0
Morbi,15.2,Number of Widal tests conducted,Number tested,6.0,13.0,17.0,13.0,4.0,13.0,11.0,27.0,10.0,0.0,0.0,0.0,114.0
Morbi,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,29.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33.0
Morbi,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,29.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33.0
Morbi,15.4.1,Number of blood smears examined for Malaria,TOTAL,4921.0,4451.0,4372.0,5456.0,7070.0,9968.0,6240.0,6510.0,5082.0,3633.0,4622.0,7399.0,69724.0
Morbi,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,62.0,94.0,110.0,110.0,324.0,636.0,144.0,102.0,134.0,70.0,32.0,44.0,1862.0
Morbi,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,13.0,20.0,16.0,6.0,93.0,201.0,173.0,122.0,145.0,72.0,17.0,4.0,882.0
Morbi,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.3,Stock position of TT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Morbi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morbi,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,2.0,,3.0,,1.0,1.0,,1.0,,8.0
Morbi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,,,,,,,,,1.0,2.0
Morbi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Morbi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,,,,,,,,1.0,2.0
Morbi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,1.0,2.0,,1.0,6.0,2.0,,,2.0,,1.0,17.0
Morbi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,1.0,,,2.0
Morbi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,1.0,2.0,,1.0,6.0,2.0,,1.0,3.0,,1.0,19.0
Morbi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,3.0,1.0,7.0,3.0,5.0,4.0,3.0,1.0,4.0,6.0,1.0,3.0,41.0
Morbi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Morbi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,1.0,7.0,3.0,5.0,4.0,3.0,1.0,4.0,6.0,1.0,3.0,41.0
Morbi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,3.0,5.0,5.0,4.0,,6.0,1.0,6.0,6.0,,4.0,43.0
Morbi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,1.0,,1.0,,,,,,,3.0
Morbi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,3.0,5.0,6.0,4.0,1.0,6.0,1.0,6.0,6.0,,4.0,46.0
Morbi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,,,1.0,1.0,,2.0,,,5.0
Morbi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Morbi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,,,1.0,1.0,,2.0,,,5.0
Morbi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Morbi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Morbi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Morbi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Morbi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Morbi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,,,,,,,,,,1.0
Morbi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Morbi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Morbi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Morbi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,4.0,1.0,6.0,2.0,3.0,2.0,3.0,,,6.0,1.0,3.0,31.0
Morbi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,,1.0,,1.0,,,2.0,,,5.0
Morbi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,1.0,6.0,2.0,4.0,2.0,4.0,,,8.0,1.0,3.0,36.0
Morbi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Morbi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Morbi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Morbi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,1.0,1.0,,,,,,,,,2.0
Morbi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Morbi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,1.0,,,1.0,,,,,,3.0
Morbi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,2.0,,2.0
Morbi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,2.0,,2.0
Morbi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,4.0,,4.0
Morbi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Morbi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Morbi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,1.0,,,,,,,1.0
Morbi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Morbi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Morbi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Morbi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Morbi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Morbi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,1.0,,,,1.0
Morbi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,3.0,1.0,,3.0,,1.0,1.0,1.0,,2.0,1.0,13.0
Morbi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,,1.0,,2.0,2.0,1.0,1.0,2.0,1.0,6.0,,19.0
Morbi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,3.0,2.0,,5.0,2.0,2.0,2.0,3.0,1.0,8.0,1.0,32.0
Morbi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Morbi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Morbi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,1.0,1.0
Morbi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Morbi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Morbi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Morbi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Morbi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Morbi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Morbi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Morbi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Morbi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Morbi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Morbi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Morbi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Morbi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Morbi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Morbi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Morbi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,,,,1.0,1.0,,,,,3.0
Morbi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Morbi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,,,,1.0,1.0,,,,,3.0
Morbi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Morbi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,2.0,1.0,,1.0,,2.0,1.0,1.0,,,,8.0
Morbi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Morbi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,2.0,1.0,,2.0,,2.0,1.0,1.0,1.0,,,10.0
Morbi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,2.0,,2.0,,,,,,2.0,,6.0
Morbi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Morbi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,2.0,,2.0,,,,,,2.0,,6.0
Morbi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Morbi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Morbi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Morbi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,,,3.0,,,1.0,1.0,,,,6.0
Morbi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,,,,1.0,,,,,,,2.0
Morbi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,2.0,,,3.0,1.0,,1.0,1.0,,,,8.0
Morbi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Morbi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Morbi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Morbi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Morbi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,,,,,1.0,,,,2.0
Morbi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,1.0,3.0,2.0,4.0,10.0,2.0,1.0,1.0,,1.0,1.0,27.0
Morbi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,4.0,7.0,6.0,4.0,10.0,9.0,15.0,9.0,10.0,3.0,11.0,8.0,96.0
Morbi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,5.0,8.0,9.0,7.0,14.0,19.0,17.0,10.0,12.0,3.0,12.0,9.0,125.0
Narmada,1.1,Total number of pregnant women Registered for ANC,TOTAL,1145.0,1029.0,1130.0,990.0,917.0,920.0,834.0,1084.0,938.0,1148.0,1229.0,1141.0,12505.0
Narmada,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,993.0,887.0,1000.0,885.0,807.0,816.0,741.0,808.0,845.0,1021.0,1102.0,1026.0,10931.0
Narmada,1.2,Number of Pregnant women registered under JSY,TOTAL,1007.0,942.0,1008.0,886.0,815.0,838.0,747.0,844.0,815.0,995.0,1111.0,1038.0,11046.0
Narmada,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,743.0,805.0,848.0,845.0,972.0,901.0,923.0,1020.0,908.0,861.0,775.0,709.0,10310.0
Narmada,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,828.0,753.0,798.0,646.0,603.0,585.0,590.0,706.0,654.0,798.0,843.0,803.0,8607.0
Narmada,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1146.0,1016.0,1074.0,1005.0,645.0,621.0,793.0,827.0,827.0,926.0,1082.0,1060.0,11022.0
Narmada,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,985.0,865.0,947.0,909.0,859.0,783.0,1102.0,1348.0,1058.0,1249.0,1213.0,1180.0,12498.0
Narmada,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,7.0,13.0,7.0,8.0,4.0,9.0,2.0,4.0,10.0,10.0,12.0,23.0,109.0
Narmada,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,2.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,1.0,1.0,0.0,9.0
Narmada,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1204.0,1224.0,1457.0,1381.0,1355.0,1217.0,1249.0,1308.0,1458.0,1463.0,1454.0,1764.0,16534.0
Narmada,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,12.0,15.0,18.0,28.0,27.0,15.0,17.0,13.0,9.0,6.0,5.0,20.0,185.0
Narmada,1.8,Number of pregnancy test kits used at SC level,TOTAL,529.0,548.0,536.0,485.0,499.0,480.0,458.0,497.0,527.0,724.0,702.0,574.0,6559.0
Narmada,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,1.0,0.0,0.0,2.0,2.0,0.0,23.0,12.0,18.0,15.0,15.0,89.0
Narmada,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,73.0,76.0,83.0,72.0,109.0,84.0,73.0,76.0,68.0,55.0,36.0,53.0,858.0
Narmada,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,74.0,77.0,83.0,72.0,111.0,86.0,73.0,99.0,80.0,73.0,51.0,68.0,947.0
Narmada,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,60.0,72.0,74.0,65.0,100.0,79.0,61.0,71.0,72.0,59.0,46.0,60.0,819.0
Narmada,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,46.0,51.0,41.0,50.0,82.0,70.0,51.0,62.0,79.0,56.0,41.0,65.0,694.0
Narmada,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,465.0,587.0,479.0,516.0,592.0,604.0,628.0,612.0,610.0,566.0,437.0,466.0,6562.0
Narmada,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,60.0,66.0,42.0,52.0,80.0,104.0,192.0,114.0,133.0,123.0,200.0,136.0,1302.0
Narmada,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,21.0,19.0,28.0,85.0,22.0,50.0,37.0,101.0,146.0,89.0,45.0,91.0,734.0
Narmada,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,11.0,3.0,8.0,8.0,8.0,33.0,8.0,42.0,115.0,64.0,35.0,43.0,378.0
Narmada,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Narmada,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,41.0,66.0,95.0,62.0,102.0,99.0,101.0,103.0,108.0,75.0,60.0,86.0,998.0
Narmada,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,17.0,19.0,8.0,19.0,22.0,17.0,14.0,21.0,12.0,17.0,13.0,15.0,194.0
Narmada,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Narmada,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narmada,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,17.0,19.0,8.0,19.0,22.0,17.0,14.0,21.0,12.0,17.0,13.0,16.0,195.0
Narmada,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,4.1.1.a,Number of male live births,TOTAL,287.0,365.0,314.0,320.0,410.0,424.0,408.0,444.0,433.0,365.0,308.0,329.0,4407.0
Narmada,4.1.1.b,Number of female live births,TOTAL,287.0,354.0,329.0,319.0,372.0,357.0,376.0,357.0,376.0,341.0,266.0,295.0,4029.0
Narmada,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,574.0,719.0,643.0,639.0,782.0,781.0,784.0,801.0,809.0,706.0,574.0,624.0,8436.0
Narmada,4.1.2,Number of still births,TOTAL,9.0,16.0,13.0,18.0,21.0,18.0,21.0,16.0,16.0,18.0,12.0,16.0,194.0
Narmada,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,9.0,15.0,12.0,22.0,15.0,21.0,20.0,28.0,18.0,28.0,23.0,27.0,238.0
Narmada,4.2.1,Number of Newborns weighed at birth,TOTAL,570.0,716.0,642.0,629.0,778.0,779.0,781.0,809.0,803.0,721.0,569.0,616.0,8413.0
Narmada,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,113.0,185.0,152.0,167.0,215.0,227.0,226.0,225.0,213.0,219.0,157.0,187.0,2286.0
Narmada,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,528.0,644.0,596.0,594.0,692.0,720.0,584.0,749.0,798.0,716.0,598.0,616.0,7835.0
Narmada,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,10.0,9.0,1.0,2.0,5.0,2.0,13.0,0.0,0.0,1.0,0.0,0.0,43.0
Narmada,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,19.0,37.0,24.0,15.0,26.0,23.0,21.0,8.0,8.0,11.0,9.0,6.0,207.0
Narmada,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,8.0,12.0,15.0,10.0,12.0,5.0,12.0,4.0,0.0,0.0,0.0,0.0,78.0
Narmada,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narmada,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,37.0,58.0,40.0,27.0,43.0,30.0,46.0,12.0,8.0,12.0,9.0,6.0,328.0
Narmada,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,40.0,50.0,51.0,32.0,40.0,25.0,39.0,26.0,14.0,21.0,24.0,23.0,385.0
Narmada,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,13.0,11.0,3.0,4.0,5.0,0.0,0.0,0.0,1.0,1.0,12.0,4.0,54.0
Narmada,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,35.0,51.0,61.0,37.0,49.0,38.0,45.0,26.0,24.0,18.0,29.0,36.0,449.0
Narmada,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,6.0,7.0,0.0,1.0,1.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,19.0
Narmada,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,627.0,801.0,696.0,687.0,853.0,821.0,825.0,847.0,951.0,848.0,695.0,720.0,9371.0
Narmada,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,480.0,541.0,465.0,384.0,531.0,512.0,511.0,609.0,619.0,520.0,432.0,404.0,6008.0
Narmada,6.3,PNC maternal complications attended,TOTAL,2.0,4.0,6.0,5.0,0.0,0.0,1.0,0.0,3.0,3.0,2.0,0.0,26.0
Narmada,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,3.0,14.0
Narmada,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,3.0
Narmada,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0,3.0,17.0
Narmada,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Narmada,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,25.0,26.0,18.0,28.0,30.0,23.0,15.0,5.0,6.0,5.0,14.0,14.0,209.0
Narmada,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,49.0,69.0,89.0,107.0,94.0,131.0,87.0,86.0,77.0,81.0,84.0,105.0,1059.0
Narmada,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,74.0,95.0,107.0,135.0,124.0,154.0,102.0,91.0,83.0,86.0,98.0,119.0,1268.0
Narmada,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,9.0,0.0,0.0,9.0,4.0,0.0,0.0,0.0,0.0,22.0
Narmada,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narmada,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Narmada,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,5.0,2.0,0.0,68.0,61.0,0.0,0.0,220.0,381.0,389.0,419.0,149.0,1694.0
Narmada,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,13.0,15.0,9.0,13.0,12.0,11.0,18.0,193.0,225.0,158.0,95.0,35.0,797.0
Narmada,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narmada,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,18.0,17.0,9.0,81.0,73.0,11.0,18.0,413.0,606.0,547.0,514.0,184.0,2491.0
Narmada,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Narmada,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narmada,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Narmada,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Narmada,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narmada,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,1.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Narmada,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,58.0,54.0,97.0,113.0,119.0,92.0,75.0,69.0,65.0,79.0,100.0,83.0,1004.0
Narmada,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,71.0,81.0,88.0,128.0,119.0,110.0,109.0,96.0,144.0,115.0,106.0,111.0,1278.0
Narmada,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,1.0,3.0,5.0,2.0,0.0,0.0,0.0,0.0,4.0,0.0,1.0,16.0
Narmada,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,5.0,7.0,3.0,5.0,4.0,3.0,2.0,2.0,1.0,0.0,1.0,6.0,39.0
Narmada,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narmada,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,134.0,143.0,191.0,251.0,244.0,205.0,186.0,167.0,210.0,198.0,207.0,201.0,2337.0
Narmada,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,5.0,4.0,4.0,0.0,0.0,5.0,3.0,1.0,3.0,10.0,8.0,43.0
Narmada,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.06,Number of IUCD removals,TOTAL,50.0,44.0,95.0,86.0,79.0,66.0,56.0,78.0,80.0,89.0,365.0,93.0,1181.0
Narmada,9.07,Number of Oral Pills cycles distributed,TOTAL,394.0,567.0,710.0,528.0,557.0,782.0,665.0,781.0,871.0,934.0,863.0,1143.0,8795.0
Narmada,9.08,Number of Condom pieces distributed,TOTAL,6641.0,11129.0,10472.0,10682.0,8132.0,9776.0,6830.0,6999.0,9008.0,9864.0,10369.0,9737.0,109639.0
Narmada,9.09,Number of Centchroman (weekly) pills given,TOTAL,4.0,0.0,0.0,0.0,1.0,0.0,10.0,15.0,8.0,0.0,0.0,11.0,49.0
Narmada,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,2.0,0.0,6.0,4.0,4.0,11.0,12.0,10.0,31.0,31.0,29.0,23.0,163.0
Narmada,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Narmada,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Narmada,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,3.0,2.0,2.0,4.0,4.0,6.0,5.0,6.0,7.0,7.0,-1.0
Narmada,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,634.0,753.0,672.0,682.0,920.0,1024.0,980.0,991.0,961.0,918.0,784.0,822.0,10141.0
Narmada,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,10.0,4.0,2.0,39.0,70.0
Narmada,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,2.0,0.0,0.0,58.0,64.0
Narmada,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,6.0,0.0,11.0,49.0,69.0
Narmada,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,749.0,782.0,687.0,711.0,814.0,926.0,889.0,962.0,902.0,945.0,829.0,758.0,9954.0
Narmada,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,873.0,729.0,796.0,655.0,779.0,805.0,728.0,885.0,952.0,851.0,996.0,793.0,9842.0
Narmada,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,949.0,869.0,753.0,770.0,694.0,639.0,802.0,773.0,868.0,896.0,920.0,977.0,9910.0
Narmada,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,616.0,753.0,733.0,589.0,777.0,774.0,821.0,830.0,788.0,846.0,691.0,660.0,8878.0
Narmada,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,749.0,782.0,687.0,711.0,814.0,926.0,889.0,962.0,967.0,911.0,795.0,769.0,9962.0
Narmada,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,873.0,729.0,796.0,655.0,779.0,805.0,728.0,885.0,982.0,818.0,935.0,820.0,9805.0
Narmada,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,949.0,869.0,753.0,770.0,694.0,639.0,802.0,773.0,925.0,1016.0,993.0,976.0,10159.0
Narmada,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,264.0,414.0,346.0,301.0,373.0,430.0,444.0,449.0,442.0,485.0,277.0,366.0,4591.0
Narmada,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,4.0
Narmada,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,9.0
Narmada,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,842.0,978.0,1050.0,907.0,965.0,887.0,854.0,845.0,725.0,672.0,728.0,811.0,10264.0
Narmada,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,774.0,789.0,699.0,729.0,705.0,748.0,707.0,674.0,658.0,652.0,824.0,921.0,8880.0
Narmada,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,4.0
Narmada,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,418.0,506.0,522.0,448.0,488.0,443.0,443.0,427.0,338.0,330.0,333.0,447.0,5143.0
Narmada,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,388.0,468.0,510.0,435.0,468.0,440.0,396.0,381.0,339.0,322.0,376.0,372.0,4895.0
Narmada,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,806.0,974.0,1032.0,883.0,956.0,883.0,839.0,808.0,677.0,652.0,709.0,819.0,10038.0
Narmada,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,796.0,808.0,751.0,739.0,744.0,759.0,722.0,690.0,732.0,763.0,893.0,1030.0,9427.0
Narmada,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,796.0,808.0,751.0,738.0,744.0,759.0,722.0,690.0,699.0,750.0,862.0,1029.0,9348.0
Narmada,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,184.0,183.0,198.0,179.0,239.0,171.0,146.0,168.0,140.0,179.0,184.0,153.0,2124.0
Narmada,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,176.0,162.0,175.0,170.0,184.0,150.0,151.0,165.0,155.0,145.0,143.0,156.0,1932.0
Narmada,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,360.0,345.0,373.0,349.0,423.0,321.0,297.0,333.0,295.0,324.0,327.0,309.0,4056.0
Narmada,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,143.0,206.0,368.0,723.0,1205.0,951.0,439.0,628.0,806.0,200.0,415.0,223.0,6307.0
Narmada,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,168.0,200.0,449.0,1043.0,1584.0,1290.0,539.0,708.0,998.0,344.0,447.0,368.0,8138.0
Narmada,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,620.0,813.0,1146.0,1394.0,1519.0,1169.0,920.0,937.0,766.0,612.0,725.0,706.0,11327.0
Narmada,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0,1.0,3.0,9.0
Narmada,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,58.0,65.0,59.0,38.0,45.0,62.0,56.0,65.0,102.0,79.0,102.0,149.0,880.0
Narmada,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,694.0,658.0,679.0,647.0,672.0,669.0,671.0,667.0,681.0,681.0,684.0,678.0,8081.0
Narmada,10.4.2,Number of Immunisation sessions held during the month,TOTAL,683.0,648.0,671.0,634.0,656.0,649.0,656.0,661.0,677.0,663.0,680.0,665.0,7943.0
Narmada,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,622.0,605.0,627.0,596.0,612.0,622.0,627.0,628.0,631.0,612.0,626.0,608.0,7416.0
Narmada,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Narmada,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,705.0,736.0,882.0,799.0,892.0,791.0,1283.0,706.0,651.0,631.0,636.0,875.0,9587.0
Narmada,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,579.0,30.0,59.0,36.0,1553.0,714.0,5158.0,168.0,164.0,36.0,209.0,4932.0,13638.0
Narmada,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,809.0,0.0,7.0,4.0,1723.0,590.0,4224.0,97.0,130.0,2.0,171.0,5151.0,12908.0
Narmada,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Narmada,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,3.0,0.0,6.0
Narmada,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1498.0,1618.0,1406.0,1385.0,1594.0,1831.0,1795.0,1558.0,1875.0,1855.0,1767.0,1887.0,20069.0
Narmada,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,4.0,0.0,0.0,0.0,8.0,16.0,0.0,16.0,45.0
Narmada,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,5.0,2.0,1.0,1.0,1.0,6.0,4.0,5.0,0.0,10.0,0.0,6.0,41.0
Narmada,13.1,Number of Patients operated for cataract,TOTAL,5.0,3.0,5.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Narmada,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,5.0,3.0,5.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Narmada,13.3,Number of School children detected with Refractive errors,TOTAL,30.0,0.0,13.0,478.0,263.0,776.0,62.0,48.0,1231.0,2100.0,130.0,478.0,5609.0
Narmada,13.4,Number of children provided free glasses,TOTAL,30.0,0.0,13.0,40.0,62.0,82.0,72.0,100.0,77.0,228.0,97.0,113.0,914.0
Narmada,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Narmada,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,3.0,5.0,6.0,6.0,6.0,6.0,9.0,8.0,-1.0
Narmada,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1038.0,1145.0,1241.0,1225.0,562.0,545.0,569.0,2330.0,708.0,707.0,782.0,487.0,-1.0
Narmada,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,4.0,4.0,4.0,-1.0
Narmada,14.05,Number of RKS meetings held during the month,TOTAL,6.0,3.0,5.0,3.0,4.0,8.0,2.0,8.0,10.0,6.0,11.0,8.0,74.0
Narmada,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,23.0,21.0,21.0,21.0,21.0,21.0,20.0,21.0,18.0,18.0,19.0,20.0,-1.0
Narmada,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,119.0,128.0,145.0,134.0,139.0,205.0,192.0,210.0,245.0,229.0,159.0,94.0,1999.0
Narmada,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,4.0,4.0,4.0,4.0,4.0,4.0,5.0,5.0,4.0,3.0,3.0,-1.0
Narmada,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,3.0,4.0,4.0,4.0,4.0,4.0,5.0,5.0,11.0,11.0,7.0,-1.0
Narmada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,161.0,453.0,240.0,288.0,287.0,249.0,174.0,214.0,222.0,250.0,208.0,216.0,2962.0
Narmada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,717.0,567.0,828.0,737.0,888.0,957.0,688.0,598.0,522.0,627.0,542.0,749.0,8420.0
Narmada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,188.0,483.0,235.0,308.0,341.0,233.0,327.0,182.0,206.0,239.0,202.0,198.0,3142.0
Narmada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1066.0,1110.0,1440.0,1651.0,1532.0,1602.0,1504.0,1681.0,1510.0,1442.0,1419.0,1308.0,17265.0
Narmada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,349.0,936.0,475.0,596.0,628.0,482.0,501.0,396.0,428.0,489.0,410.0,414.0,6104.0
Narmada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1783.0,1677.0,2268.0,2388.0,2420.0,2559.0,2192.0,2279.0,2032.0,2069.0,1961.0,2057.0,25685.0
Narmada,14.10.2.a,Number of death cases of Inpatient males,TOTAL,15.0,13.0,9.0,16.0,23.0,23.0,22.0,19.0,18.0,34.0,21.0,16.0,229.0
Narmada,14.10.2.b,Number of death cases of Inpatient females,TOTAL,11.0,6.0,9.0,11.0,12.0,18.0,10.0,10.0,6.0,7.0,11.0,31.0,142.0
Narmada,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,26.0,19.0,18.0,27.0,35.0,41.0,32.0,29.0,24.0,41.0,32.0,47.0,371.0
Narmada,14.11,In-Patient Head Count at midnight,TOTAL,5553.0,6247.0,6431.0,6151.0,7379.0,7373.0,6600.0,4570.0,4736.0,5283.0,4390.0,3850.0,68563.0
Narmada,14.12.1,OPD attendance (All),TOTAL,26843.0,26639.0,30662.0,33475.0,39836.0,42142.0,33745.0,32242.0,33806.0,36411.0,39415.0,43352.0,418568.0
Narmada,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,21.0,30.0,21.0,34.0,18.0,19.0,26.0,194.0,225.0,1341.0,106.0,48.0,2083.0
Narmada,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Narmada,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,83.0,107.0,129.0,70.0,109.0,48.0,35.0,160.0,309.0,331.0,253.0,179.0,1813.0
Narmada,14.14.a,Number of patients given AYUSH treatment,TOTAL,89.0,2.0,183.0,93.0,80.0,82.0,41.0,72.0,85.0,86.0,87.0,82.0,982.0
Narmada,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,250.0,358.0,345.0,300.0,341.0,226.0,270.0,220.0,210.0,233.0,320.0,3073.0
Narmada,14.14.c,Number of Adolescents counselled,TOTAL,20.0,12.0,11.0,14.0,23.0,14.0,16.0,7.0,3.0,7.0,5.0,11.0,143.0
Narmada,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3005.0,3061.0,3851.0,4086.0,4235.0,4013.0,3748.0,3863.0,4143.0,4380.0,4925.0,5479.0,48789.0
Narmada,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,216.0,170.0,193.0,145.0,154.0,150.0,162.0,165.0,186.0,143.0,117.0,207.0,2008.0
Narmada,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,108.0,164.0,159.0,183.0,157.0,198.0,142.0,160.0,143.0,187.0,165.0,175.0,1941.0
Narmada,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,118.0,123.0,226.0,148.0,203.0,160.0,161.0,125.0,144.0,129.0,132.0,212.0,1881.0
Narmada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,3.0
Narmada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,414.0,468.0,708.0,664.0,608.0,520.0,438.0,568.0,535.0,548.0,706.0,644.0,6821.0
Narmada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,1.0,10.0,1.0,21.0,0.0,0.0,33.0
Narmada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,640.0,755.0,1093.0,995.0,968.0,878.0,741.0,853.0,822.0,864.0,1003.0,1031.0,10643.0
Narmada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,1.0,11.0,1.0,23.0,0.0,0.0,36.0
Narmada,15.2,Number of Widal tests conducted,Number tested,228.0,244.0,235.0,310.0,364.0,417.0,308.0,310.0,223.0,253.0,226.0,352.0,3470.0
Narmada,15.3.a,Number of VDRL tests conducted on males,Number tested,15.0,21.0,12.0,26.0,34.0,48.0,26.0,15.0,24.0,10.0,18.0,19.0,268.0
Narmada,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,14.0,29.0,30.0,20.0,21.0,39.0,28.0,19.0,41.0,25.0,27.0,78.0,371.0
Narmada,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,78.0,96.0,86.0,81.0,106.0,85.0,64.0,57.0,75.0,95.0,75.0,99.0,997.0
Narmada,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,107.0,146.0,128.0,127.0,161.0,172.0,118.0,91.0,140.0,130.0,120.0,196.0,1636.0
Narmada,15.4.1,Number of blood smears examined for Malaria,TOTAL,5413.0,4957.0,6377.0,6881.0,9105.0,8739.0,7647.0,6238.0,6536.0,6231.0,8168.0,6345.0,82637.0
Narmada,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,4.0,10.0,28.0,21.0,52.0,46.0,12.0,387.0,17.0,5.0,4.0,10.0,596.0
Narmada,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,1.0,0.0,5.0,5.0,9.0,11.0,8.0,6.0,3.0,2.0,50.0
Narmada,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1930.0,720.0,170.0,410.0,2250.0,2170.0,4100.0,3760.0,4760.0,3140.0,4080.0,1860.0,29350.0
Narmada,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,3000.0,5000.0,2500.0,5000.0,2500.0,2500.0,0.0,2500.0,0.0,4000.0,27000.0
Narmada,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1210.0,550.0,2760.0,3160.0,2580.0,3070.0,2840.0,1500.0,1620.0,1560.0,2220.0,2400.0,25470.0
Narmada,16.1.1,Stock position of DPT vaccines,5. Total Stock,720.0,170.0,410.0,2250.0,2170.0,4100.0,3760.0,4760.0,3140.0,4080.0,1860.0,3460.0,30880.0
Narmada,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1550.0,1040.0,3840.0,7600.0,4820.0,5220.0,2480.0,2880.0,4930.0,5010.0,2550.0,3930.0,45850.0
Narmada,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2000.0,3000.0,9000.0,0.0,3000.0,0.0,3000.0,4000.0,3000.0,0.0,5000.0,6000.0,38000.0
Narmada,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2510.0,200.0,5240.0,2780.0,2600.0,2740.0,2600.0,1950.0,2920.0,2460.0,3620.0,3100.0,32720.0
Narmada,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1040.0,3840.0,7600.0,4820.0,5220.0,2480.0,2880.0,4930.0,5010.0,2550.0,3930.0,6830.0,51130.0
Narmada,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,11550.0,1940.0,14440.0,12220.0,5060.0,4360.0,5020.0,3720.0,3880.0,3880.0,920.0,2820.0,69810.0
Narmada,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000.0,15000.0,9000.0,0.0,6000.0,6000.0,5000.0,5000.0,6000.0,75000.0,86000.0,9000.0,224000.0
Narmada,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,11610.0,2500.0,11220.0,7160.0,6700.0,5340.0,6300.0,4840.0,6000.0,77960.0,84100.0,5900.0,229630.0
Narmada,16.1.2,Stock position of OPV vaccines,5. Total Stock,1940.0,14440.0,12220.0,5060.0,4360.0,5020.0,3720.0,3880.0,3880.0,920.0,2820.0,5920.0,64180.0
Narmada,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1690.0,2650.0,5580.0,8250.0,2850.0,6300.0,6450.0,5350.0,4670.0,4540.0,3740.0,3090.0,55160.0
Narmada,16.1.3,Stock position of TT vaccines,2. Stocks Received,5000.0,4000.0,10000.0,0.0,8000.0,5000.0,2500.0,2500.0,3000.0,2500.0,5000.0,5000.0,52500.0
Narmada,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.3,Stock position of TT vaccines,4. Stock Distributed,4040.0,1070.0,7330.0,5400.0,4550.0,4850.0,3600.0,3180.0,3130.0,3300.0,5650.0,4200.0,50300.0
Narmada,16.1.3,Stock position of TT vaccines,5. Total Stock,2650.0,5580.0,8250.0,2850.0,6300.0,6450.0,5350.0,4670.0,4540.0,3740.0,3090.0,3890.0,57360.0
Narmada,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1160.0,2000.0,4040.0,4370.0,3490.0,3990.0,1450.0,1640.0,3240.0,1440.0,2290.0,2190.0,31300.0
Narmada,16.1.5,Stock position of BCG vaccines,2. Stocks Received,3000.0,3000.0,5000.0,1500.0,2000.0,0.0,2500.0,3000.0,0.0,3000.0,3000.0,2500.0,28500.0
Narmada,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2160.0,960.0,4670.0,2380.0,1500.0,2540.0,2310.0,1400.0,1800.0,2150.0,3100.0,1930.0,26900.0
Narmada,16.1.5,Stock position of BCG vaccines,5. Total Stock,2000.0,4040.0,4370.0,3490.0,3990.0,1450.0,1640.0,3240.0,1440.0,2290.0,2190.0,2760.0,32900.0
Narmada,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,300.0,1300.0,585.0,5555.0,4445.0,5275.0,2995.0,2835.0,3535.0,6385.0,4035.0,4585.0,41830.0
Narmada,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,0.0,10000.0,1000.0,3000.0,0.0,2500.0,2500.0,5000.0,0.0,3000.0,2500.0,32500.0
Narmada,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2000.0,715.0,5030.0,2110.0,2170.0,2280.0,2660.0,1800.0,2150.0,2350.0,2450.0,2550.0,28265.0
Narmada,16.1.6,Stock position of Measles vaccines,5. Total Stock,1300.0,585.0,5555.0,4445.0,5275.0,2995.0,2835.0,3535.0,6385.0,4035.0,4585.0,4535.0,46065.0
Narmada,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3570.0,3570.0,3360.0,2650.0,2570.0,2500.0,2110.0,1950.0,1220.0,760.0,470.0,1010.0,25740.0
Narmada,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,500.0,1700.0
Narmada,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,210.0,710.0,80.0,70.0,390.0,160.0,730.0,460.0,290.0,660.0,550.0,4310.0
Narmada,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3570.0,3360.0,2650.0,2570.0,2500.0,2110.0,1950.0,1220.0,760.0,470.0,1010.0,960.0,23130.0
Narmada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2500.0,2500.0,1950.0,1200.0,2200.0,2050.0,1450.0,1450.0,1450.0,1200.0,1200.0,1200.0,20350.0
Narmada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0
Narmada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,550.0,750.0,200.0,150.0,600.0,0.0,0.0,460.0,0.0,0.0,0.0,2710.0
Narmada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2500.0,1950.0,1200.0,2200.0,2050.0,1450.0,1450.0,1450.0,990.0,1200.0,1200.0,1200.0,18840.0
Narmada,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,19930.0,3360.0,90070.0,81050.0,76850.0,72150.0,57110.0,57110.0,56280.0,108580.0,98480.0,98480.0,819450.0
Narmada,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,97210.0,0.0,0.0,0.0,0.0,0.0,0.0,187200.0,0.0,0.0,0.0,284410.0
Narmada,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,16570.0,10500.0,9020.0,4200.0,4700.0,15040.0,0.0,830.0,134900.0,10100.0,0.0,0.0,205860.0
Narmada,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,3360.0,90070.0,81050.0,76850.0,72150.0,57110.0,57110.0,56280.0,108580.0,98480.0,98480.0,98480.0,898000.0
Narmada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,4840.0,2440.0,4340.0,2940.0,151940.0,151140.0,12840.0,12840.0,12640.0,6140.0,4140.0,3640.0,369880.0
Narmada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,2400.0,0.0,150000.0,0.0,0.0,0.0,0.0,17000.0,0.0,0.0,0.0,169400.0
Narmada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,2400.0,500.0,1400.0,1000.0,800.0,138300.0,0.0,200.0,23500.0,2000.0,500.0,0.0,170600.0
Narmada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,2440.0,4340.0,2940.0,151940.0,151140.0,12840.0,12840.0,12640.0,6140.0,4140.0,3640.0,3640.0,368680.0
Narmada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,180.0,180.0,180.0,120.0,1590.0,1500.0,1260.0,1260.0,1260.0,160.0,60.0,60.0,7810.0
Narmada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0
Narmada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,60.0,30.0,90.0,240.0,0.0,0.0,1100.0,100.0,0.0,0.0,1620.0
Narmada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,180.0,180.0,120.0,1590.0,1500.0,1260.0,1260.0,1260.0,160.0,60.0,60.0,60.0,7690.0
Narmada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3900.0,3900.0,3900.0,3900.0,8400.0,7800.0,6200.0,6200.0,6000.0,3000.0,3000.0,3000.0,59200.0
Narmada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,4500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4500.0
Narmada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,600.0,1600.0,0.0,200.0,3000.0,0.0,0.0,0.0,5400.0
Narmada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3900.0,3900.0,3900.0,8400.0,7800.0,6200.0,6200.0,6000.0,3000.0,3000.0,3000.0,3000.0,58300.0
Narmada,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,400.0,350.0,3350.0,13400.0,17350.0,15050.0,10500.0,9900.0,9450.0,6725.0,6500.0,6300.0,99275.0
Narmada,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,3000.0,10050.0,4700.0,4700.0,0.0,0.0,0.0,375.0,0.0,0.0,0.0,22825.0
Narmada,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.02,Stock Position of Gloves,4. Stock Distributed,50.0,0.0,0.0,750.0,7000.0,4550.0,600.0,450.0,3100.0,225.0,200.0,400.0,17325.0
Narmada,16.3.02,Stock Position of Gloves,5. Total Stock,350.0,3350.0,13400.0,17350.0,15050.0,10500.0,9900.0,9450.0,6725.0,6500.0,6300.0,5900.0,104775.0
Narmada,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,7600.0,6900.0,5600.0,4000.0,3400.0,3100.0,1500.0,1000.0,11900.0,18000.0,8000.0,7000.0,78000.0
Narmada,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,9000.0,0.0,0.0,0.0,29000.0
Narmada,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,700.0,1300.0,1600.0,600.0,300.0,1600.0,500.0,9100.0,2900.0,10000.0,1000.0,1000.0,30600.0
Narmada,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,6900.0,5600.0,4000.0,3400.0,3100.0,1500.0,1000.0,11900.0,18000.0,8000.0,7000.0,6000.0,76400.0
Narmada,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,44.0,34.0,34.0,114.0
Narmada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,58.0,0.0,0.0,0.0,60.0
Narmada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,10.0,0.0,7.0,33.0
Narmada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,44.0,34.0,34.0,27.0,141.0
Narmada,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,161000.0,151000.0,151000.0,208000.0,185000.0,70000.0,94000.0,14000.0,106500.0,136500.0,556500.0,142500.0,1976000.0
Narmada,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,60000.0,20000.0,0.0,80000.0,0.0,445500.0,30000.0,420000.0,0.0,0.0,1055500.0
Narmada,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,10000.0,0.0,3000.0,43000.0,115000.0,56000.0,80000.0,353000.0,0.0,0.0,414000.0,10000.0,1084000.0
Narmada,16.3.07,Stock Position of IFA Tablets,5. Total Stock,151000.0,151000.0,208000.0,185000.0,70000.0,94000.0,14000.0,106500.0,136500.0,556500.0,142500.0,132500.0,1947500.0
Narmada,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,2600.0,2600.0,4200.0,3200.0,3000.0,2600.0,1900.0,1700.0,1500.0,1200.0,1100.0,1000.0,26600.0
Narmada,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,2200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2200.0
Narmada,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,600.0,1000.0,200.0,400.0,700.0,200.0,200.0,300.0,100.0,100.0,300.0,4100.0
Narmada,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,2600.0,4200.0,3200.0,3000.0,2600.0,1900.0,1700.0,1500.0,1200.0,1100.0,1000.0,700.0,24700.0
Narmada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,43320.0,36000.0,20000.0,16000.0,9000.0,5000.0,0.0,0.0,30000.0,27000.0,25000.0,19000.0,230320.0
Narmada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,54000.0,0.0,0.0,0.0,0.0,54000.0
Narmada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,7320.0,16000.0,4000.0,7000.0,4000.0,5000.0,0.0,24000.0,3000.0,2000.0,6000.0,16000.0,94320.0
Narmada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,36000.0,20000.0,16000.0,9000.0,5000.0,0.0,0.0,30000.0,27000.0,25000.0,19000.0,3000.0,190000.0
Narmada,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,3018.0,3018.0,3018.0,0.0,3018.0,2750.0,2450.0,1150.0,530.0,490.0,490.0,490.0,20422.0
Narmada,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,3018.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,450.0,3468.0
Narmada,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,3018.0,0.0,268.0,300.0,1300.0,620.0,40.0,0.0,0.0,735.0,6281.0
Narmada,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,3018.0,3018.0,0.0,3018.0,2750.0,2450.0,1150.0,530.0,490.0,490.0,490.0,205.0,17609.0
Narmada,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,58250.0,54050.0,48050.0,41000.0,39000.0,25000.0,32500.0,11500.0,10000.0,15450.0,25900.0,25900.0,386600.0
Narmada,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,5000.0,5000.0,0.0,0.0,17000.0,0.0,5000.0,6200.0,17000.0,0.0,0.0,55200.0
Narmada,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,4200.0,11000.0,12050.0,2000.0,14000.0,9500.0,21000.0,6500.0,750.0,6550.0,0.0,19400.0,106950.0
Narmada,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,54050.0,48050.0,41000.0,39000.0,25000.0,32500.0,11500.0,10000.0,15450.0,25900.0,25900.0,6500.0,334850.0
Narmada,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,7500.0,4600.0,4600.0,4100.0,3900.0,3200.0,2500.0,2500.0,900.0,300.0,34100.0
Narmada,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,9900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9900.0
Narmada,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,2400.0,2900.0,0.0,500.0,200.0,700.0,700.0,0.0,1600.0,600.0,200.0,9800.0
Narmada,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,7500.0,4600.0,4600.0,4100.0,3900.0,3200.0,2500.0,2500.0,900.0,300.0,100.0,34200.0
Narmada,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,26000.0,26000.0,26000.0,0.0,24000.0,22000.0,162000.0,162000.0,162000.0,162000.0,162000.0,162000.0,1096000.0
Narmada,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,26000.0,0.0,140000.0,0.0,0.0,0.0,0.0,0.0,0.0,166000.0
Narmada,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,26000.0,2000.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30000.0
Narmada,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,26000.0,26000.0,0.0,24000.0,22000.0,162000.0,162000.0,162000.0,162000.0,162000.0,162000.0,162000.0,1232000.0
Narmada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3600.0,2400.0,4000.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,700.0,100.0,22000.0
Narmada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0
Narmada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narmada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1200.0,2400.0,2400.0,0.0,0.0,0.0,0.0,0.0,0.0,900.0,600.0,0.0,7500.0
Narmada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2400.0,4000.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,700.0,100.0,100.0,18500.0
Narmada,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,2.0,1.0,,1.0,,,4.0
Narmada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Narmada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Narmada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Narmada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,,1.0,2.0
Narmada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Narmada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,1.0,,,,,,,1.0,2.0
Narmada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,2.0,,1.0,1.0,3.0,2.0,,1.0,1.0,3.0,1.0,15.0
Narmada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Narmada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,2.0,,1.0,1.0,3.0,2.0,,1.0,1.0,3.0,1.0,15.0
Narmada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,2.0,,3.0,2.0,3.0,1.0,1.0,,1.0,1.0,2.0,17.0
Narmada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Narmada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,3.0,,3.0,2.0,3.0,1.0,1.0,,1.0,1.0,2.0,18.0
Narmada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,1.0,,,,,,,,1.0
Narmada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Narmada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,2.0,,,,,,,,2.0
Narmada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Narmada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Narmada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Narmada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Narmada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Narmada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Narmada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Narmada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Narmada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Narmada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,6.0,2.0,1.0,5.0,1.0,3.0,2.0,4.0,1.0,1.0,1.0,1.0,28.0
Narmada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,4.0,4.0,2.0,3.0,2.0,1.0,5.0,2.0,2.0,1.0,,2.0,28.0
Narmada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,10.0,6.0,3.0,8.0,3.0,4.0,7.0,6.0,3.0,2.0,1.0,3.0,56.0
Narmada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,1.0,,,,2.0
Narmada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Narmada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,,,,1.0,,,,2.0
Narmada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,,2.0,3.0,2.0,,3.0,2.0,2.0,3.0,1.0,20.0
Narmada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,1.0,1.0,1.0,,3.0,,,1.0,,8.0
Narmada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,1.0,1.0,3.0,4.0,3.0,,6.0,2.0,2.0,4.0,1.0,28.0
Narmada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,,,,2.0,1.0,1.0,,,1.0,,,7.0
Narmada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,1.0,1.0,1.0,,3.0,4.0,,,,11.0
Narmada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,,,1.0,3.0,2.0,1.0,3.0,4.0,1.0,,,18.0
Narmada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Narmada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Narmada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,1.0,,,,1.0
Narmada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,4.0,7.0,2.0,2.0,6.0,1.0,3.0,4.0,2.0,,1.0,,32.0
Narmada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,8.0,13.0,1.0,,5.0,1.0,6.0,,2.0,1.0,2.0,,39.0
Narmada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,12.0,20.0,3.0,2.0,11.0,2.0,9.0,4.0,4.0,1.0,3.0,,71.0
Narmada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Narmada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Narmada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,,,,1.0,,,,,2.0
Narmada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Narmada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,3.0,2.0,3.0,3.0,5.0,2.0,3.0,5.0,,1.0,3.0,32.0
Narmada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,5.0,2.0,3.0,3.0,3.0,7.0,1.0,4.0,5.0,2.0,2.0,4.0,41.0
Narmada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,7.0,5.0,5.0,6.0,6.0,12.0,3.0,8.0,10.0,2.0,3.0,7.0,74.0
Narmada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,1.0,,,,1.0,,1.0,,,4.0
Narmada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Narmada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,1.0,1.0,,,,1.0,1.0,1.0,,,5.0
Narmada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Narmada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Narmada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Narmada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Narmada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Narmada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Narmada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Narmada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Narmada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Narmada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Narmada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Narmada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Narmada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Narmada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Narmada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Narmada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,1.0,,,1.0,,,,2.0
Narmada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Narmada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,1.0,,,1.0,,,,2.0
Narmada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Narmada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,3.0,1.0,4.0,,5.0,2.0,1.0,3.0,3.0,3.0,4.0,33.0
Narmada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,1.0,1.0,,1.0,,,,2.0,,2.0,8.0
Narmada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,3.0,2.0,5.0,,6.0,3.0,1.0,3.0,5.0,3.0,6.0,42.0
Narmada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Narmada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,1.0,2.0,,2.0,2.0,3.0,2.0,1.0,1.0,5.0,,22.0
Narmada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,1.0,1.0,,,,,,1.0,,,4.0
Narmada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,1.0,3.0,1.0,2.0,2.0,3.0,2.0,1.0,3.0,5.0,,27.0
Narmada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Narmada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,2.0,2.0,2.0,1.0,,,,,8.0
Narmada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Narmada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,3.0,2.0,2.0,1.0,,,,,9.0
Narmada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Narmada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,,1.0,3.0,2.0,1.0,4.0,7.0,1.0,1.0,1.0,1.0,23.0
Narmada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,8.0,4.0,,2.0,,1.0,5.0,1.0,1.0,1.0,1.0,25.0
Narmada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,8.0,5.0,3.0,4.0,1.0,5.0,12.0,2.0,2.0,2.0,2.0,48.0
Narmada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Narmada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,3.0,2.0,5.0,,2.0,,1.0,,,,13.0
Narmada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,5.0,1.0,2.0,,2.0,1.0,,,,1.0,12.0
Narmada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,8.0,3.0,7.0,,4.0,1.0,1.0,1.0,,1.0,26.0
Narmada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,,,,1.0,1.0,,,1.0,,4.0
Narmada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,23.0,22.0,11.0,6.0,9.0,19.0,10.0,19.0,21.0,18.0,22.0,17.0,197.0
Narmada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,41.0,36.0,37.0,26.0,23.0,46.0,46.0,55.0,41.0,54.0,36.0,29.0,470.0
Narmada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,65.0,58.0,48.0,32.0,32.0,65.0,57.0,75.0,62.0,72.0,59.0,46.0,671.0
Navsari,1.1,Total number of pregnant women Registered for ANC,TOTAL,2064.0,1812.0,2098.0,1941.0,1993.0,1809.0,1526.0,1818.0,1900.0,1752.0,1723.0,1925.0,22361.0
Navsari,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1651.0,1486.0,1677.0,1530.0,1585.0,1485.0,1251.0,1480.0,1524.0,1421.0,1439.0,1445.0,17974.0
Navsari,1.2,Number of Pregnant women registered under JSY,TOTAL,1028.0,912.0,1064.0,1024.0,1003.0,988.0,724.0,853.0,845.0,862.0,810.0,754.0,10867.0
Navsari,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1505.0,1364.0,1461.0,1535.0,1547.0,1630.0,1487.0,1667.0,1729.0,1648.0,1543.0,1621.0,18737.0
Navsari,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1631.0,1417.0,1621.0,1481.0,1510.0,1573.0,1222.0,1454.0,1613.0,1425.0,1808.0,1485.0,18240.0
Navsari,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1503.0,1606.0,1659.0,1724.0,1702.0,1661.0,1517.0,1421.0,1622.0,1718.0,2138.0,1805.0,20076.0
Navsari,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1674.0,1516.0,1733.0,1613.0,1815.0,1723.0,1665.0,1542.0,1772.0,1736.0,1628.0,1632.0,20049.0
Navsari,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,10.0,13.0,33.0,6.0,4.0,9.0,25.0,10.0,49.0,43.0,23.0,12.0,237.0
Navsari,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,7.0,1.0,0.0,0.0,1.0,0.0,0.0,5.0,4.0,1.0,2.0,0.0,21.0
Navsari,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1310.0,1108.0,1297.0,1285.0,1353.0,1395.0,1152.0,1264.0,1345.0,1254.0,1186.0,1273.0,15222.0
Navsari,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,29.0,39.0,70.0,57.0,75.0,78.0,44.0,39.0,101.0,37.0,63.0,48.0,680.0
Navsari,1.8,Number of pregnancy test kits used at SC level,TOTAL,21.0,17.0,188.0,163.0,193.0,221.0,202.0,204.0,196.0,220.0,238.0,208.0,2071.0
Navsari,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,6.0,5.0,6.0,5.0,0.0,2.0,3.0,8.0,1.0,3.0,12.0,53.0
Navsari,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,4.0
Navsari,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,2.0,7.0,7.0,6.0,5.0,0.0,2.0,3.0,8.0,1.0,4.0,12.0,57.0
Navsari,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,2.0,4.0,7.0,6.0,0.0,0.0,2.0,3.0,8.0,1.0,4.0,12.0,49.0
Navsari,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,3.0,2.0,1.0,2.0,0.0,2.0,2.0,4.0,1.0,2.0,6.0,27.0
Navsari,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,687.0,607.0,502.0,516.0,587.0,670.0,676.0,764.0,616.0,718.0,602.0,709.0,7654.0
Navsari,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,411.0,275.0,267.0,264.0,278.0,247.0,284.0,330.0,343.0,470.0,360.0,164.0,3693.0
Navsari,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,50.0,27.0,19.0,73.0,80.0,51.0,36.0,72.0,21.0,56.0,67.0,60.0,612.0
Navsari,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,8.0,19.0
Navsari,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,947.0,837.0,784.0,688.0,826.0,780.0,757.0,958.0,819.0,868.0,624.0,1442.0,10330.0
Navsari,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,21.0,31.0,40.0,31.0,25.0,23.0,33.0,38.0,28.0,20.0,23.0,26.0,339.0
Navsari,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,17.0,24.0,24.0,22.0,28.0,39.0,26.0,34.0,24.0,27.0,26.0,21.0,312.0
Navsari,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Navsari,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,38.0,55.0,64.0,53.0,53.0,62.0,59.0,72.0,52.0,47.0,49.0,47.0,651.0
Navsari,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,310.0,270.0,250.0,201.0,251.0,247.0,256.0,241.0,257.0,265.0,234.0,378.0,3160.0
Navsari,4.1.1.a,Number of male live births,TOTAL,853.0,757.0,688.0,614.0,688.0,757.0,780.0,914.0,746.0,806.0,630.0,1111.0,9344.0
Navsari,4.1.1.b,Number of female live births,TOTAL,778.0,695.0,600.0,590.0,722.0,687.0,655.0,832.0,695.0,783.0,599.0,1051.0,8687.0
Navsari,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1631.0,1452.0,1288.0,1204.0,1410.0,1444.0,1435.0,1746.0,1441.0,1589.0,1229.0,2162.0,18031.0
Navsari,4.1.2,Number of still births,TOTAL,15.0,10.0,8.0,10.0,13.0,13.0,7.0,7.0,5.0,11.0,10.0,10.0,119.0
Navsari,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,32.0,51.0,66.0,46.0,53.0,48.0,53.0,37.0,37.0,60.0,52.0,55.0,590.0
Navsari,4.2.1,Number of Newborns weighed at birth,TOTAL,1620.0,1432.0,1289.0,1204.0,1411.0,1446.0,1433.0,1736.0,1436.0,1383.0,1151.0,1958.0,17499.0
Navsari,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,234.0,221.0,215.0,254.0,237.0,258.0,301.0,241.0,256.0,248.0,227.0,229.0,2921.0
Navsari,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1276.0,881.0,1153.0,999.0,1255.0,1336.0,1222.0,1554.0,1300.0,1461.0,1020.0,1821.0,15278.0
Navsari,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,5.0
Navsari,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,18.0,10.0,13.0,54.0,22.0,22.0,26.0,29.0,15.0,14.0,25.0,17.0,265.0
Navsari,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,78.0,72.0,55.0,41.0,68.0,73.0,24.0,30.0,55.0,49.0,51.0,62.0,658.0
Navsari,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Navsari,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,96.0,82.0,68.0,97.0,90.0,97.0,51.0,59.0,70.0,63.0,76.0,79.0,928.0
Navsari,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,158.0,21.0,7.0,18.0,10.0,0.0,2.0,13.0,3.0,2.0,0.0,0.0,234.0
Navsari,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,254.0,99.0,91.0,120.0,116.0,115.0,124.0,108.0,96.0,104.0,110.0,96.0,1433.0
Navsari,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,176.0,43.0,32.0,51.0,41.0,14.0,13.0,17.0,4.0,1.0,2.0,0.0,394.0
Navsari,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,191.0,54.0,154.0,151.0,58.0,198.0,202.0,224.0,199.0,142.0,148.0,99.0,1820.0
Navsari,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,46.0,57.0,43.0,35.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,181.0
Navsari,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1522.0,1222.0,1342.0,1369.0,1546.0,1441.0,1550.0,1544.0,1591.0,1655.0,1323.0,1244.0,17349.0
Navsari,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1607.0,1303.0,1188.0,1183.0,1399.0,1277.0,1315.0,1459.0,1471.0,1720.0,1361.0,1247.0,16530.0
Navsari,6.3,PNC maternal complications attended,TOTAL,13.0,19.0,41.0,4.0,17.0,0.0,7.0,5.0,15.0,5.0,5.0,2.0,133.0
Navsari,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,15.0,7.0,8.0,25.0,16.0,21.0,15.0,39.0,23.0,44.0,28.0,24.0,265.0
Navsari,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0,1.0,16.0,1.0,2.0,24.0
Navsari,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,15.0,7.0,8.0,25.0,16.0,22.0,16.0,41.0,24.0,60.0,29.0,26.0,289.0
Navsari,7.2,Number of MTPs conducted at Private Facilities,TOTAL,14.0,17.0,3.0,0.0,5.0,6.0,0.0,4.0,3.0,4.0,4.0,6.0,66.0
Navsari,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,220.0,256.0,281.0,255.0,280.0,300.0,325.0,289.0,296.0,243.0,250.0,235.0,3230.0
Navsari,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,309.0,322.0,367.0,343.0,402.0,414.0,364.0,333.0,313.0,334.0,346.0,301.0,4148.0
Navsari,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,529.0,578.0,648.0,598.0,682.0,714.0,689.0,622.0,609.0,577.0,596.0,536.0,7378.0
Navsari,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,10.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Navsari,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Navsari,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,2.0,1.0,0.0,0.0,6.0
Navsari,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Navsari,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,2.0,1.0,0.0,0.0,2.0,2.0,1.0,0.0,0.0,8.0
Navsari,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Navsari,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Navsari,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Navsari,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,1.0,6.0,3.0,5.0,9.0,4.0,0.0,12.0,5.0,4.0,14.0,6.0,69.0
Navsari,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,123.0,78.0,116.0,124.0,202.0,196.0,99.0,216.0,175.0,209.0,79.0,101.0,1718.0
Navsari,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,62.0,31.0,45.0,50.0,31.0,50.0,41.0,64.0,94.0,54.0,43.0,35.0,600.0
Navsari,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,49.0,35.0,43.0,36.0,39.0,39.0,39.0,96.0,69.0,64.0,183.0,90.0,782.0
Navsari,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Navsari,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,234.0,144.0,204.0,210.0,272.0,285.0,179.0,376.0,338.0,327.0,305.0,226.0,3100.0
Navsari,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,31.0,41.0,22.0,30.0,28.0,39.0,33.0,55.0,36.0,51.0,29.0,3.0,398.0
Navsari,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,5.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,33.0,2.0,44.0
Navsari,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,47.0,22.0,43.0,21.0,21.0,27.0,28.0,35.0,50.0,34.0,17.0,24.0,369.0
Navsari,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,35.0,24.0,32.0,20.0,19.0,32.0,9.0,18.0,12.0,36.0,17.0,11.0,265.0
Navsari,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Navsari,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,82.0,46.0,80.0,45.0,40.0,59.0,37.0,53.0,62.0,70.0,67.0,37.0,678.0
Navsari,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,18.0,33.0,22.0,15.0,20.0,17.0,21.0,28.0,31.0,21.0,23.0,14.0,263.0
Navsari,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,355.0,392.0,378.0,494.0,386.0,435.0,396.0,421.0,399.0,403.0,343.0,304.0,4706.0
Navsari,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,127.0,122.0,151.0,190.0,153.0,155.0,149.0,159.0,126.0,122.0,250.0,144.0,1848.0
Navsari,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,10.0,9.0,8.0,5.0,7.0,10.0,8.0,11.0,10.0,7.0,27.0,25.0,137.0
Navsari,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,36.0,13.0,17.0,19.0,17.0,19.0,15.0,33.0,42.0,26.0,66.0,37.0,340.0
Navsari,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Navsari,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,528.0,536.0,554.0,708.0,563.0,619.0,568.0,624.0,577.0,558.0,686.0,510.0,7031.0
Navsari,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,10.0,17.0,17.0,26.0,9.0,3.0,9.0,11.0,12.0,6.0,5.0,58.0,183.0
Navsari,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,10.0,33.0,14.0,35.0,28.0,19.0,7.0,23.0,20.0,32.0,22.0,24.0,267.0
Navsari,9.06,Number of IUCD removals,TOTAL,109.0,80.0,119.0,98.0,94.0,113.0,102.0,107.0,116.0,136.0,107.0,126.0,1307.0
Navsari,9.07,Number of Oral Pills cycles distributed,TOTAL,1925.0,1824.0,2534.0,2079.0,2599.0,2560.0,2054.0,1952.0,2422.0,2183.0,2228.0,2493.0,26853.0
Navsari,9.08,Number of Condom pieces distributed,TOTAL,10435.0,9688.0,16057.0,14509.0,23353.0,15057.0,13785.0,8532.0,12792.0,11844.0,9540.0,10769.0,156361.0
Navsari,9.09,Number of Centchroman (weekly) pills given,TOTAL,6.0,1.0,35.0,1.0,6.0,13.0,11.0,1.0,2.0,1.0,0.0,2.0,79.0
Navsari,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,21.0,37.0,322.0,6.0,45.0,30.0,19.0,3.0,11.0,8.0,7.0,5.0,514.0
Navsari,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,9.12,Number of Institutions having NSV trained doctors,TOTAL,36.0,38.0,36.0,39.0,40.0,39.0,41.0,42.0,41.0,42.0,41.0,42.0,-1.0
Navsari,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1786.0,1526.0,1297.0,1222.0,1565.0,1679.0,1674.0,2173.0,2074.0,2034.0,2120.0,2266.0,21416.0
Navsari,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1628.0,1699.0,1573.0,1400.0,1545.0,1309.0,1445.0,1799.0,1840.0,2005.0,1720.0,1891.0,19854.0
Navsari,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1589.0,1466.0,1736.0,1460.0,1539.0,1366.0,1236.0,1483.0,1826.0,1939.0,2028.0,1948.0,19616.0
Navsari,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1726.0,1509.0,1602.0,1718.0,1562.0,1437.0,1393.0,1385.0,1524.0,2002.0,2072.0,2443.0,20373.0
Navsari,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1625.0,1399.0,1251.0,1209.0,1445.0,1586.0,1648.0,2065.0,1952.0,1987.0,2150.0,2234.0,20551.0
Navsari,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1617.0,1699.0,1582.0,1397.0,1472.0,1310.0,1452.0,1798.0,1840.0,1996.0,1721.0,1891.0,19775.0
Navsari,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1589.0,1464.0,1732.0,1461.0,1538.0,1367.0,1239.0,1484.0,1816.0,1942.0,2030.0,1954.0,19616.0
Navsari,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1720.0,1511.0,1604.0,1713.0,1565.0,1441.0,1392.0,1382.0,1517.0,1999.0,2071.0,2453.0,20368.0
Navsari,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,370.0,376.0,274.0,263.0,350.0,383.0,432.0,526.0,481.0,448.0,440.0,481.0,4824.0
Navsari,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,4.0
Navsari,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1477.0,1552.0,1781.0,1853.0,2046.0,1769.0,1484.0,1643.0,1562.0,1723.0,1801.0,1889.0,20580.0
Navsari,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1547.0,1412.0,1665.0,1535.0,1641.0,1521.0,1420.0,1520.0,1311.0,1421.0,1458.0,1689.0,18140.0
Navsari,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,766.0,841.0,923.0,991.0,1077.0,924.0,769.0,843.0,805.0,887.0,950.0,988.0,10764.0
Navsari,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,718.0,712.0,864.0,867.0,969.0,840.0,730.0,799.0,752.0,828.0,856.0,902.0,9837.0
Navsari,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1484.0,1553.0,1787.0,1858.0,2046.0,1764.0,1499.0,1642.0,1557.0,1715.0,1806.0,1890.0,20601.0
Navsari,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1624.0,1460.0,1719.0,1593.0,1673.0,1556.0,1474.0,1543.0,1329.0,1426.0,1470.0,1712.0,18579.0
Navsari,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1625.0,1453.0,1711.0,1593.0,1673.0,1556.0,1474.0,1541.0,1326.0,1423.0,1470.0,1712.0,18557.0
Navsari,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,5.0
Navsari,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,300.0,227.0,177.0,190.0,185.0,86.0,78.0,63.0,50.0,79.0,58.0,134.0,1627.0
Navsari,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,285.0,182.0,180.0,142.0,160.0,80.0,95.0,60.0,60.0,55.0,55.0,94.0,1448.0
Navsari,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,585.0,409.0,357.0,332.0,345.0,166.0,173.0,123.0,110.0,134.0,113.0,228.0,3075.0
Navsari,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,664.0,620.0,665.0,1776.0,3533.0,3715.0,1057.0,1042.0,749.0,642.0,486.0,763.0,15712.0
Navsari,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,202.0,334.0,307.0,2015.0,3987.0,6717.0,1986.0,1793.0,982.0,508.0,796.0,566.0,20193.0
Navsari,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,411.0,605.0,572.0,2116.0,4839.0,7106.0,2053.0,2325.0,1694.0,527.0,377.0,598.0,23223.0
Navsari,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1236.0,1288.0,1247.0,1287.0,1282.0,1235.0,1245.0,1249.0,1257.0,1252.0,1253.0,1253.0,15084.0
Navsari,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1227.0,1285.0,1246.0,1286.0,1279.0,1235.0,1244.0,1252.0,1255.0,1248.0,1253.0,1253.0,15063.0
Navsari,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1183.0,1238.0,1198.0,1238.0,1242.0,1197.0,1199.0,1215.0,1221.0,1212.0,1218.0,1223.0,14584.0
Navsari,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1488.0,1528.0,1776.0,1840.0,2020.0,1757.0,1497.0,1633.0,1559.0,1719.0,1730.0,1904.0,20451.0
Navsari,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,6176.0,14.0,26.0,10.0,3.0,0.0,7616.0,3699.0,135.0,63.0,52.0,10647.0,28441.0
Navsari,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,5554.0,0.0,1.0,3.0,0.0,0.0,7177.0,3831.0,121.0,51.0,0.0,10618.0,27356.0
Navsari,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,8.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,14.0
Navsari,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1663.0,1815.0,1897.0,1867.0,2301.0,2395.0,2486.0,2787.0,2590.0,2721.0,2437.0,2359.0,27318.0
Navsari,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,5.0,6.0,0.0,1.0,1.0,1.0,3.0,3.0,3.0,0.0,0.0,25.0
Navsari,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,108.0,101.0,112.0,160.0,161.0,137.0,104.0,95.0,72.0,133.0,109.0,155.0,1447.0
Navsari,13.1,Number of Patients operated for cataract,TOTAL,195.0,51.0,159.0,134.0,128.0,188.0,145.0,117.0,189.0,204.0,205.0,145.0,1860.0
Navsari,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,195.0,51.0,138.0,134.0,128.0,188.0,145.0,117.0,189.0,204.0,205.0,145.0,1839.0
Navsari,13.3,Number of School children detected with Refractive errors,TOTAL,878.0,0.0,0.0,624.0,1260.0,240.0,50.0,140.0,920.0,416.0,380.0,70.0,4978.0
Navsari,13.4,Number of children provided free glasses,TOTAL,878.0,0.0,0.0,10.0,80.0,130.0,130.0,110.0,250.0,506.0,360.0,50.0,2504.0
Navsari,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,11.0,12.0,14.0,15.0,14.0,14.0,13.0,14.0,11.0,12.0,11.0,12.0,-1.0
Navsari,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,26.0,28.0,28.0,27.0,25.0,26.0,29.0,28.0,30.0,32.0,30.0,27.0,-1.0
Navsari,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,670.0,586.0,668.0,542.0,639.0,675.0,656.0,703.0,591.0,561.0,576.0,619.0,-1.0
Navsari,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,18.0,20.0,20.0,20.0,19.0,19.0,20.0,18.0,19.0,18.0,19.0,18.0,-1.0
Navsari,14.05,Number of RKS meetings held during the month,TOTAL,6.0,12.0,29.0,6.0,11.0,15.0,5.0,12.0,12.0,13.0,9.0,16.0,146.0
Navsari,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,53.0,52.0,52.0,52.0,54.0,50.0,49.0,46.0,48.0,45.0,46.0,44.0,-1.0
Navsari,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,265.0,246.0,327.0,539.0,532.0,668.0,581.0,711.0,372.0,438.0,525.0,801.0,6005.0
Navsari,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,14.0,15.0,18.0,17.0,19.0,20.0,17.0,17.0,16.0,18.0,16.0,19.0,-1.0
Navsari,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,1.0,0.0,0.0,4.0,4.0,4.0,0.0,233.0,0.0,0.0,11.0,-1.0
Navsari,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,592.0,574.0,764.0,528.0,837.0,1682.0,922.0,720.0,631.0,494.0,726.0,623.0,9093.0
Navsari,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2405.0,2520.0,2973.0,2397.0,2909.0,4649.0,3757.0,2992.0,3029.0,2582.0,3284.0,3141.0,36638.0
Navsari,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,661.0,1193.0,826.0,581.0,912.0,1650.0,935.0,710.0,631.0,458.0,626.0,812.0,9995.0
Navsari,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3564.0,2868.0,4050.0,3751.0,3773.0,5739.0,5208.0,4281.0,4315.0,3397.0,4275.0,4568.0,49789.0
Navsari,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1253.0,1767.0,1590.0,1109.0,1749.0,3332.0,1857.0,1430.0,1262.0,952.0,1352.0,1435.0,19088.0
Navsari,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5969.0,5388.0,7023.0,6148.0,6682.0,10388.0,8965.0,7273.0,7344.0,5979.0,7559.0,7709.0,86427.0
Navsari,14.10.2.a,Number of death cases of Inpatient males,TOTAL,30.0,34.0,27.0,40.0,42.0,44.0,57.0,57.0,55.0,33.0,34.0,38.0,491.0
Navsari,14.10.2.b,Number of death cases of Inpatient females,TOTAL,15.0,12.0,19.0,24.0,23.0,34.0,19.0,8.0,17.0,19.0,30.0,17.0,237.0
Navsari,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,45.0,46.0,46.0,64.0,65.0,78.0,76.0,65.0,72.0,52.0,64.0,55.0,728.0
Navsari,14.11,In-Patient Head Count at midnight,TOTAL,4129.0,4365.0,3380.0,4455.0,6223.0,5070.0,3802.0,3929.0,4016.0,5077.0,3941.0,6265.0,54652.0
Navsari,14.12.1,OPD attendance (All),TOTAL,101090.0,101859.0,108190.0,122020.0,126761.0,140023.0,114864.0,117315.0,122449.0,121800.0,135726.0,133263.0,1445360.0
Navsari,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,451.0,302.0,3666.0,444.0,779.0,832.0,521.0,1064.0,541.0,545.0,425.0,316.0,9886.0
Navsari,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,0.0,5.0,7.0,25.0
Navsari,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,457.0,598.0,423.0,522.0,915.0,745.0,763.0,689.0,552.0,593.0,573.0,468.0,7298.0
Navsari,14.14.a,Number of patients given AYUSH treatment,TOTAL,535.0,640.0,481.0,391.0,600.0,278.0,256.0,259.0,216.0,25.0,103.0,182.0,3966.0
Navsari,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,457.0,520.0,727.0,1117.0,1703.0,1203.0,952.0,1603.0,1946.0,1314.0,1222.0,1292.0,14056.0
Navsari,14.14.c,Number of Adolescents counselled,TOTAL,56.0,70.0,228.0,427.0,179.0,239.0,233.0,148.0,111.0,138.0,136.0,354.0,2319.0
Navsari,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,12050.0,11944.0,13581.0,15330.0,15431.0,17096.0,13186.0,15282.0,14719.0,15007.0,16486.0,17380.0,177492.0
Navsari,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,743.0,1112.0,783.0,744.0,1657.0,1841.0,1290.0,1867.0,1269.0,1176.0,1183.0,1368.0,15033.0
Navsari,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,954.0,1222.0,1495.0,1700.0,1825.0,2057.0,1810.0,1509.0,2121.0,1746.0,1763.0,1980.0,20182.0
Navsari,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,11.0,6.0,8.0,3.0,13.0,14.0,64.0,13.0,12.0,16.0,16.0,17.0,193.0
Navsari,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1045.0,1104.0,1426.0,1504.0,1610.0,1777.0,1360.0,1207.0,1700.0,1412.0,1693.0,1616.0,17454.0
Navsari,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,8.0,3.0,3.0,7.0,13.0,7.0,94.0,7.0,3.0,3.0,6.0,4.0,158.0
Navsari,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,987.0,1255.0,2044.0,1574.0,1713.0,1545.0,1100.0,1357.0,1515.0,1393.0,1739.0,1660.0,17882.0
Navsari,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,2.0,0.0,1.0,1.0,2.0,1.0,4.0,3.0,3.0,0.0,18.0
Navsari,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2986.0,3581.0,4965.0,4778.0,5148.0,5379.0,4270.0,4073.0,5336.0,4551.0,5195.0,5256.0,55518.0
Navsari,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,20.0,9.0,13.0,10.0,27.0,22.0,160.0,21.0,19.0,22.0,25.0,21.0,369.0
Navsari,15.2,Number of Widal tests conducted,Number tested,579.0,755.0,1036.0,1298.0,1329.0,2242.0,1201.0,1432.0,1002.0,981.0,1006.0,1324.0,14185.0
Navsari,15.3.a,Number of VDRL tests conducted on males,Number tested,123.0,73.0,74.0,98.0,74.0,124.0,109.0,164.0,109.0,85.0,82.0,97.0,1212.0
Navsari,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,156.0,300.0,210.0,142.0,134.0,231.0,153.0,157.0,210.0,246.0,162.0,222.0,2323.0
Navsari,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,531.0,806.0,807.0,871.0,881.0,857.0,532.0,868.0,709.0,780.0,810.0,874.0,9326.0
Navsari,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,810.0,1179.0,1091.0,1111.0,1089.0,1212.0,794.0,1189.0,1028.0,1111.0,1054.0,1193.0,12861.0
Navsari,15.4.1,Number of blood smears examined for Malaria,TOTAL,18575.0,18574.0,19514.0,24548.0,33372.0,34899.0,20382.0,17946.0,18306.0,17282.0,19862.0,19962.0,263222.0
Navsari,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,39.0,58.0,48.0,84.0,121.0,173.0,77.0,108.0,40.0,15.0,33.0,25.0,821.0
Navsari,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,9.0,4.0,10.0,7.0,15.0,20.0,31.0,32.0,25.0,19.0,5.0,5.0,182.0
Navsari,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,5500.0,3300.0,1500.0,7500.0,6500.0,7500.0,10000.0,14500.0,16990.0,23275.0,19830.0,21975.0,138370.0
Navsari,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,9000.0,5000.0,7500.0,10000.0,10000.0,7500.0,0.0,0.0,6500.0,7500.0,63000.0
Navsari,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2200.0,1800.0,3000.0,6000.0,6500.0,7500.0,5500.0,5010.0,3990.0,3445.0,4355.0,3880.0,53180.0
Navsari,16.1.1,Stock position of DPT vaccines,5. Total Stock,3300.0,1500.0,7500.0,6500.0,7500.0,10000.0,14500.0,16990.0,13000.0,19830.0,21975.0,25595.0,148190.0
Navsari,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,8000.0,11000.0,7000.0,17000.0,19000.0,17500.0,16500.0,22000.0,23500.0,27995.0,21465.0,24775.0,215735.0
Navsari,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,9000.0,0.0,15000.0,6000.0,6000.0,6000.0,9000.0,6000.0,0.0,0.0,9000.0,9000.0,75000.0
Navsari,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,6000.0,4000.0,5000.0,4000.0,7500.0,7000.0,3500.0,4500.0,5100.0,6530.0,5690.0,5930.0,64750.0
Navsari,16.1.1A,Stock Position of Pentavalent,5. Total Stock,11000.0,7000.0,17000.0,19000.0,17500.0,16500.0,22000.0,23500.0,18400.0,21465.0,24775.0,27845.0,225985.0
Navsari,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,19500.0,16500.0,9500.0,25500.0,18000.0,26000.0,28500.0,29500.0,30500.0,209085.0,49685.0,55090.0,517360.0
Navsari,16.1.2,Stock position of OPV vaccines,2. Stocks Received,5000.0,0.0,25000.0,5000.0,20000.0,17000.0,10000.0,10000.0,174360.0,0.0,172500.0,8000.0,446860.0
Navsari,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,8000.0,7000.0,9000.0,12500.0,12000.0,14500.0,9000.0,9000.0,12500.0,159400.0,167095.0,14645.0,434640.0
Navsari,16.1.2,Stock position of OPV vaccines,5. Total Stock,16500.0,9500.0,25500.0,18000.0,26000.0,28500.0,29500.0,30500.0,192360.0,49685.0,55090.0,48445.0,529580.0
Navsari,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,13500.0,12000.0,6500.0,20000.0,25500.0,15000.0,7500.0,20000.0,24500.0,33730.0,27190.0,31490.0,236910.0
Navsari,16.1.3,Stock position of TT vaccines,2. Stocks Received,4000.0,0.0,20000.0,20000.0,10000.0,7500.0,20000.0,12500.0,0.0,0.0,10000.0,10000.0,114000.0
Navsari,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5500.0,5500.0,6500.0,14500.0,20500.0,15000.0,7500.0,8000.0,7500.0,6540.0,5700.0,6290.0,109030.0
Navsari,16.1.3,Stock position of TT vaccines,5. Total Stock,12000.0,6500.0,20000.0,25500.0,15000.0,7500.0,20000.0,24500.0,17000.0,27190.0,31490.0,35200.0,241880.0
Navsari,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4500.0,9000.0,5500.0,10000.0,16000.0,10000.0,7000.0,10900.0,9900.0,20721.0,19291.0,18111.0,140923.0
Navsari,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,0.0,7000.0,10000.0,0.0,2000.0,6000.0,3000.0,5000.0,3000.0,3000.0,10000.0,59000.0
Navsari,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,5500.0,3500.0,2500.0,4000.0,6000.0,5000.0,2100.0,4000.0,4000.0,4430.0,4180.0,4170.0,49380.0
Navsari,16.1.5,Stock position of BCG vaccines,5. Total Stock,9000.0,5500.0,10000.0,16000.0,10000.0,7000.0,10900.0,9900.0,10900.0,19291.0,18111.0,23941.0,150543.0
Navsari,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1750.0,0.0,1250.0,10500.0,8500.0,7750.0,7500.0,8750.0,8750.0,15615.0,15660.0,11215.0,97240.0
Navsari,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,5000.0,15000.0,2500.0,5000.0,5000.0,5000.0,5000.0,5000.0,5000.0,0.0,10000.0,64500.0
Navsari,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3750.0,3750.0,5750.0,4500.0,5750.0,5250.0,3750.0,5000.0,5500.0,4955.0,4445.0,4605.0,57005.0
Navsari,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,1250.0,10500.0,8500.0,7750.0,7500.0,8750.0,8750.0,8250.0,15660.0,11215.0,16610.0,104735.0
Navsari,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,4360.0,3960.0,3620.0,3420.0,1980.0,1410.0,1140.0,940.0,680.0,2705.0,3080.0,3103.0,30398.0
Navsari,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,300.0,900.0,600.0,600.0,2400.0
Navsari,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,400.0,340.0,200.0,1440.0,570.0,270.0,200.0,260.0,680.0,525.0,577.0,658.0,6120.0
Navsari,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3960.0,3620.0,3420.0,1980.0,1410.0,1140.0,940.0,680.0,300.0,3080.0,3103.0,3045.0,26678.0
Navsari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Navsari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,6000.0
Navsari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Navsari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,6000.0
Navsari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,151950.0,131572.0,168519.0,144662.0,122972.0,168472.0,138595.0,119541.0,106140.0,101869.0,91487.0,84738.0,1530517.0
Navsari,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,500.0,63980.0,1680.0,1000.0,92380.0,0.0,0.0,300.0,9200.0,0.0,3500.0,56400.0,228940.0
Navsari,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,20878.0,27033.0,25537.0,22690.0,46824.0,29877.0,19054.0,13701.0,13471.0,10382.0,10249.0,14022.0,253718.0
Navsari,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,131572.0,168519.0,144662.0,122972.0,168528.0,138595.0,119541.0,106140.0,101869.0,91487.0,84738.0,127116.0,1505739.0
Navsari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,16278.0,13166.0,18714.0,16168.0,14044.0,19343.0,15893.0,13406.0,11633.0,46924.0,44028.0,41061.0,270658.0
Navsari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,8800.0,300.0,200.0,9600.0,0.0,0.0,200.0,38480.0,0.0,100.0,0.0,57680.0
Navsari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,3112.0,3252.0,2846.0,2324.0,4329.0,3450.0,2487.0,1973.0,3189.0,2896.0,3067.0,3236.0,36161.0
Navsari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,13166.0,18714.0,16168.0,14044.0,19315.0,15893.0,13406.0,11633.0,46924.0,44028.0,41061.0,37825.0,292177.0
Navsari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2305.0,2018.0,1961.0,1876.0,1805.0,3110.0,2779.0,2566.0,2282.0,2070.0,1851.0,1703.0,26326.0
Navsari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,110.0,0.0,0.0,1800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1910.0
Navsari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,287.0,167.0,85.0,71.0,467.0,331.0,213.0,284.0,212.0,219.0,148.0,158.0,2642.0
Navsari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,2018.0,1961.0,1876.0,1805.0,3138.0,2779.0,2566.0,2282.0,2070.0,1851.0,1703.0,1545.0,25594.0
Navsari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Navsari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Navsari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Navsari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Navsari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Navsari,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Navsari,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7366.0,6299.0,4741.0,18406.0
Navsari,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,16500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16500.0,33000.0
Navsari,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,16500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1067.0,1558.0,1545.0,20670.0
Navsari,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6299.0,4741.0,19696.0,30736.0
Navsari,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,90000.0,348247.0,331377.0,316385.0,1086009.0
Navsari,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,120000.0,0.0,0.0,0.0,0.0,0.0,0.0,150000.0,0.0,0.0,0.0,0.0,270000.0
Navsari,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,120000.0,0.0,0.0,0.0,0.0,0.0,0.0,60000.0,90000.0,16870.0,14992.0,16301.0,318163.0
Navsari,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,90000.0,0.0,331377.0,316385.0,300084.0,1037846.0
Navsari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6172.0,3695.0,0.0,9867.0
Navsari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30000.0,30000.0
Navsari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Navsari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3089.0,3695.0,3528.0,10312.0
Navsari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3083.0,0.0,26472.0,29555.0
Navsari,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,1.0,,,,,,1.0
Navsari,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,,,2.0,,1.0,1.0,1.0,6.0
Navsari,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Navsari,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,1.0,,,2.0,,1.0,1.0,1.0,6.0
Navsari,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,,,,,1.0,1.0,2.0,1.0,,,6.0
Navsari,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Navsari,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,,,,,1.0,1.0,2.0,1.0,,,6.0
Navsari,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,6.0,1.0,,,,3.0,,3.0,,,,,13.0
Navsari,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Navsari,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,6.0,1.0,,,,3.0,,3.0,,,,,13.0
Navsari,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,1.0,,,,1.0,,1.0,,,1.0,5.0
Navsari,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Navsari,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,1.0,,,,1.0,,1.0,,,1.0,5.0
Navsari,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Navsari,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Navsari,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Navsari,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Navsari,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Navsari,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Navsari,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Navsari,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Navsari,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Navsari,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Navsari,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Navsari,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Navsari,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,1.0,,,,,1.0,,2.0,,,2.0,9.0
Navsari,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,,,,1.0,,1.0,,,1.0,4.0
Navsari,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,1.0,,,,,2.0,,3.0,,,3.0,13.0
Navsari,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Navsari,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Navsari,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Navsari,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,5.0,3.0,1.0,1.0,1.0,,2.0,3.0,3.0,,3.0,3.0,25.0
Navsari,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,3.0,1.0,,,1.0,,,1.0,,,,8.0
Navsari,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,7.0,6.0,2.0,1.0,1.0,1.0,2.0,3.0,4.0,,3.0,3.0,33.0
Navsari,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,2.0,4.0,5.0,3.0,3.0,5.0,2.0,2.0,1.0,4.0,33.0
Navsari,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,14.0,4.0,5.0,1.0,8.0,12.0,19.0,16.0,15.0,8.0,10.0,9.0,121.0
Navsari,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,15.0,5.0,7.0,5.0,13.0,15.0,22.0,21.0,17.0,10.0,11.0,13.0,154.0
Navsari,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Navsari,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Navsari,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Navsari,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,1.0,,,1.0,,,,,2.0
Navsari,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,1.0,2.0,1.0,1.0,,1.0,,,,7.0
Navsari,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,1.0,,,,,,3.0,,4.0
Navsari,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,1.0,4.0,1.0,1.0,1.0,1.0,,3.0,,13.0
Navsari,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,2.0,,,,1.0,,,,,3.0
Navsari,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Navsari,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,2.0,,,,1.0,,,,,3.0
Navsari,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,7.0,6.0,3.0,3.0,3.0,8.0,4.0,6.0,3.0,4.0,4.0,4.0,55.0
Navsari,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,12.0,10.0,7.0,6.0,7.0,8.0,7.0,10.0,11.0,9.0,10.0,6.0,103.0
Navsari,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,19.0,16.0,10.0,9.0,10.0,16.0,11.0,16.0,14.0,13.0,14.0,10.0,158.0
Navsari,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Navsari,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,1.0,,,,1.0,2.0,1.0,1.0,,2.0,9.0
Navsari,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,4.0,2.0,1.0,3.0,2.0,2.0,3.0,2.0,3.0,5.0,1.0,,28.0
Navsari,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,5.0,2.0,2.0,3.0,2.0,2.0,4.0,4.0,5.0,6.0,1.0,2.0,38.0
Navsari,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Navsari,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Navsari,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Navsari,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Navsari,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Navsari,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,,,,,,,,,,,1.0
Navsari,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Navsari,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Navsari,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Navsari,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Navsari,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Navsari,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Navsari,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Navsari,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Navsari,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Navsari,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,,,,1.0,,,,,1.0,3.0
Navsari,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Navsari,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,,,,1.0,,,,,1.0,3.0
Navsari,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,1.0,,1.0,,,1.0,1.0,,,6.0
Navsari,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,6.0,1.0,3.0,1.0,4.0,4.0,4.0,2.0,6.0,1.0,6.0,8.0,46.0
Navsari,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,1.0,2.0,,3.0,2.0,2.0,1.0,2.0,1.0,,2.0,19.0
Navsari,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,9.0,3.0,6.0,2.0,7.0,7.0,6.0,3.0,9.0,3.0,6.0,10.0,71.0
Navsari,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,4.0,,2.0,1.0,1.0,8.0,2.0,2.0,,3.0,3.0,30.0
Navsari,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,1.0,1.0,1.0,,,,,,,4.0
Navsari,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,4.0,1.0,3.0,2.0,2.0,8.0,2.0,2.0,,3.0,3.0,34.0
Navsari,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Navsari,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,,1.0,,2.0,,,,4.0
Navsari,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,,1.0,,,1.0,,2.0,,,,5.0
Navsari,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Navsari,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,3.0,1.0,,1.0,1.0,,,,,,,7.0
Navsari,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Navsari,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,3.0,1.0,,1.0,1.0,1.0,,,,,,9.0
Navsari,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Navsari,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,2.0,,1.0,1.0,,1.0,2.0,1.0,2.0,1.0,1.0,13.0
Navsari,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,1.0,2.0,1.0,1.0,5.0,1.0,1.0,1.0,13.0
Navsari,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,2.0,,1.0,2.0,2.0,2.0,3.0,6.0,3.0,2.0,2.0,26.0
Navsari,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,1.0,1.0,,1.0,2.0,1.0,1.0,,,1.0,2.0,11.0
Navsari,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,44.0,33.0,39.0,32.0,43.0,37.0,34.0,44.0,32.0,33.0,31.0,37.0,439.0
Navsari,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,82.0,75.0,79.0,62.0,84.0,97.0,65.0,51.0,96.0,69.0,74.0,67.0,901.0
Navsari,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,127.0,109.0,119.0,94.0,128.0,136.0,100.0,96.0,128.0,102.0,106.0,106.0,1351.0
Panch Mahals,1.1,Total number of pregnant women Registered for ANC,TOTAL,3621.0,3215.0,4011.0,3912.0,3944.0,3846.0,3247.0,3397.0,3358.0,3577.0,3588.0,3476.0,43192.0
Panch Mahals,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2497.0,2258.0,2942.0,2994.0,2971.0,2977.0,2521.0,2679.0,2537.0,2806.0,2856.0,2555.0,32593.0
Panch Mahals,1.2,Number of Pregnant women registered under JSY,TOTAL,1096.0,1059.0,1270.0,1198.0,1278.0,1223.0,1118.0,1157.0,1179.0,1184.0,1205.0,1063.0,14030.0
Panch Mahals,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2298.0,2181.0,2806.0,2829.0,2923.0,2964.0,2508.0,2591.0,2560.0,2661.0,2791.0,2557.0,31669.0
Panch Mahals,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2900.0,2651.0,3164.0,3236.0,3220.0,3053.0,2758.0,2938.0,2803.0,2851.0,2924.0,2747.0,35245.0
Panch Mahals,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3017.0,3024.0,3113.0,3518.0,3667.0,3690.0,3192.0,3002.0,3222.0,3052.0,3150.0,3125.0,38772.0
Panch Mahals,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2853.0,2874.0,6511.0,3061.0,3237.0,3302.0,3002.0,2982.0,2960.0,3106.0,3058.0,3349.0,40295.0
Panch Mahals,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,209.0,6.0,14.0,21.0,26.0,9.0,13.0,5.0,5.0,2.0,7.0,5.0,322.0
Panch Mahals,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Panch Mahals,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1451.0,862.0,1098.0,1083.0,1220.0,1144.0,955.0,814.0,858.0,971.0,1124.0,1034.0,12614.0
Panch Mahals,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,45.0,63.0,43.0,48.0,58.0,53.0,21.0,15.0,38.0,28.0,50.0,58.0,520.0
Panch Mahals,1.8,Number of pregnancy test kits used at SC level,TOTAL,154.0,28.0,72.0,33.0,112.0,55.0,55.0,47.0,84.0,65.0,50.0,53.0,808.0
Panch Mahals,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,47.0,50.0,45.0,27.0,23.0,26.0,18.0,32.0,18.0,13.0,24.0,11.0,334.0
Panch Mahals,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,75.0,54.0,47.0,30.0,29.0,37.0,32.0,51.0,14.0,19.0,20.0,12.0,420.0
Panch Mahals,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,122.0,104.0,92.0,57.0,52.0,63.0,50.0,83.0,32.0,32.0,44.0,23.0,754.0
Panch Mahals,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,61.0,70.0,42.0,11.0,28.0,29.0,21.0,16.0,32.0,30.0,24.0,13.0,377.0
Panch Mahals,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,29.0,14.0,26.0,7.0,13.0,11.0,13.0,12.0,20.0,26.0,13.0,10.0,194.0
Panch Mahals,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,852.0,954.0,1009.0,1012.0,1291.0,1289.0,1259.0,1175.0,1210.0,1107.0,992.0,1055.0,13205.0
Panch Mahals,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,606.0,687.0,690.0,754.0,1002.0,968.0,986.0,812.0,899.0,808.0,771.0,738.0,9721.0
Panch Mahals,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,11.0,63.0,42.0,65.0,56.0,63.0,37.0,39.0,38.0,16.0,87.0,97.0,614.0
Panch Mahals,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,17.0,101.0,33.0,43.0,0.0,10.0,11.0,12.0,25.0,62.0,64.0,50.0,428.0
Panch Mahals,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,14.0,4.0,12.0,20.0,10.0,0.0,12.0,1.0,15.0,7.0,7.0,21.0,123.0
Panch Mahals,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1298.0,1382.0,1479.0,1528.0,1925.0,1827.0,1831.0,1975.0,2011.0,1861.0,1668.0,1509.0,20294.0
Panch Mahals,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,6.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,1.0,3.0,0.0,15.0
Panch Mahals,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,3.0,6.0,6.0,12.0,15.0,18.0,8.0,14.0,17.0,19.0,8.0,13.0,139.0
Panch Mahals,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,,5.0,3.0,3.0,0.0,0.0,0.0,0.0,5.0,3.0,0.0,19.0
Panch Mahals,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panch Mahals,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,3.0,12.0,11.0,15.0,18.0,18.0,8.0,19.0,17.0,25.0,14.0,13.0,173.0
Panch Mahals,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,22.0,18.0,11.0,14.0,24.0,17.0,19.0,23.0,14.0,25.0,14.0,17.0,218.0
Panch Mahals,4.1.1.a,Number of male live births,TOTAL,1283.0,1388.0,1473.0,1451.0,1804.0,1736.0,1669.0,1671.0,1703.0,1576.0,1336.0,1458.0,18548.0
Panch Mahals,4.1.1.b,Number of female live births,TOTAL,1134.0,1273.0,1337.0,1313.0,1572.0,1555.0,1503.0,1545.0,1482.0,1485.0,1291.0,1270.0,16760.0
Panch Mahals,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2417.0,2661.0,2810.0,2764.0,3376.0,3291.0,3172.0,3216.0,3185.0,3061.0,2627.0,2728.0,35308.0
Panch Mahals,4.1.2,Number of still births,TOTAL,58.0,55.0,66.0,54.0,65.0,75.0,82.0,74.0,58.0,56.0,59.0,36.0,738.0
Panch Mahals,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,81.0,102.0,125.0,132.0,221.0,164.0,137.0,123.0,138.0,177.0,145.0,131.0,1676.0
Panch Mahals,4.2.1,Number of Newborns weighed at birth,TOTAL,2377.0,2515.0,2726.0,2685.0,3171.0,3214.0,3071.0,3071.0,3082.0,3137.0,2769.0,2792.0,34610.0
Panch Mahals,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,190.0,203.0,210.0,205.0,284.0,261.0,245.0,284.0,237.0,295.0,240.0,309.0,2963.0
Panch Mahals,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2422.0,2520.0,2759.0,2701.0,3146.0,3269.0,3129.0,3036.0,3076.0,3094.0,2777.0,2763.0,34692.0
Panch Mahals,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,7.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,11.0
Panch Mahals,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,17.0,42.0,21.0,23.0,28.0,24.0,27.0,16.0,21.0,24.0,17.0,20.0,280.0
Panch Mahals,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,5.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,12.0
Panch Mahals,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panch Mahals,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,24.0,43.0,26.0,23.0,31.0,24.0,27.0,16.0,21.0,24.0,23.0,21.0,303.0
Panch Mahals,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,4.0,13.0,44.0,58.0,68.0,80.0,93.0,6.0,75.0,80.0,49.0,46.0,616.0
Panch Mahals,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,48.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,57.0
Panch Mahals,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,34.0,45.0,44.0,129.0,138.0,169.0,181.0,68.0,161.0,83.0,227.0,211.0,1490.0
Panch Mahals,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,8.0,4.0,7.0,4.0,11.0,17.0,4.0,0.0,0.0,0.0,0.0,0.0,55.0
Panch Mahals,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2343.0,2444.0,2610.0,2472.0,2928.0,2957.0,2914.0,2845.0,2918.0,2770.0,2554.0,2220.0,31975.0
Panch Mahals,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2181.0,2274.0,2483.0,2314.0,2883.0,2759.0,2652.0,2644.0,2454.0,2598.0,2357.0,2085.0,29684.0
Panch Mahals,6.3,PNC maternal complications attended,TOTAL,0.0,3.0,4.0,0.0,7.0,8.0,0.0,0.0,2.0,0.0,82.0,95.0,201.0
Panch Mahals,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,0.0,7.0,6.0,1.0,6.0,2.0,5.0,16.0,5.0,17.0,0.0,66.0
Panch Mahals,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,5.0,16.0,5.0,20.0,0.0,49.0
Panch Mahals,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1.0,3.0,7.0,6.0,1.0,6.0,2.0,10.0,32.0,10.0,37.0,0.0,115.0
Panch Mahals,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,82.0,135.0,113.0,309.0,204.0,162.0,100.0,95.0,118.0,97.0,141.0,122.0,1678.0
Panch Mahals,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,403.0,339.0,305.0,292.0,434.0,413.0,273.0,166.0,283.0,311.0,289.0,366.0,3874.0
Panch Mahals,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,485.0,474.0,418.0,601.0,638.0,575.0,373.0,261.0,401.0,408.0,430.0,488.0,5552.0
Panch Mahals,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,3.0,0.0,9.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,25.0,49.0
Panch Mahals,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Panch Mahals,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panch Mahals,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Panch Mahals,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,13.0,1.0,2.0,4.0,1.0,0.0,13.0,49.0,51.0,93.0,33.0,7.0,267.0
Panch Mahals,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,27.0,10.0,25.0,68.0,41.0,51.0,76.0,793.0,1010.0,770.0,350.0,64.0,3285.0
Panch Mahals,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,8.0,4.0,4.0,0.0,0.0,3.0,4.0,4.0,0.0,27.0
Panch Mahals,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panch Mahals,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,40.0,11.0,27.0,80.0,46.0,55.0,89.0,842.0,1064.0,867.0,387.0,71.0,3579.0
Panch Mahals,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,10.0,0.0,0.0,12.0,0.0,1.0,4.0,13.0,12.0,13.0,7.0,0.0,72.0
Panch Mahals,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,37.0,97.0,39.0,39.0,22.0,18.0,252.0
Panch Mahals,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panch Mahals,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,10.0,0.0,0.0,12.0,0.0,1.0,41.0,110.0,51.0,52.0,29.0,18.0,324.0
Panch Mahals,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,11.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,19.0
Panch Mahals,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Panch Mahals,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Panch Mahals,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panch Mahals,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,1.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Panch Mahals,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,438.0,519.0,596.0,593.0,666.0,583.0,595.0,782.0,655.0,545.0,553.0,500.0,7025.0
Panch Mahals,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,68.0,77.0,85.0,222.0,188.0,178.0,126.0,127.0,327.0,120.0,130.0,86.0,1734.0
Panch Mahals,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,13.0,9.0,10.0,11.0,7.0,16.0,6.0,11.0,16.0,12.0,8.0,15.0,134.0
Panch Mahals,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4.0,6.0,8.0,8.0,7.0,2.0,5.0,0.0,12.0,8.0,9.0,0.0,69.0
Panch Mahals,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panch Mahals,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,523.0,611.0,699.0,834.0,868.0,779.0,732.0,920.0,1010.0,685.0,700.0,601.0,8962.0
Panch Mahals,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,37.0,61.0,69.0,51.0,49.0,98.0,51.0,42.0,76.0,41.0,39.0,17.0,631.0
Panch Mahals,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,19.0,0.0,0.0,0.0,0.0,0.0,19.0
Panch Mahals,9.06,Number of IUCD removals,TOTAL,213.0,195.0,178.0,141.0,155.0,179.0,208.0,149.0,297.0,178.0,197.0,204.0,2294.0
Panch Mahals,9.07,Number of Oral Pills cycles distributed,TOTAL,3510.0,2125.0,2068.0,1576.0,2044.0,2461.0,3096.0,2628.0,3357.0,2402.0,2690.0,3371.0,31328.0
Panch Mahals,9.08,Number of Condom pieces distributed,TOTAL,7621.0,8327.0,8677.0,12088.0,5280.0,11028.0,11272.0,11077.0,12751.0,12667.0,13165.0,11894.0,125847.0
Panch Mahals,9.09,Number of Centchroman (weekly) pills given,TOTAL,6.0,31.0,14.0,54.0,3.0,10.0,251.0,303.0,369.0,312.0,44.0,0.0,1397.0
Panch Mahals,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,2.0,10.0,13.0,22.0,21.0,35.0,12.0,31.0,27.0,2.0,5.0,180.0
Panch Mahals,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,7.0,6.0,9.0,0.0,26.0
Panch Mahals,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,2.0,1.0,1.0,0.0,0.0,1.0,0.0,20.0,19.0,0.0,8.0,2.0,54.0
Panch Mahals,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,6.0,0.0,7.0
Panch Mahals,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Panch Mahals,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,3.0,5.0,2.0,3.0,2.0,2.0,,1.0,5.0,,2.0,-1.0
Panch Mahals,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2713.0,2809.0,2984.0,2860.0,3188.0,3363.0,3059.0,3131.0,3162.0,2957.0,2812.0,2630.0,35668.0
Panch Mahals,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,144.0,145.0,214.0,147.0,181.0,196.0,137.0,111.0,136.0,178.0,152.0,135.0,1876.0
Panch Mahals,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,175.0,129.0,214.0,136.0,126.0,226.0,147.0,113.0,122.0,157.0,145.0,152.0,1842.0
Panch Mahals,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,174.0,181.0,211.0,173.0,121.0,208.0,154.0,102.0,131.0,160.0,137.0,156.0,1908.0
Panch Mahals,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2557.0,2379.0,2545.0,2562.0,2700.0,2704.0,2895.0,3004.0,2855.0,2827.0,2665.0,2488.0,32181.0
Panch Mahals,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2686.0,2358.0,2425.0,2532.0,2637.0,2730.0,2704.0,2933.0,3044.0,2683.0,2906.0,2546.0,32184.0
Panch Mahals,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2736.0,2577.0,2428.0,2568.0,2783.0,2731.0,2796.0,2769.0,3046.0,2867.0,2744.0,2681.0,32726.0
Panch Mahals,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1750.0,1910.0,2080.0,1842.0,2048.0,2059.0,2090.0,2160.0,2168.0,2130.0,1950.0,1828.0,24015.0
Panch Mahals,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2624.0,2529.0,2695.0,2694.0,2838.0,2910.0,3016.0,3047.0,2940.0,2989.0,2751.0,2554.0,33587.0
Panch Mahals,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2816.0,2499.0,2613.0,2663.0,2817.0,2954.0,2804.0,3016.0,3112.0,2782.0,2962.0,2640.0,33678.0
Panch Mahals,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2858.0,2707.0,2560.0,2658.0,2914.0,2862.0,2885.0,2728.0,3035.0,2984.0,2861.0,2723.0,33775.0
Panch Mahals,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,168.0,287.0,326.0,235.0,255.0,374.0,255.0,327.0,221.0,262.0,173.0,245.0,3128.0
Panch Mahals,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,35.0,19.0,49.0,9.0,9.0,19.0,3.0,17.0,113.0,136.0,0.0,67.0,476.0
Panch Mahals,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,17.0,12.0,8.0,3.0,4.0,6.0,27.0,13.0,0.0,55.0,0.0,3.0,148.0
Panch Mahals,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,35.0,20.0,15.0,0.0,0.0,20.0,25.0,9.0,0.0,49.0,0.0,4.0,177.0
Panch Mahals,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2589.0,2621.0,2807.0,3015.0,2978.0,2965.0,2747.0,2728.0,2556.0,2521.0,2532.0,2383.0,32442.0
Panch Mahals,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1818.0,1673.0,1792.0,1671.0,1655.0,1646.0,1613.0,1653.0,1879.0,1726.0,1883.0,1728.0,20737.0
Panch Mahals,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1260.0,1350.0,1330.0,1439.0,1391.0,1528.0,1269.0,1275.0,1266.0,1254.0,1262.0,1163.0,15787.0
Panch Mahals,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1128.0,1135.0,1165.0,1314.0,1285.0,1388.0,1206.0,1173.0,1171.0,1127.0,1170.0,1058.0,14320.0
Panch Mahals,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2388.0,2485.0,2495.0,2753.0,2676.0,2916.0,2475.0,2448.0,2437.0,2381.0,2432.0,2221.0,30107.0
Panch Mahals,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2213.0,2111.0,2371.0,2305.0,2296.0,2358.0,2184.0,2176.0,2203.0,2164.0,2309.0,2192.0,26882.0
Panch Mahals,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2198.0,2079.0,2333.0,2282.0,2271.0,2357.0,2185.0,2156.0,2158.0,2157.0,2294.0,2169.0,26639.0
Panch Mahals,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,260.0,331.0,384.0,316.0,347.0,478.0,283.0,292.0,278.0,254.0,311.0,347.0,3881.0
Panch Mahals,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,230.0,285.0,332.0,297.0,299.0,443.0,285.0,282.0,258.0,224.0,290.0,300.0,3525.0
Panch Mahals,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,490.0,616.0,716.0,613.0,646.0,921.0,568.0,574.0,536.0,478.0,601.0,647.0,7406.0
Panch Mahals,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2012.0,1988.0,2073.0,2777.0,3217.0,2723.0,2267.0,2402.0,2310.0,2088.0,2249.0,1996.0,28102.0
Panch Mahals,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1687.0,1843.0,1983.0,2804.0,3051.0,2671.0,2218.0,2246.0,2363.0,2005.0,2183.0,2142.0,27196.0
Panch Mahals,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2169.0,2283.0,2494.0,2659.0,2688.0,2585.0,2485.0,2490.0,2323.0,2112.0,2203.0,2062.0,28553.0
Panch Mahals,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,0.0,0.0,1.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0,8.0
Panch Mahals,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,30.0,26.0,26.0,25.0,35.0,32.0,33.0,25.0,22.0,16.0,19.0,32.0,321.0
Panch Mahals,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1593.0,1489.0,1501.0,1540.0,1435.0,1404.0,1461.0,1329.0,1473.0,1455.0,1462.0,1435.0,17577.0
Panch Mahals,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1575.0,1468.0,1460.0,1523.0,1414.0,1413.0,1438.0,1318.0,1441.0,1479.0,1450.0,1413.0,17392.0
Panch Mahals,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1376.0,1291.0,1271.0,1329.0,1266.0,1270.0,1298.0,1154.0,1288.0,1263.0,1302.0,1258.0,15366.0
Panch Mahals,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Panch Mahals,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2667.0,2785.0,2806.0,2950.0,2792.0,2755.0,2543.0,2502.0,2465.0,2284.0,2363.0,2160.0,31072.0
Panch Mahals,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,29390.0,1663.0,95.0,80.0,1816.0,2328.0,1348.0,9857.0,6746.0,10959.0,4122.0,256.0,68660.0
Panch Mahals,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,31662.0,1770.0,13.0,18.0,1028.0,1951.0,1124.0,7958.0,6747.0,10638.0,3564.0,179.0,66652.0
Panch Mahals,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Panch Mahals,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,30.0,57.0,49.0,36.0,14.0,2.0,10.0,14.0,12.0,81.0,4.0,2.0,311.0
Panch Mahals,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2170.0,2208.0,2728.0,2960.0,3673.0,2866.0,2073.0,1757.0,1732.0,1462.0,1505.0,1442.0,26576.0
Panch Mahals,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,10.0,3.0,0.0,1.0,23.0,17.0,34.0,32.0,12.0,4.0,2.0,9.0,147.0
Panch Mahals,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,27.0,23.0,24.0,42.0,71.0,43.0,17.0,31.0,43.0,32.0,1101.0,53.0,1507.0
Panch Mahals,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,13.3,Number of School children detected with Refractive errors,TOTAL,14.0,4.0,13.0,649.0,101.0,518.0,12.0,1332.0,589.0,601.0,2283.0,1242.0,7358.0
Panch Mahals,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,60.0,35.0,22.0,0.0,60.0,48.0,49.0,47.0,40.0,361.0
Panch Mahals,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,3.0,3.0,3.0,1.0,1.0,2.0,2.0,1.0,2.0,2.0,-1.0
Panch Mahals,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,1.0,2.0,2.0,3.0,2.0,2.0,2.0,2.0,5.0,3.0,2.0,-1.0
Panch Mahals,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,589.0,637.0,757.0,882.0,874.0,595.0,518.0,403.0,861.0,512.0,411.0,646.0,-1.0
Panch Mahals,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,7.0,9.0,8.0,8.0,6.0,7.0,8.0,7.0,7.0,7.0,7.0,-1.0
Panch Mahals,14.05,Number of RKS meetings held during the month,TOTAL,3.0,4.0,10.0,3.0,11.0,5.0,6.0,5.0,8.0,11.0,12.0,9.0,87.0
Panch Mahals,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,14.0,13.0,11.0,14.0,14.0,11.0,11.0,10.0,11.0,12.0,12.0,12.0,-1.0
Panch Mahals,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,148.0,126.0,98.0,94.0,1249.0,188.0,122.0,104.0,117.0,144.0,110.0,154.0,2654.0
Panch Mahals,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,4.0,5.0,6.0,6.0,4.0,3.0,3.0,2.0,3.0,5.0,-1.0
Panch Mahals,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,9.0,9.0,10.0,8.0,6.0,6.0,6.0,9.0,9.0,12.0,11.0,8.0,-1.0
Panch Mahals,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,339.0,163.0,135.0,158.0,601.0,213.0,140.0,401.0,511.0,192.0,199.0,423.0,3475.0
Panch Mahals,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1115.0,684.0,682.0,583.0,1585.0,767.0,311.0,1000.0,1189.0,373.0,524.0,619.0,9432.0
Panch Mahals,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,341.0,152.0,168.0,239.0,519.0,209.0,146.0,321.0,455.0,181.0,184.0,424.0,3339.0
Panch Mahals,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1340.0,1416.0,1029.0,1021.0,2205.0,1484.0,801.0,2353.0,2469.0,1592.0,1120.0,791.0,17621.0
Panch Mahals,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,680.0,315.0,303.0,397.0,1120.0,422.0,286.0,722.0,966.0,373.0,383.0,847.0,6814.0
Panch Mahals,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2455.0,2100.0,1711.0,1604.0,3790.0,2251.0,1112.0,3353.0,3658.0,1965.0,1644.0,1410.0,27053.0
Panch Mahals,14.10.2.a,Number of death cases of Inpatient males,TOTAL,39.0,1.0,2.0,2.0,48.0,2.0,3.0,0.0,2.0,5.0,1.0,3.0,108.0
Panch Mahals,14.10.2.b,Number of death cases of Inpatient females,TOTAL,23.0,1.0,0.0,1.0,40.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,67.0
Panch Mahals,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,62.0,2.0,2.0,3.0,88.0,2.0,3.0,0.0,2.0,5.0,1.0,5.0,175.0
Panch Mahals,14.11,In-Patient Head Count at midnight,TOTAL,1849.0,1735.0,2647.0,2645.0,3131.0,5481.0,1816.0,2627.0,4505.0,2385.0,3511.0,3929.0,36261.0
Panch Mahals,14.12.1,OPD attendance (All),TOTAL,44736.0,32493.0,32579.0,34694.0,64247.0,68528.0,29302.0,47309.0,53718.0,37874.0,51780.0,49131.0,546391.0
Panch Mahals,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,72.0,0.0,0.0,0.0,118.0,110.0,1.0,291.0,343.0,0.0,7.0,0.0,942.0
Panch Mahals,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,9.0,0.0,0.0,33.0,0.0,0.0,71.0,0.0,113.0
Panch Mahals,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,113.0,29.0,25.0,62.0,113.0,115.0,67.0,695.0,786.0,565.0,268.0,55.0,2893.0
Panch Mahals,14.14.a,Number of patients given AYUSH treatment,TOTAL,294.0,328.0,321.0,775.0,457.0,430.0,507.0,490.0,1549.0,1232.0,3033.0,1023.0,10439.0
Panch Mahals,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,154.0,0.0,0.0,109.0,0.0,0.0,0.0,0.0,263.0
Panch Mahals,14.14.c,Number of Adolescents counselled,TOTAL,32.0,64.0,34.0,39.0,74.0,27.0,37.0,40.0,38.0,17.0,23.0,41.0,466.0
Panch Mahals,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3802.0,3750.0,4647.0,4633.0,4420.0,4878.0,3102.0,3551.0,3577.0,3676.0,4363.0,4669.0,49068.0
Panch Mahals,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,219.0,347.0,363.0,293.0,377.0,359.0,176.0,169.0,204.0,175.0,212.0,279.0,3173.0
Panch Mahals,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,686.0,643.0,339.0,780.0,832.0,204.0,738.0,539.0,394.0,207.0,422.0,440.0,6224.0
Panch Mahals,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5.0,8.0,2.0,12.0,15.0,3.0,13.0,7.0,3.0,3.0,27.0,1.0,99.0
Panch Mahals,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,550.0,649.0,310.0,645.0,544.0,176.0,506.0,459.0,278.0,120.0,293.0,252.0,4782.0
Panch Mahals,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,10.0,10.0,4.0,7.0,11.0,2.0,5.0,2.0,3.0,1.0,5.0,1.0,61.0
Panch Mahals,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,767.0,812.0,969.0,951.0,912.0,791.0,603.0,773.0,449.0,312.0,636.0,1083.0,9058.0
Panch Mahals,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,36.0,1.0,2.0,1.0,97.0,0.0,20.0,1.0,9.0,19.0,63.0,4.0,253.0
Panch Mahals,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2003.0,2104.0,1618.0,2376.0,2288.0,1171.0,1847.0,1771.0,1121.0,639.0,1351.0,1775.0,20064.0
Panch Mahals,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,51.0,19.0,8.0,20.0,123.0,5.0,38.0,10.0,15.0,23.0,95.0,6.0,413.0
Panch Mahals,15.2,Number of Widal tests conducted,Number tested,232.0,169.0,171.0,212.0,542.0,463.0,315.0,323.0,258.0,168.0,296.0,358.0,3507.0
Panch Mahals,15.3.a,Number of VDRL tests conducted on males,Number tested,287.0,35.0,69.0,42.0,76.0,76.0,306.0,47.0,54.0,9.0,30.0,77.0,1108.0
Panch Mahals,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,274.0,63.0,57.0,70.0,144.0,50.0,218.0,48.0,96.0,68.0,80.0,23.0,1191.0
Panch Mahals,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,300.0,296.0,396.0,250.0,351.0,387.0,374.0,168.0,259.0,201.0,240.0,344.0,3566.0
Panch Mahals,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,861.0,394.0,522.0,362.0,571.0,513.0,898.0,263.0,409.0,278.0,350.0,444.0,5865.0
Panch Mahals,15.4.1,Number of blood smears examined for Malaria,TOTAL,8787.0,12427.0,11369.0,14522.0,29188.0,26175.0,12132.0,10186.0,6886.0,6385.0,12219.0,8982.0,159258.0
Panch Mahals,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,298.0,326.0,68.0,96.0,1438.0,1343.0,47.0,38.0,23.0,278.0,12.0,17.0,3984.0
Panch Mahals,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,14.0,23.0,2.0,1.0,26.0,36.0,33.0,16.0,12.0,5.0,1.0,2.0,171.0
Panch Mahals,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,6850.0,11970.0,15920.0,,80.0,3190.0,3290.0,7290.0,13440.0,9000.0,16700.0,23200.0,110930.0
Panch Mahals,16.1.1,Stock position of DPT vaccines,2. Stocks Received,12500.0,10000.0,0.0,,15000.0,15000.0,20000.0,23000.0,12000.0,15000.0,15000.0,15000.0,152500.0
Panch Mahals,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,7380.0,6050.0,5350.0,,11890.0,14900.0,16000.0,16850.0,16440.0,7300.0,8500.0,11300.0,121960.0
Panch Mahals,16.1.1,Stock position of DPT vaccines,5. Total Stock,11970.0,15920.0,10570.0,0.0,3190.0,3290.0,7290.0,13440.0,9000.0,16700.0,23200.0,26900.0,141470.0
Panch Mahals,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,200.0,750.0,6100.0,,9530.0,0.0,3500.0,22000.0,17530.0,6250.0,25000.0,35600.0,126460.0
Panch Mahals,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,12000.0,21000.0,18000.0,,0.0,24000.0,27000.0,21000.0,12000.0,21000.0,21000.0,30000.0,207000.0
Panch Mahals,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,11450.0,15650.0,18100.0,,9530.0,20500.0,8500.0,25470.0,16780.0,8750.0,10400.0,25120.0,170250.0
Panch Mahals,16.1.1A,Stock Position of Pentavalent,5. Total Stock,750.0,6100.0,6000.0,0.0,0.0,3500.0,22000.0,17530.0,12750.0,18500.0,35600.0,40480.0,163210.0
Panch Mahals,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,17280.0,21130.0,39330.0,,24630.0,11310.0,16970.0,9970.0,32580.0,183500.0,5500.0,35000.0,397200.0
Panch Mahals,16.1.2,Stock position of OPV vaccines,2. Stocks Received,25000.0,40000.0,27000.0,,22000.0,40000.0,26000.0,49000.0,459000.0,0.0,466000.0,30000.0,1184000.0
Panch Mahals,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,21150.0,21800.0,34060.0,,35320.0,34340.0,33000.0,26390.0,308080.0,178000.0,436500.0,15000.0,1143640.0
Panch Mahals,16.1.2,Stock position of OPV vaccines,5. Total Stock,21130.0,39330.0,32270.0,0.0,11310.0,16970.0,9970.0,32580.0,183500.0,5500.0,35000.0,50000.0,437560.0
Panch Mahals,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4500.0,28700.0,34450.0,,39430.0,30980.0,23800.0,11800.0,9400.0,8750.0,27500.0,46500.0,265810.0
Panch Mahals,16.1.3,Stock position of TT vaccines,2. Stocks Received,45000.0,20000.0,20000.0,,15000.0,12000.0,10000.0,15000.0,15000.0,30000.0,30000.0,25000.0,237000.0
Panch Mahals,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.3,Stock position of TT vaccines,4. Stock Distributed,20800.0,14250.0,15850.0,,23450.0,19180.0,22000.0,17400.0,15650.0,11250.0,11000.0,26200.0,197030.0
Panch Mahals,16.1.3,Stock position of TT vaccines,5. Total Stock,28700.0,34450.0,38600.0,0.0,30980.0,23800.0,11800.0,9400.0,8750.0,27500.0,46500.0,45300.0,305780.0
Panch Mahals,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1970.0,11430.0,12930.0,,13610.0,12890.0,11940.0,10000.0,9650.0,8000.0,13700.0,13400.0,119520.0
Panch Mahals,16.1.5,Stock position of BCG vaccines,2. Stocks Received,20000.0,11000.0,8000.0,,8000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,117000.0
Panch Mahals,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,10540.0,9500.0,8050.0,,8720.0,10950.0,11940.0,10350.0,11650.0,4300.0,10300.0,10660.0,106960.0
Panch Mahals,16.1.5,Stock position of BCG vaccines,5. Total Stock,11430.0,12930.0,12880.0,0.0,12890.0,11940.0,10000.0,9650.0,8000.0,13700.0,13400.0,12740.0,129560.0
Panch Mahals,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,80.0,80.0,3145.0,,3735.0,0.0,100.0,3500.0,11270.0,4750.0,13000.0,13500.0,53160.0
Panch Mahals,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,11000.0,15000.0,,5000.0,11100.0,15000.0,15000.0,5000.0,15000.0,10000.0,15000.0,117100.0
Panch Mahals,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,0.0,7935.0,13025.0,,8735.0,11000.0,11600.0,7230.0,11520.0,6750.0,9500.0,10920.0,98215.0
Panch Mahals,16.1.6,Stock position of Measles vaccines,5. Total Stock,80.0,3145.0,5120.0,0.0,0.0,100.0,3500.0,11270.0,4750.0,13000.0,13500.0,17580.0,72045.0
Panch Mahals,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,100.0,,7250.0,6930.0,6400.0,6200.0,630.0,200.0,100.0,100.0,27910.0
Panch Mahals,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,100.0,5000.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,6100.0
Panch Mahals,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,2220.0,,320.0,530.0,200.0,5570.0,430.0,100.0,0.0,0.0,9370.0
Panch Mahals,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,100.0,2880.0,0.0,6930.0,6400.0,6200.0,630.0,200.0,100.0,100.0,1100.0,24640.0
Panch Mahals,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3250.0,0.0,32000.0,,6300.0,3300.0,0.0,0.0,0.0,6700.0,2500.0,0.0,54050.0
Panch Mahals,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,8400.0,0.0,,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11400.0
Panch Mahals,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,3250.0,5200.0,32000.0,,6000.0,3300.0,0.0,0.0,0.0,4200.0,2500.0,0.0,56450.0
Panch Mahals,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,3200.0,0.0,0.0,3300.0,0.0,0.0,0.0,0.0,2500.0,0.0,0.0,9000.0
Panch Mahals,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,60480.0,38640.0,0.0,,86800.0,268960.0,27000.0,0.0,0.0,37000.0,0.0,0.0,518880.0
Panch Mahals,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,272160.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,272160.0
Panch Mahals,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,21840.0,38640.0,0.0,,90000.0,241960.0,27000.0,0.0,0.0,37000.0,0.0,0.0,456440.0
Panch Mahals,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,38640.0,0.0,0.0,0.0,268960.0,27000.0,0.0,0.0,0.0,0.0,0.0,0.0,334600.0
Panch Mahals,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3200.0,1900.0,0.0,,40100.0,8100.0,0.0,0.0,0.0,111000.0,70500.0,8000.0,242800.0
Panch Mahals,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,54000.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,54000.0
Panch Mahals,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1300.0,1900.0,4200.0,,32000.0,8100.0,0.0,0.0,0.0,40500.0,62500.0,8000.0,158500.0
Panch Mahals,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1900.0,0.0,49800.0,0.0,8100.0,0.0,0.0,0.0,0.0,70500.0,8000.0,0.0,138300.0
Panch Mahals,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,2000.0,1500.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3500.0
Panch Mahals,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,2000.0,250.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2250.0
Panch Mahals,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,1250.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1250.0
Panch Mahals,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,2900.0,2800.0,2700.0,,2200.0,21000.0,1700.0,700.0,0.0,8765.0,5465.0,3300.0,51530.0
Panch Mahals,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,4915.0,0.0,0.0,0.0,0.0,4915.0
Panch Mahals,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,100.0,100.0,100.0,,100.0,400.0,1000.0,3000.0,0.0,3300.0,2165.0,1000.0,11265.0
Panch Mahals,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,2800.0,2700.0,2600.0,0.0,2100.0,20600.0,700.0,2615.0,0.0,5465.0,3300.0,2300.0,45180.0
Panch Mahals,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,375.0,175.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,550.0
Panch Mahals,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,200.0,175.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,375.0
Panch Mahals,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,175.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,175.0
Panch Mahals,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,1250.0,1000.0,750.0,,400.0,400.0,100.0,100.0,0.0,100.0,100.0,100.0,4300.0
Panch Mahals,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.02,Stock Position of Gloves,4. Stock Distributed,250.0,250.0,200.0,,0.0,300.0,0.0,0.0,0.0,0.0,0.0,100.0,1100.0
Panch Mahals,16.3.02,Stock Position of Gloves,5. Total Stock,1000.0,750.0,550.0,0.0,400.0,100.0,100.0,100.0,0.0,100.0,100.0,0.0,3200.0
Panch Mahals,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,17000.0,0.0,17000.0,0.0,44000.0,78000.0
Panch Mahals,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,40000.0,0.0,0.0,0.0,50000.0,0.0,90000.0
Panch Mahals,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,23000.0,17000.0,0.0,17000.0,6000.0,18000.0,81000.0
Panch Mahals,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,17000.0,0.0,0.0,0.0,44000.0,26000.0,87000.0
Panch Mahals,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,56.0,56.0
Panch Mahals,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,100.0
Panch Mahals,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,44.0,56.0,100.0
Panch Mahals,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,56.0,0.0,56.0
Panch Mahals,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1561000.0,1561000.0,862000.0,,146000.0,0.0,131000.0,870000.0,0.0,16000.0,1850000.0,970000.0,7967000.0
Panch Mahals,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,,0.0,798000.0,1080000.0,100000.0,0.0,2000000.0,0.0,0.0,3978000.0
Panch Mahals,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,699000.0,513000.0,,146000.0,667000.0,341000.0,659000.0,0.0,166000.0,880000.0,770000.0,4841000.0
Panch Mahals,16.3.07,Stock Position of IFA Tablets,5. Total Stock,1561000.0,862000.0,349000.0,0.0,0.0,131000.0,870000.0,311000.0,0.0,1850000.0,970000.0,200000.0,7104000.0
Panch Mahals,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,6600.0,,1650.0,0.0,0.0,0.0,0.0,2050.0,850.0,0.0,11150.0
Panch Mahals,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,10000.0,0.0,,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,10000.0,23000.0
Panch Mahals,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,3400.0,2920.0,,1650.0,0.0,0.0,300.0,0.0,1200.0,850.0,500.0,10820.0
Panch Mahals,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,6600.0,3680.0,0.0,0.0,0.0,0.0,2700.0,0.0,850.0,0.0,9500.0,23330.0
Panch Mahals,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,20000.0,5000.0,0.0,97500.0,79500.0,41000.0,243000.0
Panch Mahals,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,,0.0,200000.0,0.0,88000.0,0.0,0.0,40000.0,0.0,328000.0
Panch Mahals,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,,0.0,180000.0,15000.0,31000.0,0.0,18000.0,78500.0,21000.0,343500.0
Panch Mahals,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,20000.0,5000.0,62000.0,0.0,79500.0,41000.0,20000.0,227500.0
Panch Mahals,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,2100.0,1300.0,0.0,,100.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,3530.0
Panch Mahals,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,100.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Panch Mahals,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,800.0,1300.0,0.0,,70.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,2200.0
Panch Mahals,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,1300.0,0.0,100.0,0.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1430.0
Panch Mahals,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,364000.0,293500.0,288900.0,,69000.0,128000.0,18500.0,133500.0,0.0,26000.0,18000.0,21000.0,1360400.0
Panch Mahals,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,269400.0,74000.0,,200000.0,27500.0,168500.0,0.0,0.0,18000.0,20000.0,0.0,777400.0
Panch Mahals,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,70500.0,274000.0,209700.0,,141000.0,137000.0,52000.0,86500.0,0.0,26000.0,17000.0,15000.0,1028700.0
Panch Mahals,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,293500.0,288900.0,153200.0,0.0,128000.0,18500.0,135000.0,47000.0,0.0,18000.0,21000.0,6000.0,1109100.0
Panch Mahals,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,4050.0,,22700.0,13500.0,6300.0,6300.0,3000.0,3000.0,2800.0,0.0,61650.0
Panch Mahals,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,6600.0,36300.0,,0.0,0.0,0.0,6600.0,6600.0,0.0,0.0,0.0,56100.0
Panch Mahals,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,2550.0,3900.0,,9200.0,7200.0,0.0,9900.0,6600.0,200.0,2800.0,0.0,42350.0
Panch Mahals,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,4050.0,36450.0,0.0,13500.0,6300.0,6300.0,3000.0,3000.0,2800.0,0.0,0.0,75400.0
Panch Mahals,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,442800.0,431800.0,468600.0,,389000.0,316600.0,285800.0,325800.0,503800.0,423800.0,418300.0,390000.0,4396300.0
Panch Mahals,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,120000.0,90000.0,120000.0,,0.0,0.0,80000.0,290000.0,70000.0,0.0,0.0,80000.0,850000.0
Panch Mahals,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,131000.0,53200.0,63000.0,,72400.0,30800.0,40000.0,112000.0,150000.0,5000.0,28300.0,0.0,685700.0
Panch Mahals,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,431800.0,468600.0,525600.0,0.0,316600.0,285800.0,325800.0,503800.0,423800.0,418800.0,390000.0,470000.0,4560600.0
Panch Mahals,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2000.0,2000.0,1600.0,,9000.0,8900.0,7900.0,7000.0,3500.0,26500.0,25000.0,25000.0,118400.0
Panch Mahals,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,22000.0,,0.0,0.0,0.0,0.0,28000.0,0.0,0.0,0.0,50000.0
Panch Mahals,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panch Mahals,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,400.0,0.0,,100.0,1000.0,900.0,3500.0,5000.0,1500.0,0.0,25000.0,37400.0
Panch Mahals,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2000.0,1600.0,23600.0,0.0,8900.0,7900.0,7000.0,3500.0,26500.0,25000.0,25000.0,0.0,131000.0
Panch Mahals,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,1.0,1.0,1.0,1.0,2.0,5.0,2.0,,,,,16.0
Panch Mahals,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Panch Mahals,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Panch Mahals,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Panch Mahals,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Panch Mahals,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Panch Mahals,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Panch Mahals,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,,2.0,2.0,4.0,,2.0,2.0,2.0,,2.0,1.0,19.0
Panch Mahals,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Panch Mahals,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,,2.0,2.0,4.0,,2.0,3.0,2.0,,2.0,1.0,20.0
Panch Mahals,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,3.0,,2.0,3.0,2.0,,2.0,,1.0,1.0,1.0,17.0
Panch Mahals,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Panch Mahals,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,3.0,,2.0,3.0,2.0,,2.0,,1.0,1.0,1.0,17.0
Panch Mahals,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Panch Mahals,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Panch Mahals,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,,,,,,,,1.0,2.0
Panch Mahals,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Panch Mahals,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Panch Mahals,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,1.0,1.0
Panch Mahals,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Panch Mahals,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Panch Mahals,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,1.0,,,,1.0
Panch Mahals,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Panch Mahals,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Panch Mahals,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Panch Mahals,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,3.0,,1.0,1.0,,,1.0,,1.0,,,7.0
Panch Mahals,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Panch Mahals,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,3.0,,1.0,1.0,,,1.0,,1.0,,,7.0
Panch Mahals,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Panch Mahals,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Panch Mahals,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,1.0,,,,,,1.0
Panch Mahals,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,2.0,5.0,3.0,7.0,3.0,2.0,2.0,5.0,2.0,3.0,3.0,38.0
Panch Mahals,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,1.0,,,,,,1.0,,1.0,1.0,5.0
Panch Mahals,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,2.0,6.0,3.0,7.0,3.0,2.0,2.0,6.0,2.0,4.0,4.0,43.0
Panch Mahals,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,2.0,1.0,2.0,2.0,1.0,2.0,3.0,3.0,,2.0,20.0
Panch Mahals,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,4.0,3.0,4.0,1.0,3.0,2.0,2.0,2.0,6.0,,2.0,29.0
Panch Mahals,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,5.0,5.0,5.0,3.0,5.0,3.0,4.0,5.0,9.0,,4.0,49.0
Panch Mahals,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Panch Mahals,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,1.0,,,,,,,,1.0,2.0
Panch Mahals,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,1.0,,,,,,,,1.0,2.0
Panch Mahals,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Panch Mahals,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,2.0,,,,,1.0,3.0
Panch Mahals,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,,,1.0,1.0,,,,1.0,,4.0
Panch Mahals,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,1.0,,,1.0,3.0,,,,1.0,1.0,8.0
Panch Mahals,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Panch Mahals,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Panch Mahals,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,1.0,,,,,,,,,,,1.0
Panch Mahals,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,2.0,,,2.0
Panch Mahals,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,4.0,6.0,9.0,7.0,5.0,3.0,4.0,4.0,2.0,5.0,4.0,5.0,58.0
Panch Mahals,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,5.0,6.0,7.0,6.0,1.0,2.0,4.0,3.0,6.0,4.0,45.0
Panch Mahals,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,5.0,6.0,14.0,13.0,12.0,9.0,5.0,6.0,6.0,10.0,10.0,9.0,105.0
Panch Mahals,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Panch Mahals,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,,,2.0,1.0,1.0,1.0,,2.0,,8.0
Panch Mahals,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,1.0,,,,,,6.0,1.0,,,8.0
Panch Mahals,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,2.0,,,2.0,1.0,1.0,7.0,1.0,2.0,,17.0
Panch Mahals,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Panch Mahals,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Panch Mahals,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Panch Mahals,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Panch Mahals,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,,,,1.0,,,,,2.0
Panch Mahals,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Panch Mahals,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,1.0,,,,1.0,,,,,2.0
Panch Mahals,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Panch Mahals,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Panch Mahals,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,,,,,,,,,1.0
Panch Mahals,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Panch Mahals,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Panch Mahals,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,3.0,1.0,,1.0,2.0,,5.0,,1.0,,13.0
Panch Mahals,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Panch Mahals,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,3.0,1.0,,1.0,2.0,,5.0,,1.0,,13.0
Panch Mahals,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,,,,,2.0,1.0,,1.0,,,,6.0
Panch Mahals,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,6.0,5.0,6.0,4.0,4.0,4.0,3.0,4.0,6.0,1.0,5.0,53.0
Panch Mahals,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,1.0,5.0,3.0,1.0,1.0,,1.0,1.0,,2.0,,17.0
Panch Mahals,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,9.0,7.0,10.0,9.0,5.0,7.0,5.0,4.0,6.0,6.0,3.0,5.0,76.0
Panch Mahals,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,7.0,6.0,5.0,4.0,2.0,3.0,5.0,3.0,,4.0,1.0,42.0
Panch Mahals,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,1.0,1.0,,,,,1.0,,2.0,6.0
Panch Mahals,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,7.0,7.0,6.0,5.0,2.0,3.0,5.0,3.0,1.0,4.0,3.0,48.0
Panch Mahals,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,1.0,1.0,,,,2.0
Panch Mahals,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,1.0,1.0,,3.0,,2.0,,,1.0,9.0
Panch Mahals,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,2.0,,,1.0,1.0,,,,5.0
Panch Mahals,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,2.0,3.0,,3.0,2.0,4.0,,,1.0,16.0
Panch Mahals,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Panch Mahals,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,2.0,,2.0,,,1.0,1.0,,1.0,1.0,9.0
Panch Mahals,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,1.0,,,1.0,,1.0,,,,3.0
Panch Mahals,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,2.0,1.0,2.0,,1.0,1.0,2.0,,2.0,1.0,13.0
Panch Mahals,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Panch Mahals,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,5.0,1.0,2.0,,,1.0,,2.0,,,12.0
Panch Mahals,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,1.0,1.0,4.0,2.0,1.0,,,,4.0,1.0,1.0,15.0
Panch Mahals,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,1.0,6.0,5.0,4.0,1.0,,1.0,,6.0,1.0,1.0,27.0
Panch Mahals,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,3.0,1.0,3.0,,3.0,3.0,,2.0,1.0,17.0
Panch Mahals,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,47.0,39.0,42.0,32.0,34.0,39.0,33.0,26.0,50.0,35.0,33.0,43.0,453.0
Panch Mahals,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,50.0,41.0,66.0,58.0,80.0,61.0,55.0,47.0,73.0,78.0,94.0,85.0,788.0
Panch Mahals,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,98.0,80.0,108.0,93.0,115.0,103.0,88.0,76.0,126.0,113.0,129.0,129.0,1258.0
Patan,1.1,Total number of pregnant women Registered for ANC,TOTAL,2626.0,2525.0,2711.0,2356.0,2071.0,2140.0,1841.0,2408.0,2308.0,2575.0,3298.0,3332.0,30191.0
Patan,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2271.0,2149.0,2315.0,2025.0,1701.0,1858.0,1626.0,2111.0,2040.0,2314.0,2809.0,2302.0,25521.0
Patan,1.2,Number of Pregnant women registered under JSY,TOTAL,550.0,668.0,883.0,772.0,662.0,800.0,657.0,830.0,917.0,843.0,985.0,838.0,9405.0
Patan,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2115.0,2322.0,2506.0,2447.0,2338.0,2373.0,2178.0,2361.0,2393.0,2439.0,2627.0,2590.0,28689.0
Patan,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2288.0,2104.0,2321.0,2190.0,1770.0,1899.0,1749.0,2092.0,2159.0,2322.0,2611.0,2705.0,26210.0
Patan,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2615.0,2248.0,2354.0,2339.0,2151.0,2027.0,1850.0,2192.0,2252.0,2356.0,2520.0,3746.0,28650.0
Patan,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2325.0,2493.0,2584.0,2591.0,2398.0,2535.0,2292.0,2707.0,2630.0,2674.0,2905.0,3105.0,31239.0
Patan,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,75.0,20.0,17.0,61.0,54.0,45.0,48.0,25.0,31.0,41.0,45.0,53.0,515.0
Patan,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,4.0,7.0,13.0,10.0,0.0,1.0,1.0,2.0,2.0,2.0,42.0
Patan,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2165.0,2601.0,2856.0,2886.0,2245.0,2336.0,2072.0,2648.0,2217.0,2520.0,2597.0,2911.0,30054.0
Patan,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,86.0,122.0,116.0,113.0,39.0,64.0,55.0,50.0,46.0,56.0,60.0,80.0,887.0
Patan,1.8,Number of pregnancy test kits used at SC level,TOTAL,933.0,948.0,846.0,932.0,1053.0,1130.0,888.0,1159.0,923.0,893.0,695.0,934.0,11334.0
Patan,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,11.0,10.0,2.0,3.0,6.0,15.0,3.0,13.0,3.0,4.0,16.0,2.0,88.0
Patan,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,8.0,12.0,14.0,3.0,9.0,9.0,12.0,10.0,10.0,16.0,10.0,8.0,121.0
Patan,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,19.0,22.0,16.0,6.0,15.0,24.0,15.0,23.0,13.0,20.0,26.0,10.0,209.0
Patan,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,16.0,21.0,15.0,4.0,13.0,23.0,15.0,21.0,10.0,21.0,22.0,10.0,191.0
Patan,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,657.0,759.0,786.0,927.0,1029.0,1095.0,963.0,993.0,953.0,933.0,774.0,749.0,10618.0
Patan,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,507.0,618.0,607.0,726.0,816.0,828.0,726.0,742.0,720.0,737.0,578.0,580.0,8185.0
Patan,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,4.0,12.0,24.0,8.0,5.0,7.0,24.0,14.0,136.0,17.0,50.0,56.0,357.0
Patan,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1.0,8.0,5.0,26.0,3.0,7.0,15.0,10.0,1.0,5.0,25.0,20.0,126.0
Patan,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1024.0,1169.0,1323.0,1183.0,1346.0,1321.0,1214.0,1599.0,1163.0,1160.0,1281.0,1108.0,14891.0
Patan,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,22.0,26.0,53.0,40.0,46.0,62.0,49.0,44.0,48.0,62.0,50.0,41.0,543.0
Patan,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,34.0,23.0,25.0,35.0,39.0,52.0,43.0,47.0,39.0,26.0,35.0,42.0,440.0
Patan,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patan,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,56.0,49.0,78.0,75.0,85.0,114.0,92.0,91.0,87.0,88.0,85.0,83.0,983.0
Patan,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,38.0,53.0,28.0,34.0,29.0,50.0,54.0,43.0,43.0,49.0,38.0,42.0,501.0
Patan,4.1.1.a,Number of male live births,TOTAL,955.0,1040.0,1135.0,1159.0,1221.0,1232.0,1158.0,1353.0,1088.0,1143.0,1080.0,944.0,13508.0
Patan,4.1.1.b,Number of female live births,TOTAL,796.0,916.0,993.0,970.0,1119.0,1213.0,1033.0,1285.0,1026.0,1013.0,1028.0,916.0,12308.0
Patan,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1751.0,1956.0,2128.0,2129.0,2340.0,2445.0,2191.0,2638.0,2114.0,2156.0,2108.0,1860.0,25816.0
Patan,4.1.2,Number of still births,TOTAL,25.0,37.0,20.0,29.0,27.0,34.0,25.0,22.0,21.0,24.0,18.0,25.0,307.0
Patan,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,40.0,29.0,28.0,19.0,23.0,31.0,9.0,15.0,18.0,7.0,28.0,12.0,259.0
Patan,4.2.1,Number of Newborns weighed at birth,TOTAL,1769.0,1960.0,2105.0,2126.0,2345.0,2440.0,2225.0,2563.0,2046.0,2103.0,2022.0,1809.0,25513.0
Patan,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,109.0,122.0,140.0,144.0,165.0,188.0,144.0,153.0,132.0,121.0,108.0,75.0,1601.0
Patan,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1744.0,1906.0,2065.0,2089.0,2306.0,2207.0,2201.0,2518.0,1999.0,2071.0,1983.0,1786.0,24875.0
Patan,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,20.0,15.0,22.0,17.0,24.0,19.0,12.0,13.0,22.0,26.0,20.0,12.0,222.0
Patan,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,36.0,26.0,27.0,40.0,45.0,54.0,45.0,54.0,51.0,42.0,41.0,44.0,505.0
Patan,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patan,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,56.0,41.0,49.0,57.0,69.0,73.0,57.0,67.0,73.0,68.0,61.0,56.0,727.0
Patan,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,151.0,189.0,196.0,247.0,311.0,670.0,796.0,689.0,717.0,284.0,506.0,151.0,4907.0
Patan,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,8.0,9.0,4.0,5.0,14.0,7.0,1.0,15.0,7.0,4.0,5.0,2.0,81.0
Patan,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,193.0,234.0,216.0,283.0,325.0,492.0,583.0,454.0,495.0,464.0,297.0,261.0,4297.0
Patan,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,5.0,14.0,9.0,17.0,9.0,13.0,10.0,22.0,10.0,16.0,11.0,17.0,153.0
Patan,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1922.0,2119.0,2511.0,2097.0,2415.0,2463.0,2232.0,2740.0,2223.0,2270.0,2098.0,1603.0,26693.0
Patan,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2324.0,2441.0,2839.0,2347.0,2605.0,2699.0,2356.0,2738.0,2327.0,2390.0,2167.0,1843.0,29076.0
Patan,6.3,PNC maternal complications attended,TOTAL,2.0,0.0,0.0,0.0,6.0,6.0,0.0,0.0,0.0,0.0,0.0,4.0,18.0
Patan,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2.0,0.0,5.0,4.0,8.0,3.0,7.0,17.0,23.0,20.0,10.0,12.0,111.0
Patan,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,1.0,3.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,8.0
Patan,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2.0,0.0,6.0,7.0,9.0,3.0,7.0,18.0,23.0,20.0,11.0,13.0,119.0
Patan,7.2,Number of MTPs conducted at Private Facilities,TOTAL,2.0,4.0,3.0,0.0,2.0,3.0,2.0,1.0,2.0,0.0,2.0,0.0,21.0
Patan,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,75.0,174.0,157.0,142.0,113.0,146.0,75.0,31.0,82.0,82.0,126.0,123.0,1326.0
Patan,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,286.0,297.0,340.0,326.0,328.0,329.0,237.0,172.0,264.0,208.0,279.0,309.0,3375.0
Patan,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,361.0,471.0,497.0,468.0,441.0,475.0,312.0,203.0,346.0,290.0,405.0,432.0,4701.0
Patan,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Patan,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Patan,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patan,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Patan,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,57.0,20.0,19.0,44.0,49.0,26.0,55.0,360.0,508.0,372.0,183.0,3.0,1696.0
Patan,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,49.0,14.0,43.0,43.0,31.0,43.0,25.0,176.0,422.0,271.0,122.0,45.0,1284.0
Patan,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patan,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,106.0,34.0,62.0,87.0,80.0,69.0,80.0,536.0,930.0,643.0,305.0,48.0,2980.0
Patan,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,84.0,96.0,142.0,109.0,103.0,150.0,163.0,172.0,158.0,252.0,79.0,134.0,1642.0
Patan,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,4.0,1.0,0.0,2.0,1.0,2.0,2.0,8.0,17.0,6.0,4.0,3.0,50.0
Patan,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patan,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,4.0,1.0,0.0,2.0,1.0,2.0,2.0,8.0,17.0,6.0,4.0,3.0,50.0
Patan,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,26.0,52.0,78.0,109.0,95.0,55.0,50.0,70.0,62.0,72.0,17.0,69.0,755.0
Patan,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,2.0,0.0,1.0,9.0
Patan,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,2.0,0.0,3.0,5.0,1.0,1.0,5.0,16.0,23.0,4.0,13.0,73.0
Patan,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patan,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,2.0,0.0,3.0,5.0,1.0,1.0,8.0,19.0,25.0,4.0,14.0,82.0
Patan,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,5.0,4.0,3.0,5.0,5.0,5.0,9.0,1.0,5.0,0.0,0.0,7.0,49.0
Patan,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,826.0,945.0,900.0,972.0,922.0,957.0,944.0,982.0,831.0,798.0,755.0,835.0,10667.0
Patan,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,75.0,100.0,83.0,76.0,99.0,52.0,75.0,60.0,67.0,58.0,54.0,66.0,865.0
Patan,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,46.0,43.0,41.0,48.0,36.0,39.0,46.0,52.0,50.0,50.0,47.0,16.0,514.0
Patan,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,23.0,23.0,29.0,29.0,26.0,60.0,29.0,32.0,40.0,35.0,36.0,33.0,395.0
Patan,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patan,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,970.0,1111.0,1053.0,1125.0,1083.0,1108.0,1094.0,1126.0,988.0,941.0,892.0,950.0,12441.0
Patan,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,3.0,1.0,26.0,27.0,26.0,39.0,20.0,37.0,20.0,40.0,44.0,35.0,318.0
Patan,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,293.0,406.0,467.0,410.0,461.0,686.0,561.0,490.0,500.0,473.0,282.0,409.0,5438.0
Patan,9.06,Number of IUCD removals,TOTAL,489.0,416.0,396.0,399.0,395.0,413.0,475.0,442.0,496.0,445.0,426.0,1069.0,5861.0
Patan,9.07,Number of Oral Pills cycles distributed,TOTAL,2901.0,3363.0,2538.0,3781.0,4364.0,3980.0,4974.0,4523.0,4695.0,4377.0,3878.0,6211.0,49585.0
Patan,9.08,Number of Condom pieces distributed,TOTAL,24423.0,21937.0,12590.0,12447.0,10244.0,8312.0,24016.0,22991.0,20704.0,18614.0,12044.0,28816.0,217138.0
Patan,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,15.0,0.0,15.0,120.0,0.0,15.0,15.0,90.0,270.0
Patan,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,15.0,13.0,5.0,23.0,27.0,25.0,33.0,21.0,13.0,25.0,11.0,88.0,299.0
Patan,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0
Patan,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Patan,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,4.0,3.0,4.0,5.0,6.0,5.0,4.0,3.0,3.0,4.0,4.0,-1.0
Patan,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1954.0,2016.0,2051.0,2104.0,2435.0,2330.0,2183.0,2470.0,2214.0,2268.0,2076.0,2830.0,26931.0
Patan,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2020.0,1865.0,1867.0,1932.0,2102.0,2103.0,2083.0,2322.0,2179.0,2225.0,2136.0,2944.0,25778.0
Patan,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2072.0,1827.0,1850.0,1797.0,2013.0,1958.0,1898.0,2098.0,2149.0,2098.0,2270.0,3140.0,25170.0
Patan,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2061.0,1950.0,1783.0,1757.0,1949.0,1888.0,1783.0,1919.0,2142.0,2202.0,2116.0,3279.0,24829.0
Patan,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1221.0,1384.0,1486.0,1592.0,1955.0,1772.0,1919.0,1963.0,1855.0,1860.0,1630.0,2293.0,20930.0
Patan,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2033.0,1912.0,1884.0,1956.0,2393.0,2134.0,2123.0,2340.0,2191.0,2250.0,2129.0,2879.0,26224.0
Patan,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2080.0,1834.0,1830.0,1824.0,2097.0,1961.0,1924.0,2121.0,2122.0,2106.0,2352.0,3171.0,25422.0
Patan,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2085.0,1989.0,1845.0,1761.0,2091.0,1911.0,1753.0,1921.0,2093.0,2186.0,2162.0,3324.0,25121.0
Patan,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,413.0,487.0,550.0,672.0,845.0,715.0,659.0,789.0,711.0,821.0,835.0,1139.0,8636.0
Patan,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2242.0,2402.0,2436.0,2267.0,2216.0,2073.0,1881.0,1975.0,1798.0,1915.0,2136.0,3400.0,26741.0
Patan,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1818.0,1497.0,1766.0,1655.0,1497.0,1598.0,1502.0,1529.0,1664.0,1778.0,1732.0,2850.0,20886.0
Patan,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1303.0,1349.0,1343.0,1346.0,1222.0,1037.0,1052.0,1040.0,1005.0,986.0,1153.0,1712.0,14548.0
Patan,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1088.0,1181.0,1200.0,1202.0,1114.0,919.0,925.0,943.0,847.0,897.0,1022.0,1462.0,12800.0
Patan,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2391.0,2530.0,2543.0,2548.0,2336.0,1956.0,1977.0,1983.0,1852.0,1883.0,2175.0,3174.0,27348.0
Patan,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3104.0,1679.0,1834.0,1734.0,1653.0,1699.0,1643.0,1635.0,1791.0,1916.0,1885.0,2799.0,23372.0
Patan,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2456.0,2179.0,1876.0,1768.0,1686.0,1690.0,1653.0,1638.0,1802.0,1935.0,1897.0,3000.0,23580.0
Patan,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,822.0,685.0,590.0,600.0,545.0,622.0,540.0,567.0,639.0,669.0,651.0,989.0,7919.0
Patan,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,615.0,594.0,526.0,532.0,507.0,556.0,513.0,488.0,555.0,599.0,575.0,883.0,6943.0
Patan,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1437.0,1279.0,1116.0,1132.0,1052.0,1178.0,1053.0,1055.0,1194.0,1268.0,1226.0,1872.0,14862.0
Patan,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1195.0,1077.0,1785.0,1981.0,3179.0,2896.0,1266.0,1110.0,1327.0,1091.0,1026.0,1213.0,19146.0
Patan,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,539.0,546.0,1601.0,4860.0,5027.0,3820.0,1084.0,778.0,1161.0,803.0,776.0,1520.0,22515.0
Patan,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1669.0,1549.0,2145.0,2913.0,2654.0,2495.0,1342.0,1356.0,1462.0,1224.0,1143.0,1227.0,21179.0
Patan,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,2.0,3.0,3.0,1.0,1.0,3.0,0.0,1.0,1.0,15.0
Patan,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,3.0,0.0,0.0,3.0,0.0,2.0,2.0,2.0,0.0,11.0,24.0
Patan,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1006.0,1018.0,1007.0,1000.0,1043.0,1032.0,1017.0,1011.0,1035.0,953.0,960.0,931.0,12013.0
Patan,10.4.2,Number of Immunisation sessions held during the month,TOTAL,938.0,1001.0,994.0,995.0,1030.0,1016.0,960.0,997.0,1023.0,940.0,933.0,922.0,11749.0
Patan,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,870.0,877.0,891.0,905.0,929.0,932.0,862.0,885.0,914.0,849.0,846.0,830.0,10590.0
Patan,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2045.0,2217.0,1942.0,2035.0,2150.0,1829.0,1647.0,1799.0,1490.0,1502.0,2455.0,1921.0,23032.0
Patan,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,14.0,12.0,18.0,11013.0,230.0,1401.0,35.0,353.0,101.0,11441.0,3766.0,28384.0
Patan,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,11.0,0.0,10657.0,184.0,1484.0,0.0,343.0,16.0,11881.0,3674.0,28250.0
Patan,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,3.0
Patan,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Patan,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5.0,1.0,10.0,5.0,1.0,0.0,5.0,3.0,0.0,0.0,1.0,12.0,43.0
Patan,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2112.0,2082.0,2190.0,2181.0,3452.0,2670.0,2052.0,2109.0,2021.0,1847.0,1876.0,1809.0,26401.0
Patan,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,21.0,20.0,66.0,24.0,38.0,20.0,17.0,28.0,12.0,23.0,10.0,13.0,292.0
Patan,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,10.0,12.0,4.0,6.0,8.0,22.0,14.0,3.0,1.0,0.0,1.0,4.0,85.0
Patan,13.1,Number of Patients operated for cataract,TOTAL,122.0,114.0,109.0,138.0,81.0,138.0,81.0,127.0,168.0,124.0,158.0,86.0,1446.0
Patan,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,120.0,114.0,109.0,136.0,81.0,137.0,81.0,127.0,164.0,124.0,157.0,85.0,1435.0
Patan,13.3,Number of School children detected with Refractive errors,TOTAL,43.0,6.0,48.0,431.0,220.0,60.0,35.0,80.0,451.0,9017.0,1213.0,20.0,11624.0
Patan,13.4,Number of children provided free glasses,TOTAL,43.0,6.0,48.0,431.0,220.0,32.0,25.0,29.0,229.0,426.0,566.0,7.0,2062.0
Patan,13.5,Number of eyes collected through eye donation,TOTAL,6.0,6.0,4.0,0.0,2.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,22.0
Patan,13.6,Number of eyes utilised for corneal transplant,TOTAL,6.0,6.0,4.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0
Patan,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,7.0,9.0,9.0,7.0,7.0,5.0,6.0,7.0,7.0,5.0,-1.0
Patan,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,3.0,3.0,3.0,2.0,2.0,2.0,1.0,3.0,2.0,2.0,3.0,-1.0
Patan,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,737.0,767.0,494.0,513.0,890.0,711.0,687.0,712.0,956.0,570.0,400.0,390.0,-1.0
Patan,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,15.0,15.0,15.0,14.0,13.0,14.0,14.0,12.0,11.0,14.0,13.0,13.0,-1.0
Patan,14.05,Number of RKS meetings held during the month,TOTAL,1.0,4.0,26.0,10.0,8.0,21.0,10.0,8.0,23.0,10.0,11.0,24.0,156.0
Patan,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,23.0,23.0,21.0,21.0,21.0,24.0,22.0,21.0,20.0,21.0,19.0,19.0,-1.0
Patan,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,304.0,384.0,373.0,318.0,286.0,296.0,310.0,303.0,347.0,390.0,292.0,238.0,3841.0
Patan,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,6.0,6.0,6.0,7.0,6.0,6.0,6.0,5.0,4.0,4.0,5.0,3.0,-1.0
Patan,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,12.0,13.0,4.0,13.0,9.0,10.0,11.0,11.0,12.0,12.0,11.0,9.0,-1.0
Patan,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,284.0,346.0,351.0,523.0,485.0,544.0,506.0,364.0,281.0,415.0,490.0,414.0,5003.0
Patan,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1897.0,2298.0,2135.0,2588.0,2928.0,2880.0,2736.0,1957.0,2876.0,2227.0,2458.0,2057.0,29037.0
Patan,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,285.0,347.0,331.0,879.0,487.0,551.0,545.0,430.0,309.0,413.0,417.0,481.0,5475.0
Patan,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2530.0,2970.0,2436.0,2786.0,3503.0,3005.0,2725.0,2692.0,3629.0,2800.0,3117.0,3043.0,35236.0
Patan,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,569.0,693.0,682.0,1402.0,972.0,1095.0,1051.0,794.0,590.0,828.0,907.0,895.0,10478.0
Patan,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4427.0,5268.0,4571.0,5374.0,6431.0,5885.0,5461.0,4649.0,6505.0,5027.0,5575.0,5100.0,64273.0
Patan,14.10.2.a,Number of death cases of Inpatient males,TOTAL,34.0,39.0,35.0,24.0,27.0,46.0,32.0,42.0,37.0,39.0,45.0,41.0,441.0
Patan,14.10.2.b,Number of death cases of Inpatient females,TOTAL,18.0,32.0,22.0,20.0,16.0,22.0,28.0,26.0,23.0,18.0,27.0,24.0,276.0
Patan,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,52.0,71.0,57.0,44.0,43.0,68.0,60.0,68.0,60.0,57.0,72.0,65.0,717.0
Patan,14.11,In-Patient Head Count at midnight,TOTAL,1203.0,1681.0,1340.0,1485.0,1818.0,1587.0,963.0,1023.0,2559.0,2863.0,2681.0,1766.0,20969.0
Patan,14.12.1,OPD attendance (All),TOTAL,77258.0,81206.0,78622.0,95325.0,102893.0,105450.0,88365.0,90880.0,95457.0,90099.0,126557.0,107113.0,1139225.0
Patan,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,282.0,273.0,269.0,339.0,282.0,377.0,270.0,437.0,443.0,363.0,334.0,286.0,3955.0
Patan,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,7.0,6.0,6.0,10.0,6.0,15.0,0.0,14.0,12.0,12.0,5.0,3.0,96.0
Patan,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,677.0,537.0,704.0,742.0,687.0,941.0,911.0,1079.0,1637.0,1332.0,976.0,532.0,10755.0
Patan,14.14.a,Number of patients given AYUSH treatment,TOTAL,922.0,954.0,1106.0,1321.0,1092.0,1839.0,1471.0,1900.0,2211.0,2140.0,5583.0,3634.0,24173.0
Patan,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,963.0,1107.0,1640.0,1249.0,1141.0,1376.0,1352.0,1188.0,778.0,716.0,838.0,687.0,13035.0
Patan,14.14.c,Number of Adolescents counselled,TOTAL,26.0,26.0,46.0,50.0,87.0,90.0,98.0,80.0,105.0,63.0,88.0,107.0,866.0
Patan,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9302.0,9362.0,11464.0,11548.0,9567.0,11398.0,9680.0,11048.0,10845.0,10073.0,11515.0,10655.0,126457.0
Patan,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,372.0,405.0,431.0,453.0,307.0,424.0,330.0,421.0,342.0,486.0,424.0,348.0,4743.0
Patan,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,783.0,982.0,965.0,845.0,982.0,1083.0,959.0,655.0,972.0,803.0,828.0,1001.0,10858.0
Patan,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,25.0,28.0,32.0,19.0,26.0,18.0,11.0,5.0,22.0,11.0,22.0,25.0,244.0
Patan,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,563.0,552.0,629.0,656.0,540.0,749.0,621.0,476.0,791.0,536.0,824.0,795.0,7732.0
Patan,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,32.0,13.0,10.0,13.0,9.0,10.0,3.0,1.0,9.0,8.0,8.0,11.0,127.0
Patan,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1863.0,1964.0,2147.0,2289.0,1642.0,1913.0,1410.0,1576.0,1600.0,1345.0,1371.0,1833.0,20953.0
Patan,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,10.0,8.0,2.0,7.0,2.0,5.0,0.0,0.0,17.0,5.0,3.0,3.0,62.0
Patan,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3209.0,3498.0,3741.0,3790.0,3164.0,3745.0,2990.0,2707.0,3363.0,2684.0,3023.0,3629.0,39543.0
Patan,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,67.0,49.0,44.0,39.0,37.0,33.0,14.0,6.0,48.0,24.0,33.0,39.0,433.0
Patan,15.2,Number of Widal tests conducted,Number tested,494.0,881.0,822.0,1068.0,597.0,788.0,1119.0,1031.0,989.0,725.0,1158.0,1053.0,10725.0
Patan,15.3.a,Number of VDRL tests conducted on males,Number tested,259.0,246.0,160.0,122.0,79.0,126.0,38.0,24.0,91.0,22.0,39.0,80.0,1286.0
Patan,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,206.0,169.0,204.0,174.0,83.0,171.0,111.0,52.0,177.0,45.0,97.0,211.0,1700.0
Patan,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,650.0,704.0,820.0,873.0,398.0,509.0,330.0,449.0,666.0,478.0,453.0,842.0,7172.0
Patan,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1115.0,1119.0,1184.0,1169.0,560.0,806.0,479.0,525.0,934.0,545.0,589.0,1133.0,10158.0
Patan,15.4.1,Number of blood smears examined for Malaria,TOTAL,14595.0,15333.0,12653.0,15138.0,18964.0,23490.0,12832.0,13971.0,11056.0,11643.0,18271.0,17816.0,185762.0
Patan,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,48.0,105.0,89.0,106.0,95.0,209.0,103.0,42.0,24.0,8.0,10.0,23.0,862.0
Patan,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,1.0,0.0,1.0,5.0,9.0,9.0,9.0,5.0,1.0,2.0,0.0,44.0
Patan,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3450.0,2300.0,6230.0,5600.0,9050.0,11900.0,12400.0,9300.0,5750.0,2100.0,2200.0,6750.0,77030.0
Patan,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,7500.0,5000.0,10000.0,10000.0,5000.0,0.0,0.0,0.0,4000.0,7500.0,7500.0,58500.0
Patan,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3150.0,3570.0,5630.0,6550.0,7150.0,4500.0,3100.0,3550.0,3650.0,3900.0,2950.0,4750.0,52450.0
Patan,16.1.1,Stock position of DPT vaccines,5. Total Stock,2300.0,6230.0,5600.0,9050.0,11900.0,12400.0,9300.0,5750.0,2100.0,2200.0,6750.0,9500.0,83080.0
Patan,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,10270.0,10470.0,10870.0,8870.0,11770.0,14220.0,16720.0,10820.0,10020.0,3520.0,8420.0,3370.0,119340.0
Patan,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,6000.0,6000.0,6000.0,9000.0,9000.0,9000.0,0.0,6000.0,0.0,12000.0,0.0,6000.0,69000.0
Patan,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,5800.0,5600.0,8000.0,6100.0,6550.0,6500.0,5900.0,6800.0,6500.0,7100.0,5050.0,7550.0,77450.0
Patan,16.1.1A,Stock Position of Pentavalent,5. Total Stock,10470.0,10870.0,8870.0,11770.0,14220.0,16720.0,10820.0,10020.0,3520.0,8420.0,3370.0,1820.0,110890.0
Patan,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,23800.0,13800.0,11700.0,8140.0,14040.0,8740.0,16040.0,19240.0,15640.0,18540.0,22680.0,31300.0,203660.0
Patan,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,10000.0,10000.0,20000.0,10000.0,20000.0,20000.0,10000.0,18000.0,260000.0,260000.0,0.0,638000.0
Patan,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,10000.0,12100.0,13560.0,14100.0,15300.0,12700.0,16800.0,13600.0,15100.0,255860.0,251380.0,9900.0,640400.0
Patan,16.1.2,Stock position of OPV vaccines,5. Total Stock,13800.0,11700.0,8140.0,14040.0,8740.0,16040.0,19240.0,15640.0,18540.0,22680.0,31300.0,21400.0,201260.0
Patan,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2270.0,8820.0,8220.0,7120.0,4320.0,13520.0,14720.0,8520.0,13620.0,7870.0,12520.0,7590.0,109110.0
Patan,16.1.3,Stock position of TT vaccines,2. Stocks Received,15000.0,7500.0,10000.0,15000.0,25000.0,9500.0,0.0,10000.0,0.0,10000.0,0.0,7500.0,109500.0
Patan,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.3,Stock position of TT vaccines,4. Stock Distributed,8450.0,8100.0,11100.0,17800.0,15800.0,8300.0,6200.0,4900.0,5720.0,5350.0,4930.0,7800.0,104450.0
Patan,16.1.3,Stock position of TT vaccines,5. Total Stock,8820.0,8220.0,7120.0,4320.0,13520.0,14720.0,8520.0,13620.0,7900.0,12520.0,7590.0,7290.0,114160.0
Patan,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4390.0,5440.0,6990.0,7240.0,6690.0,6890.0,9040.0,5190.0,5790.0,1890.0,7990.0,3570.0,71110.0
Patan,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,5000.0,4000.0,4000.0,4000.0,5000.0,0.0,5000.0,0.0,10000.0,0.0,5000.0,47000.0
Patan,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,3950.0,3450.0,3750.0,4550.0,3800.0,2850.0,3850.0,4400.0,3900.0,3900.0,4420.0,3870.0,46690.0
Patan,16.1.5,Stock position of BCG vaccines,5. Total Stock,5440.0,6990.0,7240.0,6690.0,6890.0,9040.0,5190.0,5790.0,1890.0,7990.0,3570.0,4700.0,71420.0
Patan,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,980.0,6205.0,6180.0,6480.0,5730.0,6080.0,6780.0,1630.0,6630.0,2530.0,8180.0,3980.0,61385.0
Patan,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,5000.0,5000.0,5000.0,5000.0,5000.0,0.0,10000.0,0.0,10000.0,0.0,5000.0,60000.0
Patan,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4775.0,5025.0,4700.0,5750.0,4650.0,4300.0,5150.0,5000.0,4100.0,4350.0,4200.0,4025.0,56025.0
Patan,16.1.6,Stock position of Measles vaccines,5. Total Stock,6205.0,6180.0,6480.0,5730.0,6080.0,6780.0,1630.0,6630.0,2530.0,8180.0,3980.0,4955.0,65360.0
Patan,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,6220.0,5620.0,5270.0,4920.0,4130.0,3750.0,3450.0,2730.0,2090.0,1180.0,3610.0,3100.0,46070.0
Patan,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,3000.0
Patan,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,600.0,350.0,350.0,790.0,380.0,300.0,720.0,640.0,910.0,570.0,510.0,370.0,6490.0
Patan,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5620.0,5270.0,4920.0,4130.0,3750.0,3450.0,2730.0,2090.0,1180.0,3610.0,3100.0,2730.0,42580.0
Patan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,50.0,9650.0,200.0,6800.0,1500.0,1500.0,800.0,800.0,800.0,600.0,450.0,50.0,23200.0
Patan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,9600.0,0.0,6600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16200.0
Patan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,9450.0,0.0,5300.0,0.0,700.0,0.0,0.0,200.0,150.0,400.0,50.0,16250.0
Patan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,9650.0,200.0,6800.0,1500.0,1500.0,800.0,800.0,800.0,600.0,450.0,50.0,0.0,23150.0
Patan,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,10712.0,10712.0,0.0,0.0,0.0,0.0,252000.0,17010.0,17010.0,17010.0,17010.0,0.0,341464.0
Patan,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,252000.0,0.0,0.0,0.0,0.0,0.0,186480.0,438480.0
Patan,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,10712.0,0.0,0.0,0.0,0.0,234990.0,0.0,0.0,0.0,17010.0,186480.0,449192.0
Patan,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,10712.0,0.0,0.0,0.0,0.0,252000.0,17010.0,17010.0,17010.0,17010.0,0.0,0.0,330752.0
Patan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,500.0,500.0,0.0,54000.0,7770.0,7770.0,33930.0,3520.0,616.0,616.0,616.0,0.0,109838.0
Patan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,54000.0,0.0,0.0,30000.0,0.0,0.0,0.0,0.0,0.0,0.0,84000.0
Patan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,500.0,0.0,46230.0,0.0,3840.0,30410.0,2904.0,0.0,0.0,616.0,0.0,84500.0
Patan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,500.0,0.0,54000.0,7770.0,7770.0,33930.0,3520.0,616.0,616.0,616.0,0.0,0.0,109338.0
Patan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,4000.0,2100.0,2100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8200.0
Patan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0
Patan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,1900.0,0.0,2100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0
Patan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,4000.0,2100.0,2100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8200.0
Patan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4300.0,4300.0,1800.0,1800.0,1800.0,1800.0,1800.0,600.0,0.0,4465.0,4265.0,2265.0,29195.0
Patan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4465.0,0.0,0.0,0.0,4465.0
Patan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,2500.0,0.0,0.0,0.0,0.0,1200.0,600.0,0.0,200.0,2000.0,665.0,7165.0
Patan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4300.0,1800.0,1800.0,1800.0,1800.0,1800.0,600.0,0.0,4465.0,4265.0,2265.0,1600.0,26495.0
Patan,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,1250.0,1250.0,1250.0,1250.0,1250.0,1250.0,2500.0,600.0,0.0,0.0,0.0,0.0,10600.0
Patan,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,1250.0,0.0,0.0,0.0,0.0,0.0,0.0,1250.0
Patan,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,1900.0,600.0,0.0,0.0,0.0,0.0,2500.0
Patan,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,1250.0,1250.0,1250.0,1250.0,1250.0,2500.0,600.0,0.0,0.0,0.0,0.0,0.0,9350.0
Patan,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,5.0,5.0,109.0,96.0,96.0,96.0,43.0,34.0,34.0,29.0,21.0,568.0
Patan,16.3.02,Stock Position of Gloves,2. Stocks Received,26.0,0.0,104.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,130.0
Patan,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.02,Stock Position of Gloves,4. Stock Distributed,21.0,0.0,0.0,13.0,0.0,0.0,53.0,9.0,0.0,5.0,8.0,21.0,130.0
Patan,16.3.02,Stock Position of Gloves,5. Total Stock,5.0,5.0,109.0,96.0,96.0,96.0,43.0,34.0,34.0,29.0,21.0,0.0,568.0
Patan,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,23.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0
Patan,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,25.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0
Patan,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,2.0,23.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0
Patan,16.3.03,Stock Position of MVA Syringes,5. Total Stock,23.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0
Patan,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,3000.0,200.0,200.0,0.0,0.0,30000.0,31500.0,31100.0,29000.0,29000.0,0.0,154000.0
Patan,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,3000.0,0.0,0.0,0.0,0.0,30000.0,6000.0,0.0,0.0,0.0,0.0,0.0,39000.0
Patan,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,2800.0,0.0,200.0,0.0,0.0,4500.0,400.0,2100.0,0.0,29000.0,0.0,39000.0
Patan,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,3000.0,200.0,200.0,0.0,0.0,30000.0,31500.0,31100.0,29000.0,29000.0,0.0,0.0,154000.0
Patan,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,5.0,2.0,27.0,27.0,27.0,27.0,8.0,0.0,0.0,0.0,0.0,123.0
Patan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,5.0,0.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0
Patan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,3.0,0.0,0.0,0.0,0.0,19.0,8.0,0.0,0.0,0.0,0.0,30.0
Patan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,5.0,2.0,27.0,27.0,27.0,27.0,8.0,0.0,0.0,0.0,0.0,0.0,123.0
Patan,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,600000.0,600000.0,600000.0,600000.0,600000.0,1560000.0,2820000.0,364500.0,244500.0,244500.0,244500.0,3083000.0,11561000.0
Patan,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,960000.0,1260000.0,0.0,0.0,0.0,0.0,3020000.0,0.0,5240000.0
Patan,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,2455500.0,120000.0,0.0,0.0,181500.0,3072500.0,5829500.0
Patan,16.3.07,Stock Position of IFA Tablets,5. Total Stock,600000.0,600000.0,600000.0,600000.0,1560000.0,2820000.0,364500.0,244500.0,244500.0,244500.0,3083000.0,10500.0,10971500.0
Patan,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,8500.0,8500.0,400.0,0.0,0.0,9500.0,38000.0,64900.0
Patan,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,8500.0,0.0,0.0,0.0,0.0,9500.0,37100.0,0.0,55100.0
Patan,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,8100.0,400.0,0.0,0.0,8600.0,36500.0,53600.0
Patan,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,8500.0,8500.0,400.0,0.0,0.0,9500.0,38000.0,1500.0,66400.0
Patan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,600.0,600.0,6400.0,16200.0,16200.0,6500.0,46500.0
Patan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,6000.0,10000.0,0.0,0.0,0.0,22000.0
Patan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,5400.0,0.0,200.0,200.0,0.0,9700.0,6500.0,22000.0
Patan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,600.0,600.0,6400.0,16200.0,16200.0,6500.0,0.0,46500.0
Patan,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,46.0,46.0,5.0,5.0,0.0,0.0,0.0,0.0,575.0,0.0,0.0,0.0,677.0
Patan,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2900.0,0.0,0.0,0.0,0.0,2900.0
Patan,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,41.0,0.0,5.0,0.0,0.0,0.0,2325.0,575.0,0.0,0.0,0.0,2946.0
Patan,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,46.0,5.0,5.0,0.0,0.0,0.0,0.0,575.0,0.0,0.0,0.0,0.0,631.0
Patan,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,10000.0,10000.0,0.0,0.0,60000.0,53500.0,97500.0,29500.0,27500.0,27500.0,27500.0,0.0,343000.0
Patan,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,60000.0,0.0,45000.0,0.0,0.0,0.0,0.0,0.0,0.0,105000.0
Patan,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,10000.0,0.0,0.0,6500.0,1000.0,68000.0,2000.0,0.0,0.0,27500.0,0.0,115000.0
Patan,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,10000.0,0.0,0.0,60000.0,53500.0,97500.0,29500.0,27500.0,27500.0,27500.0,0.0,0.0,333000.0
Patan,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3100.0,7400.0,1500.0,13500.0,8400.0,7800.0,2100.0,1300.0,1300.0,4600.0,4600.0,4600.0,60200.0
Patan,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6600.0,0.0,13200.0,0.0,0.0,0.0,0.0,0.0,6600.0,0.0,0.0,0.0,26400.0
Patan,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2300.0,5900.0,1200.0,5100.0,600.0,5700.0,800.0,0.0,3300.0,0.0,0.0,4000.0,28900.0
Patan,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,7400.0,1500.0,13500.0,8400.0,7800.0,2100.0,1300.0,1300.0,4600.0,4600.0,4600.0,600.0,57700.0
Patan,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,114692.0,244892.0,90892.0,90892.0,58000.0,58000.0,58000.0,47000.0,6000.0,6000.0,6000.0,6000.0,786368.0
Patan,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,168000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,168000.0
Patan,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,37800.0,154000.0,0.0,32892.0,58000.0,0.0,11000.0,41000.0,0.0,0.0,0.0,0.0,334692.0
Patan,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,244892.0,90892.0,90892.0,58000.0,0.0,58000.0,47000.0,6000.0,6000.0,6000.0,6000.0,6000.0,619676.0
Patan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,10000.0,10000.0,200.0,20200.0,12800.0,12800.0,12800.0,12500.0,4300.0,4300.0,4300.0,4300.0,108500.0
Patan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0
Patan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,9800.0,0.0,7400.0,12800.0,0.0,300.0,8200.0,0.0,0.0,0.0,2300.0,40800.0
Patan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,10000.0,200.0,20200.0,12800.0,0.0,12800.0,12500.0,4300.0,4300.0,4300.0,4300.0,2000.0,87700.0
Patan,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,,,,1.0,1.0,,,,,,1.0,6.0
Patan,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,1.0,,,,1.0
Patan,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Patan,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,1.0,,,,1.0
Patan,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,2.0,3.0,3.0,1.0,1.0,1.0,,,1.0,1.0,,14.0
Patan,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Patan,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,2.0,3.0,3.0,1.0,1.0,1.0,,,1.0,1.0,,14.0
Patan,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,5.0,9.0,6.0,5.0,7.0,4.0,3.0,5.0,4.0,3.0,1.0,3.0,55.0
Patan,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,2.0,2.0,1.0,1.0,,,1.0,1.0,1.0,,10.0
Patan,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,6.0,9.0,8.0,7.0,8.0,5.0,3.0,5.0,5.0,4.0,2.0,3.0,65.0
Patan,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,12.0,15.0,4.0,11.0,7.0,6.0,10.0,9.0,5.0,7.0,2.0,90.0
Patan,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,3.0,1.0,,3.0,,1.0,1.0,1.0,2.0,,13.0
Patan,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,13.0,18.0,5.0,11.0,10.0,6.0,11.0,10.0,6.0,9.0,2.0,103.0
Patan,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,1.0,2.0,,,,1.0,,,,1.0,1.0,7.0
Patan,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Patan,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,1.0,2.0,,,,1.0,,,,1.0,1.0,7.0
Patan,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,1.0,,1.0
Patan,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Patan,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,1.0,,1.0
Patan,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,1.0,,,,,,,,,,2.0
Patan,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Patan,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,1.0,,,,,,,,,,2.0
Patan,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Patan,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Patan,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Patan,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,,,1.0,1.0,6.0,3.0,2.0,2.0,1.0,4.0,2.0,24.0
Patan,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,2.0,1.0,2.0,2.0,,1.0,,,,1.0,2.0,13.0
Patan,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,2.0,1.0,3.0,3.0,6.0,4.0,2.0,2.0,1.0,5.0,4.0,37.0
Patan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Patan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Patan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,1.0,,,1.0
Patan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,2.0,,,,,,,4.0,6.0
Patan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,1.0,,,,,1.0,1.0,,3.0
Patan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,3.0,,,,,1.0,1.0,4.0,9.0
Patan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,7.0,,1.0,,,,1.0,,9.0
Patan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,1.0,1.0,,,,1.0,,2.0,2.0,8.0
Patan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,,,1.0,8.0,,1.0,,1.0,,3.0,2.0,17.0
Patan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Patan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Patan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Patan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,1.0,,,,1.0,,,,,2.0
Patan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Patan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,3.0,,2.0,,1.0,,,,6.0
Patan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,,,3.0,,2.0,,1.0,,,,7.0
Patan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,1.0,,,,,,,,2.0
Patan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Patan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,1.0,,,,,,,,2.0
Patan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,6.0,1.0,,,,,,1.0,8.0
Patan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,2.0,,2.0,2.0,1.0,,,2.0,,2.0,12.0
Patan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,1.0,2.0,,8.0,3.0,1.0,,,2.0,,3.0,20.0
Patan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,1.0,,,,,,1.0,2.0
Patan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Patan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,1.0,,1.0,,,,1.0,3.0
Patan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Patan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Patan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Patan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Patan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Patan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Patan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Patan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Patan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Patan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,1.0,1.0,,1.0,,,,,3.0
Patan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Patan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,1.0,1.0,,1.0,,,,,3.0
Patan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Patan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Patan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Patan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,2.0,,3.0,1.0,5.0,,2.0,,1.0,,15.0
Patan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Patan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,2.0,,3.0,1.0,5.0,,2.0,,1.0,,15.0
Patan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,4.0,2.0,,5.0,,,3.0,1.0,,1.0,2.0,18.0
Patan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,1.0,,,,,,1.0,,2.0
Patan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,4.0,2.0,,6.0,,,3.0,1.0,,2.0,2.0,20.0
Patan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,1.0,,,,,1.0,,2.0
Patan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Patan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,1.0,,,,,1.0,,2.0
Patan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Patan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Patan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,1.0,,,,,,,,1.0
Patan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Patan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Patan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,1.0,,,,,,,,1.0
Patan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,2.0,,,,,1.0,,,3.0
Patan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,1.0,1.0,1.0,,3.0
Patan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,2.0,,,,1.0,2.0,1.0,,6.0
Patan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Patan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,,1.0,,2.0,,,3.0,,3.0,6.0,1.0,17.0
Patan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,4.0,,,5.0,,4.0,6.0,4.0,5.0,9.0,3.0,41.0
Patan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,2.0,4.0,1.0,,7.0,,4.0,9.0,4.0,8.0,15.0,4.0,58.0
Porbandar,1.1,Total number of pregnant women Registered for ANC,TOTAL,1171.0,1244.0,1220.0,1158.0,1044.0,1218.0,1205.0,1038.0,1047.0,1052.0,1193.0,1062.0,13652.0
Porbandar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1018.0,1110.0,1034.0,974.0,875.0,1013.0,1066.0,959.0,870.0,892.0,999.0,874.0,11684.0
Porbandar,1.2,Number of Pregnant women registered under JSY,TOTAL,193.0,184.0,175.0,170.0,166.0,125.0,113.0,117.0,92.0,155.0,194.0,195.0,1879.0
Porbandar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1131.0,1072.0,1039.0,1065.0,1009.0,1127.0,1053.0,1115.0,1010.0,982.0,1300.0,1104.0,13007.0
Porbandar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1006.0,902.0,909.0,806.0,805.0,843.0,897.0,913.0,763.0,748.0,979.0,1039.0,10610.0
Porbandar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,994.0,1065.0,1070.0,1070.0,940.0,1000.0,1074.0,948.0,915.0,848.0,1135.0,1216.0,12275.0
Porbandar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1056.0,1090.0,1079.0,1017.0,1028.0,1041.0,1041.0,1087.0,1025.0,871.0,1137.0,1244.0,12716.0
Porbandar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,4.0,11.0,19.0,15.0,6.0,13.0,3.0,7.0,10.0,9.0,14.0,13.0,124.0
Porbandar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Porbandar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,291.0,398.0,426.0,375.0,363.0,604.0,478.0,420.0,468.0,391.0,434.0,555.0,5203.0
Porbandar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,3.0,21.0,11.0,11.0,10.0,12.0,5.0,10.0,15.0,3.0,10.0,8.0,119.0
Porbandar,1.8,Number of pregnancy test kits used at SC level,TOTAL,77.0,0.0,0.0,112.0,32.0,90.0,182.0,95.0,58.0,75.0,78.0,61.0,860.0
Porbandar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,1.0,1.0,3.0,1.0,0.0,0.0,3.0,0.0,0.0,1.0,1.0,13.0
Porbandar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,1.0,7.0
Porbandar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,3.0,1.0,1.0,3.0,2.0,1.0,1.0,3.0,2.0,0.0,1.0,2.0,20.0
Porbandar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,3.0,1.0,1.0,2.0,1.0,1.0,1.0,2.0,1.0,0.0,1.0,2.0,16.0
Porbandar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,336.0,376.0,300.0,341.0,367.0,414.0,402.0,405.0,401.0,357.0,329.0,326.0,4354.0
Porbandar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,276.0,328.0,253.0,289.0,311.0,357.0,346.0,327.0,337.0,314.0,268.0,269.0,3675.0
Porbandar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,6.0,0.0,0.0,1.0,0.0,1.0,4.0,14.0,10.0,13.0,49.0
Porbandar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,8.0
Porbandar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,379.0,403.0,432.0,464.0,462.0,441.0,426.0,464.0,469.0,445.0,509.0,375.0,5269.0
Porbandar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,37.0,27.0,33.0,38.0,35.0,38.0,36.0,37.0,28.0,33.0,27.0,33.0,402.0
Porbandar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Porbandar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,37.0,27.0,33.0,38.0,35.0,38.0,36.0,37.0,28.0,33.0,27.0,33.0,402.0
Porbandar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,57.0,26.0,44.0,76.0,116.0,87.0,84.0,109.0,114.0,151.0,135.0,73.0,1072.0
Porbandar,4.1.1.a,Number of male live births,TOTAL,386.0,420.0,366.0,452.0,427.0,449.0,434.0,472.0,454.0,392.0,420.0,362.0,5034.0
Porbandar,4.1.1.b,Number of female live births,TOTAL,329.0,362.0,364.0,354.0,403.0,405.0,394.0,393.0,415.0,410.0,415.0,341.0,4585.0
Porbandar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,715.0,782.0,730.0,806.0,830.0,854.0,828.0,865.0,869.0,802.0,835.0,703.0,9619.0
Porbandar,4.1.2,Number of still births,TOTAL,5.0,3.0,8.0,5.0,3.0,5.0,5.0,6.0,6.0,1.0,3.0,3.0,53.0
Porbandar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,36.0,39.0,30.0,29.0,28.0,27.0,24.0,36.0,18.0,17.0,26.0,35.0,345.0
Porbandar,4.2.1,Number of Newborns weighed at birth,TOTAL,617.0,679.0,646.0,695.0,754.0,758.0,733.0,759.0,745.0,688.0,751.0,593.0,8418.0
Porbandar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,43.0,60.0,49.0,65.0,71.0,98.0,84.0,89.0,55.0,39.0,58.0,47.0,758.0
Porbandar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,587.0,666.0,614.0,651.0,711.0,710.0,702.0,735.0,725.0,702.0,709.0,563.0,8075.0
Porbandar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,3.0
Porbandar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,5.0,7.0,4.0,5.0,3.0,0.0,0.0,0.0,0.0,0.0,24.0
Porbandar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,47.0,32.0,34.0,43.0,39.0,45.0,0.0,0.0,0.0,0.0,0.0,0.0,240.0
Porbandar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Porbandar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,47.0,32.0,39.0,50.0,43.0,50.0,6.0,0.0,0.0,0.0,0.0,0.0,267.0
Porbandar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,12.0,10.0,10.0,7.0,14.0,15.0,17.0,15.0,20.0,22.0,16.0,18.0,176.0
Porbandar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,6.0
Porbandar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,24.0,12.0,30.0,30.0,34.0,72.0,72.0,38.0,57.0,69.0,26.0,20.0,484.0
Porbandar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,761.0,782.0,721.0,831.0,904.0,911.0,1069.0,1038.0,926.0,885.0,1138.0,936.0,10902.0
Porbandar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,887.0,1005.0,893.0,1018.0,1022.0,1044.0,1073.0,1056.0,971.0,929.0,1225.0,1099.0,12222.0
Porbandar,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Porbandar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2.0,4.0,2.0,3.0,3.0,3.0,2.0,2.0,1.0,0.0,1.0,1.0,24.0
Porbandar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2.0,4.0,2.0,3.0,3.0,3.0,2.0,2.0,1.0,0.0,1.0,1.0,24.0
Porbandar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,41.0,31.0,18.0,36.0,39.0,39.0,44.0,49.0,36.0,43.0,46.0,50.0,472.0
Porbandar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,94.0,90.0,82.0,82.0,96.0,100.0,88.0,73.0,102.0,69.0,70.0,83.0,1029.0
Porbandar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,135.0,121.0,100.0,118.0,135.0,139.0,132.0,122.0,138.0,112.0,116.0,133.0,1501.0
Porbandar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,5.0
Porbandar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Porbandar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,5.0
Porbandar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,63.0,90.0,59.0,87.0,28.0,68.0,66.0,131.0,226.0,184.0,85.0,44.0,1131.0
Porbandar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Porbandar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,63.0,90.0,59.0,87.0,28.0,68.0,66.0,131.0,226.0,184.0,85.0,44.0,1131.0
Porbandar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,162.0,0.0,0.0,104.0,266.0
Porbandar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,1.0,2.0,1.0,3.0,6.0,0.0,1.0,0.0,0.0,0.0,0.0,14.0
Porbandar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Porbandar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,1.0,2.0,1.0,3.0,6.0,0.0,1.0,0.0,0.0,0.0,0.0,14.0
Porbandar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,7.0,0.0,0.0,9.0
Porbandar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Porbandar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,7.0,0.0,0.0,9.0
Porbandar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,213.0,291.0,299.0,393.0,300.0,303.0,281.0,269.0,274.0,329.0,156.0,97.0,3205.0
Porbandar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,31.0,8.0,12.0,13.0,31.0,14.0,37.0,14.0,2.0,0.0,26.0,17.0,205.0
Porbandar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,6.0,6.0,8.0,10.0,5.0,9.0,7.0,8.0,12.0,10.0,10.0,7.0,98.0
Porbandar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,8.0,14.0,25.0,14.0,9.0,10.0,9.0,15.0,6.0,10.0,13.0,9.0,142.0
Porbandar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Porbandar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,258.0,319.0,344.0,430.0,345.0,336.0,334.0,306.0,294.0,349.0,205.0,130.0,3650.0
Porbandar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,2.0,0.0,3.0,0.0,0.0,0.0,2.0,4.0,2.0,1.0,0.0,3.0,17.0
Porbandar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.06,Number of IUCD removals,TOTAL,60.0,64.0,55.0,71.0,59.0,47.0,41.0,75.0,63.0,37.0,35.0,44.0,651.0
Porbandar,9.07,Number of Oral Pills cycles distributed,TOTAL,1616.0,1193.0,986.0,1574.0,1574.0,1441.0,1490.0,1479.0,1380.0,1338.0,1898.0,1970.0,17939.0
Porbandar,9.08,Number of Condom pieces distributed,TOTAL,12403.0,9901.0,7813.0,15930.0,19155.0,7998.0,8914.0,10466.0,10862.0,21179.0,29509.0,24064.0,178194.0
Porbandar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,5.0,20.0,2.0,0.0,0.0,0.0,18.0,0.0,9.0,0.0,31.0,85.0
Porbandar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,4.0,9.0,6.0,12.0,21.0,8.0,7.0,101.0,3.0,3.0,3.0,1.0,178.0
Porbandar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,13.0,1.0,17.0
Porbandar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,5.0
Porbandar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,4.0,5.0,4.0,5.0,5.0,5.0,5.0,5.0,8.0,7.0,7.0,-1.0
Porbandar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,854.0,856.0,799.0,837.0,907.0,984.0,1094.0,1011.0,938.0,845.0,820.0,931.0,10876.0
Porbandar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,256.0,238.0,263.0,248.0,260.0,263.0,316.0,249.0,294.0,272.0,267.0,268.0,3194.0
Porbandar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,240.0,232.0,257.0,241.0,255.0,258.0,305.0,239.0,281.0,256.0,257.0,260.0,3081.0
Porbandar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,268.0,230.0,246.0,234.0,236.0,267.0,295.0,227.0,283.0,241.0,253.0,254.0,3034.0
Porbandar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1197.0,1055.0,1084.0,1084.0,1042.0,988.0,1005.0,1157.0,897.0,929.0,1102.0,1099.0,12639.0
Porbandar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1181.0,1068.0,1073.0,1014.0,1051.0,970.0,988.0,1036.0,903.0,641.0,1077.0,1087.0,12089.0
Porbandar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1211.0,1060.0,1116.0,989.0,981.0,1029.0,1004.0,1084.0,804.0,845.0,1036.0,1026.0,12185.0
Porbandar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,909.0,885.0,802.0,852.0,920.0,973.0,1054.0,982.0,1024.0,979.0,1034.0,954.0,11368.0
Porbandar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1173.0,1058.0,1085.0,1085.0,1039.0,969.0,1051.0,1167.0,931.0,929.0,1116.0,1123.0,12726.0
Porbandar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1157.0,1062.0,1075.0,1014.0,1051.0,951.0,1022.0,1036.0,936.0,859.0,1091.0,1111.0,12365.0
Porbandar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1189.0,1061.0,1117.0,988.0,980.0,1011.0,1044.0,1036.0,851.0,845.0,1052.0,1064.0,12238.0
Porbandar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,571.0,579.0,547.0,550.0,583.0,631.0,638.0,609.0,746.0,692.0,729.0,588.0,7463.0
Porbandar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,0.0,1.0,0.0,1.0,19.0
Porbandar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,16.0
Porbandar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0,0.0,10.0,0.0,0.0,28.0
Porbandar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1142.0,1037.0,1082.0,999.0,1034.0,1116.0,1111.0,1094.0,817.0,838.0,1007.0,1045.0,12322.0
Porbandar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,994.0,897.0,1040.0,1032.0,894.0,846.0,852.0,1013.0,907.0,824.0,1010.0,1070.0,11379.0
Porbandar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,532.0,481.0,521.0,469.0,485.0,570.0,558.0,553.0,435.0,427.0,480.0,500.0,6011.0
Porbandar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,477.0,453.0,468.0,431.0,440.0,520.0,498.0,485.0,381.0,407.0,454.0,446.0,5460.0
Porbandar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1009.0,934.0,989.0,900.0,925.0,1090.0,1056.0,1038.0,816.0,834.0,934.0,946.0,11471.0
Porbandar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1097.0,943.0,1045.0,1053.0,917.0,916.0,941.0,1002.0,896.0,822.0,1024.0,1100.0,11756.0
Porbandar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1089.0,940.0,1046.0,1045.0,900.0,916.0,941.0,997.0,896.0,820.0,1024.0,1100.0,11714.0
Porbandar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,26.0,25.0,17.0,27.0,25.0,13.0,12.0,39.0,15.0,6.0,2.0,6.0,213.0
Porbandar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,24.0,25.0,14.0,28.0,23.0,10.0,6.0,40.0,20.0,9.0,2.0,3.0,204.0
Porbandar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,50.0,50.0,31.0,55.0,48.0,23.0,18.0,79.0,35.0,15.0,4.0,9.0,417.0
Porbandar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,318.0,243.0,250.0,924.0,4132.0,1153.0,520.0,585.0,311.0,144.0,324.0,312.0,9216.0
Porbandar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,519.0,443.0,423.0,1340.0,4828.0,1447.0,784.0,831.0,499.0,292.0,506.0,481.0,12393.0
Porbandar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,487.0,431.0,432.0,901.0,4661.0,1092.0,849.0,1263.0,440.0,393.0,522.0,480.0,11951.0
Porbandar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,2.0,0.0,1.0,0.0,1.0,1.0,2.0,0.0,1.0,0.0,2.0,13.0
Porbandar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,9.0,5.0,6.0,6.0,7.0,3.0,4.0,6.0,2.0,1.0,1.0,54.0
Porbandar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,534.0,529.0,499.0,516.0,520.0,493.0,518.0,524.0,489.0,469.0,576.0,551.0,6218.0
Porbandar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,533.0,528.0,499.0,516.0,518.0,492.0,518.0,514.0,488.0,463.0,573.0,550.0,6192.0
Porbandar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,384.0,381.0,350.0,358.0,399.0,376.0,412.0,407.0,380.0,354.0,469.0,438.0,4708.0
Porbandar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,808.0,733.0,756.0,676.0,768.0,848.0,832.0,1010.0,791.0,836.0,1002.0,1076.0,10136.0
Porbandar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2612.0,109.0,32.0,0.0,7.0,1.0,8861.0,5916.0,3.0,0.0,10.0,8813.0,26364.0
Porbandar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,12746.0,116.0,10.0,4.0,24.0,18.0,6662.0,2072.0,4.0,1.0,1.0,18134.0,39792.0
Porbandar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,3.0
Porbandar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,4.0,6.0,16.0
Porbandar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,921.0,906.0,911.0,835.0,1013.0,918.0,777.0,797.0,627.0,669.0,705.0,854.0,9933.0
Porbandar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,11.0,18.0,23.0,20.0,9.0,16.0,0.0,11.0,8.0,2.0,0.0,0.0,118.0
Porbandar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,1.0,14.0,26.0,3.0,12.0,90.0,19.0,0.0,12.0,4.0,0.0,4.0,185.0
Porbandar,13.1,Number of Patients operated for cataract,TOTAL,624.0,1210.0,1842.0,680.0,539.0,688.0,548.0,725.0,748.0,761.0,668.0,682.0,9715.0
Porbandar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,624.0,1210.0,1842.0,680.0,539.0,688.0,548.0,725.0,748.0,760.0,668.0,682.0,9714.0
Porbandar,13.3,Number of School children detected with Refractive errors,TOTAL,130.0,181.0,433.0,311.0,206.0,303.0,173.0,538.0,556.0,343.0,86.0,80.0,3340.0
Porbandar,13.4,Number of children provided free glasses,TOTAL,130.0,208.0,293.0,325.0,282.0,217.0,252.0,323.0,533.0,388.0,217.0,46.0,3214.0
Porbandar,13.5,Number of eyes collected through eye donation,TOTAL,46.0,114.0,178.0,62.0,64.0,74.0,56.0,72.0,60.0,58.0,40.0,18.0,842.0
Porbandar,13.6,Number of eyes utilised for corneal transplant,TOTAL,46.0,114.0,178.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,338.0
Porbandar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,2.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Porbandar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,7.0,6.0,4.0,5.0,3.0,4.0,4.0,5.0,4.0,3.0,2.0,5.0,-1.0
Porbandar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,190.0,213.0,206.0,209.0,209.0,204.0,205.0,170.0,201.0,202.0,194.0,178.0,-1.0
Porbandar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,6.0,6.0,6.0,6.0,5.0,6.0,6.0,6.0,-1.0
Porbandar,14.05,Number of RKS meetings held during the month,TOTAL,1.0,3.0,2.0,3.0,1.0,4.0,2.0,1.0,8.0,2.0,2.0,2.0,31.0
Porbandar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,16.0,15.0,14.0,14.0,15.0,15.0,16.0,15.0,15.0,15.0,15.0,15.0,-1.0
Porbandar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,89.0,90.0,58.0,53.0,95.0,84.0,66.0,88.0,87.0,100.0,109.0,91.0,1010.0
Porbandar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,4.0,4.0,4.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Porbandar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Porbandar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,288.0,192.0,184.0,180.0,191.0,202.0,195.0,157.0,173.0,170.0,167.0,174.0,2273.0
Porbandar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,527.0,584.0,575.0,626.0,700.0,719.0,757.0,601.0,664.0,658.0,688.0,870.0,7969.0
Porbandar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,115.0,129.0,175.0,178.0,150.0,190.0,161.0,170.0,161.0,152.0,195.0,169.0,1945.0
Porbandar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,943.0,1188.0,1006.0,1018.0,1066.0,1250.0,1251.0,1298.0,1300.0,1253.0,1119.0,1143.0,13835.0
Porbandar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,403.0,321.0,359.0,358.0,341.0,392.0,356.0,327.0,334.0,322.0,362.0,343.0,4218.0
Porbandar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1470.0,1772.0,1581.0,1644.0,1766.0,1969.0,2008.0,1899.0,1964.0,1911.0,1807.0,2013.0,21804.0
Porbandar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,15.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Porbandar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Porbandar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,21.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0
Porbandar,14.11,In-Patient Head Count at midnight,TOTAL,13.0,5.0,15.0,92.0,87.0,99.0,60.0,80.0,42.0,72.0,90.0,91.0,746.0
Porbandar,14.12.1,OPD attendance (All),TOTAL,41966.0,45419.0,44348.0,46551.0,44321.0,50273.0,44729.0,46792.0,48796.0,43314.0,49184.0,51001.0,556694.0
Porbandar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,173.0,46.0,86.0,83.0,56.0,35.0,44.0,97.0,83.0,51.0,198.0,182.0,1134.0
Porbandar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,229.0,273.0,286.0,385.0,130.0,255.0,284.0,423.0,329.0,394.0,244.0,224.0,3456.0
Porbandar,14.14.a,Number of patients given AYUSH treatment,TOTAL,1683.0,1957.0,2225.0,2078.0,1558.0,1620.0,1556.0,2944.0,1823.0,1823.0,2911.0,2180.0,24358.0
Porbandar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4633.0,4928.0,4776.0,6544.0,5297.0,6178.0,5042.0,5511.0,5297.0,4517.0,5596.0,6006.0,64325.0
Porbandar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,78.0,123.0,114.0,97.0,145.0,88.0,146.0,87.0,80.0,58.0,38.0,84.0,1138.0
Porbandar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,805.0,689.0,592.0,759.0,610.0,673.0,568.0,686.0,652.0,578.0,707.0,730.0,8049.0
Porbandar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,5.0,3.0,2.0,3.0,6.0,6.0,5.0,3.0,3.0,5.0,4.0,47.0
Porbandar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,406.0,488.0,478.0,535.0,409.0,458.0,311.0,513.0,684.0,341.0,371.0,491.0,5485.0
Porbandar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,19.0,13.0,10.0,1.0,3.0,4.0,3.0,0.0,1.0,14.0,0.0,71.0
Porbandar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,801.0,756.0,766.0,690.0,560.0,766.0,671.0,680.0,617.0,627.0,573.0,604.0,8111.0
Porbandar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,10.0,11.0,16.0,15.0,0.0,0.0,9.0,0.0,38.0,0.0,0.0,0.0,99.0
Porbandar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2012.0,1933.0,1836.0,1984.0,1579.0,1897.0,1550.0,1879.0,1953.0,1546.0,1651.0,1825.0,21645.0
Porbandar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,15.0,35.0,32.0,27.0,4.0,9.0,19.0,8.0,41.0,4.0,19.0,4.0,217.0
Porbandar,15.2,Number of Widal tests conducted,Number tested,121.0,250.0,212.0,195.0,213.0,179.0,136.0,259.0,229.0,241.0,396.0,199.0,2630.0
Porbandar,15.3.a,Number of VDRL tests conducted on males,Number tested,35.0,28.0,15.0,25.0,38.0,48.0,43.0,44.0,36.0,35.0,41.0,43.0,431.0
Porbandar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,57.0,39.0,42.0,43.0,38.0,54.0,40.0,35.0,60.0,29.0,27.0,39.0,503.0
Porbandar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,323.0,438.0,376.0,368.0,264.0,492.0,314.0,312.0,338.0,260.0,291.0,315.0,4091.0
Porbandar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,415.0,505.0,433.0,436.0,340.0,594.0,397.0,391.0,434.0,324.0,359.0,397.0,5025.0
Porbandar,15.4.1,Number of blood smears examined for Malaria,TOTAL,5030.0,7587.0,5910.0,5467.0,7613.0,7042.0,4767.0,4691.0,5672.0,3946.0,6529.0,6792.0,71046.0
Porbandar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,10.0,13.0,14.0,16.0,30.0,50.0,41.0,51.0,21.0,7.0,8.0,7.0,268.0
Porbandar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,2.0,3.0,7.0,8.0,3.0,0.0,0.0,2.0,25.0
Porbandar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,600.0,2000.0,1940.0,2720.0,10300.0,2410.0,1330.0,410.0,3360.0,3460.0,4570.0,2770.0,35870.0
Porbandar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2500.0,1500.0,2500.0,10000.0,0.0,0.0,,5000.0,2500.0,2500.0,0.0,2500.0,29000.0
Porbandar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0,0.0
Porbandar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1100.0,1560.0,1720.0,2420.0,7890.0,1080.0,920.0,2050.0,2400.0,1390.0,1800.0,2220.0,26550.0
Porbandar,16.1.1,Stock position of DPT vaccines,5. Total Stock,2000.0,1940.0,2720.0,10300.0,2410.0,1330.0,410.0,3360.0,3460.0,4570.0,2770.0,3050.0,38320.0
Porbandar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3900.0,10450.0,7860.0,6930.0,7480.0,5170.0,5310.0,2930.0,3280.0,2560.0,5110.0,3100.0,64080.0
Porbandar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,8500.0,0.0,2000.0,3000.0,0.0,3000.0,,3000.0,3000.0,5000.0,0.0,6000.0,33500.0
Porbandar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0,0.0
Porbandar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1950.0,2590.0,2930.0,2450.0,2310.0,2860.0,2380.0,2650.0,3720.0,2450.0,2010.0,4000.0,32300.0
Porbandar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,10450.0,7860.0,6930.0,7480.0,5170.0,5310.0,2930.0,3280.0,2560.0,5110.0,3100.0,5100.0,65280.0
Porbandar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,5600.0,10100.0,8800.0,10360.0,9360.0,1520.0,5120.0,1640.0,3200.0,5460.0,2220.0,1120.0,64500.0
Porbandar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,7000.0,3000.0,10000.0,5000.0,0.0,12000.0,,10000.0,10000.0,0.0,0.0,7800.0,64800.0
Porbandar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0,0.0
Porbandar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2500.0,4300.0,8440.0,6000.0,7840.0,8400.0,3480.0,8440.0,7740.0,3240.0,1100.0,2800.0,64280.0
Porbandar,16.1.2,Stock position of OPV vaccines,5. Total Stock,10100.0,8800.0,10360.0,9360.0,1520.0,5120.0,1640.0,3200.0,5460.0,2220.0,1120.0,6120.0,65020.0
Porbandar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4380.0,7630.0,5540.0,4900.0,21200.0,6930.0,9610.0,7710.0,5930.0,2680.0,6190.0,2960.0,85660.0
Porbandar,16.1.3,Stock position of TT vaccines,2. Stocks Received,5000.0,0.0,2000.0,20000.0,0.0,4000.0,,0.0,0.0,5000.0,0.0,5000.0,41000.0
Porbandar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0
Porbandar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1750.0,2090.0,2640.0,3700.0,14270.0,1320.0,1900.0,1780.0,3250.0,1490.0,3230.0,2070.0,39490.0
Porbandar,16.1.3,Stock position of TT vaccines,5. Total Stock,7630.0,5540.0,4900.0,21200.0,6930.0,9610.0,7710.0,5930.0,2680.0,6190.0,2960.0,5890.0,87170.0
Porbandar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0
Porbandar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0
Porbandar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0
Porbandar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0
Porbandar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1280.0,3630.0,2510.0,2870.0,3450.0,2100.0,3200.0,1850.0,2230.0,1750.0,1490.0,1220.0,27580.0
Porbandar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,3000.0,0.0,1500.0,1500.0,0.0,3000.0,,1500.0,1500.0,1500.0,0.0,1500.0,15000.0
Porbandar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0
Porbandar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,650.0,1120.0,1140.0,920.0,1350.0,1900.0,1350.0,1120.0,1980.0,1760.0,270.0,1670.0,15230.0
Porbandar,16.1.5,Stock position of BCG vaccines,5. Total Stock,3630.0,2510.0,2870.0,3450.0,2100.0,3200.0,1850.0,2230.0,1750.0,1490.0,1220.0,1050.0,27350.0
Porbandar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1250.0,1100.0,2625.0,2485.0,3580.0,970.0,2340.0,630.0,530.0,2605.0,2595.0,5175.0,25885.0
Porbandar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1000.0,4000.0,2000.0,3500.0,0.0,4000.0,,2500.0,5000.0,2000.0,5000.0,0.0,29000.0
Porbandar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0
Porbandar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1150.0,2475.0,2140.0,2405.0,2610.0,2630.0,1710.0,2600.0,2925.0,2010.0,2420.0,1985.0,27060.0
Porbandar,16.1.6,Stock position of Measles vaccines,5. Total Stock,1100.0,2625.0,2485.0,3580.0,970.0,2340.0,630.0,530.0,2605.0,2595.0,5175.0,3190.0,27825.0
Porbandar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Porbandar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Porbandar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Porbandar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Porbandar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1060.0,880.0,540.0,2100.0,1630.0,1450.0,930.0,580.0,1900.0,1090.0,2490.0,1810.0,16460.0
Porbandar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,1900.0,0.0,0.0,0.0,0.0,1500.0,0.0,1500.0,0.0,0.0,4900.0
Porbandar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Porbandar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,180.0,340.0,340.0,470.0,180.0,520.0,350.0,180.0,810.0,100.0,680.0,220.0,4370.0
Porbandar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,880.0,540.0,2100.0,1630.0,1450.0,930.0,580.0,1900.0,1090.0,2490.0,1810.0,1590.0,16990.0
Porbandar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,650.0,150.0,13650.0,4800.0,3600.0,3600.0,3600.0,3600.0,3600.0,3600.0,2400.0,2400.0,45650.0
Porbandar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,15000.0,0.0,0.0,0.0,,0.0,0.0,,,0.0,0.0,15000.0
Porbandar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0,0.0,0.0
Porbandar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,500.0,1500.0,8850.0,1200.0,0.0,,0.0,0.0,,1200.0,0.0,0.0,13250.0
Porbandar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,150.0,13650.0,4800.0,3600.0,3600.0,3600.0,3600.0,3600.0,3600.0,2400.0,2400.0,2400.0,47400.0
Porbandar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,17780.0,0.0,0.0,25040.0,17040.0,17040.0,17040.0,17040.0,102600.0,37000.0,37000.0,37000.0,324580.0
Porbandar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,75360.0,0.0,0.0,,0.0,105600.0,0.0,,0.0,0.0,180960.0
Porbandar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0,0.0,0.0
Porbandar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,17780.0,0.0,50320.0,8000.0,0.0,,0.0,20040.0,65600.0,,0.0,0.0,161740.0
Porbandar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,25040.0,17040.0,17040.0,17040.0,17040.0,102600.0,37000.0,37000.0,37000.0,37000.0,343800.0
Porbandar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1300.0,0.0,0.0,6400.0,4400.0,4400.0,4400.0,4400.0,28400.0,9200.0,9200.0,9200.0,81300.0
Porbandar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,29000.0,0.0,,0.0,0.0,29000.0
Porbandar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0,0.0,0.0
Porbandar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1300.0,0.0,0.0,2000.0,0.0,,0.0,5000.0,19200.0,,0.0,0.0,27500.0
Porbandar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,4400.0,4400.0,4400.0,4400.0,28400.0,9200.0,9200.0,9200.0,9200.0,82800.0
Porbandar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,500.0,0.0,0.0,300.0,300.0,300.0,300.0,300.0,300.0,300.0,300.0,300.0,3200.0
Porbandar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,1500.0,0.0,0.0,,0.0,0.0,,,0.0,0.0,1500.0
Porbandar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0,0.0,0.0
Porbandar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,500.0,0.0,1200.0,0.0,0.0,,0.0,0.0,,,0.0,0.0,1700.0
Porbandar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,300.0,300.0,300.0,300.0,300.0,300.0,300.0,300.0,300.0,300.0,3000.0
Porbandar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,6000.0
Porbandar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0,0.0,0.0
Porbandar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0,0.0,0.0
Porbandar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0,0.0,0.0
Porbandar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,6000.0
Porbandar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,400.0,750.0,750.0,750.0,0.0,,0.0,,,,0.0,0.0,2650.0
Porbandar,16.3.02,Stock Position of Gloves,2. Stocks Received,750.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,750.0
Porbandar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.02,Stock Position of Gloves,4. Stock Distributed,400.0,0.0,750.0,750.0,0.0,,0.0,,,,0.0,0.0,1900.0
Porbandar,16.3.02,Stock Position of Gloves,5. Total Stock,750.0,750.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0
Porbandar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Porbandar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,319000.0,319000.0,319000.0,319000.0,664000.0,213000.0,370000.0,686000.0,290000.0,130000.0,162000.0,540000.0,4331000.0
Porbandar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,345000.0,723000.0,273000.0,538000.0,,0.0,32000.0,378000.0,275000.0,2564000.0
Porbandar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0
Porbandar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,1174000.0,116000.0,222000.0,396000.0,160000.0,,0.0,609000.0,2677000.0
Porbandar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,319000.0,319000.0,319000.0,664000.0,213000.0,370000.0,686000.0,290000.0,130000.0,162000.0,540000.0,206000.0,4218000.0
Porbandar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,54000.0,203000.0,16000.0,437000.0,32000.0,32000.0,32000.0,2300.0,13370.0,821670.0
Porbandar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,149000.0,0.0,461000.0,,0.0,,2300.0,11070.0,0.0,623370.0
Porbandar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0
Porbandar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,187000.0,40000.0,405000.0,0.0,,32000.0,0.0,12670.0,676670.0
Porbandar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,203000.0,16000.0,437000.0,32000.0,32000.0,32000.0,2300.0,13370.0,700.0,768370.0
Porbandar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0,0.0,0.0
Porbandar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,600.0,600.0,1200.0
Porbandar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,600.0,1200.0
Porbandar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,135.0,150.0,150.0,150.0,135.0,135.0,177.0,300.0,156.0,55.0,55.0,55.0,1653.0
Porbandar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,150.0,0.0,0.0,0.0,0.0,42.0,300.0,558.0,0.0,,0.0,0.0,1050.0
Porbandar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0
Porbandar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,135.0,0.0,15.0,15.0,0.0,0.0,177.0,702.0,101.0,,0.0,52.0,1197.0
Porbandar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,150.0,150.0,135.0,135.0,135.0,177.0,300.0,156.0,55.0,55.0,55.0,3.0,1506.0
Porbandar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,6000.0,11000.0,6000.0,6000.0,6000.0,35000.0
Porbandar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,24000.0,16500.0,,,0.0,0.0,40500.0
Porbandar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0,0.0
Porbandar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,18000.0,11500.0,5000.0,,0.0,0.0,34500.0
Porbandar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,11000.0,6000.0,6000.0,6000.0,6000.0,41000.0
Porbandar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,200.0,200.0,200.0,3860.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,8460.0
Porbandar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,10800.0,0.0,0.0,,,,,,0.0,0.0,10800.0
Porbandar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0
Porbandar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,600.0,3360.0,0.0,,,,,,0.0,0.0,3960.0
Porbandar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,200.0,200.0,10400.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,15300.0
Porbandar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,72000.0
Porbandar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0
Porbandar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0
Porbandar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0
Porbandar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,72000.0
Porbandar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,400.0,400.0,400.0,850.0,0.0,,,,,,0.0,0.0,2050.0
Porbandar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,10000.0,0.0,0.0,,,,,,0.0,0.0,10000.0
Porbandar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0
Porbandar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,10400.0,850.0,0.0,,,,,,0.0,0.0,11250.0
Porbandar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,400.0,400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,800.0
Porbandar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,2.0,,1.0,,,1.0,,1.0,2.0,,,8.0
Porbandar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,1.0,,,,,,,,,1.0
Porbandar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Porbandar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,1.0,,,,,,,,,1.0
Porbandar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,1.0,,2.0,,,1.0,,1.0,,,,6.0
Porbandar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Porbandar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,1.0,,2.0,,,1.0,,1.0,,,,6.0
Porbandar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,1.0,2.0,1.0,3.0,3.0,3.0,,,3.0,2.0,19.0
Porbandar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Porbandar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,1.0,2.0,1.0,3.0,3.0,3.0,,,3.0,2.0,19.0
Porbandar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,2.0,3.0,2.0,1.0,1.0,2.0,3.0,2.0,2.0,3.0,1.0,22.0
Porbandar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Porbandar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,2.0,3.0,2.0,1.0,1.0,2.0,3.0,2.0,2.0,3.0,1.0,22.0
Porbandar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,,,1.0,,,,,,,2.0
Porbandar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Porbandar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,,,1.0,,,,,,,2.0
Porbandar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Porbandar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Porbandar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,1.0,,,1.0
Porbandar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,1.0,,1.0,,,,2.0
Porbandar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Porbandar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,1.0,,1.0,,,,2.0
Porbandar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Porbandar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Porbandar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Porbandar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,3.0,,3.0,3.0,2.0,,1.0,4.0,2.0,,3.0,21.0
Porbandar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,2.0,1.0,1.0,2.0,1.0,1.0,,,8.0
Porbandar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,3.0,,3.0,5.0,3.0,1.0,3.0,5.0,3.0,,3.0,29.0
Porbandar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Porbandar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Porbandar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Porbandar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,1.0,,2.0,1.0,,1.0,2.0,1.0,,2.0,,12.0
Porbandar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,2.0,2.0,3.0,1.0,,,,1.0,9.0
Porbandar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,1.0,,2.0,3.0,2.0,4.0,3.0,1.0,,2.0,1.0,21.0
Porbandar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,5.0,,,3.0,1.0,5.0,1.0,1.0,,1.0,,17.0
Porbandar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,4.0,6.0,9.0,4.0,7.0,7.0,10.0,12.0,15.0,8.0,10.0,3.0,95.0
Porbandar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,4.0,11.0,9.0,4.0,10.0,8.0,15.0,13.0,16.0,8.0,11.0,3.0,112.0
Porbandar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Porbandar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Porbandar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Porbandar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,,,1.0,,,,,,,2.0
Porbandar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Porbandar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,1.0,,,1.0,,,,,,,3.0
Porbandar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,1.0,,1.0,1.0,,,,1.0,1.0,,,5.0
Porbandar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Porbandar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,1.0,,1.0,1.0,,,,1.0,1.0,,,6.0
Porbandar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,18.0,7.0,14.0,12.0,6.0,7.0,4.0,11.0,16.0,8.0,12.0,120.0
Porbandar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,21.0,14.0,19.0,15.0,24.0,14.0,11.0,22.0,27.0,23.0,26.0,12.0,228.0
Porbandar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,26.0,32.0,26.0,29.0,36.0,20.0,18.0,26.0,38.0,39.0,34.0,24.0,348.0
Porbandar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,2.0,,1.0,2.0,1.0,2.0,,1.0,3.0,2.0,14.0
Porbandar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,3.0,4.0,1.0,2.0,2.0,3.0,2.0,,1.0,2.0,2.0,2.0,24.0
Porbandar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,3.0,4.0,3.0,2.0,3.0,5.0,3.0,2.0,1.0,3.0,5.0,4.0,38.0
Porbandar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Porbandar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Porbandar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Porbandar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Porbandar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Porbandar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Porbandar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Porbandar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Porbandar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Porbandar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,2.0,,,,,,,2.0
Porbandar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Porbandar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,2.0,,,,,,,2.0
Porbandar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Porbandar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Porbandar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,1.0,,,,,,1.0
Porbandar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,,,2.0,,,2.0,,,,5.0
Porbandar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Porbandar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,,,2.0,,,2.0,,,,5.0
Porbandar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Porbandar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,13.0,9.0,8.0,6.0,5.0,5.0,2.0,8.0,4.0,4.0,10.0,6.0,80.0
Porbandar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,2.0,1.0,1.0,2.0,,2.0,1.0,3.0,5.0,1.0,2.0,20.0
Porbandar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,13.0,11.0,10.0,7.0,7.0,5.0,4.0,9.0,7.0,9.0,11.0,8.0,101.0
Porbandar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Porbandar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,6.0,4.0,4.0,3.0,7.0,4.0,3.0,4.0,3.0,6.0,5.0,3.0,52.0
Porbandar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,1.0,1.0,2.0,2.0,,3.0,2.0,1.0,1.0,3.0,,17.0
Porbandar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,7.0,5.0,5.0,5.0,9.0,4.0,6.0,6.0,4.0,7.0,8.0,3.0,69.0
Porbandar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,,,2.0,,1.0,2.0,,,,6.0
Porbandar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,2.0,,1.0,,,,,1.0,5.0
Porbandar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,2.0,1.0,,,2.0,3.0,1.0,1.0,,1.0,,11.0
Porbandar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,2.0,2.0,1.0,2.0,4.0,4.0,2.0,3.0,,1.0,1.0,22.0
Porbandar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,1.0,,,,,,,,,1.0,3.0
Porbandar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,1.0,1.0,4.0,2.0,1.0,,1.0,4.0,1.0,,1.0,18.0
Porbandar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,5.0,5.0,1.0,3.0,7.0,1.0,1.0,7.0,7.0,8.0,1.0,6.0,52.0
Porbandar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,8.0,6.0,3.0,7.0,9.0,2.0,1.0,8.0,11.0,9.0,1.0,8.0,73.0
Porbandar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,,,,1.0,,,,,,2.0
Porbandar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,5.0,6.0,2.0,7.0,1.0,5.0,4.0,1.0,6.0,2.0,3.0,4.0,46.0
Porbandar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,5.0,4.0,11.0,13.0,5.0,9.0,19.0,19.0,10.0,9.0,9.0,11.0,124.0
Porbandar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,10.0,10.0,14.0,20.0,6.0,14.0,24.0,20.0,16.0,11.0,12.0,15.0,172.0
Porbandar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,,,,,,,1.0,1.0,1.0,4.0
Porbandar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,12.0,9.0,6.0,3.0,13.0,6.0,5.0,10.0,8.0,7.0,18.0,7.0,104.0
Porbandar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,40.0,38.0,42.0,40.0,52.0,26.0,40.0,31.0,61.0,52.0,54.0,54.0,530.0
Porbandar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,52.0,47.0,49.0,43.0,65.0,32.0,45.0,41.0,69.0,60.0,73.0,62.0,638.0
Rajkot,1.1,Total number of pregnant women Registered for ANC,TOTAL,4600.0,5240.0,6165.0,6581.0,5183.0,6629.0,5938.0,6037.0,5864.0,6014.0,6169.0,7165.0,71585.0
Rajkot,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3267.0,3662.0,4248.0,4467.0,3577.0,4478.0,4297.0,4310.0,4384.0,4416.0,4487.0,5178.0,50771.0
Rajkot,1.2,Number of Pregnant women registered under JSY,TOTAL,392.0,557.0,554.0,791.0,594.0,829.0,726.0,645.0,733.0,753.0,704.0,825.0,8103.0
Rajkot,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3568.0,3795.0,4014.0,4656.0,4722.0,5728.0,5144.0,4756.0,5233.0,4853.0,5357.0,6413.0,58239.0
Rajkot,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3382.0,3700.0,4348.0,4733.0,3927.0,4859.0,4479.0,4555.0,4520.0,4554.0,4766.0,5319.0,53142.0
Rajkot,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3388.0,3791.0,4239.0,4623.0,4431.0,5020.0,4841.0,4595.0,4592.0,4757.0,4786.0,5300.0,54363.0
Rajkot,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4075.0,4678.0,5586.0,4991.0,4911.0,6397.0,5507.0,5630.0,5392.0,5810.0,5767.0,6708.0,65452.0
Rajkot,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,55.0,65.0,116.0,94.0,87.0,93.0,89.0,129.0,111.0,115.0,156.0,190.0,1300.0
Rajkot,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,36.0,6.0,43.0,25.0,16.0,14.0,11.0,0.0,0.0,13.0,14.0,180.0
Rajkot,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1756.0,1638.0,2209.0,2730.0,2493.0,2783.0,2210.0,2360.0,2294.0,2213.0,2635.0,3222.0,28543.0
Rajkot,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,30.0,31.0,75.0,20.0,25.0,52.0,44.0,79.0,85.0,99.0,37.0,102.0,679.0
Rajkot,1.8,Number of pregnancy test kits used at SC level,TOTAL,75.0,157.0,212.0,299.0,343.0,509.0,414.0,468.0,421.0,409.0,401.0,560.0,4268.0
Rajkot,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,11.0,24.0,19.0,22.0,22.0,22.0,17.0,62.0,68.0,30.0,11.0,19.0,327.0
Rajkot,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,14.0,21.0,16.0,18.0,26.0,32.0,31.0,31.0,36.0,25.0,10.0,20.0,280.0
Rajkot,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,25.0,45.0,35.0,40.0,48.0,54.0,48.0,93.0,104.0,55.0,21.0,39.0,607.0
Rajkot,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,21.0,33.0,27.0,29.0,40.0,38.0,31.0,65.0,81.0,38.0,13.0,23.0,439.0
Rajkot,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,6.0,2.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,9.0
Rajkot,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,661.0,1455.0,1510.0,1528.0,1819.0,1955.0,1816.0,1881.0,1869.0,1881.0,1610.0,1865.0,19850.0
Rajkot,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,510.0,704.0,504.0,724.0,861.0,861.0,753.0,713.0,784.0,761.0,577.0,635.0,8387.0
Rajkot,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,45.0,98.0,90.0,97.0,100.0,69.0,109.0,50.0,75.0,58.0,93.0,106.0,990.0
Rajkot,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,9.0,13.0,9.0,13.0,13.0,1.0,6.0,4.0,2.0,3.0,0.0,1.0,74.0
Rajkot,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,2321.0,2603.0,3149.0,2905.0,2936.0,3209.0,3035.0,3396.0,3251.0,3011.0,3624.0,3691.0,37131.0
Rajkot,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,13.0,11.0,14.0,16.0,22.0,22.0,0.0,0.0,0.0,0.0,0.0,0.0,98.0
Rajkot,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,36.0,20.0,38.0,39.0,55.0,56.0,57.0,46.0,54.0,37.0,74.0,512.0
Rajkot,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,2.0,1.0,1.0,0.0,0.0,11.0,0.0,121.0,109.0,134.0,89.0,154.0,622.0
Rajkot,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajkot,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,2.0,37.0,21.0,38.0,39.0,66.0,56.0,178.0,155.0,188.0,126.0,228.0,1134.0
Rajkot,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,203.0,291.0,336.0,344.0,360.0,338.0,379.0,378.0,439.0,330.0,272.0,358.0,4028.0
Rajkot,4.1.1.a,Number of male live births,TOTAL,1771.0,2168.0,2429.0,2279.0,2486.0,2619.0,2523.0,2735.0,2614.0,2547.0,2676.0,2779.0,29626.0
Rajkot,4.1.1.b,Number of female live births,TOTAL,1530.0,1773.0,2152.0,2038.0,2182.0,2352.0,2210.0,2379.0,2352.0,2294.0,2384.0,2606.0,26252.0
Rajkot,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3301.0,3941.0,4581.0,4317.0,4668.0,4971.0,4733.0,5114.0,4966.0,4841.0,5060.0,5385.0,55878.0
Rajkot,4.1.2,Number of still births,TOTAL,54.0,39.0,42.0,52.0,56.0,71.0,64.0,69.0,63.0,54.0,64.0,47.0,675.0
Rajkot,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,108.0,144.0,155.0,173.0,155.0,168.0,168.0,195.0,163.0,172.0,179.0,212.0,1992.0
Rajkot,4.2.1,Number of Newborns weighed at birth,TOTAL,3271.0,3885.0,4559.0,4290.0,4663.0,4938.0,4660.0,5020.0,4696.0,4583.0,4848.0,4803.0,54216.0
Rajkot,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,395.0,252.0,327.0,341.0,421.0,391.0,432.0,681.0,385.0,344.0,382.0,374.0,4725.0
Rajkot,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2890.0,3468.0,4084.0,3829.0,4249.0,4592.0,3946.0,4367.0,4171.0,4175.0,4396.0,4383.0,48550.0
Rajkot,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,98.0,132.0,46.0,46.0,48.0,71.0,58.0,100.0,49.0,93.0,95.0,49.0,885.0
Rajkot,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,98.0,244.0,246.0,220.0,268.0,247.0,231.0,233.0,207.0,262.0,160.0,268.0,2684.0
Rajkot,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajkot,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,196.0,376.0,292.0,266.0,316.0,318.0,289.0,333.0,256.0,355.0,255.0,317.0,3569.0
Rajkot,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,261.0,14.0,35.0,396.0,297.0,459.0,307.0,291.0,379.0,353.0,341.0,409.0,3542.0
Rajkot,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,441.0,284.0,315.0,588.0,558.0,658.0,593.0,658.0,685.0,693.0,584.0,722.0,6779.0
Rajkot,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,69.0,101.0,52.0,52.0,64.0,56.0,152.0,148.0,159.0,26.0,57.0,69.0,1005.0
Rajkot,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,523.0,347.0,312.0,659.0,647.0,772.0,668.0,743.0,728.0,753.0,553.0,713.0,7418.0
Rajkot,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,66.0,82.0,111.0,59.0,94.0,79.0,147.0,96.0,126.0,98.0,84.0,139.0,1181.0
Rajkot,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2522.0,3358.0,4057.0,3913.0,4183.0,4258.0,3946.0,4268.0,4134.0,4121.0,4085.0,4227.0,47072.0
Rajkot,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,980.0,1624.0,1567.0,1645.0,2266.0,2453.0,1860.0,2289.0,2179.0,1975.0,2305.0,2564.0,23707.0
Rajkot,6.3,PNC maternal complications attended,TOTAL,6.0,26.0,25.0,20.0,28.0,25.0,25.0,20.0,20.0,27.0,21.0,30.0,273.0
Rajkot,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,45.0,73.0,87.0,69.0,55.0,64.0,56.0,73.0,79.0,92.0,89.0,107.0,889.0
Rajkot,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,8.0,7.0,6.0,7.0,8.0,60.0,6.0,7.0,8.0,2.0,5.0,10.0,134.0
Rajkot,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,53.0,80.0,93.0,76.0,63.0,124.0,62.0,80.0,87.0,94.0,94.0,117.0,1023.0
Rajkot,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,42.0,31.0,13.0,23.0,7.0,34.0,28.0,29.0,35.0,33.0,35.0,310.0
Rajkot,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,119.0,98.0,140.0,135.0,159.0,112.0,133.0,96.0,131.0,146.0,101.0,135.0,1505.0
Rajkot,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,513.0,472.0,514.0,571.0,644.0,720.0,568.0,467.0,602.0,452.0,499.0,731.0,6753.0
Rajkot,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,632.0,570.0,654.0,706.0,803.0,832.0,701.0,563.0,733.0,598.0,600.0,866.0,8258.0
Rajkot,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,0.0,2.0,0.0,1.0,1.0,2.0,0.0,4.0,3.0,2.0,16.0
Rajkot,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,1.0,2.0,2.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,2.0,13.0
Rajkot,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajkot,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,1.0,2.0,4.0,1.0,2.0,1.0,3.0,0.0,5.0,4.0,4.0,29.0
Rajkot,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,43.0,72.0,58.0,45.0,39.0,48.0,55.0,124.0,212.0,217.0,216.0,136.0,1265.0
Rajkot,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,112.0,106.0,89.0,71.0,40.0,71.0,70.0,100.0,179.0,137.0,208.0,238.0,1421.0
Rajkot,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,89.0,140.0,122.0,133.0,128.0,185.0,153.0,284.0,390.0,424.0,384.0,200.0,2632.0
Rajkot,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajkot,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,244.0,318.0,269.0,249.0,207.0,304.0,278.0,508.0,781.0,778.0,808.0,574.0,5318.0
Rajkot,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,46.0,60.0,66.0,74.0,63.0,79.0,73.0,83.0,67.0,52.0,30.0,54.0,747.0
Rajkot,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,3.0,1.0,0.0,60.0,0.0,0.0,66.0
Rajkot,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,3.0,2.0,4.0,2.0,6.0,19.0
Rajkot,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajkot,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,1.0,1.0,2.0,0.0,0.0,3.0,4.0,2.0,64.0,2.0,6.0,85.0
Rajkot,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,7.0,4.0,7.0,13.0,6.0,4.0,2.0,8.0,7.0,5.0,0.0,0.0,63.0
Rajkot,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,3.0,1.0,2.0,2.0,20.0
Rajkot,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajkot,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,3.0,1.0,2.0,2.0,20.0
Rajkot,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,8.0,0.0,0.0,13.0
Rajkot,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,967.0,943.0,1081.0,1184.0,1053.0,1311.0,1156.0,1150.0,1137.0,972.0,872.0,579.0,12405.0
Rajkot,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,197.0,261.0,229.0,267.0,243.0,405.0,488.0,436.0,451.0,435.0,472.0,550.0,4434.0
Rajkot,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,41.0,60.0,71.0,96.0,81.0,92.0,88.0,94.0,97.0,91.0,107.0,108.0,1026.0
Rajkot,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,82.0,95.0,98.0,211.0,242.0,320.0,193.0,178.0,178.0,169.0,183.0,339.0,2288.0
Rajkot,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajkot,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1287.0,1359.0,1479.0,1758.0,1619.0,2128.0,1925.0,1858.0,1863.0,1667.0,1634.0,1576.0,20153.0
Rajkot,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,2.0,1.0,3.0,27.0,20.0,15.0,26.0,60.0,58.0,37.0,182.0,431.0
Rajkot,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,389.0,550.0,550.0,675.0,600.0,583.0,525.0,452.0,633.0,500.0,456.0,568.0,6481.0
Rajkot,9.06,Number of IUCD removals,TOTAL,411.0,465.0,416.0,456.0,382.0,436.0,436.0,301.0,292.0,297.0,355.0,361.0,4608.0
Rajkot,9.07,Number of Oral Pills cycles distributed,TOTAL,7361.0,6513.0,6158.0,7634.0,9064.0,6564.0,9362.0,7405.0,7113.0,6954.0,6841.0,7439.0,88408.0
Rajkot,9.08,Number of Condom pieces distributed,TOTAL,80328.0,55319.0,61734.0,66411.0,86874.0,80993.0,88522.0,94009.0,82260.0,77368.0,77265.0,66969.0,918052.0
Rajkot,9.09,Number of Centchroman (weekly) pills given,TOTAL,294.0,5.0,0.0,3.0,523.0,495.0,671.0,63.0,640.0,9.0,48.0,3.0,2754.0
Rajkot,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,37.0,36.0,31.0,67.0,54.0,65.0,104.0,84.0,59.0,41.0,35.0,98.0,711.0
Rajkot,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Rajkot,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,6.0,6.0,6.0,6.0,7.0,6.0,7.0,7.0,9.0,14.0,14.0,-1.0
Rajkot,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3990.0,4570.0,5056.0,5050.0,5039.0,6026.0,5369.0,5579.0,5609.0,5663.0,5419.0,6290.0,63660.0
Rajkot,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3807.0,3943.0,4556.0,4872.0,4549.0,5086.0,4682.0,5093.0,4996.0,4788.0,4787.0,5169.0,56328.0
Rajkot,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3698.0,3925.0,4332.0,4550.0,4546.0,4833.0,4416.0,4720.0,4837.0,4565.0,4752.0,5318.0,54492.0
Rajkot,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3720.0,3846.0,4424.0,4400.0,4433.0,4806.0,4345.0,4587.0,4674.0,4563.0,4666.0,5336.0,53800.0
Rajkot,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3768.0,4134.0,4696.0,4679.0,4715.0,5476.0,4829.0,5297.0,5252.0,5074.0,5039.0,6339.0,59298.0
Rajkot,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3809.0,4028.0,4560.0,4876.0,4549.0,5084.0,4677.0,5078.0,4920.0,4790.0,4769.0,5169.0,56309.0
Rajkot,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3697.0,3918.0,4341.0,4545.0,4546.0,4828.0,4412.0,4696.0,4799.0,4561.0,4753.0,5318.0,54414.0
Rajkot,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3724.0,3845.0,4425.0,4402.0,4430.0,4813.0,4354.0,4545.0,4670.0,4476.0,4658.0,5336.0,53678.0
Rajkot,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2003.0,2194.0,2648.0,2947.0,2736.0,2972.0,2397.0,2608.0,2929.0,2735.0,2622.0,3226.0,32017.0
Rajkot,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,98.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,5.0,104.0
Rajkot,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Rajkot,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,3.0
Rajkot,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3533.0,4202.0,5125.0,4967.0,4380.0,5200.0,4972.0,4897.0,4691.0,4531.0,4914.0,5298.0,56710.0
Rajkot,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3043.0,3386.0,4495.0,4604.0,3804.0,4562.0,4135.0,4194.0,4321.0,4093.0,4328.0,4871.0,49836.0
Rajkot,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2020.0,2335.0,2824.0,2653.0,2386.0,2830.0,2534.0,2534.0,2416.0,2386.0,2665.0,2715.0,30298.0
Rajkot,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1751.0,2022.0,2442.0,2369.0,2121.0,2579.0,2364.0,2248.0,2097.0,2120.0,2256.0,2418.0,26787.0
Rajkot,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3771.0,4357.0,5266.0,5022.0,4507.0,5409.0,4898.0,4782.0,4513.0,4506.0,4921.0,5133.0,57085.0
Rajkot,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3252.0,3567.0,4483.0,4351.0,3847.0,4475.0,4074.0,4250.0,4218.0,4087.0,4328.0,4780.0,49712.0
Rajkot,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3258.0,3568.0,4488.0,4345.0,3847.0,4475.0,4074.0,4250.0,4218.0,4089.0,4328.0,4774.0,49714.0
Rajkot,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1478.0,1761.0,2234.0,2213.0,1940.0,2252.0,2039.0,2156.0,2208.0,2071.0,2250.0,2484.0,25086.0
Rajkot,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1206.0,1558.0,1932.0,1960.0,1783.0,2013.0,1847.0,1832.0,1826.0,1821.0,1971.0,2199.0,21948.0
Rajkot,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2684.0,3319.0,4166.0,4173.0,3723.0,4265.0,3886.0,3988.0,4034.0,3892.0,4221.0,4683.0,47034.0
Rajkot,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1587.0,1897.0,2558.0,5003.0,7072.0,5729.0,3642.0,2843.0,3476.0,4291.0,2484.0,2986.0,43568.0
Rajkot,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1303.0,1551.0,1922.0,5305.0,7322.0,5618.0,3618.0,2638.0,3069.0,4012.0,2048.0,2217.0,40623.0
Rajkot,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1835.0,2136.0,2695.0,4967.0,6117.0,4293.0,3407.0,2950.0,2868.0,4040.0,2314.0,2790.0,40412.0
Rajkot,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,13.0,23.0,17.0,16.0,17.0,18.0,16.0,6.0,9.0,14.0,23.0,12.0,184.0
Rajkot,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,400.0,432.0,532.0,1033.0,658.0,800.0,644.0,551.0,693.0,560.0,478.0,449.0,7230.0
Rajkot,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1412.0,1603.0,1641.0,1667.0,1623.0,1661.0,1648.0,1689.0,1761.0,1734.0,1843.0,1819.0,20101.0
Rajkot,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1292.0,1564.0,1624.0,1628.0,1569.0,1660.0,1603.0,1652.0,1700.0,1587.0,1783.0,1778.0,19440.0
Rajkot,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1152.0,1371.0,1524.0,1467.0,1422.0,1528.0,1510.0,1539.0,1627.0,1445.0,1671.0,1690.0,17946.0
Rajkot,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3577.0,3886.0,4915.0,4927.0,4565.0,6191.0,4877.0,4790.0,4649.0,4643.0,5101.0,5723.0,57844.0
Rajkot,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,23.0,85.0,395.0,559.0,14033.0,13141.0,3008.0,158.0,375.0,444.0,27348.0,48591.0,108160.0
Rajkot,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,14.0,7.0,10.0,10.0,12631.0,11989.0,2869.0,61.0,21.0,18.0,7096.0,8915.0,43641.0
Rajkot,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1.0,0.0,17.0,0.0,0.0,0.0,0.0,2.0,0.0,6.0,1.0,11.0,38.0
Rajkot,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2109.0,2297.0,2443.0,2338.0,2745.0,2667.0,2273.0,2239.0,2238.0,2128.0,2359.0,2344.0,28180.0
Rajkot,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,7.0,91.0,106.0,183.0,282.0,296.0,217.0,222.0,204.0,113.0,309.0,864.0,2894.0
Rajkot,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,199.0,143.0,118.0,55.0,195.0,9.0,6.0,127.0,106.0,284.0,14.0,13.0,1269.0
Rajkot,13.1,Number of Patients operated for cataract,TOTAL,200.0,198.0,29.0,249.0,220.0,261.0,208.0,348.0,528.0,606.0,715.0,857.0,4419.0
Rajkot,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,189.0,187.0,2.0,220.0,192.0,238.0,189.0,335.0,336.0,336.0,341.0,332.0,2897.0
Rajkot,13.3,Number of School children detected with Refractive errors,TOTAL,63.0,116.0,305.0,418.0,412.0,366.0,354.0,347.0,188.0,582.0,482.0,427.0,4060.0
Rajkot,13.4,Number of children provided free glasses,TOTAL,63.0,0.0,0.0,15.0,49.0,47.0,71.0,178.0,0.0,284.0,482.0,427.0,1616.0
Rajkot,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,6.0,6.0,6.0,7.0,5.0,8.0,6.0,5.0,7.0,7.0,8.0,-1.0
Rajkot,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,2.0,3.0,2.0,2.0,2.0,2.0,2.0,3.0,6.0,11.0,13.0,-1.0
Rajkot,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,293.0,293.0,319.0,350.0,349.0,351.0,350.0,353.0,352.0,282.0,299.0,308.0,-1.0
Rajkot,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,17.0,16.0,16.0,17.0,14.0,15.0,15.0,17.0,16.0,16.0,16.0,17.0,-1.0
Rajkot,14.05,Number of RKS meetings held during the month,TOTAL,7.0,6.0,27.0,10.0,8.0,16.0,6.0,10.0,14.0,8.0,10.0,19.0,141.0
Rajkot,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,19.0,20.0,20.0,21.0,21.0,20.0,20.0,23.0,21.0,20.0,29.0,27.0,-1.0
Rajkot,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,371.0,367.0,445.0,445.0,499.0,424.0,498.0,586.0,527.0,579.0,480.0,534.0,5755.0
Rajkot,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,1.0,5.0,5.0,6.0,5.0,6.0,5.0,4.0,5.0,5.0,7.0,-1.0
Rajkot,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,3.0,3.0,3.0,5.0,7.0,4.0,-1.0
Rajkot,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,383.0,516.0,543.0,489.0,713.0,601.0,723.0,802.0,747.0,854.0,682.0,1287.0,8340.0
Rajkot,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1031.0,1399.0,1346.0,1402.0,1862.0,1613.0,1320.0,1154.0,1073.0,1245.0,1292.0,1705.0,16442.0
Rajkot,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,361.0,417.0,532.0,471.0,668.0,652.0,705.0,772.0,758.0,803.0,815.0,1647.0,8601.0
Rajkot,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4575.0,5157.0,7403.0,7078.0,6949.0,9340.0,6296.0,7894.0,7894.0,8103.0,7342.0,9198.0,87229.0
Rajkot,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,744.0,933.0,1075.0,960.0,1381.0,1253.0,1428.0,1574.0,1505.0,1657.0,1497.0,2934.0,16941.0
Rajkot,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5606.0,6556.0,8749.0,8480.0,8811.0,10953.0,7616.0,9048.0,8967.0,9348.0,8634.0,10903.0,103671.0
Rajkot,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,1.0,4.0,5.0,3.0,1.0,1.0,0.0,2.0,0.0,5.0,2.0,29.0
Rajkot,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,4.0,2.0,1.0,5.0,1.0,2.0,7.0,4.0,4.0,5.0,7.0,42.0
Rajkot,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,5.0,5.0,6.0,6.0,8.0,2.0,3.0,7.0,6.0,4.0,10.0,9.0,71.0
Rajkot,14.11,In-Patient Head Count at midnight,TOTAL,2998.0,3738.0,5492.0,5288.0,4198.0,6907.0,4792.0,6555.0,5884.0,6592.0,5692.0,7298.0,65434.0
Rajkot,14.12.1,OPD attendance (All),TOTAL,97476.0,119515.0,125719.0,144776.0,166956.0,212402.0,157312.0,164419.0,160200.0,161819.0,196518.0,246925.0,1954037.0
Rajkot,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,956.0,296.0,237.0,345.0,221.0,354.0,321.0,285.0,321.0,573.0,291.0,322.0,4522.0
Rajkot,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Rajkot,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,411.0,542.0,700.0,923.0,822.0,837.0,681.0,684.0,996.0,1156.0,1041.0,1116.0,9909.0
Rajkot,14.14.a,Number of patients given AYUSH treatment,TOTAL,2330.0,2102.0,2023.0,2281.0,2285.0,2320.0,1950.0,2870.0,2659.0,2792.0,2910.0,3534.0,30056.0
Rajkot,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,293.0,267.0,440.0,301.0,541.0,488.0,306.0,396.0,514.0,363.0,380.0,102.0,4391.0
Rajkot,14.14.c,Number of Adolescents counselled,TOTAL,235.0,358.0,260.0,351.0,326.0,338.0,276.0,168.0,352.0,254.0,238.0,288.0,3444.0
Rajkot,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,10318.0,11462.0,12889.0,14441.0,15201.0,16107.0,12996.0,12756.0,12644.0,12629.0,14148.0,18980.0,164571.0
Rajkot,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,243.0,274.0,315.0,254.0,356.0,331.0,326.0,334.0,301.0,258.0,205.0,331.0,3528.0
Rajkot,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1247.0,1822.0,1730.0,1856.0,2139.0,2150.0,1879.0,1921.0,1733.0,1172.0,1303.0,2035.0,20987.0
Rajkot,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,6.0,9.0,10.0,15.0,25.0,15.0,14.0,15.0,9.0,6.0,5.0,17.0,146.0
Rajkot,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1220.0,1391.0,1618.0,1775.0,1787.0,2149.0,1563.0,1728.0,1836.0,1523.0,1404.0,2053.0,20047.0
Rajkot,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,4.0,5.0,2.0,8.0,5.0,3.0,8.0,2.0,3.0,2.0,9.0,53.0
Rajkot,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1928.0,2807.0,3648.0,3977.0,3083.0,3923.0,3012.0,2871.0,3317.0,2771.0,2569.0,4058.0,37964.0
Rajkot,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,12.0,5.0,3.0,1.0,2.0,1.0,2.0,0.0,3.0,2.0,32.0
Rajkot,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4395.0,6020.0,6996.0,7608.0,7009.0,8222.0,6454.0,6520.0,6886.0,5466.0,5276.0,8146.0,78998.0
Rajkot,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8.0,14.0,27.0,22.0,36.0,21.0,19.0,24.0,13.0,9.0,10.0,28.0,231.0
Rajkot,15.2,Number of Widal tests conducted,Number tested,554.0,754.0,642.0,537.0,1121.0,1503.0,976.0,856.0,835.0,642.0,960.0,1268.0,10648.0
Rajkot,15.3.a,Number of VDRL tests conducted on males,Number tested,124.0,272.0,251.0,259.0,303.0,191.0,237.0,185.0,271.0,206.0,96.0,309.0,2704.0
Rajkot,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,195.0,271.0,361.0,303.0,329.0,297.0,347.0,323.0,282.0,336.0,186.0,551.0,3781.0
Rajkot,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,698.0,1240.0,2060.0,1531.0,1516.0,1487.0,1168.0,984.0,1219.0,911.0,803.0,1505.0,15122.0
Rajkot,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1017.0,1783.0,2672.0,2093.0,2148.0,1975.0,1752.0,1492.0,1772.0,1453.0,1085.0,2365.0,21607.0
Rajkot,15.4.1,Number of blood smears examined for Malaria,TOTAL,22306.0,16657.0,17719.0,16215.0,22230.0,28160.0,16310.0,17369.0,18161.0,14919.0,19040.0,26572.0,235658.0
Rajkot,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,23.0,46.0,68.0,52.0,81.0,127.0,64.0,73.0,48.0,25.0,16.0,23.0,646.0
Rajkot,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,3.0,2.0,0.0,0.0,5.0,17.0,17.0,37.0,42.0,19.0,4.0,0.0,146.0
Rajkot,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,6400.0,8700.0,7250.0,5400.0,19500.0,21800.0,18400.0,27700.0,23000.0,19000.0,16300.0,17000.0,190450.0
Rajkot,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2500.0,5000.0,5000.0,20000.0,20000.0,10000.0,20000.0,0.0,5000.0,5000.0,10000.0,10000.0,112500.0
Rajkot,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,200.0,6450.0,6850.0,5900.0,17700.0,13400.0,10700.0,4700.0,5000.0,8600.0,9300.0,6200.0,95000.0
Rajkot,16.1.1,Stock position of DPT vaccines,5. Total Stock,8700.0,7250.0,5400.0,19500.0,21800.0,18400.0,27700.0,23000.0,23000.0,15400.0,17000.0,20800.0,207950.0
Rajkot,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,2200.0,13400.0,14300.0,16900.0,15500.0,15600.0,15100.0,10500.0,17500.0,13200.0,14400.0,15300.0,163900.0
Rajkot,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,12000.0,12000.0,15000.0,12000.0,12000.0,9000.0,6000.0,15000.0,9000.0,12000.0,15000.0,15000.0,144000.0
Rajkot,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,800.0,11100.0,12400.0,13400.0,11900.0,9500.0,10600.0,8000.0,9000.0,10800.0,14100.0,12700.0,124300.0
Rajkot,16.1.1A,Stock Position of Pentavalent,5. Total Stock,13400.0,14300.0,16900.0,15500.0,15600.0,15100.0,10500.0,17500.0,17500.0,14400.0,15300.0,17600.0,183600.0
Rajkot,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,27500.0,53300.0,32500.0,40500.0,36300.0,41000.0,36000.0,29900.0,34800.0,35200.0,8000.0,31000.0,406000.0
Rajkot,16.1.2,Stock position of OPV vaccines,2. Stocks Received,27800.0,0.0,30000.0,20000.0,30000.0,20000.0,20000.0,30000.0,25000.0,420000.0,460000.0,30000.0,1112800.0
Rajkot,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2000.0,20800.0,22000.0,24200.0,25300.0,25000.0,26100.0,25100.0,25000.0,447200.0,437000.0,15500.0,1095200.0
Rajkot,16.1.2,Stock position of OPV vaccines,5. Total Stock,53300.0,32500.0,40500.0,36300.0,41000.0,36000.0,29900.0,34800.0,34800.0,8000.0,31000.0,45500.0,423600.0
Rajkot,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,17800.0,31800.0,36000.0,46200.0,39200.0,31800.0,38500.0,44000.0,35100.0,34800.0,32500.0,29000.0,416700.0
Rajkot,16.1.3,Stock position of TT vaccines,2. Stocks Received,15000.0,20000.0,25000.0,18000.0,20000.0,20000.0,20000.0,0.0,10000.0,10000.0,10000.0,10000.0,178000.0
Rajkot,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1000.0,15800.0,14800.0,25000.0,27400.0,13300.0,14500.0,8900.0,10000.0,12300.0,13500.0,13300.0,169800.0
Rajkot,16.1.3,Stock position of TT vaccines,5. Total Stock,31800.0,36000.0,46200.0,39200.0,31800.0,38500.0,44000.0,35100.0,35100.0,32500.0,29000.0,25700.0,424900.0
Rajkot,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2400.0,8100.0,9400.0,9200.0,9600.0,9500.0,9500.0,11000.0,10300.0,9600.0,10100.0,8800.0,107500.0
Rajkot,16.1.5,Stock position of BCG vaccines,2. Stocks Received,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,72000.0
Rajkot,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,300.0,4700.0,6200.0,5600.0,6100.0,6000.0,4500.0,6700.0,6000.0,5500.0,7300.0,6900.0,65800.0
Rajkot,16.1.5,Stock position of BCG vaccines,5. Total Stock,8100.0,9400.0,9200.0,9600.0,9500.0,9500.0,11000.0,10300.0,10300.0,10100.0,8800.0,7900.0,113700.0
Rajkot,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1750.0,11050.0,7450.0,12350.0,12000.0,3450.0,6750.0,10250.0,3250.0,15200.0,9800.0,14750.0,108050.0
Rajkot,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,5000.0,15000.0,10000.0,1000.0,5000.0,12000.0,2500.0,22500.0,5000.0,15000.0,5000.0,108000.0
Rajkot,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,700.0,8600.0,10100.0,10350.0,9550.0,1700.0,8500.0,9500.0,22500.0,10400.0,10050.0,10250.0,112200.0
Rajkot,16.1.6,Stock position of Measles vaccines,5. Total Stock,11050.0,7450.0,12350.0,12000.0,3450.0,6750.0,10250.0,3250.0,3250.0,9800.0,14750.0,9500.0,103850.0
Rajkot,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,7350.0,9350.0,4550.0,4050.0,7050.0,9250.0,8150.0,10350.0,8950.0,3650.0,3450.0,3150.0,79300.0
Rajkot,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,0.0,0.0,3000.0,3000.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,12000.0
Rajkot,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1000.0,4800.0,500.0,0.0,800.0,1100.0,800.0,1400.0,0.0,200.0,300.0,300.0,11200.0
Rajkot,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,9350.0,4550.0,4050.0,7050.0,9250.0,8150.0,10350.0,8950.0,8950.0,3450.0,3150.0,2850.0,80100.0
Rajkot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1520.0,1520.0,920.0,630.0,280.0,950.0,9500.0,900.0,2350.0,1750.0,1200.0,2250.0,23770.0
Rajkot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,7800.0,9000.0,0.0,9000.0,0.0,0.0,6000.0,0.0,31800.0
Rajkot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,600.0,290.0,350.0,7130.0,450.0,8600.0,7550.0,0.0,550.0,4950.0,,30470.0
Rajkot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1520.0,920.0,630.0,280.0,950.0,9500.0,900.0,2350.0,2350.0,1200.0,2250.0,2250.0,25100.0
Rajkot,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,96540.0,38580.0,82680.0,163320.0,12120.0,19400.0,12000.0,10000.0,9000.0,443640.0
Rajkot,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,97800.0,0.0,756000.0,105840.0,0.0,60000.0,0.0,0.0,0.0,186480.0,1206120.0
Rajkot,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,1260.0,57960.0,711900.0,25200.0,151200.0,52720.0,0.0,2000.0,1000.0,146160.0,1149400.0
Rajkot,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,96540.0,38580.0,82680.0,163320.0,12120.0,19400.0,19400.0,10000.0,9000.0,49320.0,500360.0
Rajkot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,6100.0,6100.0,5700.0,1100.0,100.0,700.0,36400.0,1000.0,5100.0,5100.0,1400.0,1400.0,70200.0
Rajkot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,54000.0,36000.0,0.0,60000.0,0.0,0.0,0.0,0.0,150000.0
Rajkot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,400.0,4600.0,1000.0,53400.0,300.0,35400.0,55900.0,0.0,3700.0,0.0,500.0,155200.0
Rajkot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,6100.0,5700.0,1100.0,100.0,700.0,36400.0,1000.0,5100.0,5100.0,1400.0,1400.0,900.0,65000.0
Rajkot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,400.0,400.0,400.0,400.0,400.0,1100.0,1100.0,0.0,0.0,0.0,0.0,0.0,4200.0
Rajkot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,13000.0
Rajkot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,2300.0,0.0,1100.0,0.0,0.0,0.0,0.0,9850.0,13250.0
Rajkot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,400.0,400.0,400.0,400.0,1100.0,1100.0,0.0,0.0,0.0,0.0,0.0,150.0,3950.0
Rajkot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,625.0,2044.0,1400.0,6400.0,6400.0,5900.0,4700.0,4700.0,3700.0,4200.0,2100.0,700.0,42869.0
Rajkot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,1919.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4550.0,11469.0
Rajkot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,500.0,644.0,0.0,0.0,500.0,1200.0,0.0,1000.0,0.0,2100.0,1400.0,950.0,8294.0
Rajkot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,2044.0,1400.0,6400.0,6400.0,5900.0,4700.0,4700.0,3700.0,3700.0,2100.0,700.0,4300.0,46044.0
Rajkot,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,350.0,350.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,704.0
Rajkot,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,350.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,350.0
Rajkot,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,346.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,350.0
Rajkot,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,350.0,350.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,704.0
Rajkot,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,62.0,62.0,20.0,210.0,196.0,235.0,40.0,29.0,29.0,29.0,29.0,29.0,970.0
Rajkot,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,190.0,0.0,270.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,560.0
Rajkot,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,42.0,0.0,14.0,231.0,195.0,11.0,0.0,0.0,0.0,0.0,19.0,512.0
Rajkot,16.3.02,Stock Position of Gloves,5. Total Stock,62.0,20.0,210.0,196.0,235.0,40.0,29.0,29.0,29.0,29.0,29.0,110.0,1018.0
Rajkot,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,57.0,52.0,52.0,52.0,44.0,44.0,44.0,148.0,60.0,553.0
Rajkot,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,66.0,0.0,0.0,0.0,0.0,0.0,0.0,122.0,0.0,0.0,188.0
Rajkot,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,9.0,5.0,0.0,0.0,8.0,0.0,0.0,18.0,88.0,28.0,156.0
Rajkot,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,57.0,52.0,52.0,52.0,44.0,44.0,44.0,148.0,60.0,32.0,585.0
Rajkot,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5500.0,5500.0,300.0,300.0,11600.0
Rajkot,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,70000.0,0.0,0.0,0.0,0.0,70000.0
Rajkot,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,64500.0,0.0,5200.0,0.0,0.0,69700.0
Rajkot,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5500.0,5500.0,300.0,300.0,300.0,11900.0
Rajkot,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,8.0,8.0,4.0,10.0,10.0,10.0,10.0,10.0,41.0,111.0
Rajkot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,8.0,0.0,0.0,20.0,0.0,0.0,0.0,0.0,38.0,0.0,66.0
Rajkot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,4.0,14.0,0.0,0.0,0.0,0.0,7.0,4.0,29.0
Rajkot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,8.0,8.0,4.0,10.0,10.0,10.0,10.0,10.0,41.0,37.0,148.0
Rajkot,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,20000.0,20000.0,20000.0,15000.0,5000.0,5000.0,5000.0,44000.0,97000.0,14850.0,314850.0,1005000.0,1565700.0
Rajkot,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,1189000.0,2378000.0,0.0,300000.0,8036000.0,0.0,11903000.0
Rajkot,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,5000.0,10000.0,0.0,0.0,1150000.0,2325000.0,0.0,0.0,7345850.0,420000.0,11255850.0
Rajkot,16.3.07,Stock Position of IFA Tablets,5. Total Stock,20000.0,20000.0,15000.0,5000.0,5000.0,5000.0,44000.0,97000.0,97000.0,314850.0,1005000.0,585000.0,2212850.0
Rajkot,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,1200.0,1200.0,1200.0,600.0,0.0,0.0,0.0,0.0,200.0,200.0,6680.0,740.0,12020.0
Rajkot,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,0.0,6480.0,10113.0,48787.0,65580.0
Rajkot,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,600.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,16053.0,0.0,17253.0
Rajkot,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,1200.0,1200.0,600.0,0.0,0.0,0.0,0.0,200.0,200.0,6680.0,740.0,49527.0,60347.0
Rajkot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,20.0,20.0,20.0,10.0,10.0,10.0,330.0,420.0
Rajkot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,31.0,0.0,0.0,0.0,0.0,0.0,320.0,0.0,351.0
Rajkot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,11.0,0.0,0.0,10.0,0.0,0.0,0.0,330.0,351.0
Rajkot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,20.0,20.0,20.0,10.0,10.0,10.0,330.0,0.0,420.0
Rajkot,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,470.0,470.0,470.0,420.0,370.0,190.0,190.0,190.0,390.0,375.0,375.0,225.0,4135.0
Rajkot,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1900.0,0.0,0.0,0.0,0.0,1900.0
Rajkot,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,50.0,50.0,180.0,0.0,0.0,1700.0,0.0,0.0,150.0,225.0,2355.0
Rajkot,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,470.0,470.0,420.0,370.0,190.0,190.0,190.0,390.0,390.0,375.0,225.0,0.0,3680.0
Rajkot,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,3000.0,3000.0,0.0,0.0,3000.0,10500.0,2500.0,7000.0,3000.0,2000.0,2000.0,4500.0,40500.0
Rajkot,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,3000.0,10000.0,0.0,143000.0,0.0,0.0,0.0,2500.0,0.0,158500.0
Rajkot,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,3000.0,0.0,0.0,2500.0,8000.0,138500.0,4000.0,0.0,0.0,0.0,500.0,156500.0
Rajkot,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,3000.0,0.0,0.0,3000.0,10500.0,2500.0,7000.0,3000.0,3000.0,2000.0,4500.0,4000.0,42500.0
Rajkot,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,32500.0,5000.0,4700.0,3400.0,2700.0,2200.0,2200.0,900.0,400.0,54000.0
Rajkot,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,33000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26400.0,59400.0
Rajkot,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,500.0,27500.0,300.0,1300.0,700.0,500.0,0.0,1300.0,500.0,21800.0,54400.0
Rajkot,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,32500.0,5000.0,4700.0,3400.0,2700.0,2200.0,2200.0,900.0,400.0,5000.0,59000.0
Rajkot,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,398000.0,74000.0,44000.0,44000.0,44000.0,44000.0,44000.0,44000.0,736000.0
Rajkot,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,440000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,440000.0
Rajkot,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,42000.0,324000.0,30000.0,0.0,0.0,0.0,0.0,0.0,16000.0,412000.0
Rajkot,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,398000.0,74000.0,44000.0,44000.0,44000.0,44000.0,44000.0,44000.0,28000.0,764000.0
Rajkot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,200.0,0.0,0.0,0.0,200.0,4000.0,200.0,200.0,200.0,200.0,200.0,200.0,5600.0
Rajkot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,200.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10200.0
Rajkot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajkot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,200.0,0.0,0.0,0.0,6200.0,3800.0,0.0,0.0,0.0,0.0,0.0,0.0,10200.0
Rajkot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,200.0,4000.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,5600.0
Rajkot,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,1.0,,2.0,,,,,2.0,,,,6.0
Rajkot,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,2.0,,,,,2.0
Rajkot,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rajkot,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,2.0,,,,,2.0
Rajkot,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,5.0,3.0,6.0,6.0,3.0,5.0,3.0,12.0,7.0,4.0,2.0,3.0,59.0
Rajkot,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,2.0,,1.0,1.0,,,,4.0
Rajkot,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,5.0,3.0,6.0,6.0,3.0,7.0,3.0,13.0,8.0,4.0,2.0,3.0,63.0
Rajkot,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,3.0,8.0,3.0,2.0,3.0,5.0,8.0,11.0,7.0,11.0,4.0,67.0
Rajkot,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,4.0,1.0,2.0,2.0,4.0,2.0,4.0,8.0,2.0,,,29.0
Rajkot,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,7.0,9.0,5.0,4.0,7.0,7.0,12.0,19.0,9.0,11.0,4.0,96.0
Rajkot,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,10.0,14.0,12.0,1.0,3.0,12.0,19.0,10.0,14.0,9.0,15.0,6.0,125.0
Rajkot,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,3.0,,3.0,1.0,3.0,3.0,1.0,2.0,5.0,1.0,23.0
Rajkot,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,10.0,15.0,15.0,1.0,6.0,13.0,22.0,13.0,15.0,11.0,20.0,7.0,148.0
Rajkot,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,1.0,,3.0,5.0,,,4.0,2.0,16.0
Rajkot,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rajkot,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,1.0,,3.0,5.0,,,4.0,2.0,16.0
Rajkot,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,1.0,,,1.0,,,,2.0
Rajkot,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rajkot,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,1.0,,,1.0,,,,2.0
Rajkot,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,1.0,1.0,,,1.0,,4.0
Rajkot,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rajkot,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,1.0,1.0,,,1.0,,4.0
Rajkot,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rajkot,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rajkot,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Rajkot,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,5.0,6.0,1.0,8.0,10.0,5.0,5.0,6.0,7.0,9.0,6.0,71.0
Rajkot,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,1.0,,1.0,,2.0
Rajkot,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,5.0,6.0,1.0,8.0,10.0,5.0,5.0,7.0,7.0,10.0,6.0,73.0
Rajkot,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Rajkot,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Rajkot,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Rajkot,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,2.0,,1.0,,,,,,,3.0
Rajkot,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,2.0,,1.0,,,1.0,,,,4.0
Rajkot,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Rajkot,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Rajkot,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Rajkot,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,1.0,,,,1.0,,2.0
Rajkot,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Rajkot,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,2.0,,1.0,1.0,,4.0
Rajkot,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,1.0,,3.0,,2.0,,2.0,6.0,,14.0
Rajkot,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,1.0,,3.0,,4.0,,3.0,7.0,,18.0
Rajkot,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Rajkot,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,1.0,,1.0
Rajkot,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Rajkot,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Rajkot,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,1.0,,,,1.0
Rajkot,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Rajkot,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Rajkot,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Rajkot,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Rajkot,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Rajkot,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,1.0,1.0
Rajkot,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,1.0,1.0,,,1.0,1.0,,2.0,,7.0
Rajkot,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Rajkot,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,1.0,1.0,,,1.0,1.0,,2.0,,7.0
Rajkot,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Rajkot,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Rajkot,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Rajkot,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,,,1.0,,,2.0,,1.0,,,5.0
Rajkot,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Rajkot,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,,,1.0,,,2.0,,1.0,,,5.0
Rajkot,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Rajkot,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,1.0,1.0,1.0,,,3.0
Rajkot,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,1.0,1.0,1.0,1.0,,4.0
Rajkot,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,1.0,,1.0,,2.0
Rajkot,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Rajkot,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,1.0,,,1.0,,1.0,,3.0
Rajkot,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Rajkot,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Rajkot,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,1.0,,,1.0
Rajkot,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Rajkot,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,2.0,,,,2.0
Rajkot,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,2.0,,,,2.0
Rajkot,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Rajkot,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,1.0,,2.0,2.0,,5.0
Rajkot,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,2.0,,7.0,,4.0,5.0,1.0,4.0,,23.0
Rajkot,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,2.0,,7.0,,5.0,5.0,3.0,6.0,,28.0
Sabar Kantha,1.1,Total number of pregnant women Registered for ANC,TOTAL,2469.0,3053.0,3136.0,2936.0,2934.0,2724.0,2505.0,2962.0,3069.0,3244.0,3058.0,2541.0,34631.0
Sabar Kantha,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1985.0,2369.0,2505.0,2343.0,2394.0,2128.0,2092.0,2414.0,2586.0,2665.0,2602.0,2195.0,28278.0
Sabar Kantha,1.2,Number of Pregnant women registered under JSY,TOTAL,1152.0,1251.0,1455.0,1499.0,1447.0,1470.0,1289.0,1440.0,1556.0,1744.0,1610.0,1282.0,17195.0
Sabar Kantha,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1979.0,2246.0,2566.0,2283.0,2354.0,2192.0,2231.0,2397.0,2354.0,2404.0,2601.0,2457.0,28064.0
Sabar Kantha,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2257.0,2743.0,2774.0,2668.0,2508.0,2485.0,2269.0,2698.0,2800.0,2948.0,2724.0,2275.0,31149.0
Sabar Kantha,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2513.0,2560.0,2823.0,2877.0,2886.0,2742.0,2567.0,2432.0,2868.0,3014.0,3158.0,3042.0,33482.0
Sabar Kantha,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2161.0,2549.0,2736.0,2753.0,2788.0,2721.0,2482.0,2850.0,2865.0,2949.0,3028.0,2628.0,32510.0
Sabar Kantha,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,37.0,32.0,112.0,104.0,20.0,19.0,45.0,76.0,38.0,33.0,54.0,29.0,599.0
Sabar Kantha,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,2.0,0.0,4.0,1.0,0.0,0.0,0.0,5.0,2.0,0.0,1.0,16.0
Sabar Kantha,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1790.0,2067.0,2128.0,2017.0,1996.0,2090.0,1730.0,2110.0,2147.0,2332.0,2122.0,2028.0,24557.0
Sabar Kantha,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,34.0,59.0,33.0,63.0,54.0,84.0,54.0,70.0,32.0,36.0,26.0,74.0,619.0
Sabar Kantha,1.8,Number of pregnancy test kits used at SC level,TOTAL,1182.0,1349.0,1796.0,1629.0,1790.0,1571.0,1330.0,1399.0,1392.0,1427.0,1917.0,1944.0,18726.0
Sabar Kantha,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,26.0,21.0,30.0,28.0,28.0,33.0,23.0,17.0,20.0,21.0,13.0,14.0,274.0
Sabar Kantha,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,40.0,57.0,19.0,16.0,13.0,16.0,18.0,17.0,14.0,16.0,14.0,16.0,256.0
Sabar Kantha,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,66.0,78.0,49.0,44.0,41.0,49.0,41.0,34.0,34.0,37.0,27.0,30.0,530.0
Sabar Kantha,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,63.0,65.0,41.0,42.0,41.0,49.0,36.0,34.0,34.0,36.0,26.0,30.0,497.0
Sabar Kantha,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,5.0,5.0,2.0,13.0,9.0,14.0,2.0,37.0,18.0,15.0,6.0,1.0,127.0
Sabar Kantha,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,482.0,528.0,474.0,513.0,621.0,601.0,603.0,560.0,508.0,622.0,531.0,568.0,6611.0
Sabar Kantha,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,61.0,61.0,41.0,38.0,29.0,57.0,40.0,67.0,70.0,105.0,68.0,81.0,718.0
Sabar Kantha,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,38.0,51.0,101.0,114.0,76.0,244.0,63.0,114.0,266.0,304.0,192.0,201.0,1764.0
Sabar Kantha,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,4.0
Sabar Kantha,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1410.0,2222.0,1956.0,1889.0,2089.0,1894.0,2549.0,2387.0,1923.0,2068.0,2134.0,2297.0,24818.0
Sabar Kantha,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,128.0,123.0,232.0,233.0,202.0,154.0,137.0,87.0,7.0,89.0,151.0,140.0,1683.0
Sabar Kantha,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,6.0,10.0,1.0,7.0,6.0,2.0,0.0,0.0,0.0,7.0,2.0,7.0,48.0
Sabar Kantha,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,11.0,18.0,22.0,18.0,20.0,33.0,26.0,23.0,18.0,19.0,16.0,27.0,251.0
Sabar Kantha,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sabar Kantha,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,17.0,28.0,23.0,25.0,26.0,35.0,26.0,23.0,18.0,26.0,18.0,34.0,299.0
Sabar Kantha,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,105.0,213.0,147.0,170.0,193.0,113.0,200.0,179.0,197.0,151.0,168.0,220.0,2056.0
Sabar Kantha,4.1.1.a,Number of male live births,TOTAL,965.0,1455.0,1312.0,1282.0,1380.0,1314.0,1752.0,1535.0,1229.0,1385.0,1363.0,1533.0,16505.0
Sabar Kantha,4.1.1.b,Number of female live births,TOTAL,957.0,1348.0,1129.0,1145.0,1292.0,1162.0,1483.0,1403.0,1141.0,1327.0,1270.0,1334.0,14991.0
Sabar Kantha,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1922.0,2803.0,2441.0,2427.0,2672.0,2476.0,3235.0,2938.0,2370.0,2712.0,2633.0,2867.0,31496.0
Sabar Kantha,4.1.2,Number of still births,TOTAL,34.0,43.0,50.0,46.0,62.0,71.0,54.0,44.0,49.0,46.0,51.0,47.0,597.0
Sabar Kantha,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,95.0,108.0,175.0,112.0,119.0,137.0,132.0,147.0,460.0,159.0,100.0,160.0,1904.0
Sabar Kantha,4.2.1,Number of Newborns weighed at birth,TOTAL,1922.0,2803.0,2438.0,2412.0,2671.0,2475.0,3228.0,2912.0,2364.0,2693.0,2635.0,2861.0,31414.0
Sabar Kantha,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,180.0,243.0,183.0,165.0,207.0,232.0,223.0,224.0,230.0,201.0,182.0,226.0,2496.0
Sabar Kantha,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1837.0,2575.0,2294.0,2335.0,2597.0,2399.0,3095.0,2855.0,2297.0,2662.0,2596.0,2803.0,30345.0
Sabar Kantha,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,2.0,0.0,0.0,7.0
Sabar Kantha,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,8.0,12.0,3.0,9.0,13.0,0.0,6.0,5.0,10.0,7.0,9.0,2.0,84.0
Sabar Kantha,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,51.0,52.0,61.0,51.0,73.0,65.0,62.0,61.0,52.0,43.0,39.0,50.0,660.0
Sabar Kantha,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sabar Kantha,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,59.0,64.0,64.0,60.0,86.0,65.0,68.0,66.0,67.0,52.0,48.0,52.0,751.0
Sabar Kantha,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,102.0,247.0,163.0,181.0,214.0,101.0,186.0,159.0,180.0,119.0,144.0,150.0,1946.0
Sabar Kantha,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,125.0,102.0,87.0,87.0,115.0,89.0,65.0,79.0,67.0,82.0,83.0,95.0,1076.0
Sabar Kantha,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5.0,11.0,10.0,9.0,7.0,7.0,10.0,13.0,19.0,13.0,17.0,7.0,128.0
Sabar Kantha,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,166.0,149.0,113.0,108.0,159.0,153.0,121.0,139.0,125.0,138.0,122.0,175.0,1668.0
Sabar Kantha,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,34.0,51.0,33.0,41.0,72.0,43.0,25.0,45.0,32.0,28.0,49.0,35.0,488.0
Sabar Kantha,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1295.0,1803.0,1593.0,1417.0,1838.0,1879.0,2702.0,2521.0,1875.0,2334.0,1369.0,2372.0,22998.0
Sabar Kantha,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1582.0,2073.0,1927.0,2003.0,2336.0,2054.0,2056.0,2150.0,2053.0,2076.0,1942.0,2024.0,24276.0
Sabar Kantha,6.3,PNC maternal complications attended,TOTAL,4.0,16.0,1.0,1.0,8.0,17.0,13.0,6.0,2.0,13.0,1.0,3.0,85.0
Sabar Kantha,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5.0,6.0,0.0,6.0,16.0,6.0,5.0,2.0,6.0,2.0,6.0,6.0,66.0
Sabar Kantha,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Sabar Kantha,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,5.0,6.0,0.0,6.0,16.0,6.0,5.0,2.0,8.0,2.0,6.0,6.0,68.0
Sabar Kantha,7.2,Number of MTPs conducted at Private Facilities,TOTAL,12.0,20.0,17.0,15.0,32.0,11.0,9.0,12.0,13.0,9.0,6.0,6.0,162.0
Sabar Kantha,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,246.0,421.0,401.0,428.0,480.0,474.0,339.0,406.0,512.0,522.0,520.0,260.0,5009.0
Sabar Kantha,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,503.0,850.0,957.0,920.0,1066.0,1000.0,645.0,711.0,931.0,841.0,921.0,468.0,9813.0
Sabar Kantha,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,749.0,1271.0,1358.0,1348.0,1546.0,1474.0,984.0,1117.0,1443.0,1363.0,1441.0,728.0,14822.0
Sabar Kantha,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,11.0,8.0,7.0,10.0,14.0,55.0
Sabar Kantha,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,2.0,0.0,5.0
Sabar Kantha,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Sabar Kantha,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sabar Kantha,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,3.0,0.0,6.0
Sabar Kantha,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Sabar Kantha,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,24.0,44.0,42.0,71.0,39.0,64.0,42.0,186.0,247.0,379.0,551.0,39.0,1728.0
Sabar Kantha,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,7.0,0.0,0.0,0.0,15.0,6.0,3.0,79.0,84.0,66.0,0.0,0.0,260.0
Sabar Kantha,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sabar Kantha,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,31.0,44.0,42.0,71.0,54.0,70.0,45.0,265.0,331.0,445.0,551.0,39.0,1988.0
Sabar Kantha,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,106.0,66.0,86.0,112.0,115.0,98.0,57.0,139.0,574.0,975.0,461.0,120.0,2909.0
Sabar Kantha,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,7.0,10.0,3.0,3.0,3.0,4.0,2.0,10.0,11.0,84.0,9.0,9.0,155.0
Sabar Kantha,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,4.0,5.0,1.0,2.0,6.0,4.0,3.0,4.0,29.0,22.0,4.0,5.0,89.0
Sabar Kantha,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sabar Kantha,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,11.0,15.0,4.0,5.0,9.0,8.0,5.0,14.0,40.0,106.0,13.0,14.0,244.0
Sabar Kantha,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,280.0,375.0,517.0,609.0,595.0,691.0,673.0,840.0,817.0,792.0,421.0,354.0,6964.0
Sabar Kantha,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,4.0
Sabar Kantha,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,2.0,1.0,1.0,3.0,0.0,2.0,0.0,2.0,5.0,4.0,5.0,25.0
Sabar Kantha,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sabar Kantha,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,4.0,2.0,1.0,3.0,0.0,2.0,0.0,2.0,6.0,4.0,5.0,29.0
Sabar Kantha,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,12.0,14.0,23.0,12.0,34.0,21.0,19.0,15.0,18.0,12.0,17.0,10.0,207.0
Sabar Kantha,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1263.0,1304.0,1729.0,1558.0,1909.0,2121.0,1971.0,2101.0,2104.0,2139.0,2071.0,1694.0,21964.0
Sabar Kantha,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,61.0,46.0,74.0,56.0,62.0,72.0,75.0,66.0,81.0,88.0,108.0,92.0,881.0
Sabar Kantha,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,34.0,21.0,18.0,19.0,13.0,9.0,21.0,16.0,19.0,24.0,19.0,18.0,231.0
Sabar Kantha,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,14.0,18.0,6.0,10.0,15.0,18.0,8.0,15.0,16.0,17.0,17.0,14.0,168.0
Sabar Kantha,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sabar Kantha,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1372.0,1389.0,1827.0,1643.0,1999.0,2220.0,2075.0,2198.0,2220.0,2268.0,2215.0,1818.0,23244.0
Sabar Kantha,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,12.0,29.0,33.0,59.0,48.0,32.0,214.0
Sabar Kantha,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,36.0,96.0,31.0,33.0,114.0,93.0,80.0,28.0,75.0,211.0,76.0,80.0,953.0
Sabar Kantha,9.06,Number of IUCD removals,TOTAL,231.0,240.0,250.0,257.0,282.0,336.0,290.0,335.0,339.0,339.0,378.0,373.0,3650.0
Sabar Kantha,9.07,Number of Oral Pills cycles distributed,TOTAL,3952.0,3303.0,3558.0,3901.0,4256.0,4305.0,4356.0,4455.0,4276.0,4833.0,4424.0,4076.0,49695.0
Sabar Kantha,9.08,Number of Condom pieces distributed,TOTAL,19591.0,8883.0,7040.0,7482.0,26035.0,54971.0,47771.0,36994.0,32421.0,24236.0,30356.0,14019.0,309799.0
Sabar Kantha,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Sabar Kantha,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,323.0,322.0,304.0,436.0,446.0,447.0,491.0,588.0,456.0,422.0,479.0,416.0,5130.0
Sabar Kantha,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,1.0,2.0,2.0,2.0,3.0,4.0,2.0,6.0,5.0,-1.0
Sabar Kantha,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2021.0,2655.0,2586.0,2418.0,2858.0,2663.0,2518.0,2834.0,2629.0,2629.0,2581.0,2582.0,30974.0
Sabar Kantha,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2085.0,2462.0,2534.0,2399.0,2382.0,2416.0,2428.0,2656.0,2784.0,2781.0,2258.0,2192.0,29377.0
Sabar Kantha,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2234.0,2327.0,2484.0,2405.0,2383.0,2328.0,2412.0,2457.0,2639.0,2664.0,2690.0,2254.0,29277.0
Sabar Kantha,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2313.0,2524.0,2343.0,2332.0,2393.0,2338.0,2299.0,2363.0,2487.0,2543.0,2663.0,2454.0,29052.0
Sabar Kantha,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1756.0,2090.0,1918.0,1922.0,2217.0,2146.0,2081.0,2271.0,2156.0,2207.0,2302.0,2186.0,25252.0
Sabar Kantha,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2079.0,2462.0,2491.0,2399.0,2385.0,2386.0,2448.0,2656.0,2784.0,2781.0,2280.0,2203.0,29354.0
Sabar Kantha,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2234.0,2327.0,2427.0,2405.0,2383.0,2319.0,2415.0,2457.0,2639.0,2664.0,2725.0,2279.0,29274.0
Sabar Kantha,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2310.0,2514.0,2291.0,2332.0,2393.0,2330.0,2309.0,2363.0,2487.0,2543.0,2680.0,2492.0,29044.0
Sabar Kantha,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,904.0,1208.0,840.0,812.0,997.0,956.0,1884.0,749.0,749.0,974.0,961.0,944.0,11978.0
Sabar Kantha,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2001.0,2510.0,2460.0,2357.0,2494.0,2240.0,2219.0,2409.0,2539.0,2358.0,2391.0,2381.0,28359.0
Sabar Kantha,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1929.0,2215.0,2294.0,2156.0,2361.0,2200.0,2136.0,2158.0,2262.0,2259.0,2330.0,2375.0,26675.0
Sabar Kantha,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1050.0,1306.0,1262.0,1261.0,1289.0,1203.0,1175.0,1295.0,1338.0,1218.0,1243.0,1268.0,14908.0
Sabar Kantha,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,959.0,1203.0,1186.0,1102.0,1212.0,1058.0,1062.0,1156.0,1188.0,1167.0,1132.0,1141.0,13566.0
Sabar Kantha,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2009.0,2509.0,2448.0,2363.0,2501.0,2261.0,2237.0,2451.0,2526.0,2385.0,2375.0,2409.0,28474.0
Sabar Kantha,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1921.0,2262.0,2336.0,2161.0,2287.0,2199.0,2160.0,2417.0,2392.0,2378.0,2394.0,2484.0,27391.0
Sabar Kantha,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1920.0,2261.0,2336.0,2161.0,2287.0,2198.0,2161.0,2417.0,2394.0,2378.0,2389.0,2472.0,27374.0
Sabar Kantha,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,539.0,669.0,638.0,599.0,598.0,626.0,640.0,632.0,697.0,678.0,750.0,782.0,7848.0
Sabar Kantha,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,447.0,628.0,594.0,513.0,563.0,539.0,641.0,618.0,625.0,602.0,671.0,752.0,7193.0
Sabar Kantha,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,986.0,1297.0,1232.0,1112.0,1161.0,1165.0,1281.0,1250.0,1322.0,1280.0,1421.0,1534.0,15041.0
Sabar Kantha,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,820.0,927.0,1119.0,1508.0,2942.0,2536.0,1488.0,2407.0,2417.0,1773.0,1407.0,2687.0,22031.0
Sabar Kantha,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,618.0,757.0,951.0,1493.0,3270.0,2790.0,1309.0,2492.0,2719.0,1698.0,1441.0,2464.0,22002.0
Sabar Kantha,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,886.0,1118.0,1319.0,1504.0,3156.0,2888.0,1434.0,2327.0,2682.0,1678.0,1562.0,2144.0,22698.0
Sabar Kantha,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,22.0,26.0,14.0,18.0,18.0,18.0,22.0,24.0,20.0,20.0,20.0,24.0,246.0
Sabar Kantha,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1144.0,1219.0,1188.0,1209.0,1259.0,1247.0,1230.0,1241.0,1241.0,1216.0,1219.0,1234.0,14647.0
Sabar Kantha,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1113.0,1199.0,1181.0,1200.0,1248.0,1246.0,1230.0,1238.0,1240.0,1205.0,1202.0,1226.0,14528.0
Sabar Kantha,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1086.0,1173.0,1147.0,1159.0,1227.0,1197.0,1194.0,1181.0,1197.0,1174.0,1168.0,1184.0,14087.0
Sabar Kantha,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1997.0,2506.0,2408.0,2347.0,2476.0,2239.0,2219.0,2415.0,2524.0,2370.0,2387.0,2404.0,28292.0
Sabar Kantha,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,5067.0,21.0,62.0,19.0,3627.0,6.0,2754.0,3071.0,1396.0,424.0,12636.0,5108.0,34191.0
Sabar Kantha,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,4214.0,0.0,7.0,7.0,6983.0,0.0,2581.0,3064.0,1393.0,420.0,11170.0,2473.0,32312.0
Sabar Kantha,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,4.0
Sabar Kantha,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2528.0,2701.0,2775.0,3539.0,4147.0,3492.0,2766.0,2828.0,2845.0,2698.0,2607.0,2760.0,35686.0
Sabar Kantha,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,0.0,4.0,2.0,7.0,8.0,7.0,10.0,2.0,3.0,0.0,0.0,45.0
Sabar Kantha,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,440.0,398.0,346.0,319.0,475.0,912.0,567.0,584.0,639.0,580.0,939.0,706.0,6905.0
Sabar Kantha,13.1,Number of Patients operated for cataract,TOTAL,163.0,60.0,61.0,90.0,151.0,123.0,74.0,86.0,153.0,136.0,185.0,159.0,1441.0
Sabar Kantha,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,160.0,60.0,61.0,90.0,151.0,123.0,74.0,86.0,153.0,136.0,185.0,159.0,1438.0
Sabar Kantha,13.3,Number of School children detected with Refractive errors,TOTAL,104.0,65.0,68.0,136.0,226.0,320.0,119.0,157.0,188.0,778.0,826.0,265.0,3252.0
Sabar Kantha,13.4,Number of children provided free glasses,TOTAL,100.0,61.0,62.0,136.0,210.0,319.0,117.0,151.0,180.0,751.0,493.0,250.0,2830.0
Sabar Kantha,13.5,Number of eyes collected through eye donation,TOTAL,4.0,6.0,8.0,4.0,4.0,6.0,2.0,6.0,11.0,0.0,11.0,6.0,68.0
Sabar Kantha,13.6,Number of eyes utilised for corneal transplant,TOTAL,4.0,6.0,8.0,0.0,4.0,10.0,2.0,6.0,11.0,0.0,11.0,6.0,68.0
Sabar Kantha,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,5.0,6.0,6.0,-1.0
Sabar Kantha,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,9.0,9.0,9.0,9.0,10.0,10.0,10.0,11.0,9.0,8.0,9.0,10.0,-1.0
Sabar Kantha,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1008.0,985.0,951.0,971.0,967.0,942.0,930.0,964.0,966.0,840.0,856.0,940.0,-1.0
Sabar Kantha,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,13.0,13.0,12.0,13.0,13.0,15.0,14.0,13.0,13.0,13.0,13.0,13.0,-1.0
Sabar Kantha,14.05,Number of RKS meetings held during the month,TOTAL,8.0,7.0,19.0,14.0,15.0,12.0,7.0,9.0,20.0,14.0,14.0,20.0,159.0
Sabar Kantha,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,28.0,29.0,30.0,24.0,30.0,28.0,30.0,30.0,32.0,33.0,33.0,32.0,-1.0
Sabar Kantha,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,228.0,338.0,219.0,331.0,451.0,447.0,410.0,348.0,367.0,342.0,287.0,349.0,4117.0
Sabar Kantha,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Sabar Kantha,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,5.0,7.0,4.0,5.0,5.0,-1.0
Sabar Kantha,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,301.0,476.0,314.0,206.0,258.0,294.0,266.0,176.0,174.0,204.0,229.0,219.0,3117.0
Sabar Kantha,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2034.0,2488.0,1971.0,1394.0,1620.0,1645.0,1660.0,1191.0,1317.0,921.0,1160.0,1207.0,18608.0
Sabar Kantha,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,326.0,525.0,422.0,192.0,272.0,292.0,264.0,244.0,222.0,312.0,293.0,266.0,3630.0
Sabar Kantha,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3370.0,4327.0,3004.0,2510.0,3076.0,3066.0,2540.0,2362.0,2372.0,2505.0,2247.0,2760.0,34139.0
Sabar Kantha,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,627.0,1001.0,736.0,398.0,530.0,586.0,530.0,420.0,396.0,516.0,522.0,485.0,6747.0
Sabar Kantha,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5404.0,6815.0,4975.0,3904.0,4696.0,4711.0,4200.0,3553.0,3689.0,3426.0,3407.0,3967.0,52747.0
Sabar Kantha,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,4.0
Sabar Kantha,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Sabar Kantha,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,6.0
Sabar Kantha,14.11,In-Patient Head Count at midnight,TOTAL,4349.0,3937.0,4151.0,3895.0,5139.0,4712.0,5120.0,4806.0,4778.0,4183.0,4012.0,3939.0,53021.0
Sabar Kantha,14.12.1,OPD attendance (All),TOTAL,85524.0,103678.0,90956.0,102424.0,113118.0,126127.0,101305.0,99114.0,106213.0,101772.0,130677.0,121999.0,1282907.0
Sabar Kantha,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,39.0,62.0,59.0,67.0,66.0,64.0,51.0,67.0,96.0,104.0,89.0,60.0,824.0
Sabar Kantha,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,3.0,0.0,0.0,45.0,43.0,46.0,35.0,51.0,67.0,86.0,72.0,38.0,486.0
Sabar Kantha,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,371.0,385.0,361.0,379.0,384.0,438.0,521.0,547.0,738.0,759.0,522.0,439.0,5844.0
Sabar Kantha,14.14.a,Number of patients given AYUSH treatment,TOTAL,7606.0,8638.0,8506.0,9787.0,9570.0,10555.0,8184.0,8659.0,10415.0,8589.0,10544.0,10272.0,111325.0
Sabar Kantha,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,22.0,26.0,11.0,32.0,443.0,16.0,16.0,20.0,21.0,14.0,23.0,10.0,654.0
Sabar Kantha,14.14.c,Number of Adolescents counselled,TOTAL,60.0,63.0,62.0,81.0,92.0,85.0,55.0,84.0,89.0,104.0,73.0,75.0,923.0
Sabar Kantha,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7252.0,8693.0,8774.0,9612.0,9557.0,8676.0,7518.0,8195.0,8015.0,8074.0,8412.0,9215.0,101993.0
Sabar Kantha,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,298.0,321.0,390.0,378.0,333.0,347.0,268.0,345.0,290.0,316.0,276.0,342.0,3904.0
Sabar Kantha,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,465.0,653.0,450.0,635.0,644.0,575.0,495.0,578.0,632.0,597.0,507.0,575.0,6806.0
Sabar Kantha,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,10.0,11.0,6.0,8.0,4.0,2.0,2.0,3.0,5.0,7.0,4.0,66.0
Sabar Kantha,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,423.0,561.0,599.0,614.0,563.0,663.0,594.0,590.0,612.0,629.0,488.0,553.0,6889.0
Sabar Kantha,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,3.0,4.0,22.0,42.0,63.0,9.0,21.0,52.0,3.0,4.0,5.0,230.0
Sabar Kantha,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1321.0,1357.0,1875.0,1580.0,1839.0,1619.0,1355.0,1553.0,1665.0,1604.0,1512.0,1748.0,19028.0
Sabar Kantha,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,0.0,2.0,1.0,39.0,1.0,12.0,0.0,1.0,21.0,8.0,2.0,89.0
Sabar Kantha,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2209.0,2571.0,2924.0,2829.0,3046.0,2857.0,2444.0,2721.0,2909.0,2830.0,2507.0,2876.0,32723.0
Sabar Kantha,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8.0,13.0,17.0,29.0,89.0,68.0,23.0,23.0,56.0,29.0,19.0,11.0,385.0
Sabar Kantha,15.2,Number of Widal tests conducted,Number tested,384.0,491.0,408.0,485.0,697.0,879.0,827.0,670.0,535.0,460.0,667.0,805.0,7308.0
Sabar Kantha,15.3.a,Number of VDRL tests conducted on males,Number tested,21.0,32.0,21.0,15.0,35.0,72.0,35.0,28.0,145.0,6.0,14.0,23.0,447.0
Sabar Kantha,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,68.0,84.0,72.0,63.0,164.0,146.0,95.0,87.0,169.0,95.0,87.0,111.0,1241.0
Sabar Kantha,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,252.0,321.0,327.0,278.0,383.0,384.0,386.0,517.0,500.0,485.0,602.0,707.0,5142.0
Sabar Kantha,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,341.0,437.0,420.0,356.0,582.0,602.0,516.0,632.0,814.0,586.0,703.0,841.0,6830.0
Sabar Kantha,15.4.1,Number of blood smears examined for Malaria,TOTAL,17582.0,17840.0,25095.0,25412.0,31376.0,31122.0,20785.0,21187.0,20597.0,16237.0,21271.0,19350.0,267854.0
Sabar Kantha,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,24.0,29.0,37.0,62.0,78.0,106.0,64.0,71.0,22.0,2.0,3.0,8.0,506.0
Sabar Kantha,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,5.0,9.0,4.0,21.0,20.0,20.0,24.0,15.0,3.0,1.0,0.0,122.0
Sabar Kantha,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3450.0,250.0,3500.0,9000.0,15630.0,16950.0,17500.0,24050.0,,19690.0,21590.0,,131610.0
Sabar Kantha,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,10000.0,15000.0,20000.0,20000.0,10000.0,20000.0,10000.0,,10000.0,0.0,,115000.0
Sabar Kantha,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,,,,,,0.0,,0.0,21590.0,,21590.0
Sabar Kantha,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3200.0,6750.0,9500.0,13370.0,18680.0,9450.0,13450.0,10000.0,,8100.0,0.0,,92500.0
Sabar Kantha,16.1.1,Stock position of DPT vaccines,5. Total Stock,250.0,3500.0,9000.0,15630.0,16950.0,17500.0,24050.0,24050.0,0.0,21590.0,0.0,0.0,132520.0
Sabar Kantha,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,9100.0,8400.0,18100.0,26600.0,30100.0,25430.0,28140.0,42070.0,,20500.0,24900.0,,233340.0
Sabar Kantha,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,15000.0,15000.0,21000.0,21000.0,10000.0,12000.0,24000.0,5000.0,,18000.0,0.0,,141000.0
Sabar Kantha,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,,,,,,0.0,,0.0,24900.0,,24900.0
Sabar Kantha,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,15700.0,5300.0,12500.0,17500.0,14670.0,9290.0,10070.0,16150.0,,13600.0,,,114780.0
Sabar Kantha,16.1.1A,Stock Position of Pentavalent,5. Total Stock,8400.0,18100.0,26600.0,30100.0,25430.0,28140.0,42070.0,30920.0,0.0,24900.0,0.0,0.0,234660.0
Sabar Kantha,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,38100.0,23800.0,27900.0,42000.0,41920.0,35560.0,39600.0,44600.0,,14075.0,44900.0,,352455.0
Sabar Kantha,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,20000.0,40000.0,30000.0,30000.0,30000.0,38000.0,27000.0,,10000.0,420000.0,,655000.0
Sabar Kantha,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,,,,,,0.0,,0.0,447500.0,,447500.0
Sabar Kantha,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,24300.0,15900.0,25900.0,30080.0,36360.0,25960.0,33000.0,29600.0,,9300.0,,,230400.0
Sabar Kantha,16.1.2,Stock position of OPV vaccines,5. Total Stock,23800.0,27900.0,42000.0,41920.0,35560.0,39600.0,44600.0,42000.0,0.0,14775.0,17400.0,0.0,329555.0
Sabar Kantha,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,12550.0,16750.0,26100.0,2900.0,34180.0,23000.0,41720.0,52920.0,,36520.0,32520.0,,279160.0
Sabar Kantha,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,15000.0,15000.0,22500.0,20000.0,32000.0,32000.0,5000.0,,10000.0,0.0,,171500.0
Sabar Kantha,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,,,,,,0.0,,0.0,16450.0,,16450.0
Sabar Kantha,16.1.3,Stock position of TT vaccines,4. Stock Distributed,15800.0,5650.0,11200.0,18220.0,31180.0,13280.0,20800.0,57920.0,,14000.0,,,188050.0
Sabar Kantha,16.1.3,Stock position of TT vaccines,5. Total Stock,16750.0,26100.0,29900.0,7180.0,23000.0,41720.0,52920.0,0.0,0.0,32520.0,16070.0,0.0,246160.0
Sabar Kantha,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4600.0,3900.0,8500.0,10300.0,8580.0,6120.0,10510.0,12010.0,,,,,64520.0
Sabar Kantha,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,,,,,80000.0
Sabar Kantha,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,,,,,,0.0,,,,,0.0
Sabar Kantha,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,10700.0,5400.0,8200.0,11720.0,11230.0,5610.0,8500.0,8500.0,,,,,69860.0
Sabar Kantha,16.1.5,Stock position of BCG vaccines,5. Total Stock,3900.0,8500.0,10300.0,8580.0,7350.0,10510.0,12010.0,13510.0,0.0,0.0,0.0,0.0,74660.0
Sabar Kantha,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1350.0,,4200.0,10700.0,13010.0,11280.0,14480.0,20505.0,20030.0,14075.0,14775.0,,124405.0
Sabar Kantha,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,,19200.0,14000.0,9500.0,10000.0,15000.0,10000.0,5000.0,10000.0,0.0,,102700.0
Sabar Kantha,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,,,,,,,0.0,,0.0,14775.0,,14775.0
Sabar Kantha,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,10275.0,,8500.0,11690.0,11230.0,6800.0,8975.0,10475.0,10955.0,9300.0,,,88200.0
Sabar Kantha,16.1.6,Stock position of Measles vaccines,5. Total Stock,1075.0,0.0,14900.0,13010.0,11280.0,14480.0,20505.0,20030.0,14075.0,14775.0,0.0,0.0,124130.0
Sabar Kantha,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2800.0,,,2350.0,4260.0,5810.0,6860.0,7330.0,6130.0,4750.0,6570.0,,46860.0
Sabar Kantha,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,,,3000.0,2100.0,3000.0,3000.0,0.0,0.0,3000.0,0.0,,14100.0
Sabar Kantha,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,,,,,,,0.0,0.0,1180.0,6570.0,,7750.0
Sabar Kantha,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,100.0,,,1090.0,550.0,1950.0,2530.0,1200.0,1380.0,,,,8800.0
Sabar Kantha,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2700.0,0.0,0.0,4260.0,5810.0,6860.0,7330.0,6130.0,4750.0,6570.0,0.0,0.0,44410.0
Sabar Kantha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,23160.0,,2000.0,15480.0,402840.0,3900.0,39000.0,33000.0,15000.0,6000.0,57000.0,2940.0,600320.0
Sabar Kantha,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,,60000.0,403200.0,,,0.0,0.0,0.0,54000.0,0.0,352800.0,870000.0
Sabar Kantha,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,,,0.0,,,,,,0.0,36000.0,0.0,36000.0
Sabar Kantha,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,,8000.0,413280.0,226800.0,3900.0,6000.0,18000.0,9000.0,3000.0,,164520.0,852500.0
Sabar Kantha,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,23160.0,0.0,54000.0,5400.0,176040.0,0.0,33000.0,15000.0,6000.0,57000.0,21000.0,191220.0,581820.0
Sabar Kantha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3700.0,,1000.0,1000.0,16780.0,900.0,900.0,900.0,9100.0,8100.0,,4000.0,46380.0
Sabar Kantha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,0.0,,,,0.0,10000.0,0.0,0.0,,0.0,10000.0
Sabar Kantha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,0.0,,0.0,0.0
Sabar Kantha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,,0.0,,9600.0,900.0,0.0,1800.0,1000.0,1500.0,,1000.0,15800.0
Sabar Kantha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,3700.0,0.0,1000.0,1000.0,7180.0,0.0,900.0,9100.0,8100.0,6600.0,0.0,3000.0,40580.0
Sabar Kantha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2880.0,,7792.0,2092.0,300.0,300.0,300.0,2400.0,80.0,300.0,,300.0,16744.0
Sabar Kantha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,0.0,2092.0,,4500.0,0.0,54000.0,0.0,0.0,,0.0,60592.0
Sabar Kantha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,0.0,,,,,,0.0,,0.0,0.0
Sabar Kantha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,,6000.0,2092.0,0.0,300.0,0.0,6600.0,80.0,0.0,,300.0,15372.0
Sabar Kantha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,2880.0,0.0,1792.0,2092.0,300.0,4500.0,300.0,49800.0,0.0,300.0,0.0,0.0,61964.0
Sabar Kantha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,1006.0,7724.0,7724.0,,,,,,,,16454.0
Sabar Kantha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,0.0,7724.0,,,,,,,,,7724.0
Sabar Kantha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Sabar Kantha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,0.0,7724.0,0.0,,,,,,,,7724.0
Sabar Kantha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,1006.0,7724.0,7724.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16454.0
Sabar Kantha,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Sabar Kantha,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Sabar Kantha,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Sabar Kantha,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Sabar Kantha,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sabar Kantha,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,177000.0,250.0,162000.0,26100.0,21100.0,19900.0,8900.0,8900.0,8400.0,6800.0,19700.0,6400.0,465450.0
Sabar Kantha,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,64000.0,9900.0,164000.0,0.0,0.0,,0.0,0.0,0.0,16500.0,0.0,13200.0,267600.0
Sabar Kantha,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,,,,,0.0,,0.0,19700.0,0.0,19700.0
Sabar Kantha,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,133000.0,7650.0,178000.0,5000.0,1200.0,11000.0,0.0,500.0,1600.0,3600.0,0.0,1700.0,343250.0
Sabar Kantha,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,108000.0,2500.0,148000.0,21100.0,19900.0,8900.0,8900.0,8400.0,6800.0,19700.0,0.0,17900.0,370100.0
Sabar Kantha,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,400.0,111000.0,2500.0,148000.0,52000.0,50000.0,18600.0,16000.0,16000.0,1740.0,28000.0,45400.0,489640.0
Sabar Kantha,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,54000.0,33000.0,0.0,0.0,,20000.0,0.0,110000.0,7360.0,60000.0,0.0,284360.0
Sabar Kantha,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,0.0,,,,,,0.0,,0.0,42600.0,0.0,42600.0
Sabar Kantha,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,200.0,3000.0,9400.0,96000.0,2000.0,34000.0,1100.0,0.0,16000.0,1840.0,,10000.0,173540.0
Sabar Kantha,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,200.0,162000.0,26100.0,52000.0,50000.0,16000.0,37500.0,16000.0,110000.0,7260.0,45400.0,35400.0,557860.0
Sabar Kantha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,200.0,1400.0,5800.0,5800.0,5600.0,23100.0,16000.0,37500.0,24000.0,23700.0,23700.0,17100.0,183900.0
Sabar Kantha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,33600.0,0.0,0.0,20000.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,63600.0
Sabar Kantha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,0.0,,,,,,0.0,,0.0,6600.0,0.0,6600.0
Sabar Kantha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,100.0,29000.0,0.0,200.0,2500.0,14500.0,0.0,13500.0,300.0,0.0,,6600.0,66700.0
Sabar Kantha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,100.0,6000.0,5800.0,5600.0,23100.0,18600.0,16000.0,24000.0,23700.0,23700.0,17100.0,10500.0,174200.0
Sabar Kantha,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,2.0,1.0,1.0,,,,,,,,,4.0
Sabar Kantha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,5.0,1.0,,,,,1.0,2.0,1.0,,,10.0
Sabar Kantha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,1.0,,,,,,,,,,1.0
Sabar Kantha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,5.0,2.0,,,,,1.0,2.0,1.0,,,11.0
Sabar Kantha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,7.0,15.0,13.0,11.0,17.0,5.0,12.0,11.0,7.0,7.0,5.0,8.0,118.0
Sabar Kantha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,1.0,,,,1.0,,,,,1.0,,3.0
Sabar Kantha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,7.0,16.0,13.0,11.0,17.0,6.0,12.0,11.0,7.0,7.0,6.0,8.0,121.0
Sabar Kantha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,16.0,14.0,26.0,14.0,11.0,13.0,7.0,15.0,16.0,18.0,16.0,8.0,174.0
Sabar Kantha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,3.0,4.0,,,3.0,,1.0,2.0,2.0,3.0,,,18.0
Sabar Kantha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,19.0,18.0,26.0,14.0,14.0,13.0,8.0,17.0,18.0,21.0,16.0,8.0,192.0
Sabar Kantha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,12.0,19.0,10.0,7.0,3.0,5.0,2.0,4.0,4.0,3.0,4.0,75.0
Sabar Kantha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,1.0,1.0,3.0,,1.0,3.0,1.0,1.0,1.0,,,13.0
Sabar Kantha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,13.0,20.0,13.0,7.0,4.0,8.0,3.0,5.0,5.0,3.0,4.0,88.0
Sabar Kantha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,3.0,2.0,1.0,2.0,3.0,1.0,1.0,,1.0,4.0,1.0,20.0
Sabar Kantha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Sabar Kantha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,3.0,2.0,1.0,2.0,3.0,1.0,1.0,,2.0,4.0,1.0,21.0
Sabar Kantha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sabar Kantha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sabar Kantha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Sabar Kantha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,,,,,,,,1.0,1.0,3.0
Sabar Kantha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Sabar Kantha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,,1.0,,,,,,1.0,1.0,4.0
Sabar Kantha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sabar Kantha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sabar Kantha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sabar Kantha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,7.0,5.0,3.0,3.0,7.0,4.0,,8.0,4.0,4.0,3.0,51.0
Sabar Kantha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,2.0,,,1.0,2.0,,1.0,,2.0,2.0,2.0,14.0
Sabar Kantha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,9.0,5.0,3.0,4.0,9.0,4.0,1.0,8.0,6.0,6.0,5.0,65.0
Sabar Kantha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Sabar Kantha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Sabar Kantha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Sabar Kantha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,2.0,2.0,1.0,,3.0,1.0,3.0,1.0,2.0,1.0,1.0,18.0
Sabar Kantha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,2.0,1.0,,2.0,,,,1.0,,,1.0,7.0
Sabar Kantha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,4.0,3.0,1.0,2.0,3.0,1.0,3.0,2.0,2.0,1.0,2.0,25.0
Sabar Kantha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,,,3.0,1.0,1.0,2.0,2.0,,3.0,1.0,15.0
Sabar Kantha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,2.0,,5.0,5.0,2.0,3.0,4.0,2.0,2.0,2.0,28.0
Sabar Kantha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,2.0,2.0,,8.0,6.0,3.0,5.0,6.0,2.0,5.0,3.0,43.0
Sabar Kantha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Sabar Kantha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Sabar Kantha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Sabar Kantha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,,,,,,,,,1.0
Sabar Kantha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,2.0,2.0
Sabar Kantha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,1.0,1.0,,1.0,1.0,1.0,1.0,1.0,1.0,,1.0,10.0
Sabar Kantha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,1.0,1.0,,1.0,1.0,1.0,1.0,1.0,1.0,,3.0,12.0
Sabar Kantha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Sabar Kantha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sabar Kantha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,1.0,,,,1.0
Sabar Kantha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,2.0,4.0,4.0,3.0,7.0,2.0,5.0,5.0,8.0,3.0,8.0,56.0
Sabar Kantha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,7.0,7.0,7.0,8.0,8.0,6.0,5.0,7.0,11.0,6.0,9.0,84.0
Sabar Kantha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,8.0,9.0,11.0,11.0,11.0,15.0,8.0,10.0,12.0,19.0,9.0,17.0,140.0
Sabar Kantha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,2.0,,,,,,,2.0,1.0,5.0
Sabar Kantha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,,,,,,,1.0,,,,,3.0
Sabar Kantha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,,,2.0,,,,1.0,,,2.0,1.0,8.0
Sabar Kantha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sabar Kantha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Sabar Kantha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sabar Kantha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Sabar Kantha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sabar Kantha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Sabar Kantha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,,,1.0,1.0,1.0,1.0,2.0,2.0,9.0
Sabar Kantha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sabar Kantha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,,,1.0,1.0,1.0,1.0,2.0,2.0,9.0
Sabar Kantha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sabar Kantha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Sabar Kantha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,2.0,1.0,,,,3.0
Sabar Kantha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sabar Kantha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,2.0,1.0,,,,3.0
Sabar Kantha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,,,1.0,,,1.0,,,,3.0
Sabar Kantha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,4.0,3.0,3.0,2.0,2.0,5.0,4.0,4.0,3.0,3.0,3.0,38.0
Sabar Kantha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Sabar Kantha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,5.0,3.0,3.0,2.0,3.0,5.0,4.0,5.0,3.0,4.0,3.0,42.0
Sabar Kantha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Sabar Kantha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,1.0,,2.0,1.0,2.0,3.0,4.0,3.0,,2.0,6.0,26.0
Sabar Kantha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,,,,,,2.0,,,,3.0
Sabar Kantha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,1.0,1.0,2.0,1.0,2.0,3.0,4.0,5.0,,2.0,6.0,29.0
Sabar Kantha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Sabar Kantha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,2.0,,,,,,,,2.0
Sabar Kantha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Sabar Kantha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,3.0,,,,,,,1.0,4.0
Sabar Kantha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,,,,,1.0,,,,,2.0
Sabar Kantha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,1.0,,1.0,1.0,1.0,1.0,,2.0,1.0,4.0,13.0
Sabar Kantha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,1.0,,1.0,2.0,,,,,,,5.0
Sabar Kantha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,3.0,2.0,,2.0,3.0,1.0,2.0,,2.0,1.0,4.0,20.0
Sabar Kantha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,,,,,,1.0,,,,2.0
Sabar Kantha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,3.0,,1.0,2.0,1.0,2.0,4.0,,,,4.0,18.0
Sabar Kantha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,10.0,2.0,9.0,7.0,6.0,5.0,7.0,4.0,1.0,1.0,6.0,58.0
Sabar Kantha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,2.0,13.0,2.0,10.0,9.0,7.0,7.0,11.0,5.0,1.0,1.0,10.0,78.0
Sabar Kantha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,,,,,,,1.0,,,2.0
Sabar Kantha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,5.0,10.0,12.0,3.0,5.0,10.0,8.0,8.0,8.0,5.0,8.0,6.0,88.0
Sabar Kantha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,24.0,28.0,30.0,27.0,14.0,28.0,22.0,32.0,59.0,40.0,47.0,51.0,402.0
Sabar Kantha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,30.0,38.0,42.0,30.0,19.0,38.0,30.0,40.0,67.0,46.0,55.0,57.0,492.0
Surat,1.1,Total number of pregnant women Registered for ANC,TOTAL,9181.0,9892.0,10449.0,10325.0,10216.0,10758.0,9601.0,10633.0,10959.0,10133.0,9747.0,10923.0,122817.0
Surat,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5570.0,5618.0,6028.0,5696.0,5734.0,6164.0,5688.0,6069.0,6137.0,5828.0,5566.0,6371.0,70469.0
Surat,1.2,Number of Pregnant women registered under JSY,TOTAL,1772.0,1061.0,1095.0,2107.0,1955.0,2054.0,1775.0,1938.0,2024.0,1824.0,1895.0,2004.0,21504.0
Surat,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,7205.0,7709.0,6075.0,6322.0,6941.0,6572.0,6713.0,7372.0,6913.0,6086.0,5775.0,7134.0,80817.0
Surat,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6158.0,5741.0,6564.0,6476.0,6199.0,6491.0,5878.0,6337.0,6917.0,6277.0,6124.0,6815.0,75977.0
Surat,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5616.0,6479.0,6380.0,6521.0,6705.0,6644.0,6047.0,6412.0,7305.0,7079.0,6740.0,6832.0,78760.0
Surat,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,9158.0,9170.0,7687.0,6851.0,8827.0,10095.0,9213.0,6722.0,6581.0,8358.0,9401.0,10929.0,102992.0
Surat,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,61.0,68.0,96.0,318.0,101.0,194.0,69.0,210.0,250.0,188.0,204.0,272.0,2031.0
Surat,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,10.0,8.0,9.0,9.0,8.0,10.0,13.0,10.0,13.0,16.0,9.0,13.0,128.0
Surat,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,5183.0,6167.0,6256.0,6293.0,6254.0,6576.0,6327.0,6628.0,6651.0,6526.0,6387.0,7228.0,76476.0
Surat,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,96.0,118.0,118.0,257.0,258.0,121.0,123.0,98.0,132.0,133.0,105.0,110.0,1669.0
Surat,1.8,Number of pregnancy test kits used at SC level,TOTAL,208.0,311.0,283.0,191.0,151.0,307.0,257.0,286.0,520.0,413.0,435.0,304.0,3666.0
Surat,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,21.0,31.0,25.0,32.0,20.0,29.0,38.0,47.0,48.0,32.0,34.0,18.0,375.0
Surat,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,43.0,37.0,51.0,43.0,54.0,77.0,43.0,44.0,25.0,49.0,57.0,65.0,588.0
Surat,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,64.0,68.0,76.0,75.0,74.0,106.0,81.0,91.0,73.0,81.0,91.0,83.0,963.0
Surat,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,43.0,59.0,58.0,54.0,53.0,85.0,54.0,75.0,56.0,55.0,59.0,63.0,714.0
Surat,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,5.0,7.0,5.0,11.0,3.0,14.0,6.0,11.0,7.0,10.0,13.0,5.0,97.0
Surat,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2174.0,2219.0,2179.0,2052.0,2155.0,2532.0,2835.0,2495.0,2558.0,2501.0,2185.0,2272.0,28157.0
Surat,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1294.0,1337.0,1375.0,1302.0,1279.0,1482.0,1845.0,1556.0,1570.0,1454.0,1321.0,1222.0,17037.0
Surat,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,85.0,74.0,143.0,112.0,131.0,75.0,112.0,115.0,101.0,86.0,84.0,113.0,1231.0
Surat,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,7.0,2.0,1.0,1.0,15.0,11.0,16.0,12.0,8.0,11.0,11.0,3.0,98.0
Surat,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,45.0,48.0
Surat,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,5767.0,4387.0,4946.0,5061.0,5872.0,4610.0,5262.0,5870.0,7008.0,6782.0,6362.0,6382.0,68309.0
Surat,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,70.0,79.0,76.0,89.0,57.0,166.0,130.0,84.0,126.0,65.0,72.0,1014.0
Surat,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,1.0,0.0,1.0,1.0,7.0
Surat,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,12.0,12.0,41.0,28.0,27.0,44.0,47.0,44.0,44.0,23.0,53.0,73.0,448.0
Surat,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,287.0,282.0,292.0,244.0,275.0,340.0,324.0,295.0,308.0,308.0,259.0,231.0,3445.0
Surat,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surat,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,300.0,294.0,333.0,273.0,302.0,384.0,373.0,339.0,353.0,331.0,313.0,305.0,3900.0
Surat,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,575.0,728.0,785.0,665.0,825.0,914.0,846.0,934.0,949.0,903.0,731.0,814.0,9669.0
Surat,4.1.1.a,Number of male live births,TOTAL,4258.0,3556.0,3862.0,3809.0,4284.0,3793.0,4209.0,4615.0,5050.0,4865.0,4508.0,4654.0,51463.0
Surat,4.1.1.b,Number of female live births,TOTAL,3725.0,3108.0,3272.0,3337.0,3768.0,3418.0,3710.0,3829.0,4575.0,4384.0,4081.0,4047.0,45254.0
Surat,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,7983.0,6664.0,7134.0,7146.0,8052.0,7211.0,7919.0,8444.0,9625.0,9249.0,8589.0,8701.0,96717.0
Surat,4.1.2,Number of still births,TOTAL,71.0,64.0,76.0,64.0,63.0,81.0,70.0,71.0,67.0,72.0,63.0,80.0,842.0
Surat,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,186.0,131.0,156.0,118.0,145.0,128.0,137.0,129.0,149.0,125.0,101.0,106.0,1611.0
Surat,4.2.1,Number of Newborns weighed at birth,TOTAL,7879.0,6734.0,7284.0,7218.0,8162.0,7307.0,7927.0,8474.0,9720.0,9308.0,8570.0,8508.0,97091.0
Surat,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,952.0,996.0,1143.0,973.0,938.0,1121.0,1135.0,990.0,1125.0,1232.0,1179.0,1135.0,12919.0
Surat,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,7151.0,5840.0,6267.0,6301.0,6695.0,6093.0,6801.0,7285.0,8520.0,8261.0,7606.0,7393.0,84213.0
Surat,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,2.0,7.0,7.0,7.0,13.0,16.0,11.0,25.0,8.0,8.0,3.0,13.0,120.0
Surat,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,9.0,18.0,8.0,16.0,48.0,46.0,20.0,25.0,11.0,48.0,16.0,55.0,320.0
Surat,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,507.0,435.0,448.0,113.0,148.0,158.0,137.0,161.0,162.0,173.0,162.0,137.0,2741.0
Surat,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surat,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,518.0,460.0,463.0,136.0,209.0,220.0,168.0,211.0,181.0,229.0,181.0,205.0,3181.0
Surat,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,29.0,21.0,29.0,127.0,39.0,54.0,42.0,84.0,123.0,93.0,102.0,151.0,894.0
Surat,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,959.0,817.0,778.0,814.0,891.0,876.0,819.0,1025.0,900.0,946.0,831.0,1068.0,10724.0
Surat,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,69.0,75.0,78.0,66.0,38.0,42.0,38.0,33.0,37.0,39.0,39.0,38.0,592.0
Surat,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,941.0,913.0,1069.0,838.0,933.0,1089.0,989.0,1040.0,1118.0,1057.0,956.0,1090.0,12033.0
Surat,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,61.0,70.0,49.0,53.0,51.0,55.0,51.0,43.0,66.0,55.0,50.0,70.0,674.0
Surat,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,8420.0,7053.0,7803.0,7814.0,8706.0,7893.0,8566.0,9067.0,10268.0,9950.0,9128.0,8899.0,103567.0
Surat,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2695.0,3038.0,3210.0,3047.0,3252.0,3472.0,3685.0,3711.0,3584.0,3675.0,3072.0,3152.0,39593.0
Surat,6.3,PNC maternal complications attended,TOTAL,228.0,195.0,172.0,138.0,180.0,178.0,166.0,187.0,222.0,195.0,173.0,151.0,2185.0
Surat,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,74.0,98.0,69.0,64.0,53.0,49.0,49.0,87.0,65.0,95.0,115.0,105.0,923.0
Surat,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,15.0,16.0,21.0,16.0,10.0,13.0,16.0,24.0,15.0,20.0,18.0,30.0,214.0
Surat,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,89.0,114.0,90.0,80.0,63.0,62.0,65.0,111.0,80.0,115.0,133.0,135.0,1137.0
Surat,7.2,Number of MTPs conducted at Private Facilities,TOTAL,79.0,88.0,83.0,60.0,102.0,41.0,126.0,119.0,35.0,27.0,72.0,67.0,899.0
Surat,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,551.0,647.0,665.0,714.0,807.0,755.0,655.0,614.0,562.0,578.0,656.0,762.0,7966.0
Surat,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1288.0,1380.0,1426.0,1644.0,1801.0,1743.0,1493.0,1531.0,1531.0,1478.0,1657.0,1888.0,18860.0
Surat,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1839.0,2027.0,2091.0,2358.0,2608.0,2498.0,2148.0,2145.0,2093.0,2056.0,2313.0,2650.0,26826.0
Surat,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,15.0,6.0,26.0
Surat,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,2.0,0.0,0.0,0.0,6.0
Surat,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Surat,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,0.0,5.0,3.0,4.0,1.0,2.0,0.0,0.0,16.0
Surat,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surat,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,1.0,1.0,1.0,6.0,4.0,4.0,3.0,2.0,0.0,0.0,23.0
Surat,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0
Surat,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,4.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
Surat,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,39.0,2.0,2.0,236.0,21.0,185.0,27.0,59.0,301.0,124.0,181.0,37.0,1214.0
Surat,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,142.0,135.0,102.0,110.0,86.0,81.0,121.0,182.0,128.0,163.0,174.0,162.0,1586.0
Surat,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surat,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,181.0,137.0,104.0,350.0,116.0,266.0,148.0,241.0,429.0,287.0,355.0,199.0,2813.0
Surat,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,344.0,388.0,463.0,517.0,490.0,531.0,690.0,426.0,532.0,392.0,294.0,433.0,5500.0
Surat,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,288.0,309.0,321.0,313.0,231.0,364.0,283.0,770.0,697.0,699.0,507.0,411.0,5193.0
Surat,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,40.0,13.0,81.0,41.0,62.0,168.0,19.0,60.0,17.0,43.0,69.0,26.0,639.0
Surat,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,13.0,17.0,15.0,11.0,4.0,19.0,84.0,28.0,13.0,8.0,18.0,2.0,232.0
Surat,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surat,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,341.0,339.0,417.0,365.0,297.0,551.0,386.0,858.0,727.0,750.0,594.0,439.0,6064.0
Surat,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,679.0,1359.0,1529.0,1479.0,1563.0,1446.0,1226.0,1611.0,1513.0,1275.0,1637.0,1796.0,17113.0
Surat,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,9.0,13.0,14.0,16.0,41.0,17.0,10.0,20.0,17.0,24.0,22.0,10.0,213.0
Surat,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,12.0,0.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0
Surat,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,13.0,16.0,42.0,24.0,24.0,22.0,25.0,27.0,33.0,40.0,17.0,55.0,338.0
Surat,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surat,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,23.0,41.0,56.0,40.0,65.0,55.0,35.0,47.0,50.0,64.0,39.0,65.0,580.0
Surat,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,193.0,215.0,150.0,210.0,181.0,305.0,154.0,162.0,236.0,232.0,232.0,225.0,2495.0
Surat,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,461.0,506.0,509.0,549.0,513.0,561.0,576.0,671.0,605.0,585.0,510.0,450.0,6496.0
Surat,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,376.0,392.0,442.0,557.0,578.0,458.0,443.0,428.0,300.0,337.0,302.0,378.0,4991.0
Surat,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,10.0,12.0,14.0,12.0,13.0,285.0,6.0,7.0,11.0,16.0,11.0,27.0,424.0
Surat,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,152.0,131.0,199.0,216.0,217.0,262.0,236.0,210.0,350.0,403.0,237.0,271.0,2884.0
Surat,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surat,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,999.0,1041.0,1164.0,1334.0,1321.0,1566.0,1261.0,1316.0,1266.0,1341.0,1060.0,1126.0,14795.0
Surat,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,41.0,36.0,32.0,100.0,5.0,13.0,5.0,5.0,4.0,8.0,19.0,74.0,342.0
Surat,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,1493.0,2307.0,2199.0,1928.0,2104.0,2356.0,2002.0,2486.0,2293.0,2074.0,2132.0,3161.0,26535.0
Surat,9.06,Number of IUCD removals,TOTAL,359.0,313.0,233.0,354.0,379.0,343.0,274.0,361.0,405.0,398.0,257.0,343.0,4019.0
Surat,9.07,Number of Oral Pills cycles distributed,TOTAL,4088.0,9089.0,5537.0,2363.0,5163.0,14233.0,12453.0,22134.0,12867.0,12607.0,13354.0,11994.0,125882.0
Surat,9.08,Number of Condom pieces distributed,TOTAL,16912.0,123136.0,50030.0,32677.0,136431.0,143295.0,206831.0,286874.0,151191.0,149982.0,96199.0,161946.0,1555504.0
Surat,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,50.0,0.0,0.0,52.0
Surat,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,74.0,68.0,39.0,47.0,37.0,26.0,113.0,48.0,17.0,37.0,25.0,14.0,545.0
Surat,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Surat,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0
Surat,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,3.0
Surat,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Surat,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,6.0,7.0,8.0,5.0,7.0,6.0,4.0,4.0,7.0,4.0,3.0,-1.0
Surat,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,7916.0,10166.0,10888.0,9353.0,10566.0,11530.0,11326.0,11111.0,11443.0,10278.0,10532.0,10589.0,125698.0
Surat,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1.0,4.0,40.0,7.0,6.0,0.0,6.0,9.0,3.0,0.0,0.0,0.0,76.0
Surat,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,5.0,8.0,56.0,31.0,23.0,28.0,17.0,15.0,23.0,12.0,3.0,12.0,233.0
Surat,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,19.0,11.0,101.0,30.0,68.0,25.0,15.0,23.0,16.0,49.0,10.0,24.0,391.0
Surat,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,7402.0,8857.0,11260.0,9596.0,9014.0,9717.0,9507.0,10162.0,10371.0,9331.0,9815.0,10444.0,115476.0
Surat,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,7508.0,8698.0,9670.0,9266.0,8907.0,9795.0,9036.0,9360.0,10176.0,9431.0,9880.0,10904.0,112631.0
Surat,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,7462.0,8558.0,9692.0,8643.0,8645.0,9573.0,8988.0,8891.0,9320.0,8948.0,9915.0,11334.0,109969.0
Surat,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,7056.0,9101.0,9712.0,8256.0,9502.0,10440.0,10079.0,9928.0,10440.0,9511.0,9849.0,9879.0,113753.0
Surat,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,7279.0,8894.0,10301.0,9512.0,8947.0,9786.0,9434.0,10118.0,10250.0,9292.0,9665.0,10492.0,113970.0
Surat,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7437.0,8639.0,9652.0,9223.0,8896.0,9793.0,8941.0,9332.0,10101.0,9408.0,9798.0,10931.0,112151.0
Surat,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,7444.0,8539.0,9569.0,8630.0,8801.0,9634.0,8947.0,8855.0,9117.0,8906.0,9843.0,11389.0,109674.0
Surat,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2349.0,3096.0,2753.0,2774.0,3262.0,3389.0,3226.0,3418.0,3100.0,3439.0,3359.0,3735.0,37900.0
Surat,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,84.0,46.0,164.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,297.0
Surat,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,20.0,120.0,107.0,153.0,75.0,63.0,54.0,101.0,71.0,56.0,39.0,40.0,899.0
Surat,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,65.0,127.0,153.0,169.0,130.0,101.0,67.0,165.0,140.0,109.0,78.0,71.0,1375.0
Surat,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,6626.0,8520.0,9828.0,9288.0,8595.0,9667.0,9061.0,8578.0,8186.0,8256.0,8673.0,10687.0,105965.0
Surat,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5580.0,6425.0,7943.0,7463.0,6994.0,7498.0,6950.0,7011.0,7247.0,6815.0,7521.0,10008.0,87455.0
Surat,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3546.0,4460.0,5244.0,4855.0,4598.0,5104.0,4727.0,4469.0,4438.0,4463.0,4694.0,5620.0,56218.0
Surat,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2986.0,3921.0,4615.0,4305.0,3913.0,4561.0,4278.0,4038.0,3813.0,3975.0,4201.0,5159.0,49765.0
Surat,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,6532.0,8381.0,9859.0,9160.0,8511.0,9665.0,9005.0,8507.0,8251.0,8438.0,8895.0,10779.0,105983.0
Surat,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6410.0,7283.0,8997.0,7797.0,7292.0,8121.0,7393.0,7414.0,7631.0,7398.0,7789.0,10502.0,94027.0
Surat,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6395.0,7311.0,9017.0,7802.0,7275.0,8119.0,7414.0,7429.0,7622.0,7380.0,7780.0,10534.0,94078.0
Surat,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1837.0,2339.0,2915.0,2250.0,2330.0,2259.0,2385.0,2336.0,2355.0,2327.0,2678.0,3472.0,29483.0
Surat,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1588.0,1973.0,2494.0,1940.0,2053.0,2067.0,2163.0,2162.0,2066.0,2106.0,2402.0,3061.0,26075.0
Surat,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3425.0,4312.0,5409.0,4190.0,4383.0,4326.0,4548.0,4498.0,4421.0,4433.0,5080.0,6533.0,55558.0
Surat,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2621.0,3610.0,4031.0,4775.0,4893.0,18979.0,10521.0,5465.0,6773.0,3927.0,4548.0,4247.0,74390.0
Surat,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1929.0,2600.0,2977.0,4153.0,4280.0,21086.0,8991.0,4966.0,5920.0,2979.0,2999.0,3228.0,66108.0
Surat,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2571.0,2995.0,3354.0,3607.0,4179.0,10667.0,6796.0,4567.0,4088.0,3191.0,3135.0,3444.0,52594.0
Surat,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,4.0,1.0,3.0,1.0,6.0,0.0,1.0,0.0,0.0,0.0,2.0,19.0
Surat,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,12.0,1.0,6.0,1.0,0.0,6.0,7.0,2.0,4.0,0.0,11.0,5.0,55.0
Surat,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2933.0,3394.0,3389.0,3281.0,3062.0,3356.0,3229.0,3310.0,3412.0,3312.0,3340.0,3749.0,39767.0
Surat,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2896.0,3377.0,3382.0,3265.0,3044.0,3346.0,3214.0,3289.0,3397.0,3283.0,3326.0,3738.0,39557.0
Surat,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2017.0,1992.0,1962.0,2010.0,1840.0,2079.0,1955.0,1937.0,1942.0,1911.0,1939.0,2061.0,23645.0
Surat,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,6395.0,6948.0,9718.0,8984.0,8568.0,9694.0,8945.0,8713.0,7874.0,7936.0,8713.0,11548.0,104036.0
Surat,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,10666.0,140.0,220.0,405.0,9926.0,15386.0,10890.0,330.0,536.0,542.0,10922.0,21968.0,81931.0
Surat,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,14744.0,232.0,45.0,94.0,9016.0,20143.0,20754.0,415.0,102.0,123.0,11398.0,24958.0,102024.0
Surat,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Surat,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,85.0,29.0,26.0,28.0,28.0,38.0,11.0,44.0,32.0,26.0,110.0,110.0,567.0
Surat,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,3183.0,4217.0,4800.0,5101.0,5045.0,6158.0,5447.0,5385.0,5679.0,5377.0,5449.0,5533.0,61374.0
Surat,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,728.0,37.0,39.0,46.0,52.0,110.0,721.0,64.0,63.0,58.0,114.0,173.0,2205.0
Surat,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,40.0,113.0,121.0,173.0,191.0,171.0,279.0,164.0,296.0,257.0,216.0,261.0,2282.0
Surat,13.1,Number of Patients operated for cataract,TOTAL,253.0,293.0,396.0,479.0,441.0,909.0,297.0,267.0,484.0,609.0,750.0,38.0,5216.0
Surat,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,253.0,298.0,396.0,487.0,293.0,935.0,312.0,297.0,484.0,609.0,750.0,38.0,5152.0
Surat,13.3,Number of School children detected with Refractive errors,TOTAL,45.0,40.0,1425.0,218.0,291.0,1841.0,371.0,319.0,2515.0,1858.0,633.0,712.0,10268.0
Surat,13.4,Number of children provided free glasses,TOTAL,541.0,261.0,231.0,29.0,89.0,400.0,117.0,40.0,622.0,370.0,381.0,619.0,3700.0
Surat,13.5,Number of eyes collected through eye donation,TOTAL,0.0,2.0,0.0,0.0,0.0,25.0,30.0,0.0,0.0,0.0,0.0,0.0,57.0
Surat,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Surat,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,10.0,8.0,8.0,8.0,8.0,7.0,6.0,5.0,6.0,6.0,7.0,-1.0
Surat,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,19.0,20.0,23.0,23.0,20.0,19.0,21.0,19.0,21.0,25.0,23.0,25.0,-1.0
Surat,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1031.0,1155.0,1172.0,1010.0,1034.0,816.0,849.0,684.0,628.0,561.0,544.0,639.0,-1.0
Surat,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,11.0,12.0,15.0,13.0,15.0,15.0,14.0,13.0,12.0,14.0,14.0,14.0,-1.0
Surat,14.05,Number of RKS meetings held during the month,TOTAL,9.0,6.0,21.0,14.0,8.0,27.0,12.0,42.0,43.0,43.0,16.0,35.0,276.0
Surat,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,41.0,45.0,44.0,47.0,44.0,47.0,46.0,45.0,49.0,52.0,49.0,49.0,-1.0
Surat,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,323.0,423.0,330.0,401.0,462.0,467.0,451.0,401.0,480.0,518.0,458.0,441.0,5155.0
Surat,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,8.0,8.0,8.0,9.0,9.0,12.0,11.0,7.0,6.0,7.0,8.0,8.0,-1.0
Surat,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,6.0,6.0,7.0,6.0,10.0,6.0,5.0,7.0,7.0,8.0,8.0,-1.0
Surat,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1037.0,1123.0,1204.0,1097.0,1265.0,1466.0,2122.0,1272.0,1424.0,1309.0,1261.0,1377.0,15957.0
Surat,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2062.0,2780.0,2986.0,3276.0,3534.0,4251.0,3541.0,3505.0,3687.0,3287.0,3316.0,3669.0,39894.0
Surat,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,830.0,1801.0,1013.0,987.0,1180.0,1362.0,2748.0,1249.0,1456.0,1144.0,1314.0,1259.0,16343.0
Surat,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4274.0,5368.0,5884.0,5720.0,6514.0,8160.0,5572.0,5922.0,6646.0,6312.0,6519.0,6706.0,73597.0
Surat,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1867.0,2924.0,2217.0,2084.0,2445.0,2828.0,4870.0,2521.0,2880.0,2453.0,2575.0,2636.0,32300.0
Surat,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6336.0,8148.0,8870.0,8996.0,10048.0,12411.0,9113.0,9427.0,10333.0,9599.0,9835.0,10375.0,113491.0
Surat,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,4.0,3.0,2.0,3.0,5.0,5.0,5.0,5.0,5.0,7.0,2.0,46.0
Surat,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,2.0,2.0,1.0,7.0,5.0,5.0,3.0,1.0,2.0,0.0,2.0,31.0
Surat,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,1.0,6.0,5.0,3.0,10.0,10.0,10.0,8.0,6.0,7.0,7.0,4.0,77.0
Surat,14.11,In-Patient Head Count at midnight,TOTAL,2837.0,3133.0,3045.0,2917.0,4785.0,4697.0,3929.0,3760.0,3084.0,2972.0,4148.0,3720.0,43027.0
Surat,14.12.1,OPD attendance (All),TOTAL,110046.0,120568.0,138705.0,142681.0,151074.0,169343.0,135300.0,136070.0,147821.0,139743.0,180666.0,214980.0,1786997.0
Surat,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,207.0,142.0,5271.0,555.0,524.0,692.0,528.0,583.0,564.0,1186.0,1265.0,1216.0,12733.0
Surat,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,39.0,0.0,9.0,0.0,29.0,44.0,63.0,42.0,0.0,0.0,2.0,1.0,229.0
Surat,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,281.0,306.0,341.0,309.0,304.0,284.0,347.0,394.0,398.0,501.0,605.0,453.0,4523.0
Surat,14.14.a,Number of patients given AYUSH treatment,TOTAL,1138.0,1623.0,2289.0,1833.0,1505.0,2723.0,1844.0,1798.0,2331.0,1984.0,2931.0,4961.0,26960.0
Surat,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,332.0,333.0,358.0,330.0,259.0,207.0,247.0,327.0,238.0,338.0,2969.0
Surat,14.14.c,Number of Adolescents counselled,TOTAL,428.0,624.0,805.0,795.0,795.0,830.0,524.0,545.0,713.0,610.0,801.0,1108.0,8578.0
Surat,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7969.0,8482.0,11160.0,11824.0,11999.0,13356.0,11399.0,11815.0,14986.0,13463.0,13979.0,14501.0,144933.0
Surat,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,686.0,377.0,419.0,342.0,494.0,571.0,416.0,256.0,276.0,252.0,278.0,342.0,4709.0
Surat,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1973.0,2373.0,3641.0,4504.0,3599.0,4132.0,3671.0,3379.0,3687.0,3203.0,3847.0,4551.0,42560.0
Surat,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,10.0,15.0,17.0,102.0,24.0,17.0,9.0,10.0,12.0,15.0,7.0,245.0
Surat,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1775.0,2162.0,2727.0,2879.0,2940.0,3529.0,2594.0,2772.0,2836.0,2955.0,3301.0,3755.0,34225.0
Surat,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,6.0,6.0,4.0,8.0,91.0,7.0,4.0,4.0,5.0,7.0,6.0,7.0,155.0
Surat,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2815.0,2703.0,3636.0,3249.0,3091.0,3592.0,2689.0,2786.0,3367.0,3295.0,3554.0,4199.0,38976.0
Surat,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,4.0,3.0,1.0,0.0,159.0,4.0,2.0,6.0,42.0,1.0,3.0,2.0,227.0
Surat,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6563.0,7238.0,10004.0,10632.0,9630.0,11253.0,8954.0,8937.0,9890.0,9453.0,10702.0,12505.0,115761.0
Surat,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,17.0,19.0,20.0,25.0,352.0,35.0,23.0,19.0,57.0,20.0,24.0,16.0,627.0
Surat,15.2,Number of Widal tests conducted,Number tested,110.0,129.0,123.0,146.0,348.0,554.0,386.0,103.0,168.0,139.0,173.0,226.0,2605.0
Surat,15.3.a,Number of VDRL tests conducted on males,Number tested,780.0,1279.0,1238.0,1755.0,1803.0,1847.0,1907.0,1553.0,1701.0,1570.0,2069.0,2473.0,19975.0
Surat,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,699.0,927.0,1090.0,1424.0,1534.0,1570.0,1405.0,1327.0,1390.0,1529.0,1838.0,2117.0,16850.0
Surat,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1517.0,1372.0,1915.0,1907.0,1872.0,2118.0,1902.0,1768.0,2219.0,2271.0,2425.0,3005.0,24291.0
Surat,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2996.0,3578.0,4243.0,5086.0,5209.0,5535.0,5214.0,4648.0,5310.0,5370.0,6332.0,7595.0,61116.0
Surat,15.4.1,Number of blood smears examined for Malaria,TOTAL,25056.0,30391.0,41252.0,37796.0,37351.0,47838.0,30964.0,27138.0,30285.0,24385.0,37488.0,41008.0,410952.0
Surat,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,808.0,401.0,469.0,553.0,838.0,882.0,780.0,442.0,337.0,95.0,142.0,193.0,5940.0
Surat,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,17.0,15.0,45.0,55.0,105.0,192.0,386.0,164.0,209.0,53.0,11.0,30.0,1282.0
Surat,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,500.0,3650.0,400.0,400.0,100.0,1950.0,50.0,50.0,1100.0,2650.0,2500.0,730.0,14080.0
Surat,16.1.1,Stock position of DPT vaccines,2. Stocks Received,7500.0,2500.0,2500.0,5000.0,15000.0,7500.0,5000.0,7500.0,7500.0,5000.0,5000.0,5000.0,75000.0
Surat,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4350.0,5750.0,2500.0,5300.0,13150.0,9400.0,5000.0,6450.0,5950.0,5150.0,6770.0,4450.0,74220.0
Surat,16.1.1,Stock position of DPT vaccines,5. Total Stock,3650.0,400.0,400.0,100.0,1950.0,50.0,50.0,1100.0,2650.0,2500.0,730.0,1280.0,14860.0
Surat,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,60.0,1960.0,410.0,1210.0,2710.0,310.0,910.0,60.0,960.0,110.0,110.0,360.0,9170.0
Surat,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,9000.0,6000.0,6000.0,12000.0,9000.0,9000.0,3000.0,10000.0,9000.0,9000.0,9000.0,15000.0,106000.0
Surat,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,7100.0,7550.0,5200.0,10500.0,11400.0,8400.0,3850.0,9100.0,9850.0,8900.0,8750.0,7050.0,97650.0
Surat,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1960.0,410.0,1210.0,2710.0,310.0,910.0,60.0,960.0,110.0,210.0,360.0,8310.0,17520.0
Surat,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,740.0,4840.0,2940.0,1040.0,40.0,40.0,340.0,640.0,640.0,40.0,40.0,1040.0,12380.0
Surat,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,15000.0,15000.0,15000.0,20000.0,20000.0,15000.0,18000.0,20000.0,0.0,15000.0,11000.0,184000.0
Surat,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,15900.0,16900.0,16900.0,16000.0,20000.0,19700.0,14700.0,18000.0,20600.0,0.0,15000.0,8600.0,182300.0
Surat,16.1.2,Stock position of OPV vaccines,5. Total Stock,4840.0,2940.0,1040.0,40.0,40.0,340.0,640.0,640.0,40.0,40.0,40.0,3440.0,14080.0
Surat,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1500.0,5750.0,1700.0,500.0,1800.0,1750.0,450.0,1600.0,100.0,1200.0,1200.0,0.0,17550.0
Surat,16.1.3,Stock position of TT vaccines,2. Stocks Received,12000.0,4000.0,4000.0,12000.0,16000.0,9000.0,15000.0,7500.0,12500.0,10000.0,7500.0,10000.0,119500.0
Surat,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.3,Stock position of TT vaccines,4. Stock Distributed,7750.0,8050.0,5200.0,10700.0,16050.0,10300.0,13850.0,9000.0,11400.0,9100.0,8700.0,7150.0,117250.0
Surat,16.1.3,Stock position of TT vaccines,5. Total Stock,5750.0,1700.0,500.0,1800.0,1750.0,450.0,1600.0,100.0,1200.0,2100.0,0.0,2850.0,19800.0
Surat,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1850.0,3050.0,1950.0,250.0,4050.0,4800.0,2150.0,800.0,250.0,1530.0,1530.0,30.0,22240.0
Surat,16.1.5,Stock position of BCG vaccines,2. Stocks Received,9000.0,6000.0,6000.0,10000.0,9000.0,5000.0,6000.0,7000.0,10000.0,10000.0,5000.0,6000.0,89000.0
Surat,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7800.0,7100.0,7700.0,6200.0,8250.0,7650.0,7350.0,7550.0,8720.0,6620.0,6500.0,6000.0,87440.0
Surat,16.1.5,Stock position of BCG vaccines,5. Total Stock,3050.0,1950.0,250.0,4050.0,4800.0,2150.0,800.0,250.0,1530.0,4910.0,30.0,30.0,23800.0
Surat,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,245.0,1195.0,1795.0,295.0,815.0,115.0,65.0,65.0,65.0,1570.0,1570.0,740.0,8535.0
Surat,16.1.6,Stock position of Measles vaccines,2. Stocks Received,6000.0,6000.0,3000.0,5500.0,7000.0,6000.0,5000.0,6000.0,9000.0,10000.0,5000.0,5000.0,73500.0
Surat,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5050.0,5400.0,4500.0,4980.0,7700.0,6050.0,5000.0,6000.0,7495.0,6280.0,5830.0,5200.0,69485.0
Surat,16.1.6,Stock position of Measles vaccines,5. Total Stock,1195.0,1795.0,295.0,815.0,115.0,65.0,65.0,65.0,1570.0,5290.0,740.0,540.0,12550.0
Surat,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,6150.0,5100.0,4300.0,3650.0,4550.0,6750.0,5750.0,3250.0,4550.0,3500.0,3500.0,4930.0,55980.0
Surat,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,2100.0,3000.0,0.0,0.0,2100.0,0.0,0.0,2100.0,0.0,9300.0
Surat,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1050.0,800.0,650.0,1200.0,800.0,1000.0,2500.0,800.0,1050.0,700.0,670.0,1530.0,12750.0
Surat,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5100.0,4300.0,3650.0,4550.0,6750.0,5750.0,3250.0,4550.0,3500.0,2800.0,4930.0,3400.0,52530.0
Surat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surat,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surat,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surat,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Surat,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Surat,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Surat,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Surat,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Surat,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Surat,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Surat,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Surat,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Surat,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Surat,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Surat,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Surat,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Surat,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Surat,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Surat,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Surat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Surat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Surat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Surat,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Surat,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Surat,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Surat,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Surat,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Surat,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Surat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Surat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Surat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Surat,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Surat,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Surat,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Surat,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Surat,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Surat,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Surat,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,160000.0,158280.0,156560.0,0.0,0.0,0.0,0.0,0.0,24600.0,0.0,0.0,0.0,499440.0
Surat,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,160000.0,158280.0,156560.0,0.0,0.0,0.0,0.0,0.0,24600.0,0.0,0.0,0.0,499440.0
Surat,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,160000.0,0.0,0.0,0.0,0.0,0.0,160000.0
Surat,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,160000.0,0.0,0.0,0.0,0.0,0.0,160000.0
Surat,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,10000.0
Surat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,10000.0
Surat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surat,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Surat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,1.0,,,1.0,,1.0,,,1.0,,,5.0
Surat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Surat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,1.0,,,1.0,,1.0,,,1.0,,,5.0
Surat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,2.0,1.0,,,1.0,1.0,,,1.0,1.0,8.0
Surat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Surat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,2.0,1.0,,,1.0,1.0,,,1.0,1.0,8.0
Surat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,4.0,6.0,3.0,3.0,4.0,,1.0,2.0,3.0,1.0,,29.0
Surat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,1.0,1.0,,,1.0,1.0,2.0,6.0
Surat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,4.0,6.0,3.0,3.0,5.0,1.0,1.0,2.0,4.0,2.0,2.0,35.0
Surat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,4.0,1.0,,1.0,1.0,,1.0,1.0,1.0,,1.0,13.0
Surat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,2.0,,,,,,2.0,,1.0,,1.0,6.0
Surat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,6.0,1.0,,1.0,1.0,,3.0,1.0,2.0,,2.0,19.0
Surat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Surat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Surat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,1.0,,,,,,,,1.0
Surat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,1.0,,,,,,,,1.0
Surat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Surat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,1.0,,,,,,,,1.0
Surat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,1.0,,,,,,,,,,,2.0
Surat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Surat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,,,,,,,,,,,2.0
Surat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Surat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Surat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Surat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,4.0,,1.0,2.0,1.0,1.0,4.0,3.0,1.0,,18.0
Surat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,,1.0,3.0,,,,,1.0,,1.0,7.0
Surat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,1.0,4.0,1.0,4.0,2.0,1.0,1.0,4.0,4.0,1.0,1.0,25.0
Surat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,,1.0,,,,,1.0,3.0
Surat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Surat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,1.0,,1.0,,,,,1.0,3.0
Surat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,4.0,4.0,7.0,6.0,1.0,3.0,4.0,2.0,5.0,7.0,3.0,4.0,50.0
Surat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,,1.0,1.0,1.0,,,,,1.0,,,6.0
Surat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,6.0,4.0,8.0,7.0,2.0,3.0,4.0,2.0,5.0,8.0,3.0,4.0,56.0
Surat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,2.0,1.0,3.0,2.0,4.0,9.0,1.0,4.0,2.0,2.0,32.0
Surat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,3.0,5.0,,5.0,9.0,3.0,5.0,,1.0,1.0,3.0,37.0
Surat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,4.0,7.0,1.0,8.0,11.0,7.0,14.0,1.0,5.0,3.0,5.0,69.0
Surat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Surat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Surat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,,,,,,,,,,1.0,2.0
Surat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Surat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,2.0,,,1.0,,1.0,4.0
Surat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,,,,,1.0,,,,,,2.0
Surat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,,,,,4.0,,,1.0,,1.0,7.0
Surat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,2.0,1.0,,,,,,2.0,,3.0,1.0,9.0
Surat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Surat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,2.0,1.0,,,,,,2.0,,3.0,1.0,9.0
Surat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,6.0,5.0,3.0,7.0,2.0,1.0,6.0,7.0,8.0,6.0,4.0,4.0,59.0
Surat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,7.0,5.0,7.0,2.0,6.0,5.0,7.0,8.0,6.0,10.0,4.0,2.0,69.0
Surat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,13.0,10.0,10.0,9.0,8.0,6.0,13.0,15.0,14.0,16.0,8.0,6.0,128.0
Surat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Surat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,2.0,2.0,1.0,,1.0,,,5.0,,,11.0
Surat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,,1.0,,,,1.0,,,,2.0,,5.0
Surat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,,3.0,2.0,1.0,1.0,2.0,,,5.0,2.0,,17.0
Surat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Surat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Surat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Surat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Surat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Surat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Surat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Surat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Surat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Surat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,2.0,,1.0,1.0,,,1.0,,,,6.0
Surat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Surat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,2.0,,1.0,1.0,,,1.0,,,,6.0
Surat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Surat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Surat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Surat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,2.0,3.0,,1.0,1.0,,,,,8.0
Surat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Surat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,2.0,3.0,,1.0,1.0,,,,,8.0
Surat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,1.0,,2.0,,,,,2.0,1.0,,8.0
Surat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,7.0,4.0,10.0,5.0,6.0,5.0,4.0,14.0,6.0,6.0,6.0,9.0,82.0
Surat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,,1.0,2.0,2.0,1.0,2.0,5.0,3.0,2.0,3.0,1.0,24.0
Surat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,10.0,5.0,12.0,7.0,10.0,6.0,6.0,19.0,9.0,10.0,10.0,10.0,114.0
Surat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Surat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,7.0,5.0,10.0,13.0,7.0,5.0,4.0,4.0,3.0,5.0,6.0,8.0,77.0
Surat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,3.0,,1.0,,,1.0,1.0,,1.0,1.0,9.0
Surat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,8.0,5.0,13.0,13.0,8.0,5.0,4.0,5.0,4.0,5.0,7.0,9.0,86.0
Surat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Surat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,,1.0,2.0,,,,,,,5.0
Surat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Surat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,1.0,1.0,1.0,1.0,2.0,,,,,,,7.0
Surat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Surat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,2.0,4.0,1.0,1.0,2.0,3.0,1.0,1.0,,,,15.0
Surat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,2.0,2.0,2.0,1.0,1.0,,1.0,1.0,,1.0,,11.0
Surat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,4.0,6.0,3.0,2.0,3.0,4.0,2.0,2.0,,1.0,,27.0
Surat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,,,,,,,1.0,2.0
Surat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,4.0,6.0,8.0,7.0,4.0,13.0,4.0,5.0,8.0,6.0,6.0,3.0,74.0
Surat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,12.0,6.0,6.0,7.0,7.0,7.0,3.0,15.0,10.0,5.0,7.0,3.0,88.0
Surat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,16.0,13.0,14.0,14.0,11.0,20.0,7.0,20.0,18.0,11.0,13.0,7.0,164.0
Surat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,1.0,,,,,1.0,1.0,1.0,1.0,,,8.0
Surat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,59.0,70.0,53.0,48.0,68.0,76.0,59.0,78.0,70.0,73.0,68.0,66.0,788.0
Surat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,93.0,84.0,85.0,71.0,87.0,98.0,102.0,111.0,119.0,144.0,90.0,92.0,1176.0
Surat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,155.0,155.0,138.0,119.0,155.0,174.0,162.0,190.0,190.0,218.0,158.0,158.0,1972.0
Surendranagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,2754.0,3085.0,3142.0,2983.0,2607.0,2820.0,2519.0,2823.0,2727.0,3060.0,2928.0,2621.0,34069.0
Surendranagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2106.0,2342.0,2264.0,2113.0,1884.0,2215.0,2067.0,2178.0,2153.0,2390.0,2254.0,2006.0,25972.0
Surendranagar,1.2,Number of Pregnant women registered under JSY,TOTAL,697.0,804.0,837.0,884.0,742.0,964.0,885.0,891.0,924.0,1010.0,949.0,899.0,10486.0
Surendranagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1983.0,2248.0,2341.0,2225.0,2091.0,2247.0,2329.0,2381.0,2080.0,2303.0,2212.0,2138.0,26578.0
Surendranagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1910.0,2170.0,2265.0,2095.0,1824.0,2014.0,1855.0,1943.0,1978.0,2119.0,2117.0,2047.0,24337.0
Surendranagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2275.0,2601.0,2700.0,2684.0,2379.0,2460.0,2762.0,2361.0,2548.0,2674.0,2678.0,2703.0,30825.0
Surendranagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2717.0,2964.0,3096.0,3091.0,2968.0,3107.0,2940.0,3168.0,2766.0,2880.0,2838.0,2685.0,35220.0
Surendranagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,33.0,31.0,45.0,15.0,13.0,34.0,20.0,21.0,22.0,34.0,15.0,11.0,294.0
Surendranagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,0.0,0.0,2.0,2.0,7.0,1.0,1.0,1.0,0.0,0.0,0.0,17.0
Surendranagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1206.0,1391.0,1500.0,1371.0,1263.0,1280.0,1104.0,1418.0,1511.0,1356.0,1510.0,1252.0,16162.0
Surendranagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,15.0,36.0,8.0,23.0,22.0,18.0,25.0,9.0,16.0,17.0,7.0,18.0,214.0
Surendranagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,983.0,1004.0,1018.0,990.0,1023.0,1014.0,797.0,875.0,849.0,880.0,758.0,755.0,10946.0
Surendranagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,25.0,56.0,32.0,27.0,60.0,40.0,43.0,41.0,44.0,34.0,31.0,36.0,469.0
Surendranagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,74.0,95.0,74.0,88.0,103.0,92.0,94.0,140.0,97.0,97.0,75.0,70.0,1099.0
Surendranagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,99.0,151.0,106.0,115.0,163.0,132.0,137.0,181.0,141.0,131.0,106.0,106.0,1568.0
Surendranagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,91.0,133.0,95.0,100.0,124.0,108.0,123.0,147.0,110.0,106.0,79.0,83.0,1299.0
Surendranagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,6.0,11.0,6.0,7.0,7.0,15.0,10.0,7.0,7.0,15.0,5.0,8.0,104.0
Surendranagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,653.0,872.0,874.0,847.0,1205.0,1139.0,963.0,1093.0,969.0,1059.0,785.0,810.0,11269.0
Surendranagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,575.0,829.0,700.0,712.0,1025.0,948.0,783.0,996.0,828.0,962.0,632.0,752.0,9742.0
Surendranagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,3.0,3.0,1.0,4.0,26.0,20.0,0.0,4.0,17.0,16.0,7.0,20.0,121.0
Surendranagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,2.0,36.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,43.0
Surendranagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,823.0,1257.0,1162.0,1067.0,1550.0,1392.0,1259.0,1413.0,1658.0,1213.0,1128.0,1135.0,15057.0
Surendranagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,9.0,9.0,7.0,17.0,46.0,28.0,29.0,21.0,21.0,34.0,24.0,14.0,259.0
Surendranagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,7.0,7.0,4.0,8.0,11.0,3.0,0.0,2.0,1.0,2.0,1.0,1.0,47.0
Surendranagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surendranagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,16.0,16.0,11.0,25.0,57.0,31.0,29.0,23.0,22.0,36.0,25.0,15.0,306.0
Surendranagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,74.0,91.0,100.0,130.0,71.0,167.0,90.0,119.0,283.0,159.0,93.0,140.0,1517.0
Surendranagar,4.1.1.a,Number of male live births,TOTAL,836.0,1211.0,1124.0,1054.0,1477.0,1452.0,1201.0,1367.0,1450.0,1277.0,1029.0,1067.0,14545.0
Surendranagar,4.1.1.b,Number of female live births,TOTAL,725.0,1065.0,1001.0,960.0,1404.0,1182.0,1133.0,1293.0,1291.0,1102.0,964.0,960.0,13080.0
Surendranagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1561.0,2276.0,2125.0,2014.0,2881.0,2634.0,2334.0,2660.0,2741.0,2379.0,1993.0,2027.0,27625.0
Surendranagar,4.1.2,Number of still births,TOTAL,18.0,23.0,70.0,51.0,41.0,44.0,41.0,39.0,31.0,34.0,26.0,26.0,444.0
Surendranagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,34.0,65.0,41.0,43.0,31.0,34.0,39.0,52.0,39.0,33.0,25.0,36.0,472.0
Surendranagar,4.2.1,Number of Newborns weighed at birth,TOTAL,1558.0,2202.0,2031.0,1934.0,2660.0,2486.0,2220.0,2580.0,2616.0,2309.0,1918.0,1953.0,26467.0
Surendranagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,178.0,185.0,186.0,118.0,191.0,209.0,174.0,146.0,184.0,184.0,170.0,173.0,2098.0
Surendranagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1555.0,2188.0,2026.0,1929.0,2658.0,2507.0,2242.0,2573.0,2613.0,2206.0,1838.0,1956.0,26291.0
Surendranagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,5.0,0.0,3.0,3.0,14.0,18.0,3.0,4.0,1.0,0.0,0.0,0.0,51.0
Surendranagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,156.0,147.0,105.0,25.0,117.0,39.0,132.0,119.0,42.0,92.0,25.0,46.0,1045.0
Surendranagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,10.0,15.0,10.0,11.0,10.0,10.0,10.0,10.0,2.0,2.0,6.0,20.0,116.0
Surendranagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surendranagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,171.0,162.0,118.0,39.0,141.0,67.0,145.0,133.0,45.0,94.0,31.0,66.0,1212.0
Surendranagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,98.0,99.0,114.0,55.0,57.0,76.0,103.0,60.0,89.0,133.0,97.0,94.0,1075.0
Surendranagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,2.0,11.0,1.0,2.0,10.0,2.0,1.0,0.0,0.0,0.0,29.0
Surendranagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,151.0,154.0,114.0,106.0,132.0,140.0,170.0,154.0,150.0,174.0,228.0,227.0,1900.0
Surendranagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,2.0,3.0,11.0,5.0,9.0,4.0,6.0,2.0,2.0,5.0,3.0,54.0
Surendranagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1482.0,2070.0,1889.0,1767.0,2629.0,2417.0,2007.0,2304.0,2516.0,2180.0,1801.0,1805.0,24867.0
Surendranagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1607.0,2284.0,2064.0,1802.0,2454.0,2415.0,2169.0,2449.0,2846.0,2396.0,1934.0,2155.0,26575.0
Surendranagar,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,13.0,2.0,5.0,0.0,0.0,0.0,0.0,0.0,2.0,136.0,158.0
Surendranagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,1.0,1.0,3.0,4.0,17.0
Surendranagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,2.0,3.0,2.0,2.0,2.0,10.0,1.0,0.0,0.0,0.0,22.0
Surendranagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,2.0,3.0,2.0,2.0,2.0,18.0,2.0,1.0,3.0,4.0,39.0
Surendranagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,10.0,2.0,0.0,0.0,0.0,11.0,0.0,1.0,0.0,2.0,1.0,0.0,27.0
Surendranagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,44.0,53.0,33.0,51.0,27.0,92.0,79.0,28.0,32.0,37.0,27.0,31.0,534.0
Surendranagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,111.0,153.0,121.0,144.0,149.0,212.0,171.0,146.0,125.0,111.0,121.0,146.0,1710.0
Surendranagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,155.0,206.0,154.0,195.0,176.0,304.0,250.0,174.0,157.0,148.0,148.0,177.0,2244.0
Surendranagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,4.0,0.0,5.0,12.0,8.0,9.0,44.0,53.0,45.0,5.0,4.0,45.0,234.0
Surendranagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,2.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Surendranagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,3.0
Surendranagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surendranagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,6.0
Surendranagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0
Surendranagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,7.0,2.0,2.0,3.0,8.0,10.0,4.0,0.0,19.0,2.0,57.0
Surendranagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,108.0,59.0,65.0,68.0,38.0,36.0,42.0,56.0,333.0,573.0,513.0,160.0,2051.0
Surendranagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,48.0,27.0,16.0,25.0,31.0,15.0,21.0,63.0,162.0,157.0,109.0,33.0,707.0
Surendranagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surendranagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,156.0,86.0,88.0,95.0,71.0,54.0,71.0,129.0,499.0,730.0,641.0,195.0,2815.0
Surendranagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,47.0,137.0,111.0,96.0,94.0,140.0,41.0,112.0,202.0,87.0,11.0,41.0,1119.0
Surendranagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,19.0,22.0,33.0,12.0,6.0,41.0,135.0
Surendranagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,25.0,31.0,19.0,37.0,30.0,36.0,26.0,123.0,129.0,172.0,133.0,94.0,855.0
Surendranagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,37.0,34.0,41.0,41.0,33.0,34.0,25.0,68.0,85.0,107.0,67.0,35.0,607.0
Surendranagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surendranagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,64.0,65.0,60.0,78.0,63.0,70.0,70.0,213.0,247.0,291.0,206.0,170.0,1597.0
Surendranagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,21.0,40.0,11.0,8.0,6.0,11.0,114.0,106.0,163.0,80.0,56.0,111.0,727.0
Surendranagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,1.0,6.0
Surendranagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,38.0,0.0,2.0,4.0,1.0,45.0
Surendranagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,13.0,16.0,13.0,8.0,8.0,4.0,14.0,17.0,59.0,41.0,14.0,4.0,211.0
Surendranagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surendranagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,13.0,16.0,13.0,8.0,8.0,4.0,14.0,55.0,59.0,43.0,23.0,6.0,262.0
Surendranagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,3.0,5.0,0.0,0.0,0.0,0.0,8.0
Surendranagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,810.0,1022.0,996.0,1103.0,1083.0,980.0,972.0,1026.0,1006.0,839.0,857.0,631.0,11325.0
Surendranagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,88.0,126.0,115.0,115.0,148.0,136.0,148.0,126.0,137.0,231.0,185.0,87.0,1642.0
Surendranagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,38.0,41.0,40.0,42.0,31.0,39.0,34.0,203.0,48.0,69.0,69.0,91.0,745.0
Surendranagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,28.0,32.0,37.0,110.0,22.0,24.0,53.0,65.0,126.0,40.0,29.0,101.0,667.0
Surendranagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surendranagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,964.0,1221.0,1188.0,1370.0,1284.0,1179.0,1207.0,1420.0,1317.0,1179.0,1140.0,910.0,14379.0
Surendranagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,25.0,12.0,24.0,16.0,27.0,19.0,23.0,10.0,27.0,5.0,4.0,19.0,211.0
Surendranagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,25.0,19.0,20.0,6.0,6.0,6.0,27.0,20.0,34.0,26.0,10.0,7.0,206.0
Surendranagar,9.06,Number of IUCD removals,TOTAL,242.0,301.0,279.0,257.0,280.0,272.0,302.0,333.0,378.0,281.0,332.0,263.0,3520.0
Surendranagar,9.07,Number of Oral Pills cycles distributed,TOTAL,3130.0,3088.0,2809.0,2578.0,3339.0,3919.0,4644.0,4439.0,4337.0,4196.0,4557.0,3985.0,45021.0
Surendranagar,9.08,Number of Condom pieces distributed,TOTAL,25489.0,26731.0,23926.0,16594.0,28652.0,35345.0,44891.0,40819.0,32701.0,30361.0,31191.0,20296.0,356996.0
Surendranagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,395.0,42.0,25.0,9.0,510.0,643.0,443.0,0.0,15.0,4.0,9.0,36.0,2131.0
Surendranagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,49.0,63.0,76.0,38.0,74.0,162.0,114.0,140.0,115.0,91.0,53.0,42.0,1017.0
Surendranagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,0.0,2.0,0.0,0.0,3.0,2.0,0.0,0.0,0.0,8.0
Surendranagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,2.0,1.0,1.0,1.0,2.0,0.0,0.0,0.0,0.0,8.0
Surendranagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,26.0,27.0,27.0,26.0,31.0,26.0,29.0,32.0,33.0,25.0,29.0,26.0,-1.0
Surendranagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1802.0,2687.0,2585.0,2289.0,2567.0,2743.0,2658.0,2977.0,2860.0,2732.0,2572.0,2478.0,30950.0
Surendranagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Surendranagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,2.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Surendranagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,3.0,0.0,0.0,2.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Surendranagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2128.0,2508.0,2674.0,2419.0,2505.0,2572.0,2705.0,2752.0,2875.0,2822.0,2639.0,2516.0,31115.0
Surendranagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2164.0,2373.0,2587.0,2346.0,2466.0,2453.0,2538.0,2626.0,2687.0,2695.0,2667.0,2789.0,30391.0
Surendranagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2119.0,2493.0,2506.0,2266.0,2431.0,2481.0,2426.0,2518.0,2575.0,2558.0,2544.0,2868.0,29785.0
Surendranagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1405.0,2082.0,2096.0,1851.0,2225.0,2435.0,2297.0,2355.0,2603.0,2565.0,2153.0,2370.0,26437.0
Surendranagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2127.0,2511.0,2676.0,2407.0,2502.0,2569.0,2698.0,2757.0,2856.0,2843.0,2639.0,2525.0,31110.0
Surendranagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2164.0,2369.0,2588.0,2317.0,2467.0,2445.0,2532.0,2626.0,2681.0,2713.0,2677.0,2789.0,30368.0
Surendranagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2103.0,2496.0,2508.0,2248.0,2427.0,2482.0,2432.0,2513.0,2576.0,2577.0,2541.0,2854.0,29757.0
Surendranagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,563.0,1005.0,900.0,962.0,1072.0,972.0,959.0,934.0,1222.0,1156.0,1100.0,1124.0,11969.0
Surendranagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1.0,2.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Surendranagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,6.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Surendranagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,18.0,7.0,34.0,25.0,18.0,0.0,0.0,0.0,0.0,0.0,0.0,102.0
Surendranagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1785.0,2598.0,2748.0,2395.0,2505.0,2486.0,2490.0,2483.0,2354.0,2541.0,2370.0,2773.0,29528.0
Surendranagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1340.0,1958.0,2152.0,2051.0,1940.0,2032.0,2096.0,1928.0,2063.0,2151.0,2037.0,2325.0,24073.0
Surendranagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,937.0,1309.0,1428.0,1222.0,1224.0,1299.0,1268.0,1254.0,1196.0,1234.0,1189.0,1377.0,14937.0
Surendranagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,789.0,1132.0,1227.0,1079.0,1156.0,1122.0,1099.0,1120.0,1064.0,1100.0,1053.0,1270.0,13211.0
Surendranagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1726.0,2441.0,2655.0,2301.0,2380.0,2421.0,2367.0,2374.0,2260.0,2334.0,2242.0,2647.0,28148.0
Surendranagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1791.0,2067.0,2282.0,2230.0,2089.0,2207.0,2263.0,2237.0,2172.0,2290.0,2209.0,2427.0,26264.0
Surendranagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1793.0,2069.0,2276.0,2226.0,2092.0,2201.0,2260.0,2233.0,2161.0,2288.0,2208.0,2423.0,26230.0
Surendranagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,442.0,492.0,452.0,427.0,469.0,427.0,488.0,437.0,369.0,405.0,439.0,387.0,5234.0
Surendranagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,390.0,403.0,414.0,383.0,385.0,376.0,440.0,411.0,333.0,336.0,411.0,371.0,4653.0
Surendranagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,832.0,895.0,866.0,810.0,854.0,803.0,928.0,848.0,702.0,741.0,850.0,758.0,9887.0
Surendranagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1120.0,1463.0,1588.0,1720.0,1725.0,2257.0,1794.0,1789.0,2131.0,2157.0,1802.0,1983.0,21529.0
Surendranagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1500.0,1816.0,1926.0,2303.0,2252.0,2630.0,2105.0,2024.0,2256.0,2272.0,2052.0,2031.0,25167.0
Surendranagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1514.0,1803.0,1931.0,2247.0,2096.0,2152.0,1890.0,1944.0,1960.0,2032.0,2025.0,1923.0,23517.0
Surendranagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,3.0,3.0,11.0,5.0,5.0,7.0,5.0,6.0,5.0,11.0,3.0,65.0
Surendranagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Surendranagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,39.0,44.0,47.0,38.0,45.0,39.0,36.0,34.0,37.0,22.0,32.0,45.0,458.0
Surendranagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1139.0,1332.0,1284.0,1212.0,1229.0,1250.0,1240.0,1239.0,1267.0,1229.0,1223.0,1238.0,14882.0
Surendranagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1043.0,1325.0,1267.0,1185.0,1207.0,1218.0,1203.0,1217.0,1242.0,1194.0,1151.0,1189.0,14441.0
Surendranagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,983.0,1230.0,1207.0,1117.0,1127.0,1151.0,1140.0,1147.0,1139.0,1098.0,1102.0,1096.0,13537.0
Surendranagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1727.0,2576.0,2649.0,2375.0,2446.0,2449.0,2443.0,2457.0,2327.0,2367.0,2295.0,2633.0,28744.0
Surendranagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,8922.0,120.0,52.0,38.0,82.0,37.0,37.0,5767.0,1679.0,253.0,85.0,8330.0,25402.0
Surendranagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,11893.0,66.0,35.0,4.0,26.0,6.0,15.0,5775.0,1620.0,166.0,39.0,8240.0,27885.0
Surendranagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,25.0,1.0,2.0,1.0,4.0,50.0,50.0,2.0,2.0,25.0,9.0,35.0,206.0
Surendranagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2042.0,2181.0,2247.0,2109.0,2524.0,2422.0,2025.0,1656.0,1957.0,1837.0,1677.0,1768.0,24445.0
Surendranagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,16.0,5.0,126.0,22.0,21.0,23.0,24.0,47.0,0.0,5.0,42.0,25.0,356.0
Surendranagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,2.0,4.0,1.0,6.0,1.0,0.0,6.0,0.0,20.0
Surendranagar,13.1,Number of Patients operated for cataract,TOTAL,319.0,313.0,311.0,396.0,282.0,284.0,375.0,450.0,257.0,418.0,252.0,362.0,4019.0
Surendranagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,272.0,266.0,264.0,354.0,282.0,283.0,375.0,450.0,257.0,418.0,252.0,362.0,3835.0
Surendranagar,13.3,Number of School children detected with Refractive errors,TOTAL,107.0,68.0,81.0,87.0,290.0,216.0,147.0,305.0,251.0,172.0,175.0,171.0,2070.0
Surendranagar,13.4,Number of children provided free glasses,TOTAL,50.0,68.0,91.0,79.0,280.0,216.0,147.0,276.0,223.0,172.0,126.0,186.0,1914.0
Surendranagar,13.5,Number of eyes collected through eye donation,TOTAL,2.0,2.0,2.0,2.0,8.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0
Surendranagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,12.0,13.0,13.0,14.0,15.0,13.0,13.0,13.0,13.0,13.0,13.0,12.0,-1.0
Surendranagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,18.0,19.0,17.0,18.0,15.0,15.0,15.0,19.0,15.0,20.0,17.0,20.0,-1.0
Surendranagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,479.0,479.0,581.0,497.0,490.0,489.0,505.0,491.0,491.0,503.0,479.0,416.0,-1.0
Surendranagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,16.0,17.0,17.0,16.0,16.0,17.0,17.0,17.0,17.0,17.0,17.0,17.0,-1.0
Surendranagar,14.05,Number of RKS meetings held during the month,TOTAL,10.0,23.0,12.0,15.0,13.0,14.0,12.0,10.0,11.0,11.0,13.0,16.0,160.0
Surendranagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,33.0,34.0,35.0,35.0,35.0,34.0,32.0,34.0,31.0,37.0,34.0,36.0,-1.0
Surendranagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,204.0,196.0,278.0,256.0,236.0,240.0,290.0,193.0,269.0,265.0,240.0,274.0,2941.0
Surendranagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,18.0,19.0,18.0,17.0,18.0,17.0,16.0,17.0,18.0,19.0,17.0,18.0,-1.0
Surendranagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,4.0,5.0,6.0,6.0,5.0,5.0,7.0,8.0,9.0,12.0,6.0,-1.0
Surendranagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1042.0,576.0,487.0,534.0,899.0,780.0,379.0,391.0,486.0,263.0,503.0,272.0,6612.0
Surendranagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,5596.0,2616.0,2415.0,2005.0,2679.0,3631.0,2571.0,2088.0,1965.0,2059.0,1810.0,2337.0,31772.0
Surendranagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,903.0,608.0,583.0,760.0,901.0,1029.0,382.0,402.0,436.0,572.0,517.0,468.0,7561.0
Surendranagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4312.0,3709.0,3175.0,2877.0,3351.0,4075.0,2803.0,2811.0,3087.0,2478.0,2809.0,2579.0,38066.0
Surendranagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1945.0,1184.0,1070.0,1294.0,1800.0,1809.0,761.0,793.0,922.0,835.0,1020.0,740.0,14173.0
Surendranagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9908.0,6325.0,5590.0,4882.0,6030.0,7706.0,5374.0,4899.0,5052.0,4537.0,4619.0,4916.0,69838.0
Surendranagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,8.0,15.0,11.0,8.0,7.0,3.0,1.0,10.0,7.0,7.0,5.0,89.0
Surendranagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,6.0,4.0,10.0,3.0,10.0,5.0,4.0,6.0,5.0,4.0,2.0,63.0
Surendranagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,11.0,14.0,19.0,21.0,11.0,17.0,8.0,5.0,16.0,12.0,11.0,7.0,152.0
Surendranagar,14.11,In-Patient Head Count at midnight,TOTAL,852.0,1053.0,999.0,823.0,1197.0,1551.0,1180.0,1289.0,1508.0,4642.0,1352.0,1346.0,17792.0
Surendranagar,14.12.1,OPD attendance (All),TOTAL,72008.0,85316.0,87553.0,90240.0,103048.0,120647.0,82485.0,85114.0,84163.0,81181.0,96975.0,97342.0,1086072.0
Surendranagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,176.0,213.0,136.0,476.0,161.0,149.0,2607.0,152.0,424.0,832.0,336.0,183.0,5845.0
Surendranagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,6.0,10.0,2.0,10.0,26.0,27.0,14.0,12.0,18.0,18.0,20.0,163.0
Surendranagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,613.0,801.0,718.0,1133.0,747.0,674.0,714.0,555.0,717.0,643.0,727.0,711.0,8753.0
Surendranagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,296.0,7.0,5.0,7.0,60.0,60.0,6.0,404.0,34.0,507.0,618.0,397.0,2401.0
Surendranagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1436.0,1372.0,833.0,1416.0,1140.0,322.0,0.0,630.0,667.0,727.0,681.0,696.0,9920.0
Surendranagar,14.14.c,Number of Adolescents counselled,TOTAL,144.0,101.0,101.0,91.0,5.0,5.0,59.0,60.0,57.0,7.0,7.0,0.0,637.0
Surendranagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6802.0,6942.0,7039.0,7496.0,7157.0,8141.0,6064.0,6580.0,7102.0,6831.0,6714.0,7307.0,84175.0
Surendranagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,149.0,194.0,178.0,166.0,186.0,230.0,229.0,111.0,122.0,111.0,107.0,137.0,1920.0
Surendranagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1277.0,1542.0,1423.0,1246.0,1320.0,2009.0,1495.0,1214.0,1407.0,567.0,957.0,1394.0,15851.0
Surendranagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,15.0,117.0,93.0,3.0,10.0,8.0,3.0,8.0,4.0,6.0,7.0,278.0
Surendranagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1148.0,1375.0,1278.0,1404.0,1495.0,1765.0,1388.0,1186.0,1649.0,787.0,1477.0,1452.0,16404.0
Surendranagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,3.0,106.0,117.0,3.0,4.0,4.0,0.0,13.0,12.0,15.0,15.0,294.0
Surendranagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1424.0,1395.0,1754.0,1452.0,1496.0,1919.0,1334.0,1239.0,1223.0,834.0,1015.0,1455.0,16540.0
Surendranagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,28.0,144.0,65.0,27.0,2.0,2.0,17.0,2.0,21.0,15.0,1.0,324.0
Surendranagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3849.0,4312.0,4455.0,4102.0,4311.0,5693.0,4217.0,3639.0,4279.0,2188.0,3449.0,4301.0,48795.0
Surendranagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,6.0,46.0,367.0,275.0,33.0,16.0,14.0,20.0,23.0,37.0,36.0,23.0,896.0
Surendranagar,15.2,Number of Widal tests conducted,Number tested,1157.0,1071.0,767.0,814.0,1328.0,1797.0,1857.0,971.0,723.0,612.0,789.0,1348.0,13234.0
Surendranagar,15.3.a,Number of VDRL tests conducted on males,Number tested,139.0,169.0,95.0,99.0,22.0,99.0,79.0,34.0,58.0,58.0,66.0,600.0,1518.0
Surendranagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,66.0,94.0,161.0,193.0,38.0,144.0,71.0,38.0,94.0,65.0,67.0,38.0,1069.0
Surendranagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,333.0,346.0,356.0,396.0,295.0,473.0,288.0,181.0,257.0,140.0,187.0,236.0,3488.0
Surendranagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,538.0,609.0,612.0,688.0,355.0,716.0,438.0,253.0,409.0,263.0,320.0,874.0,6075.0
Surendranagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,9737.0,9731.0,8024.0,10248.0,15476.0,19511.0,12706.0,8748.0,8673.0,6850.0,10998.0,9418.0,130120.0
Surendranagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,39.0,81.0,48.0,61.0,201.0,247.0,129.0,168.0,84.0,34.0,23.0,29.0,1144.0
Surendranagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,11.0,1.0,0.0,0.0,17.0,20.0,28.0,33.0,39.0,12.0,17.0,2.0,180.0
Surendranagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1150.0,5000.0,5600.0,7060.0,7550.0,6920.0,7080.0,10550.0,10380.0,7050.0,5280.0,8080.0,81700.0
Surendranagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,7500.0,6500.0,7500.0,7500.0,5000.0,7500.0,8000.0,8000.0,4000.0,4000.0,9000.0,29270.0,103770.0
Surendranagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3650.0,5900.0,6040.0,7010.0,5630.0,7340.0,4530.0,8170.0,7330.0,5770.0,6200.0,4930.0,72500.0
Surendranagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,5000.0,5600.0,7060.0,7550.0,6920.0,7080.0,10550.0,10380.0,7050.0,5280.0,8080.0,32420.0,112970.0
Surendranagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,11430.0,11730.0,12850.0,12890.0,8510.0,6960.0,70.0,24000.0,11480.0,1900.0,11910.0,13050.0,126780.0
Surendranagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,6000.0,12000.0,9000.0,6470.0,6000.0,0.0,28000.0,0.0,0.0,12000.0,9000.0,16070.0,104540.0
Surendranagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,5700.0,10880.0,8960.0,10850.0,7550.0,6890.0,4070.0,12520.0,9580.0,1990.0,7860.0,7150.0,94000.0
Surendranagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,11730.0,12850.0,12890.0,8510.0,6960.0,70.0,24000.0,11480.0,1900.0,11910.0,13050.0,21970.0,137320.0
Surendranagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,50060.0,41000.0,22900.0,21500.0,16680.0,20880.0,4320.0,11300.0,23060.0,120720.0,5220.0,25020.0,362660.0
Surendranagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,14000.0,15000.0,20000.0,4000.0,22000.0,30340.0,310000.0,3000.0,325000.0,12580.0,755920.0
Surendranagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,9060.0,18100.0,15400.0,19820.0,15800.0,20560.0,15020.0,18580.0,212340.0,118500.0,305200.0,9560.0,777940.0
Surendranagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,41000.0,22900.0,21500.0,16680.0,20880.0,4320.0,11300.0,23060.0,120720.0,5220.0,25020.0,28040.0,340640.0
Surendranagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,9910.0,14310.0,13300.0,12930.0,8830.0,12900.0,12750.0,15600.0,8670.0,2380.0,9990.0,10110.0,131680.0
Surendranagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,10000.0,8000.0,8000.0,12000.0,10000.0,10000.0,5000.0,5000.0,10000.0,10000.0,30970.0,128970.0
Surendranagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5600.0,11010.0,8370.0,12100.0,7930.0,10150.0,7150.0,11930.0,11290.0,2390.0,9880.0,8710.0,106510.0
Surendranagar,16.1.3,Stock position of TT vaccines,5. Total Stock,14310.0,13300.0,12930.0,8830.0,12900.0,12750.0,15600.0,8670.0,2380.0,9990.0,10110.0,32370.0,154140.0
Surendranagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1300.0,10050.0,8610.0,7650.0,5050.0,20100.0,12720.0,18170.0,8950.0,5070.0,12750.0,15010.0,125430.0
Surendranagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,13000.0,6000.0,6000.0,5000.0,20000.0,0.0,10000.0,480.0,5000.0,10000.0,10000.0,10550.0,96030.0
Surendranagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4250.0,7440.0,6960.0,7600.0,4950.0,7380.0,4550.0,9700.0,8880.0,2320.0,7740.0,5210.0,76980.0
Surendranagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,10050.0,8610.0,7650.0,5050.0,20100.0,12720.0,18170.0,8950.0,5070.0,12750.0,15010.0,20350.0,144480.0
Surendranagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0.0,3800.0,5115.0,9530.0,8250.0,7700.0,6800.0,10450.0,7530.0,5330.0,8825.0,7465.0,80795.0
Surendranagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,6000.0,8500.0,10000.0,7500.0,5000.0,5000.0,8000.0,5000.0,5000.0,5000.0,5000.0,16310.0,86310.0
Surendranagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2200.0,7185.0,5585.0,8780.0,5550.0,5900.0,4350.0,7920.0,7200.0,1505.0,6360.0,4650.0,67185.0
Surendranagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,3800.0,5115.0,9530.0,8250.0,7700.0,6800.0,10450.0,7530.0,5330.0,8825.0,7465.0,19125.0,99920.0
Surendranagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,930.0,620.0,650.0,1080.0,440.0,620.0,150.0,1750.0,1930.0,1090.0,820.0,1240.0,11320.0
Surendranagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,670.0,900.0,300.0,600.0,0.0,1800.0,600.0,0.0,0.0,1200.0,930.0,7000.0
Surendranagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,310.0,640.0,470.0,940.0,420.0,470.0,200.0,420.0,840.0,270.0,780.0,1070.0,6830.0
Surendranagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,620.0,650.0,1080.0,440.0,620.0,150.0,1750.0,1930.0,1090.0,820.0,1240.0,1100.0,11490.0
Surendranagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,650.0,15050.0,10750.0,4650.0,4250.0,2000.0,1200.0,1000.0,800.0,650.0,650.0,450.0,42100.0
Surendranagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,14400.0,0.0,0.0,0.0,3600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18000.0
Surendranagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,4300.0,6100.0,400.0,5850.0,800.0,200.0,200.0,150.0,100.0,200.0,400.0,18700.0
Surendranagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,15050.0,10750.0,4650.0,4250.0,2000.0,1200.0,1000.0,800.0,650.0,550.0,450.0,50.0,41400.0
Surendranagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,21400.0,21400.0,0.0,0.0,0.0,174720.0,95760.0,50400.0,420.0,0.0,0.0,0.0,364100.0
Surendranagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,423360.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,423360.0
Surendranagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,21400.0,0.0,0.0,248640.0,78960.0,45360.0,49980.0,420.0,0.0,0.0,0.0,444760.0
Surendranagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,21400.0,0.0,0.0,0.0,174720.0,95760.0,50400.0,420.0,0.0,0.0,0.0,0.0,342700.0
Surendranagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2200.0,2200.0,0.0,34400.0,23000.0,10500.0,5300.0,1400.0,25800.0,15500.0,15500.0,2400.0,138200.0
Surendranagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,36000.0,0.0,0.0,0.0,0.0,60000.0,0.0,0.0,0.0,0.0,96000.0
Surendranagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,2200.0,1600.0,11400.0,12500.0,5200.0,3900.0,35600.0,10300.0,12100.0,13100.0,1300.0,109200.0
Surendranagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,2200.0,0.0,34400.0,23000.0,10500.0,5300.0,1400.0,25800.0,15500.0,3400.0,2400.0,1100.0,125000.0
Surendranagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,150.0,150.0,0.0,0.0,0.0,500.0,50.0,50.0,50.0,50.0,50.0,0.0,1050.0
Surendranagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0
Surendranagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,150.0,0.0,0.0,2500.0,450.0,450.0,0.0,0.0,50.0,50.0,0.0,3650.0
Surendranagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,150.0,0.0,0.0,0.0,500.0,50.0,-400.0,50.0,50.0,0.0,0.0,0.0,400.0
Surendranagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1100.0,1100.0,1100.0,1100.0,800.0,800.0,800.0,600.0,2550.0,0.0,0.0,1200.0,11150.0
Surendranagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3055.0,0.0,4465.0,4465.0,0.0,11985.0
Surendranagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,300.0,0.0,0.0,200.0,1105.0,2550.0,2765.0,3265.0,500.0,10685.0
Surendranagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1100.0,1100.0,1100.0,800.0,800.0,800.0,600.0,2550.0,0.0,1700.0,1200.0,700.0,12450.0
Surendranagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,1475.0,1275.0,4475.0,950.0,575.0,5200.0,4650.0,4225.0,3300.0,2900.0,2900.0,1400.0,33325.0
Surendranagar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,3500.0,0.0,1000.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,950.0,10450.0
Surendranagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,200.0,300.0,3525.0,1375.0,375.0,550.0,425.0,925.0,400.0,400.0,1500.0,225.0,10200.0
Surendranagar,16.3.02,Stock Position of Gloves,5. Total Stock,1275.0,4475.0,950.0,575.0,5200.0,4650.0,4225.0,3300.0,2900.0,2500.0,1400.0,2125.0,33575.0
Surendranagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,200.0,0.0,0.0,0.0,0.0,18600.0,18600.0,700.0,38100.0
Surendranagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,200.0,0.0,0.0,0.0,0.0,20000.0,0.0,0.0,0.0,20200.0
Surendranagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,200.0,0.0,0.0,,1400.0,15400.0,17900.0,700.0,35600.0
Surendranagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,200.0,0.0,0.0,0.0,0.0,18600.0,3200.0,700.0,0.0,22700.0
Surendranagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,19.0,17.0,17.0,16.0,13.0,12.0,12.0,12.0,7.0,6.0,6.0,4.0,141.0
Surendranagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,2.0,0.0,1.0,3.0,1.0,0.0,0.0,5.0,1.0,2.0,2.0,3.0,20.0
Surendranagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,17.0,17.0,16.0,13.0,12.0,12.0,12.0,7.0,6.0,4.0,4.0,1.0,121.0
Surendranagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,52000.0,52000.0,1000.0,0.0,40000.0,13000.0,835000.0,212000.0,307500.0,118000.0,11800.0,5004000.0,6646300.0
Surendranagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,40000.0,0.0,840000.0,0.0,1270000.0,0.0,0.0,5004000.0,60000.0,7214000.0
Surendranagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,51000.0,1000.0,0.0,27000.0,18000.0,623000.0,1174500.0,189500.0,34000.0,11800.0,4882000.0,7011800.0
Surendranagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,52000.0,1000.0,0.0,40000.0,13000.0,835000.0,212000.0,307500.0,118000.0,84000.0,5004000.0,182000.0,6848500.0
Surendranagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,520.0,160.0,120.0,80.0,80.0,0.0,0.0,12500.0,13460.0
Surendranagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,520.0,0.0,0.0,0.0,0.0,0.0,0.0,12500.0,0.0,13020.0
Surendranagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,360.0,40.0,40.0,0.0,80.0,0.0,0.0,12370.0,12890.0
Surendranagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,520.0,160.0,120.0,80.0,80.0,0.0,0.0,12500.0,130.0,13590.0
Surendranagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,,0.0
Surendranagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,,0.0
Surendranagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,90.0,90.0,90.0,70.0,70.0,70.0,70.0,50.0,20.0,2100.0,2100.0,130.0,4950.0
Surendranagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3700.0,0.0,0.0,0.0,3700.0
Surendranagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,20.0,0.0,0.0,0.0,20.0,30.0,1620.0,1100.0,1970.0,30.0,4790.0
Surendranagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,90.0,90.0,70.0,70.0,70.0,70.0,50.0,20.0,2100.0,1000.0,130.0,100.0,3860.0
Surendranagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,6000.0,5600.0,92900.0,14400.0,12400.0,9400.0,56400.0,21600.0,17000.0,16450.0,16450.0,8100.0,276700.0
Surendranagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,105000.0,0.0,0.0,0.0,75000.0,0.0,0.0,2500.0,0.0,0.0,0.0,182500.0
Surendranagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,400.0,17700.0,78500.0,2000.0,3000.0,28000.0,34800.0,4600.0,3050.0,4250.0,8350.0,0.0,184650.0
Surendranagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,5600.0,92900.0,14400.0,12400.0,9400.0,56400.0,21600.0,17000.0,16450.0,12200.0,8100.0,8100.0,274550.0
Surendranagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,300.0,6600.0,4000.0,15300.0,7500.0,900.0,300.0,300.0,250.0,0.0,0.0,0.0,35450.0
Surendranagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6600.0,0.0,16500.0,0.0,0.0,0.0,0.0,3300.0,0.0,0.0,0.0,0.0,26400.0
Surendranagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,2600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2600.0
Surendranagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,300.0,,5200.0,7800.0,6600.0,600.0,0.0,3350.0,250.0,0.0,0.0,0.0,24100.0
Surendranagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,6600.0,4000.0,15300.0,7500.0,900.0,300.0,300.0,250.0,0.0,0.0,0.0,0.0,35150.0
Surendranagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,400.0,400.0,200.0,200.0,200.0,0.0,0.0,0.0,26400.0,15800.0,15800.0,2800.0,62200.0
Surendranagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,75000.0,0.0,0.0,0.0,0.0,75000.0
Surendranagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,200.0,200.0,0.0,0.0,200.0,0.0,0.0,48600.0,10600.0,9400.0,13000.0,600.0,82800.0
Surendranagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,200.0,200.0,200.0,200.0,0.0,0.0,0.0,26400.0,15800.0,6400.0,2800.0,2200.0,54400.0
Surendranagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,2250.0,1300.0,800.0,400.0,0.0,0.0,0.0,0.0,4750.0
Surendranagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,4000.0,0.0,,,0.0,0.0,0.0,0.0,0.0,4000.0
Surendranagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surendranagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,1750.0,950.0,500.0,400.0,400.0,0.0,0.0,0.0,0.0,4000.0
Surendranagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,2250.0,1300.0,800.0,400.0,0.0,0.0,0.0,0.0,0.0,4750.0
Surendranagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,,,1.0,2.0,1.0,1.0,2.0,1.0,,,,10.0
Surendranagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,1.0,,2.0
Surendranagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Surendranagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,1.0,,,,,,1.0,,2.0
Surendranagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,6.0,3.0,1.0,1.0,2.0,1.0,2.0,2.0,1.0,,2.0,21.0
Surendranagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Surendranagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,6.0,3.0,1.0,1.0,2.0,1.0,2.0,2.0,1.0,,2.0,21.0
Surendranagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,7.0,6.0,3.0,5.0,7.0,7.0,6.0,11.0,11.0,3.0,6.0,76.0
Surendranagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,1.0,1.0
Surendranagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,7.0,6.0,3.0,5.0,7.0,7.0,6.0,11.0,11.0,3.0,7.0,77.0
Surendranagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,4.0,12.0,8.0,6.0,5.0,11.0,10.0,7.0,8.0,9.0,9.0,93.0
Surendranagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,,,,,,,1.0,1.0,1.0,4.0
Surendranagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,4.0,13.0,8.0,6.0,5.0,11.0,10.0,7.0,9.0,10.0,10.0,97.0
Surendranagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,2.0,1.0,1.0,4.0,2.0,1.0,,1.0,,12.0
Surendranagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,2.0,,,,,,3.0
Surendranagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,2.0,1.0,1.0,6.0,2.0,1.0,,1.0,,15.0
Surendranagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Surendranagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Surendranagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,1.0,,,,,,1.0
Surendranagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,1.0,,,,,1.0,2.0,1.0,,1.0,7.0
Surendranagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Surendranagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,1.0,,,,,1.0,2.0,1.0,,1.0,8.0
Surendranagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
Surendranagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Surendranagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,1.0,,,,,,,,,,,1.0
Surendranagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,3.0,3.0,2.0,7.0,3.0,6.0,4.0,4.0,7.0,6.0,3.0,49.0
Surendranagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,4.0,1.0,3.0,3.0,1.0,2.0,3.0,2.0,3.0,2.0,2.0,26.0
Surendranagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,7.0,4.0,5.0,10.0,4.0,8.0,7.0,6.0,10.0,8.0,5.0,75.0
Surendranagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Surendranagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,2.0,2.0
Surendranagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,2.0,2.0
Surendranagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,5.0,3.0,,4.0,,1.0,2.0,2.0,2.0,2.0,2.0,23.0
Surendranagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,1.0,2.0,,1.0,2.0,,,1.0,,1.0,1.0,11.0
Surendranagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,6.0,5.0,,5.0,2.0,1.0,2.0,3.0,2.0,3.0,3.0,34.0
Surendranagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,4.0,2.0,1.0,4.0,3.0,,1.0,3.0,2.0,2.0,2.0,2.0,26.0
Surendranagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,15.0,22.0,13.0,14.0,11.0,11.0,12.0,9.0,19.0,11.0,18.0,8.0,163.0
Surendranagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,19.0,24.0,14.0,18.0,14.0,11.0,13.0,12.0,21.0,13.0,20.0,10.0,189.0
Surendranagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,1.0,,,1.0,,,2.0
Surendranagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Surendranagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,1.0,,,1.0,,,2.0
Surendranagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,1.0,,1.0,,2.0,4.0
Surendranagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,2.0,,1.0,,,,1.0,,2.0,,1.0,9.0
Surendranagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,3.0,1.0,1.0,2.0,2.0,,,1.0,2.0,2.0,4.0,18.0
Surendranagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,5.0,1.0,2.0,2.0,2.0,,2.0,1.0,5.0,2.0,7.0,31.0
Surendranagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,1.0,,,2.0,,1.0,1.0,,,1.0,1.0,7.0
Surendranagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Surendranagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,1.0,,,3.0,,1.0,1.0,,,1.0,1.0,8.0
Surendranagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,11.0,20.0,7.0,9.0,10.0,18.0,6.0,12.0,14.0,21.0,10.0,10.0,148.0
Surendranagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,13.0,15.0,17.0,14.0,22.0,26.0,20.0,12.0,18.0,21.0,19.0,10.0,207.0
Surendranagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,24.0,35.0,24.0,23.0,32.0,44.0,26.0,24.0,32.0,42.0,29.0,20.0,355.0
Surendranagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,1.0,1.0,1.0,,3.0,1.0,,,,,2.0,10.0
Surendranagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,1.0,2.0,3.0,1.0,1.0,1.0,1.0,2.0,1.0,,1.0,16.0
Surendranagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,3.0,2.0,3.0,4.0,1.0,4.0,2.0,1.0,2.0,1.0,,3.0,26.0
Surendranagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Surendranagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Surendranagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Surendranagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Surendranagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Surendranagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Surendranagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,1.0,,,,,,2.0,,,,4.0
Surendranagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Surendranagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,1.0,,,,,,2.0,,,,4.0
Surendranagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Surendranagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Surendranagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,1.0,1.0
Surendranagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Surendranagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Surendranagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Surendranagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,1.0,,,,1.0,3.0,1.0,,2.0,2.0,12.0
Surendranagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Surendranagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,1.0,,,,1.0,3.0,1.0,,2.0,2.0,12.0
Surendranagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,,,,,1.0,2.0,,,2.0,1.0,8.0
Surendranagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,6.0,15.0,15.0,11.0,10.0,10.0,5.0,6.0,7.0,12.0,4.0,4.0,105.0
Surendranagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,2.0,2.0,3.0,3.0,,,1.0,3.0,,1.0,2.0,18.0
Surendranagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,7.0,19.0,17.0,14.0,13.0,10.0,6.0,9.0,10.0,12.0,7.0,7.0,131.0
Surendranagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,1.0,1.0,,,1.0,,1.0,1.0,2.0,,7.0
Surendranagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,5.0,13.0,8.0,5.0,13.0,13.0,10.0,15.0,11.0,11.0,7.0,12.0,123.0
Surendranagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,3.0,1.0,1.0,3.0,3.0,1.0,1.0,2.0,2.0,1.0,1.0,20.0
Surendranagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,6.0,16.0,10.0,7.0,16.0,16.0,12.0,16.0,14.0,14.0,10.0,13.0,150.0
Surendranagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,1.0,3.0,2.0,,,,,,,,7.0
Surendranagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,,,4.0,2.0,,1.0,,,,,8.0
Surendranagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,1.0,1.0,,,,1.0,,,,4.0
Surendranagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,3.0,1.0,4.0,7.0,2.0,,1.0,1.0,,,,19.0
Surendranagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Surendranagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,4.0,2.0,1.0,3.0,,1.0,1.0,,2.0,1.0,1.0,16.0
Surendranagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,5.0,9.0,3.0,6.0,1.0,4.0,1.0,4.0,1.0,3.0,3.0,44.0
Surendranagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,4.0,9.0,11.0,4.0,9.0,1.0,5.0,2.0,4.0,3.0,4.0,4.0,60.0
Surendranagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Surendranagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,1.0,1.0,1.0,2.0,3.0,1.0,2.0,1.0,,3.0,1.0,17.0
Surendranagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,7.0,3.0,2.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,24.0
Surendranagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,8.0,5.0,3.0,3.0,3.0,4.0,3.0,3.0,2.0,1.0,4.0,3.0,42.0
Surendranagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,3.0,,1.0,3.0,1.0,2.0,,1.0,,1.0,12.0
Surendranagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,15.0,16.0,31.0,18.0,22.0,29.0,26.0,16.0,19.0,25.0,14.0,23.0,254.0
Surendranagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,64.0,125.0,100.0,66.0,75.0,100.0,95.0,72.0,91.0,95.0,83.0,76.0,1042.0
Surendranagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,79.0,141.0,134.0,84.0,98.0,132.0,122.0,90.0,110.0,121.0,97.0,100.0,1308.0
Tapi,1.1,Total number of pregnant women Registered for ANC,TOTAL,1247.0,1084.0,1182.0,1219.0,1083.0,971.0,874.0,908.0,1010.0,1011.0,1100.0,986.0,12675.0
Tapi,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1067.0,987.0,1041.0,1077.0,974.0,876.0,811.0,835.0,899.0,903.0,993.0,897.0,11360.0
Tapi,1.2,Number of Pregnant women registered under JSY,TOTAL,1100.0,1002.0,1068.0,1078.0,981.0,863.0,760.0,814.0,847.0,898.0,960.0,893.0,11264.0
Tapi,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,944.0,887.0,953.0,923.0,973.0,973.0,960.0,1004.0,1007.0,931.0,897.0,906.0,11358.0
Tapi,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,931.0,804.0,927.0,892.0,820.0,737.0,717.0,729.0,763.0,739.0,810.0,770.0,9639.0
Tapi,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,956.0,1069.0,1041.0,1078.0,1069.0,988.0,909.0,838.0,903.0,917.0,960.0,1005.0,11733.0
Tapi,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1121.0,1211.0,1259.0,1319.0,1248.0,1137.0,1184.0,1280.0,1131.0,1118.0,1037.0,1204.0,14249.0
Tapi,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,141.0,3.0,7.0,1.0,11.0,2.0,110.0,3.0,5.0,5.0,10.0,16.0,314.0
Tapi,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,0.0,1.0,0.0,0.0,2.0,4.0,0.0,0.0,1.0,0.0,0.0,10.0
Tapi,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1727.0,1842.0,2100.0,2305.0,2094.0,1972.0,1533.0,1691.0,1546.0,1507.0,1653.0,2135.0,22105.0
Tapi,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,84.0,24.0,274.0,208.0,254.0,146.0,74.0,88.0,98.0,69.0,107.0,183.0,1609.0
Tapi,1.8,Number of pregnancy test kits used at SC level,TOTAL,179.0,270.0,433.0,681.0,616.0,684.0,663.0,603.0,711.0,791.0,816.0,767.0,7214.0
Tapi,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,3.0,2.0,1.0,1.0,5.0,6.0,4.0,9.0,7.0,4.0,3.0,5.0,50.0
Tapi,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,27.0,16.0,15.0,16.0,15.0,20.0,14.0,14.0,16.0,2.0,5.0,8.0,168.0
Tapi,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,30.0,18.0,16.0,17.0,20.0,26.0,18.0,23.0,23.0,6.0,8.0,13.0,218.0
Tapi,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,27.0,16.0,16.0,17.0,18.0,26.0,14.0,23.0,23.0,5.0,7.0,12.0,204.0
Tapi,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,5.0,0.0,0.0,0.0,0.0,2.0,3.0,0.0,2.0,2.0,15.0
Tapi,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,514.0,493.0,434.0,464.0,497.0,539.0,559.0,548.0,540.0,497.0,448.0,464.0,5997.0
Tapi,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,92.0,91.0,81.0,103.0,105.0,283.0,76.0,93.0,127.0,98.0,94.0,88.0,1331.0
Tapi,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,1.0,0.0,29.0,4.0,50.0,46.0,29.0,19.0,43.0,40.0,0.0,261.0
Tapi,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Tapi,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,328.0,329.0,296.0,264.0,336.0,370.0,346.0,380.0,379.0,330.0,289.0,306.0,3953.0
Tapi,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,3.0,0.0,4.0,2.0,6.0,7.0,7.0,4.0,5.0,7.0,3.0,5.0,53.0
Tapi,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,30.0,48.0,33.0,42.0,45.0,40.0,29.0,41.0,35.0,41.0,33.0,35.0,452.0
Tapi,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tapi,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,33.0,48.0,37.0,44.0,51.0,47.0,36.0,45.0,40.0,48.0,36.0,40.0,505.0
Tapi,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,42.0,43.0,40.0,36.0,57.0,52.0,52.0,41.0,51.0,51.0,36.0,40.0,541.0
Tapi,4.1.1.a,Number of male live births,TOTAL,426.0,417.0,365.0,375.0,432.0,483.0,486.0,475.0,473.0,453.0,365.0,424.0,5174.0
Tapi,4.1.1.b,Number of female live births,TOTAL,432.0,411.0,378.0,360.0,405.0,445.0,400.0,476.0,458.0,361.0,372.0,349.0,4847.0
Tapi,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,858.0,828.0,743.0,735.0,837.0,928.0,886.0,951.0,931.0,814.0,737.0,773.0,10021.0
Tapi,4.1.2,Number of still births,TOTAL,15.0,17.0,9.0,13.0,21.0,13.0,18.0,7.0,13.0,14.0,14.0,13.0,167.0
Tapi,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,31.0,44.0,38.0,55.0,49.0,46.0,48.0,51.0,40.0,71.0,55.0,68.0,596.0
Tapi,4.2.1,Number of Newborns weighed at birth,TOTAL,852.0,827.0,749.0,739.0,827.0,929.0,884.0,931.0,917.0,823.0,723.0,767.0,9968.0
Tapi,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,170.0,181.0,149.0,178.0,180.0,205.0,155.0,217.0,188.0,170.0,170.0,174.0,2137.0
Tapi,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,812.0,797.0,699.0,715.0,798.0,899.0,865.0,927.0,916.0,794.0,726.0,752.0,9700.0
Tapi,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Tapi,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,32.0,18.0,13.0,20.0,21.0,21.0,31.0,17.0,30.0,22.0,13.0,27.0,265.0
Tapi,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,97.0,83.0,80.0,87.0,93.0,106.0,129.0,180.0,102.0,104.0,117.0,137.0,1315.0
Tapi,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tapi,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,138.0,101.0,93.0,107.0,114.0,127.0,160.0,197.0,132.0,126.0,130.0,164.0,1589.0
Tapi,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,160.0,223.0,185.0,213.0,144.0,142.0,998.0,166.0,120.0,129.0,104.0,136.0,2720.0
Tapi,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,7.0,6.0,6.0,6.0,72.0,11.0,4.0,4.0,1.0,9.0,0.0,0.0,126.0
Tapi,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,246.0,256.0,228.0,299.0,320.0,303.0,301.0,267.0,219.0,169.0,211.0,152.0,2971.0
Tapi,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,45.0,52.0,42.0,11.0,50.0,50.0,150.0,93.0,40.0,96.0,33.0,79.0,741.0
Tapi,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,719.0,753.0,681.0,577.0,792.0,971.0,1023.0,948.0,940.0,913.0,768.0,632.0,9717.0
Tapi,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,779.0,771.0,772.0,679.0,883.0,1008.0,913.0,967.0,951.0,909.0,790.0,659.0,10081.0
Tapi,6.3,PNC maternal complications attended,TOTAL,97.0,84.0,80.0,87.0,93.0,106.0,129.0,132.0,0.0,104.0,177.0,35.0,1124.0
Tapi,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,13.0,10.0,7.0,9.0,7.0,6.0,14.0,5.0,3.0,9.0,13.0,17.0,113.0
Tapi,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,13.0,10.0,7.0,9.0,7.0,6.0,14.0,5.0,3.0,9.0,13.0,17.0,113.0
Tapi,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,43.0,68.0,70.0,64.0,73.0,83.0,70.0,60.0,55.0,63.0,61.0,74.0,784.0
Tapi,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,192.0,214.0,229.0,222.0,206.0,288.0,256.0,246.0,229.0,259.0,259.0,310.0,2910.0
Tapi,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,235.0,282.0,299.0,286.0,279.0,371.0,326.0,306.0,284.0,322.0,320.0,384.0,3694.0
Tapi,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,50.0,23.0,18.0,23.0,19.0,23.0,32.0,30.0,26.0,13.0,257.0
Tapi,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,28.0,2.0,32.0,34.0,39.0,36.0,15.0,20.0,47.0,35.0,47.0,23.0,358.0
Tapi,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,2.0,59.0,0.0,0.0,35.0,30.0,5.0,2.0,2.0,5.0,140.0
Tapi,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,2.0,0.0,0.0,5.0,0.0,0.0,0.0,2.0,0.0,0.0,9.0
Tapi,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tapi,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,28.0,2.0,36.0,93.0,39.0,41.0,50.0,50.0,52.0,39.0,49.0,28.0,507.0
Tapi,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,192.0,370.0,22.0,132.0,97.0,152.0,88.0,68.0,82.0,241.0,1444.0
Tapi,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,15.0,0.0,49.0,12.0,0.0,30.0,6.0,70.0,39.0,42.0,0.0,0.0,263.0
Tapi,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tapi,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,15.0,0.0,241.0,382.0,22.0,162.0,103.0,222.0,127.0,110.0,82.0,241.0,1707.0
Tapi,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,41.0,46.0,179.0,57.0,152.0,166.0,119.0,136.0,56.0,12.0,67.0,34.0,1065.0
Tapi,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,15.0,10.0,7.0,18.0,17.0,18.0,23.0,31.0,6.0,28.0,14.0,21.0,208.0
Tapi,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tapi,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,56.0,56.0,186.0,75.0,169.0,184.0,142.0,167.0,62.0,40.0,81.0,55.0,1273.0
Tapi,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,4.0,7.0
Tapi,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,10.0,11.0,10.0,5.0,9.0,50.0
Tapi,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tapi,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,10.0,11.0,11.0,7.0,13.0,57.0
Tapi,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,148.0,188.0,193.0,244.0,231.0,238.0,214.0,204.0,237.0,217.0,229.0,199.0,2542.0
Tapi,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,20.0,55.0,38.0,58.0,45.0,68.0,46.0,72.0,53.0,51.0,53.0,47.0,606.0
Tapi,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,3.0,1.0,2.0,1.0,1.0,2.0,2.0,1.0,1.0,0.0,0.0,0.0,14.0
Tapi,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,11.0,9.0,10.0,8.0,8.0,9.0,13.0,3.0,2.0,3.0,10.0,10.0,96.0
Tapi,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tapi,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,182.0,253.0,243.0,311.0,285.0,317.0,275.0,280.0,293.0,271.0,292.0,256.0,3258.0
Tapi,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,9.0,14.0,14.0,13.0,18.0,12.0,5.0,13.0,5.0,4.0,12.0,11.0,130.0
Tapi,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,9.06,Number of IUCD removals,TOTAL,54.0,50.0,45.0,102.0,64.0,61.0,51.0,88.0,76.0,81.0,74.0,107.0,853.0
Tapi,9.07,Number of Oral Pills cycles distributed,TOTAL,151.0,136.0,104.0,2365.0,1336.0,1048.0,503.0,966.0,2401.0,2765.0,2824.0,3038.0,17637.0
Tapi,9.08,Number of Condom pieces distributed,TOTAL,2336.0,2020.0,825.0,8538.0,6580.0,4579.0,6041.0,12192.0,15639.0,16238.0,15097.0,13492.0,103577.0
Tapi,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,210.0,0.0,210.0
Tapi,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,8.0
Tapi,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Tapi,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,3.0,0.0,2.0,0.0,3.0,6.0,0.0,0.0,0.0,0.0,14.0
Tapi,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,3.0
Tapi,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,9.12,Number of Institutions having NSV trained doctors,TOTAL,14.0,11.0,11.0,11.0,10.0,13.0,14.0,14.0,13.0,15.0,14.0,15.0,-1.0
Tapi,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,903.0,932.0,964.0,825.0,972.0,1107.0,1020.0,1011.0,1032.0,1021.0,925.0,935.0,11647.0
Tapi,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Tapi,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,848.0,967.0,878.0,804.0,883.0,804.0,918.0,1005.0,919.0,1036.0,909.0,891.0,10862.0
Tapi,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,884.0,865.0,949.0,874.0,804.0,882.0,785.0,894.0,985.0,870.0,1011.0,930.0,10733.0
Tapi,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,958.0,917.0,851.0,939.0,872.0,844.0,832.0,778.0,894.0,933.0,858.0,1011.0,10687.0
Tapi,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,757.0,693.0,672.0,617.0,701.0,714.0,733.0,672.0,704.0,669.0,631.0,601.0,8164.0
Tapi,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,848.0,967.0,878.0,804.0,883.0,804.0,918.0,1005.0,919.0,1036.0,909.0,891.0,10862.0
Tapi,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,884.0,865.0,949.0,874.0,804.0,882.0,785.0,894.0,986.0,871.0,1011.0,930.0,10735.0
Tapi,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,958.0,893.0,851.0,939.0,872.0,844.0,832.0,778.0,894.0,933.0,858.0,1011.0,10663.0
Tapi,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,333.0,289.0,365.0,374.0,358.0,421.0,466.0,407.0,423.0,414.0,336.0,351.0,4537.0
Tapi,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Tapi,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,856.0,955.0,1052.0,1082.0,1095.0,1022.0,889.0,989.0,760.0,906.0,799.0,827.0,11232.0
Tapi,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,838.0,849.0,897.0,927.0,830.0,808.0,870.0,824.0,770.0,814.0,872.0,950.0,10249.0
Tapi,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,3.0
Tapi,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,456.0,495.0,514.0,557.0,539.0,533.0,464.0,558.0,403.0,432.0,426.0,428.0,5805.0
Tapi,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,397.0,459.0,537.0,524.0,556.0,482.0,425.0,431.0,353.0,456.0,370.0,399.0,5389.0
Tapi,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,853.0,954.0,1051.0,1081.0,1095.0,1015.0,889.0,989.0,756.0,888.0,796.0,827.0,11194.0
Tapi,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,838.0,849.0,897.0,927.0,830.0,808.0,870.0,824.0,769.0,817.0,872.0,945.0,10246.0
Tapi,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,838.0,849.0,897.0,927.0,830.0,808.0,870.0,824.0,769.0,817.0,872.0,945.0,10246.0
Tapi,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,3.0,6.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,5.0,23.0
Tapi,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,2.0,7.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,3.0,19.0
Tapi,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,0.0,5.0,13.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,8.0,42.0
Tapi,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,365.0,354.0,305.0,698.0,860.0,1202.0,986.0,1066.0,488.0,692.0,793.0,847.0,8656.0
Tapi,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,210.0,260.0,259.0,1119.0,994.0,2081.0,988.0,1234.0,1131.0,1038.0,1127.0,839.0,11280.0
Tapi,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,663.0,735.0,618.0,1172.0,1148.0,1308.0,1017.0,1171.0,1012.0,1730.0,891.0,669.0,12134.0
Tapi,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Tapi,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,7.0,6.0,11.0,4.0,12.0,8.0,2.0,0.0,4.0,3.0,2.0,3.0,62.0
Tapi,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,727.0,735.0,738.0,725.0,725.0,715.0,731.0,732.0,741.0,718.0,724.0,740.0,8751.0
Tapi,10.4.2,Number of Immunisation sessions held during the month,TOTAL,722.0,731.0,728.0,721.0,713.0,711.0,724.0,728.0,733.0,716.0,718.0,736.0,8681.0
Tapi,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,709.0,718.0,716.0,705.0,699.0,701.0,708.0,711.0,715.0,699.0,699.0,711.0,8491.0
Tapi,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,856.0,954.0,1052.0,1082.0,1095.0,1022.0,889.0,989.0,755.0,914.0,782.0,826.0,11216.0
Tapi,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,867.0,0.0,0.0,5.0,0.0,0.0,147.0,5744.0,989.0,3.0,6.0,1756.0,9517.0
Tapi,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,928.0,0.0,0.0,0.0,0.0,0.0,145.0,5148.0,1015.0,0.0,0.0,1722.0,8958.0
Tapi,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,3.0
Tapi,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1940.0,1895.0,2130.0,2219.0,2516.0,2147.0,2276.0,2670.0,2675.0,3150.0,2467.0,2496.0,28581.0
Tapi,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,265.0,0.0,0.0,267.0
Tapi,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,57.0,53.0,49.0,25.0,10.0,156.0,101.0,14.0,10.0,121.0,168.0,170.0,934.0
Tapi,13.1,Number of Patients operated for cataract,TOTAL,106.0,0.0,10.0,87.0,97.0,136.0,41.0,0.0,139.0,0.0,108.0,10.0,734.0
Tapi,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,106.0,0.0,10.0,87.0,97.0,136.0,41.0,0.0,139.0,0.0,108.0,10.0,734.0
Tapi,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,63.0,178.0,435.0,115.0,0.0,182.0,185.0,126.0,458.0,1742.0
Tapi,13.4,Number of children provided free glasses,TOTAL,90.0,0.0,0.0,0.0,53.0,627.0,156.0,0.0,198.0,518.0,77.0,431.0,2150.0
Tapi,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0,0.0,30.0
Tapi,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,4.0,3.0,4.0,4.0,5.0,6.0,-1.0
Tapi,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,7.0,8.0,10.0,9.0,14.0,13.0,16.0,14.0,13.0,13.0,12.0,14.0,-1.0
Tapi,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,344.0,343.0,353.0,332.0,331.0,334.0,419.0,427.0,475.0,368.0,363.0,347.0,-1.0
Tapi,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,6.0,5.0,5.0,5.0,5.0,5.0,4.0,5.0,5.0,6.0,6.0,-1.0
Tapi,14.05,Number of RKS meetings held during the month,TOTAL,5.0,9.0,14.0,11.0,8.0,13.0,6.0,7.0,12.0,9.0,7.0,10.0,111.0
Tapi,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,13.0,14.0,12.0,16.0,14.0,14.0,17.0,17.0,14.0,15.0,17.0,16.0,-1.0
Tapi,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,138.0,95.0,123.0,245.0,445.0,358.0,204.0,173.0,191.0,175.0,238.0,179.0,2564.0
Tapi,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,6.0,4.0,5.0,4.0,4.0,4.0,5.0,4.0,4.0,5.0,5.0,-1.0
Tapi,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,2.0,2.0,2.0,1.0,1.0,1.0,2.0,2.0,4.0,-1.0
Tapi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,323.0,330.0,368.0,367.0,884.0,998.0,224.0,175.0,634.0,635.0,860.0,448.0,6246.0
Tapi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,875.0,958.0,985.0,1256.0,2261.0,3072.0,1444.0,1367.0,1766.0,1866.0,1646.0,2196.0,19692.0
Tapi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,539.0,427.0,642.0,644.0,1140.0,1256.0,186.0,178.0,657.0,624.0,1073.0,644.0,8010.0
Tapi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1897.0,2195.0,2612.0,2365.0,4522.0,5632.0,3333.0,2915.0,3912.0,3648.0,3628.0,4952.0,41611.0
Tapi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,862.0,757.0,1010.0,1011.0,2024.0,2254.0,410.0,353.0,1291.0,1259.0,1933.0,1092.0,14256.0
Tapi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2772.0,3153.0,3597.0,3621.0,6783.0,8704.0,4777.0,4282.0,5678.0,5514.0,5274.0,7148.0,61303.0
Tapi,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,2.0,0.0,2.0,5.0,12.0,5.0,7.0,6.0,14.0,12.0,22.0,88.0
Tapi,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,1.0,2.0,1.0,7.0,5.0,6.0,0.0,6.0,5.0,6.0,7.0,46.0
Tapi,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,1.0,3.0,2.0,3.0,12.0,17.0,11.0,7.0,12.0,19.0,18.0,29.0,134.0
Tapi,14.11,In-Patient Head Count at midnight,TOTAL,5193.0,5971.0,5610.0,2667.0,4017.0,3655.0,2765.0,4444.0,1475.0,1501.0,4107.0,8407.0,49812.0
Tapi,14.12.1,OPD attendance (All),TOTAL,45356.0,45846.0,53250.0,56363.0,65526.0,77486.0,59765.0,59787.0,61329.0,59190.0,67830.0,70750.0,722478.0
Tapi,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,119.0,74.0,58.0,142.0,122.0,137.0,80.0,67.0,78.0,92.0,79.0,49.0,1097.0
Tapi,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,38.0,7.0,19.0,7.0,71.0
Tapi,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,101.0,134.0,245.0,386.0,127.0,556.0,327.0,205.0,476.0,547.0,362.0,163.0,3629.0
Tapi,14.14.a,Number of patients given AYUSH treatment,TOTAL,766.0,791.0,751.0,263.0,142.0,152.0,93.0,94.0,101.0,108.0,180.0,742.0,4183.0
Tapi,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,670.0,672.0,586.0,653.0,545.0,680.0,512.0,368.0,676.0,360.0,609.0,792.0,7123.0
Tapi,14.14.c,Number of Adolescents counselled,TOTAL,23.0,15.0,30.0,22.0,0.0,121.0,34.0,29.0,0.0,13.0,8.0,20.0,315.0
Tapi,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5152.0,3925.0,6294.0,7371.0,7041.0,8127.0,5879.0,6362.0,6233.0,5810.0,6241.0,6888.0,75323.0
Tapi,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,320.0,96.0,548.0,426.0,536.0,825.0,296.0,302.0,289.0,304.0,196.0,420.0,4558.0
Tapi,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,541.0,282.0,544.0,551.0,591.0,692.0,461.0,478.0,490.0,466.0,504.0,532.0,6132.0
Tapi,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,3.0,5.0,3.0,4.0,2.0,12.0,2.0,5.0,8.0,4.0,1.0,51.0
Tapi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,450.0,265.0,675.0,741.0,581.0,667.0,541.0,1931.0,592.0,489.0,682.0,823.0,8437.0
Tapi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,1.0,4.0,2.0,3.0,3.0,6.0,2.0,6.0,0.0,2.0,24.0,56.0
Tapi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1077.0,568.0,1351.0,1233.0,1110.0,1218.0,1018.0,1090.0,1153.0,965.0,1065.0,1202.0,13050.0
Tapi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,2.0,1.0,0.0,0.0,0.0,0.0,2.0,34.0,3.0,1.0,0.0,43.0
Tapi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2068.0,1115.0,2570.0,2525.0,2282.0,2577.0,2020.0,3499.0,2235.0,1920.0,2251.0,2557.0,27619.0
Tapi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5.0,6.0,10.0,5.0,7.0,5.0,18.0,6.0,45.0,11.0,7.0,25.0,150.0
Tapi,15.2,Number of Widal tests conducted,Number tested,559.0,499.0,831.0,640.0,1099.0,1652.0,1609.0,969.0,754.0,579.0,469.0,677.0,10337.0
Tapi,15.3.a,Number of VDRL tests conducted on males,Number tested,247.0,8.0,289.0,189.0,105.0,147.0,176.0,202.0,186.0,208.0,160.0,201.0,2118.0
Tapi,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,184.0,23.0,72.0,120.0,162.0,87.0,207.0,108.0,119.0,73.0,104.0,133.0,1392.0
Tapi,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,846.0,259.0,877.0,787.0,806.0,974.0,820.0,755.0,731.0,668.0,718.0,834.0,9075.0
Tapi,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1277.0,290.0,1238.0,1096.0,1073.0,1208.0,1203.0,1065.0,1036.0,949.0,982.0,1168.0,12585.0
Tapi,15.4.1,Number of blood smears examined for Malaria,TOTAL,10139.0,10076.0,14231.0,16980.0,18243.0,23011.0,15545.0,11199.0,11255.0,9833.0,13140.0,13703.0,167355.0
Tapi,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,12.0,15.0,20.0,27.0,22.0,47.0,14.0,11.0,932.0,37.0,4.0,5.0,1146.0
Tapi,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,1.0,6.0,6.0,8.0,7.0,6.0,2.0,1.0,1.0,38.0
Tapi,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,11710.0,8500.0,8230.0,6880.0,8940.0,10860.0,9670.0,6520.0,13250.0,9155.0,11845.0,10110.0,115670.0
Tapi,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,5000.0,0.0,5000.0,5000.0,2500.0,0.0,10000.0,0.0,5000.0,1000.0,5000.0,38500.0
Tapi,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3210.0,5270.0,1350.0,2940.0,3075.0,3690.0,3150.0,5000.0,4095.0,2310.0,2735.0,3050.0,39875.0
Tapi,16.1.1,Stock position of DPT vaccines,5. Total Stock,8500.0,8230.0,6880.0,8940.0,10865.0,9670.0,6520.0,11520.0,9155.0,11845.0,10110.0,12060.0,114295.0
Tapi,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,15410.0,16750.0,15930.0,14150.0,13295.0,18360.0,13790.0,9950.0,15150.0,11680.0,13120.0,9290.0,166875.0
Tapi,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,6000.0,3000.0,3000.0,3000.0,9000.0,0.0,0.0,9000.0,0.0,6000.0,0.0,6000.0,45000.0
Tapi,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,4660.0,3820.0,4780.0,3855.0,4165.0,4570.0,3840.0,3800.0,3470.0,4560.0,3830.0,3830.0,49180.0
Tapi,16.1.1A,Stock Position of Pentavalent,5. Total Stock,16750.0,15930.0,14150.0,13295.0,18130.0,13790.0,9950.0,15150.0,11680.0,13120.0,9290.0,11460.0,162695.0
Tapi,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,45460.0,33560.0,27760.0,25190.0,15850.0,16280.0,16490.0,7680.0,22940.0,130080.0,16900.0,17290.0,375480.0
Tapi,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,10000.0,0.0,10000.0,10000.0,0.0,25000.0,0.0,0.0,98500.0,8000.0,161500.0
Tapi,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,11900.0,5800.0,12570.0,9340.0,9570.0,9790.0,8810.0,9740.0,8480.0,113180.0,98110.0,10980.0,308270.0
Tapi,16.1.2,Stock position of OPV vaccines,5. Total Stock,33560.0,27760.0,25190.0,15850.0,16280.0,16490.0,7680.0,22940.0,14460.0,16900.0,17290.0,14310.0,228710.0
Tapi,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,15370.0,22060.0,17560.0,15990.0,17980.0,20410.0,15690.0,10400.0,19080.0,13150.0,17360.0,14000.0,199050.0
Tapi,16.1.3,Stock position of TT vaccines,2. Stocks Received,12000.0,0.0,4000.0,8000.0,8000.0,2500.0,0.0,15000.0,0.0,10000.0,1000.0,7500.0,68000.0
Tapi,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5310.0,4500.0,5570.0,6010.0,5570.0,7220.0,5290.0,6320.0,5930.0,5790.0,4360.0,4930.0,66800.0
Tapi,16.1.3,Stock position of TT vaccines,5. Total Stock,22060.0,17560.0,15990.0,17980.0,20410.0,15690.0,10400.0,19080.0,13150.0,17360.0,14000.0,16570.0,200250.0
Tapi,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,12660.0,15370.0,13030.0,9890.0,10770.0,8900.0,6620.0,4670.0,8530.0,6340.0,4320.0,4500.0,105600.0
Tapi,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,0.0,0.0,2000.0,0.0,0.0,0.0,6000.0,0.0,0.0,2000.0,2000.0,17000.0
Tapi,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2290.0,2340.0,3140.0,1120.0,1870.0,2280.0,1950.0,2300.0,2190.0,2020.0,1820.0,1910.0,25230.0
Tapi,16.1.5,Stock position of BCG vaccines,5. Total Stock,15370.0,13030.0,9890.0,10770.0,8900.0,6620.0,4670.0,8370.0,6340.0,4320.0,4500.0,4590.0,97370.0
Tapi,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,8420.0,5335.0,6890.0,8570.0,7395.0,7770.0,8770.0,6075.0,10780.0,8250.0,10655.0,8635.0,97545.0
Tapi,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,4000.0,5000.0,2000.0,3000.0,4000.0,0.0,8000.0,0.0,5000.0,1000.0,5000.0,37000.0
Tapi,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3085.0,2445.0,3320.0,3175.0,2625.0,3000.0,2695.0,3295.0,2530.0,2595.0,3020.0,3010.0,34795.0
Tapi,16.1.6,Stock position of Measles vaccines,5. Total Stock,5335.0,6890.0,8570.0,7395.0,7770.0,8770.0,6075.0,10780.0,8250.0,10655.0,8635.0,10625.0,99750.0
Tapi,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,14910.0,14540.0,14030.0,13730.0,13300.0,12890.0,12250.0,11730.0,11280.0,10430.0,7790.0,5370.0,142250.0
Tapi,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,370.0,510.0,300.0,430.0,410.0,640.0,520.0,450.0,850.0,2640.0,2420.0,2390.0,11930.0
Tapi,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,14540.0,14030.0,13730.0,13300.0,12890.0,12250.0,11730.0,11280.0,10430.0,7790.0,5370.0,2980.0,130320.0
Tapi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,2400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2400.0
Tapi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,12000.0
Tapi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,3600.0,2400.0,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,12000.0
Tapi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,2400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2400.0
Tapi,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,20136.0,0.0,66000.0,0.0,0.0,0.0,0.0,0.0,0.0,86136.0
Tapi,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,50400.0,0.0,66000.0,0.0,0.0,100800.0,0.0,0.0,0.0,0.0,217200.0
Tapi,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,30264.0,20136.0,0.0,66000.0,0.0,100800.0,0.0,0.0,0.0,0.0,217200.0
Tapi,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,20136.0,0.0,66000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,86136.0
Tapi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,2440.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2440.0
Tapi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,72000.0,0.0,0.0,0.0,0.0,78000.0
Tapi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,3560.0,2440.0,0.0,0.0,0.0,72000.0,0.0,0.0,0.0,0.0,78000.0
Tapi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,2440.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2440.0
Tapi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,390.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,390.0
Tapi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,900.0
Tapi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,510.0,390.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,900.0
Tapi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,390.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,390.0
Tapi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3865.0,3865.0,3865.0,3865.0,3865.0,3865.0,2365.0,2365.0,2365.0,2365.0,2365.0,2365.0,37380.0
Tapi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,1500.0,0.0,0.0,0.0,0.0,0.0,2365.0,3865.0
Tapi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3865.0,3865.0,3865.0,3865.0,3865.0,2365.0,2365.0,2365.0,2365.0,2365.0,2365.0,0.0,33515.0
Tapi,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,890.0,360.0,360.0,100.0,100.0,0.0,0.0,0.0,0.0,1810.0
Tapi,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0
Tapi,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,610.0,530.0,0.0,260.0,0.0,100.0,0.0,0.0,0.0,0.0,1500.0
Tapi,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,890.0,360.0,360.0,100.0,100.0,0.0,0.0,0.0,0.0,0.0,1810.0
Tapi,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,15000.0,0.0,6350.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21350.0
Tapi,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,15000.0,0.0,0.0,0.0,0.0,0.0,2500.0,0.0,0.0,0.0,17500.0
Tapi,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,15000.0,8650.0,6350.0,0.0,0.0,0.0,0.0,2500.0,0.0,0.0,0.0,32500.0
Tapi,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,6350.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6350.0
Tapi,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,600.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21000.0,0.0,22200.0
Tapi,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21000.0,0.0,0.0,21000.0
Tapi,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21000.0,0.0,21600.0
Tapi,16.3.03,Stock Position of MVA Syringes,5. Total Stock,600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21000.0,0.0,0.0,21600.0
Tapi,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,30000.0,0.0,0.0,0.0,0.0,0.0,0.0,30000.0
Tapi,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,30000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30000.0
Tapi,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,30000.0,0.0,0.0,0.0,0.0,0.0,0.0,30000.0
Tapi,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,30000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30000.0
Tapi,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,771000.0,309000.0,309000.0,0.0,0.0,750000.0,0.0,2139000.0
Tapi,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,771000.0,571500.0,0.0,60000.0,0.0,750000.0,0.0,960000.0,3112500.0
Tapi,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,1033500.0,0.0,369000.0,0.0,0.0,750000.0,960000.0,3112500.0
Tapi,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,771000.0,309000.0,309000.0,0.0,0.0,750000.0,0.0,0.0,2139000.0
Tapi,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,4100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4100.0
Tapi,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,3596.0,0.0,17100.0,25696.0
Tapi,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,900.0,4100.0,0.0,0.0,0.0,0.0,3596.0,0.0,4900.0,13496.0
Tapi,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,4100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12200.0,16300.0
Tapi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1400.0,0.0,0.0,0.0,0.0,1400.0
Tapi,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1400.0,0.0,0.0,0.0,0.0,1400.0
Tapi,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,2800.0,2300.0,1900.0,1800.0,1800.0,1200.0,200.0,200.0,200.0,12400.0
Tapi,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,16500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16500.0
Tapi,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,13700.0,500.0,400.0,100.0,0.0,600.0,1000.0,0.0,0.0,200.0,16500.0
Tapi,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,2800.0,2300.0,1900.0,1800.0,1800.0,1200.0,200.0,200.0,200.0,0.0,12400.0
Tapi,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Tapi,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,800.0,800.0,800.0,800.0,800.0,800.0,800.0,800.0,6400.0
Tapi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0
Tapi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tapi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,3200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3200.0
Tapi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,800.0,800.0,800.0,800.0,800.0,800.0,800.0,800.0,800.0,7200.0
Tapi,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,,,,1.0,1.0,,,1.0,,,4.0
Tapi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,,,,,,,,,2.0,3.0
Tapi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tapi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,,,,,,,,2.0,3.0
Tapi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,1.0,1.0,1.0,2.0,5.0,,,1.0,2.0,2.0,5.0,22.0
Tapi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,1.0,1.0
Tapi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,1.0,1.0,1.0,2.0,5.0,,,1.0,2.0,2.0,6.0,23.0
Tapi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,3.0,7.0,3.0,,5.0,1.0,2.0,7.0,5.0,5.0,,42.0
Tapi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,,,1.0,,,,1.0,,3.0
Tapi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,4.0,7.0,3.0,,5.0,2.0,2.0,7.0,5.0,6.0,,45.0
Tapi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,6.0,3.0,3.0,2.0,4.0,2.0,5.0,1.0,3.0,2.0,5.0,,36.0
Tapi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,,,,1.0,,,1.0,1.0,4.0
Tapi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,6.0,4.0,3.0,2.0,4.0,2.0,5.0,2.0,3.0,2.0,6.0,1.0,40.0
Tapi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,1.0,3.0,,,2.0,,,1.0,8.0
Tapi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tapi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,1.0,3.0,,,2.0,,,1.0,8.0
Tapi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Tapi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tapi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,1.0,,,,1.0
Tapi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,2.0,,,1.0,1.0,,,,1.0,,1.0,6.0
Tapi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tapi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,2.0,,,1.0,1.0,,,,1.0,,1.0,6.0
Tapi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Tapi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tapi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,1.0,,,,,,1.0
Tapi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,2.0,3.0,1.0,1.0,3.0,3.0,5.0,8.0,3.0,,3.0,34.0
Tapi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,1.0,2.0,1.0,,2.0,,,,2.0,1.0,,11.0
Tapi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,3.0,5.0,2.0,1.0,5.0,3.0,5.0,8.0,5.0,1.0,3.0,45.0
Tapi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Tapi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Tapi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Tapi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Tapi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,3.0,2.0,3.0,3.0,4.0,2.0,2.0,6.0,5.0,5.0,6.0,44.0
Tapi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,3.0,1.0,1.0,,2.0,3.0,3.0,3.0,3.0,1.0,1.0,1.0,22.0
Tapi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,7.0,4.0,3.0,3.0,5.0,7.0,5.0,5.0,9.0,6.0,6.0,7.0,67.0
Tapi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,3.0,2.0,2.0,1.0,4.0,2.0,1.0,6.0,6.0,2.0,6.0,35.0
Tapi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,3.0,3.0,4.0,3.0,,4.0,1.0,2.0,6.0,3.0,1.0,7.0,37.0
Tapi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,6.0,6.0,5.0,1.0,8.0,3.0,3.0,12.0,9.0,3.0,13.0,72.0
Tapi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Tapi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Tapi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Tapi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Tapi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Tapi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,1.0,,1.0,,,,,,2.0
Tapi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,,,,1.0,1.0,,,3.0
Tapi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,1.0,,1.0,,,,,1.0,2.0,,5.0
Tapi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,2.0,,1.0,,,,1.0,2.0,2.0,,8.0
Tapi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,,,,,,1.0,2.0
Tapi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,3.0,4.0,3.0,5.0,4.0,10.0,3.0,12.0,8.0,5.0,13.0,75.0
Tapi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,11.0,8.0,6.0,4.0,9.0,13.0,13.0,7.0,24.0,12.0,9.0,8.0,124.0
Tapi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,16.0,11.0,11.0,7.0,14.0,17.0,23.0,10.0,36.0,20.0,14.0,22.0,201.0
Tapi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,4.0,1.0,,3.0,1.0,2.0,,3.0,4.0,2.0,,2.0,22.0
Tapi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,3.0,2.0,2.0,2.0,7.0,4.0,3.0,2.0,5.0,11.0,2.0,2.0,45.0
Tapi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,7.0,3.0,2.0,5.0,8.0,6.0,3.0,5.0,9.0,13.0,2.0,4.0,67.0
Tapi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Tapi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Tapi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Tapi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Tapi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Tapi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Tapi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,,,,,,,1.0,,,2.0
Tapi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Tapi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,,,,,,,1.0,,,2.0
Tapi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,1.0,,,,,,2.0
Tapi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Tapi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,1.0,,,,,,2.0
Tapi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Tapi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Tapi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Tapi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,,,1.0,1.0,,3.0,1.0,2.0,1.0,1.0,1.0,13.0
Tapi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Tapi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,,,1.0,1.0,,3.0,1.0,2.0,1.0,1.0,1.0,13.0
Tapi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,1.0,,,,,,,,,,2.0
Tapi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,11.0,13.0,14.0,9.0,9.0,12.0,9.0,3.0,14.0,8.0,10.0,9.0,121.0
Tapi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,3.0,2.0,3.0,3.0,1.0,2.0,1.0,,2.0,2.0,,21.0
Tapi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,14.0,16.0,17.0,12.0,12.0,13.0,11.0,4.0,14.0,10.0,12.0,9.0,144.0
Tapi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,1.0,,1.0,,,2.0
Tapi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,5.0,4.0,12.0,4.0,10.0,4.0,7.0,10.0,3.0,4.0,4.0,10.0,77.0
Tapi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,3.0,1.0,1.0,,1.0,1.0,1.0,,1.0,,,1.0,10.0
Tapi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,8.0,5.0,13.0,4.0,11.0,5.0,8.0,11.0,4.0,5.0,4.0,11.0,89.0
Tapi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,1.0,,,,,,,,2.0
Tapi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,2.0,2.0,3.0,2.0,1.0,2.0,1.0,,1.0,1.0,16.0
Tapi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,,1.0,2.0,3.0,1.0,,,,2.0,,,10.0
Tapi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,1.0,3.0,5.0,7.0,3.0,1.0,2.0,1.0,2.0,1.0,1.0,28.0
Tapi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Tapi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,,1.0,2.0,,,1.0,4.0,3.0,4.0,3.0,3.0,24.0
Tapi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,1.0,,,2.0,3.0,1.0,,4.0,3.0,2.0,16.0
Tapi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,,2.0,2.0,,2.0,4.0,5.0,3.0,8.0,6.0,5.0,40.0
Tapi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,1.0,1.0,,2.0
Tapi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,7.0,7.0,4.0,8.0,2.0,7.0,10.0,9.0,13.0,11.0,79.0
Tapi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,7.0,3.0,9.0,6.0,2.0,7.0,4.0,5.0,9.0,19.0,5.0,5.0,81.0
Tapi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,7.0,4.0,16.0,13.0,6.0,15.0,6.0,12.0,19.0,29.0,19.0,16.0,162.0
Tapi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,1.0,,2.0,1.0,,1.0,3.0,4.0,4.0,1.0,18.0
Tapi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,27.0,54.0,49.0,44.0,48.0,67.0,57.0,62.0,57.0,70.0,57.0,44.0,636.0
Tapi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,66.0,78.0,83.0,65.0,117.0,135.0,99.0,131.0,134.0,141.0,86.0,107.0,1242.0
Tapi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,94.0,132.0,133.0,109.0,167.0,203.0,156.0,194.0,194.0,215.0,147.0,152.0,1896.0
The Dangs,1.1,Total number of pregnant women Registered for ANC,TOTAL,700.0,694.0,722.0,646.0,729.0,690.0,597.0,479.0,441.0,597.0,499.0,517.0,7311.0
The Dangs,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,468.0,498.0,558.0,471.0,570.0,544.0,490.0,381.0,352.0,421.0,377.0,385.0,5515.0
The Dangs,1.2,Number of Pregnant women registered under JSY,TOTAL,650.0,654.0,667.0,616.0,696.0,642.0,484.0,487.0,423.0,583.0,454.0,510.0,6866.0
The Dangs,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,576.0,618.0,563.0,709.0,731.0,720.0,704.0,549.0,560.0,540.0,495.0,506.0,7271.0
The Dangs,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,667.0,674.0,654.0,638.0,657.0,682.0,529.0,443.0,450.0,563.0,534.0,509.0,7000.0
The Dangs,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,539.0,640.0,618.0,626.0,590.0,628.0,608.0,503.0,461.0,423.0,505.0,486.0,6627.0
The Dangs,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,704.0,693.0,712.0,737.0,901.0,781.0,780.0,636.0,633.0,530.0,581.0,628.0,8316.0
The Dangs,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,35.0,20.0,30.0,19.0,23.0,20.0,13.0,21.0,20.0,76.0,12.0,16.0,305.0
The Dangs,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,3.0
The Dangs,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,264.0,255.0,300.0,383.0,265.0,374.0,391.0,422.0,252.0,277.0,410.0,721.0,4314.0
The Dangs,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,16.0,12.0,9.0,7.0,11.0,5.0,6.0,9.0,3.0,140.0,7.0,2.0,227.0
The Dangs,1.8,Number of pregnancy test kits used at SC level,TOTAL,75.0,88.0,136.0,94.0,140.0,173.0,186.0,276.0,213.0,310.0,296.0,314.0,2301.0
The Dangs,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,35.0,19.0,23.0,39.0,143.0,28.0,40.0,25.0,40.0,54.0,7.0,26.0,479.0
The Dangs,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,213.0,278.0,247.0,242.0,161.0,203.0,168.0,199.0,193.0,168.0,145.0,207.0,2424.0
The Dangs,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,248.0,297.0,270.0,281.0,304.0,231.0,208.0,224.0,233.0,222.0,152.0,233.0,2903.0
The Dangs,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,197.0,215.0,211.0,194.0,224.0,184.0,145.0,184.0,147.0,161.0,123.0,162.0,2147.0
The Dangs,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,27.0,52.0,69.0,194.0,192.0,73.0,40.0,79.0,182.0,145.0,44.0,64.0,1161.0
The Dangs,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,171.0,172.0,161.0,180.0,175.0,182.0,198.0,193.0,201.0,190.0,211.0,238.0,2272.0
The Dangs,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,179.0,186.0,162.0,177.0,177.0,198.0,191.0,195.0,202.0,187.0,179.0,146.0,2179.0
The Dangs,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,23.0,11.0,20.0,312.0,302.0,425.0,101.0,43.0,166.0,153.0,31.0,150.0,1737.0
The Dangs,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,4.0,0.0,0.0,10.0,13.0,0.0,0.0,9.0,0.0,0.0,36.0
The Dangs,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,8.0,0.0,4.0,8.0,20.0,30.0,12.0,8.0,0.0,8.0,0.0,0.0,98.0
The Dangs,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,56.0,65.0,63.0,59.0,42.0,42.0,35.0,32.0,41.0,38.0,48.0,51.0,572.0
The Dangs,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,41.0,0.0,1.0,1.0,7.0,7.0,57.0
The Dangs,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
The Dangs,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,41.0,0.0,1.0,1.0,7.0,7.0,57.0
The Dangs,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,4.1.1.a,Number of male live births,TOTAL,253.0,290.0,263.0,291.0,280.0,251.0,256.0,249.0,240.0,287.0,209.0,285.0,3154.0
The Dangs,4.1.1.b,Number of female live births,TOTAL,243.0,269.0,275.0,266.0,280.0,225.0,230.0,261.0,251.0,222.0,241.0,265.0,3028.0
The Dangs,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,496.0,559.0,538.0,557.0,560.0,476.0,486.0,510.0,491.0,509.0,450.0,550.0,6182.0
The Dangs,4.1.2,Number of still births,TOTAL,13.0,13.0,12.0,16.0,20.0,7.0,15.0,14.0,14.0,20.0,8.0,15.0,167.0
The Dangs,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,11.0,18.0,27.0,39.0,33.0,36.0,38.0,26.0,15.0,30.0,28.0,28.0,329.0
The Dangs,4.2.1,Number of Newborns weighed at birth,TOTAL,486.0,544.0,524.0,545.0,529.0,494.0,503.0,499.0,509.0,509.0,456.0,555.0,6153.0
The Dangs,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,71.0,88.0,65.0,65.0,82.0,58.0,72.0,101.0,74.0,112.0,93.0,118.0,999.0
The Dangs,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,478.0,528.0,519.0,538.0,539.0,463.0,465.0,502.0,501.0,511.0,445.0,539.0,6028.0
The Dangs,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,2.0,5.0,2.0,3.0,6.0,11.0,4.0,5.0,0.0,2.0,0.0,5.0,45.0
The Dangs,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,1.0,3.0,0.0,14.0,10.0,12.0,24.0,12.0,14.0,7.0,10.0,8.0,115.0
The Dangs,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,1.0,1.0,0.0,1.0,1.0,3.0,0.0,1.0,1.0,1.0,0.0,7.0,17.0
The Dangs,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
The Dangs,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,4.0,9.0,2.0,18.0,17.0,26.0,28.0,18.0,15.0,10.0,10.0,20.0,177.0
The Dangs,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,3.0,123.0,36.0,52.0,43.0,108.0,48.0,39.0,7.0,13.0,17.0,15.0,504.0
The Dangs,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,74.0,2.0,0.0,40.0,1.0,41.0,4.0,4.0,7.0,2.0,8.0,184.0
The Dangs,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,2.0,91.0,30.0,3.0,44.0,111.0,45.0,6.0,3.0,10.0,7.0,11.0,363.0
The Dangs,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,6.0,6.0,4.0,20.0,9.0,9.0,3.0,5.0,9.0,6.0,4.0,83.0
The Dangs,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,257.0,408.0,375.0,360.0,375.0,355.0,409.0,340.0,343.0,369.0,322.0,410.0,4323.0
The Dangs,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,221.0,315.0,318.0,277.0,313.0,317.0,328.0,303.0,280.0,278.0,214.0,327.0,3491.0
The Dangs,6.3,PNC maternal complications attended,TOTAL,2.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,2.0,8.0
The Dangs,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,6.0,2.0,37.0,9.0,4.0,7.0,2.0,2.0,11.0,0.0,80.0
The Dangs,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,113.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,113.0
The Dangs,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,6.0,2.0,150.0,9.0,4.0,7.0,2.0,2.0,11.0,0.0,193.0
The Dangs,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,17.0,24.0,26.0,31.0,47.0,47.0,28.0,45.0,37.0,42.0,39.0,68.0,451.0
The Dangs,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,49.0,61.0,52.0,57.0,69.0,77.0,81.0,95.0,83.0,82.0,77.0,93.0,876.0
The Dangs,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,66.0,85.0,78.0,88.0,116.0,124.0,109.0,140.0,120.0,124.0,116.0,161.0,1327.0
The Dangs,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,12.0,1.0,3.0,0.0,0.0,0.0,71.0,0.0,0.0,4.0,0.0,0.0,91.0
The Dangs,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,1.0,8.0,18.0,8.0,28.0,5.0,0.0,1.0,2.0,0.0,1.0,72.0
The Dangs,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,2.0,5.0,12.0,17.0,0.0,3.0,6.0,5.0,5.0,7.0,62.0
The Dangs,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,0.0,27.0,36.0,42.0,77.0,21.0,5.0,1.0,2.0,1.0,0.0,215.0
The Dangs,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
The Dangs,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,1.0,37.0,59.0,62.0,122.0,26.0,8.0,8.0,9.0,6.0,8.0,349.0
The Dangs,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
The Dangs,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,24.0,42.0,32.0,91.0,0.0,6.0,0.0,0.0,0.0,0.0,195.0
The Dangs,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,9.0,0.0,133.0,216.0,88.0,299.0,66.0,40.0,0.0,0.0,0.0,0.0,851.0
The Dangs,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
The Dangs,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,9.0,0.0,157.0,258.0,120.0,390.0,66.0,46.0,0.0,0.0,0.0,0.0,1046.0
The Dangs,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,10.0,6.0,7.0,7.0,4.0,5.0,4.0,16.0,7.0,3.0,70.0
The Dangs,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
The Dangs,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,0.0,10.0,6.0,7.0,7.0,4.0,5.0,4.0,16.0,7.0,3.0,70.0
The Dangs,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,108.0,83.0,77.0,73.0,71.0,62.0,58.0,65.0,61.0,50.0,43.0,41.0,792.0
The Dangs,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,13.0,4.0,9.0,17.0,10.0,13.0,10.0,10.0,13.0,14.0,9.0,23.0,145.0
The Dangs,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,6.0
The Dangs,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,5.0,3.0,11.0,5.0,4.0,10.0,10.0,11.0,12.0,11.0,10.0,14.0,106.0
The Dangs,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
The Dangs,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,128.0,90.0,98.0,96.0,85.0,85.0,78.0,87.0,86.0,75.0,63.0,78.0,1049.0
The Dangs,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,15.0,7.0,16.0,43.0,16.0,7.0,7.0,4.0,12.0,12.0,5.0,2.0,146.0
The Dangs,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.06,Number of IUCD removals,TOTAL,117.0,13.0,13.0,39.0,19.0,23.0,23.0,26.0,24.0,25.0,25.0,23.0,370.0
The Dangs,9.07,Number of Oral Pills cycles distributed,TOTAL,1834.0,1595.0,1477.0,1606.0,1664.0,1693.0,1689.0,1716.0,1468.0,1352.0,1247.0,1318.0,18659.0
The Dangs,9.08,Number of Condom pieces distributed,TOTAL,5101.0,4666.0,4197.0,4216.0,4518.0,5037.0,5701.0,5414.0,4797.0,5182.0,2795.0,3103.0,54727.0
The Dangs,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,9.0,5.0,0.0,11.0,0.0,0.0,0.0,6.0,3.0,0.0,34.0
The Dangs,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,18.0,5.0,10.0,16.0,23.0,23.0,30.0,7.0,12.0,24.0,5.0,3.0,176.0
The Dangs,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
The Dangs,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,1.0,0.0,1.0,8.0,3.0,0.0,0.0,3.0,0.0,0.0,16.0
The Dangs,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
The Dangs,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
The Dangs,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,9.12,Number of Institutions having NSV trained doctors,TOTAL,10.0,7.0,6.0,8.0,8.0,6.0,6.0,7.0,7.0,6.0,7.0,6.0,-1.0
The Dangs,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,451.0,516.0,544.0,570.0,577.0,513.0,431.0,495.0,417.0,500.0,465.0,493.0,5972.0
The Dangs,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,13.0
The Dangs,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0,19.0
The Dangs,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0,14.0
The Dangs,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,458.0,642.0,535.0,553.0,605.0,572.0,462.0,467.0,443.0,484.0,454.0,386.0,6061.0
The Dangs,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,443.0,524.0,575.0,551.0,563.0,600.0,546.0,501.0,436.0,427.0,473.0,423.0,6062.0
The Dangs,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,415.0,471.0,505.0,573.0,520.0,607.0,593.0,515.0,446.0,453.0,431.0,437.0,5966.0
The Dangs,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,236.0,225.0,191.0,247.0,252.0,229.0,300.0,315.0,245.0,219.0,278.0,318.0,3055.0
The Dangs,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,516.0,646.0,547.0,571.0,606.0,562.0,485.0,460.0,449.0,487.0,451.0,412.0,6192.0
The Dangs,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,497.0,525.0,572.0,557.0,567.0,585.0,552.0,505.0,437.0,425.0,471.0,445.0,6138.0
The Dangs,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,478.0,472.0,497.0,567.0,522.0,601.0,558.0,476.0,445.0,451.0,430.0,458.0,5955.0
The Dangs,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,121.0,137.0,121.0,158.0,213.0,191.0,218.0,254.0,235.0,239.0,233.0,272.0,2392.0
The Dangs,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
The Dangs,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,466.0,519.0,484.0,519.0,527.0,550.0,480.0,487.0,429.0,461.0,461.0,418.0,5801.0
The Dangs,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,345.0,396.0,417.0,385.0,349.0,439.0,393.0,431.0,397.0,392.0,383.0,402.0,4729.0
The Dangs,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,225.0,279.0,251.0,253.0,206.0,249.0,202.0,260.0,200.0,220.0,225.0,217.0,2787.0
The Dangs,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,236.0,256.0,247.0,220.0,231.0,239.0,245.0,271.0,219.0,228.0,201.0,202.0,2795.0
The Dangs,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,461.0,535.0,498.0,473.0,437.0,488.0,447.0,531.0,419.0,448.0,426.0,419.0,5582.0
The Dangs,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,417.0,453.0,445.0,426.0,428.0,480.0,446.0,448.0,414.0,416.0,423.0,418.0,5214.0
The Dangs,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,416.0,450.0,424.0,413.0,423.0,479.0,447.0,438.0,414.0,423.0,426.0,420.0,5173.0
The Dangs,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,5.0
The Dangs,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,121.0,157.0,147.0,160.0,149.0,169.0,139.0,155.0,155.0,179.0,139.0,138.0,1808.0
The Dangs,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,142.0,142.0,135.0,165.0,135.0,184.0,145.0,164.0,134.0,140.0,124.0,135.0,1745.0
The Dangs,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,263.0,299.0,282.0,325.0,284.0,353.0,284.0,319.0,289.0,319.0,263.0,273.0,3553.0
The Dangs,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,10.0,5.0,19.0,24.0,66.0,545.0,386.0,252.0,407.0,342.0,458.0,272.0,2786.0
The Dangs,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,14.0,13.0,47.0,54.0,89.0,556.0,425.0,487.0,495.0,370.0,594.0,249.0,3393.0
The Dangs,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,329.0,417.0,538.0,740.0,536.0,606.0,472.0,483.0,826.0,595.0,555.0,357.0,6454.0
The Dangs,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,1.0,12.0,1.0,14.0,17.0,5.0,1.0,3.0,16.0,12.0,83.0
The Dangs,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,16.0,27.0,28.0,30.0,31.0,38.0,39.0,33.0,32.0,14.0,7.0,16.0,311.0
The Dangs,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,317.0,335.0,303.0,360.0,362.0,358.0,360.0,367.0,365.0,345.0,318.0,336.0,4126.0
The Dangs,10.4.2,Number of Immunisation sessions held during the month,TOTAL,299.0,303.0,283.0,331.0,350.0,348.0,350.0,348.0,354.0,336.0,307.0,320.0,3929.0
The Dangs,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,274.0,285.0,265.0,309.0,317.0,324.0,324.0,332.0,330.0,307.0,282.0,296.0,3645.0
The Dangs,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,567.0,508.0,517.0,491.0,673.0,571.0,475.0,476.0,428.0,437.0,459.0,440.0,6042.0
The Dangs,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,133.0,21.0,25.0,35.0,321.0,376.0,17.0,73.0,28.0,33.0,190.0,322.0,1574.0
The Dangs,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,101.0,6.0,0.0,0.0,250.0,381.0,1.0,59.0,0.0,0.0,185.0,386.0,1369.0
The Dangs,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
The Dangs,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,45.0,17.0,24.0,60.0,0.0,38.0,48.0,51.0,71.0,3.0,15.0,46.0,418.0
The Dangs,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,864.0,638.0,611.0,605.0,726.0,778.0,601.0,499.0,590.0,612.0,605.0,636.0,7765.0
The Dangs,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,15.0,17.0,22.0,34.0,46.0,31.0,43.0,15.0,9.0,14.0,7.0,9.0,262.0
The Dangs,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,225.0,295.0,193.0,129.0,121.0,145.0,102.0,129.0,93.0,114.0,95.0,124.0,1765.0
The Dangs,13.1,Number of Patients operated for cataract,TOTAL,48.0,0.0,50.0,137.0,45.0,76.0,59.0,145.0,136.0,116.0,104.0,70.0,986.0
The Dangs,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,48.0,0.0,66.0,137.0,45.0,76.0,59.0,145.0,136.0,116.0,98.0,70.0,996.0
The Dangs,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,202.0,0.0,106.0,221.0,0.0,0.0,0.0,529.0
The Dangs,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,100.0
The Dangs,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,116.0,0.0,0.0,116.0
The Dangs,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,,,,,,,,-1.0
The Dangs,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,5.0,6.0,6.0,6.0,5.0,5.0,7.0,7.0,7.0,6.0,6.0,-1.0
The Dangs,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,175.0,186.0,211.0,201.0,266.0,225.0,253.0,300.0,305.0,297.0,263.0,255.0,-1.0
The Dangs,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,2.0,3.0,3.0,3.0,2.0,2.0,2.0,2.0,2.0,2.0,1.0,-1.0
The Dangs,14.05,Number of RKS meetings held during the month,TOTAL,4.0,3.0,2.0,1.0,3.0,2.0,3.0,2.0,4.0,2.0,3.0,3.0,32.0
The Dangs,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,10.0,10.0,10.0,10.0,10.0,9.0,10.0,9.0,9.0,8.0,9.0,-1.0
The Dangs,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,182.0,122.0,167.0,156.0,137.0,219.0,211.0,220.0,180.0,241.0,143.0,171.0,2149.0
The Dangs,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,2.0,2.0,2.0,2.0,1.0,,,,,,,-1.0
The Dangs,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
The Dangs,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,150.0,110.0,126.0,141.0,219.0,188.0,125.0,83.0,95.0,133.0,148.0,281.0,1799.0
The Dangs,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,422.0,466.0,538.0,586.0,621.0,748.0,499.0,406.0,426.0,382.0,410.0,592.0,6096.0
The Dangs,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,161.0,225.0,101.0,151.0,189.0,207.0,153.0,98.0,94.0,120.0,149.0,272.0,1920.0
The Dangs,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,463.0,494.0,766.0,1046.0,929.0,1399.0,806.0,666.0,786.0,674.0,844.0,992.0,9865.0
The Dangs,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,311.0,335.0,227.0,292.0,408.0,395.0,278.0,181.0,189.0,253.0,297.0,553.0,3719.0
The Dangs,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,885.0,960.0,1304.0,1632.0,1550.0,2147.0,1305.0,1072.0,1212.0,1056.0,1254.0,1584.0,15961.0
The Dangs,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,3.0,3.0,3.0,5.0,7.0,3.0,6.0,2.0,5.0,2.0,2.0,42.0
The Dangs,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,1.0,3.0,4.0,2.0,7.0,4.0,1.0,0.0,2.0,1.0,1.0,27.0
The Dangs,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,2.0,4.0,6.0,7.0,7.0,14.0,7.0,7.0,2.0,7.0,3.0,3.0,69.0
The Dangs,14.11,In-Patient Head Count at midnight,TOTAL,164.0,142.0,191.0,302.0,214.0,243.0,317.0,374.0,246.0,181.0,169.0,258.0,2801.0
The Dangs,14.12.1,OPD attendance (All),TOTAL,12387.0,13623.0,17393.0,20989.0,23790.0,30176.0,20750.0,16596.0,19414.0,17774.0,19016.0,20488.0,232396.0
The Dangs,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,6.0,0.0,0.0,44.0,99.0,0.0,127.0,77.0,51.0,192.0,142.0,738.0
The Dangs,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
The Dangs,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,156.0,258.0,341.0,634.0,261.0,579.0,154.0,142.0,216.0,382.0,246.0,191.0,3560.0
The Dangs,14.14.a,Number of patients given AYUSH treatment,TOTAL,593.0,779.0,628.0,592.0,899.0,1167.0,874.0,2117.0,2004.0,1932.0,1681.0,1847.0,15113.0
The Dangs,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,166.0,149.0,194.0,103.0,187.0,209.0,155.0,239.0,343.0,401.0,186.0,274.0,2606.0
The Dangs,14.14.c,Number of Adolescents counselled,TOTAL,120.0,120.0,120.0,150.0,12.0,161.0,306.0,282.0,210.0,174.0,180.0,250.0,2085.0
The Dangs,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1591.0,1584.0,2046.0,2554.0,2370.0,3618.0,2193.0,1875.0,2045.0,1890.0,1926.0,2289.0,25981.0
The Dangs,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,107.0,148.0,152.0,155.0,198.0,203.0,176.0,133.0,155.0,176.0,60.0,129.0,1792.0
The Dangs,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,112.0,130.0,134.0,127.0,156.0,172.0,150.0,135.0,154.0,74.0,71.0,125.0,1540.0
The Dangs,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,3.0,1.0,0.0,1.0,0.0,2.0,2.0,0.0,1.0,0.0,0.0,10.0
The Dangs,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,110.0,107.0,131.0,142.0,142.0,172.0,164.0,144.0,171.0,80.0,100.0,132.0,1595.0
The Dangs,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,4.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,8.0
The Dangs,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,419.0,344.0,454.0,393.0,341.0,399.0,292.0,296.0,367.0,270.0,302.0,298.0,4175.0
The Dangs,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
The Dangs,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,641.0,581.0,719.0,662.0,639.0,743.0,606.0,575.0,692.0,424.0,473.0,555.0,7310.0
The Dangs,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,4.0,5.0,2.0,1.0,0.0,2.0,5.0,0.0,1.0,0.0,0.0,20.0
The Dangs,15.2,Number of Widal tests conducted,Number tested,260.0,224.0,359.0,449.0,562.0,525.0,495.0,431.0,320.0,238.0,391.0,421.0,4675.0
The Dangs,15.3.a,Number of VDRL tests conducted on males,Number tested,26.0,17.0,39.0,23.0,29.0,23.0,0.0,8.0,29.0,24.0,35.0,0.0,253.0
The Dangs,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,47.0,20.0,43.0,42.0,37.0,26.0,0.0,30.0,52.0,40.0,54.0,0.0,391.0
The Dangs,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,309.0,240.0,268.0,273.0,218.0,385.0,0.0,156.0,213.0,200.0,196.0,0.0,2458.0
The Dangs,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,382.0,277.0,350.0,338.0,284.0,434.0,0.0,194.0,294.0,264.0,285.0,0.0,3102.0
The Dangs,15.4.1,Number of blood smears examined for Malaria,TOTAL,1459.0,1492.0,1451.0,2535.0,3802.0,5433.0,3033.0,1858.0,1495.0,849.0,1370.0,1214.0,25991.0
The Dangs,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,49.0,32.0,47.0,65.0,108.0,38.0,7.0,3.0,2.0,2.0,7.0,3.0,363.0
The Dangs,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,1.0,2.0,1.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,6.0
The Dangs,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1500.0,2700.0,3360.0,6280.0,4620.0,5620.0,3960.0,2300.0,5950.0,3580.0,7380.0,5915.0,53165.0
The Dangs,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2500.0,0.0,5000.0,0.0,2500.0,0.0,0.0,5000.0,0.0,5000.0,0.0,0.0,20000.0
The Dangs,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1300.0,870.0,2970.0,1660.0,1500.0,1660.0,1660.0,2800.0,2370.0,1200.0,1465.0,790.0,20245.0
The Dangs,16.1.1,Stock position of DPT vaccines,5. Total Stock,2700.0,1830.0,5390.0,4620.0,5620.0,3960.0,2300.0,4500.0,3580.0,7380.0,5915.0,5125.0,52920.0
The Dangs,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,7290.0,4900.0,6130.0,7850.0,5290.0,5840.0,3800.0,1760.0,5930.0,3910.0,7910.0,6130.0,66740.0
The Dangs,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,6000.0,0.0,6000.0,0.0,0.0,15000.0
The Dangs,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2390.0,1390.0,5820.0,2560.0,2450.0,2040.0,2040.0,1830.0,2020.0,2000.0,1780.0,1360.0,27680.0
The Dangs,16.1.1A,Stock Position of Pentavalent,5. Total Stock,4900.0,3510.0,310.0,5290.0,5840.0,3800.0,1760.0,5930.0,3910.0,7910.0,6130.0,4770.0,54060.0
The Dangs,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,8940.0,6500.0,8560.0,10340.0,6760.0,13280.0,9540.0,5790.0,11910.0,63960.0,12740.0,20560.0,178880.0
The Dangs,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,5000.0,0.0,10000.0,0.0,0.0,10000.0,55000.0,0.0,52000.0,0.0,132000.0
The Dangs,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2440.0,3130.0,6550.0,3580.0,3480.0,3740.0,3750.0,3880.0,2950.0,51220.0,44180.0,4940.0,133840.0
The Dangs,16.1.2,Stock position of OPV vaccines,5. Total Stock,6500.0,3370.0,7010.0,6760.0,13280.0,9540.0,5790.0,11910.0,63960.0,12740.0,20560.0,15620.0,177040.0
The Dangs,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,3080.0,5760.0,6350.0,5800.0,2015.0,7565.0,4315.0,1635.0,8745.0,6080.0,9060.0,6750.0,67155.0
The Dangs,16.1.3,Stock position of TT vaccines,2. Stocks Received,5000.0,0.0,0.0,0.0,8000.0,0.0,0.0,10000.0,0.0,5000.0,0.0,0.0,28000.0
The Dangs,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2320.0,1470.0,4550.0,3785.0,2450.0,3250.0,2680.0,2890.0,2670.0,2020.0,2310.0,1800.0,32195.0
The Dangs,16.1.3,Stock position of TT vaccines,5. Total Stock,5760.0,4290.0,1800.0,2015.0,7565.0,4315.0,1635.0,8745.0,6075.0,9060.0,6750.0,4950.0,62960.0
The Dangs,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,11110.0,9300.0,2560.0,11610.0,9915.0,7650.0,10980.0,8620.0,10820.0,8550.0,11350.0,9440.0,111905.0
The Dangs,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,5000.0,0.0,0.0,5000.0,0.0,5000.0,0.0,5000.0,0.0,0.0,20000.0
The Dangs,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1810.0,1100.0,6650.0,1695.0,2250.0,1670.0,2360.0,2800.0,2270.0,2200.0,1910.0,2020.0,28735.0
The Dangs,16.1.5,Stock position of BCG vaccines,5. Total Stock,9300.0,8200.0,910.0,9915.0,7665.0,10980.0,8620.0,10820.0,8550.0,11350.0,9440.0,7420.0,103170.0
The Dangs,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2345.0,5000.0,7575.0,5225.0,3370.0,2120.0,3960.0,2505.0,3505.0,2525.0,1525.0,5455.0,45110.0
The Dangs,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000.0,0.0,0.0,0.0,0.0,3000.0,0.0,2000.0,0.0,0.0,5000.0,0.0,14000.0
The Dangs,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1345.0,805.0,965.0,1355.0,1250.0,1160.0,1455.0,1000.0,980.0,2000.0,1070.0,915.0,14300.0
The Dangs,16.1.6,Stock position of Measles vaccines,5. Total Stock,5000.0,4195.0,6610.0,3870.0,2120.0,3960.0,2505.0,3505.0,2525.0,525.0,5455.0,4540.0,44810.0
The Dangs,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,9090.0,8920.0,6130.0,8710.0,8460.0,7970.0,7450.0,2715.0,6645.0,6055.0,5755.0,4965.0,82865.0
The Dangs,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,170.0,110.0,2900.0,250.0,490.0,520.0,235.0,570.0,590.0,300.0,790.0,530.0,7455.0
The Dangs,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,8920.0,8810.0,3230.0,8460.0,7970.0,7450.0,7215.0,2145.0,6055.0,5755.0,4965.0,4435.0,75410.0
The Dangs,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
The Dangs,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
The Dangs,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
The Dangs,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
The Dangs,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
The Dangs,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
The Dangs,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
The Dangs,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
The Dangs,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
The Dangs,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,2.0,,,,,,2.0
The Dangs,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
The Dangs,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,2.0,,,,,,2.0
The Dangs,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,1.0,3.0,,3.0,1.0,2.0,2.0,12.0
The Dangs,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
The Dangs,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,1.0,3.0,,3.0,1.0,2.0,2.0,12.0
The Dangs,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,1.0,,1.0
The Dangs,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
The Dangs,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,1.0,,1.0
The Dangs,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,1.0,1.0,,,,,1.0,3.0
The Dangs,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,1.0,,1.0,,2.0
The Dangs,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,1.0,1.0,,1.0,,1.0,1.0,5.0
The Dangs,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
The Dangs,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
The Dangs,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,1.0,1.0,2.0
The Dangs,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
The Dangs,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
The Dangs,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
The Dangs,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
The Dangs,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
The Dangs,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
The Dangs,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
The Dangs,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
The Dangs,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
The Dangs,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
The Dangs,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
The Dangs,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
The Dangs,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,1.0,,,,,,1.0,,,2.0
The Dangs,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
The Dangs,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,1.0,,,,,,1.0,,,2.0
The Dangs,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,1.0,,,,1.0,,2.0
The Dangs,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,2.0,1.0,,,,,3.0
The Dangs,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,3.0,1.0,,,1.0,,5.0
The Dangs,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
The Dangs,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
The Dangs,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
The Dangs,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,1.0,1.0,,,1.0,,,,,4.0
The Dangs,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
The Dangs,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,1.0,1.0,,,1.0,,1.0,,,5.0
The Dangs,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
The Dangs,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
The Dangs,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
The Dangs,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,1.0,,1.0,,,2.0
The Dangs,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,1.0,,,,,1.0,1.0,,1.0,1.0,5.0
The Dangs,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,1.0,,,,,2.0,1.0,1.0,1.0,1.0,7.0
The Dangs,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
The Dangs,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,1.0,,,,,2.0,3.0
The Dangs,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,1.0,,,,,2.0,3.0
The Dangs,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
The Dangs,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
The Dangs,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
The Dangs,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
The Dangs,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
The Dangs,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
The Dangs,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
The Dangs,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
The Dangs,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
The Dangs,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
The Dangs,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
The Dangs,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
The Dangs,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
The Dangs,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
The Dangs,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
The Dangs,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,3.0,1.0,,,,,,,4.0
The Dangs,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
The Dangs,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,3.0,1.0,,,,,,,4.0
The Dangs,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
The Dangs,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,1.0,2.0,2.0,,1.0,,4.0,,1.0,1.0,12.0
The Dangs,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,1.0,,1.0,2.0,,1.0,5.0
The Dangs,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,1.0,2.0,2.0,,2.0,,6.0,2.0,1.0,2.0,18.0
The Dangs,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,2.0,2.0,,2.0,1.0,1.0,1.0,4.0,2.0,15.0
The Dangs,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
The Dangs,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,2.0,2.0,,2.0,1.0,1.0,1.0,4.0,2.0,15.0
The Dangs,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,1.0,,1.0,,,1.0,,,4.0
The Dangs,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,1.0,1.0,,,,,2.0
The Dangs,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,1.0,,2.0,1.0,,1.0,,,6.0
The Dangs,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,1.0,,,,,,,,,1.0,2.0
The Dangs,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,1.0,,,,1.0,,,2.0,2.0,,6.0
The Dangs,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,2.0,,,,1.0,,,2.0,2.0,1.0,8.0
The Dangs,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,1.0,,2.0,,2.0,,5.0
The Dangs,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,1.0,,,2.0,,1.0,2.0,6.0
The Dangs,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,1.0,1.0,,4.0,,3.0,2.0,11.0
The Dangs,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
The Dangs,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,1.0,1.0,4.0,1.0,3.0,3.0,3.0,1.0,2.0,3.0,1.0,23.0
The Dangs,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,1.0,2.0,8.0,2.0,5.0,4.0,6.0,1.0,5.0,7.0,5.0,46.0
The Dangs,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,2.0,3.0,12.0,3.0,8.0,7.0,9.0,2.0,7.0,10.0,6.0,69.0
Vadodara,1.1,Total number of pregnant women Registered for ANC,TOTAL,4517.0,5486.0,6080.0,5662.0,5508.0,5602.0,5886.0,6738.0,5165.0,5875.0,6850.0,6350.0,69719.0
Vadodara,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3621.0,4066.0,4489.0,4203.0,4088.0,4215.0,4386.0,5203.0,4260.0,4454.0,5722.0,4736.0,53443.0
Vadodara,1.2,Number of Pregnant women registered under JSY,TOTAL,1007.0,1134.0,1165.0,1095.0,976.0,977.0,858.0,1379.0,1093.0,1177.0,1181.0,1271.0,13313.0
Vadodara,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3215.0,3719.0,4176.0,4233.0,4079.0,4184.0,4459.0,4753.0,3980.0,4191.0,5493.0,4622.0,51104.0
Vadodara,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3132.0,3739.0,4391.0,4079.0,3890.0,3866.0,4094.0,5016.0,3925.0,3959.0,5182.0,4316.0,49589.0
Vadodara,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3680.0,4513.0,4789.0,5148.0,4667.0,4574.0,5388.0,5605.0,4503.0,4619.0,5731.0,5263.0,58480.0
Vadodara,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3340.0,3796.0,4305.0,4771.0,4663.0,4914.0,4679.0,5351.0,4302.0,4575.0,5763.0,10705.0,61164.0
Vadodara,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,57.0,46.0,55.0,58.0,171.0,83.0,80.0,98.0,100.0,125.0,127.0,131.0,1131.0
Vadodara,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,22.0,19.0,38.0,22.0,30.0,30.0,41.0,31.0,74.0,22.0,19.0,81.0,429.0
Vadodara,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2119.0,2541.0,2736.0,2669.0,2665.0,2779.0,2959.0,2939.0,2128.0,2146.0,2453.0,2790.0,30924.0
Vadodara,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,74.0,159.0,171.0,104.0,96.0,71.0,103.0,75.0,60.0,37.0,71.0,100.0,1121.0
Vadodara,1.8,Number of pregnancy test kits used at SC level,TOTAL,313.0,420.0,437.0,363.0,439.0,403.0,389.0,464.0,441.0,454.0,485.0,480.0,5088.0
Vadodara,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,3.0,1.0,4.0,1.0,5.0,2.0,2.0,3.0,4.0,1.0,4.0,31.0
Vadodara,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,28.0,41.0,26.0,20.0,19.0,9.0,28.0,25.0,18.0,16.0,20.0,23.0,273.0
Vadodara,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,29.0,44.0,27.0,24.0,20.0,14.0,30.0,27.0,21.0,20.0,21.0,27.0,304.0
Vadodara,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,7.0,13.0,8.0,9.0,7.0,14.0,8.0,3.0,4.0,7.0,5.0,7.0,92.0
Vadodara,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,1.0,4.0,2.0,2.0,1.0,2.0,1.0,0.0,0.0,0.0,5.0,19.0
Vadodara,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1215.0,1723.0,1555.0,1521.0,1919.0,2168.0,2003.0,2176.0,2031.0,1746.0,1842.0,3525.0,23424.0
Vadodara,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,848.0,1136.0,1023.0,1116.0,1188.0,1359.0,1303.0,1384.0,1204.0,1124.0,1062.0,2166.0,14913.0
Vadodara,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,3.0,2.0,17.0,19.0,47.0,15.0,7.0,8.0,37.0,28.0,6.0,294.0,483.0
Vadodara,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,7.0,0.0,0.0,28.0,12.0,7.0,0.0,0.0,2.0,36.0,92.0
Vadodara,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,1.0,5.0,10.0
Vadodara,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1522.0,2019.0,2205.0,2357.0,2484.0,2541.0,2406.0,2356.0,2201.0,2346.0,3099.0,2828.0,28364.0
Vadodara,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,18.0,54.0,69.0,120.0,125.0,102.0,94.0,112.0,122.0,52.0,155.0,235.0,1258.0
Vadodara,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,21.0,8.0,2.0,0.0,0.0,0.0,15.0,4.0,2.0,4.0,14.0,70.0
Vadodara,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,475.0,475.0
Vadodara,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,23.0,23.0,25.0,28.0,27.0,31.0,35.0,5.0,10.0,18.0,24.0,14.0,263.0
Vadodara,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,111.0,227.0,223.0,205.0,254.0,263.0,262.0,240.0,223.0,198.0,207.0,285.0,2698.0
Vadodara,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vadodara,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,134.0,250.0,248.0,233.0,281.0,294.0,297.0,245.0,233.0,216.0,231.0,774.0,3436.0
Vadodara,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,363.0,559.0,596.0,642.0,694.0,769.0,708.0,651.0,529.0,600.0,733.0,552.0,7396.0
Vadodara,4.1.1.a,Number of male live births,TOTAL,1479.0,1961.0,2051.0,2068.0,2281.0,2577.0,2260.0,2176.0,2114.0,2090.0,2146.0,2761.0,25964.0
Vadodara,4.1.1.b,Number of female live births,TOTAL,1315.0,1806.0,1713.0,1794.0,2127.0,2134.0,2044.0,2119.0,1914.0,1977.0,1943.0,2682.0,23568.0
Vadodara,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2794.0,3767.0,3764.0,3862.0,4408.0,4711.0,4304.0,4295.0,4028.0,4067.0,4089.0,5443.0,49532.0
Vadodara,4.1.2,Number of still births,TOTAL,28.0,51.0,59.0,79.0,66.0,68.0,81.0,73.0,163.0,46.0,50.0,58.0,822.0
Vadodara,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,48.0,85.0,73.0,81.0,363.0,120.0,79.0,58.0,50.0,340.0,62.0,64.0,1423.0
Vadodara,4.2.1,Number of Newborns weighed at birth,TOTAL,2585.0,3563.0,3578.0,3711.0,4121.0,4449.0,4211.0,4125.0,3758.0,3910.0,3978.0,5349.0,47338.0
Vadodara,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,404.0,750.0,596.0,626.0,671.0,842.0,636.0,698.0,558.0,617.0,537.0,716.0,7651.0
Vadodara,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2315.0,3045.0,3196.0,3248.0,3831.0,4063.0,3854.0,3712.0,3445.0,3559.0,3593.0,4883.0,42744.0
Vadodara,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,7.0,16.0,15.0,7.0,4.0,4.0,2.0,0.0,2.0,0.0,17.0,161.0,235.0
Vadodara,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,29.0,18.0,31.0,43.0,13.0,16.0,36.0,13.0,11.0,6.0,13.0,17.0,246.0
Vadodara,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,102.0,47.0,210.0,294.0,237.0,240.0,237.0,215.0,199.0,170.0,197.0,281.0,2429.0
Vadodara,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vadodara,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,138.0,81.0,256.0,344.0,254.0,260.0,275.0,228.0,212.0,176.0,227.0,459.0,2910.0
Vadodara,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,119.0,278.0,332.0,248.0,193.0,256.0,312.0,296.0,253.0,240.0,291.0,217.0,3035.0
Vadodara,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,289.0,362.0,415.0,428.0,309.0,375.0,487.0,506.0,397.0,415.0,449.0,501.0,4933.0
Vadodara,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,19.0,22.0,20.0,66.0,81.0,92.0,30.0,46.0,41.0,25.0,45.0,53.0,540.0
Vadodara,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,204.0,271.0,284.0,270.0,309.0,335.0,406.0,379.0,439.0,284.0,311.0,416.0,3908.0
Vadodara,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,15.0,21.0,32.0,40.0,28.0,32.0,17.0,18.0,29.0,13.0,17.0,32.0,294.0
Vadodara,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2124.0,2945.0,2806.0,3002.0,3586.0,3965.0,3622.0,3060.0,2836.0,3162.0,3981.0,4639.0,39728.0
Vadodara,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1365.0,1797.0,1847.0,1964.0,2377.0,2547.0,2354.0,1826.0,1807.0,2190.0,3260.0,3853.0,27187.0
Vadodara,6.3,PNC maternal complications attended,TOTAL,15.0,1.0,11.0,8.0,156.0,119.0,69.0,78.0,90.0,86.0,85.0,42.0,760.0
Vadodara,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,99.0,210.0,240.0,188.0,153.0,158.0,245.0,135.0,227.0,332.0,446.0,298.0,2731.0
Vadodara,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,22.0,5.0,39.0,5.0,2.0,0.0,6.0,3.0,0.0,11.0,194.0,1.0,288.0
Vadodara,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,121.0,215.0,279.0,193.0,155.0,158.0,251.0,138.0,227.0,343.0,640.0,299.0,3019.0
Vadodara,7.2,Number of MTPs conducted at Private Facilities,TOTAL,1.0,2.0,0.0,0.0,2.0,0.0,1.0,27.0,54.0,97.0,254.0,285.0,723.0
Vadodara,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,111.0,132.0,151.0,130.0,154.0,108.0,117.0,127.0,106.0,120.0,217.0,134.0,1607.0
Vadodara,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,464.0,494.0,548.0,497.0,503.0,487.0,510.0,425.0,400.0,427.0,596.0,458.0,5809.0
Vadodara,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,575.0,626.0,699.0,627.0,657.0,595.0,627.0,552.0,506.0,547.0,813.0,592.0,7416.0
Vadodara,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,31.0,22.0,20.0,17.0,22.0,0.0,0.0,1.0,5.0,3.0,0.0,6.0,127.0
Vadodara,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0
Vadodara,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,2.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,6.0
Vadodara,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,1.0,2.0,1.0,0.0,2.0,0.0,2.0,0.0,1.0,10.0
Vadodara,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vadodara,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,1.0,0.0,2.0,3.0,1.0,2.0,3.0,0.0,3.0,0.0,1.0,18.0
Vadodara,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,23.0,0.0,0.0,0.0,196.0,298.0,365.0,471.0,237.0,1590.0
Vadodara,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,241.0,305.0,279.0,286.0,243.0,245.0,326.0,1285.0,1319.0,741.0,340.0,196.0,5806.0
Vadodara,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,56.0,64.0,38.0,46.0,38.0,43.0,37.0,70.0,130.0,107.0,108.0,84.0,821.0
Vadodara,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vadodara,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,297.0,369.0,317.0,355.0,281.0,288.0,363.0,1551.0,1747.0,1213.0,919.0,517.0,8217.0
Vadodara,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,14.0,10.0,6.0,5.0,10.0,4.0,11.0,26.0,0.0,0.0,0.0,0.0,86.0
Vadodara,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,51.0,60.0,47.0,47.0,63.0,273.0
Vadodara,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,30.0,40.0,46.0,48.0,18.0,20.0,28.0,18.0,0.0,0.0,0.0,0.0,248.0
Vadodara,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,3.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,6.0,1.0,2.0,13.0
Vadodara,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vadodara,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,33.0,40.0,46.0,53.0,18.0,21.0,28.0,69.0,60.0,53.0,48.0,65.0,534.0
Vadodara,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,7.0,0.0,4.0,0.0,50.0,56.0,34.0,32.0,51.0,234.0
Vadodara,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,37.0,46.0,50.0,50.0,62.0,58.0,64.0,2.0,0.0,0.0,0.0,0.0,369.0
Vadodara,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,4.0,0.0,2.0,3.0,0.0,4.0,4.0,9.0,5.0,5.0,13.0,4.0,53.0
Vadodara,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vadodara,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,41.0,46.0,52.0,60.0,62.0,66.0,68.0,61.0,61.0,39.0,45.0,55.0,656.0
Vadodara,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,322.0,342.0,433.0,486.0,437.0,505.0,488.0,545.0,496.0,469.0,386.0,319.0,5228.0
Vadodara,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,156.0,172.0,174.0,254.0,213.0,142.0,208.0,781.0,840.0,1108.0,1354.0,1139.0,6541.0
Vadodara,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,569.0,827.0,960.0,933.0,840.0,942.0,844.0,32.0,43.0,18.0,29.0,35.0,6072.0
Vadodara,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,41.0,57.0,45.0,26.0,36.0,51.0,46.0,55.0,50.0,114.0,158.0,93.0,772.0
Vadodara,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vadodara,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1088.0,1398.0,1612.0,1699.0,1526.0,1640.0,1586.0,1413.0,1429.0,1709.0,1927.0,1586.0,18613.0
Vadodara,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,13.0,28.0,30.0,17.0,43.0,18.0,30.0,63.0,58.0,63.0,27.0,67.0,457.0
Vadodara,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,3.0
Vadodara,9.06,Number of IUCD removals,TOTAL,173.0,164.0,213.0,225.0,196.0,204.0,305.0,670.0,212.0,625.0,379.0,267.0,3633.0
Vadodara,9.07,Number of Oral Pills cycles distributed,TOTAL,11782.0,12404.0,12408.0,12909.0,10927.0,12868.0,13996.0,17201.0,10242.0,20498.0,18275.0,13488.0,166998.0
Vadodara,9.08,Number of Condom pieces distributed,TOTAL,189854.0,204263.0,201594.0,211492.0,174192.0,209209.0,218846.0,127882.0,158891.0,168746.0,255729.0,203336.0,2324034.0
Vadodara,9.09,Number of Centchroman (weekly) pills given,TOTAL,27.0,18.0,35.0,31.0,0.0,23.0,37.0,19.0,87.0,118.0,23.0,0.0,418.0
Vadodara,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,27.0,40.0,8.0,8.0,2.0,4.0,10.0,37.0,12.0,3.0,25.0,0.0,176.0
Vadodara,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,3.0
Vadodara,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,9.12,Number of Institutions having NSV trained doctors,TOTAL,15.0,23.0,19.0,29.0,24.0,21.0,36.0,23.0,18.0,19.0,19.0,16.0,-1.0
Vadodara,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3347.0,4739.0,4796.0,5310.0,5637.0,6066.0,6714.0,4795.0,4533.0,4922.0,5552.0,6055.0,62466.0
Vadodara,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,807.0,139.0,435.0,222.0,46.0,110.0,34.0,354.0,342.0,175.0,299.0,334.0,3297.0
Vadodara,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,831.0,161.0,252.0,196.0,35.0,117.0,29.0,285.0,330.0,171.0,284.0,338.0,3029.0
Vadodara,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,840.0,154.0,241.0,194.0,38.0,103.0,33.0,373.0,317.0,176.0,295.0,378.0,3142.0
Vadodara,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2464.0,3822.0,4460.0,4732.0,4407.0,4848.0,5380.0,4241.0,4298.0,4589.0,5207.0,5454.0,53902.0
Vadodara,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2581.0,3750.0,4236.0,4502.0,4483.0,4729.0,5086.0,3974.0,4239.0,4601.0,5206.0,5584.0,52971.0
Vadodara,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2664.0,3905.0,4240.0,4756.0,4457.0,4748.0,4551.0,3881.0,3902.0,4422.0,5355.0,5664.0,52545.0
Vadodara,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2866.0,3946.0,3818.0,3885.0,4759.0,5089.0,5039.0,3909.0,3711.0,4078.0,4582.0,4794.0,50476.0
Vadodara,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3152.0,3512.0,4172.0,4225.0,4134.0,4522.0,5036.0,4338.0,4369.0,4603.0,5226.0,5453.0,52742.0
Vadodara,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3237.0,3533.0,3976.0,3963.0,4168.0,4412.0,4780.0,4061.0,4143.0,4605.0,5238.0,5783.0,51899.0
Vadodara,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3285.0,3714.0,3978.0,4163.0,4146.0,4404.0,4552.0,3957.0,3944.0,4424.0,5354.0,5985.0,51906.0
Vadodara,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,277.0,334.0,420.0,482.0,706.0,950.0,831.0,548.0,509.0,1339.0,1472.0,1387.0,9255.0
Vadodara,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,78.0,165.0,108.0,737.0,560.0,945.0,870.0,794.0,913.0,76.0,54.0,47.0,5347.0
Vadodara,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,166.0,151.0,219.0,53.0,32.0,59.0,52.0,46.0,106.0,49.0,14.0,8.0,955.0
Vadodara,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,44.0,38.0,60.0,53.0,81.0,50.0,47.0,45.0,122.0,43.0,0.0,2.0,585.0
Vadodara,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3045.0,4150.0,4811.0,5520.0,5184.0,5097.0,4867.0,3674.0,4115.0,3681.0,4600.0,5230.0,53974.0
Vadodara,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1513.0,1743.0,1751.0,2011.0,2427.0,2559.0,2954.0,3137.0,2973.0,3108.0,3952.0,4714.0,32842.0
Vadodara,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1553.0,2119.0,2669.0,2904.0,2655.0,2821.0,2434.0,1868.0,1729.0,2378.0,2424.0,2755.0,28309.0
Vadodara,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1418.0,1954.0,2395.0,2533.0,2365.0,2472.0,2206.0,1680.0,1524.0,2341.0,2200.0,2453.0,25541.0
Vadodara,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2971.0,4073.0,5064.0,5437.0,5020.0,5293.0,4640.0,3548.0,3253.0,4719.0,4624.0,5208.0,53850.0
Vadodara,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2904.0,3998.0,4578.0,4818.0,3913.0,4082.0,3755.0,3433.0,3547.0,3622.0,4501.0,5347.0,48498.0
Vadodara,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2895.0,3948.0,4500.0,4711.0,3894.0,4055.0,3748.0,3433.0,3537.0,3610.0,4494.0,5341.0,48166.0
Vadodara,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Vadodara,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1091.0,1637.0,1749.0,1814.0,1767.0,1721.0,1416.0,1145.0,1198.0,1217.0,1722.0,2063.0,18540.0
Vadodara,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,974.0,1453.0,1516.0,1609.0,1562.0,1542.0,1277.0,1027.0,1095.0,1174.0,1546.0,1862.0,16637.0
Vadodara,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2065.0,3090.0,3265.0,3423.0,3329.0,3263.0,2693.0,2172.0,2293.0,2391.0,3268.0,3925.0,35177.0
Vadodara,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1910.0,3091.0,3495.0,3293.0,4011.0,4400.0,3502.0,3066.0,2688.0,2562.0,2996.0,3263.0,38277.0
Vadodara,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1043.0,1459.0,1932.0,4266.0,6304.0,5466.0,2585.0,2721.0,2644.0,2385.0,2287.0,3006.0,36098.0
Vadodara,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1956.0,2502.0,3227.0,3989.0,5022.0,4372.0,2949.0,2547.0,2262.0,1971.0,1962.0,2362.0,35121.0
Vadodara,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,8.0,5.0,1.0,2.0,2.0,3.0,3.0,0.0,3.0,0.0,0.0,27.0
Vadodara,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,27.0,34.0,48.0,31.0,72.0,54.0,69.0,63.0,56.0,63.0,40.0,46.0,603.0
Vadodara,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1432.0,1586.0,1542.0,1528.0,1527.0,1479.0,1474.0,1447.0,1428.0,1447.0,1619.0,1562.0,18071.0
Vadodara,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1383.0,1539.0,1525.0,1524.0,1492.0,1395.0,1432.0,1400.0,1416.0,1416.0,1586.0,1516.0,17624.0
Vadodara,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1242.0,1389.0,1389.0,1439.0,1417.0,1319.0,1321.0,1344.0,1349.0,1307.0,1522.0,1418.0,16456.0
Vadodara,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Vadodara,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2999.0,3768.0,4549.0,4631.0,4610.0,4622.0,5385.0,3442.0,3225.0,3676.0,6464.0,4831.0,52202.0
Vadodara,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,3811.0,2377.0,157.0,296.0,25240.0,39239.0,9327.0,289.0,1233.0,213.0,16346.0,41408.0,139936.0
Vadodara,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,3306.0,38.0,62.0,34.0,10372.0,21547.0,2714.0,191.0,93.0,124.0,14730.0,37087.0,90298.0
Vadodara,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Vadodara,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,8.0,37.0,10.0,0.0,80.0,68.0,45.0,3.0,3.0,4.0,0.0,11.0,269.0
Vadodara,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,651.0,856.0,1153.0,1273.0,1535.0,1592.0,1060.0,980.0,890.0,901.0,1108.0,1007.0,13006.0
Vadodara,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,69.0,13.0,192.0,274.0,490.0,920.0,559.0,459.0,756.0,662.0,825.0,668.0,5887.0
Vadodara,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,65.0,93.0,61.0,102.0,101.0,229.0,118.0,120.0,119.0,135.0,374.0,200.0,1717.0
Vadodara,13.1,Number of Patients operated for cataract,TOTAL,140.0,117.0,65.0,129.0,83.0,77.0,72.0,36.0,70.0,519.0,99.0,132.0,1539.0
Vadodara,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,121.0,94.0,27.0,91.0,70.0,76.0,64.0,47.0,112.0,118.0,112.0,140.0,1072.0
Vadodara,13.3,Number of School children detected with Refractive errors,TOTAL,9.0,287.0,349.0,251.0,984.0,785.0,860.0,10894.0,11727.0,12445.0,595.0,192.0,39378.0
Vadodara,13.4,Number of children provided free glasses,TOTAL,194.0,0.0,4.0,26.0,54.0,101.0,173.0,474.0,800.0,96.0,90.0,80.0,2092.0
Vadodara,13.5,Number of eyes collected through eye donation,TOTAL,12.0,14.0,4.0,3.0,12.0,4.0,12.0,8.0,0.0,10.0,8.0,8.0,95.0
Vadodara,13.6,Number of eyes utilised for corneal transplant,TOTAL,7.0,12.0,0.0,1.0,1.0,4.0,11.0,6.0,9.0,0.0,7.0,7.0,65.0
Vadodara,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,7.0,6.0,7.0,8.0,7.0,7.0,8.0,8.0,8.0,8.0,-1.0
Vadodara,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,25.0,21.0,22.0,25.0,19.0,18.0,22.0,21.0,23.0,22.0,23.0,25.0,-1.0
Vadodara,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2192.0,1992.0,1246.0,1454.0,2038.0,1999.0,3250.0,2019.0,1911.0,2163.0,2028.0,2131.0,-1.0
Vadodara,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,7.0,8.0,7.0,9.0,10.0,10.0,8.0,7.0,6.0,7.0,7.0,-1.0
Vadodara,14.05,Number of RKS meetings held during the month,TOTAL,18.0,16.0,20.0,16.0,16.0,13.0,14.0,11.0,14.0,15.0,18.0,23.0,194.0
Vadodara,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,35.0,37.0,31.0,33.0,29.0,33.0,33.0,36.0,36.0,34.0,39.0,35.0,-1.0
Vadodara,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,318.0,379.0,276.0,313.0,516.0,512.0,447.0,468.0,481.0,383.0,349.0,353.0,4795.0
Vadodara,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,6.0,7.0,5.0,5.0,6.0,5.0,5.0,6.0,7.0,5.0,6.0,-1.0
Vadodara,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,11.0,11.0,11.0,9.0,9.0,11.0,9.0,9.0,9.0,9.0,8.0,8.0,-1.0
Vadodara,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,548.0,732.0,751.0,585.0,750.0,1072.0,996.0,801.0,820.0,809.0,779.0,817.0,9460.0
Vadodara,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1664.0,1841.0,2190.0,1518.0,2233.0,3139.0,2499.0,1878.0,1993.0,1836.0,2037.0,1930.0,24758.0
Vadodara,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,399.0,448.0,446.0,311.0,422.0,581.0,561.0,575.0,546.0,526.0,933.0,660.0,6408.0
Vadodara,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2652.0,3065.0,3006.0,3121.0,2897.0,3660.0,3586.0,3626.0,3727.0,2984.0,2922.0,3229.0,38475.0
Vadodara,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,947.0,1180.0,1197.0,896.0,1172.0,1653.0,1557.0,1376.0,1366.0,1335.0,1712.0,1477.0,15868.0
Vadodara,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4316.0,4906.0,5196.0,4639.0,5130.0,6799.0,6085.0,5504.0,5720.0,4820.0,4959.0,5159.0,63233.0
Vadodara,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,7.0,4.0,2.0,13.0,12.0,23.0,12.0,22.0,29.0,37.0,37.0,201.0
Vadodara,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5.0,9.0,2.0,3.0,9.0,11.0,11.0,11.0,15.0,18.0,18.0,19.0,131.0
Vadodara,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,8.0,16.0,6.0,5.0,22.0,23.0,34.0,23.0,37.0,47.0,55.0,56.0,332.0
Vadodara,14.11,In-Patient Head Count at midnight,TOTAL,13714.0,15075.0,14005.0,13305.0,15487.0,17084.0,13137.0,17503.0,16770.0,15878.0,16110.0,20013.0,188081.0
Vadodara,14.12.1,OPD attendance (All),TOTAL,87300.0,98057.0,123534.0,122523.0,149185.0,165578.0,133772.0,132031.0,134259.0,79045.0,115753.0,141397.0,1482434.0
Vadodara,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,349.0,271.0,262.0,980.0,372.0,400.0,266.0,427.0,392.0,493.0,483.0,422.0,5117.0
Vadodara,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,44.0,15.0,41.0,62.0,31.0,34.0,61.0,238.0,245.0,58.0,44.0,49.0,922.0
Vadodara,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,418.0,438.0,499.0,660.0,528.0,611.0,569.0,1152.0,1257.0,910.0,809.0,768.0,8619.0
Vadodara,14.14.a,Number of patients given AYUSH treatment,TOTAL,2545.0,3041.0,2287.0,2331.0,3439.0,2774.0,2038.0,2180.0,2695.0,2712.0,3577.0,2702.0,32321.0
Vadodara,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1116.0,1009.0,1431.0,1296.0,1212.0,1402.0,1434.0,1262.0,1451.0,1309.0,1152.0,1542.0,15616.0
Vadodara,14.14.c,Number of Adolescents counselled,TOTAL,600.0,768.0,903.0,443.0,650.0,686.0,532.0,367.0,693.0,263.0,194.0,181.0,6280.0
Vadodara,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9901.0,11864.0,12888.0,13329.0,13975.0,13835.0,10701.0,10647.0,11329.0,10838.0,12126.0,11605.0,143038.0
Vadodara,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,256.0,267.0,382.0,381.0,346.0,346.0,334.0,239.0,245.0,165.0,233.0,372.0,3566.0
Vadodara,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1761.0,1883.0,2222.0,2384.0,2572.0,3529.0,1711.0,2836.0,2837.0,2712.0,2981.0,3142.0,30570.0
Vadodara,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,57.0,45.0,40.0,60.0,62.0,49.0,13.0,52.0,60.0,41.0,47.0,72.0,598.0
Vadodara,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1282.0,1423.0,1648.0,1781.0,1729.0,2261.0,1369.0,1936.0,1841.0,1596.0,1690.0,1886.0,20442.0
Vadodara,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,24.0,29.0,19.0,29.0,25.0,20.0,9.0,60.0,47.0,37.0,15.0,63.0,377.0
Vadodara,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2058.0,2632.0,3483.0,3235.0,3676.0,3096.0,1797.0,2630.0,2627.0,2691.0,2386.0,3346.0,33657.0
Vadodara,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,34.0,39.0,1.0,65.0,97.0,6.0,0.0,116.0,19.0,21.0,40.0,58.0,496.0
Vadodara,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,5101.0,5938.0,7353.0,7400.0,7977.0,8886.0,4877.0,7402.0,7305.0,6999.0,7057.0,8374.0,84669.0
Vadodara,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,115.0,113.0,60.0,154.0,184.0,75.0,22.0,228.0,126.0,99.0,102.0,193.0,1471.0
Vadodara,15.2,Number of Widal tests conducted,Number tested,810.0,940.0,1440.0,1155.0,2134.0,2167.0,1662.0,1030.0,697.0,638.0,1111.0,980.0,14764.0
Vadodara,15.3.a,Number of VDRL tests conducted on males,Number tested,57.0,116.0,396.0,573.0,248.0,245.0,244.0,182.0,195.0,166.0,303.0,664.0,3389.0
Vadodara,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,121.0,260.0,192.0,234.0,155.0,164.0,182.0,118.0,116.0,83.0,121.0,210.0,1956.0
Vadodara,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,644.0,920.0,861.0,785.0,1164.0,1070.0,797.0,763.0,728.0,663.0,1002.0,1220.0,10617.0
Vadodara,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,822.0,1296.0,1449.0,1592.0,1567.0,1479.0,1223.0,1063.0,1039.0,912.0,1426.0,2094.0,15962.0
Vadodara,15.4.1,Number of blood smears examined for Malaria,TOTAL,21777.0,23920.0,25499.0,27131.0,44712.0,55519.0,35527.0,24339.0,26356.0,24488.0,39621.0,34239.0,383128.0
Vadodara,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,71.0,726.0,164.0,166.0,304.0,295.0,382.0,80.0,38.0,173.0,297.0,267.0,2963.0
Vadodara,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,8.0,2.0,1.0,9.0,49.0,51.0,31.0,31.0,7.0,7.0,0.0,198.0
Vadodara,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3000.0,500.0,200.0,2900.0,7320.0,6670.0,4230.0,8230.0,16360.0,9010.0,5810.0,3960.0,68190.0
Vadodara,16.1.1,Stock position of DPT vaccines,2. Stocks Received,12500.0,5000.0,7500.0,22500.0,15000.0,12500.0,16000.0,28000.0,5000.0,10000.0,12500.0,12000.0,158500.0
Vadodara,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,5300.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5300.0
Vadodara,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,15000.0,200.0,4800.0,18080.0,15650.0,14940.0,12000.0,19870.0,12350.0,13200.0,14350.0,12300.0,152740.0
Vadodara,16.1.1,Stock position of DPT vaccines,5. Total Stock,500.0,0.0,2900.0,7320.0,6670.0,4230.0,8230.0,16360.0,9010.0,5810.0,3960.0,3660.0,68650.0
Vadodara,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1640.0,1090.0,6540.0,7040.0,860.0,1700.0,1000.0,1000.0,5310.0,11910.0,13960.0,9060.0,61110.0
Vadodara,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,25000.0,27000.0,18000.0,8900.0,20000.0,15000.0,0.0,35260.0,25000.0,21000.0,15000.0,18000.0,228160.0
Vadodara,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,19810.0,21550.0,17500.0,15080.0,19160.0,15700.0,0.0,23400.0,17500.0,18950.0,19900.0,12550.0,201100.0
Vadodara,16.1.1A,Stock Position of Pentavalent,5. Total Stock,6830.0,6540.0,7040.0,860.0,1700.0,1000.0,1000.0,12860.0,12810.0,13960.0,9060.0,14510.0,88170.0
Vadodara,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,22900.0,18400.0,19360.0,14160.0,6460.0,8020.0,5100.0,2950.0,3920.0,2640.0,9840.0,5220.0,118970.0
Vadodara,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,27000.0,27000.0,27000.0,30000.0,31000.0,30000.0,32970.0,27000.0,20000.0,446080.0,27000.0,745050.0
Vadodara,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,24500.0,26040.0,32200.0,34700.0,28440.0,33920.0,32150.0,32000.0,28280.0,12800.0,450700.0,27700.0,763430.0
Vadodara,16.1.2,Stock position of OPV vaccines,5. Total Stock,18400.0,19360.0,14160.0,6460.0,8020.0,5100.0,2950.0,3920.0,2640.0,9840.0,5220.0,4520.0,100590.0
Vadodara,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1640.0,6830.0,11180.0,12530.0,6230.0,300.0,5500.0,860.0,5310.0,12810.0,15860.0,16010.0,95060.0
Vadodara,16.1.3,Stock position of TT vaccines,2. Stocks Received,25000.0,25000.0,20000.0,25000.0,20000.0,25000.0,17000.0,30000.0,25000.0,25000.0,25000.0,20000.0,282000.0
Vadodara,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.1.3,Stock position of TT vaccines,4. Stock Distributed,19810.0,20650.0,18650.0,31300.0,25930.0,19800.0,21640.0,25550.0,17500.0,21950.0,24850.0,18100.0,265730.0
Vadodara,16.1.3,Stock position of TT vaccines,5. Total Stock,6830.0,11180.0,12530.0,6230.0,300.0,5500.0,860.0,5310.0,12810.0,15860.0,16010.0,17910.0,111330.0
Vadodara,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Vadodara,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Vadodara,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,0.0,,0.0,,,,,0.0
Vadodara,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Vadodara,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,800.0,1060.0,1250.0,1530.0,1760.0,1500.0,4500.0,6890.0,8530.0,10950.0,12670.0,14070.0,65510.0
Vadodara,16.1.5,Stock position of BCG vaccines,2. Stocks Received,8500.0,8500.0,8500.0,8500.0,8500.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,112500.0
Vadodara,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,8240.0,8310.0,8220.0,8270.0,8760.0,7000.0,7610.0,8360.0,7580.0,8280.0,8600.0,8030.0,97260.0
Vadodara,16.1.5,Stock position of BCG vaccines,5. Total Stock,1060.0,1250.0,1530.0,1760.0,1500.0,4500.0,6890.0,8530.0,10950.0,12670.0,14070.0,16040.0,80750.0
Vadodara,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,720.0,670.0,470.0,7200.0,2000.0,300.0,2000.0,4580.0,2730.0,8510.0,7560.0,660.0,37400.0
Vadodara,16.1.6,Stock position of Measles vaccines,2. Stocks Received,8000.0,5000.0,25000.0,9000.0,10000.0,10000.0,14000.0,10000.0,15000.0,10000.0,5000.0,10000.0,131000.0
Vadodara,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,8050.0,5200.0,18270.0,14200.0,11700.0,8300.0,11420.0,11850.0,9220.0,10950.0,11900.0,6600.0,127660.0
Vadodara,16.1.6,Stock position of Measles vaccines,5. Total Stock,670.0,470.0,7200.0,2000.0,300.0,2000.0,4580.0,2730.0,8510.0,7560.0,660.0,4060.0,40740.0
Vadodara,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,0.0,,0.0,0.0,,0.0,,0.0,0.0
Vadodara,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,0.0,,0.0,0.0,,0.0,,0.0,0.0
Vadodara,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,,0.0,,0.0,0.0
Vadodara,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,0.0,,0.0,0.0,,0.0,,0.0,0.0
Vadodara,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5930.0,4510.0,3720.0,2120.0,740.0,5850.0,3600.0,2700.0,5310.0,4300.0,2210.0,3190.0,44180.0
Vadodara,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,6000.0,0.0,0.0,3900.0,0.0,0.0,3000.0,0.0,12900.0
Vadodara,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1420.0,790.0,1600.0,1380.0,890.0,2250.0,900.0,1290.0,1010.0,2090.0,2020.0,890.0,16530.0
Vadodara,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,4510.0,3720.0,2120.0,740.0,5850.0,3600.0,2700.0,5310.0,4300.0,2210.0,3190.0,2300.0,40550.0
Vadodara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2300.0,900.0,10600.0,10600.0,10400.0,10400.0,9700.0,9400.0,7600.0,7600.0,6000.0,5500.0,91000.0
Vadodara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,12000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9720.0,21720.0
Vadodara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,1400.0,2300.0,0.0,200.0,0.0,700.0,300.0,1800.0,,1600.0,450.0,1700.0,10450.0
Vadodara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,900.0,10600.0,10600.0,10400.0,10400.0,9700.0,9400.0,7600.0,7600.0,6000.0,5550.0,13520.0,102270.0
Vadodara,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,20490.0,10410.0,10410.0,6210.0,0.0,516720.0,413400.0,398280.0,413640.0,397560.0,379440.0,395280.0,2961840.0
Vadodara,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,552000.0,0.0,0.0,50400.0,0.0,0.0,83880.0,0.0,686280.0
Vadodara,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,10080.0,0.0,4200.0,6210.0,35280.0,103320.0,15120.0,35040.0,16080.0,18120.0,68040.0,219240.0,530730.0
Vadodara,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,10410.0,10410.0,6210.0,0.0,516720.0,413400.0,398280.0,413640.0,397560.0,379440.0,395280.0,176040.0,3117390.0
Vadodara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,13100.0,8300.0,0.0,0.0,0.0,35900.0,39420.0,38820.0,31120.0,23120.0,12320.0,6920.0,209020.0
Vadodara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,42000.0,30520.0,0.0,0.0,0.0,0.0,0.0,60000.0,132520.0
Vadodara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,4800.0,8300.0,0.0,0.0,6100.0,27000.0,600.0,7700.0,8000.0,10800.0,5400.0,10700.0,89400.0
Vadodara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,8300.0,0.0,0.0,0.0,35900.0,39420.0,38820.0,31120.0,23120.0,12320.0,6920.0,56220.0,252140.0
Vadodara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1800.0,1450.0,1400.0,1350.0,1350.0,1200.0,3600.0,3200.0,2900.0,2450.0,2450.0,2150.0,25300.0
Vadodara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,4500.0,0.0,0.0,0.0,0.0,0.0,0.0,4500.0
Vadodara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,350.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,350.0
Vadodara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,50.0,50.0,0.0,150.0,2100.0,400.0,300.0,450.0,0.0,300.0,50.0,3850.0
Vadodara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1450.0,1400.0,1350.0,1350.0,1200.0,3600.0,3200.0,2900.0,2450.0,2450.0,2150.0,2100.0,25600.0
Vadodara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1500.0,900.0,20600.0,20400.0,20400.0,19000.0,14800.0,14100.0,9000.0,5800.0,5800.0,6600.0,138900.0
Vadodara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,25000.0
Vadodara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0
Vadodara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,300.0,200.0,0.0,1400.0,4200.0,700.0,5100.0,3200.0,0.0,4200.0,0.0,19300.0
Vadodara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,900.0,20600.0,20400.0,20400.0,19000.0,14800.0,14100.0,9000.0,5800.0,5800.0,6600.0,6600.0,144000.0
Vadodara,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,9800.0,7300.0,6750.0,6550.0,6550.0,5675.0,4575.0,4325.0,3175.0,350.0,250.0,0.0,55300.0
Vadodara,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,350.0,350.0
Vadodara,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.02,Stock Position of Gloves,4. Stock Distributed,2500.0,550.0,200.0,0.0,875.0,1100.0,250.0,1150.0,2825.0,100.0,250.0,0.0,9800.0
Vadodara,16.3.02,Stock Position of Gloves,5. Total Stock,7300.0,6750.0,6550.0,6550.0,5675.0,4575.0,4325.0,3175.0,350.0,250.0,0.0,350.0,45850.0
Vadodara,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,35.0,22.0,22.0,18.0,14.0,14.0,14.0,112.0,52.0,24.0,20.0,0.0,347.0
Vadodara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,2.0,102.0
Vadodara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,13.0,0.0,4.0,4.0,0.0,0.0,2.0,60.0,28.0,4.0,17.0,0.0,132.0
Vadodara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,22.0,22.0,18.0,14.0,14.0,14.0,112.0,52.0,24.0,20.0,3.0,2.0,317.0
Vadodara,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Vadodara,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Vadodara,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Vadodara,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Vadodara,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Vadodara,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Vadodara,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Vadodara,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Vadodara,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Vadodara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Vadodara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Vadodara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Vadodara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Vadodara,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Vadodara,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Vadodara,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Vadodara,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Vadodara,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Vadodara,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Vadodara,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Vadodara,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4100.0,3000.0,5400.0,5400.0,5400.0,5400.0,5400.0,5400.0,1500.0,1500.0,1500.0,1000.0,45000.0
Vadodara,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,16500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,33000.0,55500.0
Vadodara,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1100.0,14100.0,0.0,0.0,,0.0,0.0,3900.0,0.0,0.0,6500.0,27900.0,53500.0
Vadodara,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3000.0,5400.0,5400.0,5400.0,5400.0,5400.0,5400.0,1500.0,1500.0,1500.0,1000.0,6100.0,47000.0
Vadodara,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,71810.0,2000.0,13810.0,299310.0,299310.0,299310.0,299310.0,299310.0,559810.0,559810.0,559810.0,559810.0,3823410.0
Vadodara,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,70000.0,400000.0,0.0,0.0,0.0,0.0,500000.0,0.0,0.0,0.0,0.0,970000.0
Vadodara,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,69810.0,58190.0,114500.0,0.0,,0.0,0.0,239500.0,0.0,0.0,0.0,200000.0,682000.0
Vadodara,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,2000.0,13810.0,299310.0,299310.0,299310.0,299310.0,299310.0,559810.0,559810.0,559810.0,559810.0,359810.0,4111410.0
Vadodara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,22600.0,4000.0,4000.0,2300.0,2300.0,2300.0,2300.0,2300.0,1800.0,1800.0,1800.0,1800.0,49300.0
Vadodara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vadodara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,18600.0,0.0,1700.0,0.0,,0.0,0.0,500.0,0.0,0.0,0.0,0.0,20800.0
Vadodara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4000.0,4000.0,2300.0,2300.0,2300.0,2300.0,2300.0,1800.0,1800.0,1800.0,1800.0,1800.0,28500.0
Vadodara,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,,1.0,,,1.0,,1.0,1.0,,5.0
Vadodara,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,,,1.0
Vadodara,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Vadodara,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,1.0,,,,,,,,1.0
Vadodara,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,2.0,4.0,,3.0,2.0,1.0,1.0,,2.0,1.0,1.0,17.0
Vadodara,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Vadodara,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,2.0,4.0,,3.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,18.0
Vadodara,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,2.0,2.0,,3.0,2.0,4.0,2.0,1.0,1.0,3.0,,22.0
Vadodara,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Vadodara,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,2.0,2.0,1.0,3.0,2.0,4.0,2.0,1.0,1.0,3.0,,23.0
Vadodara,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,7.0,9.0,7.0,7.0,10.0,4.0,7.0,6.0,7.0,2.0,8.0,8.0,82.0
Vadodara,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Vadodara,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,7.0,9.0,7.0,7.0,10.0,4.0,8.0,6.0,7.0,2.0,8.0,8.0,83.0
Vadodara,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Vadodara,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,1.0,1.0,,,,,,,2.0
Vadodara,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,1.0,1.0,1.0,,,,,,3.0
Vadodara,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Vadodara,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Vadodara,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,1.0,,,,,,1.0
Vadodara,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Vadodara,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Vadodara,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Vadodara,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Vadodara,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Vadodara,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Vadodara,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,3.0,7.0,,4.0,6.0,4.0,3.0,5.0,3.0,4.0,4.0,44.0
Vadodara,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,2.0,,,1.0,2.0,1.0,3.0,2.0,1.0,6.0,20.0
Vadodara,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,4.0,9.0,,4.0,7.0,6.0,4.0,8.0,5.0,5.0,10.0,64.0
Vadodara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Vadodara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Vadodara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Vadodara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,1.0,2.0,1.0,,3.0,3.0,2.0,3.0,2.0,17.0
Vadodara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,1.0,,,,,,1.0,1.0,4.0
Vadodara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,1.0,3.0,1.0,,3.0,3.0,2.0,4.0,3.0,21.0
Vadodara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,,1.0,2.0,1.0,1.0,1.0,,3.0,,2.0,12.0
Vadodara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,3.0,1.0,,,,1.0,4.0,3.0,5.0,,1.0,18.0
Vadodara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,3.0,1.0,1.0,2.0,1.0,2.0,5.0,3.0,8.0,,3.0,30.0
Vadodara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Vadodara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Vadodara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Vadodara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,1.0,,,,,,1.0,,,1.0,,4.0
Vadodara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,2.0,,,,,,1.0,,,,,3.0
Vadodara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,3.0,,,,,,2.0,,,1.0,,7.0
Vadodara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,1.0,1.0,2.0
Vadodara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Vadodara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,1.0,1.0,2.0
Vadodara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,3.0,1.0,,4.0,5.0,3.0,5.0,2.0,6.0,4.0,2.0,36.0
Vadodara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,2.0,5.0,,4.0,5.0,2.0,2.0,6.0,3.0,9.0,2.0,42.0
Vadodara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,5.0,6.0,,8.0,10.0,5.0,7.0,8.0,9.0,13.0,4.0,78.0
Vadodara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,2.0,,,,,,,,,,,2.0
Vadodara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Vadodara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,,,,,,,,,,,2.0
Vadodara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Vadodara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Vadodara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Vadodara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Vadodara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Vadodara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Vadodara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Vadodara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Vadodara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Vadodara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Vadodara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Vadodara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Vadodara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Vadodara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Vadodara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Vadodara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,2.0,,,,,,2.0,,,1.0,5.0
Vadodara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Vadodara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,2.0,,,,,,2.0,,,1.0,5.0
Vadodara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,1.0,3.0,1.0,4.0,3.0,,,3.0,,2.0,,20.0
Vadodara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,,,1.0,,,,,,,1.0,3.0
Vadodara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,1.0,3.0,1.0,5.0,3.0,,,3.0,,2.0,1.0,23.0
Vadodara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,,1.0,,1.0,,1.0,1.0,2.0,2.0,1.0,1.0,11.0
Vadodara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Vadodara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,,2.0,,1.0,,1.0,1.0,2.0,2.0,1.0,1.0,12.0
Vadodara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Vadodara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,2.0,1.0,,,,1.0,,,,,4.0
Vadodara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Vadodara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,2.0,1.0,,1.0,,1.0,,,,,5.0
Vadodara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Vadodara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Vadodara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Vadodara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Vadodara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,1.0,3.0,1.0,2.0,1.0,1.0,1.0,,10.0
Vadodara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,1.0,,2.0,2.0,1.0,2.0,2.0,2.0,,1.0,,15.0
Vadodara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,2.0,1.0,,2.0,3.0,4.0,3.0,4.0,3.0,1.0,2.0,,25.0
Vadodara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,2.0,,1.0,,,1.0,,4.0
Vadodara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,4.0,2.0,12.0,4.0,11.0,5.0,3.0,6.0,8.0,12.0,2.0,6.0,75.0
Vadodara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,9.0,9.0,9.0,8.0,15.0,13.0,7.0,21.0,9.0,20.0,17.0,13.0,150.0
Vadodara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,13.0,11.0,21.0,12.0,26.0,20.0,10.0,28.0,17.0,32.0,20.0,19.0,229.0
Valsad,1.1,Total number of pregnant women Registered for ANC,TOTAL,2662.0,2563.0,2749.0,2859.0,3221.0,3287.0,2815.0,2850.0,3032.0,2897.0,2630.0,2546.0,34111.0
Valsad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2119.0,2045.0,2123.0,2297.0,2649.0,2684.0,2353.0,2328.0,2514.0,2342.0,2219.0,2080.0,27753.0
Valsad,1.2,Number of Pregnant women registered under JSY,TOTAL,1333.0,1298.0,1346.0,1431.0,1628.0,1655.0,1307.0,1389.0,1296.0,1262.0,1183.0,1194.0,16322.0
Valsad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1893.0,2071.0,2095.0,2112.0,2362.0,2581.0,2445.0,2272.0,2430.0,2423.0,2394.0,2296.0,27374.0
Valsad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2036.0,1978.0,2080.0,2219.0,2558.0,2551.0,2131.0,2251.0,2344.0,2165.0,2022.0,1916.0,26251.0
Valsad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2112.0,2428.0,2356.0,2441.0,2894.0,3271.0,3152.0,2980.0,2869.0,2979.0,2675.0,2516.0,32673.0
Valsad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2461.0,2362.0,2367.0,2452.0,3046.0,3277.0,3091.0,3137.0,3052.0,3138.0,2914.0,2897.0,34194.0
Valsad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,13.0,4.0,7.0,34.0,22.0,9.0,19.0,10.0,9.0,8.0,18.0,21.0,174.0
Valsad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,20.0,22.0,4.0,3.0,9.0,13.0,11.0,16.0,14.0,8.0,8.0,7.0,135.0
Valsad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1608.0,1426.0,1751.0,1742.0,1984.0,1974.0,1565.0,1793.0,2726.0,1592.0,1539.0,1720.0,21420.0
Valsad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,81.0,76.0,73.0,55.0,69.0,62.0,74.0,103.0,73.0,88.0,78.0,85.0,917.0
Valsad,1.8,Number of pregnancy test kits used at SC level,TOTAL,109.0,184.0,150.0,375.0,640.0,671.0,460.0,667.0,588.0,580.0,643.0,496.0,5563.0
Valsad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,51.0,61.0,71.0,65.0,68.0,54.0,47.0,73.0,87.0,110.0,81.0,130.0,898.0
Valsad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,160.0,140.0,126.0,124.0,175.0,154.0,149.0,170.0,221.0,189.0,186.0,167.0,1961.0
Valsad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,211.0,201.0,197.0,189.0,243.0,208.0,196.0,243.0,308.0,299.0,267.0,297.0,2859.0
Valsad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,200.0,199.0,193.0,172.0,224.0,201.0,194.0,240.0,304.0,298.0,262.0,286.0,2773.0
Valsad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,21.0,0.0,1.0,14.0,18.0,15.0,6.0,10.0,9.0,16.0,22.0,12.0,144.0
Valsad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,900.0,829.0,736.0,683.0,688.0,730.0,953.0,1001.0,1020.0,1022.0,1045.0,1197.0,10804.0
Valsad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,153.0,82.0,60.0,26.0,115.0,49.0,54.0,24.0,41.0,29.0,93.0,116.0,842.0
Valsad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,4.0,11.0,15.0,9.0,25.0,51.0,6.0,10.0,38.0,11.0,2.0,31.0,213.0
Valsad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,9.0
Valsad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Valsad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1284.0,1262.0,1172.0,1145.0,1314.0,1364.0,1414.0,1395.0,1432.0,1305.0,1302.0,1475.0,15864.0
Valsad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Valsad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,12.0,12.0,5.0,36.0
Valsad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,21.0,23.0,22.0,24.0,22.0,30.0,31.0,31.0,23.0,19.0,23.0,11.0,280.0
Valsad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,64.0,54.0,60.0,58.0,54.0,66.0,64.0,75.0,75.0,85.0,57.0,88.0,800.0
Valsad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Valsad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,85.0,77.0,82.0,82.0,76.0,96.0,95.0,106.0,105.0,116.0,92.0,104.0,1116.0
Valsad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,132.0,132.0,133.0,154.0,159.0,168.0,163.0,169.0,142.0,110.0,120.0,146.0,1728.0
Valsad,4.1.1.a,Number of male live births,TOTAL,1258.0,1124.0,1099.0,1036.0,1173.0,1163.0,1345.0,1370.0,1387.0,1343.0,1373.0,1555.0,15226.0
Valsad,4.1.1.b,Number of female live births,TOTAL,1125.0,1148.0,1029.0,949.0,1050.0,1117.0,1218.0,1257.0,1327.0,1259.0,1301.0,1476.0,14256.0
Valsad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2383.0,2272.0,2128.0,1985.0,2223.0,2280.0,2563.0,2627.0,2714.0,2602.0,2674.0,3031.0,29482.0
Valsad,4.1.2,Number of still births,TOTAL,37.0,35.0,35.0,27.0,41.0,35.0,28.0,136.0,37.0,47.0,41.0,63.0,562.0
Valsad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,97.0,86.0,102.0,66.0,67.0,78.0,107.0,101.0,77.0,94.0,95.0,68.0,1038.0
Valsad,4.2.1,Number of Newborns weighed at birth,TOTAL,2379.0,2273.0,2142.0,1986.0,2224.0,2272.0,2371.0,2530.0,2759.0,2580.0,2613.0,2949.0,29078.0
Valsad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,326.0,298.0,310.0,317.0,288.0,351.0,365.0,349.0,426.0,411.0,373.0,466.0,4280.0
Valsad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2363.0,2262.0,2124.0,1983.0,2206.0,2267.0,2568.0,2520.0,2748.0,2628.0,2547.0,2697.0,28913.0
Valsad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,27.0,9.0,2.0,3.0,22.0,17.0,9.0,4.0,5.0,4.0,16.0,27.0,145.0
Valsad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,38.0,32.0,23.0,31.0,26.0,33.0,31.0,26.0,7.0,51.0,36.0,50.0,384.0
Valsad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Valsad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,65.0,41.0,25.0,34.0,48.0,50.0,40.0,30.0,12.0,55.0,52.0,77.0,529.0
Valsad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,11.0,9.0,11.0,7.0,17.0,13.0,10.0,16.0,11.0,12.0,16.0,133.0
Valsad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,74.0,257.0,203.0,240.0,186.0,243.0,251.0,200.0,240.0,281.0,292.0,387.0,2854.0
Valsad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,37.0,28.0,10.0,10.0,16.0,20.0,20.0,16.0,17.0,11.0,20.0,15.0,220.0
Valsad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,68.0,277.0,233.0,357.0,174.0,197.0,244.0,26.0,237.0,292.0,288.0,383.0,2776.0
Valsad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,67.0,110.0,110.0,78.0,94.0,57.0,102.0,127.0,158.0,184.0,147.0,133.0,1367.0
Valsad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2320.0,2310.0,2052.0,1710.0,1977.0,2061.0,2178.0,2564.0,2655.0,2520.0,2490.0,2819.0,27656.0
Valsad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1878.0,1866.0,1846.0,1663.0,1918.0,1824.0,2057.0,1994.0,2064.0,2113.0,2014.0,2564.0,23801.0
Valsad,6.3,PNC maternal complications attended,TOTAL,4.0,1.0,2.0,1.0,0.0,3.0,3.0,4.0,2.0,2.0,1.0,3.0,26.0
Valsad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,38.0,33.0,34.0,36.0,41.0,18.0,23.0,28.0,7.0,33.0,20.0,10.0,321.0
Valsad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,23.0,0.0,0.0,2.0,1.0,0.0,0.0,26.0
Valsad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,38.0,33.0,34.0,36.0,41.0,41.0,23.0,28.0,9.0,34.0,20.0,10.0,347.0
Valsad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,8.0
Valsad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,435.0,455.0,497.0,462.0,416.0,605.0,522.0,550.0,555.0,536.0,527.0,627.0,6187.0
Valsad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,348.0,336.0,420.0,454.0,437.0,577.0,425.0,427.0,492.0,413.0,501.0,578.0,5408.0
Valsad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,783.0,791.0,917.0,916.0,853.0,1182.0,947.0,977.0,1047.0,949.0,1028.0,1205.0,11595.0
Valsad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,21.0,22.0,7.0,2.0,2.0,1.0,0.0,55.0
Valsad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,4.0,5.0,2.0,2.0,0.0,6.0,4.0,2.0,2.0,10.0,2.0,0.0,39.0
Valsad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,1.0,7.0,6.0,7.0,25.0,4.0,0.0,10.0,4.0,10.0,3.0,78.0
Valsad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Valsad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,5.0,6.0,9.0,8.0,7.0,31.0,8.0,2.0,12.0,14.0,12.0,3.0,117.0
Valsad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,131.0,55.0,70.0,39.0,99.0,125.0,64.0,71.0,111.0,130.0,198.0,92.0,1185.0
Valsad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,44.0,71.0,32.0,60.0,50.0,47.0,49.0,47.0,56.0,76.0,78.0,108.0,718.0
Valsad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Valsad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,175.0,126.0,102.0,99.0,149.0,172.0,113.0,118.0,167.0,206.0,276.0,200.0,1903.0
Valsad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,6.0,18.0,0.0,23.0,10.0,19.0,13.0,96.0,0.0,0.0,0.0,0.0,185.0
Valsad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,87.0,96.0,72.0,66.0,74.0,138.0,95.0,94.0,86.0,171.0,155.0,142.0,1276.0
Valsad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,167.0,12.0,68.0,163.0,154.0,94.0,87.0,122.0,329.0,20.0,58.0,35.0,1309.0
Valsad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,106.0,24.0,158.0,106.0,167.0,233.0,64.0,60.0,130.0,263.0,170.0,15.0,1496.0
Valsad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Valsad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,360.0,132.0,298.0,335.0,395.0,465.0,246.0,276.0,545.0,454.0,383.0,192.0,4081.0
Valsad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,77.0,87.0,253.0,90.0,146.0,30.0,47.0,0.0,0.0,0.0,0.0,0.0,730.0
Valsad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,8.0,5.0,6.0,3.0,5.0,9.0,7.0,5.0,2.0,0.0,0.0,0.0,50.0
Valsad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,8.0,23.0,19.0,7.0,8.0,7.0,7.0,11.0,25.0,9.0,3.0,6.0,133.0
Valsad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,13.0,2.0,8.0,10.0,6.0,8.0,9.0,10.0,8.0,13.0,9.0,18.0,114.0
Valsad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Valsad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,29.0,30.0,33.0,20.0,19.0,24.0,23.0,26.0,35.0,22.0,12.0,24.0,297.0
Valsad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,12.0,0.0,5.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Valsad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,173.0,185.0,187.0,155.0,170.0,147.0,160.0,155.0,150.0,166.0,199.0,170.0,2017.0
Valsad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,110.0,162.0,127.0,132.0,158.0,143.0,134.0,133.0,212.0,257.0,222.0,227.0,2017.0
Valsad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,65.0,49.0,100.0,83.0,135.0,111.0,102.0,101.0,36.0,105.0,27.0,34.0,948.0
Valsad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,9.0,10.0,11.0,9.0,4.0,3.0,0.0,12.0,11.0,9.0,2.0,5.0,85.0
Valsad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Valsad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,357.0,406.0,425.0,379.0,467.0,404.0,396.0,401.0,409.0,537.0,450.0,436.0,5067.0
Valsad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,39.0,30.0,15.0,14.0,6.0,1.0,2.0,4.0,8.0,9.0,6.0,8.0,142.0
Valsad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,28.0,32.0,211.0,21.0,21.0,27.0,34.0,61.0,0.0,0.0,0.0,0.0,435.0
Valsad,9.06,Number of IUCD removals,TOTAL,118.0,175.0,116.0,102.0,99.0,86.0,82.0,107.0,82.0,94.0,84.0,103.0,1248.0
Valsad,9.07,Number of Oral Pills cycles distributed,TOTAL,3466.0,3267.0,3551.0,3049.0,3078.0,3085.0,2987.0,2681.0,2850.0,3123.0,2697.0,2760.0,36594.0
Valsad,9.08,Number of Condom pieces distributed,TOTAL,27569.0,29047.0,29539.0,25092.0,29757.0,31032.0,30074.0,27752.0,27378.0,26109.0,24871.0,24431.0,332651.0
Valsad,9.09,Number of Centchroman (weekly) pills given,TOTAL,138.0,87.0,17.0,5.0,28.0,6.0,0.0,88.0,0.0,0.0,0.0,64.0,433.0
Valsad,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,127.0,30.0,21.0,26.0,45.0,144.0,44.0,8.0,5.0,10.0,11.0,14.0,485.0
Valsad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Valsad,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,9.12,Number of Institutions having NSV trained doctors,TOTAL,19.0,19.0,22.0,19.0,18.0,19.0,16.0,16.0,15.0,18.0,17.0,16.0,-1.0
Valsad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2409.0,2281.0,2242.0,2007.0,2333.0,2325.0,2602.0,2732.0,2837.0,2843.0,2785.0,3253.0,30649.0
Valsad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4.0,5.0,0.0,0.0,49.0,12.0,0.0,0.0,42.0,17.0,18.0,21.0,168.0
Valsad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2.0,8.0,0.0,0.0,47.0,0.0,0.0,0.0,37.0,15.0,17.0,19.0,145.0
Valsad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2.0,5.0,0.0,0.0,42.0,0.0,0.0,0.0,39.0,14.0,17.0,18.0,137.0
Valsad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2235.0,2465.0,2196.0,2098.0,2107.0,2136.0,2108.0,2307.0,2457.0,2475.0,2421.0,2406.0,27411.0
Valsad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2099.0,2195.0,2363.0,2170.0,2178.0,2163.0,2122.0,2144.0,2364.0,2444.0,2481.0,2509.0,27232.0
Valsad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2152.0,2113.0,2097.0,2294.0,2267.0,2157.0,2101.0,2202.0,2240.0,2397.0,2579.0,2715.0,27314.0
Valsad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1851.0,1840.0,1759.0,1618.0,1782.0,1886.0,2118.0,2184.0,2221.0,2241.0,2278.0,2565.0,24343.0
Valsad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2215.0,2429.0,2214.0,2003.0,2014.0,2044.0,2080.0,2269.0,2424.0,2442.0,2432.0,2408.0,26974.0
Valsad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2064.0,2166.0,2383.0,2081.0,2081.0,2055.0,2079.0,2118.0,2335.0,2391.0,2613.0,2509.0,26875.0
Valsad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2107.0,2062.0,2127.0,2208.0,2169.0,2053.0,2064.0,2168.0,2226.0,2560.0,2574.0,2703.0,27021.0
Valsad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,977.0,768.0,717.0,949.0,1116.0,1160.0,1174.0,1379.0,1364.0,1257.0,1362.0,1489.0,13712.0
Valsad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,20.0,0.0,0.0,0.0,0.0,8.0,2.0,12.0,1.0,13.0,1.0,1.0,58.0
Valsad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,11.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,12.0,5.0,0.0,35.0
Valsad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,8.0,88.0,0.0,1.0,0.0,0.0,0.0,7.0,1.0,210.0,3.0,2.0,320.0
Valsad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1923.0,2079.0,2138.0,2112.0,2427.0,2371.0,2163.0,2379.0,2310.0,2420.0,2404.0,2511.0,27237.0
Valsad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1196.0,1216.0,1414.0,1643.0,1931.0,1888.0,1774.0,1874.0,1758.0,1820.0,1871.0,2123.0,20508.0
Valsad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Valsad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,990.0,1078.0,1081.0,1078.0,1212.0,1219.0,1109.0,1205.0,1177.0,1240.0,1232.0,1271.0,13892.0
Valsad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,915.0,990.0,1004.0,980.0,1116.0,1160.0,1060.0,1133.0,1082.0,1137.0,1156.0,1206.0,12939.0
Valsad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1905.0,2068.0,2085.0,2058.0,2328.0,2379.0,2169.0,2338.0,2259.0,2377.0,2388.0,2477.0,26831.0
Valsad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1841.0,1931.0,2061.0,1995.0,2322.0,2326.0,2201.0,2353.0,2185.0,2241.0,2272.0,2471.0,26199.0
Valsad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1841.0,1928.0,2067.0,1995.0,2318.0,2333.0,2202.0,2352.0,2181.0,2234.0,2271.0,2473.0,26195.0
Valsad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,291.0,324.0,225.0,180.0,143.0,213.0,161.0,193.0,149.0,203.0,172.0,185.0,2439.0
Valsad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,270.0,326.0,234.0,188.0,132.0,209.0,142.0,186.0,146.0,177.0,155.0,159.0,2324.0
Valsad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,561.0,650.0,459.0,368.0,275.0,422.0,303.0,379.0,295.0,380.0,327.0,344.0,4763.0
Valsad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,784.0,954.0,1191.0,1895.0,4122.0,3395.0,1962.0,2301.0,2214.0,2291.0,1745.0,1755.0,24609.0
Valsad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,693.0,887.0,1045.0,1960.0,4997.0,3933.0,1841.0,2236.0,2311.0,2243.0,1779.0,1675.0,25600.0
Valsad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,859.0,1007.0,1248.0,1823.0,3943.0,3518.0,2255.0,2221.0,2333.0,2161.0,1430.0,1433.0,24231.0
Valsad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1439.0,1442.0,1442.0,1460.0,1428.0,1506.0,1505.0,1499.0,1509.0,1487.0,1545.0,1509.0,17771.0
Valsad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1430.0,1441.0,1436.0,1453.0,1422.0,1495.0,1498.0,1490.0,1444.0,1515.0,1543.0,1506.0,17673.0
Valsad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1343.0,1376.0,1351.0,1370.0,1349.0,1399.0,1413.0,1427.0,1387.0,1422.0,1454.0,1433.0,16724.0
Valsad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1921.0,2058.0,2115.0,2101.0,2609.0,2379.0,2183.0,2338.0,2329.0,2467.0,2380.0,2791.0,27671.0
Valsad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,14.0,9.0,0.0,8.0,1927.0,6152.0,2111.0,259.0,28.0,9.0,328.0,22471.0,33316.0
Valsad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,6.0,0.0,0.0,0.0,1567.0,6606.0,2235.0,231.0,0.0,0.0,286.0,22526.0,33457.0
Valsad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Valsad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,3.0
Valsad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,3.0,5.0,1.0,5.0,1.0,5.0,25.0
Valsad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1538.0,1546.0,1644.0,1853.0,2026.0,1853.0,1672.0,1623.0,1598.0,1758.0,1669.0,1705.0,20485.0
Valsad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,13.0,11.0,21.0,25.0,17.0,20.0,5.0,3.0,1.0,0.0,2.0,8.0,126.0
Valsad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,206.0,75.0,80.0,75.0,146.0,170.0,135.0,102.0,87.0,89.0,163.0,185.0,1513.0
Valsad,13.1,Number of Patients operated for cataract,TOTAL,237.0,136.0,91.0,315.0,205.0,316.0,116.0,234.0,267.0,252.0,120.0,293.0,2582.0
Valsad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,230.0,136.0,87.0,308.0,203.0,242.0,114.0,225.0,243.0,248.0,118.0,292.0,2446.0
Valsad,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,2.0,7.0,504.0,25.0,377.0,162.0,1102.0,1441.0,0.0,3620.0
Valsad,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,531.0,696.0,2453.0,0.0,3680.0
Valsad,13.5,Number of eyes collected through eye donation,TOTAL,12.0,10.0,14.0,16.0,12.0,10.0,4.0,12.0,18.0,20.0,11.0,16.0,155.0
Valsad,13.6,Number of eyes utilised for corneal transplant,TOTAL,12.0,10.0,14.0,16.0,12.0,10.0,4.0,12.0,18.0,20.0,11.0,16.0,155.0
Valsad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,9.0,11.0,9.0,7.0,6.0,5.0,6.0,5.0,5.0,4.0,7.0,-1.0
Valsad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,20.0,20.0,22.0,17.0,19.0,21.0,19.0,16.0,20.0,16.0,17.0,16.0,-1.0
Valsad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,900.0,880.0,871.0,909.0,1071.0,879.0,881.0,915.0,862.0,920.0,870.0,932.0,-1.0
Valsad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,8.0,10.0,9.0,7.0,7.0,5.0,6.0,7.0,8.0,5.0,8.0,-1.0
Valsad,14.05,Number of RKS meetings held during the month,TOTAL,7.0,13.0,14.0,14.0,11.0,13.0,12.0,11.0,19.0,13.0,14.0,14.0,155.0
Valsad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,32.0,31.0,36.0,26.0,26.0,30.0,25.0,28.0,30.0,29.0,28.0,31.0,-1.0
Valsad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,345.0,343.0,322.0,277.0,365.0,374.0,354.0,356.0,427.0,401.0,336.0,365.0,4265.0
Valsad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,6.0,8.0,5.0,5.0,6.0,5.0,7.0,5.0,8.0,5.0,5.0,-1.0
Valsad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,8.0,6.0,6.0,0.0,7.0,1.0,6.0,6.0,7.0,6.0,6.0,7.0,-1.0
Valsad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,542.0,534.0,761.0,921.0,982.0,917.0,808.0,1718.0,1524.0,1356.0,1457.0,1295.0,12815.0
Valsad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1907.0,1868.0,2439.0,2355.0,2425.0,2747.0,2448.0,1398.0,1408.0,1338.0,1422.0,2308.0,24063.0
Valsad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,585.0,493.0,1235.0,827.0,928.0,899.0,748.0,1505.0,1604.0,1503.0,1157.0,1280.0,12764.0
Valsad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3000.0,3026.0,3305.0,3554.0,4033.0,4458.0,3795.0,3338.0,3611.0,3700.0,2891.0,4637.0,43348.0
Valsad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1127.0,1027.0,1996.0,1748.0,1910.0,1816.0,1556.0,3223.0,3128.0,2859.0,2614.0,2575.0,25579.0
Valsad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4907.0,4894.0,5744.0,5909.0,6458.0,7205.0,6243.0,4736.0,5019.0,5038.0,4313.0,6945.0,67411.0
Valsad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,44.0,50.0,44.0,41.0,47.0,69.0,65.0,66.0,70.0,102.0,84.0,81.0,763.0
Valsad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,32.0,22.0,27.0,28.0,34.0,63.0,58.0,41.0,40.0,63.0,54.0,61.0,523.0
Valsad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,76.0,72.0,71.0,69.0,81.0,132.0,123.0,107.0,110.0,165.0,138.0,142.0,1286.0
Valsad,14.11,In-Patient Head Count at midnight,TOTAL,2356.0,2570.0,2143.0,5464.0,6065.0,7104.0,6325.0,5364.0,2793.0,6450.0,6466.0,4015.0,57115.0
Valsad,14.12.1,OPD attendance (All),TOTAL,80376.0,82939.0,91802.0,99201.0,114624.0,119423.0,91075.0,90618.0,89901.0,92646.0,94864.0,96947.0,1144416.0
Valsad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,741.0,509.0,615.0,760.0,812.0,940.0,504.0,719.0,11480.0,1164.0,637.0,11958.0,30839.0
Valsad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,77.0,51.0,20.0,38.0,122.0,25.0,19.0,21.0,38.0,54.0,31.0,39.0,535.0
Valsad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1287.0,1030.0,1698.0,1264.0,1382.0,1763.0,1283.0,1051.0,1899.0,1345.0,1179.0,1457.0,16638.0
Valsad,14.14.a,Number of patients given AYUSH treatment,TOTAL,1501.0,1181.0,1487.0,1151.0,1656.0,1923.0,1211.0,1645.0,1069.0,793.0,1328.0,1408.0,16353.0
Valsad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,567.0,266.0,273.0,507.0,565.0,312.0,256.0,606.0,654.0,725.0,692.0,849.0,6272.0
Valsad,14.14.c,Number of Adolescents counselled,TOTAL,29.0,12.0,31.0,24.0,48.0,47.0,33.0,44.0,52.0,48.0,50.0,65.0,483.0
Valsad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9711.0,7820.0,11332.0,10331.0,13419.0,13250.0,10666.0,11412.0,11473.0,11361.0,12551.0,13446.0,136772.0
Valsad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,390.0,379.0,401.0,312.0,426.0,369.0,478.0,496.0,383.0,508.0,406.0,505.0,5053.0
Valsad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,590.0,680.0,856.0,1026.0,1069.0,1125.0,872.0,826.0,838.0,599.0,839.0,1035.0,10355.0
Valsad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,99.0,12.0,22.0,21.0,14.0,15.0,11.0,9.0,7.0,14.0,14.0,22.0,260.0
Valsad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,627.0,783.0,908.0,906.0,820.0,929.0,828.0,704.0,1029.0,879.0,778.0,848.0,10039.0
Valsad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,90.0,6.0,10.0,11.0,9.0,4.0,5.0,4.0,5.0,9.0,6.0,4.0,163.0
Valsad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1277.0,1000.0,1364.0,1007.0,1261.0,1216.0,1037.0,1125.0,1024.0,879.0,1070.0,1433.0,13693.0
Valsad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,148.0,5.0,2.0,66.0,19.0,10.0,11.0,2.0,4.0,33.0,26.0,7.0,333.0
Valsad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2494.0,2463.0,3128.0,2939.0,3150.0,3270.0,2737.0,2655.0,2891.0,2357.0,2687.0,3316.0,34087.0
Valsad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,337.0,23.0,34.0,98.0,42.0,29.0,27.0,15.0,16.0,56.0,46.0,33.0,756.0
Valsad,15.2,Number of Widal tests conducted,Number tested,436.0,637.0,699.0,933.0,1183.0,1280.0,1138.0,1367.0,927.0,1237.0,779.0,546.0,11162.0
Valsad,15.3.a,Number of VDRL tests conducted on males,Number tested,81.0,40.0,74.0,157.0,142.0,44.0,58.0,44.0,176.0,176.0,109.0,215.0,1316.0
Valsad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,238.0,171.0,133.0,172.0,175.0,101.0,58.0,29.0,144.0,121.0,187.0,131.0,1660.0
Valsad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,635.0,493.0,713.0,762.0,959.0,944.0,624.0,779.0,682.0,911.0,641.0,932.0,9075.0
Valsad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,954.0,704.0,920.0,1091.0,1276.0,1089.0,740.0,852.0,1002.0,1208.0,937.0,1278.0,12051.0
Valsad,15.4.1,Number of blood smears examined for Malaria,TOTAL,14427.0,20892.0,19969.0,28620.0,43621.0,29737.0,25334.0,20321.0,13449.0,14161.0,18486.0,21603.0,270620.0
Valsad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,230.0,197.0,195.0,359.0,268.0,177.0,61.0,60.0,25.0,10.0,56.0,63.0,1701.0
Valsad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,6.0,5.0,8.0,43.0,30.0,42.0,36.0,26.0,11.0,3.0,4.0,1.0,215.0
Valsad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,9810.0,4730.0,3020.0,5040.0,6770.0,7550.0,3850.0,6280.0,10180.0,3980.0,8120.0,10190.0,79520.0
Valsad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,2500.0,5000.0,12500.0,7500.0,5000.0,5000.0,10000.0,0.0,10000.0,10000.0,2500.0,70000.0
Valsad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,5080.0,4210.0,2980.0,10770.0,6720.0,8700.0,2570.0,6100.0,6200.0,5860.0,7930.0,4590.0,71710.0
Valsad,16.1.1,Stock position of DPT vaccines,5. Total Stock,4730.0,3020.0,5040.0,6770.0,7550.0,3850.0,6280.0,10180.0,3980.0,8120.0,10190.0,8100.0,77810.0
Valsad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,10480.0,12700.0,12300.0,16220.0,16080.0,6390.0,8060.0,7270.0,10570.0,3970.0,2760.0,3880.0,110680.0
Valsad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,12000.0,6000.0,12000.0,19000.0,0.0,9000.0,3000.0,9000.0,0.0,9000.0,9000.0,12000.0,100000.0
Valsad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,9780.0,6400.0,8080.0,19140.0,9690.0,7330.0,3790.0,5700.0,6600.0,10210.0,7880.0,5950.0,100550.0
Valsad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,12700.0,12300.0,16220.0,16080.0,6390.0,8060.0,7270.0,10570.0,3970.0,2760.0,3880.0,9930.0,110130.0
Valsad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,34360.0,30440.0,28780.0,23560.0,31470.0,16820.0,14760.0,13900.0,11920.0,258260.0,1800.0,7380.0,473450.0
Valsad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,10000.0,10000.0,39000.0,0.0,13000.0,7000.0,10000.0,256000.0,0.0,247000.0,10000.0,612000.0
Valsad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,13920.0,11660.0,15220.0,31090.0,14650.0,15060.0,7860.0,11980.0,9660.0,256460.0,241420.0,7890.0,636870.0
Valsad,16.1.2,Stock position of OPV vaccines,5. Total Stock,30440.0,28780.0,23560.0,31470.0,16820.0,14760.0,13900.0,11920.0,258260.0,1800.0,7380.0,9490.0,448580.0
Valsad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,16630.0,17140.0,19450.0,27100.0,32390.0,20150.0,12690.0,19740.0,21500.0,14300.0,9710.0,13980.0,224780.0
Valsad,16.1.3,Stock position of TT vaccines,2. Stocks Received,8000.0,8000.0,16000.0,32000.0,0.0,5000.0,10000.0,10000.0,0.0,5000.0,14000.0,20000.0,128000.0
Valsad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,7490.0,5690.0,8350.0,26710.0,12240.0,12460.0,2950.0,8240.0,7200.0,9590.0,9730.0,5590.0,116240.0
Valsad,16.1.3,Stock position of TT vaccines,5. Total Stock,17140.0,19450.0,27100.0,32390.0,20150.0,12690.0,19740.0,21500.0,14300.0,9710.0,13980.0,28390.0,236540.0
Valsad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,7790.0,7000.0,7900.0,7900.0,8330.0,4370.0,9480.0,7030.0,8120.0,4240.0,3360.0,5640.0,81160.0
Valsad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,5000.0,5000.0,10000.0,0.0,10000.0,0.0,5000.0,0.0,5000.0,10000.0,3000.0,58000.0
Valsad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,5790.0,4100.0,5000.0,9570.0,3960.0,4890.0,2450.0,3910.0,3880.0,5880.0,7720.0,4720.0,61870.0
Valsad,16.1.5,Stock position of BCG vaccines,5. Total Stock,7000.0,7900.0,7900.0,8330.0,4370.0,9480.0,7030.0,8120.0,4240.0,3360.0,5640.0,3920.0,77290.0
Valsad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,7650.0,2925.0,4035.0,10160.0,7260.0,6835.0,6375.0,8875.0,14320.0,10345.0,4050.0,5840.0,88670.0
Valsad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1000.0,4000.0,10000.0,10000.0,5000.0,5000.0,5000.0,10000.0,0.0,0.0,9000.0,10000.0,69000.0
Valsad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5725.0,2890.0,3875.0,12900.0,5425.0,5460.0,2500.0,4555.0,3975.0,6295.0,7210.0,8115.0,68925.0
Valsad,16.1.6,Stock position of Measles vaccines,5. Total Stock,2925.0,4035.0,10160.0,7260.0,6835.0,6375.0,8875.0,14320.0,10345.0,4050.0,5840.0,7725.0,88745.0
Valsad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1320.0,950.0,800.0,3940.0,10910.0,10310.0,9860.0,9310.0,8980.0,8380.0,6380.0,4480.0,75620.0
Valsad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,900.0,300.0,3900.0,9000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14100.0
Valsad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1270.0,450.0,760.0,2030.0,600.0,450.0,550.0,330.0,600.0,2000.0,1900.0,160.0,11100.0
Valsad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,950.0,800.0,3940.0,10910.0,10310.0,9860.0,9310.0,8980.0,8380.0,6380.0,4480.0,4320.0,78620.0
Valsad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,400.0,400.0,6400.0,2450.0,2450.0,2450.0,2450.0,2450.0,2450.0,,,0.0,21900.0
Valsad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,6000.0
Valsad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Valsad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,3950.0,0.0,0.0,0.0,0.0,0.0,2450.0,,,0.0,6400.0
Valsad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,400.0,6400.0,2450.0,2450.0,2450.0,2450.0,2450.0,2450.0,0.0,0.0,0.0,0.0,21500.0
Valsad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,1400.0,1400.0,77000.0,26600.0,26600.0,228200.0,0.0,0.0,0.0,,,0.0,361200.0
Valsad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,75600.0,0.0,0.0,201600.0,0.0,0.0,0.0,0.0,,,151200.0,428400.0
Valsad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Valsad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,50400.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,50400.0
Valsad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,1400.0,77000.0,26600.0,26600.0,228200.0,228200.0,0.0,0.0,0.0,0.0,0.0,151200.0,739200.0
Valsad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3000.0,3000.0,12000.0,0.0,0.0,12000.0,0.0,0.0,54000.0,,,0.0,84000.0
Valsad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,9000.0,0.0,0.0,12000.0,0.0,0.0,54000.0,0.0,,,0.0,75000.0
Valsad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Valsad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,12000.0,0.0,0.0,12000.0,0.0,0.0,54000.0,,,0.0,78000.0
Valsad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,3000.0,12000.0,0.0,0.0,12000.0,0.0,0.0,54000.0,0.0,0.0,0.0,0.0,81000.0
Valsad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,,,0.0,3000.0
Valsad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,,,0.0,3000.0
Valsad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Valsad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,,,0.0,3000.0
Valsad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0
Valsad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,2900.0,2900.0,2900.0,2900.0,2900.0,2900.0,2900.0,2900.0,2900.0,,,600.0,26700.0
Valsad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Valsad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Valsad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2300.0,,,600.0,2900.0
Valsad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,2900.0,2900.0,2900.0,2900.0,2900.0,2900.0,2900.0,2900.0,600.0,0.0,0.0,0.0,23800.0
Valsad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,225.0,225.0,225.0,7500.0,7500.0,7500.0,5500.0,5500.0,5500.0,,,0.0,39675.0
Valsad,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,7500.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,7500.0
Valsad,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Valsad,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,225.0,0.0,0.0,2000.0,0.0,0.0,5500.0,,,0.0,7725.0
Valsad,16.3.02,Stock Position of Gloves,5. Total Stock,225.0,225.0,7500.0,7500.0,7500.0,5500.0,5500.0,5500.0,0.0,0.0,0.0,0.0,39450.0
Valsad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,518000.0,518000.0,518000.0,98000.0,98000.0,2098000.0,152000.0,152000.0,651000.0,,,0.0,4803000.0
Valsad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,50000.0,2000000.0,0.0,0.0,500000.0,0.0,,,0.0,2550000.0
Valsad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Valsad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,420000.0,50000.0,0.0,1946000.0,0.0,1000.0,651000.0,,,0.0,3068000.0
Valsad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,518000.0,518000.0,98000.0,98000.0,2098000.0,152000.0,152000.0,651000.0,0.0,0.0,0.0,0.0,4285000.0
Valsad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Valsad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,0.0,,,0.0,1200.0
Valsad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,0.0,0.0,,,0.0,1200.0
Valsad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Valsad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,0.0,,,0.0,1200.0
Valsad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,0.0,0.0,0.0,0.0,0.0,1200.0
Valsad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,5700.0,5700.0,3700.0,14500.0,64500.0,64500.0,,,0.0,158600.0
Valsad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,14000.0,50000.0,0.0,42000.0,,,0.0,106000.0
Valsad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Valsad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,2000.0,3200.0,0.0,0.0,106500.0,,,0.0,111700.0
Valsad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,5700.0,3700.0,14500.0,64500.0,64500.0,0.0,0.0,0.0,0.0,152900.0
Valsad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,8360.0,4850.0,31950.0,29070.0,22070.0,18820.0,14470.0,12620.0,10470.0,8970.0,6470.0,2970.0,171090.0
Valsad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,29700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16500.0,46200.0
Valsad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3510.0,2600.0,2880.0,7000.0,3250.0,4350.0,1850.0,2150.0,1500.0,2500.0,3500.0,2066.0,37156.0
Valsad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4850.0,31950.0,29070.0,22070.0,18820.0,14470.0,12620.0,10470.0,8970.0,6470.0,2970.0,17404.0,180134.0
Valsad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,15600.0,135600.0,37400.0,157400.0,155400.0,155400.0,155200.0,34000.0,184000.0,44000.0,44000.0,44000.0,1162000.0
Valsad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,120000.0,0.0,120000.0,0.0,0.0,0.0,0.0,150000.0,0.0,0.0,0.0,0.0,390000.0
Valsad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,98200.0,0.0,2000.0,0.0,200.0,121200.0,0.0,140000.0,0.0,0.0,22931.0,384531.0
Valsad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,135600.0,37400.0,157400.0,155400.0,155400.0,155200.0,34000.0,184000.0,44000.0,44000.0,44000.0,21069.0,1167469.0
Valsad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5600.0,5600.0,25600.0,23700.0,9400.0,9400.0,9100.0,8900.0,8600.0,8400.0,8200.0,8200.0,130700.0
Valsad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0
Valsad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Valsad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,1900.0,14300.0,0.0,300.0,200.0,300.0,200.0,200.0,0.0,835.0,18235.0
Valsad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,5600.0,25600.0,23700.0,9400.0,9400.0,9100.0,8900.0,8600.0,8400.0,8200.0,8200.0,7365.0,132465.0
Valsad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,,1.0,,,1.0,,,3.0,,,6.0
Valsad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Valsad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Valsad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Valsad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,2.0,,,,,1.0,1.0,1.0,,1.0,6.0
Valsad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Valsad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,2.0,,,,,1.0,1.0,1.0,,1.0,6.0
Valsad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,5.0,3.0,2.0,1.0,10.0,2.0,4.0,1.0,2.0,3.0,1.0,1.0,35.0
Valsad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,1.0,1.0,,,1.0,,1.0,1.0,,1.0,7.0
Valsad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,6.0,3.0,3.0,2.0,10.0,2.0,5.0,1.0,3.0,4.0,1.0,2.0,42.0
Valsad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,4.0,2.0,1.0,9.0,2.0,1.0,,2.0,2.0,8.0,2.0,34.0
Valsad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,2.0,,1.0,1.0,,1.0,,,2.0,,1.0,8.0
Valsad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,6.0,2.0,2.0,10.0,2.0,2.0,,2.0,4.0,8.0,3.0,42.0
Valsad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,2.0,,2.0,1.0,1.0,,,,6.0
Valsad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Valsad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,2.0,,2.0,1.0,1.0,,,,6.0
Valsad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Valsad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Valsad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Valsad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Valsad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Valsad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Valsad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Valsad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Valsad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Valsad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,,5.0,2.0,6.0,2.0,1.0,3.0,2.0,3.0,3.0,3.0,33.0
Valsad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,,,1.0,3.0,3.0,3.0,,3.0,3.0,1.0,19.0
Valsad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,1.0,5.0,2.0,7.0,5.0,4.0,6.0,2.0,6.0,6.0,4.0,52.0
Valsad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Valsad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Valsad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Valsad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Valsad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,1.0,,,1.0,1.0,2.0,,,5.0
Valsad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Valsad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,,,1.0,,,1.0,1.0,2.0,,1.0,7.0
Valsad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,1.0,1.0,,1.0,,,,,,4.0
Valsad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Valsad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,1.0,1.0,1.0,,1.0,,,,,,4.0
Valsad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Valsad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Valsad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Valsad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Valsad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Valsad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,,,,,,,,,,,1.0
Valsad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Valsad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Valsad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,1.0,,,,,1.0
Valsad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,2.0,3.0,,1.0,2.0,5.0,4.0,4.0,5.0,1.0,,27.0
Valsad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,4.0,6.0,1.0,6.0,3.0,3.0,15.0,2.0,2.0,5.0,47.0
Valsad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,2.0,7.0,6.0,2.0,8.0,8.0,7.0,19.0,7.0,3.0,5.0,74.0
Valsad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,1.0,1.0,3.0,1.0,2.0,1.0,1.0,,1.0,11.0
Valsad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,1.0,,,,1.0,,,2.0
Valsad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,1.0,1.0,4.0,1.0,2.0,1.0,2.0,,1.0,13.0
Valsad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Valsad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Valsad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Valsad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Valsad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Valsad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Valsad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Valsad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Valsad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,1.0,,,,1.0
Valsad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Valsad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Valsad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Valsad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Valsad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Valsad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Valsad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,,,2.0,1.0,,,1.0,,,,5.0
Valsad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Valsad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,,,2.0,1.0,,,1.0,,,,5.0
Valsad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,4.0,,2.0,3.0,1.0,3.0,3.0,1.0,4.0,2.0,1.0,27.0
Valsad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,1.0,,,2.0,1.0,,4.0
Valsad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,4.0,,2.0,3.0,1.0,4.0,3.0,1.0,6.0,3.0,1.0,31.0
Valsad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,,,1.0,3.0,5.0,4.0,16.0,5.0,1.0,4.0,40.0
Valsad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,1.0,,1.0,1.0,,,,,4.0
Valsad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,,1.0,2.0,3.0,6.0,5.0,16.0,5.0,1.0,4.0,44.0
Valsad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,2.0,,,2.0,,,,,4.0
Valsad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Valsad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,2.0,,,2.0,,,,,4.0
Valsad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Valsad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,2.0,2.0,1.0,2.0,,,,,1.0,8.0
Valsad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,2.0,,,1.0,3.0,1.0,2.0,,1.0,1.0,,11.0
Valsad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,2.0,,2.0,3.0,4.0,4.0,2.0,,1.0,1.0,1.0,20.0
Valsad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Valsad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,3.0,3.0,2.0,2.0,2.0,1.0,,3.0,16.0
Valsad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,1.0,1.0,,,,,3.0,5.0
Valsad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,3.0,4.0,3.0,2.0,2.0,1.0,,6.0,21.0
Valsad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,,1.0,2.0,2.0,,,,,,6.0
Valsad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,18.0,5.0,9.0,8.0,18.0,1.0,15.0,9.0,10.0,10.0,20.0,8.0,131.0
Valsad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,20.0,18.0,19.0,21.0,59.0,22.0,46.0,39.0,59.0,44.0,33.0,24.0,404.0
Valsad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,38.0,23.0,29.0,29.0,78.0,25.0,63.0,48.0,69.0,54.0,53.0,32.0,541.0
